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Preface to CMB5
Details, goals, and hopes for teaching and learning
A grasp of the logic and practice of science is essential to understanding the world around
us. So, all editions/versions of CMB focus on experimental support for what we know
about cell and molecular biology, and on showing students the relationship of cell
structure and function. Rather than trying to be comprehensive reference, the book
selectively details investigative questions, methods and experiments that lead to our
understanding of cell biology. This focus is nowhere more obvious than in the chapter
learning objectives and in links to the author’s short YouTube voice-over PowerPoint
(VOP) videos. Numbered links to each of these VOPs are embedded near relevant text and
includes edited, optional closed captions. These are easily launched by clicking a playvideo symbol or descriptive title on a computer or tablet app or by using QR codes, as in
the example below:

102 Golgi Vesicles & the Endomembrane System
Other *external online resource links are all numbered. The numbers refer to the QR
codes for the links at the end of each chapter for use by students using a print edition or
printed pages from the digital text.
All digital (the Basic, Annotated, and Instructors CMB5e) as well as the hard-copy version
(the Annotated CMB5p) include these interactive features. In addition, the Annotated
CMB5e and CMB5p have Challenge boxes that typically include questions about
significant new science that is not necessarily definitive and still subject to confirmation.
Finally, the Instructors’ CMB5e adds interactive short 25 Words or Less short writing
assignments. The Instructors’ CMB5e is available on request. All interactive elements are
intended to expand on concepts discussed in the text. My hope is that that you will
engage and experience some of them. In writing and updating CMB, I tried to make it
user-friendly, current, and accurate. I invite you to use the interactive features of the iText
to think about:
•
•
•
•

how good and great experiments were inspired and designed.
how alternative experimental results were predicted.
how data was interpreted.
how investigators (and we!) arrive at the most interesting “next questions”.

Along the way, I hope active learning about cell and molecular biology will be an exciting
way to reinforce your critical thinking and writing skills across the board.

*External online resources links are active at the time of publication but may not remain
so in the future.
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A mission Statement
Ever since I wrote my first published research paper my goal was to make my science
clear enough to be read by anyone interested in biology. Finding jargon-free ways to
explain research is not always easy. Sometimes it involves metaphor or analogy and
sometimes it requires linguistic precision. I’ve heard that writers of fiction and truth
(novelists, storytellers, playwrights, poets…) spend a lot of time revising to make
themselves understood. So, I agree with Eve. L. Ewing, a poet, Professor of Sociology of
Education and Marvel comic writer, who said in an interview that academic writing is a
creative act (Toor, R. 2020, Scholars Talk Writing, The Chronical of Higher Education). I
have used interactive components of the early editions of CMB to create assessable
homework assignments in my flipped, blended Cell Biology course. CMB5 is the latest
edition, the product of many revisions, updates, additions, and corrections. In aggregate,
all editions and versions of CMB have been downloaded more than 60,000 times and have
been adopted or made recommended reading in college and even high school and
medical school courses in the U.S. and around the world. I would like to think that this
universal appeal is due to some measure of imagination, clarity, and creative effort.

Some Notes on Using CMB5e and CMB5p
If you are reading the hardcopy Annotated CMB5p iText, you can also download the
digital CMB5e version at https://dc.uwm.edu/ into your browser’s URL line. If your
instructor has uploaded a digital version of CMB5 to your course site, expect further
instructions on how you to access and use the book. CMB5p is an open access hardcopy
version of the Annotated CMB5e, for students that would like to study from a printed
book. It is virtually identical in content and format to its digital cousin. All numbered text
and QR code links should be active in the latest digital (CMB5e) versions. Hardcopy
readers, please use QR codes to access web links. Links to the author’s POVs should be
stable (please notify the author or your instructor at of any exceptions). On the other hand,
remember that links to external online resources that are active at the time of publication
may not remain so in the future.

Special to Instructors from the Author
The complete digital Instructors CMB5e iText is available at https://dc.uwm.edu/. To get
the complete Instructors CMB5e (with additional interactive features), you will need to fill
out a short questionnaire identifying yourself as an instructor, your institutional and
departmental affiliation, and course information (title, number). When you submit the form,
you will get pdf as well as MS-Word files for all digital versions of the iText. When you have
download the digital iText(s) of your choice, you should find it an easy matter to add, subtract,
modify or enhance any parts of it to suit your purposes (in accordance with the Creative
Commons CC-BY license under which it is published (Creative Commons — Attribution 4.0
International — CC BY 4.0). You are free to provide the original or a customized version to your
students as a small pdf file (recommended) or the larger MS-Word file. If students access a
digital iText through your CMS (Course Management System (e.g., Blackboard, D2L, Canvas),
you can link assignments to Discussion Fora, a DropBox, or Quiz directly in the iText. Of
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course, remember to provide instructions to students on how they should use the book in your
class! Here are a few notes on the versioning of CMB5.
1. If you modify the digital Annotated or Instructors’ versions, the index (which is not
dynamic) may no longer function as intended.
2. The Basic version of the digital iText has no index but can (like all versions) be searched
online or after downloading.
3. An interactive OER, low-cost print version of the Annotated CMB5 iText (CMB5p) is now
available for anyone that prefers a hardcopy textbook. CMB5p is still open access, with the
a Creative Commons CC-BY-NC-SA license (Creative Commons — AttributionNonCommercial-ShareAlike 4.0 International — CC BY-NC-SA 4.0).
4. And once again, please remember that links to external online resources that are active at
the time of publication may not remain so in the future.
Finally, to assist instructors (and even students!), Open Access, high resolution copies of the
images in this book are available. Click https://dc.uwm.edu/ and search Bergtrom.
I hope that you (and maybe even your students!) will enjoy customizing interactive elements
and digging into some of the more current research included in the latest edition of the CMB.
Above all, I hope that your students will achieve a better understanding of how scientists use
skills of inductive and inferential logic to ask questions and formulate hypotheses…, and how
they apply concept and method to testing those hypotheses.

Acknowledgements
I thank my erstwhile UW-M LTC (now CETL) colleagues Matthew Russell, Megan Haak,
Melissa Davey Castillo, Jessica Hutchings and Dylan Barth for ideas on how to make OER
content more interactive and engaging. Thanks to Ann Hanlon and all my Golda Meir
Library colleagues for enabling publication of all digital CMB versions on UW-M Digital
Commons. I am most grateful to Ms. M. Terry Bott for reviewing and vetting the images in
the book, confirming their public domain or Creative Commons license status. I also owe a
debt of gratitude to our departmental lab manager Jordan Gonnering for much hardware
and software assistance during the preparation of CMB5, including the print edition. I
also thank my copy editor at Elite Authors for her thorough and knowledgeable copyediting and the team at Index Busters for their patient effort that eased the path to
completion of the latest edition of my CMB textbook, especially the print edition. Last
among these, but not least, thank you to all the artists, educators and scientists who
generously gave Creative Commons license to others to use their work, without which this
book would have been impossible. They are individually listed in Appendix I herein.
Finally, I must acknowledge the University of Wisconsin-Milwaukee for the opportunity to
research and learn both science and pedagogy for more than 35 years. My UW-M
experience has left its mark on the content, concept and purpose all CMB editions and
versions.

An OER hardcopy (print) version of this Annotated CMB5e iText
(CMB5p) is available; search Bergtrom at
https://www.lulu.com/shop/.
vii

About the Author
Dr. Bergtrom is Professor (Emeritus) of Biological Sciences at the UW-Milwaukee and a
former Teaching and Learning consultant in the UW-M Center for Excellence in Teaching
and Learning. Scientific interests include cell, molecular and evolutionary biology.
Pedagogic interests include the use of technology to serve active and engaged teaching
and learning. He has taught face-to-face, fully online, blended and flipped classes. He also
developed and co-instructed Teaching with Technology, an interdisciplinary graduate
course for graduate students that might someday be teaching. In 40+ years of teaching
and research, he has tested and adopted pedagogically proven teaching technologies in
his courses. His scientific publications are supplemented by publications on active
learning in all teaching modes1-3. The first edition of his Cell and Molecular Biology–
What We Know & How We Found Out appeared in 20154. Further editions came out in
20165, 20186, 20197 and 20228, 9.
1. Bergtrom, G. (2006) Clicker Sets as Learning Objects. Int. J. Knowl. & Learn. Obj.

2:105-110. (http://www.ijello.org/Volume2/v2p105-110Bergtrom.pdf)
2. Bergtrom, G. (2009) On Offering a Blended Cell Biology Course. J. Res. Center Ed.

Tech. 5(1) (http://www.rcetj.org/?type=art&id=91609&)
.
3. Bergtrom, G. (2011) Content vs Learning: An Old Dichotomy in Science Courses. J.

Asynchr. Learning Networks 15:33-44 (http://jaln_v15n1_bergtrom.pdf)
4. Bergtrom, G. (2015) Cell and Molecular Biology: What We Know & How We Found Out
(CMB) (If necessary, please contact the author to access this “first” edition)
5. Bergtrom, G. (2016) Cell and Molecular Biology: What We Know & How We Found Out
(CMB2e).
6. Bergtrom, G. (2018) Cell and Molecular Biology: What We Know & How We Found Out
(CMB3e)
7. Bergtrom, G. (2020) Cell and Molecular Biology: What We Know & How We Found Out
(CMB4e)
8. Bergtrom, G. (2022) Cell and Molecular Biology: What We Know & How We Found Out
(Basic, Annotated and Instructors OER digital CMB5e versions, available at

https://dc.uwm.edu/biosci_facbooks_bergtrom/)
.
9. Bergtrom, G. (2022) Cell and Molecular Biology: What We Know & How We Found Out;

(the Annotated hardcover CMB5p; Search Bergtrom at https:Lulushop.com/

viii

Table of Chapters
Use these links to navigate CMB5e (an online version of CMB5p)
Preface

v

Chapter 1:

Cell Tour, Life’s Properties and Evolution, Studying Cells

Chapter 2:

Basic Chemistry, Organic Chemistry and Biochemistry

38

Chapter 3:

Details of Protein Structure

58

Chapter 4:

Bioenergetics

80

Chapter 5:

Enzyme Catalysis and Kinetics

92

Chapter 6:

Glycolysis, the Krebs Cycle and the Atkins Diet

108

Chapter 7:

Electron Transport, Oxidative Phosphorylation and Photosynthesis

133

Chapter 8:

DNA Structure, Chromosomes and Chromatin

152

Chapter 9:

Details of DNA Replication & DNA Repair

177

Chapter 10:

Transcription and RNA Processing

204

Chapter 11:

The Genetic Code and Translation

231

Chapter 12:

Regulation of Transcription and Epigenetic Inheritance

251

Chapter 13:

Posttranscriptional Regulation of Gene Expression

282

Chapter 14:

Repetitive DNA, A Eukaryotic Genomic Phenomenon

306

Chapter 15:

DNA Technologies

338

Chapter 16:

Membrane Structure

377

Chapter 17:

Membrane Function

400

Chapter 18:

The Cytoskeleton and Cell Motility

445

Chapter 19:

Cell Division and the Cell Cycle

480

Chapter 20:

The Origins of Life

510

Epilogue

1

545

Appendix I:

List of Figures & Sources

551

Appendix II:

Context-Embedded YouTube Videos

577

INDEX

587

ix

Table of Contents
Use these links to navigate CMB5e (an online version of CMB5p)
Preface

v

Chapter 1:
Cell Tour, Life’s Properties and Evolution, Studying Cells
1.1 Introduction
1.2 Scientific Method – The Practice of Science
1.2.1
The Method as it is Really Practiced
1.2.2
Logic and the Origins of the Scientific Method
1.3 Domains of Life
1.3.1
Viruses: Dead or Alive; Big and Small; A History of Surprises
1.3.2
The Prokaryotes (Eubacteria = Bacteria and Cyanobacteria)
Bacterial Reproduction
Cell Motility and the Possibility of a Prokaryotic Cytoskeleton
Some Bacteria Have Internal Membranes
Bacterial Ribosomes Do the Same Thing as Eukaryotic Ribosomes…
and Look Like Them!
1.3.3
The Archaebacteria (Archaea)
1.3.4
The Eukaryotes
1.4 Tour of the Eukaryotic Cell
1.4.1
The Nucleus
Structure of the Interphase Nucleus
Every Cell (i.e., Nucleus) of an Organism Contains the Same Genes
1.4.2
Ribosomes
1.4.3
Internal Membranes and the Internal Membrane System
1.4.4
Mitochondria and Plastids
1.4.5
Cytoskeletal Structures
1.5 How we Know Functions of Organelles and Cell Structures: Cell Fractionation
1.6 The Origins, Evolution, Speciation, Diversity and Unity of Life
1.6.1
Random Acts of Genetic Variation, the Basis of Natural Selection
1.6.2
The Genome: An Organism’s Complete Genetic Instructions
1.6.3
Genomic ‘Fossils’ Can Confirm Evolutionary Relationships
1.7 Microscopy Reveals Life’s Diversity of Structure and Form
1.7.1
Light Microscopy
1.7.2
Electron Microscopy

1
1
3

Chapter 2:
Basic Chemistry, Organic Chemistry and Biochemistry
2.2 Introduction
2.2 Atoms and Basic Chemistry
2.2.1
Overview of Elements and Atoms
2.2.2
Electron Configuration – Shells and Subshells
2.3 Chemical Bonds
2.3.1
Covalent bonds
2.3.2
Ionic Bonds
2.3.3
Hydrogen Bonds
2.4 Water Chemistry
2.5 Basic Biochemistry: Monomers, Polymers, Macromolecular Synthesis,
Degradation
2.5.1
Isomerism in Organic Molecules and the Diversity of Shape
2.5.2
Monomers to Polymers and Back: Dehydration Synthesis and Hydrolysis
2.5.3
A Tale of Chirality Gone Awry

x

7

16

27
29

33

38
38
40
43

46
48

Chapter 3:
Details of Protein Structure
3.1 Introduction
3.2 Levels (Orders) of Protein Structure
3.2.1
Protein Primary Structure; Amino Acids and the C-N-C-N-… Polypeptide
Backbone Formation of peptide bonds leads to polypeptide primary structure
Determining Protein Primary Structure - Polypeptide Sequencing
3.2.2
Protein Secondary Structure
3.2.3
Protein Tertiary Structure
3.3 Changes in Protein Shape Can Cause Disease
3.3.1
Sickle Cell Anemia
3.3.2
The Role of Misshapen and Mis-folded Proteins in Alzheimer’s Disease
The amyloid beta (A ) peptide
Relatives of Alzheimer’s Disease
3.4 Protein Quaternary Structure, Prosthetic Groups Chemical Modifications
3.5 Domains, Motifs, and Folds in Protein Structure
3.6 Proteins, Genes and Evolution: How Many Proteins are We?
3.7 Directed Evolution: Getting Cells to Make New Proteins for our use and pleasure
3.8 View Animated 3D Protein Images in the NCBI Database

58
58
60

Chapter 4:
Bioenergetics
4.1 Introduction
4.2 Kinds of Energy
4.3 Deriving Simple Energy Relationships
4.3.1
Energy in the Universe: the Universe is a Closed System
4.3.2
Energy is Exchanged Between Systems in the Universe
4.3.3
How is Enthalpy Change ( H) Determined?
4.3.4
How is Standard Free Energy Change ( G0) Determined?
4.3.5
Working an Example Using These Equations for Closed Systems
4.4 Summary: The Properties of Closed Systems
4.5 Open Systems and Actual Free Energy Change

80
80
81
82

Chapter 5:
Enzyme Catalysis and Kinetics
5.1 Introduction
5.2 Enzymes and the Mechanisms of Enzyme Catalysis
5.2.1
Structural Considerations of Catalysis
5.2.2
Energetic Considerations of Catalysis
5.3 Enzyme Regulation
5.4 Enzyme Kinetics
5.4.1
Why Study Enzyme Kinetics
5.4.2
How We Determine Enzyme Kinetics and Interpret Kinetic Data

92
92
94

66

72
73
74
75
76

89
89

99
101

Chapter 6:
Glycolysis, the Krebs Cycle and the Atkins Diet
6.1 Introduction
6.2 Glycolysis, a Key Pathway in Energy Flow through Life
6.3 Some Details of Glycolysis
6.3.1
Glycolysis, Stage 1
6.3.2
Glycolysis, Stage 2
6.4 A Chemical and Energy Balance Sheet for Glycolysis
6.5 Gluconeogenesis
6.6 The Atkins Diet and Gluconeogenesis
6.7 The Krebs/TCA/Citric Acid Cycle

108
108
110
114

Chapter 7:
Electron Transport, Oxidative Phosphorylation and Photosynthesis
7.1 Introduction
7.2 Electron Transport Chains

133
133
134

xi

122
123
127
128

7.3
7.4
7.5

Electron Transport in Respiration
Oxidative Phosphorylation in Respiration
Photosynthesis
7.5.1
The Light-Dependent Reactions
7.5.2
The Light-Independent (“Dark” Reactions”)
C3 Photosynthesis - Light-Independent Reactions
CAM Photosynthetic Pathway - Light-Independent Reactions
C4 Photosynthetic Pathway - Light-Independent Reactions
On the Origins and Evolution of Respiration and Photosynthesis

134
136
139

Chapter 8:
DNA Structure, Chromosomes and Chromatin
8.1 Introduction
8.2 The Stuff of Genes
8.2.1
Griffith’s Experiment
8.2.2
The Avery-MacLeod-McCarty Experiment
8.2.3
The Hershey-Chase Experiment
8.3 DNA Structure
8.3.1
X-Ray Crystallography and the Beginnings of Molecular Biology
8.3.2
Wilkins, Franklin, Watson & Crick – DNA Structure Revealed
8.3.3
Meselson and Stahl’s Experiment – Replication is Semiconservative
8.4 Chromosomes
8.5 Genes and Chromatin in Eukaryotes
8.6 Structure and Organization of Bacterial DNA... and Bacterial Sex
8.7 Phage Can Integrate Their DNA Into the Bacterial Chromosome

152
152
153

Chapter 9:
Details of DNA Replication & DNA Repair
9.1 Introduction
9.2 DNA Replication
9.2.1
Visualizing Replication and Replication Forks
9.2.2
Visualizing Bidirectional Replication
9.3 DNA Polymerases Catalyze Replication
9.4 The Process of Replication
9.4.1
Initiation
9.4.2
Elongation
9.4.3
Termination
9.4.4
Is Replication Processive?
9.4.5
One more Problem with Replication
9.5 DNA Repair
9.5.1
Germline vs Somatic Mutations; A Balance Between Mutation
and Evolution
9.5.2
What Causes DNA Damage?
9.6 Molecular Consequences of Uncorrected DNA Damage
9.6.1
Depurination
9.6.2
Pyrimidine Dimerization
9.6.3
Deamination
9.7 DNA Repair Mechanisms
9.7.1
Base Excision Repair
9.7.2
Nucleotide Excision Repair
9.7.3
Mismatch Repair
9.7.4
Transcription Coupled Repair (in Eukaryotes)
9.7.5
Non-homologous End-Joining
9.7.6
Homologous Recombination
Repair of a Single-Stranded Break
Repair of a Double-Stranded Break

177
177
178

7.6

xii

150

159

164
166
171
175

181
183

192

194

196

Chapter 10: Transcription and RNA Processing
10.1 Introduction
10.2 Overview of Transcription
10.2.1 The Major Types of Cellular RNA
10.2.2 Key Steps of Transcription
10.2.3 RNAs are Extensively Processed after Transcription in Eukaryotes
10.3 Details of Transcription
10.3.1 Details of Transcription in Prokaryotes
10.3.2 Details of Transcription in Eukaryotes
Eukaryotic mRNA Transcription
Eukaryotic tRNA and 5SRNA Transcription
Transcription of the Other Eukaryotic rRNAs
10.4 Details of mRNA Processing in Eukaryotic nuclei
10.4.1 Spliceosomal Introns
10.4.2 Specific Nuclear Body Proteins Facilitate SnRNP Assembly and
Function
10.4.3 Group I and Group II Self-Splicing Introns
10.4.4 So, Why Splicing?
10.4.5 5-Prime Capping
10.4.6 3-Prime Polyadenylation
10.5 Ribosomal RNA Processing in Eukaryotic Nuclei
10.6 tRNA Processing in Eukaryotic Nuclei
10.7 Export of mRNA and Ribosomes from the Nucleus

204
204
205

Chapter 11: The Genetic Code and Translation
11.1 Introduction
11.2 Overview of the Genetic Code
11.2.1 The (Nearly) Universal, Degenerate Genetic Code
11.2.2 Comments on the Nature and Evolution of Genetic Information
11.3 Gene and Protein Colinearity and Triplet Codons
11.3.1 Colinearity of Gene and Protein
11.3.1 How is a Linear Genetic Code ‘Read’ to Account for All of An
Organisms’ Genes?
11.4 Breaking the Genetic Code
11.5 Translation
11.5.1 Even Before Initiation - Making Aminoacyl-tRNAs
11.5.2 Translation Initiation
11.5.3 Translation Elongation
Translation Elongation-1
Translation Elongation-2
Translation Elongation-3
11.5.4 Translation Termination
11.6 How Can the Genetic Code be Degenerate and Accurate at the Same Time?

231
231
233

Chapter 12: Regulation of Transcription and Epigenetic Inheritance
12.1 Introduction
12.2 Gene Regulation in Prokaryotes: the Lactose (lac) Operon
12.2.1 Working Out Regulation of the Lactose (lac) Operon in E. coli
12.2.2 Negative Regulation of the lac Operon by Lactose
12.2.3 Positive Regulation of the Lac Operon; Induction by Catabolite
Activation
12.2.4 Lac Operon Regulation by Inducer Exclusion
12.2.5 Structure of the lac Repressor Protein and Additional Operator
Sequences

251
251
252

xiii

211

218

224
226
227

235

238
241

250

12.3 Gene Regulation in Prokaryotes: the Tryptophan (trp) Operon
12.4 The Problem with Unregulated (Housekeeping) Genes in All Cells
12.5 Gene Regulation in Eukaryotes
12.5.1 Complexities of Eukaryotic Gene Regulation
12.5.2 Regulation of Gene Expression by Hormones that Enter Cells and
Those That Don’t
How Steroid Hormones Regulate Transcription
How Protein Hormones Regulate Transcription
12.6 Regulating all the Genes on a Chromosome at Once
12.7 Mechanoreceptors: Capturing Non-Chemical Signals
12.8 Epigenetics
12.9.1 Epigenetic Inheritance in Somatic Cells
12.9.2 Epigenetic Inheritance in the Germ-Line

261
262
263

Chapter 13: Posttranscriptional Regulation of Gene Expression
13.1 Introduction
13.2 Posttranscriptional Control of Gene Expression
13.2.1 Riboswitches
13.2.3 CRISPR/Cas: a Prokaryotic Adaptive Immune System
The CRISPR/Cas ‘Immune’ Response
Using CRISPR/Cas to Edit/Engineer Genes
CRISPR…, the Power and the Controversy
13.2.3 The Small RNAs: miRNA and siRNA in Eukaryotes
Small Interfering RNA (siRNA)
Micro RNAs (miRNA)

282
282
283

13.3
13.4
13.5

13.6

Piwi-Interacting RNAs
13.2.4 Long Non-Coding RNAs
13.2.5 Circular RNAs (CircRNA)
“Junk DNA” in Perspective
The RNA Methylome
Eukaryotic Translation Regulation
13.5.1 Specific Translation Control by mRNA Binding Proteins
13.5.2 Coordinating Heme and Globin Synthesis
13.5.3 Translational Regulation of Yeast GCN4
Protein Turnover in Eukaryotic Cells: Regulating Protein Half-Life

Chapter 14: Repetitive DNA, A Eukaryotic Genomic Phenomenon
14.1 Introduction
14.2 The Complexity of Genomic DNA
14.1.1 The Renaturation Kinetic Protocol
14.2.2 Renaturation Kinetic Data
14.2.3 Genomic Complexity
14.2.4 Functional Differences between Cot Classes of DNA
14.3 The ‘Jumping Genes’ of Maize
14.3.1 Discovering the Genes of Mosaicism; the Unstable Ds Gene
14.3.2 The Discovery of Mobile Genes: the Ac/Ds System
14.4 Since McClintock: Transposons in Bacteria, Plants and Animals
14.4.1 Bacterial Insertion Sequences (IS Elements)
14.4.2 Composite Bacterial Transposons: Tn Elements
14.4.3 ComplexTransposons that Can Act Like Bacteriophage
14.5 Overview of Eukaryotic Transposable Elements
14.6 The Structure of Eukaryotic DNA (Class II) Transposons
14.6.1 Cut-and-Paste Transposition
14.6.2 Replicative Transposition

xiv

273
274
275

295
295
296

302
306
306
307

312
317

321
323

14.7 The Structure of Eukaryotic RNA (Class I) Transposons
14.7.1 LTR retrotransposons: The Yeast Ty element
14.7.2 Non-LTR Retrotransposons: LINEs
14.7.3 Non-LTR Retrotransposons: LINEs
14.8 Mechanisms of Retrotransposition
14.8.1 Extrachromosomally Primed Retrotransposition (e.g., of a LINE)
14.8.2 Target-Site Primed SINE Retrotransposition (e.g., of a SINE)
14.9 On the Evolution of Transposons, Genes and Genomes
14.9.1 A Common Ancestry DNA and RNA (i.e., All) Transposons
14.9.2 Retroviruses and LTR Retrotransposons Share a Common Ancestry
14.9.3 Transposons Can Be Acquired by Horizontal Gene Transfer
14.10 Evolutionary Roles of Transposition in Genetic Diversity
14.10.1 Transposons and Exon Shuffling
14.10.2 Transposon Genes and Immune System Genes Have History
14.11 Coping with the Dangers of Rampant Transposition

325

Chapter 15: DNA Technologies
15.1 Introduction
15.2 Make and Screen a cDNA Library
15.2.1 cDNA Construction
15.2.2 Cloning cDNAs into plasmid vectors
15.2.3 Preparing recombinant plasmid vectors containing cDNA inserts
15.2.4 Recombining plasmids and cDNA inserts and transforming host cells
15.3 DNA sequencing
15.3.1 Manual DNA Sequencing
15.3.2 Automated First Generation DNA Sequencing
15.3.3 Shotgun Sequencing
15.3.4 Next Generation DNA Sequencing
15.4 Genomic Libraries
15.4.1 Preparing Specific Length Genomic DNA for Cloning; the Southern Blot
15.4.2 Recombining Size-Restricted Genomic DNA with Phage DNA
15.4.3 Creating Infectious Viral Particles with Recombinant phage DNA
15.4.4 Screening a Genomic Library; Titering Recombinant Phage Clones
14.4.5 Screening a Genomic Library; Probing the Genomic Library
15.4.6 Isolating the Gene
15.5 The Polymerase Chain Reaction (PCR)
15.5.1 PCR – the Basic Process
15.5.2 The Many Uses of PCR
15.6 Genomic Approaches: The DNA Microarray
15.7 Ome-Sweet-Ome
15.8 From Genetic Engineering to Genetic Modification

338
338
340

Chapter 16: Membrane Structure
16.1 Introduction
16.2 Plasma Membrane Structure
16.2.1 The Phospholipid Bilayer
16.2.2 Models of Membrane Structure
16.2.3 Evidence for Membrane Structure
16.2.4 Chemical Factors Affecting Membrane Fluidity
16.2.5 Making and Experimenting with Artificial Membranes
16.2.6 Separate Regions of a Plasma Membrane with Unique Fluidity and
Permeability Properties
16.3 Membrane Proteins
16.4 A Diversity of Membrane Protein Functions
16.5 Glycoproteins and Glycolipids

377
377
378

xv

327
329

334
336

350

357

364
368
371
372

389
392
394

16.6 Glycoproteins and Human Health

396

Chapter 17: Membrane Function
17.1 Introduction
17.2 Membrane Transport
17.2.1 Passive Diffusion of Solutes
17.2.2 Facilitated Diffusion of Solutes and Ions
Carrier Proteins
Ion Channels
17.3 Osmosis
17.3.1 Osmosis in Plant and Animal Cells
17.3.2 Osmosis in Plant Life
17.3.3 Osmosis in Animal Life
17.3.4 Summing Up
17.4 Active Transport
17.5 Ligand and Voltage Gated Channels in Neurotransmission
17.5.1 Measuring Ion Flow and Membrane Potential with a
Patch-Clamp Device
17.5.2 Ion Channels in Neurotransmission
17.6 Endocytosis and Exocytosis
17.6.1 Endocytosis
17.6.2 Exocytosis and the Formation of Protein Storage Organelles
17.7 Directing the Traffic of Proteins in Cells
17.7.1 Proteins Packaged in RER are Made as Larger Precursor Proteins
17.7.2 Testing the Signal Hypothesis for Packaging Secreted Protein in RER
17.8 Synthesis of Integral Membrane Proteins
17.9 Moving and Sorting Proteins to Their Final Destinations
17.9.1 Traffic on the Endomembrane Highway
17.9.2 Nuclear Protein Traffic
17.9.3 Mitochondrial Protein Traffic
17.10 How Cells are Held Together and How They Communicate
17.10.1 Cell Junctions
17.10.2 Microvesicles and Exosomes
17.10.3 Cancer and Cell Junctions
17.11 Signal Transduction
17.11.1 G-Protein Mediated Signal Transduction by PKA (Protein Kinase A)
17.11.2 Signal Transduction using PKC (Protein Kinase C)
17.11.3 Receptor Tyrosine Kinase-Mediated Signal Transduction
17.12 Signal Transduction in Evolution

400
400
402

Chapter 18: The Cytoskeleton and Cell Motility
18.1 Introduction
18.2 Overview of Cytoskeletal Filaments and Tubules
18.3 The Molecular Structure and Organization of Cytoskeletal Components
18.4 Microtubules: Dynamic Structures Composed of Tubulin Monomers
18.4.1 The Two Kinds of Microtubules in Spindle Fibers
Kinetochore Microtubules
Polar Microtubules
18.4.2 Microtubules in Cilia and Flagella
18.4.3 Microtubule Motor Proteins Move Cargo from Place to Place in Cells
18.4.4 Demonstrating Sliding Microtubules
18.4.5 The Motor Protein Dynein Enables Axonemes to Bend
18.5 Microfilaments – Structure and Role in Muscle Contraction
18.5.1 The Thin (Micro-) Filaments and Thick Filaments of Skeletal Muscle
18.5.2 The Sliding Filament Model of Skeletal Muscle Contraction

445
445
446
447
449

xvi

406

411
413

417
421
424
425

430

435

442

458

18.5.3 The Contraction Paradox: Contraction and Relaxation Require ATP
Actin-Myosin Interactions In Vitro: Dissections and Reconstitutions
Allosteric Change and the Microcontraction Cycle
The Microcontraction Cycle Resolves the Contraction Paradox
Ca++ Ions Regulate Skeletal Muscle Contraction
18.9.1 Muscle Contraction Generates Force
18.9.2 The Elastic Sarcomere: Do Myosin Rods Just Float in the Sarcomere?
18.10 Actin Microfilaments in NonMuscle Cells
18.11 Both Actins and Myosins are Encoded by Large Gene Families
18.12 Intermediate Filaments
18.6
18.7
18.8
18.9

461
466
467
468
474
476
477

Chapter 19: Cell Division and the Cell Cycle
19.1 Introduction
19.2 Cell Division in a Prokaryote
19.3 Cell Division in Eukaryotes
19.3.1 Defining the Phases of the Eukaryotic Cell Cycle
19.3.2 When Cells Stop Dividing…
19.4 Regulation of the Cell Cycle
19.4.1 Discovery and Characterization of Maturation Promoting Factor (MPF)
19.4.2 Other Cyclins, CDKs and Cell Cycle Checkpoints
The G1 Checkpoint
The G2 Checkpoint
The M Checkpoint
The Go State
19.5 When Cells Die
19.6 Disruption of the Cell Cycle Checkpoints Can Cause Cancer
19.7 p53 Protein Mediates Normal Cell Cycle Control
19.7.1 p53 is a DNA-Binding Protein
19.7.2 How p53 Works to Salvage Cells
19.7.3 How p53 Works When Cells Can’t be Saved
19.8 The Centrality of p53 Action in Cell Cycle Regulation
19.8.1 ‘Oncogenic Viruses’
19.8.2 p53 and Signal Transduction
19.9 Cancer Cell Growth and Behavior; Cancer Treatment Strategies
19.9.1 Cancer Cell Origins, Growth and Behavior
19.9.2 Cancer Treatment Strategies

480
480
481
482

Chapter 20: The Origins of Life
20.1 Introduction
20.2 Thinking about Life’s Origins: A Short Summary of a Long History
20.3 Formation of Organic Molecules in an Earthly Reducing Atmosphere
20.3.1 Origins of Organic Molecules and a Primordial Soup
20.3.2 The Tidal Pool Scenario for an Origin of Polymers and Replicating
Chemistries
20.4 Origins of Organic Molecules in a NON-Reducing Atmosphere
20.4.1 Panspermia – an Extraterrestrial Origin of Earthly Life
20.4.2 Extraterrestrial Origins of Organic molecules
20.5 Organic Molecular Origins of Life Closer to Home
20.5.1 Origins in a High-Heat Hydrothermal Vent (Black Smoker)
20.5.2 Origins in an Alkaline Deep-Sea Vent (White Smoker)
20.6 Heterotrophs-First vs Autotrophs-First: Some Evolutionary Considerations
20.7 Life Origins, A Summing Up
20.8 Origins of Life Chemistries in an RNA World
20.9 Experimental Evidence for an RNA World
20.10 Molecules Talk: Selecting Molecular Communication and Complexity

510
510
515
516

xvii

488

495
497
498

503
504

520
522
526
527
528
530
531

20.10.1 Intermolecular Communication: Establishment of Essential
Interconnected Chemistries
20.10.2 Origins of Coordination
20.10.3 An RNA World: Origins of Information Storage and Retrieval
30.10.4 From Self-Replicating RNAs to Ribozymes to Enzymes; From RNA to DNA
Ribozymes Branch Out: Replication, Transcription and Translation
Transfer of Information Storage from RNA to DNA
20.11 The Evolution of Biochemical Pathways
20.12 A Grand Summary and Some Conclusions

540
541

Epilogue

545

Appendix I:

List of Figures and Sources

551

Appendix II:

Context-Embedded YouTube Videos

577

INDEX

587

xviii

xix

Chapter 1

Cell Tour, Life’s Properties and Evolution,
Studying Cells

Life’s domains, scientific method, cell structures, Study methods (microscopy, cell fractionation,
functional analyses); Common ancestry, Genetic variation, Evolution, Species diversity
Reminder: For inactive links, google key words/terms for alternative resources.

CELLS: Left, Robert Hooke’s drawing of cork slices seen through a microscope from his 1665
Micrographia; Right, a monk’s cell.

1.1

Introduction

You will read in this book about experiments that revealed secrets of cell and molecular
biology, many of which earned their researchers Nobel and other prizes. But let’s begin here
with a Tale of Roberts, two among many giants of science in the renaissance and age of
enlightenment whose seminal studies came too early to win such coveted prizes.
One of these, Robert Boyle, was born in 1627 to wealthy, aristocrat parents. In his
teens, after the customary Grand Tour of renaissance Europe (France, Greece, Italy…) and
the death of his father, he returned to England in 1644, heir to great wealth. In the mid
1650s he moved from his estates where he had already set about studying physics and
chemistry, to Oxford. There he built a laboratory with his own money to do experiments on
the behavior of gasses under pressure. With some help, he discovered Boyle’s Law,
confirming that the gasses obey mathematical rules. He is also credited with showing that
light could travel through a vacuum, that something in air enables combustion, that sound
travels through air in waves, that heat and particulate motion were related, and that the
practice of alchemy was bogus! In fact, Boyle pretty much converted alchemy to chemistry by
performing chemical analysis, a term he coined.
As a chemist, he also rejected the old Greek concept of the elements: earth, air, fire,
and water. Instead, he defined elements as we still do today: the element is the smallest
component of a substance that cannot be further chemically subdivided. He did this a century
before Antoine Lavoisier listed and defined the first elements! Based on his physical studies
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and chemical analyses, Boyle even believed that the indivisible units of elements were atoms,
and that the behavior of elements could be explained by the motion of atoms. Finally, Boyle
codified in print the scientific method that made him a successful experimental scientist.
The second of our renaissance Roberts was Robert Hooke, born in 1635. In contrast to
Boyle parents, Hooke’s parents were of modest means. They managed nonetheless to nurture
their son’s interest in things mechanical. While he never took the Grand Tour, he learned well
and began studies of chemistry and astronomy at Christ Church College, Oxford in 1653. To
earn a living, he took a position as Robert Boyle’s assistant. It was with Hooke’s assistance that
Boyle did the experiments leading to the formulation of Boyle’s Law.
While at Oxford, he made other friends and useful connections. One friend was the
architect Christopher Wren. In 1662, Boyle, a founding member of the Royal Society of
London, supported Hooke to become the society’s curator of experiments. However, to support
himself, Hooke also hired on as professor of geometry at Gresham College (London). After “the
great fire” of London in 1666, Hooke, as city surveyor and builder, participated with
Christopher Wren in the design and reconstruction of the city. Ever interested in things
mechanical, he also studied the elastic property of springs, leading him to Hooke’s Law,
namely that the force required to compress a spring was proportional to the length that the
spring was compressed. Later, these studies led Hooke to imagine how a coil spring might
substitute for a pendulum to regulate a clock. While he never invented such a clock, he was
appointed to a Royal Commission to find the first reliable method to determine longitude at
sea. He must have been gratified to know that the solution to accurate determination of
longitude at sea turned out to involve a coil-spring clock! Along the way in his ‘practical’
studies, he also looked at little things, publishing his observations in Micrographia in 1665.
Therein he described microscopic structures of animal parts and even snowflakes. He also
described fossils as having once been alive and compared microscopic structures he saw in
thin slices of cork to monk’s cells (rooms, chambers) in a monastery. Hooke is best
remembered for his law of elasticity and of course, for coining the word cell, which we now
know as the smallest unit of living things.
Now fast-forward almost 200 years to observations of plant and animal cells early in
the nineteenth century. These observations revealed structural features common to all cells
including a nucleus and a boundary (membrane or wall) and the common organization of
cells in groups to form multicellular structures in lower life forms as well as in plants and
animals. By the 1830s an enriched understanding of cell structure and the role of cells in the
structure of animals and plants led botanist Matthias Schleiden and zoologist Theodor
Schwann to propose the first two precepts of a unified Cell Theory:(1) Cells are the basic
unit of living things; (2) Cells can have an independent existence. Later in the century, when
Louis Pasteur finally disproved spontaneous generation and German histologists observed
mitosis and meiosis (the underlying events of eukaryotic cell division), Rudolf Virchow
added a third precept to round out Cell Theory: (3) Cells come from pre-existing cells. That
is, they reproduce. We begin this chapter with a reminder of the scientific method, that way
of thinking about our world that emerged formally in the seventeenth century. Then we’ll
take a tour of the cell, reminding ourselves of basic structures and organelles. After the ‘tour’,
we consider the origin of life from a common ancestral cell and the subsequent evolution of
cellular complexity and the incredible diversity of life forms.

2

Finally, we consider some of the methods we use to study cells. Since cells are small,
several techniques of microscopy, cell fractionation (in essence a biochemical dissection of the
cell) and functional/biochemical analysis are described to illustrate how we come to
understand cell function.

Learning Objectives
When you have mastered the information in this chapter, you should be able to do the
following:
1. Compare and contrast hypotheses and theories and place them (and other elements of the
scientific enterprise) into their place in the cycle of the scientific method.
2. Compare and contrast structures common to, and that distinguish prokaryotes, eukaryotes,
and archaea, and groups within these domains of life.
3. Articulate the function of different cellular substructures.
4. Explain how prokaryotes and eukaryotes accomplish the same functions, i.e., have the
same properties of life, even though prokaryotes lack most structures found in eukaryotes.
5. Outline a procedure to study a specific cell organelle or another substructure.
6. Describe or speculate on how the different structures (particularly in eukaryotic cells)
relate/interact with each other to accomplish specific functions.
7. Describe some structural and functional features that distinguish prokaryotes (eubacteria),
eukaryotes, and archaea.
8. Place cellular organelles and other substructures in their evolutionary context, i.e.,
describe their origins and the selective pressures that could have led to their evolution.
9. Distinguish between the roles of random mutations and natural selection in evolution.
10. Relate archaea to other life forms and speculate on their origins in evolution.
11. Suggest why evolution leads to more complex ways of sustaining life.
12. Explain how fungi are more like animals than plants.

1.2

Scientific Method – The Formal Practice of Science

Let’s focus here on the essentials of the scientific method originally inspired by Robert Boyle,
and then on how science is practiced today. Scientific method is one or another standardized
protocol for observing, asking questions about, and investigating natural phenomena. Its
simplest expressions are look/listen, infer, and test your inference. According to the Oxford
English Dictionary, all scientific practice relies on the systematic observation, measurement,
and experiment, and the formulation, testing and modification of hypotheses. Here is the
scientific method as you might read it a typical science textbook:
•
•
•
•
•

Read the science of others and observe natural phenomena on your own.
Infer and state a hypothesis (explanation) based on logic and reason.
Hypotheses are declarative sentences that sound like fact but aren’t! Good hypotheses are
testable predictions, easily turned into if/then statements or yes-or-no questions.
Design experiments to test the hypothesis: results must be measurable evidence for or
against the hypothesis.
Perform that experiment and then observe, measure, collect data, and test for statistical
validity (where applicable). Then, repeat the experiment.
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•
•

Consider how your data supports or does not support your hypothesis and then integrate
your experimental results with earlier hypotheses and prior knowledge.
Finally, publish (i.e., make public) your experiments, results and conclusions. In this way,
shared data and experimental methods can be evaluated (and repeated) by other scientists.

We’ll return to the scientific method and how it is practiced shortly.
So, what are scientific hypotheses, theories and laws and how do they fit into the
scientific method? A scientific hypothesis, as suggested above, is an inference, and educated
guess about what might be going on based on evidence and logic. A hypothesis is a declarative
sentence, for example “The Sun revolves around the Earth”. This hypothesis was stated by
Aristotle (among others)! Remember, a good hypothesis can be easily turned into a yes-or-no
question, in this case “Does the sun revolve around the Earth?” By its nature, such yes-or-no
questions can be answered (i.e., a good hypothesis can be tested) by gathering more evidence
by observation and experiment. When Aristotle’s hypothesis was finally tested by the
observations and measurements of Nicolaus Copernicus, Galileo Galilei and others, it proved
to be false! But you knew that, didn’t you?
Contrary to what many people think, a scientific theory is not a guess, neither an
educated nor an uneducated one. Rather, a theory is a statement well supported by
experimental evidence and widely accepted by the scientific community. Nevertheless,
theories are not ‘facts’. Scientists know that theories are subject to further test and modification
and may even be overturned. Even scientific laws can be questioned. Astrophysicists actively
test otherwise universally accepted physical laws, occasionally threatening to modify them. In
biology, Mendel’s Law of Independent Assortment shouldn’t even be called a law. Indeed, it
was not factual as he stated it, or for that matter when he stated it. Check the Mendelian
Genetics section of an introductory textbook to see how chromosomal crossing over violates
this law, and a history of science book to see what happens when observations or experimental
results are inexplicable or as we might say today, ‘too far out’.
Even Darwin’s Theory of Evolution, one of the most enduring and tested biological
theories, has been modified over time. But in this case, the modifications have only
strengthened our understanding that biological diversity is the result of natural selection. For
commentary on the evolutionary underpinnings of biology, check out Dobzhansky T (1973,
Nothing in biology makes sense except in the light of evolution. Am. Biol. Teach. 35:125-129),
and Gould, S. J. (2002, The Structure of Evolutionary Theory. Boston, Harvard University
Press). Or, check out some of Darwin’s own work at 1.1Origin of Species.
Do you think that Darwin’s Theory of Evolution by natural selection should be
promoted to a law? To sum up, a Wikipedia entry states that the goal of a scientific inquiry is to
obtain knowledge in the form of testable explanations (hypotheses) that can predict the results of
future experiments. This allows scientists to gain an understanding of reality, and later use that
understanding to intervene in its causal mechanisms (such as to cure disease). The better a
hypothesis is at making predictions, the more useful it is. In the last analysis, think of
hypotheses as educated guesses and think of theories and/or laws not as proofs of anything,
but as one or more experimentally supported hypothesis that everyone agrees should serve as
guideposts to help us evaluate new observations and hypotheses.
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But do not making the mistake of placing hypotheses at the low end of a hierarchy of
ideas. They are in fact are the bread and butter of the scientific enterprise. Good ones are
testable and should predict either/or results of well-designed experiments. Those results
(observations, experimental data) should support or nullify the hypotheses being tested. In
either case, scientific data generates conclusions that inevitably lead to new hypotheses whose
predictive value will also be tested. If you get the impression that scientific discovery is a cyclic
process, that’s the point! Exploring scientific questions reveals more questions than answers!
A word about well-designed experiments. Erwin Schrödinger (winner of a Nobel
Prize in physics in 1933) once proposed a thought experiment. He wanted his audience to
understand the requirements of scientific investigation, but gained a fame (and notoriety) far
beyond the world of theoretical physics. Perhaps you have heard of his cat! Considered a
founding father of quantum physics, he recognized that adherence to scientific method is not
strict and that we can (and should) occasionally violate adherence to the dictates of scientific
method. In the now popular story of Schrödinger’s Cat, Schrödinger stated that if you sealed a
cat in a box with a toxic substance, how could you know if the cat was alive or dead unless you
open the box. Wearing his philosopher’s hat (yes, he had one!), he postulated that until you
open the box, the cat is both “dead and alive”. That is, until the box was opened, the cat was in
a sense, neither dead nor alive, but both! Often presented as little more than an amusing
puzzle, Schrödinger was in fact illustrating that there were two alternate hypotheses: (1) the
cat exposed to toxin survived, or (2) the cat exposed to toxin died. Note that either hypothesis is
a declarative sentence, and that either one could be tested. Just open the box!
In a twist however, Schrödinger added that by opening the box, the investigator would
become a factor in the experiment. For example, let’s say (for the sake of argument) that you
find a dead cat in the box. Is it possible that instead of dying from a poison, the cat was scared
to death by your act of opening the box? Or that the toxin made the cat more likely to die of
fright but was not lethal by itself? How then to determine whether it was the toxin or your
action that killed the cat? This made the puzzle even more beguiling, and to the many
laypersons, his greatest scientific contribution! But to a scientist, the solution to the puzzle just
means that a scientist must take all possible outcomes of the experiment into account,
including the actions of the experimenter, ensuring sound experimental design with all
necessary controls. The bottom line, and often the reason that scientific manuscripts suffer
negative peer review, is the absence or inadequacy of control experiments. See more about
Schrödinger’s cat at 1.2A Cat Video.

CHALLENGE: Assume that Schrödinger’s cat is found dead when the box
was opened. Suggest some controls for the experiment to eliminate an
alternative to the hypothesis that it was the toxin that caused the death?

1.2.1

The Method as It Is Really Practiced!

If you become a scientist, you may find that adherence to the ‘rules’ of scientific method are
honored as much in the breach as in their rigorous observance. An understanding of those
rules, or more appropriately principles of scientific method guide prudent investigators to
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balance personal bias against the leaps of intuition that successful science requires. Deviations
from protocol are allowed!
I think that we would all acknowledge that the actual practice of science by would be
considered a success by almost any measure. Science is a way of knowing the world around us
through constant test, confirmation, and rejection that ultimately reveals new knowledge,
integrating that knowledge into our worldview.
An element often missing but integral to any scientific method is that doing science is
collaborative. Less than a century ago, many scientists worked alone. Again, Gregor Mendel is
an example, and his work was not appreciated until decades after he published it. Today, most
publications have two or more coauthors. And the inherent collaborative nature of science
doesn’t end with the investigators in a study. When a paper (or a research grant for that
matter) is submitted for consideration, other scientists are recruited to evaluate the quality of
hypotheses, experimental design, and soundness of conclusions reported in a manuscript. This
peer review of fellow scientists is part and parcel of good scientific investigation.
CHALLENGE: Since laws, theories, and hypotheses are each stated as
declarative sentences and thus sound like facts, articulate the difference
between them in your own words.

1.2.2

Logic and the Origins of the Scientific Method

The scientist, defined as a both observer and investigator of natural phenomena, is only a few
centuries old. Long before that, philosophers developed formal rules of deductive and
inferential logic to try and understand nature, humanity’s relationship to nature, and the
relationship of humans to each other. We owe to those philosophers the logical basis of the
scientific enterprise. They came up with the rules and systems of deductive and inductive logic
now integral to the practice of science. Scientific method grew from those beginnings, along
with increasing empirical observation and experimentation. We recognize these origins when
we award the Ph.D. (Doctor of Philosophy), our highest academic degree! We are now going
to learn about the life of cells, their structure and function, and their classification or grouping
based on those structures and functions. Everything we know about life comes from applying
the principles of scientific method to our intuition. For a bemused take on how scientists think,
check out The Pleasure of Finding Things Out: The Best Short Works of Richard Feynman (1999,
New York, Harper Collins).
CHALLENGE: The article at (1.3How to Defend Against Science Deniers)
has a clear point of view, i.e., it takes sides!). The author feels that
defending valid science by offering up the scientific method (i.e., how
science is done) is flawed because it invites rebuttal. Summarize his
argument, list some take-home messages you feel are important, and
why… either because you agree or because you disagree with them.
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1.3

Domains of Life

We believe with good reason that all life on Earth evolved from a common ancestral cell that
existed soon after the origins of life on our planet. At one time, all life was divided into two
groups: the true bacteria and everything else! Now we group life into one of three domains:

•

•
•

Prokaryotes are among the first descendants of that common ancestral cell. They lack
nuclei (pro meaning before and karyon meaning kernel, or nucleus). They include bacteria
and cyanobacteria (blue-green algae).
Eukaryotes include all higher life forms, characterized by cells with true nuclei (Eu, true;
karyon, nucleus).
Archaebacteria, (meaning “old” bacteria) include many extremophile bacteria (‘lovers’ of
life at extreme temperatures, high salinity, and the like). Originally classified as ancient
prokaryotes, Archaebacteria were shown by 1990 to be separate from prokaryotes and
eukaryotes, in fact a third domain of life.

The archaea are found in such inhospitable environments as boiling hot springs or
arctic ice, though some also live in conditions that are more temperate. Based on comparison
of the DNA sequences of genes for ribosomal RNAs in eukaryotes, normal bacteria (eubacteria)
and extremophiles, Carl Woese proposed the three-domain phylogeny illustrated in Figure 1.1.

Fig. 1.1: A three-domain phylogeny showing a closer relationship between archaea and eukaryotes.

Based on sequence similarities and differences, Woese concluded that the archaebacteria
(Archaea) are not just a domain separate from the rest of the bacteria and from eukaryotes but
are more closely related to eukarya than eubacteria! In fact, the Achaea share genes, proteins,
and metabolic pathways found in eukaryotes but not in bacteria, supporting their close
evolutionary relationship to eukaryotes. This unique sharing is further testimony to their
domain status. Understanding that all living organisms belong to one of three domains has
dramatically changed our understanding of evolution. Archea may be prokaryotes, but their
immediate ancestors are more closely related to us than to E. coli! For a review, see (Woese, C.
2004, A new biology for a new century. Microbiol. Mol. Biol. Rev. 68:173-186) The three
domains of life (Archaea, Eubacteria and Eukarya) quickly replaced the older division of
living things into Five Kingdoms, the Monera (prokaryotes), Protista, Fungi, Plants, and
Animals (all eukaryotes!).
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At this point you may be asking, “What about viruses?” Where are they on, or do they
even belong in the tree of life? You may already know that viruses require live cellular hosts to
reproduce, but that they are not themselves alive. In fact, much about the place of viruses in
evolution is an open question that we will consider in a later chapter. For now, let’s look at
how we come to know about viruses and some of their peculiarities.
1.3.1.

Viruses: Dead or Alive; Big and Small - A History of Surprises

Viruses that infect bacteria are called bacteriophage (phage meaning eaters, hence bacteria
eaters). Eukaryotic viruses include DNA and RNA viruses, with DNA and RNA genomes.
Smallpox, hepatitis B, herpes, chicken pox/shingles, and adenovirus are caused by DNA
viruses. Common colds, influenza, SARS, and COVID-19 are caused by positive strand RNA
viruses that upon infecting a cell, replicate their RNA genome to make RNA negative strand
RNAs encoding all necessary information to make new viruses. HIV AIDS, Ebola, Zika, yellow
fever, and some cancers are caused by retroviruses, RNA viruses whose genome is reversetranscribed into a cDNA intermediate that replicates and is transcribed to generate new
viruses. Viruses were not identified as agents of disease until late in the nineteenth century,
and we have learned much in the ensuing century. In 1892, Dmitri Ivanofsky, a Russian
botanist, was studying plant diseases. One that damaged tobacco (and was therefore of
agricultural significance) was the mosaic disease (Figure 1.2, below).

Fig. 1.2: Tobacco mosaic virus symptoms (white patches) on a tobacco leaf.

Ivanofsky showed that extracts of infected tobacco leaves were themselves infectious. The
assumption was that the extracts would contain infectious bacteria. But his extracts remained
infectious even after passing them through a Chamberland-Pasteur filter with a pore size so
small that bacteria would not pass into the filtrate. Thus, the infectious agent(s) couldn’t be
bacterial. Since the infectious material was not cellular and depended on a host for
reproduction with no independent life of its own, they were soon given the name virus, a term
that originally just meant toxin, or poison. This marked the start of virology, the study of
viruses. The virus that Ivanofsky studied is now called Tobacco Mosaic Virus, or TMV.
Invisible by light microscopy, viruses are sub-microscopic non-cellular bits of lifechemistry that only become reproductive (come alive) when they parasitize a host cell. Since
many viruses cause disease in humans, we have learned much about how they are similar and
how they differ. In other chapters, we’ll learn how viruses have even become tools for the study
of cell and molecular biology. Let’s start with a recent surprise from the study of viruses.
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As eventually seen in the electron microscope, viruses (called virions or viral particles)
are typically 150 nm or less in diameter. And that is how we have thought of viruses for over a
century! But in 2002, a particle inside an amoeba, originally believed to be a bacterium, was
shown by electron microscopy to be a giant virus! Since then, several more giant, or
Megavirales were discovered.
Megavirales fall into two groups, pandoraviruses and mimiviruses. At 1000nm (1 m)
Megavirus chilensis (a pandoravirus) may be the largest. Compare a few giant viruses to a
bacterium (E. coli) and the AIDS virus in Figure 1.3 below.

Fig. 1.3: Transmission electron micrographs of 2 giant viruses, the AIDS (HIV) virus and an E. coli
bacterium. M. horridgei is twice the size of E. coli. All giant viruses dwarf HIV, a typical eukaryotic virus.

Consider that a typical virus contains a small genome, encoding an average of 10 genes. In
contrast, the Megaviurus chilensis genome contains 2.5 x 106 base pairs (bp) encoding up to
1,100 proteins. Still, it requires host cell proteins to infect and replicate. More surprising is that
75% of the sequenced 1.2 x 106 bp mimivirus genome code putative proteins with no
counterparts in other viruses or cells! Equally surprising, some mimiviruses genes encode
proteins homologous to those used for translation in prokaryotes and eukaryotes. If all viruses,
including the Megavirales, only use host cell enzymes and ribosomal machinery to synthesize
proteins, what are these genes doing in a mimivirus genome? Think of the surprises here as
questions. The big ones concern where and when Megavirales (giant viruses) evolved:
• What are those genes with no cellular counterparts all about?
• What were the selective advantages to a virus of large size and large genomes?
• Were Megavirales once large cells that invaded other cells, eventually becoming viral
parasites and losing most but not all of their genes? Or were they once small viruses that
incorporated host cell genes, increasing their genome size and coding capacity?
CHALLENGE: What information would you need (or what questions would
you ask and/or what experiments could you do) to find out what the unique
proteins encoded by those uniquely viral genes in e.g., mimivirus are doing
for the virus?
Viruses are typically identified because they are harmful. The discovery of HIV earned
Luc Montagnier, Françoise Barré-Sinoussi, and Harald Z. Hausen the 2008 Nobel Prize in
Physiology or Medicine. More recently, as this is written, we are (we hope) near the end of the
COVID-19 viral pandemic caused by the SARS-CoV-2 retrovirus. In fact, few viruses resident in
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humans are known to be beneficial. In contrast, some bacteria are harmful to humans and
animals but many are beneficial (even necessary) as symbionts in our many microbiomes.
CHALLENGE: Robert Koch discovered bacterial causes of many diseases
and won the 1905 Nobel prize in Physiology or Medicine for showing that
1.4
Mycobacterium tuberculosis caused tuberculosis. What other bacterial
diseases did he discover and why are his four postulates still relevant?
Let’s now turn our attention to cells, entities that we define as living, with all the
properties of life…, starting with eubacteria.
1.3.2

The Prokaryotes (Eubacteria = Bacteria and Cyanobacteria)

Prokaryotic cells lack nuclei and other eukaryotic organelles, such as mitochondria,
chloroplasts, endoplasmic reticulum, and assorted eukaryotic vesicles and internal
membranes. Transmission and scanning electron micrographs and an illustration of rodshaped bacteria are shown below (Figure 1.4).

Fig. 1.4: Transmission electron micrograph (left) and drawing of the gram-negative E. coli bacterium
(right) labeling its structural components, and a scanning electron micrograph of a cell cluster (middle).

Bacteria do contain bacterial microcompartments (BMCs), but these are made up
entirely of protein and are not surrounded by a phospholipid membrane. These function for
example in CO2 fixation to sequester metabolites toxic to the cells. Check out 1.5Bacterial
Organelles for more information. Bacteria are typically unicellular, although a few (like some
cyanobacteria) live colonial lives at least some of the time.
1.3.2.a Bacterial Reproduction
Without the compartments afforded by the internal membrane systems of eukaryotic cells, all
intracellular chemistries, (reproduction and gene expression (DNA replication, transcription,
translation, and all the metabolic biochemistry of life) happen in the cytoplasm. Bacterial DNA
is a circular double helix that duplicates as the cell grows. While not enclosed in a nucleus,
bacterial DNA is concentrated in a region of the cell called the nucleoid. When not crowded at
high density, bacteria replicate their DNA throughout the life of the cell, dividing by binary
fission. The result is the equal partition of duplicated bacterial chromosomes into new cells.
The bacterial chromosome is basically naked DNA, unassociated with proteins.
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1.3.2.b Cell Motility and the Possibility of a Cytoskeleton
Movement of cells is a response to environment. Some respond to chemicals (chemotaxis),
some to light (phototaxis) or even gravity (geotaxis). Bacteria move to or from nutrients,
noxious chemicals, light, dark, gravitational force, etc., by one of several mechanisms. Some
use a flagellum made up largely of the bacterial protein flagellin. The main proteins of
eukaryotic cell flagella and cilia are the tubulins. Together with actin and other proteins,
tubulins are also part of the eukaryotic cell cytoskeleton of rods and tubes. Prokaryotes were
long thought to lack similar cytoskeletal components. But two bacterial homologues of
eukaryotic actin and tubulin genes were recently discovered. MreB is the actin homologue.
Like actin, MreB monomers polymerize to form filaments that lie under the cell membrane of
bacteria (e.g., E. coli), helping to maintain their rod-like shape. In fact, E. coli with a mutant
MreB gene is spherical…, and normally spherical bacteria lack an MreB gene! MreB was also
thought to form an actin-like cortical ring that in dividing eukaryotic cells constricts to pinch
off two new cells. But this function seems to be served by the FtsZ protein that encodes a
eukaryotic tubulin homologue. FtsZ polymers form filaments that are seen in a Z ring at the
center of a bacterial cell during binary fission. FtsZ mutants divide, but abnormally; thus the
role of FtsZ in separating bacterial cells during binary fission is not yet clear. Figure 1.5 shows
a micrograph and an illustration of FtsZ in the Z rings of dividing E. coli cells.

Fig. 1.5: Immunofluorescence localization of FtsZ proteins in Z rings in cross-sections in the middle of
dividing E. coli cells (left). Drawings represent the location of Ftz protein in Z rings between dividing
cells (middle) and in cross section (right).

It seems that together with flagellin, the MreB and FtsZ proteins may be part of a primitive
prokaryotic cytoskeleton involved in cell structure and motility, from which our own evolved!
1.3.2.c Some Bacteria Have Internal Membranes
While bacteria lack organelles (the membrane-bound structures of eukaryotic cells), internal
membranes in some bacteria form as inward extensions, or invaginations of plasma membrane.
Some of these capture energy from sunlight (photosynthesis) or from inorganic molecules
(chemolithotrophy). Photosynthetic vesicles called Carboxysomes (Figure 1.6) are membrane
bound structures in which CO2 is fixed (reduced) in cyanobacteria. Photosynthetic bacteria
have less elaborate internal membrane systems.
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Fig. 1.6: Transmission electron micrograph of carboxysomes in a cyanobacterium (arrows,
(left) and isolated from a cyanobacterium (right).

1.3.2.d Bacterial Ribosomes Do the Same Thing as Eukaryotic Ribosomes… and Look Like
Them!
Ribosomes are protein-synthesizing machines. Those of prokaryotes are smaller than those of
eukaryotes but can translate eukaryotic messenger RNA (mRNA) in vitro. This is because the
sequences and structures of ribosomal RNAs are shared by all species, indicating long
conserved evolutionary relationships. Recall that it was ribosomal sequence similarities that
revealed our closer relationship to archaea than bacteria.
The prokarya (eubacteria) are a diverse group, occupying almost every wet, dry, or hot
and cold nook-and-cranny of our planet. Yet, all prokaryotic cells share structural and
functional metabolic properties with each other and with archaea and eukaryotes! As we’ve
seen with ribosomes, this sharing supports the common ancestry of all life.
Finally, we share not only common ancestry, but living arrangements with bacteria.
There are microbiomes in our gut, on our lips, in belly buttons, and in fact all over our skin
(see 1.6Our Skin Microbiome for more about that!). Gut microbiome bacteria alone number
~10X more than our own cells! And microbiomes are invisible but not quiet ( 1.7The Human
Microbiome). Interest in our microbiomes even earned them their own 1.8The NIH Human
Microbiome Project.
Challenge: Your microbiome is unique and could be another ‘fingerprint’
(1.9Microbiomes are Fingerprints). Why is this so? Suggest circumstances
in which microbiome fingerprinting might be unreliable.

1.3.3

The Archaebacteria (Archaea)

Allessandro Volta, a physicist who gave his name to the ‘volt’ (electrical potential energy),
discovered methane producing bacteria (methanogens) way back in 1776! He found them
living in the extreme environment at the bottom of Lago Maggiore, a lake shared by Italy and
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Switzerland. These unusual bacteria are chemoautotrophs that get energy from H2 and CO2
and generate methane gas in the process. It was not until the 1960s that Thomas Brock (at the
University of Wisconsin-Madison) discovered thermophilic bacteria living at temperatures
approaching 100oC in Yellowstone National Park in Wyoming. Organisms living in any
extreme environment were soon nicknamed extremophiles. One of the thermophilic bacteria,
now called Thermus aquaticus, became the source of Taq polymerase, the heat-stable DNA
polymerase that made the polymerase chain reaction (PCR), now a household name in labs
around the world! Extremophile and “normal” bacteria are similar in size and shape(s) and
lack nuclei. This initially suggested that most extremophiles were prokaryotes. But as Carl
Woese demonstrated, it is the archaea and eukarya that share a more recent common ancestry!
While some bacteria and eukaryotes can live in extreme environments, the archaea include the
most diverse extremophiles.
Here are some extremophilic archaebacteria:

•
•
•
•

Acidophiles grow at acidic (low) pH.
Alkaliphiles grow at high pH.
Halophiles require high [salt] (e.g., Halobacterium salinarium (Figure 1.7).
Heat-loving Thermophiles and hyperthermophiles live at high temperatures. Thermus
aquaticus (Figure 1.8) is athermophile that lives at 70oC, and is noted for its role in
developing the polymerase chain reaction. Pyrolobus fumarii is a hyperthermophile, lives
at 113°C!

Fig. 1.7 (left): Scanning electron micrograph of Halobacterium salinarium, a ‘salt-loving’ bacterium (Fig.
1.7). Right: Scanning electron micrograph of ‘heat-loving’ Thermus aquaticus bacteria (Fig. 1.8).

•
•
•

Methanogens produce methane.
Barophiles grow best at high hydrostatic pressure.
Psychrophiles grow best at temperature 15 °C or lower.
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•
•

Xerophiles grow at very low water activity (i.e., drought or near drought conditions).
Toxicolerants grow in the presence of high levels of damaging chemicals, for example,
pools of benzene, nuclear waste.

Archaea were originally seen as oddities of life, thriving in unfriendly environments.
But they include organisms living in less extreme environments, including soils, marshes, and
even in the human colon. They are also abundant in the oceans where they are a major part of
plankton, participating in the carbon and nitrogen cycles. In the guts of cows, humans, and
other mammals, methanogens facilitate digestion, generating methane gas in the process. In
fact, cows have even been cited as a major cause of global warming because of their prodigious
methane emissions! On the plus side, methanogenic Archaea are being exploited to create
biogas and to treat sewage. Other extremophiles are the source of enzymes that function at
high temperatures or in organic solvents. As already noted, some of these have become part of
the biotechnology toolbox.
1.3.4

The Eukaryotes

The volume of a typical eukaryotic cell is some 1000 times that of a typical bacterial cell.
Imagine a bacterium as a 100 square foot room (the size of a small bedroom, or a large walk-in
closet!) with one door. Now imagine a room 1000 times as big. That is, imagine a 100,000
square foot ‘room’. You might expect many smaller rooms inside this room for such a large
space to be functional. The eukaryotic cell is a lot like that large space, with lots of interior
rooms (i.e., organelles) with their own entryways and exits. In fact, eukaryotic life would not
even be possible without a division of labor of eukaryotic cells among different organelles (the
equivalence to the small rooms in our metaphor).
The smaller prokaryotic “room” has a much larger plasma membrane surface area-tovolume ratio than a typical eukaryotic cell. This enables required environmental chemicals to
enter and quickly diffuse throughout the cytoplasm of e.g., an E. coli cell. The communication
between chemicals and structures in a small cell is therefore rapid. In contrast, the
communication over a larger expanse of cytoplasm inside a eukaryotic cell requires the
coordinated (not to mention regulated!) activities of subcellular components and
compartments. Such communication can be relatively slow in a large space. In fact, eukaryotic
cells have lower rates of metabolism, growth, and reproduction than prokaryotic cells. Thus,
the existence of large cells required the evolution of divided labors supported by
compartmentalization.
Fungi are more closely related to animal than plant cells. They are a curious beast for
several reasons! For one thing, the organization of fungi and fungal cells is somewhat less
defined than animal cells. Septa are structures between cells that separate fungal hyphae.
They allow passage of cytoplasm and even organelles between cells. On the other hand, some
primitive fungi have few or no septa, in effect creating coenocytes, which are single giant cell
with multiple nuclei. Fungal cells are surrounded by a wall, whose principal component is
chitin. Chitin is the same material that makes up the exoskeleton of arthropods (which
includes insects and lobsters!). Typical animal and plant cells with organelles and other
structures are illustrated below, in Figure 1.9 and in Figure 1.10).
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Fig. 1.9: Labeled drawing of the structural components of a typical animal cell.

Fig. 1.10: Labeled drawing of the structural components of a typical plant cell.
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We end this look at the domains of life by noting that, while eukaryotes are a tiny minority of
all living species, “their collective worldwide biomass is estimated to be equal to that of
prokaryotes” (Wikipedia). And we already noted that the bacteria living commensally with us
humans represent 10 times as many cells as our own human cells! Clearly, each of us (and
probably most animals and even plants) owes our existence to its microbiome as much we do
to our own human cells. For now, keeping in mind that plants and animal cells share many
internal structures and organelles that perform the same or similar functions, let’s look at them
and briefly describe their functions.

1.4

Tour of the Eukaryotic Cell

Here we take a closer look at the division of labors among the organelles and structures within
eukaryotic cells. We’ll look at cells and their compartments in a microscope and see how the
organelles and other structures were isolated from cells and identified not only by microscopy,
but by biochemical and molecular analysis of their isolates.
1.4.1

The Nucleus

The nucleus is the largest organelle in the cell, separating the genetic blueprint (DNA) from
the cell cytoplasm. Although the eukaryotic nucleus breaks down during mitosis and meiosis
as chromosomes form and cells divide, it spends most of its time in its familiar form during
interphase, the time between cell divisions. The structural organization of an interphase
nucleus is shown in Figure 1.11 below.

Fig. 1.11: LEFT: Transmission electron micrograph of an insect cell nucleus showing the nuclear envelope
(ne) and nucleolus (n); RIGHT: Drawing of a nucleus with chromatin (purple) and nuclear pores.

The cross-section of the interphase nucleus in the electron micrograph shows a prominent
nucleolus (labeled n). The nucleus is enclosed in a nuclear envelope and surrounded by a
darkly granular RER (rough endoplasmic reticulum). You can make out ribosomes (small
granules) bound to the RER and to the outer nuclear membrane. The space enclosed by the
RER (the lumen) is in fact continuous with the space separating the inner and outer
membranes of the nuclear envelope, as illustrated in the drawing (above right). Nuclear pores
in the nuclear envelope (look at the drawing) let large molecules and even particles move in
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and out of the nucleus across both membranes. The eukaryotic nucleus is where genes and
RNA transcription are regulated and thus one place where cellular protein levels are
controlled. RNAs, once transcribed from genes and processed, are exported to the cytoplasm
through the nuclear pores. Even completely assembled ribosomal subunits are exported from
the nucleus. Other RNAs remain in the nucleus, often participating in the regulation of gene
activity. We learn some details of nuclear pore traffic, DNA replication, and the dynamics of
cell division in later chapters.

104-2 The nucleus
Beyond its nucleolus and nuclear envelope, the nucleus is more organized than it
appears in conventional transmission electron micrographs. The nucleolus is just the largest of
several inclusions that seem to segregate nuclear functions. Over 100 years ago Santiago
Ramón y Cajal reported other structures in the nuclei of neurons, including what came to be
known as Cajal bodies (CBs). His elegant hand-drawn illustrations of nuclear bodies (made
before the advent of photomicrography) can be seen at 1.10Cajal's Nuclear Bodies and 1.11Cajal's
Beautiful Brain Cells. Cajal and Camillo Golgi shared the Nobel Prize in Physiology or
Medicine 1906 for their studies of nerve cell structure. In the electron microscope, Cajal
bodies (CBs) look like coils of tangled thread, and were thus called coiled bodies
(conveniently, also CBs). Other nuclear bodies since identified include Gems, PML bodies,
nuclear speckles (or splicing speckles), histone locus bodies (HLBs), and more! The results of
immunofluorescence localization studies show that different nuclear bodies are associated with
specific proteins (Figure 1.12, below).

Fig. 1.12: Simulated immunolocalization of different proteins (fibrillarin, coilin and ASF/SF2) to nuclear
bodies (nucleolus, Cajal Bodies and nuclear speckles, respectively), using fluorescent antibodies.
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Nucleoli contain fibrillarin proteins, stained red by treating cells with red-fluorescence-tagged
antibodies to fibrillarin. Pink-fluorescence-tagged anticoilin antibodies light up the coilin
proteins of CBs. Green-fluorescing ASF/SF2 antibodies localize to nuclear speckles. As part of
or included in a nuclear matrix, nuclear bodies organize and regulate different aspects of
nuclear activity and molecular function. The different nuclear bodies perform specific
functions and interact with each other and with proteins DNA and RNA to do so. We will
revisit nuclear bodies in their working context later.
1.4.1.a Every Cell (i.e., Every Nucleus) of an Organism Contains the Same Genes
We read earlier that bacteria are busy doubling and partitioning their naked DNA
chromosomes at the same time as they grow and divide by binary fission. In eukaryotic cells, a
cell cycle divides life into discrete consecutive events. During most of the cell cycle, cells are
in interphase and DNA is wrapped up in proteins in chromatin inside a nucleus. It is not
merely the DNA, but chromatin that must be duplicated when cells reproduce. Duplication of
DNA also involves disturbing and rearranging the chromatin proteins resting on the DNA.
This occurs before cell division. As the time of cell division nears, chromatin associates with
even more proteins, condensing to form chromosomes, while the nuclear envelope dissolves,
marking the start of mitosis (meiosis in germline cells) and cytokinesis. You may recall that
each somatic cell of a eukaryotic organism has paired homologous chromosomes and thus two
copies of every gene the organism owns. But sperm and eggs emerge from meiosis with one of
each pair of chromosomes and only one copy of each gene. Whether by mitosis or meiosis,
duplicated chromosomes (chromatids) lined up at metaphase attach to spindle fibers (as seen
in Figure 1.13) to be separated and drawn into new daughter cells formed during cytokinesis.

Fig. 1.13: Drawing (left) and fluorescence micrograph (right) of a cell in metaphase of mitosis: aligned
chromosomes (chromatids) at the center of the cell (blue in the micrograph) are just about to be pulled
apart by microtubules of the spindle apparatus (green) extending from the poles to the center of the cell.

As chromosomes separate and daughter cells form, nuclei reappear and chromosomes
de-condense. These events mark the major visible difference between cell division in bacteria
and eukaryotes. Cytokinesis begins near the end of mitosis. Sexual reproduction, a key
characteristic of eukaryotes, involves meiosis rather than mitosis. The mechanism of meiosis,
the division of germ cells leading to production of sperm and eggs, is like mitosis except that
the ultimate daughter cells have just one each of the parental chromosomes, eventually to
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become the gametes (eggs or sperm). Google meiosis and/or mitosis to remind yourself about
the differences between the two processes, meiosis and mitosis. A key take-home message
here is that every cell in a multicellular organism, whether egg, sperm or somatic, contains the
same genome (genes) in its nucleus. This was already understood from the time that mitosis
and meiosis were first described in the late nineteenth century.
That every cell of an organism really does contain copies of all of its genes was finally
demonstrated by John Gurdon and Shinya Yamanaka in 1962. They transplanted nuclei from
the intestinal cells the frog Xenopus laevis into enucleated eggs (eggs from which their own
nuclei had been removed). These ‘eggs’ grew and developed into normal tadpoles, proving
that no genes are lost during development, but are just expressed differentially. For these
cloning experiments, Gurdon and Yamanaka shared the 2012 Nobel Prize for Physiology or
Medicine. We’ll revisit animal cloning later. For now, it’s enough to know that Molly the
cloned frog was followed by Dolly, the first cloned sheep (1966) and then other animals, all
cloned from enucleated eggs transplanted with differentiated cell nuclei. See 1.12Cuarteterra to
read about the cloning a champion polo mare whose clones are also champions!

CHALLENGE: One group of bacteria (1.13Planctomycetes) does in fact
surround their nucleoid DNA with a membrane! How do you think these
cells divide their DNA equally between daughter cells during cell division?

1.4.2

Ribosomes

On the tiny end of the size spectrum, ribosomes are protein-making machines found in all
cells. They consist of large and small subunits, each made up of proteins and ribosomal RNAs
(rRNAs). Ribosomes bind to messenger RNAs (mRNAs), moving along the mRNA to translate
3-base code words (codons) into polypeptides. Multiple ribosomes can move along the same
mRNA, forming polyribosomes (or polysomes) that simultaneously translate the same
polypeptide encoded by the mRNA as shown in Figure 1.14.

Fig. 1.14: Polysomes form when ribosomes (blue) assembled at the left on an mRNA molecule move. As
they move from left to right more ribosomes can assemble at the left, each translating the message; a
polypeptide (green) grows, emerging from the ribosomes. To accommodate size the allosteric changes
during polypeptide synthesis, there are at least 35 nucleotides separating ribosomes on polysomes.
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In the illustration, ribosomes assemble on the left (5’) end of the messenger RNA to form the
polysome. When they reach the other (3’) end of the mRNA, the ribosomes disassemble from
the RNA and release the finished polypeptide. The granular appearance of cytoplasm in
electron micrographs is largely due to the ubiquitous distribution of ribosomal subunits and
polysomes in cells. In electron micrographs of leaf cells from a dry, desiccation-tolerant dessert
plant, Selaginella lepidophylla (Figure 1.15), you can make out randomly distributed ribosomes
and ribosomal subunits (arrows, below left). In cells from a fully hydrated plant, you can see
polysomes as more organized strings of ribosomes (arrows, below right).

Fig. 1.15: Transmission electron micrographs of Selaginella lepidophylla plant cells. Small, free
ribosomal subunits in desiccated cells (left) seem to have formed larger structures (ribosomes) aligned
on polysomes in the hydrated plant cells (right). Zoom in to see these details.

Isolated ribosomes and subunits can be separated by sucrose-density-gradient
centrifugation based on differences in mass. Figure 1.16 compares ribosomal subunit ‘size’,
protein, and ribosomal RNA (rRNA) composition in eukaryotes and prokaryotes.

Fig. 1.16: Comparison of prokaryotic (upper) and eukaryotic (lower) ribosomal subunit, rRNA and protein
composition. The subunits and their component rRNAs were separated by mass (i.e., size) by sucrose
density gradient ultracentrifugation. Proteins were isolated from separated subunits for analysis.
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S (Svedberg) units are calculated from the position of particles and molecules in the gradient
after separation. Theodor Svedberg earned the 1926 Nobel Prize in Chemistry for among other
things, applying analytical ultracentrifugation to the separation and determination of
particulate and molecular masses.

101 Ribosomes & Polysomes
1.4.3

Internal membranes and the Endomembrane System

Microscopists of the nineteenth century saw many subcellular structures using the art of
histology, staining cells to increase the visual contrast between cell parts. One of these
microscopists was the early neurobiologist, Camillo Golgi. He developed a silver (black) stain
that first detected a network of vesicles which we now call Golgi bodies (or Golgi vesicles) in
nerve cells. For his studies of the membranes now named after him, Camillo Golgi shared the
1906 Nobel prize for Medicine or Physiology with Santiago Ramón y Cajal.
Golgi vesicles along with other vesicles and vacuoles in cells, including, comprise the
endomembrane system. Proteins made by ribosomes of the rough endoplasmic reticulum
(RER) either enter the interior space (lumen) or become part of the RER membrane itself. The
syntheses of RER, smooth endoplasmic reticulum (SER), Golgi bodies, microbodies,
lysosomes, and other vesicular membranes (and their protein content) all start in the RER.
transport vesicles that bud off from RER fuse with Golgi Vesicles at their cis face (Figure 1.17).

Fig. 1.17: Transmission electron micrograph of an insect cell Golgi body showing cis and trans faces
(labeled in white). Vesicles from the RER at the cis face (below, right) will fuse with the Golgi vesicles.
Vesicles emerging at the trans face (above, left) are progenitors of a variety of different organelles.

Some proteins made in the endomembrane system are secreted by exocytosis. Others
end up in organelles such as lysosomes that contain hydrolytic enzymes. These enzymes are
activated when the lysosomes fuse with other organelles destined for degradation. For
example, food vacuoles form when a plasma membrane invaginates, engulfing food particles.
They then fuse with lysosomes to digest the engulfed nutrients. Still other proteins synthesized
by ribosomes on the RER are incorporated into the RER membranes, destined to become part
of lysosomes, peroxisomes, and even the plasma membrane itself. In moving through the

21

endomembrane system, packaged proteins undergo stepwise modifications (maturation) before
becoming biologically active (Figure 1.18, below).

Fig. 1.18: Illustration of ‘packaged’ protein traffic through a cell from the RER (lower left) through Golgi
vesicles (middle) to organelles (e.g., lysosomes) and the plasma membrane (upper right) for exocytosis
(i.e., secretion). RER and Golgi vesicles are major sites for the modification (i.e., maturation) of
packaged proteins.

100-2 The RER-Rough Endoplasmic Reticulum

102 Golgi Vesicles & the Endomembrane System

Autophagosomes are small vesicles that surround and eventually encapsulate tired
organelles (for example, worn out mitochondria), eventually merging with lysosomes whose
enzymes degrade their contents. In 2016, Yoshinori Ohsumi earned the Nobel Prize in
Physiology and Medicine for nearly 30 years of research unraveling the cell and molecular
biology of autophagy. Microbodies are a class of vesicles smaller than lysosomes but formed
by a similar process. Among them are peroxisomes that break down toxic peroxides formed as
a by-product of cellular biochemistry. Some vesicles emerging from the RER lose their
ribosomes to become part of the SER, which has several different functions (e.g., alcohol
detoxification in liver cells).

103-2 Smooth Endoplasmic Reticulum
Other organelles include the contractile vacuoles of freshwater protozoa that expel
excess water that enters cells by osmosis. Some protozoa have extrusomes, vacuoles that
release chemicals or structures that deter predators or enable prey capture. A large aqueous
central vacuole dominates the volume of many higher plant cells. When filled with water, they
will push all other structures against the plasma membrane. In a properly watered plant, this
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water-filled vacuole exerts osmotic pressure that among other things keeps plant leaves from
wilting and keeps stems upright.
1.4.4

Mitochondria and Plastids

Nearly all eukaryotic cells contain mitochondria, shown in Figure 1.19.

Fig. 1.19: Transmission electron micrograph of mitochondria embedded in RER (left) and a labeled
drawing of a single mitochondrion (right).

The matrix of the mitochondrion is enclosed by a cristal membrane surrounded by an outer
membrane. Each contains and replicates its own DNA, which contains genes encoding some
of the mitochondrial proteins. The surface area of the inner mitochondrial membrane is
increased by being folded into cristae, which are sites of cellular respiration (aerobic nutrient
oxidation). Later, we’ll consider the role of mitochondria in respiration in more detail.
Earlier, we speculated that some eukaryotic organelles could have originated within
bacteria. But mitochondria probably evolved from an aerobic bacterium that was engulfed by
another cell that escaped destruction to become an endosymbiont in the host cell. Lynn
Margulis first proposed this in her Endosymbiotic Theory, in which a primitive eukaryotic cell
acquired a bacterial endosymbiont (Margulis, L. [Sagan, L], 1967, On the origin of mitosing
cells. Journal of Theoretical Biology 14: 225–274). She proposed that chloroplasts also started
as endosymbionts. Both mitochondria and the plastids of plants contain their own DNA,
transcribe it into RNA and use their own translational machinery (i.e., ribosomes) to synthesize
proteins, further supporting their bacterial and cyanobacterial origins. Living at first in
symbiosis with the rest of the cell, these endosymbionts would eventually evolve into the
organelles that we are familiar with.
Several protozoa lacking mitochondria and other organelles were discovered and
suggested to be “first ingestors” of an ancestral endosymbiont, but since these cells contain
other organelles (e.g., hydrogenosomes, mitosomes) it is thought more likely that these species
once had, but then lost mitochondria.

23

Therefore, the descendants of ancient eukaryotic cells missing mitochondria probably
no longer exist, if they ever existed at all! More evidence for the Endosymbiotic Theory is
discussed elsewhere.

CHALLENGE: Nick Lane favors an endosymbiotic event where one prokaryote
engulfed another prokaryote (1.14Mitochondria evolve from Bacterium-inBacterium Endosymbiosis). What is the dramatic, unorthodox consequence
to evolutionary thought if Lane is right about this?

Chloroplasts, photosynthetic protozoa, and cyanobacteria contain chlorophyll and use
similar photosynthetic mechanisms to make glucose. Transmission electron micrographs of
chloroplasts are shown in the Figure 1.20. The one on the right shows a few starch granules.

Fig. 1.20: Transmission electron micrographs of a typical photosynthetic chloroplast (LEFT), and one that
has photosynthesized long enough to accumulated starch granules (RIGHT). S, starch granule; T,
thylakoids.

A leucoplast is also a plastid, a chloroplast that has become filled with starch granules. In the
electron micrograph of a leucoplast in Figure 1.21, you can see that, because of the
accumulation of starch, the grana have become dispersed and indistinct.

Fig. 1.21: Electron micrograph of a leucoplast, a chloroplast that has become filled with starch granules (S).

105-2 Endosymbiosis-Mitochondria & Chloroplasts
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1.4.5

Cytoskeletal structures

We have come to understand that the cytoplasm of a eukaryotic cell is highly structured,
permeated by rods and tubules. The three main structural components of this cytoskeleton are
microfilaments, intermediate filaments, and microtubules. The structure and polarity of these
structures are shown in Figure 1.22.

Fig. 1.22: Assembly, structure and polarity of microtubules (upper), microfilaments middle), and
intermediate filaments (lower) with electron micrographs of isolated microtubules upper right) and
immunofluorescence micrographs of using fluorescent antibodies to microfilament and intermediate
filament proteins (middle and bottom right, respectively).

Microtubules are composed of − and −tubulin protein monomers. Monomeric actin
proteins make up microfilaments. Intracellular intermediate filament proteins are related to the
extracellular keratin of hair, fingernails, claws, and bird feathers. These cytoskeletal rods and
tubules not only determine cell shape, but also play a role in cell motility. This includes the
movement of cells from place to place and the movement of structures within cells.
We have already noted that a prokaryotic cytoskeleton is composed in part of proteins
homologous to the actins and tubulins. As in a eukaryotic cytoskeleton, these bacterial proteins
may play a role in maintaining or changing cell shape. On the other hand, flagellin (a protein
not found in eukaryotic cells) powers the movement of bacterial flagella.
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A bacterial flagellum is a rigid hook-like structure attached to a molecular motor in the cell
membrane that spins to propel the bacterium through a liquid medium. In contrast, eukaryotic
microtubules slide past one another causing a more flexible flagellum to undulate in wave-like
motions and a cilium to beat rather than undulate. Cilia are involved not only in motility, but
also in feeding and sensation. Microtubules in eukaryotic flagella and cilia arise from a basal
body (similar to kinetosomes or centrioles) such as the one in Figure 1.23.

Fig. 1.23: Transmission electron micrograph of a longitudinal section of a flagellum (#1) emerging from a
basal body (2). Number 3 is another basal body, this time in cross section.

Aligned in a
membrane. In
organized as
microtubules.

flagellum or cilium, microtubules form an axoneme surrounded by plasma
electron micrographs of cross sections, a ciliary or flagellar axoneme is typically
a ring of nine paired microtubules (called doublets) around two singlet
Figure 1.24 shows the 9+2 microtubule arrangement of an isolated axoneme.

Fig. 1.24: Drawing of an axoneme isolated from a eukaryotic cilium or flagellum, by removing their plasma
membrane, showing their characteristic 9+2 arrangement of microtubules in cross section (at the left) and
longitudinal section projecting to the right.

Centrioles are themselves comprised of a ring of microtubules. In animal cells they
participate in spindle fiber formation during mitosis and meiosis and are the point from which
microtubules radiate thorough the cell to help form and maintain its shape. These structures do
not involve axonemes. The spindle apparatus in plant cells typically lack centrioles but form
from an amorphous MTOC, or MicroTubule Organizing Center. The MTOC serves the same
purpose in mitosis and meiosis as centrioles serve in animal cells.

106-2 Filaments & Tubules of the Cytoskeleton
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Elsewhere, we describe how microfilaments and microtubules interact with motor
proteins (e.g., dynein, kinesin, and myosin) to generate force that results in the sliding of
filaments and tubules to allow cellular movement. You’ll see that motor proteins also transport
molecular cargo from one place to another in a cell.

1.5

How we Know Functions of Organelles and Cell Structures: Cell
Fractionation

We could see and describe cell parts in the light or electron microscope, but we could not
definitively know their function until it became possible to release them from cells and
separate them from one another. This became possible with the advent of differential
centrifugation. Under centrifugal force generated in a spinning centrifuge rotor, subcellular
structures separate by differences in mass. Structures that are more massive reach the bottom
of the centrifuge tube before less massive ones. A cell fractionation scheme is illustrated in Fig
1.25. Biochemical analysis of the isolated cell fractions can reveal what different organelles
and cellular substructures do.

Fig. 1.25: Cells are broken open to release their contents and then filtered to remove unbroken cells (far
left). Centrifugation at sequentially higher speed (G-force) sediments progressively smaller cellular parts
(organelles, ribosomes, etc.) in centrifugal pellets (the 4 tubes in the middle), leaving behind a final
supernatant, the soluble cell fraction or cytosol (tube at the far right). The smallest cell parts (membranes,
ribosomes) require ultracentrifugation at the highest G-forces.

107-2 Dissecting the Cell-a Cell Fractionation Scheme
CHALLENGE: The cell fractionation scheme pictured in Fig. 1.25 does not
include sucrose density gradient centrifugation. Offer an explanation.
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Cell fractionation separates cells into their constituent parts. The first step is to break
open the cells and release their contents. This can be done by physical means such as grinding
in a mortar and pestle, tissue grinder or similar device; exposure to ultrasound or high
pressure; or exposure to enzymes or other chemicals that can selectively degrade the plasma
membrane.
The next step is to isolate the subcellular organelles and particles from the cytoplasm
(i.e., cytosol) by differential centrifugation. The centrifugation of broken cells at progressively
higher centrifugal force separates (fractionates) particulate cell components based on their
mass. At the end of this process, a researcher will have isolated ribosomes, mitochondria,
chloroplasts, nuclei, and other subcellular structures. After re-suspension, each pellet can be
prepared for microscopy. Micrographs of some isolated subcellular fractions are shown in
Figure 1.26.

Fig. 1.26: Transmission electron micrographs of organelles isolated by eukaryotic cell fractionation: 1, nuclei;
2, RER; 3, Golgi vesicles; 4, mitochondria; 6, membrane vesicles; 7, lysosomes. The chloroplast (5) is a light
micrograph.
•

These structures can be tentatively identified by microscopy based on their dimensions and
appearance. Molecular analyses and biochemical tests on the cell fractions then help to
confirm these identities.

108-2 Isolated Nuclei

109-2 Isolated RER

110-2 Isolated Golgi Vesicles

111-2 Lysosomes & Peroxisomes

112-2 Isolated Mitochondria

113-2 Isolated Chloroplasts

114-2 Isolated Membranes Form Vesicles
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Can you tell what organelles have been purified in each of these fractions based on the
electron micrographs alone? Consider the structures on the left as an example. These were
found in a low-speed centrifugal pellet, implying that they are large structures. They look a bit
like nuclei, (which are in fact, the largest structures in a eukaryotic cell)—and indeed that’s
what they are!
Physical separation and the biochemical and molecular analysis of subcellular structures have
revealed their basic functions and continue to reveal previously un-noticed structures and
functions in cells. What biochemical tests might you do to confirm the identities of the
structures shown? At this point you may realize that all cell and molecular biology is devoted to
understanding how prokaryotic and eukaryotic cells and organisms use their common
structural and biochemical inheritance to meet very different survival strategies. As you keep
studying, watch for experiments in which cell parts are separated and reconstituted.
Reconstitution is a recurring experimental theme in the functional analysis of cell parts. Also
look for another, even bigger theme: how evolution accounts for the common biochemistry and
genetics of life— and its structural diversity!

1.6

The Origins, Evolution, Speciation, Diversity and Unity of Life

The question of how life began has been with us since the beginnings or recorded history. It is
now accepted that there was a time, however brief or long, when the Earth was a lifeless
(prebiotic) planet. Life’s origins on Earth date to about 4 billion years ago under conditions
that favored the formation of the first cell, the first entity with all of the properties of life. But
couldn’t those same conditions have spawned multiple cells independently, each with all of
the properties of life? If so, from which of these did life, as we know it today, descend?
Whether there were one or more different “first cells”, evolution (a property of life) could only
begin with ‘that or those’ cells.

115 Properties of Life
The progenote has been defined as the first cell from which all life then descended.
This implies that the origin of a cell was a unique, one-time only event. The fact that there is
no evidence of multiple, independent origins of cellular life might be evidence (albeit negative
evidence) that life originated only once, to produce a progenote as defined, and that multiple
first cells (or potential progenotes) never existed. Alternatively, we can propose that the cell we
call our ancestral progenitor originally had company, but that this progenote was
evolutionarily successful at the expense of other early life forms, which thus became extinct.
Whatever our progenote may have looked like, one of its descendants later evolved the
solutions to living that we see in force in all cells and organisms alive today, including a
common (universal) genetic code to store life’s information, as well as a common mechanism
for retrieving the encoded information, what Francis Crick called the Central Dogma of
biology. That ancestral cell is called our Last Universal Common Ancestor, or LUCA. We will
consider ideas about life’s origins, progenotes, and universal ancestors in the last chapter of
this book. For now, feel free to check out the links below for more information.
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116 The Universal Genetic Code

117 Origins of Life

118 Life Origins vs Evolution
For the moment, our focus is on evolution, the property of life that is the basis of speciation and
life’s diversity. Charles Darwin’s theory of evolution was an explanation of the structural
diversity of species. A naturalist, Darwin lived at a time of ferment where scientific discovery
was challenging religion. But by 1839, Charles Darwin had published his Narrative of the
Surveying Voyages of His Majesty's Ships Adventure and Beagle. This was the first of many
reports of his careful observations of nature, with the seeds of what was to become his theory of
natural selection. He published his more fully formed theory of evolution by natural selection
in 1859 in The Origin of Species. There, he finally acknowledged his evidence-based belief
that that new species arise when beneficial traits are selected from random genetic differences
in individuals in a population. At the same time, less fit individuals would be culled from the
population. If natural selection acts on individuals, the emergence of new species (evolution)
results from the persistence and spread of selected, heritable changes through successive
generations in a population. In this way, evolution results in an increase in biological diversity
and complexity at all levels of biological organization, from species to individual organisms
and all the way down to biomolecules.
Darwin recognized that his theory would generate discord between science and
biblical accounts of purposeful creation. He addressed the issue with great tact in introducing
The Origin of Species: “Although much remains obscure, and will long remain obscure, I can
entertain no doubt, after the most deliberate study and dispassionate judgement of which I am
capable, that the view which most naturalists entertain, and which I formerly entertained–
namely, that each species has been independently created–is erroneous.” Yet today, according
to creationists, our exquisite eyes could only have formed by the intelligent design of a creator.
For the evolutionary perspective, see the article in National Geographic by E. Yong
(Feb., 2016, with photography by D. Littschwager). Over time science favored Darwin. With
the rediscovery of Mendel’s genetic experiments at the turn of the twentieth century, it became
increasingly clear that the genes of an organism are the basis of an organism’s inherited
physical and chemical traits, those traits that are passed down through the generations. It also
became clear that Mendel had found the genetic basis for Darwin’s theory and that the
evolution even of miraculous eyes can be explained. Science and religion found ways to coexist but, the controversy persists.
Repeated speciation occurs with the continual divergence of life forms from an
ancestral cell through natural selection and evolution. Our shared cellular structures, nucleic
acid, protein, and metabolic chemistries (the ‘unity’ of life) are testimony to our common
ancestry with all life, dating back to our LUCA! Living things even share some early behaviors,
governed at least in part by genes.
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Take as an example the fact that our biological clock is an evolutionary adaptation to our
planet’s 24-hour daily cycles of light and dark. Day and night have been around since the
origins of life, and all organisms studied so far seem to have a biological clock! The discovery
of the genetic and molecular underpinnings of circadian rhythms (those daily cycles) earned
Jeffrey C. Hall, Michael Rosbash and Michael W. Young the 2017 Nobel Prize in Medicine or
Physiology (check out 1.15Circadian Rhythms Win Nobel Prize to learn more)!
The molecular relationships common to all living things largely confirm what we have
learned from the species represented in the fossil record. Morphological, biochemical, and
genetic traits that are shared across species are defined as homologous and can be used to
reconstruct evolutionary histories. The biodiversity that scientists (in particular,
environmentalists) try to protect is the result of millions of years of adaptation (natural
selection), speciation, and extinction. Biodiversity needs protection from the unwanted
acceleration of evolution arising from human activity, including blatant extinctions (think
passenger pigeon), and near extinctions (think American bison by the late 1800s). Think also
of the consequences of the introduction of invasive aquatic and terrestrial species and the
looming effects of climate change.
Let’s look at the biochemical and genetic unity among livings things. We’ve already
considered what happens when cells get larger when we tried to explain how larger cells
divide their labors among smaller intracellular structures and organelles. When eukaryotic
cells evolved further into multicellular organisms, it became necessary for the different cells to
communicate with each other and to respond to environmental cues. Some cells evolved
mechanisms to “talk” directly to adjacent cells and others evolved to transmit electrical
(neural) signals to other cells and tissues. Still other cells produced hormones to communicate
with cells far away, to which they had no physical attachment.
As species diversified to live in very different habitats, they also evolved very different
nutritional requirements, along with more extensive and elaborate biochemical pathways to
digest their nutrients and capture their chemical energy. Nevertheless, through billions of
years of evolution and astonishing diversification, the underlying genetics and biochemistry of
living things on this planet is remarkably unchanged. Early in the twentieth century, Albert
Kluyver first recognized that cells and organisms vary in form appearance in spite of an
essential biochemical unity of all organisms (see 1.16Albert Kluyver). This unity amidst the
diversity is a life paradox that we examine in this course.

1.6.1

Random Acts of Genetic Variation, the Basis of Natural Selection

DNA contains the genetic instructions for the structure and function of cells and organisms.
When and where a cell’s or organism’s genetic instructions are used (i.e., to make RNA and
proteins) are highly regulated. Genetic variation results from random mutation. Genetic
diversity arising from random mutations is in turn, the basis of natural selection during
evolution.

119 The Random Basis of Evolution
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1.6.2

The Genome: An Organism’s Complete Genetic Instructions

Recall that every cell of an organism carries the same genome as every other cell. The genome
of an organism is the entirety of its genetic material (DNA, or for some viruses, RNA),
including genes and other kinds of DNA sequences. The genome of a common experimental
strain of E. coli was sequenced by 1997 (Blattner FR et al. 1997, The complete genome
sequence of Escherichia coli K-12. Science 277:1452-1474) The human genome was completed
(more or less!) by 2001, well ahead of schedule (Venter JC 2001, The sequence of the human
genome. Science 291:1304-1351). Recall also that the analysis of rRNA gene sequences
resulted in the dramatic re-classification of life from five kingdoms into three domains.
So, comparisons of specific gene or other DNA sequences can tell us a great deal about
evolution. We now know that evolution depends on the structure of genomes as much as on
individual gene sequences, Genome sequencing confirms genetic variation between species,
but also much variation among individuals of the same species. It is this the latter variation
that is the raw material of evolution. Genomic studies tell us that genomes have been shaped
and remodeled in evolution. We’ll consider genome remodeling in more detail elsewhere.

1.6.3

Genomic ‘Fossils’ Can Confirm Evolutionary Relationships.

We have been looking to gene and protein sequencing to find evolutionary relationships and
even, familial relationships. You can read about an early demonstration of such relationships
based on amino acid sequence comparisons across evolutionary time in Zuckerkandl E and
Pauling L. (1965) Molecules as documents of evolutionary theory. J. Theor. Biol. 8:357-366. In
addition, it has been possible for some time now, to extract and sequence DNA from fossil
bones and teeth. allowing comparisons of extant and extinct species, including the fossil
remains of humans, other hominids, and many animals, revealing our relationship to animals
(from bugs to frogs to mice to chimps…) and hominids like us. In fact, we (Homo sapiens)
share 95% of our DNA with Neanderthals. We know this from the work of Svante Paabo, whose
technologies for extracting and sequencing ancient DNA, enabled him to sequence the
Neanderthal genome…, and for which he earned the 2022 Nobel prize for Physiology and
Medicine. Unfortunately, DNA from organisms older than 10,000 years is typically damaged or
absent, so that relationship building beyond that time is almost impossible.
Using what we know from gene sequences of species alive today, investigators have
recently ‘reconstructed’ a genetic phylogeny suggesting the sequences of genes of some of our
long-gone progenitors, including bacteria (to learn more, check out: 1.17Deciphering Genomic
Fossils). The comparison of these ‘reconstructed’ ancestral DNA sequences suggests when
photosynthetic organisms diversified and when our oxygenic planet became a reality. Closer to
home, many remains of ancestral humans have been discovered in the Americas. These
promise to unlock the mysteries of human settlement of the continents, though not without
controversy. Indian tribal cultures treat their ancestors as sacred and argue against sampling
such remains for DNA Analysis. In one example, a well-preserved mummified body was
discovered in the Nevada desert in the 1940s. Tests of clothing fragments and hair revealed
that this Spirit Cave mummy was over 10,000 years old. DNA sequence analysis was proposed
to confirm the origins of the mummy. But then the Fallon Paiute-Shoshone tribe, which lives
near the burial site, asserted a cultural relationship to the body and requested the right of its
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return in compliance with the Native American Graves Protection and Repatriation Act.
Anthropologists then counter-asserted a need for further study of the body to learn more about
its origins and about native American origins in general. The dispute ended only after 20
years, when the time the tribe consented DNA tests were allowed. When the DNA sequence
analysis results established that the remains were indeed that of an ancestor to the tribe, the
Spirit Cave mummy was returned to the Fallon Paiute-Shoshone to be reburied with full tribal
rites in 2018. To read more, see 1.18Resolving American Indian Ancestry or 1.19Ice Age Mummy
DNA Analysis Unlocks Tribal Secrets.

120-2 Genomic Fossils-Molecular Evolution
CHALLENGE: Tracing ancient remains to tribal descendants continues
to cause culture/science tension. See the 42,000 year-old Australian
aboriginal Mungo Man, (Perrotet, T. & Smith, D.M. 2019, The
Homecoming; Smithsonian 50: 38-49), and then reflect on what the
discovery can tell us and how the conflict was resolved.

1.7

Microscopy Reveals Life’s Diversity of Structure and Form

Broadly speaking, there are two main categories of microscopy. In Light Microscopy, the slide
is viewed through optical glass lenses that see visible light reflected from or passing through
the specimens on the slide. In Electron Microscopy, the viewer is looking at an image on a
screen created by electrons passing through or reflected from the specimen, usually mounted
on a copper grid. For a sampling of light and electron micrographs, check out this
1.20
Micrograph Gallery. Here we compare and contrast different microscopic techniques.

1.7.1

Light Microscopy

Historically one or another version of light microscopy has revealed much of what we know of
the structural diversity of cells, especially eukaryotic cells. Check out the 1.21Mitosis Drawings
for a reminder of how eukaryotic cells divide, and then check out 1.22The Optical Microscope
for descriptions of different variations of light microscopy (e.g., bright-field, dark field, phasecontrast, and fluorescence.). Limits of magnification and resolution of 1200X and 2 m,
(respectively) are common to all forms of light microscopy. Some variations of light microscopy
are briefly described here:
•

Bright-Field microscopy is the most common kind of light microscopy. The specimen is
illuminated from below; contrast between regions of the specimen comes from the
difference between light absorbed by the sample and light passing through it. Live
specimens lack contrast in conventional bright-field microscopy because differences in in
refractive index between components of the specimen (e.g., organelles and cytoplasm in
cells) diffuse the resolution of the magnified image. Therefore Bright-Field microscopy is
best suited to fixed and stained specimens.
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•

•

•

•

•

•

In Dark-field illumination, light passing through the center of the specimen is blocked and
the light passing through the periphery of the beam is diffracted (scattered) by the sample.
The result is enhanced contrast for certain kinds of specimens, including live, unfixed and
unstained ones.
In Polarized light microscopy, light is passed through a polarizing filter before passing
through the specimen. The resulting incident light (the light beamed at the object on the
slide) to pass through the specimen where it may be bent (diffracted), thereby increasing
the contrast of the specimen. The microscopist achieves the highest contrast by rotating the
plane of polarized light passing through the sample. A valuable feature of polarized light
microscopy is that samples can be unfixed, unstained or even live.
Phase-Contrast or Interference microscopy enhances contrast between parts of a specimen
with higher refractive indices (e.g., cell organelles) and lower refractive indices (e.g.,
cytoplasm). Phase–Contrast microscopy optics shift the phase of the light entering the
specimen from below by a half a wavelength to capture small differences in refractive
index to increase contrast. Phase–Contrast microscopy is a most cost-effective tool for
examining live, unfixed, and unstained specimens.
In a fluorescence microscope, a specimen is, for example, treated with a molecule tagged
with (covalently attached to) a fluorophore that fluoresces (emits visible light) when
exposed to short wavelength, high-energy (usually UV) light. The tagged molecule are
often fluorescent antibodies that will bind to specific molecules in a cell. In fluorescence
microscopy, the visible fluorescent light localizes the target molecule/structure in the cell.
Confocal microscopy, a variant of fluorescence microscopy, enables imaging through thick
samples and sections. The result is often 3D-like, with much greater depth of focus than
other light microscope methods. Look at 1.23Microscope Image Gallery-Confocal Included
to see a variety of confocal micrographs and related images; look mainly at the specimens.
Lattice Light-Sheet Microscopy is a 100-year old variant of light microscopy that allows us
to follow subcellular structures and macromolecules moving about in living cells. Read
more about the renewed interest in this technique at 1.23Lattice Light Sheet Microscopy.

1.7.2

Electron Microscopy

Transmission Electron Microscopy (TEM) microscopy generates an image by passing
electrons through a specimen treated with an electron-opaque stain (e.g., osmium). , or
reflecting electrons from a specimen, and capturing the electron image on a screen. TEM
can achieve much higher magnification (up to 10 6X) and resolution (2.0 nm) than any form
of optical microscopy. The higher voltage of High Voltage Electron microscopy allows
passage of electrons through thicker sections than regular (low voltage) TEM. The result is
micrographs with much greater resolution, depth, and contrast. Scanning Electron
Microscopy (SEM), with magnifying power up to 105X and a 3.0-20.0 nm resolution. SEM
lets us to examine the surfaces of tissues, small organisms like insects, and even of cells and
organelles. Objects of SEM must be conductive, so that biological samples are usually spray coated with a thin layer of metal (e.g., palladium, platinum) (check the link to 1.25Scanning
Electron Microscopy for more on SEM and look at the gallery of SEM images at the end of
the entry). Helium Ion Microscopy is a form of SEM that substitutes helium ions for the
vacuum in which SEM samples are normally viewed, eliminating the need for metal spray
coating. Thus, HIM enables investigators to examine e.g., cells and viruses in a more natural
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state (you can google this on your own to see some examples of this). Electron microscopy,
together with biochemical and molecular biological studies have revealed how interacting
cellular and molecular components work with each other, and continue to do so, shedding
light on all manner of biological processes and interactions.

121-2 Electron Microscopy
Some iText & VOP Key words and Terms
actin
Archaea
bacterial cell walls
bacterial flagella
binary fission
cell fractionation
cell theory
chloroplasts
chromatin
chromosomes
cilia
confocal microscopy
cytoplasm
cytoskeleton
cytosol
deductive logic
differential centrifugation
diversity
domains of life
dynein
endomembrane system

eukaryotes
eukaryotic flagella
evolution
exocytosis
extinction
hypothesis
inference
intermediate filaments
keratin
kingdoms
LUCA
lysosomes
meiosis
microbiome
microbodies
microfilaments
microtubules
mitochondria
mitosis
motor proteins
mutation

Natural Selection
nuclear envelope
nuclear pores
nucleoid
nucleolus
nucleus
optical microscopy
plant cell walls
progenote
prokaryotes
Properties of life
rough endoplasmic reticulum (RER)
scanning electron microscopy
Scientific Method
secretion vesicles
smooth endoplasmic reticulum (SER)
speciation
theory
transmission electron microscopy
tubulins
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Chapter 2

Basic Chemistry, Organic Chemistry, and Biochemistry
Atoms, elements (the nucleus, atomic models); bonds (covalent, ionic, hydrogen); water
properties, pH; organic molecules and biochemistry: chemical groups, monomers, polymers,
condensation and hydrolysis, polysaccharides, polypeptides, proteins, DNA, RNA, lipids
Reminder: For inactive links, google key words/terms for alternative resources.

Do you know? Did you guess correctly?

2.1

Introduction

In this chapter we start with a review of basic chemistry from atomic structure to molecular
bonds to the structure and properties of water, followed by a review of key principles of
organic chemistry—the chemistry of carbon-based molecules. You may find it useful to have
your old general chemistry textbook handy or to check out the excellent introduction to
general chemistry by Linus Pauling (1988, General Chemistry New York, Springer-Verlag).
We’ll see how polar covalent bonds define the structure and explain virtually all the
properties of water. These range from the energy required to melt a gram of ice to the energy
required to vaporize a gram of water and from its surface tension to its ability to hold heat,
not to mention its ability to dissolve a wide variety of solutes, from salts to proteins and other
macromolecules. We will distinguish water’s hydrophilic interactions with solutes from its
hydrophobic interactions with fatty molecules. Then we will review some basic biochemistry.
Well-known biological molecules include monomers (such as sugars, amino acids, and
nucleotides) and polymers (including polysaccharides, proteins, and nucleic acids).
Biochemical reactions that link glucose monomers into polymers on the one hand,
and that break the polymers down on the other are essential reactions for life on Earth (and
probably everywhere else!). On Earth, photosynthetic organisms link glucose monomers
into starch, a polysaccharide. Amylose, a simple starch, a large homopolymer of repeating
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glucose monomers. Likewise, polypeptides are heteropolymers of twenty different amino
acids. DNA and RNA nucleic acids are also heteropolymers, made using only four different
nucleotide monomers.
Digestive enzymes in your gut catalyze the hydrolysis (i.e., breakdown) of the plant
or animal macromolecular polymers we ate, back down to monomers. Hydrolysis adds water
molecules across the bonds linking the monomers in a polymer, breaking those linkages. Our
own cells then take up the monomers. Once there, condensation (dehydration synthesis)
reactions remove water molecules from participating monomers to grow new polymers that
are more useful to us. Strictly speaking, triglycerides (fats) and phospholipids are neither
polymers nor macromolecules. Both are broken down by hydrolysis and synthesized in
condensation reactions. Energy-rich triglyceride hydrolysis products include fatty acids that,
(like sugars) can be oxidized for energy. Phospholipids (chemical relatives of triglycerides)
are the basis of cellular membrane structure.
Weak interactions between macromolecules, for example hydrogen bonds (H-bonds),
electrostatic interactions and van der Waals forces, are responsible for holding many
cellular molecules and structures together. While individually these bonds are weak, in their
multitudes, they are collectively strong. Familiar examples are the two complementary DNA
strands held in a tight and stable double helix by millions of H-bonds, and the thousands of
H-bonds that hold a polypeptide into its folded three-dimensional shape. We will see this
theme—strength in numbers—repeated in other molecular and cellular structures. Monomers
also serve other purposes related to energy metabolism, cell signaling, and the like.
Depending on your chemistry background, you may find googling these subjects interesting
and useful. The short voice-over PowerPoint recordings (VOPs) in this chapter might also
help guide your understanding of the basic chemistry and biochemistry presented here.

Learning Objectives
When you have mastered the information in this chapter, you should be able to do the
following:
1. Compare and contrast the definitions of atom, element, and molecule.
2. List differences between atoms, elements, and molecules and between energy- and
position-based atomic models.
3. Describe the behavior of subatomic particles when they absorb and release energy.
4. State the difference between atomic shells and orbitals.
5. State how kinetic and potential energy apply to atoms and molecules.
6. Explain the behavior of atoms or molecules that fluoresce when excited by high-energy
radiation, as well as the behavior of those that do not.
7. Distinguish polar and nonpolar covalent bonds and their physical-chemical properties.
8. Predict the behavior of electrons in compounds held together by ionic interactions.
9. Explain how the properties of water account for the solubility of macromolecules and salts
and describe the role of H-bonds in supporting those properties.
10. Consider, in terms of water’s properties, why some salts are not soluble in water.
11. Describe how molecular linkages form during polymer synthesis, and place hydrolytic
and dehydration synthetic reactions in a metabolic context.
12. Distinguish between chemical bonds and linkages in polymers.
13. Categorize different chemical bonds based on their strengths.
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2.2

Atoms and Basic Chemistry

The difference between elements and atoms is often confused in casual conversation. Both
terms describe matter, substances with mass. Different elements are different kinds of matter
distinguished by different physical and chemical properties. In turn, the atom is the
fundamental unit of matter—that is, of an element. The positively charged protons and
neutral neutrons in an atomic nucleus account for most of the mass of an atom. Each
negatively charged electron that orbits a nucleus is about 1/2000 of the mass of a proton or
neutron. Thus, they do not add much to the mass of an atom.
Electrons stay in atomic orbits because of electromagnetic forces, (i.e., their attraction to the
positively charged nuclei). Its nuclear size (mass) and the space occupied by the cloud of
electrons around its nucleus define structure of an atom, and that structure dictates the
different properties of the elements. Let’s take a closer look at the elements and their atoms
and how their atomic properties account for the formation of molecules and molecular
structure.
2.2.1

Overview of Elements and Atoms

We model atoms to illustrate the average physical location of electrons (the orbital model) on
one hand and their potential energy levels (the Bohr or shell model) on the other (Figure
2.1).

Fig. 2.1: The Bohr (shell) model of an atom (above) emphasizes electron kinetic energy; the orbital
model (below) emphasizes the space occupied by electrons moving around the atomic nucleus.
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Up to two electrons move in a space defined as an orbital. In addition to occupying
different areas around the nucleus, electrons exist at different energy levels and move with
different kinetic energy. As we will learn, electrons can absorb or lose energy, jumping or
falling from one energy level to another.
Recall that atoms are chemically most stable when they are electrically uncharged,
with an equal number of protons and electrons. Isotopes of the same element are atoms with
the same number of protons and electrons but a different number of neutrons and thus,
different masses. Isotopes of an element are chemically stable but may not be physically
stable. For example, the most abundant isotope of hydrogen contains one proton, one
electron, and no neutrons. The nucleus of the deuterium isotope of hydrogen contains one
neutron, and that of tritium contains two neutrons. Both isotopes can be found in water
molecules. Deuterium is stable. In contrast, the tritium atom is radioactive, subject to nuclear
decay over time. Whether they are physically stable or not, all isotopes of an element share
the same electromagnetic and chemical properties and behave the same way in chemical
reactions. The electromagnetic forces that keep electrons orbiting their nuclei allow the
formation of chemical bonds in molecules.
The partial periodic table below (Figure 2.2) shows the elements that are essential for
all life (in greater or lesser amounts), as well as some that may also be essential in humans.

Fig. 2.2: Partial Periodic Table of Elements emphasizing elements found in living things.
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The table shows the unique atomic number (number of protons) and atomic mass
(usually measured in daltons, or Da) that characterize the different elements. For example,
the atomic number of carbon (C) is 6, which is the number of protons in its nucleus. Its mass
is 12 Da (six protons plus six neutrons, at 1 Da each). Remember that the mass of all the
electrons in a C atom is negligible! Find the C atom and look at some of the other atoms of
elements in the partial periodic table (Figure 2.2). Superscripted atomic numbers and
subscripted atomic mass numbers uniquely define each element.

122-2 Atoms & Elements
CHALLENGE: The periodic table shows the most abundant isotope of
hydrogen. What are the masses of the 3 common isotopes of hydrogen?
2.2.2

Electron Configuration—Shells and Subshells

The Bohr model of the atom reveals how electrons can absorb and release energy. The shells
indicate the energy levels of electrons. Electrons can absorb different kinds of energy,
including electrical energy, radiation, and light (which is just a form of radiation—weaker
than some and stronger than others).
CHALLENGE: What are some stronger forms of radiation, and what makes
them stronger?
Ultraviolet (UV) light beamed at atoms can excite electrons. If an electron in an atom
absorbs a full quantum (a photon) of UV radiant energy, it will be boosted from the ground
state (the shell it normally occupies) into a higher shell, an excited state. Excited electrons
move at greater speed around the nucleus and with more kinetic energy than they did at
ground state. Excited electrons also have more potential energy than ground-state electrons.
This is because they are unstable, releasing some of the energy gained during excitation as
they return to ground (i.e., their starting energy level, or shell, as seen below in Figure 2.3).
Electrons falling back to ground typically release excitation energy as heat. Atoms
whose excited electrons release their energy as light fluoresce; we say they are fluorescent.
A fluorescent light is an example of this phenomenon. Electrical energy excites electrons out
of their atomic orbitals in the molecules that coat the interior surface of the bulb. As all those
excited electrons return to ground state, they fluoresce, releasing light. These atoms can be
repeatedly excited by electricity.
As we shall see, biologists and chemists have turned fluorescence into a tool of
biochemistry, molecular biology, and microscopy. The ground state is also called the resting
state, but electrons at ground are by no means resting! They just move with less kinetic
energy than excited electrons.
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Fig. 2.3: When an electron absorbs e.g., light energy, it moves faster. Absorbance of one photon causes
an electron to jump to a shell farther from the atomic nucleus. While having higher kinetic energy, excited
electrons are unstable. Thus, they have potential energy, which is released as the electron returns to
ground state, releasing heat or light (fluorescence).

123 Electron Energy and Fluorescence

2.3

Chemical bonds

Atoms form bonds to make molecules, and there are three main classes of chemical bonds.
There are two subsets of covalent bonds, both of which are strong bonds. They involve
unequal or equal sharing of a pair of electrons. Unequal sharing of electrons results in polar
covalent bonds. Equal sharing forms nonpolar covalent bonds. Ionic bonds are created by
electrostatic interactions between elements after they gain or lose electrons, and these bonds
are weaker than covalent bonds. Hydrogen bonds (H-bonds) are in a class by themselves.
Their electrostatic interactions account for the physical and chemical properties of water.
They are also involved in interactions between and within other molecules. Note that while
atoms can share, gain, or lose electrons in chemical reactions, they will neither gain nor lose
protons or neutrons. Let’s look more closely at chemical bonds and how even the “weak”
bonds are essential to life.
2.3.1

Covalent Bonds

Electrons are shared in covalent bonds. Hydrogen gas (H2) is a molecule, not an atom! The two
H atoms in the H2 molecule share their electrons equally. Likewise, the carbon atom in
methane (CH4) shares electrons equally with four hydrogen atoms. A single pair of electrons
forms the covalent bond between two H atoms in the hydrogen molecule (H2). In methane, the
carbon (C) atom has four electrons in its outer shell that it can share. Each H atom has one
electron to share.
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If a C atom shares each of its four electrons with the electron in each of four H atoms,
there will be eight (four paired) electrons moving in filled orbitals around the nucleus of the C
atom some of the time and one pair moving around each of the H atomic nuclei some of the
time. Thus, the outer shells of the C atom and the H atoms are filled at least some of the time.
This stabilizes the molecule. Remember that atoms are most stable when their outer shells are
filled and when each electron orbital is filled (i.e., with a pair of electrons). The equal sharing of
electrons in nonpolar covalent bonds in H2 and CH4 is shown in Figure 2.4.

Fig. 2.4: Nonpolar covalent bonds in hydrogen gas (left) and methane (right).

Polar covalent bonds form when electrons in a molecule are shared unequally. This occurs if
the atomic nuclei in a molecule are very different in size, as is the case with water (Figure
2.5).

Fig. 2.5: Electrons on the H atoms of water molecules are drawn close to the large, positively charged
nucleus of the O atom (molecule at left). As a result, H atoms “lose” electrons and acquire a partial
positive charge (δ+) while oxygen atoms “gain” those electrons and have a partial negative charge (δ-).
The polar covalent water molecules then attract and bind to other water molecules (molecules at the right).
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The larger nucleus of the oxygen atom in H2O attracts electrons more strongly than does
either of the two H atoms. As a result, the shared electrons spend more of their time orbiting
the O atom, such that the O atom carries a partial negative charge while each of the H atoms
carries a partial positive charge. The Greek letter delta (δ) indicates partial charges in polar
covalent bonds. In Figures 2.4 and 2.5, compare the position of the paired electrons in water
with those illustrated for hydrogen gas or methane.
Water’s polar covalent bonds allow it to attract and to interact with other polar
covalent molecules, including other water molecules. The polar covalent nature of water also
goes a long way to explaining its physical and chemical properties and the reason why water
is essential to life on this planet!

124 Covalent Bonds
Both polar and nonpolar covalent bonds play a major role in the structure of
macromolecules, as in the protein hormone insulin, modeled in Figure 2.6.

Fig. 2.6: Computer-generated space-filling (left) and “ribbon” models (right) of insulin.

The X-ray image of a space-filling model of the hexameric form of stored insulin
(Figure 2.6, left) emphasizes its tertiary structure in detail. The ribbon diagram (Figure 2.6,
right) highlights regions of internal secondary structure. When secreted from the Islets of
Langerhans cells of the pancreas, active insulin is a dimer of A and B polypeptides (blue and
cyan in the ribbon diagram, respectively). The subunit structure and the interactions holding
the subunits together result from many electrostatic interactions (including H-bonds) and
other weak interactions. The disulfide bonds or bridges (seen as yellow Vs in the ribbon
diagram) stabilize the associated A and B monomers. We will look at protein structure in
more detail in an upcoming chapter.
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2.3.2

Ionic Bonds

Atoms that gain or lose electrons to achieve a filled outer shell acquire a negative or a
positive charge (respectively) to form ions. Despite their electrical charge, ions are stable
because their outer electron shells are filled. Common table salt (Figure 2.7) is a good
example.

Fig. 2.7: Ionic bonds in table-salt (NaCl) crystals result from the attraction of oppositely charged small
Na+ and large Cl− ions that bind them together in a regular, crystalline array.

Na (sodium) atoms can donate a single electron to Cl (chlorine) atoms, generating partially
charged Na+ (sodium) and Cl− (chloride) ions. The oppositely charged ions then come
together to form an ionic bond, an electrostatic interaction of opposite charges that holds the
Na+ and Cl− ions together in crystal salt. Look up the Bohr models of these two elements, and
see how ionization of each leaves filled outer shells (energy levels) in the ions.
2.3.3

Hydrogen Bonds

The hydrogen bond is a subcategory of electrostatic interactions formed by the attraction of
opposite charges. As noted above, water molecules attract one another ( cohere) because of
strong electrostatic interactions that form the H-bonds. Water’s polar covalent structure
enables it to attract positively and negatively charged groups of molecules, making it a good
solvent. Solutes (soluble molecules) or polar (charged) molecular surfaces that are attracted
to water are hydrophilic. Lipids, like fats and oils, are not polar molecules and therefore do
not dissolve in water; they are hydrophobic (from hydro: “water”; phobic: “fearing”). Next,
we’ll take a closer look at the chemistry and properties of water.

2.4

Water Chemistry

Soluble salts like NaCl dissolve because the Cl− and Na+ ions attract the partial positive and
negative charges (respectively) of water molecules more strongly than other water molecules
do. As a result, the salt ionizes; the ions separate from each other. The ionization of NaCl
dissolving in water is shown below (Figure 2.8).
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Fig. 2.8: Water’s solvent properties result from its polar covalent structure, allowing electrostatic
interactions between water molecules at the right and NaCl at the upper left, disrupting ionic
bonds, drawing the Na+ and Cl- ions into solution.

Water is also a good solvent for macromolecules (e.g., proteins and nucleic acids)
with exposed polar chemical groups on their surface that attract water molecules (Figure 2.9).

Fig. 2.9: In hydrophilic interactions, charged groups on a macromolecule (e.g., a protein) attract
the partial charges on water molecules, hydrating the molecule.

125-2 Water: Hydrogen & Ionic Bonds
CHALLENGE: What are some examples on insoluble salts and why don’t
they dissolve in water? See if you can reason this out…or look it up!
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In addition to its being a good solvent, we recognize the following properties of water
(all of which result from its polar nature and H-bonding abilities):
• Cohesion: Water molecules stick together via H-bonds.
• High surface tension: Water’s high cohesion means that it can be hard to break the
surface; think of the water strider, an insect that literally walks on water.
• Adhesion: This results from water’s electrostatic interactions with ions and with the partial
charges on polar covalent molecules or functional groups. Adhesion explains water’s
solvent properties and (at least in part) capillary action, in which water molecules crawl
along hydrophilic surfaces, often against the force of gravity.
• High specific heat: The cohesion of water molecules is so strong that it takes a lot of
energy to separate them and to make them move faster, i.e., it takes a lot of energy to heat
water. Specifically, it takes 1 Kcal, (1 Calorie, with a capital C) to heat a gram of water 1oC.
High specific heat explains why water “holds heat,” staying hot longer that the pot it’s in!
• High heat of vaporization: It takes even more energy/gm to turn water into vapor (steam)!
One last property of water: it ionizes weakly to form H+ and OH− ions—or more
correctly, H3O+ and OH− ions. You can think of this as happening in the following two
reactions:

Acid molecules added to water will dissociate and release protons. This drives reaction 2 to
form more H3O+ ions in the solution, in turn driving reaction 1 forward. A pH meter measures
the relative acidity or concentration of protons in a solution. Acidic solutions have a pH
below 7.0 (neutrality). Bases ionizing in water release hydroxyl (OH−) ions. The increase in
OH−ions removes protons from the solution, driving both reactions in reverse and raising the
pH of the solution. To summarize acid-base chemistry: when dissolved in water, acids release
H+, while bases accept H+. Since the pH of a solution is the negative logarithm of the
hydrogen ion concentration, the following are true:
• A solution at pH 7.0 is neutral.
• A solution below a pH of 7.0 is acidic.
• A solution above a pH of 7.0 is basic.
Check a basic chemistry textbook to be reminded of the relationship between pH and the
[H+] in a solution!

2.5

Basic Biochemistry: Monomers, Polymers; Macromolecular
Synthesis, Degradation

Like evolution, the origin of life involved a prebiotic chemical selection— a kind of “natural
selection” of environmental chemicals that favored increasing biochemical possibilities and
diversity.
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In simple terms, atoms that could interact with a maximal number of other atoms to form the
largest number of stable molecules would have been most likely to accumulate in the
environment. The tetravalent C atom met these criteria for chemical selection, proving ideal
for building an organic chemistry set.
At the same time, water turned out to be the perfect place to launch prebiotic
chemical selection experiments. Water persists as life’s universal solvent, which explains why
evidence of water in places beyond our Earth (e.g., other planets in our solar system, the
moons of other planets, and other planets in other solar systems) gets us all excited!
2.5.1

Isomerism in Organic Molecules and the Diversity of Shape

The carbon skeleton is a perfect platform for organic molecule diversity. The different
possible arrangements of atoms and functional chemical groups around C atoms result in
isomerism. Isomers of an organic molecule have the same chemical formula but different
shapes, and thus, potentially different chemical properties and biochemical functions. The
larger the C-skeleton of an organic molecule, the greater the diversity of molecular shapes
available for chemical selection. Look at the examples of structural isomers and geometric
isomers in Figure 2.10.

Fig. 2.10: Structural and geometric isomers of hydrocarbons create molecules with the same chemical
formula but different shapes.

It is easy to see that the structural isomers of C4H10 (Figure 2.10, top panel, left and right)
have different shapes. You cannot convert one structural isomer to the other without breaking
covalent bonds. In the geometric isomers of C4H8 in the lower panel, the H atoms on the
double-bonded C atoms can be on the same (cis) or opposite (trans) side of the planar double
bond. Geometric isomers, too, cannot be interconverted without breaking chemical bonds.
Optical isomers are a third kind of isomer. They exist around optically active (asymmetric or
chiral) carbons. A chiral C is one that is covalently linked to four different atoms and/or
molecular groups.
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The principle of chirality is illustrated in Figure 2.11.

Fig. 2.11: The two different generic molecules (an enantiomeric pair) are mirror images of one
another. They form from alternate arrangements of the same molecular groups around a chiral carbon.

A pair of molecules that can exist as different optical isomers is called an
enantiomer. Each optical isomer of an enantiomeric pair structurally identical, but differs in
shape from its mate. Just like structural and geometric isomers, they can’t be interconverted
without breaking and remaking covalent bonds. A molecule is defined as optically active
because it bends (rotates) a plane of light in opposite directions in a polarimeter: light
passing through a solution of one optical isomer is rotated in one direction, while light
passing through the other isomer is rotated in the opposite direction. These directions are
referred to as l for levo (meaning left) and d for dextro (meaning right). If a molecule has more
than one chiral C (e.g., glucose has four chiral carbons), it comprises 4 enantiomers! The
behavior of such a multi-chiral molecule in a polarimeter will be based on the sum of the
optical activities of all the chiral carbons.
The common enantiomer of glucose in our diet, (d)glucose, is the enantiomeric pair
shown in Figure 2.12 below. These optical isomers are also called D glucose and L glucose, a
convention based on the configuration of the four different atoms or groups around the last
optically active carbon in a molecule C5 in this case.

Fig. 2.12: Two straight-chain forms of glucose - (d)glucose and (l)glucose - are enantiomers (optical
isomers), differing in the arrangement of the H atom and the OH group around C5.
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For glucose, d and l in fact correspond to D and L, respectively. As we will see for
some molecules, the uppercase designation of a chiral molecule does not always indicate
how it bends light in a polarimeter, while the lowercase d and l always do! The chiral carbons
in glucose are shown in red above.
Remember that the shape and chemical properties of a molecule dictate its function.
Isomerism in organic (carbon-based) molecules would have increased the diversity of
molecular shapes available for chemical selection. Early selection of isomers (specific optical
isomers in particular) during chemical evolution contributed greatly to the chemical
functions and reactions we recognize in cells now, even before there was life on Earth. All life
uses the same isomers of glucose in energy reactions and of amino acids in protein-building,
a fact that confirms the prebiotic selection of those isomers!
2.5.2

Monomers to Polymers and Back: Dehydration Synthesis and Hydrolysis

All living things build and break down polymers (macromolecules) by dehydration synthesis
(condensation reactions) and hydrolysis, respectively. Dehydration synthesis and hydrolysis
reactions are essentially the reverse of each other (Figure 2.13).

Fig. 2.13: A generic monomer is linked to a growing polymer by water removal (dehydration synthesis).
Water addition across the linkage between monomers (hydrolysis) breaks the polymer back down to
monomers.

Condensation reactions build macromolecules by removing a water molecule from
interacting monomers. The “bond” that forms in a condensation reaction is not a single bond;
rather, it is a linkage involving several bonds! Polymer synthesis happens when an OH from
one monomer and an H group from another are removed and combine to form a water
molecule.

126 Organic Molecules, Monomers, & Polymers
Cells perform repeated dehydration synthesis reactions to build diverse polymers,
including polysaccharides and polynucleotides (the RNA and DNA nucleic acids). Repeated
condensation reactions between two amino acids (Figure 2.14, below) form the peptide
linkages that build polypeptides during translation.
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Fig. 2.14: Dehydration synthesis forms peptide linkage (circled) between amino acid monomers.
Hydrolysis, the reverse reaction is also shown. Hydrolysis, the reverse reaction is also shown.

Next let’s consider the polymerization of glucose. Natural selection settled on using
the (d)glucose optical isomer for energy metabolism - all living things do it! And none of
them, with one known exception (a plant bacterial pathogen) either contain or use the
(l)glucose isomer. In solution, straight-chain (d)glucose becomes cyclic as shown in Figure
2.15.

Fig. 2.15: When straight-chain glucose forms a cyclic molecule in solution in water, C1 becomes
optically active (chiral), creating a racemic mixture of (d)glucose and (d)glucose enantiomers.
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Having selected (d)glucose for most cellular energy metabolism, life then exploited
the cyclic (d)glucose to make the different polysaccharide polymers we now find in plants
and animals. Recall that in glucose, C2, C3, C4 and C5 are optically active carbons. As
(d)glucose becomes cyclic, the molecule gains a fifth chiral carbon, namely, the #1 carbon
(C1), forming (d)glucose and β(d)glucose in equal amounts.
Straight-chain and cyclic glucose exist in equilibrium in solution, with 90% of
glucose monomers in the cyclic form. (d)glucose and β(d)glucose are also in equilibrium,
each at 45% of the total dissolved glucose. Furthermore, the reaction forming cyclic glucose
is reversible, with (d)glucose easily converting to β(d)glucose as cells consume the latter
(and vice versa). This is an especially important property since the two enantiomers (optical
isomers) are used differently, especially in plants.
It is the cyclic forms of glucose that are polymerized. The condensation reactions
shown in Figure 2.16 link (d)glucose monomers to form storage polysaccharides, and
β(d)glucose to make structural polysaccharides..

Fig. 2.16: Glucose monomers polymerize by dehydration synthesis (essentially a reversal of hydrolysis)
to form polysaccharides. (d)glucose monomers polymerize to form energy-storage molecules (e.g.,
starch and glycogen); (d)glucose monomers polymerize to form structural polysaccharides (e.g.,
starch and cellulose).
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The –OH ions (hydroxyl groups) on the C1 of (d)glucose are below the glucose rings. The
condensation reaction removes a water molecule, linking the sugars by an 1,4 glycoside
linkage in the dimer, connecting them by their C1 and C4 carbons. Other linkages are
possible. For example, diverse -glycoside linkages characterize branched storage
polysaccharides—like glycogen in animals and starches in plants. On the other hand, when
(d)glucose isomers polymerize, they form rigid structural polysaccharides, such as those of
cellulose in plant cell walls. A modified -glucose called N-acetyl glucosamine (not shown)
polymerizes to form chitin, the principal component of fungal cell walls and of the tough
exoskeleton of arthropods (e.g., insects and crustaceans). Later, when we look at translation
we’ll consider why only L amino acids are used to make polypeptides! And when we look at
replication and transcription, we’ll see the condensation reactions that form phosphate ester
(phosphodiester) linkages when DNA and RNA are synthesized from nucleotide monomers.
Summarizing the role of condensation reactions in the formation of biological polymers:
• Linkages in biopolymers are broken down and re-formed daily in our lives! Digestion (the
breakdown) begins after a meal. The hydrolysis of glycoside linkages starts in your
mouth. Further polysaccharide digestion and the breakdown of peptide (among other)
linkages continues in your stomach and small intestines. Then our cells use condensation
reactions to finish the job of turning carrot- and cow-derived monomers into you and me!
• Prebiotic chemical evolution has selected only one each of the optical isomers of glucose,
amino acids, and other enantiomeric monomers with which to build polymers. This is so
even though some of the different isomers are available and even used by cells for
different purposes. The flexible (d)glucose polymers were selected as storage
polysaccharides to be used for energy. The storage polysaccharides include plant
starches and animal glycogen. Likewise, the rigid inflexibility of (d)glucose polymers
was selected precisely because it reinforced cell structure and stability. Since all
organisms store carbohydrate energy in (d)glucose polymers, and since (d)glucose
polymers are almost universally used to strengthen cell structure, these selections must
have occurred early in the history of life.

127-2 Carbohydrates: Sugars and Polysaccharides

128-2 Lipids, Triglycerides, and Phospholipids

129-2 Proteins: Amino Acids and Polypeptides

130-2 130-2 Nucleic Acids: Nucleotides, DNA, and RNA
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2.5.3

A Tale of Chirality Gone Awry

To conclude this chapter and to emphasize the significance of chirality to life, here is what
can happen if the wrong isomer ends up in the wrong place at the wrong time….
Consider the story of thalidomide, a tragic example of what happens when we are
unaware of enantiomeric possibilities. Introduced in 1957, thalidomide was sold as an overthe-counter anti-nausea drug for patients undergoing cancer therapies and as a very effective
morning-sickness remedy for pregnant women. However, by the early 1960s, the births of
about ten thousand infants with severely deformed limbs were connected to the drug. These
deformities characterized roughly half of these infants that survived. Once the connection
was made, the response was, of course, to pull thalidomide off the market.
Thalidomide is a teratogen. Teratogens are substances or conditions (drugs,
chemicals, radiation, illness during pregnancy…) that cause deformities during
embryogenesis and fetal development. The chemical bases of thalidomide’s effects are based
on its enantiomeric (chiral) structure, in which an amine-containing ring can exist in front of
or behind the rest of the molecule. The optical isomers of thalidomide are shown below in
Figure 2.17.

Fig. 2.17: Two enantiomers (optical isomers) of thalidomide (R and S) form in water.

The two optical isomers are referred to as “S” and “R.” Of these, the S isomer is the
teratogen. While synthesis of pure R is possible, when used in treatment, R and S easily
interconvert, creating a racemic mixture (recall that - and -(d)glucose are such a solution.
In the mother, S isomers are transferred to the embryo or fetus, with terrible consequences.
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Remarkably, there were relatively few cases of thalidomide-induced birth deformities
in the United States, largely because of the efforts of 2.1Frances Oldham Kelsey, the person in
charge of the FDA’s review of the drug. The German pharmaceutical company Chemie
Grünenthal (developer of Thalidomide) and an American pharmaceutical company had
applied for FDA approval for US distribution of the drug. Dr. Oldham Kelsey refused
approval on multiple occasions, arguing that the safety of thalidomide had not been
demonstrated. This was even before it was shown to cause birth deformities! In 1962
President John F. Kennedy presented her with the President’s Award for Distinguished
Federal Civilian Service for not allowing thalidomide to be approved for sale in the United
States without sufficient safety testing—potentially saving thousands of lives.
Of course, we already knew that cells synthesized polymers from specific optical
isomers of their precursor monomers. So the sad thalidomide story resulted from the untested
effects of an unexpected optical isomer. Many countries quickly tightened their preapproval
drug-testing regulations because of this tragedy.
In a more hopeful twist of the tale, thalidomide has turned out to be effective in
treating cancer, leprosy, rheumatoid arthritis, and other autoimmune diseases. Such
therapeutic benefits may be due to its anti-inflammatory effects. The effects of thalidomide on
tumor growth seem to be due to its inhibition of angiogenesis (development of blood vessels)
in the tumors. Ironically, blockage of angiogenesis may also have contributed to the failure of
proper limb growth during pregnancy.
To conclude, when all is normal, the shapes of molecules have been uniquely
selected for the specificity of reactions essential to life.

131-2 Shape and the Specificity of Molecular interactions
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Chapter 3

Details of Protein Structure
Protein structure and configuration: primary, secondary, tertiary, quaternary; protein folding,
domains and motifs, studying proteins
Reminder: For inactive links, google key words/terms for alternative resources.

3.1

Introduction

Protein molecules, which are each comprised of one or more polypeptides, are the workhorse of
the cell, responsible for just about all aspects of life:
•

They are the catalysts that make biochemical reactions possible.

•

They are membrane components that selectively let substances in and out of cells.

•

They allow cell–cell communication and cell response to environmental change.

•

They form the internal structure of cells (cytoskeleton) and nuclei (nucleoskeleton).

•

They enable the motility of cells and e.g., particles and organelles within cells.

•

They are responsible for other cell functions too numerous to summarize here!

We owe much of what we know about biomolecular structure to the development of Xray crystallography. In fact, an early determination of the structure of insulin (as well as
penicillin and vitamin B12) using X-ray crystallography earned Dorothy Hodgkin the 1964
Nobel Prize in Chemistry. In this chapter, we look at the different levels (orders) of protein
structure and at what it takes to be a functional protein. The primary structure (1o structure) of
a polypeptide is its amino acid sequence.
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Interactions between amino acids near each other in the sequence will cause the
polypeptide to fold into secondary (2o) structures, including the −helix and the −pleated
sheet (or just −sheet) conformations. Tertiary (3o) structures form when noncovalent
interactions occur between amino acid sidechains at some distance from one another in the
primary sequence, causing a polypeptide to further fold into a more complex 3D shape. Other
proteins (called chaperones!) facilitate the accurate folding of a polypeptide into its correct,
bioactive, 3D conformation. Quaternary (4o) structure refers to proteins made up of two or
more polypeptides. Refer to the four levels or orders of structure in Figure 3.1 as we explore
how each level affects the shape and biological/biochemical function of the protein.

Fig. 3.1: Three orders (levels) of protein structure describe polypeptides: primary (upper left),
defined by peptide bonds between amino acids), secondary (upper right), based on H-bonds
between amino and carboxyl groups of nearby amino acids in a polypeptide chain, and tertiary
(lower left), based mostly on non-covalent interactions between amino acid side-chains in a
polypetide). A fourth order of protein structure, or quaternary structure (lower right) applies to
proteins composed of two or more polypeptides.

In addition to protein structures dictated by noncovalent interactions, we’ll see
covalent bonds between specific amino acids (e.g., cysteines) that end up near each other after
folding. These function to stabilize tertiary and quaternary structures. Many proteins must also
bind metal ions (e.g., Mg++, Mn++) or small organic molecules (e.g., heme) to become
biologically active. Finally, we look beyond these orders of structure at protein domains and
motifs, which evolved to perform specific protein functions.
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As we try to understand molecular (especially macromolecular) function, a clear
recurring theme emerges: a protein’s function depends on its shape, its conformation. In turn,
protein conformation is based on the location and physical and chemical properties of critical
functional groups, usually amino acid side chains. Watch for this theme as we look at enzyme
catalysis, the movement of molecules in and out of cells, the response of cells to changing
environments, the ability of cells to travel, the ability of organelles to move around inside of
cells, the process of DNA replication, the regulation of gene transcription and protein
synthesis… and just about everything a cell does!
We will conclude this chapter with a look at some techniques for studying protein
structure.

Learning Objectives
When you have mastered the information in this chapter, you should be able to do the
following:
1. Define and distinguish between the orders of protein structure.
2. Differentiate between −sheet,  helix, and random coil structures based on the atomic
interactions involved on each.
3. Trace the path to the formation of a polypeptide, define its primary structure and explain
how its final structure might be determined by its amino acid sequence.
4. Describe how globular proteins arise from the hydrophobic and hydrophilic interactions
that drive protein folding and how changes in protein shape can cause disease.
5. Formulate a hypothesis (or look one up) to explain why the amino acid glycine is a
disruptor of alpha-helical polypeptide structure.
6. Compare and contrast motif and domain structure of proteins and polypeptides, as well as
their contributions to protein function.
7. Describe different techniques for studying proteins and explain what physical/chemical
differences and features might distinguish between proteins that make each technique
possible.

3.2

Levels (Orders) of Protein Structure

The three levels of polypeptide structure are primary, secondary, and tertiary structure.
Quaternary structure arises from an association of two or more polypeptides that create higherorder protein structures. Superimposed on these levels, or orders. are still other features of
protein structure. These are created by the specific amino acid configurations in a mature,
biologically active protein. Let’s begin with a look at primary structure.
3.2.1

Protein Primary Structure: L-Amino Acids and the -C-C-N- Polypeptide Backbone

The primary structure of a protein simply refers to the amino acid sequence of its polypeptide
chain(s). Cells use only twenty amino acids to make polypeptides and proteins, although they
do use a few additional amino acids for other purposes. The peptide linkages between amino
acids in polypeptides form in condensation reactions in cells during protein synthesis (i.e.,
translation). The linkages involve multiple covalent bonds. They break and rearrange between
the carboxyl and amino groups of amino acids during linkage formation.
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The twenty amino acids found in proteins are shown below in Figure 3.2.

Fig. 3.2: Chemical characteristics of the twenty amino acids found in the proteins of cells. All
side chains (R groups) are shown at the bottom of each structure, bound to an  carbon.

In all twenty amino acids (except glycine), the −carbon is bound to four different
groups, making them chiral or optically active.
CHALLENGE: Circle the -carbon in each of the amino acids in Figure 3.2.
Why is glycine not optically active?
3.2.1.a Peptide Bond Formation and Polypeptide Primary Structure
Recall that chiral carbons allow for mirror image D and L (or d and l) optical isomers.
Remember, only the lower-case d and l define the optical properties of isomers. Just to make
life interesting, L–amino acids are dextrorotary in a polarimeter, making them (d)–amino
acids! While both (d)– and (l)–amino acid enantiomers exist in cells, only (d)– (i.e., L–) amino
acids (along with glycine) are used by cells to build polypeptides and proteins by the process
called translation.
We say that polypeptides have polarity because they have “free” carboxyl ends and “free”
amino ends. Within a polypeptide, amino acid side chains end up alternating on opposite
sides of a C-C-N-C-C-N-… polypeptide backbone because of covalent-bond angles along the
backbone. You can prove this to yourself by making a short polypeptide with the kind of
molecular modeling kit you may have used in a chemistry class! The C-C-N-C-C-N- backbone
is the underlying basis of higher orders (or levels) of protein structure. A partial polypeptide is
shown below in Figure 3.3.
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Fig. 3.3: The amino and carboxyl ends of a polypeptide define its polarity, with positively charged
amino and negatively charged carboxyl ends at physiological pH. The positions of the circled amino
acid R groups alternate along the polypeptide backbone. The two R groups in the carboxyl region
(right) are hydrophobic; the two in the amine region (left) are polar.

132-2 Amino Acid Sequence & Protein Primary Structure
3.2.1.b Determining Protein Primary Structure—Polypeptide Sequencing
Primary structure is dictated directly by the gene encoding the protein. After transcription of a
gene, a ribosome translates the resulting mRNA into a polypeptide. Frederick Sanger
demonstrated the first practical protein sequencing method when he reported the amino-acid
sequence of the two polypeptides of bovine (cow) insulin. His technique involves stepwise
hydrolysis (called an Edman Degradation) of polypeptide fragments; each hydrolysis leaves
behind a single amino acid that can be identified, and a polypeptide fragment shortened by
one amino acid. Sanger received a Nobel Prize in 1958 for this feat. By convention, the display
and counting of amino acids always starts at the amino end (N-terminus), the end with a free
NH2-group (as suggested in Figure 3.3).
For some time now, the sequencing of DNA has replaced most direct protein
sequencing. The method of DNA sequencing, colloquially referred to as the Sanger dideoxy
method, quickly became widespread and was eventually automated, enabling rapid gene (and
even whole-genome) sequencing. Now, instead of sequencing polypeptides directly, we can
infer amino-acid sequences from gene sequences isolated by cloning or revealed after
complete genome sequencing projects. This is the same Sanger who first sequenced proteins,
and yes, he won a second Nobel Prize for the DNA sequencing work in 1980!
CHALLENGE: Both optical forms of amino acids exist in cells, but only the
L-isomer occurs in biological proteins. When and why do you think that Lamino acid isomers were selected for use in proteins of living cells today?
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The different physical and chemical properties of each amino acid result from the side chains
on its −carbons. The unique physical and chemical properties of polypeptides and proteins
are determined by their unique combination of amino acid side chains and their interactions
within and between polypeptides. In this way, primary structure reflects the genetic
underpinnings of polypeptide and protein function. The higher-order structures that account
for the functional motifs and domains of a mature protein derive from its primary structure.
Christian Anfinsen won a half share of the 1972 Nobel Prize in Chemistry for demonstrating
that this was the case for the ribonuclease (RNAse) enzyme; Stanford Moore and William H.
Stein earned their quarter shares of the prize for relating the structure of the active site of the
enzyme to its tertiary structure and its catalytic function. See 3.1Anfinsen et al. 1972 Chemistry
Nobel Prize for more.
3.2.2

Protein Secondary Structure

Secondary structure refers to highly regular local structures within a polypeptide (e.g.,
−helix) and either within or between polypeptides (−pleated sheets). Linus Pauling and his
coworkers suggested these two types of secondary structure in 1951. A little Linus Pauling
history would be relevant here! By 1932 Pauling had developed his electronegativity scale of
the elements, which could predict the strength of atomic bonds in molecules. He contributed
much to our understanding of atomic orbitals and later of the structure of biological molecules.
He earned the 1954 Nobel Prize in Chemistry for this work. Pauling and his colleagues went
on to predict the  helical and −pleated sheet secondary structure of proteins (Figure 3.4,
below).

Fig. 3.4: Left: a computer-generated 3D image (left) shows -helical and pleated sheet “ribbon”
regions separated by less-organized random-coils of amino acids in each of the two polypeptides
(upper pink and lower green) of a two-subunit protein. The -pleated sheet regions are shown as
aligned arrow-ribbons. Right: Pleated sheet structures result when hydrogen bonds form between
adjacent regions shown at the right.
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In 1962, Max F. Perutz and John C. Kendrew earned the Nobel Prize in Chemistry for
their X-ray crystallographic studies of the 3D structure of hemoglobin, confirming some pf
Pauling’s predictions. Although Pauling did not earn a second Nobel for his studies predicting
hemoglobin protein structure, he did win the 1962 Nobel Peace prize for convincing almost ten
thousand scientists to sign a petition to the United Nations urging a vote to ban atmospheric
nuclear bomb tests. Clearly, 1962 was a good year for Nobel prizes for ‘hemoglobinologists’!
More about Pauling’s extraordinary life (e.g., at 3.2L. Pauling-a Short Biography) is worth a
read!
Secondary structure conformations occur due to the spontaneous formation of
hydrogen bonds between amino groups and oxygens along the polypeptide backbone, as
shown in the two left panels in Figure 3.4. Note that amino acid side chains play no significant
role in secondary structure. The  helix or  sheets are the most stable arrangement of H-bonds
in the chain(s), and both are typically found in the same protein (on the right in Figure 3.4).
These regions of ordered secondary structure in a polypeptide can be separated by varying
lengths of less-structured peptides called random coils.
As illustrated in Fig. 3.4, all three of these protein secondary structure features can be
found in a single or polypeptide (left) or in each of the polypeptides of a multi-subunit protein
(right), each of which has already folded into its tertiary structure (see below) Pleated sheets
are shown as ribbons with arrowheads representing N-to-C or C-to-N polarity of the sheets. As
you can see, a pair of ribbons, (peptide regions forming a pleated sheet, may do so either in the
parallel or antiparallel directions. Whether aligned ribbons are parallel or antiparallel depends
on other influences on how the polypeptide(s) will fold to form tertiary structure.
Some polypeptides never go beyond their secondary structure, remaining fibrous and
insoluble. Keratin is perhaps the best-known example of a fibrous protein, making up hair,
fingernails, bird feathers, reptilian (but not fish!) scales, and even one of the filaments of the
cytoskeleton. However, most polypeptides and proteins do fold and assume tertiary structure,
becoming soluble globular proteins.

133-2 Protein Secondary Structure
3.2.3

Protein Tertiary Structure

Polypeptides acquire their tertiary structure when hydrophobic and nonpolar interactions
between amino acid side chains spontaneously draw them together to exclude water. This
folding is aided by the formation of salt bridges and H-bonds between polar side chains in the
interior of the globular polypeptide, incorporating  helices and  sheets into globular shapes.
Polar (hydrophilic) side chains with no other polar side-chain partners typically stay on the
outer surface of the “globule,” interacting with water to dissolve the protein (recall water of
hydration). Though based on noncovalent bonds, tertiary structures are nonetheless strong
simply because of the large numbers of otherwise-weak interactions that form them. The forces
that cooperate to form and stabilize 3D polypeptide and protein structures are illustrated below
in Figure 3.5.
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Fig. 3.5: Tertiary structure is created by noncovalent hydrophobic (non-polar) amino acid interactions as
well as H-bonding and ionic interactions in the interior of a polypeptide, leaving charged (hydrophilic)
amino acid side chains to interact with water on the exterior of a typical “globular” protein. Covalent
disulfide bonds between cysteine amino acids help stabilize tertiary structures.

Covalent disulfide bonds between cysteine amino acids in the polypeptide (shown in
Figure 3.5) can further stabilize tertiary structure. Disulfide bonds (bridges) form in a
polypeptide when cysteines far apart in its primary structure of the molecule end up near each
other. Then the SH (sulfhydryl) groups in the cysteine side chains are oxidized, forming the
disulfide (-S-S-) bonds (Figure 3.6).

Fig. 3.6: Disulfide bonds (or bridges) form when cysteine amino acids in one or more polypeptides
end up near each after it (or they) fold into higher-order structures. Oxidation reactions between the
close SH (sulfhydryl) groups (left) result in linking their two sulfurs in a disulfide bond, or bridge (right).

134-2 Protein Tertiary Structure

135-2 Disulfide Bridges Stabilize 30 Structure
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Disulfide bridges in a protein are crucial to the active protein. Imagine how changes in
temperature or ionic strength would disrupt noncovalent bonds required for the correct 3D
shape of the active protein. Unaffected by such changes, disulfide bridges limit the disruption
and enable proteins to refold correctly when conditions return to normal (think homeostasis!).

CHALLENGE: Disulfide bonds are more common in blood proteins than in
intracellular proteins. Since cytosol is typically a reducing environment,
cysteines tend to be reduced (i.e., in the –SH state). What does this tell you
about blood?

As we’ll see, protein activity can be regulated by chemical modification (e.g., phosphorylation).

3.3

Changes in Protein Shape Can Cause Disease

While the conformation of a protein determines its biological function, an allosteric (shape)
change can moderate or disrupt its function. Under normal circumstances, cells use changes in
protein shape to regulate metabolism. Such allosteric regulation is well documented in familiar
biochemical pathways such as glycolysis and is discussed in more detail elsewhere. Less well
understood is how (or why) conformational change in some protein’s cells can have
devastating effects.
3.3.1

Sickle Cell Anemia

Mutations of globin genes can cause hemoglobin disorders characterized by inefficient oxygen
delivery by blood. In the 1940s, the British biochemist J. B. S. Haldane studied southern
African regions and made a correlation between high incidences of hemoglobin disorders and
low incidences of malaria, suggesting that heterozygous individuals (i.e., those that had only
one copy of a mutant hemoglobin gene) were somehow protected from malaria. Sickle cell
anemia is a well-known example of a hemoglobin disorder and is caused by a single base
change in the gene for human −hemoglobin (one of the polypeptides in hemoglobin). Since
red blood cells are rich in hemoglobin, the abnormal shape of the −hemoglobin can cause the
cells themselves to become sickle shaped. Sickle cells disrupt capillary flow and oxygen
delivery, causing the symptoms of anemia.
While sickle cell anemia originated in Africa, it probably spread to the United States
because of the slave trade. It may even have abetted the slave trade. Europeans exploiting
their African colonies’ natural resources were dying of malaria, but African natives seemed
unaffected. Europeans, having brought stowaway malarial mosquitos to the new world in the
first place, figured that enslaved Africans would survive the illness in the Americas.
We know now that individuals heterozygous for the mutant −hemoglobin suffer sicklecell trait and are generally unaffected, because at least some of their hemoglobin is normal.
Homozygous individuals that make only the sickle-cell −hemoglobin variant suffer more
frequent and more severe episodes of the disease. Stressors that can trigger sickling include
infection or dehydration. Compare normal red blood cells to a sickle cell below in Figure 3.7.
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Fig. 3.7: Light micrograph of a sickled erythrocyte (the red blood cell at the top).

The sickle-cell gene mutation affects perhaps more than one hundred million people
worldwide, including 8–10% of African Americans. For more demographic information, see
3.3
Sickle Cell Trait Demographics and 3.4Sickle Cell Data. In Africa, heterozygotes with sicklecell trait are protected from malaria, confirming Haldane’s hypothesis. But patients
homozygous for the −hemoglobin mutation derive little benefit from its antimalarial effects.
In the meantime, despite a 33% reduction in cases of malaria in recent years, this
disease, caused by a mosquito-borne parasite, still threatens half of the people on the planet,
causing over a half-million deaths per year. There are treatments (other than mosquito nets
and killing mosquitos), but at this time there is still no preventive vaccine.
3.3.2

The Role of Misshapen and Misfolded Proteins in Alzheimer’s Disease

Prion proteins, when first discovered, seemed to behave as infectious agents that could
reproduce without DNA or other nucleic acid. As you can imagine, this highly unorthodox and
novel hereditary mechanism generated its share of controversy. Read about research on the
cellular prion (PrPc) protein at 3.5Wikipedia Take on Prions.
Of course, prions turned out not to be reproductive agents of infection after all. Recent studies
of prions have revealed several normal prion protein functions, including roles in memory
formation in mice and sporulation in yeast (check out 3.6Prion Proteins and the Formation of
Memory).
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A mutant version of the prion protein (PrPSc) was discovered that could mis-fold and to
take on an abnormal shape. The deformed PrPSc could then go on and induce abnormal folding
in other, normal PrPc molecules. These events, illustrated in Figure 3.8, result in the formation
of so-called amyloid plaques.

c

Fig. 3.8: Mutations in the gene for the normal prion PrP protein (left) may produce some abnormally
Sc
Sc
folded prion PrP proteins (at the right). The misfolded PrP molecules interact with other (even normal)
Sc

prions, causing them to mis-fold, precipitating PrP proteins into aggregated amyloid plaques.

Abnormally folded prions (PrPSc) have been associated with Alzheimer’s disease, which
affects about 5.5 million Americans. PrPSc is also associated with mad cow disease and
Creutzfeldt-Jakob disease (mad cow disease in humans), as well as scrapie in sheep, among
others. We are beginning to understand that the role of prion proteins in Alzheimer’s disease
is less causal than indirect.
3.3.2.a The Amyloid Beta (A) peptide
Postmortem brains from patients Alzheimer’s disease patients show the characteristic
extracellular amyloid plaques. These plaques were shown to be composed largely of betaamyloid (A) peptides. In affected cells, an amyloid precursor protein (APP) is enzymatically
digested, generating thirty-nine to forty-three extracellular amino acid (A ) amyloid peptide
fragments.
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Normally, excess (A) peptides are themselves digested. However, an unregulated (A) peptide
accumulation leads to the formation of the beta-amyloid plaques seen in Alzheimer’s disease
(Figure 3.9).

Fig. 3.9: Cell membrane amyloid precursor protein (APP, left) is enzymatically cleaved to release -amyloid
peptide fragments (middle) that aggregate, forming the characteristic amyloid plaques of Alzheimer's disease

The scissors in the illustration represents two enzymes that digest the APP. Prion
proteins are not a proximal cause of Alzheimer’s disease but may have a role in initiating
events that lead to it. Normal prion protein (PrPc) is itself a membrane receptor and is thought
to bind (A) peptides, effectively preventing their aggregation into plaques. An experimental
reduction of PrPc was shown to increase the extracellular (A) peptides. Presumably, prion
protein aggregation induced by the mutant PrP protein (PrPSc) prevents prion proteins from
binding to (A) peptides, leading to (A) peptide accumulation and ultimately to amyloid
plaque formation and neurodegeneration.
3.3.2.b The Tau Protein
The tau protein is also associated with Alzheimer’s disease. MAP-T (Microtubule-Associated
Protein-Tau) is as its name indicates, one of several microtubule-associated proteins (MAPS).
In normal neurons, MAP-T is phosphorylated, and the phosphorylated MAP-T binds to, and
stabilizes microtubules. But misshapen tau that accumulates in neurofibrillary tangles in
hippocampus brain neurons may be a more immediate cause of the neuronal dysfunction
associated with Alzheimer’s disease than (A) peptides.
When neuronal tau becomes hyperphosphorylated, its conformation changes, making it
unable to associate with microtubules. No longer stabilized, the microtubules disassemble and
the deformed tau proteins form neurofibrillary tangles. Immunostaining of hippocampal
neurons with antibodies against tau protein localizes the neurofibrillary tau protein tangles, as
seen in the light micrograph below (Figure 3.10).
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Recent studies suggest further that at least two structurally related tau proteins
isoforms make up the tau tangles (3.7Multiple tau proteins in a Tangle).

Fig. 3.10: Non-fluorescent immunostaining micrograph of tau proteins in brain cells of an Alzheimer’s
brain; pointers indicate tau tangles.

The formation of neurofibrillary tau protein tangles in a diseased neuron is compared
to normal neurons in Figure 3.11. The tangled clumps of tau proteins in this illustration are
what appear as deep purple in Figure 3.10.

Fig. 3.11: The formation of tau tangles (lower left) occurs in diseased neurons that cannot maintain
normal microtubule structure (upper middle). In the absence of stabilizing tau molecules, microtubules
degenerate and tau proteins clump (lower right).
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There is no cure yet for Alzheimer’s disease, although treatments with cholinesterase
inhibitors seem to slow its advancement. For example, the drug Aricept inhibits acetylcholine
breakdown by acetylcholinesterase, thereby enhancing cholinergic neurotransmission, which
may in turn prolong the brain’s neural function.
Sadly too, there is as yet no treatment to restore lost memories or the significant
cognitive decline associated with Alzheimer’s disease. Perhaps more promising in this respect
is a recent development. Proteins or peptides associated with Alzheimer’s disease have been
detected in the blood and serum. Amyloid beta- (A) and/or tau-protein fragments that escape
into the blood stream can be detected six to eight (or more) years before Alzheimer’s symptoms
appear. A neurofilament light chain (NfL) that is seen in a familial form of Alzheimer’s
disease (among other neuropathies) is detectable sixteen years before the symptoms!
The ability to detect these marker proteins and Alzheimer’s-associated peptides so far
in advance of symptoms raises hopes for early monitoring of at-risk individuals and for new
therapies for Alzheimer’s disease. For brief reviews, see 3.8Early Detection of Circulating Ab
Peptides and 3.9Early Detection of Circulating Tau Peptides. For a recent report on tracking the
NfL protein, see 3.10Early Detection of Circulating Neurofilament Light-Chain Protein.
3.3.2.c Some Relatives of Alzheimer’s Disease
Some of the same protein abnormalities seen in Alzheimer’s disease are also seen in other
neurodegenerative diseases as well as traumatic brain damage. An abnormal accumulation of
tau protein is diagnostic of Chronic Traumatic Encephalopathy (CTE).
First described in the early twentieth century, disoriented boxers staggering about after
a fight were called “punch drunk,” suffering from dementia pugilistica. We now know they
suffered from CTE, as do other athletes exposed to repetitive mild-to-severe brain trauma, such
as football players. Immunostaining of whole brains and brain tissue from autopsied CTE
patients using antibodies to tau protein, show accumulations of abnormal tau proteins and tau
neurofibrillary tangles very much like those found in Alzheimer’s patients.
Many National Football League and other football players have been diagnosed
postmortem with CTE, and many still living show signs of degenerative cognition and behavior
consistent with CTE. (See a 3.112020 List of NFL players with CTE to see how many!)
Parkinson’s disease is yet another example of a neurodegenerative disease that results
when a single protein changes shape in brain cells. Though they are not characterized as
plaques, aggregates can form in brain cells when the protein alpha-synuclein undergoes
anomalous conformational change. The change results in MSA (Multiple System Atrophy) or
Parkinson’s disease. To read details of this recent research and how it may lead to treatments,
see 3.12Targeting Alpha Synuclein for Parkinson’s Therapy. Much of the high-resolution
electron microscopy that can reveal details of the structure and conformational changes in
proteins came from the work of Jacques Dubochet, Joachim Frank, and Richard Henderson,
who shared the 2017 Nobel Prize for developing and refining cryoelectron microscopy for
biomolecular imaging (For details, see 3.13Nobel Prize-Cryoelectron Microscopy).
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3.4

Protein Quaternary Structure, Prosthetic Groups, and Chemical
Modifications

Quaternary structure describes proteins composed of two or more polypeptides. Like tertiary
structure, such multimeric proteins are formed by noncovalent interactions and may be
stabilized disulfide bonds. Dimers contain two, a trimer three, a tetramer four polypeptides, and
so on. Multimers made up of identical subunits are referred to with a prefix of homo- (e.g., a
homotetramer). Multimers made up of different subunits are called heteromers. The vertebrate
hemoglobin molecule is a heterotetramer, with two  and two  globins (Figure 3.12).

Fig. 3.12: The vertebrate hemoglobin molecule, consisting of four globin subunits (two − and two
−polypeptides). Each globin is associated with a heme group bound to iron.

Hemoglobins exemplify the role of organic molecules groups in protein function. To be
biologically active, each globin polypeptide must associate with heme (a cyclic organic
molecule) with an iron ion at its center. The iron is what reversibly binds oxygen. All kinds of
organisms, from bacteria to plants and animals (and even some anaerobes!) contain
hemoglobin variants, each with a heme-like molecule. The organic molecules associated with
proteins are called prosthetic groups. Other proteins must be bound directly to metal ions
(e.g., magnesium, manganese, and cobalt) to be biologically active.

136-2 Protein Quaternary Structure & Prosthetic Groups
CHALLENGE: Hemoglobins bind and distribute the oxygen required for
animal respiration. Anaerobic organisms also have hemoglobin. Why?
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Chemical modifications are posttranslational enzyme-catalyzed events, which are
required to make a protein fully functional or to regulate its activity. Many polypeptides are
structurally modified by glycosylation (e.g., to make membrane glycoproteins). Others are
phosphorylated at one or more specific amino acids in the chain, to regulate their biological
activity. These and other modifications account for and enhance the molecular and functional
diversity of proteins within and across species.

3.5

Domains, Motifs, and Folds in Protein Structure

The structures of two different proteins in Figure 3.13 share a common domain: the PH
(Pleckstrin Homology) domain.

Fig. 3.13: The pleckstrin homology (PH) domains shown here in pink (arrows) are examples of common
domains in two different proteins. By virtue of these common PH domains, otherwise different proteins
can interact with the same cell-signaling factors with roles in coordinating intercellular communication.

These two (and many other) proteins have this domain, allowing them to bind a
molecule of phosphatidyl-inositol triphosphate, which is generated as part of a common cellsignaling pathway. The implication of this common domain is that a cell’s signaling pathways
allow it to respond to different signals that lead to the same response, albeit under different
conditions and probably at different times. Proteins are typically described as consisting of
several distinct substructures, discussed here.
A domain is an element of the protein’s overall structure that is stable and often folds
independently of the rest of the protein chain. Like the PH domain above, many domains are
not unique to the protein products of one gene but instead appear in a variety of proteins.
Proteins sharing more than a few common domains are encoded by members of evolutionarily
related genes comprising gene families. Genes for proteins that share only one or a few
domains may belong to gene superfamilies. Superfamily members can have one function in
common, but the rest of their sequences are otherwise unrelated.
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Domain names often derive from their prominent biological function in the protein
they belong to (e.g., the calcium-binding domain of calmodulin) or from their discoverers (the
PH domain). The domain-swapping that gives rise to gene families and superfamilies is a
natural genetic event. Because protein domains can also be swapped on purpose by genetic
engineering, we can make chimeric proteins with novel functions.

137-2 Protein Domain Structure and Function
Protein motifs are small regions of protein 3D structure or of amino-acid sequence
shared among different proteins. They are recognizable regions of protein structure that may
(or may not) be defined by a unique chemical or biological function.

Supersecondary structure refers to a combination of secondary-structure features,
such as beta-alpha-beta units or the helix-turn-helix motif. They may also be referred to as
structural motifs. See 3.14Supersecondary structure for examples.
A protein fold refers to a general aspect of protein architecture, like helix bundle, betabarrel, Rossmann fold, or other “folds” provided in the 3.15Structural Classification of Proteins
database. Look at 3.16Protein Folds to read more about these structures.

3.6

Proteins, Genes, and Evolution: How Many Proteins Are We?

If evolution did not have to select totally new proteins for each new cellular function, then how
many genes does it really take to make an organism? Estimates suggest that it takes from
nineteen thousand to twenty-five thousand coding genes to make and to operate a human and
all its proteins (Check out Pertea and Salzberg at 3.17# of genes in a human genome and
Abascal, F. et al. at 3.18~20% of human genes are mysterious!). But our cells, and those of
eukaryotes generally, may express as many as one hundred thousand different proteins. In
other words, our protein-coding genes seem to be far fewer than the number of proteins we
need to make. How is this possible? It appears that there must be better, more efficient ways to
evolve new and useful complex cellular tasks than evolving more and more new genes!
As we already noted, the use of the same twenty amino acids to make proteins in all
living things speaks to their early (even prebiotic) selection and to the common ancestry of all
living things. Complex conserved domain structures shared among otherwise different proteins
imply that evolution of protein function has occurred as much by recombinatorial exchange of
DNA segments encoding such substructures as by an accumulation of base substitutions in
otherwise redundant genes. Likewise, motifs and folds might also be shared in this way. The
protein count also exceeds gene number in part because cells can produce different mRNA
variants from the same genes by alternate splicing, a process that produces mRNAs that code
for different combinations of substructures from the same gene! Alternate splicing is discussed
in detail in a later chapter. These transcriptional and post-transcriptional phenomena explain
eukaryotic protein numbers, but also the conservation of gene and amino-acid sequences
across species (e.g., histones and globins), the key testimony to their common ancestry.
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Along with the synthesis of alternate versions of a single RNA, an ongoing
repurposing of useful regions of protein structure may prove a strategy for producing new
proteins without adding new genes to a genome.
CHALLENGE: After your readings here (and maybe some extra research),
cite examples of additional proteins that share a domain or motif, and
explain why shared domains or motifs might be selected in evolution.

CHALLENGE: Mycoplasma mycoides has a 106 bp-genome encoding only
about a thousand genes. C. Venter (of human genome fame) engineered M.

mycoides to survive with just 473 genes from the related M. capricolum
species (the cause of leprosy and tuberculosis). This is the smallest
genome known to support life (see

3.19Synthetic

Mycobacterium Lives with

Small Genome for more). What are some likely functions of the 473 M.

capricolum genes, and what might proteins encoded by the “other” (nearly
five hundred) genes in normal M. capricolum cells be doing?

3.7

Directed Evolution: Getting Cells to Make New Proteins…for Our
Use and Pleasure

Investigators have long speculated that proteins with useful functions could be adapted to
human use. Enzyme additives in laundry detergents or spot-removers are already used to
digest organic stains. Such enzymes must be extracted from a suitable biological source. But
what if we could engineer even better versions of an enzyme? At the molecular level, protein
evolution is the natural selection of gene sequences that encode functional polypeptides. This
implies that variant “mutant” versions of a gene that encode related polypeptides already exist,
from which nature can select one. Thus, changing environmental circumstances might favor
one variant protein over another. In nature, mutations that could create polypeptide variants
are entirely random. In other words, we humans might wait a very long time before a better
version of a protein, say an enzyme, would be available for human use through natural
selection. Can we speed up the selective process and more rapidly evolve better, more useful
proteins? Yes, we can!
Many industries (e.g., fuel and pharmaceutical industries) have used molecular
techniques to create new proteins. It is possible to clone a desired gene, to make targeted
mutations in the gene, and then to express them in suitable cells. The expressed proteins can
then be screened for example, for mutant enzymes with improved or even novel useful
activities. This is a far cry from older techniques that irradiated or otherwise mutagenized cells
or organisms, which would then be screened for mutants that looked interesting! Since we can
now target mutations to a single specific base within a gene (for example, one that avoids
drastic changes in protein folding), it is possible to study the functional effects of very subtle
conformational changes in a protein.
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The technique, called directed evolution, was originally pioneered by Frances Arnold, who
engineered enzymes that could make renewable fuels (e.g., isobutanol), environmentally
friendly pharmaceuticals, and enzymes that function hundreds of times faster and/or at a
broader temperature range than their naturally occurring counterparts. For these
achievements, Frances Arnold was awarded the Nobel Prize for Chemistry in 2018!

3.8

View Animated 3D Protein Images in the NCBI Database

Viewed by X-ray diffraction, we can see that proteins exhibit exquisite diversity. Look at X-ray
views of protein tertiary (and even quaternary structures at the Cn3D database of the National
Center for Biotechnology Information (NCBI). Using this free tool, you can search for any
protein in the database. As an example, we’ll follow the steps to find human insulin and look at
it from all angles. Here are the detailed steps:
1. To access 3D animated images of proteins from the database, click or copy the link below
into your browser and hit Return: 3.20https://www.ncbi.nlm.nih.gov/structure?db=Structure
2. In the Structure screen than appears (Fig. 3.14), type “normal human insulin” into the
search box and click Search.

Fig. 3.14: Screenshot of NCBI portal to 3D protein structure database based on X-Ray crystallographs.

3. The first batch of X-ray crystallographic insulin structures appears in the Search results
screen below (Fig. 3.15). Scroll down to item 4 and click on its URL link (red arrow), or on
the image itself.
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Fig. 3.15: Screenshot of NCBI protein structure database search leading to available macromolecular
structures for human insulin (21normal human insulin - Structure - NCBI (nih.gov)).

4. If the protein does not start rotating in the next screen (Fig. 3.17 below, click View, then
Rotate, then Autorotate, then any ‘direction’. To control the rotation, click on the molecule
and move the cursor to rotate the molecule manually. When you can roll the molecule
around, like a beautiful marble in your hand, you’ll see its structure and how it might
account for its function.

Fig. 3.16: Screenshot of the dynamic 3D X-Ray structure of a human insulin in the NCBI protein structure
database (223I40(MMDB) in iCn3D (nih.gov)
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To rotate the molecule, click View, then Rotate, then Autorotation, then play with the
directional options…, and then spin…and enjoy!
Some iText & VOP Key Words and Terms
A
-carbon
alpha (a-) helix
allosteric regulation
Alzheimer’s disease
amino-acid residues
amino end
amyloid beta protein
amyloid plaques
beta barrel
beta (b-) sheet
carboxyl end
catalysts
chaperones
configuration
Creutzfeldt-Jakob disease
cytoskeleton
disulfide bonds
Edman degradation

enzymes
functional groups
gene family
gene superfamily
glycosylation
helix-turn-helix motif
hemoglobin
hydrophobic interactions
levels of protein structure
mad cow disease
multimer
NCBI Cn3D database
neurofibrillary tangles
nucleoskeleton
orders of protein structure
Parkinson’s disease
peptide bonds
peptide linkages
pleated sheet

polypeptide backbone
primary structure
prion
protein folding
PrP
quaternary structure
random coil
recombinatorial exchange
salt bridges
scales, feathers, fingernails
secondary structure
sequence motifs
sickle cell anemia
side chains
structural domain
structural motif
sulfhydryl groups
tau protein
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Chapter 4
Bioenergetics
Thermodynamics (Free Energy, Enthalpy, Entropy) Chemical Energy, Open vs Closed Systems
Reminder: For inactive links, google key words/terms for alternative resources.

4.1

Introduction

Three Laws of Thermodynamics describe the flow and transfer of energy in the universe:
•
•
•

Energy can neither be created nor destroyed. The rule is also stated as “universal energy
is constant.”
Universal entropy (disorder) is always increasing.
Entropy declines with temperature—as temperatures approach absolute zero, so goes
entropy.

In living systems, we do not have to worry about the third law because the equations
for energy exchange in living systems already reflect the temperature dependence of entropy
change during reactions. In this chapter we will look at how we came to understand the basic
thermodynamic principles and how they apply to living systems. First, we will look at different
kinds of energy and at how redox reactions govern the flow of energy through living things.
Next, we’ll look at some simple arithmetic statements of the laws of thermodynamics for
closed systems and at how they apply to chemical reactions conducted under standard
conditions. Finally, since there is really no such thing as a closed system, we look at the
energetics of reactions occurring in open systems. For an excellent discussion about the
application of basic thermodynamic principles to living things, check out Lehninger A. (1971)
Bioenergetics: The Molecular Basis of Biological Energy Transformation. Benjamin Cummings,
San Francisco.
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Learning Objectives
When you have mastered the information in this chapter, you should be able to do the
following:
1. Explain the difference between energy transfer and energy transduction.
2. Compare and contrast potential, kinetic and other kinds of energy (e.g., mass, heat, light).
3. Explain the idea that chemical equilibrium is a dynamic equilibrium
4. Explain the reciprocal changes in universal free energy and entropy.
5. Derive the algebraic relationship between free energy, enthalpy, and entropy.
6. Distinguish between exothermic, endothermic, exergonic, and endergonic reactions.
7. Predict changes in free energy in a chemical reaction based on changes in the
concentrations of reactants and products in closed systems as well as open systems.
8. Predict how and when an endothermic biochemical reaction will release free energy. (You
should be able to do this after working some sample problems of closed system energetics.)
9. Explain how an exergonic reaction occurring in a cell might be energetically unfavorable.
10. Explain and distinguish between the equilibrium and the steady state of reactions.
11. Explain the thermodynamic laws.

4.2

Kinds of Energy

We can easily recognize different kinds of energy around us, like heat, light, electricity,
chemical energy, nuclear energy, sound, etc. These different forms of energy are measurable
(e.g., calories, joules, volts, decibels, quanta, photons). Even mass is a form of energy; recall
Albert Einstein’s e = mc2 equation, the theory of special relativity (or the law of relativity).
CHALLENGE: Nuclear energy arises out of the Theory of Relativity. Explain
this in a sentence or two.
The problem in thinking about thermodynamics is that the universe is so big; there
are too many kinds of energy to contemplate at once! To simplify, let’s imagine only two
kinds of energy in the universe: potential energy and kinetic energy. A helpful example is a
dam. The water above the dam has potential energy. As the water flows over (or through) the
dam, its potential energy is released as kinetic energy. In the old days, the kinetic energy of
flowing water could be used to power (i.e., turn) a millstone to grind wheat and other grains
into flour. These days, water is more likely to flow through a hydroelectric dam, where kinetic
energy is converted (transduced) to electricity.
In this simple view, heat (molecular motion), electricity (a current of electrons), sound
(waves), and light (waves or moving “particles”) are different forms of kinetic energy. The
energy of mass or its position in the universe is potential energy. For example, the energy in
a molecule of ATP is potential energy. Physicists talk a lot about potential energy and about
the flow and conversion kinetic energy.
CHALLENGE: Why are hydroelectric energy, nuclear energy, and potential
energy in coal controversial sources of electricity?

81

Here is an equally simple way to conceptualize energy: it is either useful or useless.
This concept led directly to the arithmetic formulation of the thermodynamic laws. In this
utilitarian way of thinking about energy, useless energy is entropy, while useful energy can be
any of the other forms of energy (potential or kinetic).
Key to understanding bioenergetics is recognizing the differences between closed and
open systems in the universe. Biochemical reactions in a test tube are closed systems that will
reach equilibrium. Closed systems are artificial and can only be created in a laboratory, where
one can restrict and measure the amount of energy and mass entering or escaping the system.
Cells on the other hand (and in fact, every reaction or event in the rest of the universe), are
open systems. Open systems readily exchange energy and mass with their surroundings.
With this introduction, let’s imagine ourselves to be early scientists trying to
understand energy flow in the universe by asking how the laws of thermodynamics apply to
living systems (bioenergetics). We’ll see that the laws can be mathematically demonstrated
precisely because all kinds of energy can be measured and all units of energy (e.g., volts into
calories, light quanta into volts, and joules into decibels, mass into photons…) can be
interconverted.
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4.3

Deriving Simple Energy Relationships

Thermodynamic laws lead us to equations that help us understand how energy moves (flows)
between components of the universe. As we’ll discuss, the universe is most easily thought of
as a giant closed system within which energy can be transferred and even transduced (i.e.,
from one form to another) between those components. We can’t measure energy flow in or
across an entire universe. But we can isolate bits within the universe so that we can quantify
energy as it is transferred or transduced within smaller, more manageable closed systems.
4.3.1

Energy in the Universe: The Universe Is a Closed System

Consider an event, any event. I think we can agree that when stuff happens, the participants in
the happening go from an unstable state to a relatively more stable state. For example, you are
carrying a bag of marbles, the bag tears open, the marbles fall to the floor, then roll and spread
out, eventually coming to a stop. At that point, the marbles are in a more stable state than they
were when you were holding the un-ripped bag.
We can all agree that gravity made the marbles fall out of the bag. We might further
agree to say that the fallen marbles are in a more stable state than they were in the bag in your
hands. That much certainly seems true. If so, we could extend our observation to conclude that
the drive to greater stability is what made the marbles fall! In fact, regardless of the force or
impetus for any event, the science says that the drive to achieve greater stability is what makes
stuff (i.e., events) happen!
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This is the essence of the second law of thermodynamics: all universal energy-transfer
events occur with an increase in stability—that is, an increase in entropy. We’ll consider the
second law and entropy in detail shortly.
The tendency of things to go from unstable to more stable is a natural, rational state of
affairs, as seen with those marbles on the floor or a messy bedroom with clothes strewn about.
Intuitively, mess and disorder are more stable than is a state of order. Of course, marbles
dropping or clothing going from folded and hung to wrinkled on the floor releases energy
(potential energy) as they fall (kinetic energy). If you don’t believe that this release of energy is
real, just think of how much energy you will need to pick up the marbles or to refold your
clothes (after laundering them of course!).
We can model the flow of energy in the universe in a way that is consistent with the
laws of thermodynamics. Since the first law of thermodynamics says that energy can be
neither created nor destroyed, a simple statement of the first law could be the following:

Euniversal = Elight + Eheat + Eelectrical + Emass + …
This equation sums up the different kinds of energy in the universe. In Figure 4.1, consider the
circle (also called a Venn diagram) to be the universe.

Fig. 4.1: Venn diagram depicting all things in the universe including mass and more familiar kinds of
energy. The diagram implies a as a "closed system"; nothing (mass, energy) can enter or exit the
universe, consistent with the first law of thermodynamics.
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From this we conclude that energy cannot get into or out of the universe, but energy
can be transferred within the universe from one place to another or converted from one form to
another. It follows then that Euniversal is the sum of all kinds of energy in the universe and that
this sum is a constant—in other words, universal energy is conserved; in the words of the first
law, universal energy is constant. The following equation expresses this idea; it is a statement
of the first law of thermodynamics:

Elight + Eheat + Eelectrical + Emass + … = a constant
139 First Law of Thermodynamics
In the late nineteenth century, John Venn formalized this visual approach to
segregating things and concepts into circles as a way of logically viewing relationships
between them. The Venn diagrams used in the following figures are simple and help clarify
concepts of energy in the universe. For more complex examples showing overlapping
components of the universe (i.e., those that share some but not all attributes), google “Venn
diagrams.” For our purposes, let’s stay simple and go with the simpler binary notion of useful
and useless energy, our equation shortens to the sum of just two kinds of energy in the
universe:

Euniversal = Guniversal + TSuniversal
In this equation, G is useful energy; it stands for “Gibbs” free energy, named after Josiah W.
Gibbs, who is credited with applying the inductive scientific method to the study of
thermodynamics. S is useless energy (entropy), and T is absolute temperature (included
because of the third law). This equation is also a statement of the first law, and it is shown in
the revised Venn diagram in Figure 4.2.

Fig. 4.2: Since even mass is a form of energy, the universe depicted at the left consists of only two
components: entropy and free energy (defined as energy that is available to do work. The universe
redrawn at the right just redefines free energy as the useful kind, and entropy as useless energy
(the opposite of useful!). Both models are still consistent with the first law of thermodynamics.
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In this binary energy model, it follows that as universal entropy increases, free energy
in the universe must decrease (as graphed in Figure 4.3).

Fig. 4.3: Entropy and free energy have a reciprocal relationship, which is graphed here as it changes
over time. If all activities in the universe proceed by increasing entropy, and if the universe consists only
of free energy and entropy, then as entropy increases, free energy must be decreasing in the universe.

Free or potentially useful energy is higher in more ordered and complex and therefore
relatively unstable systems. Such unstable, ordered systems will release free energy
spontaneously. In other words, stuff (i.e., spontaneous reactions) will happen!

140-2 Second Law of Thermodynamics
4.3.2

Energy Is Exchanged Between Systems in the Universe

While the arithmetic statements about changes in energy are useful concepts, the parameters
are, of course, not measurable! But if we isolate a bit of the universe, we can measure energies
and watch energy flow. If we can measure the amount of energy put into or removed from a
system within the universe, we can write a more useful equation to follow the transfer of
energy between a system and its surroundings:

H = G + TS
In this formula, H is the change () in enthalpy, (i.e., it is the energy entering/leaving the
system in units of heat energy); G is change in free energy; S is change in entropy; and T is
the absolute temperature in degrees Kelvin (K).
Heat given off in a reaction (or other event) is often confused with entropy. True, much
of the increase in entropy that occurs in living things is indeed in the form of random
molecular motion, or heat. But remember that heat can have its uses; not all heat is entropic!
Hence, it is more interesting (and accurate!) to think of energy in terms of changes in
enthalpy, free energy, and entropy during energy transfers. Thus, we must consider the
arithmetic of energy transfers to involve not two, but three terms!
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According to the equation ΔH = ΔG + TΔS, interacting systems in our universe would
seem to be closed systems. Accordingly, energy put into or taken from the system (H) will be
exactly balanced by increases or decreases in the other two terms in the equation (G, TS).
Recall that we say a system is closed not because it is really closed but because we can
isolate it well enough to measure energy flow into and out of it. This or any algebraic equation
with three variables is useful since, if you know two of the values you can calculate the third!
Here is a simple situation to illustrate the point: If I put a liter of water onto a burner and light
the flame, the water gets hot. If the temperature of the liter of water rises by 1 oC, we know that
it has absorbed 1,000 calories (1 kilocalorie, or 1 food Calorie) of the heat from the burner.
Since energy interactions depend on physical conditions, such as temperature and air
pressure, we need to standardize those conditions when we conduct experiments that measure
energy changes in experimentally isolated systems. For more on how this standardization
enables the measuring of energy change in chemical reactions (in fact, any energy exchange),
go to the following link.
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Turning to bioenergetics, let’s apply the equation ΔH = ΔG + TΔS to the conditions in
which chemical reactions occur in cells. Because most life on Earth lives at sea level, where
the air pressure is 1 atm (atmosphere), typical determinations of ΔH, ΔG, and TΔS are made
under defined, well-controlled standard conditions that include “unimolar conditions,” an
absolute T of 298 oK (25oC), 1 atm, and a constant pH of 7.0. The latter is defined as such
because the pH inside of a typical cell is close to neutral. Our equation for reactions under
these standard conditions becomes the following:

H = Go + TS
ΔGo is the standard free energy change for a reaction conducted in a closed system under
standard conditions. ΔH and ΔS are still the enthalpy and entropy changes, but they are
determined under standard conditions.
Now what are those “unimolar conditions”? To meet these conditions, you would
measure the calories released by burning (oxidizing) a small amount, say 180 mg of glucose.
Then just multiply the number of calories released by 1,000 to get ΔH, which equates to the
number of calories that would have been released by burning 180 gm (i.e., the molecular mass,
or a whole mole) of the stuff.
CHALLENGE: From the information provided here, answer the following:
What is the molecular weight of glucose? What is the mass of a mole of
glucose? And how many moles of glucose were burned?
Now we are ready to consider examples of how we determine the energetics of reactions.
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4.3.3

How is Enthalpy Change (ΔH) Determined?

ΔH (the heat released or absorbed) in a chemical reaction can easily be determined by
conducting the reaction under standard conditions in a bomb calorimeter, which is essentially
an inner chamber surrounded by an outer chamber filled with water (Figure 4.4).

Fig. 4.4: Basic design of a bomb calorimeter, with an inner chamber for conducting reactions and an
outer chamber containing water with a thermometer to measure temperature change (heat absorption
or release, or H) during the reaction.

Food manufacturers determine the Calorie content of food by bomb calorimetry. As a
reaction takes place in the beaker, it will either release or absorb heat, either heating or
cooling the water in the calorimeter jacket, as measured by the thermometer. A closed system
reaction that releases heat as it reaches equilibrium is defined as exothermic; the ΔH for an
exothermic reaction is negative. For example, a package says that a chocolate bar has 90
Calories. This means that burning the bar will generate 90 kilocalories (Kcal) of heat as
measured in the calorimeter.
Recall that 1 Calorie (with a capital C) is equal to 1,000 calories, (1 Kcal). One calorie
(cal; lowercase) is the energy needed to raise the temperature of 1 gram of water by one degree
Celsius.
You are probably most familiar with reactions that release heat, but some chemical
reactions actually absorb heat. Take the common hospital cold pack, for example. Squeeze it to
get it going and toss it into the calorimeter; then watch the temperature in the calorimeter drop
as the pack absorbs heat from its surroundings! Such reactions are defined as endothermic,
with a positive ΔH. OK, so we can determine the value of one of the energy parameters, but we
will need to know at least one other, either ΔGo or ΔS before the equation ΔH = ΔGo + TΔS
becomes useful.
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4.3.4

How Is Standard Free Energy Change (ΔGo) Determined?

As it turns out, ΔGo (the standard free energy change) is directly proportional to the
concentrations of the reactants and the products of a reaction conducted to completion (i.e.,
equilibrium) under standard conditions. Therefore, to determine ΔGo, we need to know or to
be able to measure the concentration of reactants and reaction products before and after a
chemical reaction (i.e., when the reaction reaches equilibrium). Take the following generic
chemical reaction:

2A + B <====> 2C + D
The Boltzmann equation relates ΔGo to equilibrium concentrations of A, B, C, and D:

ΔGo = −RTlnKeq = RTln [C]2[D]
[A]2[B]
In this equation, R is the gas constant (1.806 cal/mol-deg); T is 298 0K; and Keq is the
equilibrium constant. As you can see, the Keq for the reaction is the ratio of the product of the
concentrations of the products (raised to their stoichiometric powers) to the product of the
concentrations of the reactants (raised to their stoichiometric powers).
CHALLENGE: Define (or look up) the stoichiometry in chemical reactions.
Once you know (or have determined) the equilibrium concentrations of reactants and
products in a chemical reaction, you can use this equation to calculate the ΔGo for a reaction.
Remember, if the ΔGo is a negative number, the reaction is defined as exergonic; i.e., reactions
release free energy. Reactions that release fee energy are also referred to as spontaneous
reactions. If the ΔGo is a positive number, the reaction absorbs free energy. Defined as
endergonic, such uphill reactions are not spontaneous.
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1.3.5

Working an Example Using These Equations for Closed Systems

Consider the following reaction:

This reaction is endergonic, but if you do not know [X] or [Y] (and therefore don’t know the
ΔGo), how can you tell? If you are given [X] and [Y], you can also do the math. Assume we
measure the concentrations of reactants and products for this reaction at equilibrium, with the
following results:

[X] = 2.5 Kcal/mol and [Y] = 500 cal/mol
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Try using the Boltzmann equation (in section 4.3.4) to calculate the standard free energy for
this reaction. What is the Keq for this reaction? What is the ΔGo for the reaction? If you did not
come up with a Keq of 0.2 and an absolute value for the standard free energy for |ΔGo| of
866.2 Kcal/mol, recalculate or collaborate with a classmate. Hint: make sure that you convert
the units in your equation so that they are all the same (e.g., calories to Kcal)! Based on the
calculated value of ΔGo, is this reaction in fact endergonic? Now if you conduct the reaction in
a bomb calorimeter, you find that it proceeds to equilibrium with a ΔH = -750 Kcal/mol. What
kind of reaction is this? Together with the enthalpy change, it is now possible to use the
equation ΔH = ΔGo + TΔS to calculate an absolute value for the entropy change: |ΔS| =
116.2 cal/mol-deg for the reaction. At equilibrium, the reaction proceeded with an increase in
entropy under standard conditions.
If you still did not get the correct answer, recalculate, or collaborate with a classmate.
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4.4

Summary: The Properties of Closed Systems

First, let’s reiterate that there is no such thing as a closed system, unless of course the universe
is one! What we call a closed system is simply one for which we can measure the energy
entering and exiting it and within which we can measure energy transfers and transductions
(changes from one kind of energy to another). Features of closed systems can be defined by
their properties:
Closed systems are experimentally defined by an investigator.
Defined standard conditions apply.
Energy entering or leaving the system is measurable.
Reactions reach equilibrium regardless of reaction rate.
Product and reactant concentrations at equilibrium are constant (hence the Keq).
Measured energy transfers/transductions are constant for a set of defined conditions.

•
•
•
•
•
•

Now let’s turn our attention to open systems, since that’s what cells are!

4.5

Open Systems and Actual Free Energy Change

Cells are open systems that are constantly exchanging mass and energy with their
environment; they never reach equilibrium. In addition, diverse organisms live under very
different atmospheric conditions and maintain different body temperatures (e.g., your cat has a
higher body temperature than you do!). Clearly, the conditions under which cells conduct their
biochemical reactions are decidedly nonstandard. However, while open systems do not reach
equilibrium, they do achieve a steady state in which the rate of input of energy and matter is
equal to the rate of output of energy and matter. Think of a biochemical pathway like
glycolysis. If a cell’s energy needs are constant, the pathway will reach a steady state. Of
course, a cell’s need for energy (as ATP) can change as energy needs change. If it does, then
the steady state of ATP production will change to meet the needs of the cell.
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Later we will discuss just how energy flows through living things, from sunlight into the
chemical energy of nutrient molecules, into energy-rich fuels like ATP, and finally into the
performance of all manner of cellular work. For now, let’s characterize open systems by their
properties:
•
•
•
•
•

Open systems exchange energy and mass with their surroundings.
Open systems never reach equilibrium
They achieve steady state where the energy input rate = output rate.
The steady state can change.
In open systems, endergonic reactions can be energetically favorable (spontaneous)
reactions), and exergonic reactions can become energetically unfavorable.

Fortunately, there is an equation to determine free energy changes in open systems.
For our chemical reaction 2A + B <====> 2C + D, this equation would be the following:

ΔG′ = ΔGo+ RTln [C]ss2 [D] ss
[A] ss2 [B] ss
ΔG′ is the actual free energy change for a reaction in an open system; ΔGo is the standard free
energy change for the same reaction under standard conditions in a closed system; R is again
the gas constant (1.806 cal/mol-deg); and T is the absolute temperature in which the reaction
actually occurs. The ss subscripts designate reactant and product concentrations measured
under steady-state conditions. You can see here that this equation states a relationship
between ΔGo and ΔG′. So, to determine the actual free energy of a biochemical reaction in a
cell or any living tissue, all you need to know are the ΔGo for the reaction, the steady-state
concentrations of reaction components in the cells/tissues, and the absolute T under which the
reactions are occurring.

144 The Energetics of Open Systems
Elsewhere, we will use the reactions of the glycolytic pathway to exemplify the
properties, as well as the energetics of open and closed systems. At that time, pay careful
attention to the application of the terminology of energetics in describing energy flow in closed
vs open systems.
Some iText & VOP Key Words and Terms
actual free energy
ATP
bioenergetics
Boltzmann equation
calories
calorimeter
chemical energy
chemical equilibrium
closed systems

endothermic
energy
energy transduction
energy transfer
enthalpy
entropy
equilibrium constant
exergonic
exothermic
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law of conservation
laws of thermodynamics
light
mass
open-system properties
open systems
order vs entropy
standard conditions
standard free energy

decibels
e = mc2
electricity
endergonic

free energy
gas constant
Gibbs free energy
Keq
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steady state
useful energy
useless energy
volts

Chapter 5

Enzyme Catalysis and Kinetics
Mechanism of enzyme catalysis, induced fit, activation energy, understanding enzyme kinetics
Reminder: For inactive links, google key words/terms for alternative resources.

5.2Listen

HereVersion 2

5.1Listen

HereVersion 1

5.1

Introduction

By definition, all catalysts accelerate chemical reactions, including enzymes. But enzymes and
inorganic catalysts differ in important ways (Table 5.1).
Table 5.1
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In this chapter, we look at the properties and mechanism of action of enzymes. These
include allosteric change (induced fit, enzyme regulation), energetic events (changes in
activation energy), and how enzymes work in open and closed (experimental) systems.
Most enzymes are proteins; a few are RNAs. All enzymes are long flexible polymers
that fold into intricate shapes, able to recognize and tightly bind specific target molecules. In
contrast, inorganic catalysts are rigid, weakly binding many molecules and catalyzing many
random reactions. The specificity of an enzyme lies in the structure and flexibility of its active
site. We will see that the active site of an enzyme undergoes conformational change during
catalysis.
The structural flexibility of enzymes also explains their ability to respond to metabolites
in a cell, metabolites which indicate the cell’s biochemical status. When such regulatory
metabolites bind to an enzyme, the resulting conformational changes can speed up or slow
down the catalytic rate of the reaction—a phenomenon called allosteric regulation. As you
might imagine, changing the rate of a biochemical reaction can change the rate of an entire
biochemical pathway—and ultimately the steady-state concentrations of products and
reactants in that pathway.
To understand the importance of allosteric regulation, we’ll look at how we measure
the speed of enzyme catalysis. As we consider the classic early twentieth-century enzyme
kinetic studies of Leonor Michaelis and Maud Menten, we’ll focus on the significance of the
Km and Vmax values that they derived from their data. But before we begin our discussion,
remember that chemical reactions are by definition reversible. The action of catalysts, either
organic or inorganic, depends on this concept of reversibility.
CHALLENGE: Either now or when you are done reading this chapter, see if
you can explain in your own words the relationship between catalysis and
the inherent reversibility of chemical reactions.
Finally, let’s give a nod to recent human ingenuity that enabled enzyme action to turn
an extracellular profit! You can now find enzymes in household cleaning products like spot
removers and detergents, where they function to digest and to remove stains caused by fats
and pigmented proteins. Enzymes added to meat tenderizers also digest (hydrolyze) animal
proteins down to smaller peptides. Enzymes can even clean a clogged drain!

Learning Objectives
When you have mastered the information in this chapter, you should be able to do the
following:
1. Describe how the flexibility of proteins and RNAs makes them ideal biological catalysts.
2. Compare and contrast the properties of inorganic and organic catalysts.
3. Explain why catalysts do not change equilibrium concentrations of a reaction conducted in
a closed system.
4. Compare the activation energies of catalyzed and uncatalyzed reactions and explain the
roles of allosteric effectors in enzymatic reactions.
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5. Discuss how allosteric sites interact with an enzyme’s active site and explain the concept of
the rate-limiting reaction in a biochemical pathway.
6. Write simple rate equations for chemical reactions.
7. Write possible chemical rate equations for catalyzed reactions.
8. Distinguish between Vmax and Km in the Michaelis-Menten kinetics equation.
9. State what Vmax and Km say about the progress of an enzyme-catalyzed reaction.
10. Interpret enzyme kinetics and the progress of an enzyme-catalyzed reaction from this data.
11. More accurately identify Leonor Michaelis and Maud Menten!

5.2

Enzymes and the Mechanisms of Enzyme Catalysis

Studies by George W. Beadle and Edward L. Tatum correlating mutations with enzyme
deficiencies in Neurospora crassa (bread mold) and Drosophila melanogaster led them to
propose the one-gene/one-enzyme hypothesis in 1941. By 1958, they shared the Nobel Prize
in Physiology or Medicine for this work. Their original hypothesis had already morphed
twice—first into the one-gene/one-protein, and then into the one-gene/one-polypeptide
hypothesis…, helping to launch the age of molecular biology. The subsequent discovery of
RNA catalysts came as quite a surprise! The revelation of RNA catalysts, dubbed ribozymes,
earned Sidney Altman and Thomas Cech a Nobel Prize in Chemistry in 1989. Ribozymes are
now known to catalyze RNA splicing (the removal of unwanted regions of a precursor RNA).
They also catalyze a step in the protein synthesis (translation) by ribosomes. In fact, almost no
biochemical reactions or pathways exist that are not directly the result of enzyme catalysis,
from the digestion of nutrients in your mouth, stomach, and small intestines to pretty much
every chemical reaction inside your cells (check out Kornberg A. 1989. Never a Dull Enzyme.
Ann. Rev. Biochem. 58:1-30). The focus in this chapter is on the long history of protein enzyme
catalysis. But as you study, you may recognize that the mechanisms of enzyme catalysis
described here involve common essential features seen in all biocatalysts.
Most enzymes are soluble inside or outside cells, while a few are part of membranes or
other cellular structures. In all cases, they bind to soluble substrates (the reactants in enzymecatalyzed reactions). The large size and exquisite diversity of protein structures make enzymes
highly specific catalysts. As already noted, the specificity of an enzyme results from the shape
of its active site, which is dependent on the 3D arrangement of amino acids in and around the
region. The substrates of a catalyzed biochemical reaction are bound to and held in place on
the enzyme while rapid bond rearrangements take place. The flexibility of enzymes allows
enzymes to change in shape at the active site during catalysis.
The flexibility of enzymes also enables small metabolites in cells to interact with an
enzyme, change its shape and thereby changing its catalytic rate. The latter phenomenon
enables allosteric regulation, allowing cells to control the rates and even the direction of many
biochemical reactions and pathways. As we will see, enzymes may be bound to prosthetic
groups or ions, which contribute to the shape and activity of the enzyme. Any understanding
the mechanism of catalysis must also include knowledge about the energetics of catalyzed
reactions. We’ll see that enzymes lower the activation energy of a chemical reaction, and that
activation energy is an inherent energy barrier to the reaction. Finally, we look at the
energetics of enzyme action.
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We will also describe the action of biological catalysis in terms biochemical pathways
and the structural features of enzymes (e.g., active-site and overall conformation and the
affinities of an enzyme for its substrates), as well as free energy changes that occur during
catalysis. Of course, structural and energy considerations of enzyme catalysis are related, as
we will see in more detail in a later chapter.

145 Enzymes vs Other Catalysts
5.2.1

Structural Considerations of Catalysis

From a chemistry course, you may recall that the rate of an uncatalyzed reaction is dependent
on the concentration of the reactants in solution. This is the law of mass action, recognized in
the nineteenth century. Look at this simple reaction:

A+B⇌C+D
The law of mass action makes two key assumptions:
1. At any given time following the start of the reaction, the rate of product formation is
proportional to the concentrations of the reactants and products ([A], [B], [C], and [D] in
this case).
2. Chemical reactions in the laboratory (i.e., a “closed system”) eventually reach equilibrium,
at which point the net rate of formation of reaction products is zero. In other words, the
forward and reverse reactions occur at the same rate.)

CHALLENGE: Imagine and graph the expected rate of our chemical
reaction over time, plotting time on the X axis and concentration of
product (say, [C]) measured at different times.

There are no products (i.e., C and D) at the start of the reaction written above. As there
are no products yet, the reaction rate should be directly proportional only to the concentration
of the reactants. The law of mass action predicts that any chemical reaction will occur its
fastest rate when reactants (e.g., A and B above) are first mixed—that is, when A and B at their
highest concentrations. This is because there are more reactant molecules in solution and a
greater likelihood that they will collide in an orientation that allows the bond rearrangements
necessary for the reaction to occur.
Of course, chemical rates decline as reactant concentrations diminish products
accumulate over time. But even as the rate of formation of C and D slows down, their rising
levels of should also influence the rate of their own production. Remember, all chemical
reactions are inherently reversible; those rising concentrations of products will begin to push
the reaction in reverse to form A and B, further slowing down the net accumulation of C and D.
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The chemical rate equations that you may recall from a chemistry course in fact treat
all chemical reactions as reversible (elsewhere we’ll address the concept that some reactions in
cells are biologically irreversible!). Chemical rate equations enable the determination of
reaction rates for our sample reaction. Here is an equation for the rate of formation of the
products C & D:

rate of formation of C and D = k1[A][B] − k-1[C][D]
In this equation, k1[A][B] is the rate of the forward reaction and k-1[C][D] is the rate of the
reverse reaction. This equation recognizes that the reaction is reversible. The equation states
that the net reaction rate is equal to the rate of the forward reaction (k1[A][B]) minus the rate of
the back reaction (k-1[C][D]). The equation is valid (applicable) at any time during the reaction.
k1 and k-1 are rate constants for the forward and reverse reactions, respectively.
CHALLENGE: Using the equation for the rate of formation of C and D, can
you determine what the rate will be at the end of the reaction? Answer this
question arithmetically and include a text explanation.
So how do catalysts work? Catalysts increase chemical reaction rates by bringing
reactants (now called substrates) together more rapidly than they would encounter each other
based just on random molecular motion in solution. This is possible because catalysts have an
affinity for their substrates. In the case of inorganic catalysts, relatively weak, generic forces
account for the affinity of reactants and inorganic catalysts. Thus, a metallic catalyst (e.g.,
silver or platinum) attracts molecules with an appropriate (usually a charge) configuration. If
the attraction (affinity) is sufficient, the metal will hold reactants in place long enough to
catalyze the bond rearrangements of a chemical reaction. In contrast to inorganic catalysts,
enzymes have evolved highly specific shapes with physical-chemical properties. As a result,
typical enzymes only attract substrates for specific reactions, and with high affinities. The lockand-key mechanism was the first explanation for enzyme-substrate specificity (Figure 5.1).

Fig. 5.1: In the lock-and-key model, reactants i.e., substrates (S) are ‘keys’ that fit in enzyme (E)
‘locks’: (1, left), E and S attract each other; (2, middle) S enters the catalytic site on E like a key in a
lock, forming an E-S complex (middle); (3, right) catalysis occurs, E and P separate.
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The active site of an enzyme has an exquisite, selective affinity for its substrate(s). This
affinity is many times greater than those of inorganic catalysts for generic reactants. The result
is that enzymes are more efficient and faster than inorganic catalysts. According to this model,
the affinity of an enzyme for a particular substrate engages the substrate “key” in the tumblers
(i.e., in the active site) of the enzyme’s “lock” Thus engaged, the substrate(s) would undergo
the bond rearrangements specific for the catalyzed reaction to generate products and to
regenerate an unchanged enzyme.
However, X-ray crystallography of enzyme-substrate interactions revealed that the
active sites of enzymes change shape during catalysis. This allosteric change suggested the
induced-fit mechanism of enzyme action (modeled in Figure 5.2).

Fig. 5.2: In the induced-fit model, E and S attract each, other initially forming a short-lived ES*, inducing
an allosteric (shape) change leading to a tight fit of S in the catalytic site of E to form an E-S complex.
Catalysis occurs and E and P separate.

In this model, enzyme-substrate affinity causes the substrate to bind to the enzyme
surface. Once bound, the enzyme undergoes an allosteric change, drawing the substrate(s)
more tightly into the active site and catalyzing the reaction. Of course, after the reaction
products detach from the enzyme, it returns to its original shape.

146-2 Induced-Fit Mechanism of Enzyme Action
CHALLENGE: Note that when an enzyme (or any catalyst) catalyzes a biochemical reaction in a closed system, it still reaches equilibrium, despite
the higher rate of the catalyzed reaction. What does this tell you about the
energetics of catalyzed reactions in closed systems? And why do
biochemical pathways never reach equilibrium?
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5.2.2

Energetic Considerations of Catalysis

Consider the random motion of substrates in solution, which only occasionally encounter one
another. They even more rarely bump into one another in just the right orientation to cause a
reaction. This explains why adding more reactants or increasing the temperature of a reaction
can speed it up: it increases the number of random as well as productive molecular collisions.
Unlike molecules and reactions in a test tube, living organisms do not have these options for
increasing reaction rates. But they do have enzymes! All catalysts work by lowering the
activation energy (Ea) for a reaction, thereby increasing the rate of the reaction. Activation
energy is essentially a barrier that makes it difficult for interacting substrates to come together
to actually undergo a biochemical reaction.
Inorganic catalytic surfaces attract reactants where catalysis can occur. The attractions
are weak compared to those of enzymes and their substrates. An enzyme’s active site very
strongly attracts otherwise randomly distributed substrates, making enzyme catalysis faster
than inorganic catalysis. Again, cells cannot use inorganic catalysts, most of which are
insoluble and would attract reactants indiscriminately—not a good way for cells to control
metabolism! The advent of enzymes with their specificity and high rate of catalysis was a key
event in chemical evolution and was required for the origins of life. As we saw, allosteric
change during the “induction of fit” enables specific catalysis. In fact, a catalyzed reaction will
be faster than the same reaction catalyzed by a piece of metal, and of course much faster
(millions of times faster!) than the uncatalyzed reaction. The energetics of catalysis helps to
explain why. Let’s look at the energetics of a simple reaction in which A and B are converted to
C and D (Figure 5.3).

Fig. 5.3: This graph follows the free energy change over time as reactants A and B react. The activationenergy peak in the middle of the curve defines that free energy barrier which A and B must overcome
before much C and D can be made. The barrier is due mainly to thermal motion of A and B molecules
that rarely encounter each other in relatively dilute solutions. Enzymes are even more efficient that
inorganic catalysts in lowering the activation-energy barrier to a reaction.
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Conducted in a closed system, enzyme-catalyzed reactions rapidly reach equilibrium.
Like all catalysts, enzymes are not consumed by the reactions they catalyze, nor do they alter
equilibrium concentrations of reactants and products of these reactions. One estimate is that as
few as 4,000 biochemical reactions are catalyzed in a given cell at a given time. Another
estimate is that there are 20,000-25,000 genes in the human genome. Many of these encode
enzymes. What are these genes and their protein products good for if so few biochemical
reactions are needed by an average cell? Is this in fact an underestimate?

147 Enzyme Activation Energy
CHALLENGE: What do you make of what seems to be an inherent conflict
between the estimates of the number of genes and the number of enzymecatalyzed reactions in cells?

5.3

Enzyme Regulation

We noted that some enzymes are regulated, which just means that there are factors in the cell
that can slow down or speed up their rate of catalysis. In this way the cell can respond quickly
to the metabolic needs reflected by the intracellular levels of these factors. Factors that slow
down catalysis are inhibitors. Those that speed up catalysis are called activators.
In addition to responding to intracellular molecular indicators of the metabolic status of the
cell, enzymes may also be inhibited by drugs, poisons, or changes in the chemical milieu (e.g.,
pH). Since cellular reactions occur as part of biochemical pathways, regulating a single
enzyme can affect an entire pathway (e.g., Figure 5.4).

Fig. 5.4: Reaction products in a biochemical pathway can alter the rate of synthesis of the pathway's
final products. In this generic pathway, the end-product (D) accumulates (far right). At some point,
excess E binds to the allosteric regulatory sites on enzyme 1 at the left, blocking the formation of B,
an intermediate product. This kind of feed-back inhibition prevents a wasteful overproduction of D.
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This biochemical pathway will produce substance E. Under normal conditions, another
series of metabolic reactions would consume E. However, if the cell no longer needs so much
E, it will accumulate in the cell. If there is an excess of E in the cell, some of the excess might
bind to one of the enzymes. In the pathway shown, E binds to enzyme 1. This binding causes
an allosteric change in the enzyme, inhibiting catalysis and slowing down the entire pathway.
In this example of allosteric regulation, the inhibitory regulation of enzyme 1 evolved
to control the rate of production of substance E. This common mode of allosteric regulation is
called feedback inhibition. Enzymes can be regulated precisely because they can be bent out
of shape (or into shape for that matter!). Some small metabolites are chemical information
when they accumulate in cells and can communicate cellular metabolic status. The result is a
decrease or increase in enzyme activities to achieve an appropriate cellular response.
Whether an activator or an inhibitor of enzyme catalysis, regulatory molecules typically
bind to enzymes at allosteric regulatory sites, causing local conformational changes in the
enzyme, which are transmitted to the active site. Enzyme inhibition would occur if a change in
shape reduced the affinity of the enzyme for a substrate—or if it reduced the rate of bond
rearrangements after the substrate had already entered the active site. Enzyme activation
would occur if the allosteric effect were to increase this affinity and/or catalytic rate. The
mechanism of allosteric regulation of enzyme activity is shown in Figure 5.5.

Fig. 5.5: Levels of small metabolic chemicals (metabolites) can reflect and control a cell’s metabolic
status. Such metabolites, called allosteric effectors, have an affinity for regulatory sites on an
enzyme (shown at the left), causing conformational (shape) changes in its active site (seen at the
right). Allosteric regulation can reduce or increase the affinity of enzyme and substrate, either
inhibiting catalysis, as suggested here, or stimulating it.

148-2 Allosteric Regulation of Enzyme Activity
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5.4

Enzyme Kinetics

Studying enzyme kinetics can not only tell us about the catalytic properties of a particular
enzyme but can also reveal important properties of biochemical pathways. Thus, one can
determine a standard rate-limiting reaction under a given set of conditions by comparing
kinetic data for each enzyme in a biochemical pathway. But what else can we do with kinetic
data?
5.4.1

Why Study Enzyme Kinetics?

Apart from their value in teaching us how a given enzyme actually works, kinetic data has
considerable clinical value. For example, let’s assume that we know the kinetics of every
enzyme in the biochemical pathway ending in the synthesis of a liver metabolite in a healthy
person. Also assume we know what the rate-limiting (slowest) enzyme in the pathway is.
Consider the following scenario: A patient presents with higher-than-normal blood levels of X.
Is this because the normal rate-limiting reaction is no longer rate-limiting in the patient? If so,
what is new rate-limiting enzyme?
CHALLENGE: If we can answer these two questions, there are at least two
ways we might approach researching a therapy to reduce blood levels of X
in this and other patients with the same condition. What might they be?
One can ask similar questions of an alternate scenario in which a patient is producing too little
of the metabolite. A cellular biochemical might deviate from “normal” levels for a variety of
reasons:
• Viral and bacterial infection or environmental poisons: These can interfere with a
specific reaction in a metabolic pathway; remedies depend on this information!
• Chronic illness resulting from mutational enzyme deficiencies: Treatments might include
medications designed to enhance or to inhibit (as appropriate) enzyme activity.
• Genetic illness tied to metabolic deficiency: If a specific enzyme is the culprit,
investigation of a pre- and/or postnatal course of treatment might be possible (e.g.,
medication or perhaps even gene therapy).
• Lifestyle changes and choices: These might include eating habits, usually remediated by a
change in diet.
• Lifestyle changes brought on by circumstance rather than choice: These are changes due
to aging. An all-too-common example is the onset of type 2 diabetes. This can be treated
with medication and/or delayed by switching to a low-carb diet favoring hormonal changes
that would improve proper sugar metabolism.
Knowing the rate-limiting reaction(s) in biochemical pathways can help us identify regulated
enzymes. This knowledge allows research to focus on the search for remedies to correct a
metabolic imbalance. As noted, ribozymes are RNA molecules that catalyze biochemical
reactions; their kinetics can also be analyzed and classified. We will consider how enzymes are
regulated later, when we discuss glycolysis, a biochemical pathway that most living things use
to extract energy from nutrients. For now, let’s look at an overview of experimental enzyme
kinetics.
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5.4.2

How We Determine Enzyme Kinetics and Interpret Kinetic Data

In enzyme kinetic studies, the enzyme is considered to be a reactant, albeit one that is
regenerated by the end of the reaction. The reaction begins when substrate is added to the
enzyme. In enzyme kinetic studies, the concentration of the enzyme is held constant while
reaction rates are measured, after different amounts of substrate are added. As a consequence,
all catalyzed reactions will reflect saturation of the enzyme at high concentration of substrate.
This is the basis of saturation kinetics illustrated in Figure 5.6.

Fig. 5.6: Enzyme saturation occurs when all available enzymes in solution are bound to substrate(s).
Saturation kinetics experiments measure catalytic rates at different substrate(s) concentrations. At
high substrate concentrations the active sites of all the enzymes are occupied, i.e., enzyme is
saturated with substrate (far right). Under these conditions the reaction occurs at its fastest rate.

In the illustration, the active sites on all the enzyme molecules are bound to substrate
molecules at a high substrate concentration. Under these conditions, a catalyzed reaction is
proceeding at its fastest. Let’s generate some kinetic data to see saturation in action. The
experiment illustrated in Figure 5.7 will determine the kinetics of the conversion of substrate
(S) to product (P) by an enzyme (E).

Fig. 5.7: The test tubes shown in this experiment each contain the same concentration of enzyme.
After adding different amounts of substrate(s) to each tube, rates of product formation near the start
of the reaction are measured to determine the kinetics of the enzyme-catalyzed reaction.
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A series of reaction tubes are set up, each containing the same concentrations of E
([E]) but different concentrations of S ([S]). The concentration of P ([P]) produced at different
times (beginning just after the start of the reaction in each tube) is plotted to determine the
initial rate of P formation for each [S] tested. Figure 5.8 is such a plot.

Fig. 5.8: This graph plots the rate of product (P) formation at different substrate concentrations ([S]) while
holding the enzyme concentration ([E]) constant, as described in the experimental protocol in Fig. 5.7.

In this hypothetical example, the rates of the reactions (amounts of P made over time)
do not increase beyond an [S] higher than 4 x 10−5 M. The upper curves thus represent the
maximal rate of the reaction at the experimental concentration of enzyme. We say that the
maximal reaction rate occurs at saturation.
CHALLENGE: What’s happening in this graph? Why do all the curves level
off? Answer by imagining what the physical enzyme is doing at each point
on the curves.

149 Measuring Enzyme Kinetics
Next, we can estimate the initial reaction rate (vo) at each substrate concentration by
plotting the slope of the first few time points through the origin of each curve in the graph.
Consider the graph of the initial reaction rates estimated in this way in Figure 5.9 (below).
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Fig. 5.9: This graph shows the slopes (straight lines at the left) of the initial reaction rates taken from
the curves in the previous graph (Fig. 5.8). From the graph we can say that the enzyme became
saturated somewhere between the two highest concentrations of substrate.

The slope of each straight line is the vo for the reaction at a different [S] value near the
very beginning of the reaction, when [S] is high and [P] is vanishingly low. Next, we plot these
rates (slopes, or vo values) against the different [S] values in the experiment to get the curve of
the reaction kinetics in Figure 5.10.

Fig. 5.10: This graph plots the initial reaction rates (slopes, or v0) for the reactions plotted in Figure
5.9. The curve is approaching a maximum v0 (the asymptote at the right). The formula shown for
this curve describes a rectangular hyperbola.

This is an example of Michaelis-Menten kinetics, which is common to many enzymes.
Named after the biochemists who realized that the curve described rectangular hyperbola. Put
another way, the equation mathematically describes the mechanism of catalysis of the enzyme!
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The following equation mathematically describes a rectangular hyperbola:

y=

xa
x+b

You might be asked to understand the derivation of the Michaelis-Menten equation in
a biochemistry course. You might even be asked to do the derivation yourself! We won’t make
you do that but suffice it to say that Michaelis and Menten started with some simple
assumptions about how an enzyme-catalyzed reaction would proceed and then wrote
reasonable chemical and rate equations for those reactions. The goal here is to understand
those assumptions, to see how the kinetic data support those assumptions, and to realize what
this tells us about how enzymes really work.
Here is one way to write the chemical equation for a simple reaction in which an
enzyme (E) catalyzes the conversion of substrate (S) to product (P):

S⇌P
E
Michaelis and Menten rationalized that this reaction might actually proceed in three steps. In
each step, enzyme E is treated as a reactant in the conversion of S to P. The resulting chemical
equations are these:

Reasoning that the middle reaction (the conversion of E and S to E and P) would be the fastest
one and therefore would not be the rate-limiting reaction of catalysis, they only considered the
first and third reactions to be relevant in determining the overall kinetics of product formation.
Then they wrote the following rate equations for just these two chemical reactions (as one
would in an introductory chemistry course):

vE-S formation = k1[E][S] - k-1[E-S]
vP formation = k2[E-S] - k-2[E][P]
Both of these equations describe a straight line. Therefore, neither describe the observed
hyperbolic reaction kinetics. Finally, if you solve one of the equations for a term common to
both (e.g., E-S) and then plug your solution into the other equation, your combined equation
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still describes described a straight line—again, not the expected rectangular hyperbola. To
arrive at a chemical rate equation consistent with a rectangular hyperbola, Michaelis and
Menten had to make several assumptions, including those made by G. E. Briggs and J. B. S.
Haldane, about how E, S, and P would behave in a catalyzed reaction. Those assumptions
allowed them to rewrite each equation, then to combine and to rewrite them into a single
mathematical equation—one that did indeed describe a rectangular hyperbola. Here are
Briggs and Haldane’s assumptions:

1. [S] >> [E] at the start and during the “steady state”
2. [P] << [S] at the start of a reaction.
3. All E is bound to S at the start of the reaction.
4. [E]total = [E]free + [E− S] at all times.
We’ve already seen the equation that Michaelis and Menten derived from these assumptions,
which is now known as the Michaelis-Menten equation:

V0 =

Vmax[S]
Km + [S]

The take-home message here is that the assumptions about an enzyme-catalyzed reaction are
a good approximation of how the reaction proceeds over time. Michaelis and Menten defined
Vmax and Km as key kinetic factors in enzyme-catalyzed reactions. In the generic example of
substrate conversion to product, we saw that increasing [S] results in a higher rate of product
formation because there is a higher rate of encounters between enzyme and substrate
molecules. At some point, however, increasing [S] does not increase the initial reaction rate
any further. Instead, vo asymptotically approaches a theoretical maximum for the reaction,
defined as Vmax, the maximum initial rate. As we have already seen, Vmax occurs when all
available enzyme active sites are saturated (occupied by substrate). At this point, the intrinsic
catalytic rate determines the turnover rate of the enzyme. The substrate concentration at which
the reaction rate has reached ½ Vmax is defined as Km (the Michaelis-Menten constant),
which is a ratio of the rate constants derived when rate equations for E-S and P formation
(above) are rewritten and then combined into the single equation that describes a rectangular
hyperbola.

150 Graphing Enzyme Kinetic Data
CHALLENGE: The Km is equivalent to a dissociation constant, while the
reciprocal of the Km is often called the Ka, or affinity constant. Look
carefully at the Michaelis-Menten curve and describe in words why the
Km would be a measure of the tendency of enzyme and substrate to stay
together (or conversely, to come apart).
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To recapitulate, the two most important kinetic properties of an enzyme are the
following:
1. The rate at which the enzyme becomes saturated with a particular substrate, which is
related to the reaction’s Km
2. The maximum rate of the catalyzed reaction, which is described by the reaction’s Vmax
These properties suggest how an enzyme might behave under cellular conditions and can
show how the enzyme should respond to allosteric regulation by natural inhibitory or
activating factors, as well as how it might respond to poisons or other noxious chemicals.
For clear, detailed explanations of enzyme catalytic mechanisms, check out Jencks WP
1987, Catalysis in Chemistry and Enzymology Mineola, NY, Courier Dover Publications. You
can also find more details of how kinetic equations are derived (an important step in
understanding how the enzyme works) in any good biochemistry textbook, or you can check
out the Michaelis-Menten Kinetics entry in the 5.3All About Enzymes Wikipedia link.
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Chapter 6

Glycolysis, the Krebs Cycle, and the Atkins Diet

Glycolysis, gluconeogenesis, the Krebs cycle—getting energy from food; enzyme regulation; how
cells capture free energy (bioenergetics); liver cells glucose metabolism; diets to fool your body
Reminder: For inactive links, google key words/terms for alternative resources.

This (in fact, any!) metabolic pathway chart highlights the centrality of the Krebs (citric-acid) cycle to
virtually all biochemical pathways. See a sizable version of this chart at 6.1Human Metabolic Pathways

6.1

Introduction

We used to get free metabolic pathway wall charts like this one from vendors of biochemical
reagents. The big picture is correct (as noted, a sizable version is available at the link below
the chart), but the charts may be out of date in small details of metabolism. In this chapter,
we’ll zoom in on the middle of the chart, encompassing glycolysis and the Krebs cycle (named
for Hand Krebs, its discoverer) to see how thermodynamic laws apply to chemical reactions.
We’ve looked at the principles governing thermodynamics (the flow of energy in the universe)
and bioenergetics (energy flow in living systems). We saw evidence that energy is exchanged
between components in the universe, but that it can be neither created nor destroyed. That
makes the universe a closed system, a conclusion codified as the first law of thermodynamics.
Personally, I find the idea of a closed universe troubling since there is no escape from it—that
is, until I remind myself that the universe is a big place, and I am only a small part of a small
system that you can define for yourself: the solar system, planet Earth, the country you pledge
allegiance to, your city or village, your school, your farm, or your homestead!
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You may derive comfort from the realization that you can move from one system to
another and even exchange goods and services between them. This is a metaphor for energy
flow between systems in the universe. We also saw that the first law applies to closed systems
within the universe, and that there are no closed systems in the universe! Any system in the
universe is open, always exchanging energy and mass with neighboring systems. What we
mean by the term closed system is that we can define and isolate some small part of the
universe and then measure any energy that this isolated system gives up to its environment or
takes in from it. The simplest demonstration of the first law in action is the bomb calorimeter,
which measures heat released or absorbed during a chemical reaction.
A second thermodynamic concept says that energy flows from one place to another
only when it can. In the vernacular, we say that energy flows downhill. Anything that happens
in the universe (a galaxy moving through space, a planet rotating, you getting out of bed in the
morning, coffee perking you up, your cells burning sugar, DNA replicating…) does so because
energy flows downhill. We saw that any happening or event in the universe, however large or
small, must be spontaneous. That is, it occurs with a release of free energy. Remember,
spontaneous means “by itself” and not necessarily “instantaneous” or “fast”! Finally, we noted
that when enzymes catalyze biochemical reactions in a closed system, the reactions still reach
equilibrium, despite the higher rate of the catalyzed reaction. What does this tell you about the
energetics of catalyzed reactions in closed systems?
With this brief reminder about energy flow and what enzymes do, we’ll look at how our
cells capture nutrient free energy (the chemical energy in foods), a topic that will include
examples of the energetics of closed systems that reach equilibrium and open systems that
don’t! First, we tackle glycolysis, an anaerobic fermentation pathway for generating chemical
energy from glucose, as well as the first of several aerobic pathways of respiration. We’ll see
that most of the energy from glycolysis and respiration is captured in molecules of ATP, the
universal energy currency of life, used by cells to…live! Then we look at gluconeogenesis, a
regulated reversal of glycolysis. We ask when, where, and why we would want to make rather
than burn glucose. Finally, we begin a discussion of respiration with a look at the Krebs cycle.
The complete respiratory pathway can be summarized by the following equation:

The standard free energy change for this reaction (Go) is about −687 Kcal/mol. This
is the maximum amount of nutrient free energy that is (at least in theory) available from the
complete respiration of a mole of glucose. Given a cost of about 7.3 Kcal to make each mole of
ATP (adenosine triphosphate), how many moles of ATP might a cell produce after burning a
mole of glucose? We’ll figure this out here.

Learning Objectives
When you have mastered the information in this chapter, you should be able to do the
following:
1. Explain the difference between fermentation and respiratory glycolysis and the role of
redox reactions in both processes.
2. Calculate, compare, and contrast ΔGo and ΔG’ for the same reaction, and explain any
differences in free energy in open and closed systems.
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3. Describe and explain the major events of the first stage of glycolysis, and then trace the
free energy changes through the formation of G-3-P.
4. Describe and explain the major events of the second stage of glycolysis and trace the free
energy changes through the formation of pyruvate and lactic acid.
5. State the role of redox reactions in glycolysis and fermentation.
6. Compare and contrast glucose (i.e., carbohydrates in general), ATP, NADH, and FADH2 as
high-energy molecules.
7. Explain why only a few cell types in the human body conduct gluconeogenesis.
8. Explain how gluconeogenesis, an energetically unfavorable pathway, can occur at all.
9. Explain why the Atkins diet (and similar low carbohydrate/high protein diets) works and
speculate on any downsides.
10. Explain the supercatalyst concept and speculate on why a supercatalyst (e.g., the Krebs
cycle) would have evolved.
11. Explain the role of high-energy linkages and electron carriers in the Krebs cycle.
12. In terms of energetics and biochemical reactions, compare phosphate ester linkages in ATP
and GTP with the thioester linkages in acetyl-S-CoA and succinyl-S-CoA.
13. Speculate on why the E. coli Krebs cycle generates GTP rather than ATP molecules.

6.2

Glycolysis: A Key Pathway in Energy Flow through Life

One of the properties of life is that living things require energy. The pathways of energy flow
through life are shown in Figure 6.1.

Fig. 6.1: Three paths (top, middle and bottom, respectively) follow of the flow of free energy through life,
from visible light to chemical energy (e.g., photosynthesis of glucose) to the high-energy intermediates like
ATP (fermentation or respiration), and finally to the work of a cell (growth and metabolism).
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To begin with, recall that the most common intracellular energy currency with which
livings things “pay” for cellular work is ATP. The energy to make ATP on planet Earth
ultimately comes from the sun via photosynthesis. Recall that light energy fuels the formation
of glucose and O2 from CO2 and water in green plants, algae, cyanobacteria, and a few other
bacteria. Photosynthesis even produces some ATP directly, but not enough to fuel all cellular
and organismic growth and metabolism. In fact, all cells, even plant cells, use fermentation
and/or respiration (anaerobic or aerobic processes, respectively) to capture nutrient free
energy (mostly) as ATP.
ATP is called a high-energy intermediate because its hydrolysis releases a large
amount to free energy. In the condensation reactions that make ATP, it takes about 7.3 Kcal of
free energy to link a phosphate to ADP in a phosphate ester linkage.
Having captured nutrient free energy in a form that cells can use, ATP hydrolysis then
releases that free energy to fuel cellular work. Cellular work includes bending cilia, whipping
flagella, contracting muscles, transmitting neural information, building polymers from
monomers, and more. The free energy needed to make ATP in animal cells comes exclusively
from nutrients (sugars, fats, and proteins). As noted, plants get free energy directly from
sunlight, but they mobilize nutrient free energy, which they make in much the same way as
the rest of us get it from what we eat! The energetics of ATP hydrolysis and synthesis are
summarized in Figure 6.2.

Fig. 6.2: For cells, the flow of free energy involves hydrolyzing ATP (the main chemical
energy currency of life on earth) to power the cellular work (upper chemical equation) and
harnessing free energy from the environment to make more of it (lower chemical equation)!
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In all living things, glucose oxidation releases a considerable amount of free energy—
enough to synthesize many molecules of ATP (Figure 6.3).

Fig. 6.3: The exergonic oxidation of one glucose molecule by glycolysis, the Krebs cycle, electron transport,
and oxidative phosphorylation (upper reaction) is coupled to the synthesis of up to 36 molecules of ATP (lower
reaction).

Cellular respiration—the oxidation of glucose—starts with glycolysis. Derived from the
Greek glykos-(“sweet”) + -lysis (“loosening”), glycolysis is the breakdown of sugar. Otto
Meyerhof and Archibald V. Hill shared a Nobel Prize in Physiology or Medicine in 1923 for
isolating enzymes of glucose metabolism from muscle cells. Thanks to their efforts and the
efforts of others (e.g., Gustav Embden, Otto Warburg, Gerty Cori, and Carl Cori), all the
enzymes and reactions of the glycolytic pathway were known by 1940, when the pathway
became known as the Embden-Meyerhof pathway.
As we will see, glycolysis is an evolutionarily conserved biochemical fermentation used
by all organisms to capture a small amount of nutrient free energy. Check out FothergillGilmore LA [(1986) The evolution of the glycolytic pathway. Trends Biochem. Sci. 11:47-51] for
more detail. The glycolytic pathway occurs in the cytosol of cells, where it breaks down each
molecule of glucose (C6H12O6) into two molecules of pyruvic acid (pyruvate: CH3COCOOH).
This occurs in two stages, capturing nutrient free energy in two ATP molecules per glucose
molecule that enters the pathway. Figure 6.4 (below) gives an overview of glycolysis,
highlighting its two stages.

Stage 1 of glycolysis consumes ATP. Phosphates are transferred first from ATP to
glucose and then to fructose-6-phosphate, reactions catalyzed by hexokinase and
phosphofructokinase, respectively. So, these Stage-1 phosphorylations consume free energy.
Later, in Stage 2 of glycolysis, nutrient free energy is captured in ATP and NADH (reduced
nicotinamide adenine dinucleotide). NADH forms in redox reactions, in which NAD+ is
reduced as some metabolite is oxidized. In Stage 2, it is glyceraldehyde-3-phosphate that is
oxidized—but more on that later! To summarize, by the end of glycolysis, a single starting
glucose molecule has been split into two molecules of pyruvate while four molecules of ATP
and two molecules of NADH have been produced.
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Fig. 6.4: In this overview of glycolysis, a 6C glucose splits into 3C pyruvates. Two ATPs are consumed
in Stage 1. The oxidation of glyceraldehyde-3-P marks the start of Stage 2, in which 4 ATPs are made.

Pyruvate will be metabolized either anaerobically or aerobically. The alternate fates of
pyruvate are summarized in Figure 6.5.

Fig. 6.5: Alternate Fates of Pyruvate: fermentation, the anaerobic reduction to alcohol or other endproducts…, or respiration, the aerobic oxidation, using oxygen as a final electron acceptor, resulting
in H2O and CO2 production).

151 Overview of Glycolysis
Overall, anaerobic (complete) glycolysis is an exergonic fermentation. Two NADH
molecules are made per glucose, and two will reduce pyruvate at the end of the fermentation
pathway. Thus, by the end of complete glycolysis, there is no consumption of O2 and no net
oxidation of nutrient (i.e., glucose).
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A familiar anaerobic glycolytic pathway is the production of alcohol by yeast in the
absence of oxygen. Another is the production of lactic acid by skeletal muscle during strenuous
exercise, which leads to the muscle fatigue you might have experienced after an especially
vigorous workout. Muscle fatigue is due to a buildup of lactic acid in the muscle cells, which
under these conditions can’t oxidize pyruvate and instead reduces it to lactate. Other cell types
produce different fermentative end products, while still capturing free energy in two ATPs per
starting glucose.
We will also consider gluconeogenesis, a pathway that essentially reverses the
glycolysis and results in glucose synthesis. Gluconeogenesis may occur under normal
conditions as well as during high-protein/low-carb diets and during fasting or starvation. Next,
we learn that cellular respiration—the aerobic oxidation of pyruvate after incomplete
glycolysis—takes place in the mitochondria of eukaryotic cells. We’ll see the role of the Krebs
cycle (also called the TCA, or Tri-Carboxylic Acid cycle) in the complete oxidation of pyruvate
and why the oxidation takes a cycle. We will take a moment to look at the experiments of Hans
Krebs that revealed this cycle that starts a respiratory pathway that oxidizes glucose to CO2
and H2O, leaving no carbohydrates behind. As we look at the reactions of glycolysis and the
Krebs cycle, watch for redox reactions in both pathways.

6.3

Some Details of Glycolysis

Here we focus on the enzyme-catalyzed reactions and free energy transfers between pathway
components, looking at the energetics and enzymatic features of each reaction.
6.3.1

Glycolysis, Stage 1

Reaction 1: In the first reaction of glycolysis, hexokinase rapidly phosphorylates glucose
entering the cell, forming glucose-6-phosphate (G-6-P). Figure 6.6 (below) shows that the
overall reaction is exergonic. The standard free energy change for the reaction is −4 Kcal per
mole of G-6-P synthesized.

Fig. 6.6: In reaction 1, phosphorylation of glucose to make glucose-6-phosphate (G-6-P) consumes a
molecule of ATP. If cellular energy needs are being met, G-6-P will be polymerized to make storage
polysaccharides. In animals, G-6-P can be retrieved by glycogen hydrolysis to G-1-P by glycogen
phosphorylase when the cells require nutrient energy; at that time, the G-6-P will resume glycolysis.
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The hexokinase reaction is a coupled reaction, in which phosphorylation of glucose is
coupled to ATP hydrolysis. The free energy of ATP hydrolysis (an energetically favorable
reaction) fuels glucose phosphorylation (an energetically unfavorable reaction). The reaction is
also biologically irreversible, as shown by the single vertical arrow.
Excess dietary glucose can be stored in most cells (especially liver and kidney cells) as

glycogen—a highly branched polymer of glucose monomers. In green algae and plants,
glucose made by photosynthesis is stored as polymers of starch. When glucose is necessary for
energy, glycogen and starch hydrolysis form glucose-1-phosphate (G-1-P), which is then
converted to G-6-P. Let’s look at the energetics, i.e., the flow of free energy in the hexokinasecatalyzed reaction. This reaction can be seen as the sum of two reactions in Figure 6.7.

Fig. 6.7: Free energy flow (exchange) for reaction 1 of glycolysis, and for the removal (hydrolysis) of the
phosphate from G-6-P. The hexokinase reaction is the sum of 2 reactions in which the exergonic
hydrolysis of ATP is coupled to the endergonic phosphorylation of glucose to G-6-P. What do you think
the delta-Go is for the hydrolysis of G-6-P, shown in the reaction at the bottom of the slide? Can you
figure out the standard free energy change for the hydrolysis of G-6-P?

Recall that ATP hydrolysis is an exergonic reaction, releasing about 7 (~7) Kcal/mol
(rounding down!) in a closed system under standard conditions. The condensation reaction of
glucose phosphorylation occurs with a Go of +3 Kcal/mol. Under standard conditions, this is
an endergonic reaction. Summing up the free energy changes of the two reactions, we can
calculate the overall Go of −4 Kcal/mol for the coupled reaction under standard conditions in
a closed system.
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The reactions in Figure 6.7 are written as if they are reversible. However, we said that
the overall coupled reaction is biologically irreversible. Why the contradiction? To explain, we
say that an enzyme-catalyzed reaction is biologically irreversible when the products have a
relatively low affinity for the enzyme’s active site, making catalysis (acceleration) of the reverse
reaction very inefficient. While enzymes catalyzing biologically irreversible reactions don’t
facilitate the return of products back into reactants, they are often allosterically regulated. This
is the case for hexokinase. Imagine a cell that slows its consumption of G-6-P because its
energy needs are being met. As a result, G-6-P levels rise in cells. As you might expect, the
hexokinase reaction slows down so that the cell doesn’t unnecessarily consume a precious
nutrient free energy resource. The allosteric regulation of hexokinase is shown in Figure 6.8.

Fig. 6.8: Enzymatics of the hexokinase reaction: this enzyme catalyzes a biologically irreversible reaction
and is allosterically regulated. This ensures that glucose entering a cell cannot leave it as G-6-P.
Hexokinase is one of several 'allosterically regulated' glycolytic enzymes whose regulation allows some
cells to slow the reaction and divert glucose to other cells.

As G-6-P concentrations rise in the cell, excess G-6-P binds to an allosteric site on
hexokinase. The resulting conformational change in the enzyme is then transferred to the
active site, inhibiting the glucose phosphorylation reaction. The inhibition is reversible: when
G-6-P levels decline in the cell, it comes off of the enzyme, the allosteric change is reversed
and uninhibited reaction rates resume.

152-2 Glycolysis Stage 1, Reaction 1
CHALLENGE: Hexokinase regulation was selected in evolution. Speculate
on the benefit of this trait.

Reaction 2: In this slightly endergonic and reversible reaction, isomerase catalyzes the
isomerization of G-6-P to fructose-6-P (F-6-P). The reaction is shown below in Figure 6.9.
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Fig. 6.9: Reaction 2 of glycolysis is the isomerization of G-6-P to F-6-P by an isomerase (fructose is
a structural isomer of glucose). The reaction is endergonic and reversible.

Reaction 3: In this biologically irreversible reaction, 6-P-fructokinase catalyzes the
phosphorylation of F-6-P to make fructose 1,6-diphosphate (F1,6-diP). In this coupled reaction,
ATP again provides the second phosphate. The overall reaction is written as the sum of two
reactions in Figure 6.10.

Fig. 6.10: In reaction 3 of glycolysis, a kinase catalyzes the phosphorylation of F-6-P to F1,6-diP in a
biologically irreversible reaction, consuming molecule of ATP.

Like the hexokinase reaction, the 6-P-fructokinase reaction is a coupled, exergonic, and
allosterically regulated reaction. Multiple allosteric effectors, including ATP, ADP, AMP, and
long-chain fatty acids, regulate this enzyme.
CHALLENGE: Explain when and how each of the different allosteric
effectors regulates this kinase-catalyzed reaction.
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Reactions 4 and 5: These are the last reactions of the first stage of glycolysis. In
reaction 4, F1,6-diP (a 6-C sugar) is reversibly split into dihydroxyacetone phosphate (DHAP)
and glyceraldehyde-3-phosphate (G-3-P). In reaction 5 (also reversible), DHAP is converted
into another G-3-P. These reactions are shown in Figure 6.11.

Fig. 6.11: In reaction 4, F1,6-diP is split into glyceraldehyde-3-P (G-3-P) and dihydroxyacetone
phosphate (DHAP) by an aldolase. In reaction 5, DHAP is isomerized to G-3-P. Both reactions
are endergonic, consuming free energy. The two reactions mark the end of Stage 1 of glycolysis.

The net result is the formation of two molecules of G-3-P at the end of the reactions of
Stage 1. The enzymes F-diP aldolase and triose-P-isomerase both catalyze freely reversible
reactions. Also, both reactions proceed with a positive free energy change and are therefore
endergonic. The sum of the free energy changes for splitting F1,6-diP into two G-3-Ps is a
whopping +7.5 Kcal/mol, a very energetically unfavorable process.

CHALLENGE: Given that these reactions are both endergonic, how is it
possible that glycolysis ever gets past the synthesis of F1,6-diP?

In summary, by the end of Stage 1 of glycolysis, two ATP molecules have been
consumed, and one 6-C carbohydrate has been split into two 3-C carbohydrates. We have also
seen two biologically irreversible and allosterically regulated enzymes.

153 Glycolysis Stage 1, Reactions 2–5
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6.3.2

Glycolysis, Stage 2

We will follow just one of the two molecules of G-3-P generated by the end of Stage 1 of
glycolysis but remember that both proceed through Stage 2 (the remainder) of glycolysis.

Reaction 6: In this redox reaction, G-3-P is oxidized to 1,3-diphosphoglyceric acid (1,3diPG), and NAD+ is reduced to NADH. The reaction catalyzed by the G-3-P dehydrogenase
enzyme, as shown in Figure 6.12.

Fig. 6.12: Reaction 6, a redox reaction catalyzed by G-3-P dehydrogenase, is freely reversible. hydride
(H-) ions are transferred to NAD+ from G-3-P to make NADH and 1,3 diphosphoglyceric acid (1,3diPG).

This freely reversible endergonic redox reaction, removes a hydrogen molecule (H2
from G-3-P, leaving behind phosphoglyceric acid. This short-lived oxidation intermediate is
phosphorylated to make 1,3 diphosphoglyceric acid (1,3diPG). At the same time, the hydrogen
molecule is split into a hydride ion (H−) and a proton (H+). The H− ions reduce NAD+ to
NADH, leaving the protons behind in solution. Remember that all of this is happening in the
active site of the same enzyme! Remind yourself of what is oxidized and what is reduced here!
Even though it catalyzes a reversible reaction, G-3-P dehydrogenase is allosterically
regulated. However, in contrast to the regulation of hexokinase, that of G-3-P dehydrogenase
is more complicated! The regulator is NAD+, and the mechanism of allosteric regulation is
called negative cooperativity. It turns out that the higher the [NAD+] in the cell, the lower the
affinity of the enzyme for more NAD+ and the faster the reaction in the cell! The mechanism is
discussed at the following link.

154 Glycolysis Stage 2, Reaction 6
CHALLENGE: How might you explain the logic of negative cooperativity
in regulating 1,3-diPG formation?
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Reaction 7: This reaction, catalyzed by phosphoglycerate kinase, is freely reversible
and exergonic (Figure 6.13), yielding ATP and 3-phosphoglyceric acid (3PG).

Fig. 6.13: Reaction 7—a reversible, exergonic, coupled reaction generates ATP using free energy
released by the hydrolysis of one of the phosphates from 1,3diPG. The mechanism of ATP synthesis
here is called substrate-level phosphorylation.

In glycolysis, catalysis of phosphate group transfer between molecules by kinases is
called substrate-level phosphorylation, one of the ways of phosphorylating ADP to make ATP.
In this coupled reaction, the free energy released by hydrolyzing a phosphate from 1,3diPG is
used to make ATP.
Remember that this reaction occurs twice per starting molecule of glucose, so that two
ATPs have been synthesized during this reaction of glycolysis. We call 1,3diPG a very highenergy phosphate compound.

Reaction 8: This freely reversible endergonic reaction transfers the phosphate from the
number 3-C of 3PG to the number 2-C (Figure 6.14). Mutases like phosphoglyceromutase are
enzymes that catalyze the transfer of functional groups within a molecule.

Fig. 6.14: Reaction 8 is a reversible, endergonic reaction catalyzed by a mutase. Mutases catalyze the
transfer of a chemical group from one part of a molecule to another. Here, 3-PG is converted to 2-PG.
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Reaction 9: In this reaction (Figure 6.15), enolase catalyzes the conversion of 2-PG to
phosphoenolpyruvate (PEP).

Fig. 6.15: Reaction 9 is a reversible endergonic reaction. An enolase catalyzes the conversion of 2-PG
to phosphoenolpyruvate (PEP).

Reaction 10: This reaction results in the formation of a molecule of pyruvic acid
(pyruvate), illustrated in Figure 6.16.

Fig. 6.16: Reaction 10 is biologically irreversible. In a coupled reaction, pyruvate kinase catalyzes a highly
exergonic transfer of a phosphate on PEP to ADP to make ATP.

Remember again that two pyruvates are produced per starting glucose molecule. The
enzyme pyruvate kinase couples the biologically irreversible, exergonic hydrolysis of a
phosphate from PEP and the transfer of that phosphate to ADP in a coupled reaction. The
reaction produces PEP, another very high-energy phosphate compound.

155-2 Glycolysis Stage 2, Reactions 7–10
CHALLENGE: 1,3-diPG and PEP are very high-energy phosphate compounds
compared to ATP, which is just called a high-energy-phosphate compound.
Explain the difference.
Pyruvate kinase is allosterically regulated by increases in cellular levels of ATP, citric
acid, long-chain fatty acids, F1,6-diP—or even PEP, one of its own substrates.
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CHALLENGE: Predict and explain how each of these allosteric effectors
should change the rate of pyruvate kinase catalysis.

As we have seen, there are alternate fates of pyruvate, the product of incomplete
glycolysis. One is the aerobic mitochondrial oxidation of pyruvate, following incomplete
glycolysis. The other is an anaerobic fermentation, or complete glycolysis, in which pyruvate is
reduced to one or another end product. Recall that muscle fatigue results when skeletal muscle
uses anaerobic fermentation to get the free energy required for vigorous exercise by reducing
pyruvate to lactic acid. It is the accumulation of lactic acid in skeletal-muscle cells that causes
muscle fatigue. The enzyme LDH (lactate dehydrogenase) that catalyzes the reduction of
pyruvate to lactate is regulated—but not allosterically! Instead, different types of muscle
tissues regulate LDH by making different versions of the enzyme. Go to the following link for a
more detailed explanation.

156 Fermentation: Regulation of Pyruvate Reduction Is NOT Allosteric!

6.4

A Chemical and Energy Balance Sheet for Glycolysis

Compare the balance sheets for complete glycolysis (fermentation) to lactic acid and for
incomplete (aerobic) glycolysis, showing chemical products and energy transfers (Figure 6.17).

Fig. 6.17: The free energy and ATP yields of complete glycolysis (fermentation) and incomplete
glycolysis (respiration) result from net exergonic pathways. The percentages, which represent the
efficiency of ATP production, are based on the ratios of the free energy captured as ATP to the free
energy released by the different pathways for metabolizing glucose. From the data, incomplete
glycolysis is a more efficient way to extract nutrient free energy.
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There are two reactions in Stage 2 of glycolysis that each yield a molecule of ATP, and
each occurs twice per starting glucose molecule. Stage 2 of glycolysis thus produces four ATP
molecules per glucose. Since Stage 2 consumed two ATPs, the net yield of chemical energy for
the cell by the end of glycolysis is two ATPs, whether complete to lactate or incomplete to
pyruvate! Because anaerobic cells can’t make use of oxygen, they have to settle for the measly
few (15) kilocalories’ worth of ATP that they get from a fermentation. Since there are 687
kilocalories potentially available from the complete combustion of a mole of glucose, there is a
lot of nutrient free energy left on the table, to be captured during the rest of respiration (i.e.,
pyruvate oxidation).

157-2 Balance Sheet of Glycolysis
CHALLENGE: After aerobic glycolysis, where is the rest of the nutrient
free energy that was in glucose?
Remember also that the only redox reaction in aerobic glycolysis is in Stage 2. This is
the oxidation of G-3-P, a 3-C glycolytic intermediate. Now check out the redox reaction of a
fermentation pathway. Since pyruvate, also a 3-C intermediate, was reduced, there has been
no net oxidation of glucose (i.e., glycolytic intermediates) in complete glycolysis.
By this time, you will have realized that glycolysis is a net energetically favorable
(downhill, spontaneous) pathway in a closed system, with an overall negative ΔGo. Under
normal circumstances, glycolysis is also spontaneous in most of our cells, driven of course, by a
constant need for energy to do cellular work. Thus, you would expect that the actual free
energy, or ΔG′, of glycolysis, is also normally negative. In fact, glycolysis in actively respiring
cells proceeds with a release of more free energy than it would in a closed system. In other
words, the ΔG′ for glycolysis in active cells is more negative than the ΔGo of glycolysis! Feel
free to investigate the truth of this statement on your own.
Before we discuss the aerobic fate of pyruvate, let’s take look at gluconeogenesis, the
Atkins diet, and at not-so-normal circumstances when glycolysis essentially goes in reverse (at
least in a few cell types). Under these conditions, glycolysis is energetically unfavorable, and
even the otherwise-exergonic reactions of glycolysis (those with a negative ΔGo) will proceed
with a negative G’.

6.5

Gluconeogenesis

In well-fed animals, most cells can store some of glucose as glycogen, which they break down
as needed to retrieve nutrient energy as G-6-P. Glycogen hydrolysis (glycogenolysis) produces
G-1-P, which is converted to G-6-P as we saw at the beginning of Stage 1 of glycolysis. But
glycogen in most cells is quickly used up between meals. Therefore, most cells depend on a
different, external source of carbohydrates (i.e., glucose) other than diet. Those sources are
liver (and to a lesser extent kidney) that can store large amounts of glycogen after meals. In
continual feeders (cows and other ruminants), glycogenolysis is ongoing.
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Glycogenolysis by liver cells supplies glucose to the blood for up to six to eight hours
between meals in intermittent feeders (like us), to be distributed as needed to all cells of the
body. Thus, you can expect to use up liver and kidney glycogen reserves after a good night’s
sleep, a period of intense exercise, or any prolonged period of low carbohydrate intake (fasting
or starvation). Under these circumstances, animals use gluconeogenesis (literally, new glucose
synthesis) in liver and kidney cells to provide systemic glucose to nourish other cells.
In healthy individuals, the hormones glucagon and insulin regulate blood glucose
homeostasis, depending on cellular glucose (energy) needs. These hormones raise or lower
blood glucose levels to protect the organism from hypoglycemia (low blood sugar) and
hyperglycemia (high blood sugar), respectively. The gluconeogenic pathway produces glucose
from carbohydrate and non-carbohydrate precursors that include pyruvate, lactate, glycerol,
and gluconeogenic amino acids. The latter are amino acids that can be converted to alanine.
The reactions of glycolysis and gluconeogenesis are shown side-by-side in Figure 6.18.

Fig. 6.18: Comparison of incomplete glycolysis to gluconeogenesis. The two pathways are essentially
the reverse of one another, except for the bypass enzymes in gluconeogenesis (shown in green), which
are required to get around biologically irreversible enzymes of glycolysis.
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In Figure 6.18, look for bypass reactions that are catalyzed by carboxylases and
phosphatases and the glycolytic reactions that function in reverse during gluconeogenesis. If
glycolysis is an exergonic pathway, then gluconeogenesis must be an endergonic one. In fact,
while glycolysis generates a net of two ATPs from two pyruvates, making glucose from two
pyruvates during gluconeogenesis in contrast, costs four ATPs and two GTPs!
Likewise, gluconeogenesis is only possible if the bypass enzymes are present. These
are necessary to get around the three biologically irreversible reactions of glycolysis. Except for
the bypass reactions, gluconeogenesis is essentially a reversal of glycolysis.
CHALLENGE: Where do the nucleotide triphosphates (ATP and GTP) necessary
to fuel gluconeogenesis come from?
As drawn in the pathways in Figure 6.18, glycolysis and gluconeogenesis would seem
to be cyclic. In fact, this apparent cycle was recognized by Carl and Gerty Cori, who shared the
1947 Nobel Prize for Medicine or Physiology with Bernardo Houssay for discovering how
glycogen is broken down in muscle cells (and in fact in most cells) to pyruvate to be
reconverted to glucose in liver cells. Named after the Coris, The Cori cycle (Figure 6.19)
recognizes the interdependence of liver and muscle in glucose breakdown and re-synthesis.

Fig. 6.19: The Cori cycle reveals the relationship between glycolysis and gluconeogenesis. Lactic
acid produced by complete glycolysis in active skeletal muscle goes to the liver, where it could be
converted to pyruvate and then to glucose.

Despite the free energy requirement of gluconeogenic reactions under standard conditions (in
a closed system), active gluconeogenesis in liver and kidney cells is energetically favorable!
This is because the cells are open systems. The accumulation of pyruvate in liver cells and a
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rapid release of new glucose into the blood drive the now energetically favorable reactions of
gluconeogenesis forward. Therefore, glucose synthesis occurs under gluconeogenic conditions
with a negative G′, a decline in actual free energy. Of course, glycolysis and gluconeogenesis
are not simultaneous. Which pathways operate in which cells is tightly controlled. Glycolysis is
the norm in all cell types, even liver and kidney. However, the cessation of glycolysis in favor
of gluconeogenesis in the latter cells is under hormonal control (Figure 6.20).

Fig. 6.20: Hormones of the hypothalamic-pituitary axis control gluconeogenesis. A need for
glucose-derived energy stimulates hypothalamic hormones, which in turn stimulate the pituitary
gland to release ACTH (adrenocorticotropic hormone). ACTH then stimulates the adrenal glands
to release glucocorticoid hormones stimulate many tissues to control gluconeogenic glucose
production, as well as the use of alternate nutrient fuels by many cells in the body.

Key in turning on liver gluconeogenesis is the role of glucocorticoid hormones. What causes
the secretion of glucocorticoids? A long night’s sleep, fasting and in the extreme, and
starvation are forms of stress. Stress responses start in the hypothalamic-pituitary axis.
Different stressors cause the hypothalamus to secrete a neurohormone which stimulates the
release of ACTH (adrenocorticotropic hormone) from the pituitary gland.
ACTH then stimulates the release of cortisone and other glucocorticoids from the
cortex (outer layer) of the adrenal glands. As the name glucocorticoid suggests, these
hormones participate in the regulation of glucose metabolism.
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Here is what happens at times of low blood sugar (e.g., when carbohydrate intake is
low):
1. Glucocorticoids stimulate the synthesis of gluconeogenic bypass enzymes in liver cells.

2. Glucocorticoids stimulate protease synthesis in skeletal muscle, causing hydrolysis of the
peptide bonds between amino acids. Gluconeogenic amino acids circulate to the liver
where they are converted to pyruvate, a major precursor of gluconeogenesis. Some amino
acids are ketogenic and are converted to Acetyl-S-CoA, a precursor to ketone bodies.
3. Glucocorticoids stimulate increased levels of enzymes including lipases which catalyze
hydrolysis of the ester linkages in triglycerides (fat) in adipose and other cells. This
generates fatty acids and glycerol.
4. Glycerol circulates to liver cells where it is taken up and converted into to G-3-P,
augmenting gluconeogenesis. Fatty acids circulate to liver cells where they are oxidized to
Acetyl-S-CoA that is then converted to ketone bodies. and released to the circulation.
5. Most cells switch from glycolysis to fatty acid oxidation an alternate energy source when
glucose is limiting. Heart and brain cells depend on glucose for energy, but under extreme
conditions (prolonged fasting, starvation), brain cells can use ketone bodies as an energy
source of last resort.
Thus, the essential roles of glucocorticoids include the following:
1. Enabling most cells to oxidize fats (fatty acids) for energy
2. Allowing brain cells to use gluconeogenic glucose for energy, and in the extreme, ketone
bodies as an alternate energy source
3. Allowing cardiac muscle to use gluconeogenic glucose as its energy source
It’s a pity that we humans can’t use fatty acids as gluconeogenic substrates! Plants and
some lower animals have a glyoxylate cycle pathway that can convert fatty-acid oxidation
products directly into gluconeogenic carbohydrate substrates. Lacking this pathway, we (and
higher animals in general) cannot convert fats to carbohydrates, in spite of the fact that we can
all too easily convert the latter to the former! For us, when the gluconeogenic response is
inadequate to the task, the body can resort to ketogenic fat metabolism. Think of this as a last
resort, leading to the production of ketone bodies and the “acetone breath” in long-term
fasting or people with severe eating disorders (e.g., anorexia nervosa).
The dark side of the limits of gluconeogenic metabolism is prolonged starvation, which
will eventually overwhelm the gluconeogenic response. You see this in reports from third
world regions where many people may suffer starvation due to drought, other natural disasters,
or war. The spindly arms and legs of starving children result from muscle wasting as the body
tries to provide the glucose necessary for survival.

6.6

The Atkins Diet and Gluconeogenesis

You may know the Atkins diet as an ultra-low-carb diet, one of several ketogenic diets.
Glucocorticoid hormones released on such a diet trick the body into a constant gluconeogenic
state. Glucose production by the gluconeogenic liver is limited and reserved for brain and
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heart cells; the rest of the cells in our bodies switch to burning fats, hence the weight loss.
Carried to an extreme, restriction of carbohydrate intake results in high blood levels of ketones
and the acetone breath also encountered during extreme malnutrition. Discredited some years
ago, the Atkins and similar ‘ketogenic’ diets (e.g., Paleo, South Beach) are now back in favor.
When not exaggerated, low-carb diets are important in the control of diabetes. Older
folks with type-2 (adult-onset) diabetes can control their disease with a low-carb diet, with
exercise, and with medication. For example, metformin is a drug that blocks gluconeogenesis
to reduce glucose synthesis from gluconeogenic substrates, at the same time stimulating
cellular receptors to take up available glucose. Look at Hundal RS et al. (2000. Mechanism by
Which Metformin Reduces Glucose Production in Type 2 Diabetes. Diabetes 49: 2063–9) for
more details on how metformin works. Given the prevalence of adult obesity and type 2
diabetes in the United States, it’s likely that someone you know is taking metformin or another
similar medication! Unfortunately, a high rate of obesity in children may lead to type 2
diabetes in youngsters in the U.S.

158-2 Gluconeogenesis & the Atkins Diet

6.7

The Krebs/TCA/Citric acid cycle

The glycolytic reactions through fermentative reactions to pyruvate produce ATP
anaerobically. The evolution of respiration (the aerobic use of oxygen to efficiently burn
nutrient fuels) had to wait until photosynthesis created the oxygenic atmosphere we live in
now. Read more about the source of our oxygenic atmosphere in Dismukes GC et al. [(2001)
The origin of atmospheric oxygen on Earth: the innovation of oxygenic photosynthesis. Proc.
Nat. Acad. Sci. USA 98:2170-2175].
The Krebs cycle is the earliest pathway of eukaryotic mitochondrial oxygenic
respiration. The Krebs cycle no doubt evolved a few reactions at a time, perhaps in the
beginning, as a means of protecting anaerobic cells from the “poisonous” effects of oxygen as
photosynthetic organisms spread. Along the way, natural selection elaborated the aerobic
Krebs cycle, electron transport and oxidative phosphorylation metabolic pathways we see
today. Whatever their initial utility, these reactions were an adaptive response to the increase
in oxygen in the Earth’s atmosphere. As we’ve seen, respiration is a much more efficient
pathway than glycolysis is for extracting chemical energy from nutrients. Animals rely on it,
but even plants and photosynthetic algae use the respiratory pathway when sunlight is not
available! Here we focus on oxidative reactions in the mitochondrion, beginning with pyruvate
oxidation and continuing to the redox reactions of the Krebs cycle.
In mitochondria, pyruvate dehydrogenase catalyzes pyruvate oxidation to Acetyl-SCoenzyme A (Ac-S-CoA). The Krebs cycle then completely oxidizes Ac-S-CoA. These
mitochondrial redox reactions generate CO 2 and a lot of reduced electron carriers (NADH,
FADH2). The free energy released in these redox reactions is coupled to the synthesis of
only one ATP per oxidized pyruvate (i.e., two per the glucose we started with). In fact, it is
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the NADH and FADH2 molecules that have captured most of the free energy in the original
glucose molecules.
The entry of pyruvate from glycolysis into the mitochondrion and its oxidation are
summarized in Figure 6.21.

Fig. 6.21: Pyruvate enters the mitochondrion to be oxidized to acetyl-S-Coenzyme A (acetyl-S-CoA).

Pyruvate oxidation by pyruvate dehydrogenase converts a 3-C carbohydrate into a 2-C
acetate molecule, releasing a molecule of CO2. In this highly exergonic reaction, a reduced
coenzyme A, CoA-SH, forms a high-energy thioester (-S-) linkage with the acetate in Ac-SCoA. Pyruvate oxidation results in the reduction of NAD + to NADH and the production of a
molecule of CO2, along with the production of Ac-S-CoA (Figure 6.22).

Fig. 6.22: Pyruvate dehydrogenase catalyzes pyruvate oxidation to Ac-S-CoA, releasing a molecule
of CO2 and reducing NAD+ to NADH.

The Krebs cycle functions during respiration to oxidize Ac-S-CoA and to reduce NAD+
and FAD to NADH and FADH2, respectively. Overall, the cycle is exergonic. Intermediates of
the Krebs cycle also function in amino acid metabolism and interconversions. All aerobic
organisms alive today share the Krebs cycle. This is consistent with its spread early in the
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evolution of our oxygenic environment. Because of the central role of Krebs cycle
intermediates in other biochemical pathways, parts of the pathway may even have predated
the complete respiratory pathway. This centrality of the Krebs cycle to cellular metabolism is
emphasized in the biochemical pathways chart shown at the top of this chapter, and it is shown
as it occurs in animals in Figure 6.23 (below).

Fig. 6.23: Krebs Cycle highlights: The first reaction is the condensation of Ac-S-CoA and oxaloacetate
(OAA), forming citric acid (citrate). Four reactions in the cycle are redox reactions which create reduced
electron carriers (NADH, FADH2); one reaction makes GTP by substrate-level phosphorylation.

After the oxidation of pyruvate in mitochondria, the resulting Ac-S-CoA enters the
Krebs cycle in the first reaction, condensing with oxaloacetate (OAA) to form citric acid, or
citrate. Citrate is a tricarboxylic acid (TCA), for which the cycle was first named. There are four
redox reactions in the Krebs cycle. As we discuss the cycle, look for the accumulation of
reduced electron carriers (FADH2, NADH) and a small amount of ATP synthesis by substratelevel phosphorylation. Also follow the carbons in pyruvate into CO2. The following checklist
will help you understand the events of the cycle:
1. Find the two molecules of CO2 produced in the Krebs cycle itself.
2. Find GTP (which quickly transfers its phosphate to ADP to make ATP). Note that in
bacteria, ATP is made directly at this step.
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3. Count all the reduced electron carriers (NADH, FADH2) in the biochemical pathway. Each
will “carry” a pair of electrons into the mitochondria. If you include the electrons on each
of the NADH molecules made in glycolysis, how many electrons have been removed from
cytoplasmic glucose for during its complete oxidation in mitochondria?
Remember that glycolysis produces two pyruvates per glucose and thus two molecules
of Ac-S-CoA. Thus, the Krebs cycle turns twice per glucose that enters the glycolytic pathway.
The high-energy thioester linkages formed in the Krebs cycle fuel ATP synthesis as well as the
condensation of oxaloacetate and acetate to form citrate in the first reaction. Each NADH
carries about 50 Kcal of the 687 Kcal of free energy originally available in a mole of glucose;
each FADH2 carries about 45 Kcal of this free energy. This energy will fuel ATP production
during electron transport and oxidative phosphorylation.

159-2 Highlights of the Krebs Cycle
CHALLENGE: While you’re counting stuff, figure out the Go for oxidizing
a mole of glucose through the Krebs cycle. Is the cycle exergonic?
Finally, the story of the discovery of the Krebs cycle is at least as interesting as the
cycle itself! Albert von Szent-Györgyi initially discovered several organic acid oxidation
reactions that were thought at the time to be part of a linear pathway of nutrient oxidation, and
for which he won a Nobel Prize in 1937. Hans Krebs then performed the elegant experiments
showing that the reactions were part of a cyclic pathway. He proposed (correctly!) that the
cycle would be a supercatalyst that would catalyze the oxidation of yet another organic acid.
Some of the experiments are described by Krebs and his coworkers in their classic paper:
Krebs HA, et al. [(1938) The formation of citric and α-ketoglutaric acids in the mammalian
body. Biochem. J. 32: 113–117].
Hans Krebs and Fritz Lipmann shared the 1953 Nobel Prize in Physiology or
Medicine. Krebs was recognized for his discovery of the TCA cycle, which more commonly
carries his name. Lipmann was recognized for proposing ATP as the mediator between food
(nutrient) energy and intracellular work energy and for discovering the reactions that oxidize
pyruvate and synthesize Ac-S-CoA, bridging the Krebs cycle and oxidative phosphorylation (to
be considered in the next chapter).

160 Discovery of the Krebs Cycle
You can read Krebs’ review of his own research in Krebs HA [(1970) The history of the
tricarboxylic acid cycle. Perspect. Biol. Med. 14:154-170]. For a classic read on how Krebs
described his supercatalyst suggestion, check out 6.2Citrate and α-Ketoglutarate Formation in
Mammals . For more about the life of Lipmann, check the brief Nobel note on the 6.3Fritz
Lipmann Biography.
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CHALLENGE: Thinking about the endosymbiotic origins of mitochondria,
where does the Krebs cycle occur in bacteria?
Some iText & VOP Key Words and Terms
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Chapter 7

Electron Transport, Oxidative Phosphorylation,
Photosynthesis
Electron transport, oxidative phosphorylation, and protein motors make ATP in mitochondria;
H2O is split, CO2, “fixation by “light” and “dark” reactions makes glucose in chloroplasts
Reminder: For inactive links, google key words/terms for alternative resources.

7.1

Introduction

Listen Here! or use the QR code above.

We saw that glycolysis generates two pyruvates per glucose, and that subsequent oxidation of
each pyruvate generates two Ac-S-CoA molecules. In aerobic cells, oxidation of each Ac-SCoA by the Krebs cycle captures about 4% (30/687 Kcal) available in a mole of glucose—in just
two ATP molecules; not much for all that biochemical effort! But a total of twenty-four H+ ions
(protons) in glucose have captured in reduced electron carriers (NADH, FADH2) in redox
reactions. Here we’ll see how oxidation of NADH and FADH2 by an electron transport system
releases free energy that fuels the creation of a proton (H+) gradient. Then we’ll see how
dissipation of this gradient powers oxidative phosphorylation and ATP synthesis. Electron
transport and oxidative phosphorylation account for the cellular capture most nutrient free
energy in ATP. We’ll contrast oxidative phosphorylation with glycolytic and Krebs cycle
substrate-level phosphorylation and look at an energy balance sheet for respiration. Then we’ll
look at cellular free energy capture from alternate nutrients. Finally, we look at
photosynthesis, and then compare ATP production in what are essentially, opposite pathways.

Learning Objectives
When you have mastered the information in this chapter, you should be able to do the
following:
1. Explain the centrality of the Krebs cycle to aerobic metabolism (cellular respiration).
2. Identify sources of electrons in redox reactions leading to and within the Krebs cycle.
3. Draw the path of electrons from the Krebs cycle to the electron transport chain to O2.
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4. Trace the evolution of the electron transport chain from its location on an aerobic bacterial
membrane to its location in eukaryotic cells.
5. List the expected properties of a proton gate and a proton pump.
6. Interpret experiments involving redox reactions, ATP synthesis, and ATP hydrolysis
conducted with intact mitochondria and separated mitochondrial membranes.
7. Distinguish between the pH, proton (H+) and electrical gradients established by electron
transport.
8. Explain the chemiosmotic mechanism of ATP synthesis and contrast it with substrate-level
phosphorylation.
9. Discuss the evolution of electron transport in respiration and in photosynthesis and each.
10. Trace the different paths that electrons can take in photosynthesis and explain the
circumstances that would result in the different paths.
11. Explain the similar (or identical) biochemical intermediates in respiration and
photosynthesis.

7.2

Electron Transport Chains

All cells use an electron transport chain (ETC) to oxidize substrates (Krebs cycle products) in
exergonic reactions. The flow of electrons from reduced substrates through an ETC is like the
movement of electrons between the poles of a battery. In the case of the battery, the electron
flow releases free energy to power motors, lights, cell phones.... During mitochondrial
respiration, reduced electron carriers (NADH, FADH2) are oxidized, and electrons flow down
an ETC to molecular oxygen (O2) to make water. In plants and other photosynthetic organisms,
electron flow down an ETC oxidizes NADPH (nicotinamide adenine dinucleotide phosphate, a
phosphorylated version of NADH), eventually reducing CO2 to sugars.
In both respiration and photosynthesis, the oxidation of energy-rich reduced electron
carriers releases free energy. This free energy of electron flow is coupled to the active
transport of protons (H+ ions) across a membrane by proton pumps. The proton pumps create
a chemical (proton) gradient and consequently a pH and electrical gradient. In shorthand, we
say that the free energy once in reduced substrates is now in an electrochemical gradient. The
proton gradient (in fact, any gradient) is a source of potential (i.e., free) energy. The proton
gradients of respiration and of photosynthesis will be used to make ATP by oxidative
phosphorylation and by photophosphorylation, respectively.
The Chemiosmotic Mechanism explains how the electrochemical gradient forms and
how it stores free energy, and how its free energy ends up in ATP. For his insight on this
mechanism, Peter Mitchell won the Nobel Prize in Chemistry in 1978. Read Mitchell’s original
proposal of the chemiosmosis model of mitochondrial ATP synthesis in Mitchell P (1961)
Coupling of phosphorylation to electron and hydrogen transfer by a chemiosmotic type of
mechanism. Nature 191:144-148.

7.3

Electron Transport in Respiration

Here we focus on the details of respiration as it occurs in the mitochondria of eukaryotic cells.
The end products of electron transport are NAD+, FAD, water, and protons. The protons end
up outside the mitochondrial matrix because they are pumped across the cristal membrane
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using the free energy of electron transport. Electron transport and oxidative phosphorylation
are summarized in Figure 7.1.

Fig. 7.1: Electron transport and oxidative phosphorylation on the cristal membrane: NADH and FADH2
oxidation feeds electrons into electron transport, releasing free energy to powers proton pumps that force
H+ ions (i.e., protons) out of the mitochondrion. The resulting pH (i.e., H+) gradient fuels ATP synthesis
when protons flow into the mitochondrial matrix through a regulated cristal membrane ATP synthase (red).

Roman-numbered protein complexes, along with coenzyme Q (“Q”) and cytochrome C
(“Cyt C”) constitute the ETC. The role of the respiratory ETC is to oxidize NADH or FADH2 to
NAD+ and FAD, respectively. Electrons from these reduced electron carriers are transferred
from one ETC complex to the next. At the end of the chain, electrons, protons, and oxygen
unite in complex IV to make water. Under standard conditions in a closed system, electron
transport is downhill, with an overall release of free energy (a negative Go) at equilibrium.

161 Electron Transport Oxidizes Reduced Electron Carriers

162-2 Finding the Free Energy of Electron Transport

163-2 Separating Electron Transport from Oxidative Phosphorylation
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In the illustration above, we can see three sites in the respiratory ETC that function as
H+ pumps. At these sites, the negative change in free energy of electron transfer is large and
coupled to the action of a proton pump, which forces protons out of the mitochondrial matrix
and across the cristal membrane. Because the outer mitochondrial membrane is freely
permeable to protons, the gradient created is, in effect, between the cytoplasm and the
mitochondrial matrix. Protons flow back into the mitochondrial matrix through lollipop-shaped
ATP synthase complexes on the cristal membrane, and this flow releases the gradient free
(potential) energy that will be harnessed to make ATP by oxidative phosphorylation.

164-2 Proton Pumps Store Free Energy of the ETC in Proton Gradients

7.4

Oxidative Phosphorylation in Respiration

Oxidative phosphorylation is the mechanism by which ATP captures the free energy in the
mitochondrial proton gradient. Most of the ATP made in aerobic organisms is made by
oxidative phosphorylation, and not by substrate-level phosphorylation (the mechanism of ATP
synthesis in reactions of glycolysis or the Krebs cycle). Some oxidative biochemistry may have
existed early in evolution. After photosynthetic organisms appeared, the response of anaerobic
organisms to the toxicity of rising environmental oxygen levels may have been to coopt early
oxidative biochemistries oxygen detoxification. The later elaboration of respiratory metabolism
was undoubtedly selected because it turned out to be significantly more efficient at making
ATP than were the anaerobic fermentations (such as “complete” glycolysis). In other words,
oxidative phosphorylation is more efficient than substrate-level phosphorylation.
CHALLENGE: What abundant environmental substrate of oxidative
phosphorylation contributes to its high efficiency?
To summarize, the movement of electrons down the electron-transport chain fuels the
three proton pumps that establish a proton gradient across the cristal membrane, which stores
free energy. Oxidative phosphorylation then allows the controlled diffusion of protons back
into the mitochondrial matrix through the cristal membrane’s ATP synthases, fueling ATP
production. We say that the proton gradient has a proton motive force. However, we also
recognize that the proton gradient is also a pH gradient, and an electrical gradient (i.e., the
difference in electric potential).
The use of this proton motive force to make ATP is regulated. Conditions in the cell
control when the energy stored in this gradient will be released to make ATP. The switch that
allows protons to flow across the cristal membrane to relieve the proton gradient is a
mitochondrial cristal membrane ATP synthase, a tiny, complex enzymatic protein motor.
When this “switch” is open, protons pumped out of the mitochondrial matrix during
electron transport can flow back into the matrix through the ATP synthase. For a clear
discussion of this complex enzyme, see P. D. Boyer (1997) The ATP synthase – a splendid
molecular machine. Ann. Rev. Biochem. 66:717-749.
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The splendid molecular machine was discovered when isolated mitochondria were
themselves fractionated. When a membrane fraction (Fraction 1) of the organelle was shown to
hydrolyze ATP, the putative enzyme responsible was designated an F1 ATPase. Intact
mitochondria cannot hydrolyze ATP! In further experiments, vesicles formed from isolated
mitochondrial membranes were exposed to high pH in the presence of ADP and inorganic
phosphate, resulting in ATP synthesis. Hence, F1 ATPase was redesignated the mitochondrial
ATP synthase (or F1 ATP synthase). The capture of free energy of protons flowing through this
lollipop-shaped ATP synthase by facilitated diffusion is shown in Figure 7.2.

Fig. 7.2: The passive diffusion of protons through the cristal membrane ATP synthase relieves
the proton gradient, releasing free energy that fuels ATP synthesis in the mitochondrial matrix.

If the three ETC sites in the cristal membrane that actively transport protons are proton
pumps, then the cristal membrane ATP synthase complexes function as regulated proton gates
which catalyze ATP synthesis as protons flow through. For their discovery of the details of ATP
synthase function, P. D. Boyer and J. E. Walker shared the Nobel Prize in Chemistry in 1997.

165-2 Proton Gates Capture Proton Gradient Free Energy as ATP
The ratio of ATP to ADP concentrations regulates proton flow through the ATP
synthase gates. A high ATP/ADP ratio in the mitochondrial matrix indicates that the cell does
not need more ATP and closes the proton gate so that the proton gradient cannot be relieved.
On the other hand, a low ATP/ADP ratio in the matrix means that the cell is hydrolyzing a lot of
ATP and that the cell needs more. Then the proton gate opens, and protons flow through cristal
membrane ATP synthases back into the matrix, going down the concentration gradient. As
they flow, they release free energy to power a protein motor in the enzyme, which in turn
activates ATP synthesis. Just as we did for glycolysis, we can count the ATPs and see how
much free energy we get from aerobic respiration, (i.e., the complete oxidation of glucose). You
can see this in the following link.

166 A Balance Sheet for Respiration
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CHALLENGE: While warm-blooded animals keep nearly constant aboveambient body temperatures, their cells may be hotter yet! Mitochondria
work at temperatures up to 500C (7.2Hot Mitochondria.) How then might
you account for our normal 370C body temperatures?
CHALLENGE: Some experiments suggest that C. elegans longevity is
assisted by normal mitochondrial ATP synthase activity. Other
experiments suggest that the curcumin in turmeric, rejuvenates aging
mouse and fly cells by targeting their ATP synthase! What does this spicy
news suggest to you? (See 7.3ATP Synthase-Aging-Alzheimer’s Disease).
If the endosymbiotic theory is correct, then aerobic bacteria are the evolutionary
ancestor to mitochondria, and the bacterial cell membrane should be the site an ETC and a
chemiosmotic mechanism of ATP generation, much like that in mitochondria. This is in fact the
case. And proton gradients not only power molecular motors linked to ATP synthesis but are
also linked directly to the spinning of a bacterial flagellum (yet another “splendid molecular
machine”, Figure 7.3, below.

Fig. 7.3: A bacterial electron transport system can pump protons and other cations (Na+, Ca++) from the
cytoplasm into the periplasmic space, at the left on the inner (cell) membrane. Relief of the proton
gradient can power an ATP synthase or motility by fueling a spinning flagellum (at the right). In both
cases. proton flow into the cell powers complex protein motors.

Electron transport in the cell membrane creates the gradient, in some cases cotransporting a proton and another cation (Na+, Ca++). Relief of the proton gradient typically
powers both ATP synthesis and the flagellum, though recent studies indicate that relief of the
Na+ gradient can also spin the flagellum in some species of bacteria.
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7.5

Photosynthesis

Plants have evolved different photosynthetic adaptations, called C3, CAM and C4. All are
essentially the reverse of respiration.
We’ll consider each in turn later. Chemically,
photosynthesis is the reverse reaction of respiration. Compare the following chemical reactions
of respiration and photosynthesis:

If respiration (reaction 1) is a complete oxidation of glucose to H2O and CO2, then
photosynthesis (reaction 2) is a reduction of CO2 by electrons from H2O to make glucose. Thus,
photosynthesis is an endergonic reaction pathway. During photosynthesis, sunlight (i.e.,
visible light) fuels the reduction of CO2 (Figure 7.4).

Fig. 7.4: The flow of carbon through life. Oxidation of organic carbon (e.g., glucose) releases free energy to
make ATP. Free energy from sunlight fuels photosynthesis, turning CO2 back into organic carbon (glucose).

Photosynthesis began in the absence of oxygen; it preceded oxygenic respiration on
Earth. But after it evolved, it led to increasing levels of atmospheric oxygen that resulted in the
selection of oxygenic respiratory pathways (the Krebs cycle, electron transport, and oxidative
phosphorylation). We will see here that photosynthesis and respiration both have electrontransport-ATP-synthesizing systems that share similar features. This suggests that both
pathways share a common evolutionary ancestry. Elsewhere, we will consider what a common
ancestral system might have looked like. Two biochemical pathways make up photosynthesis:
•

Light-dependent reactions use visible light energy to remove electrons from water to

•

reduce electron carriers, to pump protons, and to make ATP.
Light-independent reactions use ATP to transfer electrons from the reduced electron
carriers to CO2 to synthesize glucose.
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These light-dependent and light-independent pathways of photosynthesis are summarized
below in Figure. 7.5.

Fig. 7.5: The light-dependent (“light”) reactions of photosynthesis “split” water, releasing oxygen and
protons, and capturing solar free energy as chemical energy. The light-independent (“dark”) reactions
use this chemical free energy to “fix” CO2 into organic molecules (nutrients).

7.5.1

The Light-Dependent Reactions

Colored substances contain pigments which reflect the colors that we see, and which
simultaneously absorb all the other colors of visible light. Early studies asked which plant
pigments absorbed the light that allow (or as we say now, “support”) photosynthesis. The
abundant chlorophyll pigment we see in plant tissues is actually two separate green pigments:
chlorophyll a and chlorophyll b. One might therefore predict that light absorbed by either or
both chlorophylls will support photosynthesis. Figure 7.6 illustrates the experiment that tested
this hypothesis.

Fig. 7.6: This experiment asks which wavelengths of light support photosynthesis. Visible light is
separated into different colors (wavelengths) by a prism (left), and then passed through filters
(center) that block all but one wavelength of light (right) to see which wavelengths support plant
growth and carbohydrate synthesis.
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The action spectrum of photosynthesis (Figure 7.7) plots the results of this experiment.

Fig. 7.7: The action spectrum of photosynthesis plots the rate of photosynthesis (e.g., glucose
synthesis) of a plant illuminated by different wavelengths of light. The graph shows that a wide range
of visible-light wavelengths support photosynthesis.

The spectrum shows that all wavelengths of visible light energy can support
photosynthesis. In addition, other experiments revealed that radiation other than visible light
(e.g., ultraviolet and infrared light) do not support photosynthesis. One can conclude that
chlorophylls are likely not the only pigments to support photosynthesis.
Chlorophylls are easily purified from leaves. The graph in Figure 7.8 shows an average
absorbance spectrum of chlorophylls. The absorbance of chlorophyll a and chlorophyll b are
slightly different, but they center at wavelengths of 450 nm and 675 nm.

Fig. 7.8: This graph plots the absorbance spectrum of purified chlorophylls, showing two main peaks of
absorbance, suggesting the hypothesis that different pigments must be absorbing other wavelengths of
light that support photosynthesis.

Comparing the action and absorbance spectra, we can conclude that the chlorophylls
support photosynthesis, but that chlorophylls alone do not account for the action spectrum of
photosynthesis!
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In fact, other pigments absorbing light elsewhere in the visible spectrum also support
photosynthesis. Of course, we knew that these other pigments were present in leaves and other
photosynthetic plant tissues because we could see many of them as fall colors. All of these
pigments (including chlorophylls) are found in chloroplasts, the organelles that conduct
photosynthesis in plants. Take another look at the structure of chloroplasts in the electron
micrographs in Figure 7.9.

Fig. 7.9: A low-power transmission micrograph of a chloroplast (left) shows grana (thylakoid stacks).
A high-power micrograph (right) shows a few grana in detail, revealing thylakoid membranes in a
granum and the interthylakoid membranes linking grana.

Figure 7.10 shows that the visible light absorbance spectra of the chlorophylls,
carotenoids and possibly other pigments coincide with the photosynthetic action spectrum.
This implies that the absorption of light by those pigments is responsible for photosynthesis.

Fig. 7.10: Here a photosynthetic action spectrum is shown above the absorbance spectra of different
plant pigments. The absorbance peaks of different chloroplast pigments lie under different regions of the
action spectrum, consistent with the hypothesis that multiple pigments support photosynthesis.

In fact, chlorophyll a, chlorophyll b, carotenoids, and other accessory pigments
participate in capturing light energy for photosynthesis. Two pigment clusters, called reaction
centers, capture light energy as part of photosystem 1 (PSI) and photosystem 2 (PSII) on
thylakoid membranes of chloroplasts.
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Johann Deisenhofer, Robert Huber and Hartmut Michel first determined the 3D
structure of a bacterial reaction center. Then they unraveled the relationship between the
structure of the proteins in the center and the membrane in which they were embedded. For
this, they shared the 1988 Nobel Prize in Chemistry.
The activities of PSI are animated at 7.4Photosystem I Action. You can watch as photon
of light excites electron (e−) pairs from PSI pigments, which then transfer their energy from
pigment to pigment, ultimately to chlorophyll a P700. The impact of the electron pair excites a
pair of electrons from chlorophyll a P700, and that pair is captured by a PSI e− acceptor, an
event referred to as charge separation. Next, the reduced PSI acceptor is oxidized as electrons
move down a short ETC, eventually reducing NADP+ to NADPH. Electrons on NADPH will
eventually be used to reduce CO2 to a carbohydrate. So far, so good! But that leaves an
electron deficit in PSI. The Z-Scheme illustrated in Figure 7.11 (below) follows electrons taken
from water (absorbed through roots) into PSII, which will replace those electrons missing from
PSI.

Fig. 7.11: In the “Z-Scheme” of photosynthesis, pigments in PSI and PSII absorb light energy that
excites electrons captured by electron acceptors. Electrons excited from PSI reduce NADPH, the
starting point of the light-independent reactions (right). Electrons excited out of PSII come from splitting
water, releasing oxygen (left). These electrons will flow down a photosynthetic electron transport chain
to replace electrons lost from PSI. Along the way, free energy from those excited electrons fuels ATP
synthesis (middle of the illustration).

Let’s summarize electron flow from water through the Z-scheme. Light excites an e−
pair from the P680 form of chlorophyll a in PSII. A PSII electron acceptor in the thylakoid
membrane, identified as pheophytin, captures these electrons, another act of photosynthetic
charge separation. An electron transport chain oxidizes the pheophytin, transferring e− pairs
down to PSI.
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Some of the free energy released then pumps protons from the stroma into the luminal
space of the thylakoid membranes. The gradient free energy fuels ATP synthesis as protons
flow back into the stroma through a chloroplast ATP synthase. The video at 7.5Z-Scheme
Action animates the entire Z-Scheme, showing first how PSI electrons reduce NADP + and then
how PSII electrons replace missing PSI electrons, making ATP along the way. The oxygen
released by splitting water ends up in the atmosphere.
CHALLENGE: To help you get a handle on the Z-scheme, list all the
products of the light reactions of photosynthesis.
The goal of photosynthesis is to make and to store glucose, so the photosynthesizing
cells get ATP to power glucose production by photophosphorylation during electron transport
via the Z-scheme. However, cyclic photophosphorylation can occur when the cell’s need for
ATP exceeds the capacity of the Z-scheme to supply it. Cyclic photophosphorylation is
illustrated in Figure 7.12.

Fig. 7.12: In Cyclic Photophosphorylation electrons excited from PSI don’t reduce NADP+, PSII is
not active, water is not split, and the excited PSI electrons are captured by the photosynthetic
electron transport chain, to be returned to PSI. ATP made by this cycle is used for cellular work
when there is no need or capacity to make more sugar.

Cyclic Photophosphorylation is a variation on the light-dependent reactions, a kind of
time-out to make ATP without reducing NADP + and thus, without reducing CO2 to make
sugar). The cycle simply takes excited electrons to the PSI electron acceptor, and instead of
sending them to NADP+, it deposits them on PC (plastocyanin) in the electron transport chain
between PSII and PSI. These electrons then flow down the “long line” of the Z, right back to
PSI, releasing their free energy to make ATP. In light, the electrons just go up and around,
hence the name Cyclic Photophosphorylation. The path of electrons shown in Figure 7.12 is
also animated at 7.6Cyclic Photophosphorylation Activity.

144

7.5.2

The Light-Independent (“Dark”) Reactions of Photosynthesis

As we have seen, the light-dependent reactions of photosynthesis require light energy and
water to generate O2, ATP, and NADPH. In the light-independent (or “dark”) reactions of
chloroplasts, the ATP and NADPH will provide free energy and electrons (respectively) for
carbon fixation (the reduction of CO2 to make carbohydrates). There are three main pathways
for the so-called “dark reactions.”
7.5.2.a The Calvin-Cycle C3 Pathway
The Calvin cycle is the most common light-independent reaction pathway. In 1950 Melvin
Calvin and his colleagues (James Bassham and Andrew Benson) described the complete cycle
from CO2 to glucose (Figure 7.13). They followed the radioactive 14C isotope of carbon into
14
CO2, then into glucose, and then into carbohydrates in photosynthesizing plants. For his
work, Calvin received the Nobel Prize in Chemistry in 1961.

Fig. 7.13: In the Calvin cycle in C3 (i.e., most) plants, three ribulose bisphosphate (RuBP) molecules
are fixed to three CO2 molecules, catalyzed by RuBisCO. The 3 resulting 6-C molecules are split into
six 3-C carbohydrates that then make six glyceraldehyde-3-phosphate molecules (G3P, or GA3P in
the illustration). Five of these go on to regenerate three RuBP molecules; the sixth G3P waits for the
Calvin cycle to repeat, producing another G3P. Two G3Ps from two turns of the cycle are substrates
for glucose synthesis.

CHALLENGE: Why is the C3 photosynthetic pathway called C3?
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Check the animation at 7.7Calvin Cycle Action. Each carbon dioxide entering the
Calvin cycle is “fixed” to a 5-C ribulose bisphosphate molecule (RuBP), catalyzed by the
enzyme RuBP carboxylase-oxygenase, or RUBISCO for short. Seemingly, the expected 6-C
molecule quickly splits into two 3-C molecules since it has not been found as an intermediate
to date! The first detectable products are two molecules of 3PGA (3-phosphoglyceric acid).
Each 3PGA is in turn reduced to glyceraldehyde-3-phosphate (GA3P in the illustration, or G-3P). Some of the Calvin cycle intermediates should look familiar: the cycle regenerates the
RuBP and the essential intermediates of glucose production. Figure 7.14 may help with the
arithmetic of the Calvin cycle.

Fig. 7.14: Visualizing the events in each turn of the Calvin Cycle can be difficult. This presentation
of Calvin Cycle arithmetic explains how 6 turns of the cycle accounts for making one glucose and
regenerating five RuBP molecules.

Perhaps the easiest way to see this is to imagine the cycle going around six times,
fixing six molecules of CO2, as shown in the illustration. In fact, a photosynthetic cell must fix
six CO2 carbons onto six RuBP molecules to generate a single 6-C glucose. This leaves thirty
carbons on the table (as G-3-P molecules) with which to make six 5-C RuBP molecules.
CHALLENGE: In 2020, scientists engineered artificial chloroplasts based
on spinach photosynthetic cells. The artificial chloroplasts used light to
fix CO2 even more efficiently than the real things (7.8A Better
Chloroplast)! What does this tell you about evolution?
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There are times that even plants in temperate environments suffer prolonged hot, dry
spells. Perhaps you have seen a lawn grow more slowly and turn brown after a dry heat wave
in summer, only to grow and re-green after the rains resume. C3 plants resort to
photorespiration during drought and dry weather, closing their stomata to conserve water.
Under these conditions, CO2 can’t get into the leaves—and O2 can’t get out! As CO2 levels
drop and O2 levels rise in photosynthetic cells, the Calvin cycle slows down. Instead of fixing
CO2, the enzyme RUBISCO now catalyzes “O2 fixation” using its oxygenase activity. The
combination of RuBP with O2 splits RuBP into a three-carbon and a two-carbon molecule: 3phosphoglyceric acid (3-PG) and phosphoglycolate, respectively (Figure 7.15).

Fig. 7.15: Photorespiration, the reaction shown here, is a C3-plant strategy to conserve water during a
dry spell. Under these conditions, RuBP carboxylase-oxygenase uses its oxygenase activity to, in effect,
'fix oxygen', by splitting ribulose bisphosphate (at the left) into 3-phosphoglyceric acid and 2phosphoglycolate (at the right).

Under these conditions, not only does photorespiration result in only one three-carbon
carbohydrate (compared to two in the Calvin cycle), but the phosphoglycolate produced is
cytotoxic (not healthy for cells!). Removing phosphate and metabolizing the remaining glycolic
acid costs energy. Therefore, photorespiration can only be sustained for a short time.
On the other hand, plants that have adapted to live in hot, arid environments all the
time have evolved one of two alternate pathways: the CAM (Crassulacean Acid Metabolism)
and the C4 pathway. Each is an alternative to the C3 pathway of carbon fixation.
7.5.2.b The CAM Photosynthetic Pathway

Crassulacean acid metabolism (CAM) was discovered in the Crassulaceae family, which
contains succulents like sedum (a common ground cover), cactuses, jade plants, and some
orchids. This pathway was selected in evolution to allow plants to conserve water, especially
during the high daytime temperatures.
The CAM pathway is shown below in Figure 7.16. Stomata in chlorenchyma (mesophyll leaf
cells) close during the day to minimize water loss, which would result from transpiration. The
stomata open at night, allowing plant tissues to take up CO 2. CAM plants fix CO2 by
combining it with PEP (phosphoenolpyruvate) to make oxaloacetate (OAA). This eventually
produces malic acid that is stored in plant cell vacuoles.
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Fig. 7.16: Crassulacean Acid Metabolism evolve to help some plants conserve water during high daytime
temperatures. Chlorenchymal cell stomata open at night, fixing CO2 to oxaloacetate (OAA) which is
converted to malic acid to be stored. Stomata close at daybreak to conserve water while stored malic acid
releases CO2 to be refixed to make glucose.

By day, stored malic acid retrieved from the vacuoles splits into pyruvate and CO 2. The
CO2 then enters chloroplasts and joins the Calvin cycle to make glucose and the starches. In
sum, CAM plant mesophyll cells do the following:
•
•
•

They open stomata at night to collect, to fix, and to store CO2 as an organic acid.
They close stomata to conserve water in the daytime.
They re-fix the stored CO2 as carbohydrates, using the NADPH and ATP from the light
reactions the next the day.

7.5.2.c The C4 Photosynthetic Pathway
The end-product of the C4 pathway is the malic acid (4 carbons). As in the CAM pathway,
phosphoenolpyruvate (PEP) carboxylase catalyzes carbon fixation, converting PEP to
oxaloacetate (OAA) and OAA to malate. But the pathways differ in what next happens to
malate (malic acid). Figure 7.17 (below) shows the role of malate in the C4 pathway.
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Fig. 7.17: Some plants that spend a lot of time in hot conditions have adapted to use the C4
photosynthetic pathway. In these plants the “dark” reactions are shared by mesophyll and bundle sheath
cells, allowing efficient photosynthesis during the day, even hot ones! Stomata open part of day in
mesophyll cells, CO2 enter and is fixed to PEP that is converted to OAA, then malate. The malate moves
to bundle sheath cells, where it releases CO2 to be re-fixed by the Calvin cycle.

C4 metabolism diverges from the CAM pathway after malate formation. PEP-carboxylase
catalysis is rapid in C4 plants, in part because malic acid does not accumulate in the mesophyll
cells. Instead, malate is rapidly transferred from the mesophyll cells into adjacent bundle
sheath cells, where it enters chloroplasts. As a result, the C4 plants can keep their stomata
open to capture CO2 for part of the day (unlike CAM plants), but they must close them for at
least part of the day to conserve water. The four-carbon malic acid is oxidized to pyruvate
(three carbons) in the bundle-sheath-cell chloroplasts. The CO2 that is released then enters the
Calvin cycle to be rapidly fixed by RUBISCO. Of course, the result is that, compared to C3
photosynthetic metabolism, C4 plant photosynthesis results in a more efficient use of water
and faster carbon fixation, properties most useful under dry, hot conditions. Corn is perhaps
the best-known C4 plant! By the way, we don’t think of corn as tropical plant! Why not?
CHALLENGE: Thinking about the economies of evolution, how many of
the intermediates common to respiration and the light-independent
photosynthetic reactions can you recognize?
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7.6

On the Origins and Evolution of Respiration and Photosynthesis

In one scenario, abundant chemical energy on our once-cooling planet favored the formation
of cells that could capture free energy from energy-rich nutrients in the absence of any O2. We
initially thought that these first cells would extract nutrient free energy by non-oxidative,
fermentation pathways. But they would have been voracious, quickly depleting environmental
nutrient resources. Of course, this didn’t happen!
It was the evolution of autotrophy that saved heterotrophic life from an early extinction! Why?
Because autotrophs create organic molecules by extracting free energy from inorganic
molecules or from light. An alternative scenario gaining traction suggests that the first cells
may respired but using something other than oxygen as a final electron acceptor. In this
scenario (considered in detail elsewhere), non-oxygenic “oxidative” chemistries came first,
followed by the evolution of anoxic fermentative chemistries, then by photosynthesis, and
finally by oxygenic respiratory pathways. In either scenario, we can assume that
photosynthesis existed before oxygenic respiration.
CHALLENGE: Why is this assumption a safe one?
We also assume that oxygenic photoautotrophs that capture free energy from light would
become the most abundant autotrophs, if for no other reason than sunlight is always available
(during the day!), and of course, O2 is now abundant in the air! Early photoautotrophs were
likely the ancestors of today’s cyanobacteria, and in fact, a phylogenetic study of many genes—
including genes in plastids and in nuclei that encode plastid proteins—along with a wealth of
cyanobacterial genome data, suggests a common ancestry of freshwater cyanobacteria and
eukaryotic chloroplasts (Ponce-Toledo, R.I. et al., 2017, An Early-Branching Freshwater
Cyanobacterium at the Origin of Plastids. Current Biology 27:386-391).
Finally, think about the origins of respiratory metabolism and the endosymbiotic
origins of mitochondria. How did cellular respiration co-opt the photosynthetic electron
transport reactions that captured the electrons from H2O needed to reduce CO2 and then direct
those reactions to the task of burning sugars back to H 2O and CO2? As photosynthetic
organisms emerged and atmospheric O2 increased, higher O2 levels would become toxic to
most living things. Still, some autotrophic cells must have had a preexisting genetic potential
to conduct detoxifying respiratory chemistry. These would have been facultative aerobes able
to switch from photosynthesis to respiration as O2 levels rose. Today’s purple non-sulfur
bacteria (e.g., Rhodobacter sphaeroides) are just such facultative aerobes! Perhaps we aerobes
descend from the ancestors of Rhodobacter-like cells that survived and spread from localized
environments, where small amounts of O2 threatened their otherwise strictly anaerobic
neighbors. Is it possible that the endosymbiotic critter that became the first mitochondrion in a
eukaryotic cell was not just any aerobic bacterium, but a purple photosynthetic bacterium?
CHALLENGE: Contrast possible origins of mitochondria from purple nonsulfur bacteria with the endosymbiotic theory; see 7.9Alternate
Mitochondrial Roots).
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Chapter 8

DNA, Chromosomes and Chromatin

The “stuff of genes”; the double helix; chromosomes and chromatin;
naked, circular bacterial DNA
Reminder: For inactive links, google key words/terms for alternative resources.

8.1

Introduction

In 1868, seeking a source for the hereditary variation to support evolution by natural selection,
Charles Darwin came up with pangenesis (from the Greek pan, “all”; genetikos, “origins”) in
which hereditary particles that he called gemmules (from Greek, meaning “small buds”) are
gathered from all cells of the body cells, to be funneled into germ cells and later redistributed
to body cells during embryogenesis.
In the 1890s, Hugo de Vries, at first unaware of Mendel’s work independently rediscovered
the Mendelian laws of heredity in plants, adopting and repurposing Darwin’s term pangenes
for Mendel’s heritable factors. One of three scientists credited with the rediscovery of Mendel’s
work, he also coined the term mutation for novel traits that suddenly appeared in his plants. In
1905, William Bateson first defined genetics as the study of inheritance and in 1909, Wilhelm
Johannsen, a Danish botanist, shortened pangene to gene, also coining the terms genotype
and phenotype to distinguish genes from the visible traits they determine. Finally, we knew by
the start of the twentieth century that chromosome shapes were species-specific, that each
species had a characteristic karyotype (from the Greek karyo, “nuclear”). Feel free to search for
more historical details. This brief etymological history brings us to the topic of this chapter –
the stuff of genes!
Here we look at classic experiments that led to our understanding that genes are composed of
DNA. We already knew that genes are on chromosomes (chromo: “colored”; soma: “body”).
Early twentieth-century gene mapping had shown the relative location (locus) of genes on the
linear chromosomes of eukaryotes. We’ll see that eukaryotic chromosomes are highly
condensed structures composed of DNA and protein, visible only during mitosis or meiosis.
During the much longer interphase portion of the eukaryotic cell cycle, chromosomes
decondense to chromatin, a less-organized form of protein-associated DNA in the nucleus. In
this chapter, we’ll learn that eukaryotic chromatin is the gatekeeper of gene activity, a situation
quite different from the case in bacterial cells. Unlike eukaryotic cells, bacteria contain a tiny
amount of more simply organized DNA. We’ll learn that bacterial gene (mutation) mapping
revealed the bacterial “chromosome” to be a closed, naked, and circular DNA double helix.
Such knowledge of DNA structure and organization is essential to our understanding of how
and when cells turn genes on and off. When we look at the gene regulation in an upcoming
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chapter, remember this and that the genetic content of eukaryotic as well as of prokaryotic
organisms is species-specific.

Learning Objectives
When you have mastered the information in this chapter, you should be able to do the
following:
1. Summarize the evidence that led to acceptance that genes are made of DNA.
2. Discuss how Chargaff’s DNA base ratios support DNA as the “stuff of genes.”
3. Interpret the findings of Griffith, of Avery et al. and of Hershey and Chase in their
historical context.
4. Outline and explain how Watson and Crick built their model of a DNA double helix.
5. Distinguish between conservative, semiconservative, and dispersive replication.
6. Describe and/or draw the progress of a viral infection.
7. Trace the fate of 35SO4 (sulfate) into proteins that are synthesized in cultured bacteria.
8. Distinguish between chromatin and chromosomes in terms of DNA organization and
speculate on how this organization impacts replication.
9. List some different uses of karyotypes.
10. Compare and contrast euchromatin and heterochromatin structure and function.
11. Outline an experiment to purify histone H1 from chromatin.
12. Formulate a hypothesis to explain why chromatin is found only in eukaryotes.
13. Describe the roles of different histones in nucleosome structure.
14. Explain the role of Hfr strains in mapping genes in E. coli.
15. Explain the chemical rationale of using different salt concentrations to extract 10 nm
nucleosome filaments vs 30 nm solenoid structures from chromatin.
8.2

The Stuff of Genes

Mendel presented his Laws of Inheritance in 1865 but they were not widely
understood—probably because they included a strong dose of math and statistics at a time
when quantitative biology was not in vogue. By the late 1800s we knew that all eukaryotic
cells contain a nucleus, shown by histological staining to contain mainly proteins and nucleic
acids; the nucleus as the site genetic information was gaining traction. As the 19th century was
ending and the 20th was beginning, the discovery paired chromosomes emerging from nuclei
during mitosis and the rediscovery of Mendel’s work on paired hereditary factors, set off an
explosion of genetic studies that led to the understanding that any organism’s observable traits
are based on patterns of inheritance of paired genetic factors housed in the nuclei of cells. In
honor of Gregor Mendel, we call this seminal insight Mendelian Genetics. By 1901, Albrecht
had discovered the four DNA bases (adenine, thymine, cytosine and guanine) and uracil, the
substitute for thymine in RNA, earning him the 1910 Nobel Prize in Physiology or Medicine.
Yet for many years, DNA was thought to be just a small molecule made up of only its four
bases. How could such a simple molecule account for the inheritance of so many different
physical and physiological traits? Recall Beadle Tatum and Lederberg’s one-gene/one-enzyme
hypothesis, recognizing the inheritance of enzyme activities according to Mendelian rules.
After morphing first into the one-gene/one-protein, and then into the one-gene/onepolypeptide hypothesis, this relationship between genes and polypeptides supported proteins
as the stuff of genes, and an enduring prejudice against DNA as the genetic material, despite
early and growing evidence to the contrary.
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Compared to DNA, only chains of up to twenty different amino acids in polypeptides
and proteins seemed to have had the potential for enough structural diversity to account for
the growing number of heritable traits in each organism. Proteins were arguably the most
likely candidates for the molecules of inheritance. The experiments you’ll read about here
began around the start of World War I and lasted until just after World War II. The work of
Phoebus Levene over this period revealed that DNA was no mere tetramer of deoxynucleotides
but was in fact a long polymer (check it out at 8.1Long Nucleotide Polymers). This led to the
clever experiments that eventually forced the conclusion that DNA, not protein, was the
genetic molecule, despite it being composed of just four monomeric units. Finally, we will look
at the classic work of Watson, Crick, Franklin, and Wilkins, which revealed the structure of the
genetic molecule.
8.2.1

Griffith’s Experiment

Fred Neufeld, a German bacteriologist studying pneumococcal bacteria in the early 1900s,
discovered three immunologically different strains of Streptococcus pneumoniae (types I, II
and III). The virulent strain (type III) was responsible for much of the mortality during the
Spanish flu (influenza) pandemic of 1918–20. This pandemic killed between twenty million
and one hundred million people, commonly because of bacterial pneumonia, a superinfection
by Streptococcus pneumoniae.
Viral infection may weaken the immune defense against S. pneumoniae, and a recent study
suggests how: the virus causes bronchial and alveolar capillary leakage increasing
susceptibility of the lungs to bacterial infection (see 8.2Influenza Causes Bronchoalveolar
Capillary Leakage).
In the 1920s, Frederick Griffith was working with virulent wild-type (type III) and
benign (type II) strains of S. pneumoniae. The two strains are easy to tell apart in petri dishes
because the virulent strain grew as morphologically smooth (S) colonies, while the benign
strain formed rough (R) colonies. It turns out that the S cells are coated with a polysaccharide
(mucus) capsule, which makes their colonies appear smooth, and The R cell colonies look
rough (i.e., don’t glisten) because they lack the polysaccharide coating. Griffith knew that
injecting mice with S cells killed them within about a day, and that injecting them with
nonlethal R cells, on the other hand, caused no harm. He decided to test the hypothesis that
exposure of mice to the R strain of S. pneumoniae might immunize them against lethal
infection by subsequent exposure to S cells.
To test his hypothesis, Griffith injected mice with R cells. Sometime later, he injected
them with S cells. Unfortunately, the attempt to immunize the mice against S. pneumoniae was
unsuccessful: both the control mice injected with S cells, and the experimental mice (that
received the R-strain cells first and then S cells) all died in short order! As expected, mice
injected only with R cells survived. Griffith also checked the blood of his mice for the presence
of bacterial cells by growing the cells from the blood in petri dishes; he made the following
observations:
• Mice injected with benign R-strain cells survived, and after he plated blood from the mice
on a nutrient medium, no bacterial cells grew.
• Mice injected with S-strain cells died, and bacterial cell colonies grew from their blood.
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Griffith’s experiments and results, published in 1928, are summarized in Figure 8.1.

Fig. 8.1: Griffith did the experiments shown here, hoping to make antibodies against streptococcal
pneumonia. Across the top are his experiments, with 2 control experiments at the left. The 2 key
experiments are at the right. Neither of these yielded the desired antibodies. Instead, he discovered a
chemical from dead cells that genetically transformed live bacteria (the experiment at the far right). He
called the chemical a "transforming principle", what we now know as DNA.

CHALLENGE: What on the coating of S cells might make them virulent and
why are R cells unable to immunize mice against virulent S cells?
Griffith then performed two other experiments, also shown in the illustration:
• He injected mice with heat-killed S cells; these mice survived. Blood from these mice
contained no bacterial cells. This was expected, since heating the S cells would likely have
the same effect as pasteurization has on bacteria in milk!
• Griffith also injected mice with a mixture of live R cells and heat-killed S cells, in the hope
that the combination might induce immunity in the mouse, whereas injecting the R cells
alone had failed. You can imagine his surprise when, far from being immunized against Scell infection, the injected mice died, and abundant S cells had accumulated in their blood.
Griffith realized that something important had happened in his experiments: in the mixture of
live R cells and heat-killed S cells, something released from the dead S cells had transformed
some R cells. Griffith named this “something” the transforming principle—a molecule in the
debris of dead S cells that could sometimes be acquired by a few live R cells and turn them into
virulent S cells.
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CHALLENGE: How many of the R cells initially injected into a mouse do you
think would have to acquire the transforming principle from dead S cells in
order to kill the mouse so quickly? Explain your answer.

8.2.2

The Avery-MacLeod-McCarty Experiment

While Griffith didn’t know the chemical identity of his transforming principle, his experiments
led to studies that proved DNA to be the stuff of genes. With improved molecular purification
techniques developed in the 1930s, Oswald Avery, Colin MacLeod, and Maclyn McCarty
transformed R cells in vitro (that is, without the help of a mouse!). They purified heat-killed Scell DNA, proteins, carbohydrates, and lipids and separately tested the transforming ability of
each molecular component on R cells in a test tube. Since only the DNA fraction of the dead S
cells could cause bacterial transformation, the three scientists concluded that DNA must be the
transforming principle. Figure 8.2 summarizes their experiments. But despite the evidence,
DNA was not yet readily accepted as the stuff of genes.

Fig. 8.2: The experiments of Avery et al. demonstrated for the first time that the chemical “stuff of
genes” (i.e., of inheritance) is DNA.

The sticking point was that DNA is composed of only the four nucleotides:
monophosphates of adenosine, cytidine, guanosine, and thymidine. Scientists knew that DNA
was a large polymer, but they still thought of it as a simple molecule—a polymer made up of
repeating sequences of the four bases (e.g., -A-G-C-T-A-G-C-T-A-G-C-T-A-G-C-T-A-G-C-T…).
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It seemed that only the endless possible combinations of the twenty amino acids in
proteins seemed to promise the biological specificity necessary to account for an organism’s
many genetic traits. Lacking structural diversity, DNA was explained as a mere scaffold for
protein genes.
To adapt Marshall McLuhan’s famous statement: “The medium is the message” (i.e.,
airwaves do not merely convey but are the message), many scientists still believed that
proteins were the medium of genetic information as well as the functional message itself. The
reluctance of influential scientists of the day to accept DNA as a transforming principle
deprived its discoverers of the Nobel Prize stature they deserved. After new evidence made
further resistance to that idea untenable, even the Nobel Committee admitted its error in
failing to award a Nobel Prize for the discoveries of Avery, MacLeod, and McCarty. It took the
experiments of Alfred Hershey and Martha Chase finally put to rest any notion that proteins
were genes.

167-2 Transformation In and Out of Mice—Griffith, McCarty, et al.
8.2.3

The Hershey-Chase Experiment

Earlier we learned that viruses cannot live an independent life! A bacterial virus, called a
bacteriophage (or just phage for short), consists of DNA inside a protein capsule. The life cycle
of bacterial viruses is shown in Figure 8.3.

Fig. 8.3: Life cycle of a bacteriophage: the phage’s coat remains attached to a cell after infection, but the
chemicals inside the phage enter the infected cell.

Phage are inert particles until they bind to and infect bacterial cells. Phage added to a
bacterial culture can be seen attached to bacterial surfaces with an electron microscope.
Investigators found that they could detach phage particles from bacteria simply by agitation in
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a blender (like one you might have in your kitchen). Centrifugation then separated the
bacterial cells in a pellet at the bottom of the centrifuge tube, leaving the detached phage
particles in the supernatant.
By adding phage to bacteria, then detaching them from the bacteria at different times,
investigators were able to determine how long the phage had to remain attached before the
bacteria would become infected. It turned out that pelleted cells that had been attached to
phage for short times would survive and reproduce when resuspended in a growth medium,
but pelleted cells left attached to phage for longer times would become infected. When
centrifugally separated from the detached phage particles and resuspended in fresh medium,
these infected cells would go on to lyse, releasing new phage. Therefore, the transfer of genetic
information for virulence (i.e., infectivity) from the phage to cells took some time. Furthermore,
the viral genetic material responsible for infection was apparently no longer associated with
the phage capsule, which could be recovered from the centrifugal supernatant.
Alfred Hershey and Martha Chase designed an experiment to determine whether the
DNA that was enclosed by the viral protein capsule or the capsule protein itself caused a phage
to infect the bacterium. In the experiment, they separately grew Escherichia coli cells infected
with T2 bacteriophage in the presence of either 32P or 35S (radioactive isotopes of phosphorous
and sulfur, respectively). The result was to generate phage that contained either radioactive
DNA or radioactive proteins, but not both (recall that only DNA contains phosphorous and
only proteins contain sulfur). They then separately infected fresh E. coli cells with either 32P- or
35
S-labeled radioactive phage. Their experiment is illustrated in Figure 8.4.

Fig. 8.4: Alfred Hershey and Martha Chase demonstrated that the chemical stuff of viral genes is DNA
by showing that cells exposed to phage for the short time needed to become infected contained only
the DNA from the virus, and not the viral proteins.
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Phage and cells were incubated with either 32P or 35S just long enough to allow
infection. Some of each culture was allowed to go on and lyse to prove that the cells were
infected. The remainder of each mixture was sent to the blender. After centrifugation of each
blend, the pellets and supernatants were examined to see where the radioactive proteins or
DNA had gone. From the results, the 32P always ended up in the pellet of bacterial cells, while
the 35S was found in the phage remnant in the supernatant. Hershey and Chase concluded that
the genetic material of bacterial viruses was DNA, not protein, and that—just as Avery’s group
had suggested—DNA was the bacterial transforming principle. Given the earlier resistance to
“simple” DNA being the genetic material, Hershey and Chase used cautious language in
framing their conclusions. They need not have; all subsequent experiments confirmed that
DNA was the genetic material. Concurrent with these confirmations were experiments
demonstrating that DNA might not be (indeed, was not) such a simple, uncomplicated
molecule!
For their final contributions to pinning down DNA as the “stuff of genes,” Hershey
shared the 1969 Nobel Prize in Physiology or Medicine with Max Delbrück and Salvador E.
Luria. So why didn’t Martha Chase get a share of the recognition in the Nobel Prize, given that
she was Hershey’s sole coauthor on the paper presenting their findings? You may well ask!

168 Hershey and Chase: Viral Genes Are in Viral DNA
In a later chapter you will read about our benevolent (even crucial) microbiomes and the
phenomenon of horizontal gene transfer (essentially, what Griffith discovered). Under the
rubric not only in the lab, you can read about the role of horizontal gene transfer how gut
bacteria can become harmful in 8.3 A link to the full paper is in Nature Communications at
8.3
Not Only In the Lab: Gut Bacteria Breaking Bad.

8.3

DNA Structure

By 1878 a substance in the pus of wounded soldiers derived from cell nuclei (called nuclein)
was shown to be composed of five bases (the familiar ones of DNA and RNA). The four bases
known to make up DNA (as part of nucleotides) were thought to be connected through the
phosphate groups, in short repeating chains of four nucleotides. By the 1940s, we knew that
DNA was a long polymer. Nevertheless, it was still considered too simple to account for genes.
After the Hershey and Chase experiments, only a few holdouts would not accept DNA as the
genetic material. When the scientific community finally accepted DNA as the stuff of genes,
the next questions were the following:
•
•

What did DNA look like?
How did its structure account for its ability to encode and reproduce life? While the four
phosphate-linked nucleotide composition of DNA was known for some time, it became
mandatory to explain how such a “simple molecule” could inform the thousands of
proteins necessary for life. The answer to this question lay (at least in part) in an
understanding of the physical structure of DNA, made possible by the advent of X-ray
crystallography.
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8.3.1

X-Ray Crystallography and the Beginnings of Molecular Biology

If a substance can be crystallized, the crystal will diffract X-rays at angles revealing regular
(repeating) structures of the crystal. William Astbury demonstrated that high molecular-weight
DNA had just such a regular structure. His crystallographs suggested DNA to be a linear
polymer of stacked bases (nucleotides), each separated from the next by 0.34 nm. Astbury is
also remembered for coining the term “molecular biology” to describe his studies. The term
now covers all aspects of biomolecular structure, encompassing all of the topics covered in this
book!
In an irony of history, the Russian biologist Nikolai Konstantinovich Koltsov had
already intuited in 1927 that the basis for the genetic transfer of traits would be a “giant
hereditary molecule” made up of “two mirror strands that would replicate in a
semiconservative fashion using each strand as a template” (8.4The Remarkable Nikolai Koltsov
- scroll down to read the biography). This was a pretty fantastic inference if you think about it,
since it was proposed long before Watson, Crick, and their colleagues worked out the structure
of the DNA double-helix!
8.3.2

Wilkins, Franklin, Watson, and Crick—DNA Structure Revealed

Maurice Wilkins, an English biophysicist at King’s College, London, had obtained samples of a
highly purified, very high molecular weight DNA “gel” (or “fibers”) that he obtained from a
Swiss colleague, Rudolph Signer. Wilkins’ first X-ray diffraction studies with these fibers
yielded good results. After joining Wilkin’s lab, Rosalind Franklin and her assistant, Raymond
Gosling, produced even higher resolution X-ray diffraction images of Signer’s fibers, among
which was her most famous (and definitive) crystallograph, Photo 51 (Figure 8.5).

Fig. 8.5: Photo 51, the X-ray crystallograph of DNA taken by Rosalind Franklin, revealed three crucial
molecular dimensions that ultimately led to the double-helical DNA model.

This image confirmed Astbury’s 0.34 nm repeated dimension and revealed two more
numbers, 3.4 nm and 2 nm, reflecting additional repeat structures in the DNA crystal. These
numbers and other evidence suggested to Franklin that DNA’s negatively charged phosphates
were on the outer surface of what was likely a helix. At some point, Wilkins shared Photo 51
with James Watson and Francis Crick, who instantly realized its significance, used it along
with other data to build DNA models out of nuts, bolts, and tubes.
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Their models eventually revealed DNA to be a double helix, a pair of DNA strands
held together in a by complementary H-bonding between the bases—shades of Koltsov’s
mirror-image macromolecules! Each strand is a string of nucleotides linked by phosphodiester
linkages, Let’s look at the evidence for these conclusions. As we do, refer to the two
illustrations of the double helix in Figure 8.6.

Fig. 8.6: The three molecular dimensions from Franklin’s Photo 51 could be best explained by the
proposition of a DNA double helix (left). Model-building by Watson and Crick revealed the antiparallel
structure of the double helix (right).

Recalling that Astbury’s 0.34 nm dimension was the distance between successive
nucleotides in a DNA strand, Watson and Crick surmised that the 3.4 nm repeat was a
structurally meaningful tenfold multiple of Astbury’s number. When they began building their
DNA models, Watson and Crick confirmed from the bond angles connecting the nucleotides,
that the DNA strands were forming a helix, from which they suggested that the 3.4 nm repeat
was detecting the pitch of the helix (i.e., the length of one complete turn of the helix). This
meant that there were ten bases per turn of the helix. They further suggested that the 2.0 nm
number might reflect the diameter of the helix. When their scale models of a single-stranded
DNA helix predicted a helical diameter much less than 2.0 nm, they were able to confirm an
intertwined double-stranded DNA in their model (their double helix) that more nearly met the
requirement for a 2.0 nm diameter. In building this double helix, Watson and Crick realized
that bases in opposing strands would indeed come together within the double helix to form Hbonds, holding the helices together. However, for their double helix to have a constant
diameter of 2.0 nm, they also realized that the smaller pyrimidine bases, thymine (T) and
cytosine (C), would have to H-bond to the larger purine bases, adenine (A) and guanine (G),
and that neither A-G nor C-T pairing could account for a uniform 2.0 nm diameter along the
length of the double helix.
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And now to the question of how a “simple” DNA molecule could have the structural
diversity needed to encode thousands of different polypeptides and proteins. In early studies,
purified E. coli DNA was chemically hydrolyzed down to nucleotide monomers. The hydrolytic
products contained nearly equal amounts of each base, reinforcing the notion that DNA was
that simple molecule that could not encode genes. But Watson and Crick had private access to
data from Erwin Chargaff, who had determined the base composition of DNA isolated from
different species, including E. coli. He found that the base composition of DNA from different
species was not always equimolar, meaning that for some species, the DNA was not composed
of equal amounts of each of the four bases (see some of this data in Table 8.1).
Table 8.1

Composition of DNA from Different Organisms
base
purine
pyrimidine
purine
pyrimidine

A
C
G
T

human

yeast

fly

27%
23%
23%
27%

21%
32%
32%
21%

15%
35%
35%
15%

The mere fact that Chargaff had shown that DNA from some species could have base
compositions that deviated from equimolarity put to rest the argument that DNA had to be a
very simple sequence. Finally, it was safe to accept the obvious, namely that DNA sequences
could vary almost infinitely and could indeed be the stuff of genes. Even more convincing was
his data showing unique patterns of base ratios. Although base compositions could vary
between species, the A/T and G/C ratios were always 1 for every species; likewise, the ratio of
(A+C)/(G+T) and (A+G)/(C+T). From this information, Watson and Crick inferred that A (a
purine) would H-bond with T (a pyrimidine), and that G (a purine) would H-bond with C (a
pyrimidine) in the double helix. Building their model with this new information, they also
confirmed that H-bonding between the complementary bases would be maximal only if the two
DNA strands were antiparallel, leading to the most stable structure of the double helix.
Watson and Crick published their paper A Structure for Deoxyribose Nucleic Acid in 1953 in
Nature (read an annotated version of this seminal article at 8.5The Classic 1953 Watson-Crick.
Their article is also famous for predicting a semiconservative mechanism of replication,
something that had been predicted by Koltsov twenty-six years earlier, albeit based on
intuition… and much less evidence! Watson, Crick, and Wilkins shared a Nobel Prize in 1962
for their work on DNA structure. Franklin was never nominated for her work on DNA
structure, and since she died in 1958, her chances ended since Nobel prizes are not awarded
posthumously. In the years between 1953 and 1958, Franklin had left King’s College for
Cambridge where she studied Tobacco Mosaic Virus, an RNA virus. By X-ray crystallography,
she showed that the RNA was inside the virus, interwoven with the viral coat proteins.
Posthumously she did get delayed recognition, including a named building at King’s College
and later, a whole Chicago university There remain questions about why Franklin did not get
more timely credit for her role in the work, but a BBC documentary at
8.6
https://www.youtube.com/watch?v=FpZQvDFQpmg sheds some light in the controversy.

169-2 Unraveling the Structure of DNA

162

8.3.3

Meselson and Stahl’s Experiment—Replication is Semiconservative

Confirmation of Watson and Crick’s suggestion of semiconservative replication came from
Matthew Meselson and Franklin Stahl’s very elegant experiment, which tested the three
possible models of replication (Figure 8.7)

Fig. 8.7: Three possible modes of DNA replication could be imagined.

In their experiment, E. coli cells were grown in a medium containing 15N, a “heavy”
nitrogen isotope. After many generations, the DNA in all of the cells had become labeled with
the heavy isotope. At that point, the 15N-tagged cells were placed back into a medium
containing the more common, “light” 14N isotope and were allowed to grow for exactly one
generation. Figure 8.8 shows Meselson and Stahl’s predictions for their experiment. Meselson
and Stahl knew that 14N-labeled and 15N-labeled DNA would form separate bands after
centrifugation on CsCl (cesium chloride) density gradients.

Fig. 8.8: Meselson and Stahl predicted experimental outcomes based on possible modes of replication.

They tested their predictions by purifying and centrifuging the DNA from the 15N-labeled cells
grown in the 14N medium for one generation. They found that this DNA formed a single band
with a density between that of 15N-labeled DNA and 14N-labeled DNA, thereby eliminating the
conservative model of DNA replication (possibility #1), as Watson and Crick had also
predicted.
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That left two possibilities: replication was either semiconservative (possibility #2) or
dispersive (possibility #3). The dispersive model was eliminated when DNA isolated from cells
that had been grown for a second generation on 14N were shown to contain two bands of DNA
on the CsCl density gradients.

170 Replication is Semiconservative

8.4

Chromosomes

It was clear by the twentieth century that eukaryotic nuclei were somehow involved in
inheritance and further, that the behavior of paired chromosomes in meiosis mimicked the
behavior of Mendel’s heritable factors. Hence, the chromosome theory of heredity, which posits
that chromosomes contain genes. Let’s take a brief look at how we came to know this. As with
much of genetics, it begins with Mendel! He was unable to account for deviations from his
Law of Independent Assortment— e.g., an unexpected green pea plant among the many yellow
pea plants expected from a genetic cross. But, in the early 1900s, genetic studies of Drosophila
melanogaster in Thomas Hunt Morgan’s lab showed that Mendel’s misbehaving pea plant
traits were due to recombination (crossing over) between bits of homologous chromosomes
during meiosis. Furthermore, these crossings over were frequent. In fact, the recombination
frequency of a given pair of genes was reproducible, effectively a constant. This suggested that
such gene pairs were linked on the same chromosome, consistent with chromosome theory. For
this work, Morgan earned the 1933 Nobel Prize for Physiology or Medicine. He further
suggested that genes far apart on a chromosome would cross over more often than those closer
together. Alfred H. Sturtevant (one of Morgan’s students) tested the possibility that
recombination frequencies might be used to map the position (locus) of genes on
chromosomes. He confirmed this by generating the first maps of D. melanogaster’s four
chromosomes! See 8.7D. melanogaster Gene Mapping (or I. Lobo & K. Shaw, 2008; T. H.
Morgan, Genetic recombination, and gene mapping. Nature Educ. 1:205) for more details.)
Let’s look at a typical chromosome (Figure 8.9).

Fig. 8.9: A female chromosome stained for banding and defining a centromere and two telomeres.

Late nineteenth-century microscopists saw chromosomes condense a dispersed state as
the nucleus broke down during mitosis or meiosis. They were visible as they moved to opposite
poles of the cell during cell division. Look at chromatids separating in mitotic anaphase in the
computer-colorized micrograph at 8.8Chromatid Separation in Anaphase.
CHALLENGE: Why are virtually all genes in dividing cells inactive?
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It’s possible to distinguish one chromosome from another by karyotyping. Cells in
metaphase of mitosis placed under pressure will burst and the chromosomes spread out.
Figure 8.10 shows such a chromosomal spread.

Fig. 8.10: Spread of human mitotic cell chromosomes.

Such spreads showed that chromosomes come in matched pairs, again parallel to Mendel’s
paired heritable factors. By the early 1900s, the number, sizes, and shapes of chromosomes
were known to be species-specific. Cutting apart micrographs like the ones in Figures 8.10 and
8.11, and then pairing the chromosomes by their morphology, generates a karyotype. Paired
human homologs are easily identified in the modern colorized micrograph (Figure 8.11).

Fig. 8.11: Computer-colorized human chromosome spread (right) and karyotype (inset at left).
An intact nucleus is seen above the karyotype.
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As seen in cells undergoing mitosis, all dividing human cells contain twenty-three pairs of
homologous chromosomes. The karyotype in Figure 8.11 is from a female; note the pair of
homologous sex (X) chromosomes (lower right of the inset). X and Y chromosomes in males
are not truly homologous. Chromosomes in the original spread and in the aligned karyotype
were stained with fluorescent antibodies against chromosome-specific DNA sequences to
”light up” the different chromosomes.

171-2 DNA, Chromosomes, Karyotypes, & Gene Maps

8.5

Genes and Chromatin in Eukaryotes

Chromosomes and chromatin are a uniquely eukaryotic association of DNA with proteins of
different types and amounts. Bacterial DNA (as well as prokaryotic DNA generally) is
relatively “naked”—that is, not visibly associated with protein.
CHALLENGE: Why do you think prokaryotic DNA is mostly “naked”?

The electron micrograph of an interphase cell (Figure 8.12) reveals that the chromatin
can itself exist in various states of condensation.

Fig. 8.12: Transmission micrograph of euchromatin and heterochromatin in the nucleus.

Chromatin is maximally condensed during mitosis to form chromosomes. During
interphase, chromatin exists in more- or less-condensed forms, called heterochromatin and
euchromatin, respectively.
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Transition between these chromatin forms involves changes in the amounts and types
of proteins that can bind to the chromatin during gene regulation (i.e., when genes are turned
on or off). Experiments (to be described later) showed that active genes tend to be in the more
dispersed euchromatin, where enzymes of replication and transcription have easier access to
the DNA. Transcriptionally inactive genes are heterochromatic, obscured by additional
chromatin proteins present in heterochromatin.
CHALLENGE: What likely effects of the chemical modification of chromatin
proteins could explain their behavior?
We can define three levels of chromatin organization in general terms:
1. DNA is wrapped around histone proteins (nucleosomes) like “beads on a string.”
2. Multiple nucleosomes are coiled (condensed) into 30 nm fiber (solenoid) structures.
3. The 30 nm fibers are packed in higher order to form the familiar metaphase chromosome.
CHALLENGE: Describe the difference(s) between anaphase and metaphase
chromosomes, using appropriate terminology.
These aspects of chromatin structure were determined by gentle disruption of the
nuclear envelope of nuclei, followed by salt extraction of extracted chromatin. Salt extraction
dissociates most of the proteins from the chromatin. The results of a low-salt extraction are
shown in Figure 8.13.

Fig. 8.13: Low-salt fractionation of interphase nuclei yields 10 nm nucleosome beads on a string.
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When the low-salt extract is centrifuged and the pellet is resuspended, the remaining
chromatin looks like a 10 nm filament of attached nucleosomes, or beads on a string. DNAwrapped nucleosomes are the beads, which are in turn linked by uniform lengths of the
metaphorical DNA “string.”
After a high-salt chromatin extraction, the structure visible in the electron microscope
is the 30 nm solenoid, the coil of nucleosomes, themselves a polymer of histone proteins
encoiled (wrapped up in) DNA, as modeled below in Figure 8.14. The effect of the higher [salt]
is to change the chromatin conformation by re-aggregating nucleosomes with non-histone
nuclear proteins. As shown in the illustration, increasing the salt concentration of an alreadyextracted nucleosome preparation will cause the “necklace” to re-fold into the 30 nm solenoid
structure.

Fig. 8.14: High-salt chromatin extraction from nuclei, or high-salt treatment of 10 nm filaments selectively
removes chromatin proteins, yielding 30 nm solenoid structures, essentially coils of 10 nm filaments. The
solenoid can also form by adding salt to isolated 10nm filament extracts.

In fact, there are at least five levels (orders) of chromatin structure. These are
illustrated below in Figure 8.15. The first two orders, as we have discussed, are the string of
beads (#1) and the solenoid (#2). Other extraction protocols have revealed other aspects of
chromatin structure (#3 and #4). Chromosomes in metaphase (#5) of mitosis are the “highest
order,” or most condensed form of chromatin.
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Fig. 8.15: Five different levels (orders) of chromatin structure.

The results of deoxyribonuclease (DNAse I) digestion of a beads-on-a-string extract
are shown in Figure 8.16. DNase I briefly digests nucleosome “necklaces,” degrading DNA
between the “beads” and leaving behind shortened, different length 10 nm filaments. After a
longer digestion, only single beads (nucleosomes) remain, bound to small amounts of DNA.

Fig. 8.16: Short digestion times with DNase I leave behind shortened 10 nm filaments (or beads
on a string). Longer digestion releases single nucleosomes associated with some DNA.
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Roger Kornberg, one son of Nobel laureate Arthur Kornberg (discoverer of the first
DNA polymerase enzyme of replication—see the next chapter), participated in the discovery
and characterization of nucleosomes while still a postdoc! He found that each nucleosome is
associated with about two hundred base pairs of DNA. Electrophoresis of DNA that had been
extracted from digests of nucleosome beads-on-a-string showed that nucleosomes are
separated by a DNA “linker” of about eighty base pairs. DNA extracted from nucleosomes was
about 147 base pairs long, a closer estimate of the DNA wrapped around the proteins of the
nucleosome. It is appropriate to note here that Roger Kornberg earned the 2006 Nobel Prize for
Chemistry for his work on eukaryotic transcription and the structure of RNA polymerase
(among other things), topics we cover in a later chapter! Five histone proteins could be
isolated from nucleosomes and separated by electrophoresis; the results are illustrated in
Figure 8.17.

Fig. 8.17: Electrophoretic separation of five histones extracted from 10 nm filaments (left) and the role of
histones in the nucleosome.

Histones are basic proteins containing many lysine and arginine amino acids. Their positively
charged side chains enable these amino acids to bind to the acidic negatively charged
phosphodiester backbone of double helical DNA. The DNA wraps around octamers, each of
which is composed of two out of four histones (H3, H2A, H3B, H4), to form the nucleosome
(Figure 8.17, right). Histone H1 serves as a linker between nucleosomes. About a gram of
histones is associated with each gram of DNA.
CHALLENGE: Histones are among the most highly conserved proteins.
Very few amino-acid differences distinguish a human histone from
histones in a mouse, sea urchin, or yeast cell. Why do you think that is?

172-2 Nucleosomes: DNA and Protein

173-2 Chromatin Structure: Dissecting Chromatin
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As you might guess, an acidic extraction of chromatin should selectively remove the
basic histone proteins, leaving behind an association of DNA with nonhistone proteins. This
proves to be the case. An electron micrograph of the chromatin remnant after an acid
extraction of metaphase chromosomes is shown in Figure 8.18. DNA freed of the regularly
spaced histone-based nucleosomes, loops out and away from the long axis of the chromatin.
The dark material along this axis is a protein scaffold, which makes up what’s left after histone
extraction. Much of this protein is topoisomerase, an enzyme that prevents DNA from
breaking apart under the strain of replication (to be detailed in a later chapter).

Fig. 8.18: Acid extraction of chromatin removes histones, leaving nonhistone proteins behind.
(See the original micrograph at 8.9Acid Extract of Chromatin.)

8.6

Structure and Organization of Bacterial DNA… and Bacterial Sex

Sexual reproduction allows compatible genders (think male and female) to share genes, a
strategy that increases species diversity. It turns out that bacteria and other single-celled
organisms can also share genes and spread diversity with the help of plasmids. Plasmids are
circular, extrachromosomal bits of DNA that contain their own genes (often, antibioticresistance genes), and which replicate themselves in bacteria. We’ll close this chapter with a
look at sex (E. coli style!) and plasmid-assisted gene-mapping experiments showing linearly
arranged genes on a circular bacterial DNA molecule (the bacterial “chromosome”).
E. coli sex begins when F+ and F− cells meet. These “opposite” mating type cells can
share DNA during conjugation. F+ cells contain the extrachromosomal fertility plasmid, or F
plasmid, which is separate from the E. coli chromosome. The F plasmid has genes that encode
sex pili on F+ cells, as well as factors needed to form a “mating bridge”, or conjugation tube.
Figure 8.19 (below) illustrates the behavior of the F plasmid during conjugation.
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Fig. 8.19: Bacterial conjugation (sex in bacteria): F plasmids (Fertility plasmids) transfer chromosomal
DNA from E. coli F+ mating strain cells to F− strain cells, leading to genetic diversity.

When an F+ (donor) cell meets an F− (recipient) cell, donor cell sex pili initiate recognition. A
conjugation tube then forms, linking the cytoplasm of both cells. After the donor F+ cell nicks
one strand of the F plasmid DNA, the nicked strand enters the conjugation tube, rolling into
the F− cell. Both the “traveling” DNA strand and the intact DNA circle remaining in the donor
cell replicate (shown in red in Figure 8.19). E. coli conjugation can have different outcomes:
1. One of two semi-conservatively replicated F plasmids stays in the donor cell, and the other
ends up in the recipient cell, making the recipient cell a new F + donor cell!
2. The F plasmid inserts itself into recipient cell’s chromosomal DNA, typically at a specific
site in the DNA where there is sufficient sequence similarity between the plasmid and the
chromosomal DNA. This allows insertion by recombination. With the fertility-factor genes
now part of its chromosome, the recipient cell becomes an Hfr (High-frequency
recombination) cell, and it will produce Hfr-strain progeny cells.
In both outcomes the mating type of the recipient F− cell becomes either an F+ or an Hfr cell
that can initiate mating with other F− cells as illustrated in Figure 8.20.

Fig. 8.20: After conjugal F plasmid transfer, F- recipients can become F+ or, if the plasmid integrates
into the recipient genome, it will become an Hfr cell.
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Hfr cells readily express their integrated F-plasmid genes, and like F+ cells, they
develop sex pili and form a conjugation tube with an F− cell. One strand of the bacterial
chromosomal DNA will be nicked at the original insertion site of the F plasmid. The next
events parallel the replicative transfer of an F plasmid during F +/F− conjugation, except that
only part of the Hfr donor chromosomal DNA is transferred, as seen in Figure 8.21.

Fig. 8.21: During conjugation with Hfr-donor strain cells, a portion of the donor’s chromosomal DNA
follows the excised plasmid across the conjugation bridge into the F − recipient cell.

In the illustration, the F plasmid (red) has inserted itself in front of an A gene so that when it
enters the conjugation tube, it brings along several E. coli chromosomal genes. Because of the
size of the bacterial chromosome, only a few bacterial genes enter the recipient gene before
transfer is aborted. But in the brief time of DNA transfer, at least some genes did get into the
recipient F− strain where they can be expressed. Here is the outline of an experiment that
allowed bacterial genes on a circular DNA chromosome to be mapped:
1. Hfr cells containing functional A, B, C, and D genes were mated with recipient cells
containing mutants of the A, B, C, or D genes.
2. Conjugation was mechanically disrupted at different times after the formation of a
conjugation tube.
3. Recipient cells from each of the disrupted conjugations were then grown into culture and
analyzed for specific gene function.
In this hypothetical example, the results were that a recipient cell with a mutant A gene
acquired a wild-type A gene (and therefore A-gene function) when there was only a short time
before conjugation disruption. Progressively longer conjugation times (measured in separate
experiments) were required to transfer genes B, then C, then D to the recipient cell. Thus, the
order of these genes on the bacterial chromosome was -A-B-C-D-.
The timing of conjugation that led to F− mutants acquiring a functional gene from the
Hfr strain was so refined that it was possible to determine not only the gene locus but also the
size (length) of the genes! Thus, the time to transfer a complete gene to an F − cell reflects the
length of the gene, and also, the linear order of genes on bacterial DNA.
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Recall that genes mapped along the eukaryotic chromosomes had already implied a
linear order of the genes. However, little was known about eukaryotic chromosome structure at
the time, and the role of DNA as the “stuff of genes” was not yet appreciated. These bacterial
mating experiments demonstrated for the first time that genes are linearly arranged not just
along a chromosome but also along the DNA molecule.
Over time, many bacterial genes were mapped all along the E. coli chromosome by
isolating many different Hfr strains in which an F plasmid had been inserted into different
sites around the DNA circle. These Hfr strains were mated to F − bacteria, each with mutations
in one or another known bacterial gene. As in the original “ABCD” experiment, the order of
many genes was determined and even shown to be linked at a greater or lesser distance to
those ABCD genes and each other. Using these Hfr strains in conjugation experiments, it was
shown that in fact, the different Hfr cells transferred different genes into the recipient cells in
the order implied by the chromosome map illustrated in Figure 8.22.

Fig. 8.22: Map of the E. coli chromosome (its genome!) based on conjugation of F− recipient cells
with different strains of Hfr donor cells (indicated as Hfr 1, 2, 3…): the different Hfr donors are cells in
from which Hfr plasmids have integrated at different places on a recipient cell’s chromosome. When
the Hfr strains transfer DNA to new F− cells, they bring along different regions of the donor cell
chromosome (and thus different genes) into their conjugated recipient cells.

What’s more, when the experiment was done with Hfr4 (in this generic diagram), the order of
genes transferred after longer times of conjugation was found to be -V-W-X-Y-Z-A-B-…. The
obvious conclusion is that an E. coli DNA molecule (i.e., its “chromosome”) is a closed circle!
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We will see visual evidence of circular E. coli chromosomes in the next chapter, with some
discussion of how this evidence informed our understanding of DNA replication.

8.7

Phage Can Integrate Their DNA into the Bacterial Chromosome

We have seen how a phage can infect bacterial cells and co-opt the host’s bacterial metabolic
machinery to reproduce itself, eventually lysing the bacterium and releasing the phage. This
lytic activity of infection is one of two alternate phage life cycles. Lysogeny is the other lifecycle pathway for bacteriophage.
Lysogeny typically begins when the phage DNA is incorporated (i.e., is spliced) into the host
bacterium’s genome. There it will replicate along with the host’s chromosome during rounds of
binary fission. Upon excision, usually when the bacterium is under stress (e.g., nutrientdeprivation), the phage DNA can reenter the lytic pathway, reproducing and lysing the host
cell.
During excision, phage DNA can pick up bacterial DNA (i.e., genes) that will then be
transferred to a new host cell in a subsequent infection. The transfer of genes from one
bacterial cell to another in this way is called bacterial transduction. Esther and Joshua
Lederberg studied the lysogenic activity of lambda phage (λ phage) in E. coli, showing that—
like conjugation—bacterial transduction by λ phage results in lateral gene transfer between
bacteria. In general, lateral gene transfer increases genetic diversity in bacteria (and, in fact, in
many prokaryotic and eukaryotic organisms). We will see more examples of lateral gene
transfer in later chapters.
The events of lysogenic phage infection are illustrated in Figure 8.23.

Fig. 8.23: The lysogenic life cycle of phage.

Recall that Joshua Lederberg shared a Nobel Prize with George Beadle and Edward
Tatum for proposing the one-gene/one-enzyme hypothesis (eventually the one-gene/onepolypeptide relationship). Esther Lederberg had studied earlier with Beadle, Tatum, and her
husband at Stanford University in 1944, and many credit her with helping her mentors win
that 1958 Nobel Prize. In her own right, she held adjunct or directorial positions at the
University of Wisconsin–Madison and at Stanford University, where her other seminal
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research included the discovery of lambda phage (1950), the invention of the replica-plating
technique (1951), the demonstration of lambda-phage transduction in E. coli, and the discovery
of the fertility factor in E. coli. See 8.10Esther Lederberg's Accomplishments to explore why she
was never a faculty member or a Nobel laureate.
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Chapter 9
Details of DNA Replication and Repair
Replicons, replication origins and forks; bidirectional replication; many enzymes of replication;
Okazaki fragments; mechanisms, actions, and enzymes of DNA repair; when DNA repair fails
Reminder: For inactive links, google key words/terms for alternative resources.

9.1

Introduction

Replication begins at one or more origins of replication along DNA. Helicase enzymes
catalyze unwinding of the double helix, creating replicating bubbles, or replicons, with
replication forks at either end. Making a new DNA strand starts with making an RNA primer
using RNA nucleotides and primase enzymes. DNA nucleotides are added to the 3′ ends of
primers by a DNA polymerase. Later, other DNA polymerases catalyze removal of RNA
primers and the replacement of the hydrolyzed ribonucleotides with new deoxyribonucleotides. Finally, DNA ligases stitch together the fragments of new DNA synthesized at the
replication forks. This complex mechanism is common to the replication of “naked”
prokaryotic DNA and of chromatin-encased eukaryotic DNA and must therefore have arisen
early in the evolution of replication biochemistry. In this chapter, we’ll see details of
replication, including differences between prokaryotic and eukaryotic replication that arise
because of differences in DNA packing. As with any process with many moving parts,
replication is error prone, so we’ll also see how the overall fidelity of replication relies on DNA
repair mechanisms that target specific kinds of replication mistakes, or mutations. Lest we
think that uncorrected errors in replication are always bad, we’ll learn that they usually do not
have bad outcomes. Instead, that they leave behind the mutations necessary for natural
selection and the evolution of diversity.

Learning Objectives
When you have mastered the information in this chapter, you should be able to do the
following:
1. Explain how Cairns interpreted his theta () images.
2. Compare and contrast the activities of enzymes required for replication.
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3. Describe the order of events at an origin of replication and at each replication fork.
4. Compare unidirectional and bidirectional DNA synthesis from an origin of replication.
5. Outline the basic synthesis and proofreading functions of DNA polymerase I and explain
why only this one of the several DNA polymerases can proofread newly synthesized DNA.
6. Identify the major players and their roles in the initiation of replication.
7. Explain how Reiji Okazaki’s experimental results were not entirely consistent with how
both strands of DNA replicate.
8. List the major molecular players (enzymes, etc.) that elongate a growing DNA strand.
9. List the nonenzymatic players in replication and describe their functions.
10. Describe how the structure of telomerase enables proper replication.
11. Compare the activities of topoisomerases 1 and 2.
12. Explain the reasoning behind the hypothesis of processive replication.
13. Compare and contrast the impacts of germline and somatic mutations.
14. Describe common forms of DNA damage.
15. List enzymes of replication that were adapted to tasks of DNA repair.
16. Explain why a DNA glycosylase is useful in DNA repair.
17. Explain the connection between “breast cancer genes” and DNA repair.

9.2

DNA Replication

As we’ve seen, single DNA strands have directionality, with a 5′ nucleotide phosphate end and
a 3′ deoxyribose hydroxyl end. This is also true for circular bacterial chromosomes; you can see
this if the circle is broken! Because the strands of the double helix are antiparallel, the 5′ end of
one strand aligns with the 3′ end of the other at both ends of the double helix. In looking at the
complementary pairing of bases of deoxynucleotides in the double helix, Watson and Crick
quickly realized that the base sequence of one strand of DNA could serve as a template to
make a new complementary strand. As we’ll see, this structure raised questions about DNA
replication. Finding answers began with experiments that visualized the replication process.
9.2.1

Visualizing Replication and Replication Forks

Recall the phenomenon of bacterial conjugation showing that the bacterial chromosome (i.e.,
genome) is circular. In 1963, John Cairns confirmed this fact by direct visualization of bacterial
DNA. He cultured E. coli cells for long periods on 3H-thymidine (3H-T), a radioactive precursor
to DNA, to make their entire cellular DNA radioactive. He then disrupted the cells gently to
minimize damage to the DNA. The released DNA was allowed to settle and to adhere to
membranes. Cairns placed a sensitive film over the membrane, allowed time for the radiation
to expose the film and then developed the films (autoradiographs).
When he examined the autoradiographs in the electron microscope, Cairns saw tracks of silver
grains, the same kind of silver in a photographic emulsion that make up an image on film in
old-fashioned photography. A facsimile of Cairns’ results is illustrated in Fig. 9.1 below. He
measured the length of the “silver” tracks on his autoradiographs, which most often consisted
of three different closed loops, or circles (see the right-hand drawing in the figure). The
circumferences of two of these circles were always equal, and their lengths, measured in
nanometers, corresponded closely to a predicted DNA content of a single, non-dividing cell.
Cairns therefore interpreted these images to be bacterial DNA in the process of replication.
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Fig. 9.1: Cairns cultured E. coli cells in radioactive ( 3H-) thymidine to let the cells to make radioactive ('hot’)
DNA. He extracted the 'hot' DNA and spread it on electron microscope (EM) 'grids', coating them with
radiation-sensitive emulsion. After exposing the grids he saw ‘silver tracks’ in the EM, like those drawn here.
In each image, Cairns could always trace at least 2 equal length (circumference) intersecting circles,
consistent with the known DNA content per bacterial cell.

Cairns called his replicating chromosomes “theta images” because they resembled the
Greek letter theta (). From many  images, he arranged a sequence (shown in Figure 9.2) to
illustrate his inference that replication starts at a single origin of replication on the bacterial
chromosome, before proceeding around the circle at replication forks to completion.

Fig. 9.2: Many of Cairns' silver tracks resembled the Greek letter theta, so called them theta images.
He could order his theta images to suggest the progress of chromosomal replication, as drawn here.

175 Seeing E. coli Chromosomes
CHALLENGE: Identify the three closed loops in on the left in Fig. 9.1. Why
does the third loop differ in circumference from the other two loops?
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11.2.2 Visualizing Bidirectional Replication
David Prescott demonstrated bidirectional replication, which began at a replication origin but
replicated DNA in opposite directions at not one but two replication forks (Figure 9.3).

Fig. 9.3: Theta images suggested that DNA replication happens where silver tracks intersect, but at one
or both intersections? D. Prescott showed that in the E. coli circular chromosome, the intersections were
replication forks (RFs) where DNA was unwinding and replicating in opposite directions from a single
origin of replication (OR). The E. coli OR was later shown to be a specific sequence.

176 Semiconservative Bidirectional Replication from Two RFs
A typical rate of DNA synthesis is about 2 × 10 6 base pairs per hour, just about the size
of the E. coli genome! A typical eukaryotic cell nucleus contains thousands of times more DNA
than a bacterium but divides every fifteen to twenty hours. Even a small eukaryotic
chromosome can contain hundreds or thousands of times as much DNA as a bacterium. Thus,
eukaryotic cells can’t afford to replicate DNA at a bacterial rate! Eukaryotes solved this
problem not by evolving faster replication biochemistry, but by synthesizing their DNA
bidirectionally from multiple origins of replication, creating multiple replicons. These grow,
joining other growing replicons along each linear chromosome, as suggested in Figure 9.4.

Fig. 9.4: Replication in linear eukaryotic chromosomes begins at many ORs and proceeds bidirectionally,
forming 'replicons' that eventually merge.

177 Multiple Replicons in Eukaryotes
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Before we consider the biochemical events at replication forks in detail, let’s look at the role of
DNA-polymerase enzymes in the process.

9.3

DNA Polymerases Catalyze Replication

Before considering what happens at replication forks in detail, let’s look at the role of DNA
polymerases in the process. The first DNA polymerase enzyme was discovered in E. coli by
Arthur Kornberg, for which he received the 1959 Nobel Prize in Chemistry. However, the rate
of catalysis of new DNA, at least in vitro, was too slow to account for the in vivo rate of E. coli
replication. It was Thomas Kornberg, one of Arthur’s sons, who later found two additional,
faster-acting DNA polymerases. (We already met the older Kornberg brother, Roger!)
All DNA polymerases require a template strand against which to synthesize the new
complementary strand. In successive condensation reactions, all DNA polymerases catalyze
the addition of nucleotides to the 3′ end of the growing DNA strand. Finally, all DNA
polymerases also have the odd property that they can only add to a preexisting strand of
nucleic acid, raising the question of where the “preexisting” strand comes from! The
polymerases catalyze the formation of a phosphodiester linkage between the end of a growing
strand and an incoming nucleotide. The latter must complement a nucleotide in the template
strand. Energy for the formation of the phosphodiester linkage comes in part from the
hydrolysis of two phosphates (pyrophosphate) from the incoming nucleotide during the
reaction. While replication requires the participation of many nuclear proteins in both
prokaryotes and eukaryotes, polymerases perform the basic steps of replication (Figure 9.5).

Fig. 9.5: DNA polymerases require a template strand and use deoxynucleotide triphosphate
precursors (upper illustration) to catalyze the replication of new DNA in the 5′ to 3’ direction, shown
here extending the new DNA by one nucleotide (lower illustration).

178 DNA Polymerases & Their Activities
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Although DNA polymerases replicate DNA with high fidelity and make as few errors as
one per 107 nucleotides, mistakes do occur. The proofreading ability of some DNA polymerases
corrects many of these mistakes. The polymerase can sense a mismatched base pair, slow
down, and then catalyze repeated hydrolyses of nucleotides until it reaches the mismatched
base pair. Figure 9.6 illustrates this basic proofreading by a DNA polymerase.

Fig. 9.6: If during replication, a wrong nucleotide is inserted in a growing DNA (upper illustration),
some DNA polymerases will detect and proofread the incorrect nucleotide and replace it with the
correct one (middle illustration). Replication will then resume (lower illustration.

After mismatch repair, the DNA polymerase resumes its forward movement at replication forks.
Of course, not all mistakes are caught by this or other repair mechanisms (see section 9.5,
“DNA Repair”). While mutations in eukaryotic germline cells that escape correction can cause
genetic diseases, most of these replication errors are the very mutations that fuel evolution.
Without mutations in germline cells (i.e., egg and sperm cells), there would be no mutations
and no evolution, and without evolution, life itself would have reached a quick dead end! On
the other hand, replication mistakes can generate mutations in somatic cells. If these somatic
mutations escape correction, they can have serious consequences, including the generation of
tumors and cancers.
CHALLENGE: In classical genetic terms, any mutation in a gene that
produces an inactive enzyme would be recessive. In old-fashioned
Mendelian genetic terms, what would the genotype and phenotype be of
the progeny of a cross between a male and a female that are both
heterozygous for the gene for this enzyme?
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9.4

The Process of Replication

As noted, DNA replication is a sequence of repeated condensation (dehydration synthesis)
reactions linking nucleotide monomers into a DNA polymer. Replication, like all biological
polymerizations, proceeds in three enzymatically catalyzed and coordinated steps: initiation,
elongation, and termination.
9.4.1

Initiation

As we have seen, DNA synthesis starts at one or more origins of replication. These are DNA
sequences targeted by initiation proteins (Figure 9.7).

Fig. 9.7: In E. coli, replication starts when initiation proteins and SSBs (Single-Stranded Binding proteins
bind to the DNA at the origin of replication (OR), bending the DNA (upper illustration). Helicase begins
unwinding the DNA as DNA polymerase and other enzymes of replication bind to the DNA to begin
replication (lower illustration).

After these proteins break the hydrogen (H-) bonds at the origin of replication, the
DNA double helix is progressively unzipped in both directions (i.e., by bidirectional
replication). The separated DNA strands serve as templates for new DNA synthesis. Sequences
at replication origins that bind to initiation proteins tend to be rich in adenine and thymine
bases. This is because A-T base pairs have two H-bonds, which require less energy to break
than the three H-bonds that hold G-C pairs together. Once initiation proteins loosen H-bonds
at a replication origin, DNA helicase uses the energy of ATP hydrolysis to further unwind the
double helix. DNA polymerase III is the main enzyme that then elongates new DNA. Once
initiated, a replication bubble (replicon) forms as repeated cycles of elongation proceed at
opposite replication forks.

179 Replication Initiation in E. coli
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Recall that new nucleotides are only added to the free 3’ hydroxyl end of a preexisting
nucleic acid strand. Since no known DNA polymerase can start synthesizing new DNA strands
from scratch, this is a problem!
CHALLENGE: of Why might the evolution of replication have led to strandelongation that adds only to the 3′ end of a growing strand?

DNA polymerases require a primer, a nucleic acid strand onto which they can add
nucleotides. So, what is that primer, and where does it come from? RNA polymerases catalyze
RNA synthesis from in a 5’-to-3’ direction and are the only polymerases that grow a new
nucleic acid strand from the first base). Therefore, it was suggested that primers for replication
might actually be RNA. Discovery of short stretches of RNA at the 5′ end of Okazaki fragments
confirmed the notion of RNA primers. We now know that cells use a special RNA polymerase
called primase, to make RNA primers against DNA templates. Replication from the 3’ end of a
primer implies that DNA polymerases are able to add deoxynucleotides to the 3’ end of the
RNA. We’ll see in the next section that the requirement for RNA primers is nowhere more
evident than in the events at a replication fork.
9.4.2

Elongation

Looking at elongation at one replication fork, we see another problem: one of the two new
DNA strands will grow continuously toward the replication fork as the double helix unwinds.
But what about the other strand? Either this other strand must grow in pieces in the opposite
direction, or it must wait to begin synthesis until the double helix is fully unwound. The
problem is illustrated in Figure 9.8.

Fig. 9.8: In replication, the 5'-to-3' strand elongation catalyzed by all DNA polymerases presents a
problem at the RF: only one new DNA strand (the leading strand) can be made continuously along its
parental template strand. How does replication progress along the opposite template strand?
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If one strand of DNA must be replicated in fragments, then those fragments would have to be
stitched (i.e., ligated) together, as hypothesized in Figure 9.9.

Fig. 9.9: The hypothesis proposed here is that during the elongation of DNA strands, at least one DNA
strand at a replication fork (the lower, so-called lagging strand) must be synthesized discontinuously,
i.e., in pieces. Each new “piece” would begin with an RNA primer. And these pieces would have to be
correctly stitched together into a continuous DNA strand.

According to this hypothesis, a new leading strand of DNA grows (is lengthened)
continuously by sequential addition of nucleotides to its 3′ end, against its leading-strand
template. The other strand, however, would be made in pieces that would be joined in
phosphodiester linkages in a subsequent reaction (discontinuous replication). Because joining
these new DNA fragments should take extra time, this new DNA is called the lagging strand,
making its template the lagging-strand template.
Reiji Okazaki and his colleagues were studying infections of slow-growing mutants of
T4 phage in E. coli host cells. A DNA ligase enzyme was already known to catalyze the
circularization of the linear phage DNA molecules that were being replicated in infected host
cells. Okazaki’s hypothesis was that a deficient DNA ligase in the mutant phage not only
slowed down the circularization of the replicating T4 phage DNA but would also slow the
joining phage DNA fragments replicated against at least one of the two template DNA strands.
The investigators compared the growth rates of wild-type and mutant T4 phage and
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demonstrated that slow growth of the mutant phage was due to a deficient DNA ligase
enzyme. (Figure 9.10).

Fig. 9.10: Growth curves for wild-type T4 bacteriophage (left) and a mutant T4 phage (right) are
compared. Slow growth of the T4 mutant phage in infected cells was due a slow-acting DNA ligase
enzyme encoded by a mutant T4 gene. R. Okazaki hypothesized that slower growth was due to an
inefficient ligation (and therefore slower elongation) of lagging strand DNA fragments, as well as the
slow circularization of the linear T4 DNA that enters host cells during infection.

When they tested the hypothesis, they found that short DNA fragments did indeed accumulate
in E. coli cells infected with ligase-deficient mutants but not in cells infected with wild type
phage. The lagging strand fragments are now called Okazaki fragments. You can check out
Reiji Okazaki’s original research at 9.11968 Okazaki article.

180-2 Okazaki Experiments: Solving a Problem at an RF

181 Okazaki Fragments Are Made Beginning with RNA Primers
Each Okazaki fragment would have to begin with a 5’ RNA primer, creating yet
another dilemma! The RNA primer must be replaced with deoxynucleotides before the
fragments could be stitched together—a process that indeed happens (Figure 9.11, below).
Removal of RNA primer nucleotides from Okazaki fragments requires the action of DNA
polymerase I.
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This is the slow-acting DNA polymerase first characterized by Arthur Kornberg. DNA
polymerase I has the unique ability to catalyze hydrolysis of the phosphodiester linkages
between the RNA (or DNA) nucleotides and the 5’ end of a nucleic acid strand.

Fig. 9.11: Steps in the synthesis of DNA against the lagging template strand.

Another enzyme, flap endonuclease 1 (FEN1) plays a role in removing “flaps” of
nucleic acid from the 5’ ends of the fragments. These flaps are often displaced by polymerase
as the enzyme replaces the replication primer. At the same time as the RNA nucleotides are
removed, DNA polymerase I catalyzes their replacement by appropriate deoxynucleotides.
Finally, when a fragment is composed entirely of DNA, DNA ligase links it to the rest
of the already-assembled lagging-strand DNA. Because of its 5’ exonuclease activity (not
found in other DNA polymerases), DNA polymerase I also plays unique roles in DNA repair
(discussed further in section 9.5).
As Cairns suggested and as others had demonstrated, replication proceeds in two
directions from the origin and forms a replicon with two replication forks (RFs). Each RF has a
primase associated with replicating Okazaki fragments along lagging strand templates. Figure
9.12 below illustrates the requirement for primases at replication forks.
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Fig. 9.12: As replication proceeds, all the enzymes (primase, DNA polymerase III, DNA polymerase I,
DNA ligase, helicase) and other proteins required for replication are assembled in each replication fork
(RF) of replicons. Note that primase is present at both RFs, but only on the lagging strands.

Now we can ask what happens when replicons reach the ends of linear chromosomes in
eukaryotes.

182 Replication Elongation in E. coli
9.4.3

Termination

In prokaryotes, replication is complete when two replication forks meet after replicating their
portion of the circular DNA molecule. In eukaryotes, many replicons fuse to become larger
replicons, eventually reaching the ends of the chromosomes. And now there is still another
problem, illustrated in Figure 9.13!

Fig. 9.13: Problems arising in lagging strand replication when replication reaches the ends
(telomeres) of linear chromosomal DNA. After a final Okazaki strand is primed and replicated
(panel 1) the primer is removed from the penultimate fragment (panel 2). Then primer on the last
strand is removed (panel 3). But then, there would be no DNA strand 3' end at which to add
replacement DNA nucleotides. This would cause chromosomal shortening at each cell division.
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When a replicon nears the end of a double-stranded DNA molecule (i.e., the end of a
chromosome), the new continuously synthesized strand stops when it reaches the 5’ end of its
template DNA, and the primer is removed, having completed its replication. But what about
lagging-strand replication? The illustration shows primer removal from an Okazaki fragment
primed near the end of the chromosome, and replacement with DNA nucleotides catalyzed by
DNA polymerase I. The question marks above the DNA point to a dilemma: if a final Okazaki
fragment is primed and synthesized, DNA polymerase I has no free 3’ end to begin RNA
nucleotide replacement with DNA nucleotides. The problem then would be that every time a
cell replicates, at least one strand of new DNA would get shorter. Of course, this would not
do—and doesn’t happen! Eukaryotic replication undergoes a termination process that extends
the length of one of the two strands using the enzyme telomerase, as illustrated in Figure 9.14.

Fig. 9.14: Following removal of the primer from a telomeric Okazaki fragment, the ribonucleoprotein
enzyme telomerase prevents chromosome-shortening. Its RNA serves as a template to generate
repeats at the 3’ telomeric end of lagging-strand DNA. When the extended repeated sequences on the
3’ end of the template DNA are long enough, they then serve as templates for new primer and Okazaki
fragment synthesis, maintaining chromosome length.

Telomerase consists of several proteins and an RNA molecule. From the drawing, the
RNA component serves as a template for 5′→ 3’ extension of the problematic DNA strand. The
protein with the requisite reverse transcriptase activity is called Telomerase Reverse
Transcriptase, or TERT. The Telomerase RNA Component is called TERC. Carol Greider, Jack
Szostak, and Elizabeth Blackburn shared the 2009 Nobel Prize in Physiology or Medicine for
discovering telomerase.

183 Telomere Replication Prevents Chromosome Shortening
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We know now that differentiated, non-dividing cells no longer produce the telomerase enzyme
but that telomerase genes are still active in dividing cells (e.g., stem cells and cancer cells),
which contain abundant telomerase.
CHALLENGE: Why the difference in telomerase activities between the two
cell types here!? What is the connection between telomerase action and
the Hayflick Limit? And… what is the Hayflick Limit
9.4.4

Is Replication Processive?

Drawings of replicons and replication forks suggest separate events on each DNA strand. Yet
events at replication forks seem to be coordinated. Thus, replication may be processive,
meaning both new DNA strands are replicated in the same direction at the same time,
smoothing out the process. How might this be possible? The drawing in Figure 9.15 shows how
lagging-strand template DNA bends so that it points in the same direction as the leading
strand at the replication fork.

Fig. 9.15: The Processive Replication hypothesis unites all components for replicating both DNA strands
in a replisome. In this model, the lagging strand template is "looped backwards" so the direction of
replication new DNA strands occurs in the same direction.

184 Processive Replication
The replisome structure cartooned at the replication fork consists of clamp proteins,
primase, helicase, DNA polymerase, and single-stranded binding proteins, among others.
Now, newer techniques of visualizing replication by real-time fluorescence videography have
called the processive model into question, suggesting that the replication process is anything
but smooth! Is the observed jerky movement of DNA elongation in the video an artifact? Or is
the model of smooth, coordinated replication integrated at a replisome no longer valid? And if
not, must coordination of replication be defined and achieved in some other way? Or, finally,
are lagging-strand and leading-strand replication simply just not coordinated? Check out the
video yourself at 9.2Real-Time Fluorescent Replication Video.
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9.4.5

One More Problem with Replication

Cairns recorded many images of E. coli of the sort shown in Figure 9.16.

Fig. 9.16: Unwinding a circular DNA molecule or any eukaryotic double helix (rigidly associated with
chromosomal proteins) causes the DNA to form supercoils, twisting and coiling in on itself. Cairns saw
such supercoils in E. coli chromosome, as in this illustration.

The coiled, twisted appearance of the replicating circles was interpreted to be a natural
consequence of the helically intertwined strands of DNA pulling apart (as is the case with
intertwined strands of any material). As the strands continued to unwind, the DNA would twist
into a supercoil of DNA. Too much unwinding would cause the phosphodiester linkages in the
DNA to rupture, fragmenting the DNA. Obviously, this does not happen.
Experiments were devised to demonstrate supercoiling and to test hypotheses explaining how
cells would relax the supercoils during replication. Testing these hypotheses revealed the
topoisomerase enzymes. These enzymes bind and hold on to DNA, catalyze the hydrolysis of
phosphodiester linkages, control the unwinding of the double helix, and finally catalyze the reformation of the phosphodiester linkages. It is important to note that the topoisomerases are
not part of a replisome and can act far from a replication fork, probably responding to tensions
anywhere in the supercoiled DNA. Recall that topoisomerases comprise much of the protein
lying along eukaryotic chromatin.

185-2 Topoisomerases Relieve Supercoiling During Replication
We have considered most of the molecular players in replication. Key replication proteins and
their functions are listed in Table 9.2 below, taken from 9.3DNA Replication.
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Table 9.2

ENZYME
DNA helicase
DNA polymerase
DNA clamp protein
Single-strand
binding proteins
(SSBs)
topoisomerases
DNA gyrases
DNA ligase
primase
telomerase

9.5

FUNCTION IN DNA REPLICATION
A helix destabilizing protein that unwinds a double helix at
replication forks
Builds new double-stranded DNA, adding deoxy-nucleotides 5’3’; some can proofread and correct errors
Prevents DNA pol III from separating from the parent template
strand.
Keep unwound DNA strands at replication forks from reannealing during replication
Relax supercoiled DNA caused by DNA unwinding during
replication
A specific kind of topoisomerase
Joins Okazaki Fragments to growing DNA strands during
replication
Initiates replication using nucleotides to synthesize an RNA
primer required for DNA polymerases to then add
deoxynucleotides
Enzyme that adds repetitive DNA sequences to telomeric DNA
to maintain the length of eukaryotic chromosomal DNA

DNA Repair

We generally accept the notion that replication faithfully duplicates the genetic material,
occasional making mistakes (i.e., mutating). At the same time, evolution would not be possible
without those mistakes, those mutations, and mutation is not possible without at least some
adverse consequences. Because we see the results of mutation as disease, the word mutation in
common parlance (and even among scientists) anticipates dire consequences. But mutations
(changes in DNA sequence) are a requirement of life. In fact, mutations occur frequently
between generations. Most are inconsequential, and many are corrected by one or another
mechanism of DNA repair.
9.5.1

Germline vs Somatic Mutations: A Balance Between Mutation and Evolution

Germline mutations are heritable. When present in one, but especially in both alleles of a

gene, such mutations can result in genetic disease (e.g., Tay-Sachs disease, cystic fibrosis,
hemophilia, and sickle cell anemia). Rather than causing disease, some germline mutations
may increase the likelihood of becoming ill (e.g., mutations of the BRCA2 gene greatly increase
a woman’s odds of getting 195, cancer).

Somatic mutations in actively dividing cells might result in benign “cysts” or malignant

tumors (i.e., cancer). Other somatic mutations may play a role in dementia (Alzheimer’s
disease) or in some neuropathologies (e.g., along the autism spectrum). Since the complex
chemistry of replication is subject to an inherently high rate of error, cells have evolved
systems of DNA repair, so that they may survive high mutation rates. As we saw, DNA
polymerases themselves can proofread, so incorrectly inserted bases can be quickly removed
and replaced.
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Beyond this, multiple mechanisms have evolved to repair mismatched base pairs and other
kinds of damaged DNA that escape early detection. How often and where DNA damage occurs
is random, as is which damage will be repaired and which will escape to become a mutation.
For those suffering the awful consequences of unrepaired mutation, the balance between
retained and repaired DNA damage is, to say the least, imperfect. However, evolution and the
continuance of life itself rely on this balance.
9.5.2

What Causes DNA Damage?

The simplest damage to DNA is a point mutation, the accidental insertion of a “wrong”
nucleotide into a growing DNA strand. Other mutations, equally accidental, include DNA
deletions, insertions, duplications, inversions, and the like, any of which might escape repair.
The causes of DNA damage can be chemical or physical and include spontaneous intracellular
events (e.g., oxidative reactions) and environmental factors (e.g., radiation, exogenous
chemicals).
These random events are in fact not rare, but frequent. Basing his calculations on studies of
different kinds of DNA damage, Tomas Lindahl estimated that DNA-damaging events might
be occurring at the rate of ten thousand per day! Lindahl realized that there must be some
basic DNA repair mechanisms at work to protect cells against such a high rate of DNA
damage. The discovery of the base excision repair mechanism earned Tomas Lindahl a share
of the 2015 Nobel Prize in Chemistry.
Specific environmental factors that can damage DNA include UV light, X-rays, and other
radiation, as well as chemicals (e.g., toxins, carcinogens, and even drugs). Both germline and
somatic cells can be affected. While mutations can and do cause often debilitating diseases, it
is instructive to keep the impact of mutations in perspective. Most mutations are in fact silent;
they do not cause disease. And among mutations that could cause disease, much of the DNA
damage is repaired. Cells correct more than 99.9% of mistaken base changes before they have
a chance to become mutations. That is why we think of replication as a “faithful” process. Let’s
look at some common types of DNA damage that are usually repaired:
• Pyrimidine dimers: the dimerization of adjacent pyrimidines (typically thymines, but
occasionally cytosines) in a single DNA strand, caused by UV exposure
• Depurination: the hydrolytic removal of guanine or adenine from the #1 carbon of
deoxyribose in a DNA strand
• Deamination: the hydrolytic removal of amino (-NH2) groups from guanine (most common),
cytosine, or adenine
• Oxidative damage of the deoxyribose sugar with any base (but most commonly with a purine
base)
• Inappropriate methylation of any bases (but most commonly of purine bases)
• DNA strand breakage during replication or from radiation or chemical exposure
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9.6

Molecular Consequences of Uncorrected DNA Damage

While bacteria also suffer DNA damage, we will focus here on eukaryotes, since they have
evolved the most sophisticated repair mechanisms. Remember that unrepaired DNA damage
will be passed on to daughter cells in mitosis and might be passed on to the next generation if
the mutation occurs in a germline cell.
CHALLENGE: Why do I say “might” here?
9.6.1

Depurination

Depurination is the spontaneous hydrolytic removal of guanine or adenine from the #1 carbon
of deoxyribose in a DNA strand. Its frequency of five thousand depurinations per cell per day
emphasizes the high rate of DNA damage that demands a fix! If not repaired, depurination
results in a single base-pair deletion in the DNA of one chromosome after replication, leaving
the DNA in the same region of the other chromosome unchanged. Figure 9.17 shows the
effects.

Fig. 9.17: Spontaneous depurination is the hydrolytic removal of a guanine or adenine from a nucleotide,
resulting in a nucleotide deletion at that site in the DNA during replication.

The replisome ignores the depurinated nucleotide (an A in this example), jumping to the C in
the template DNA. Unrepaired, one new double-stranded DNA will have a deletion, leaving
the other new one with no mutation.
9.6.2

Pyrimidine Dimerization

Exposure of DNA to UV light can cause adjacent pyrimidines (commonly thymines; less often,
cytosines) on a DNA strand to dimerize. Pyrimidine dimers form at a rate of a bit less than one
hundred per cell per day! Uncorrected dimerization results in a two-base deletion in one
chromosome, while the other remains unchanged (Figure 9.18, below).
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Fig. 9.18: Exposure of DNA to UV light can cause adjacent thymines to dimerize, resulting in deletion
of two nucleotides at that site in the DNA during replication.

You can predict that the correction of this radiation-induced damage will either involve
disrupting the dimers (in this example, thymine dimers) or removing the dimerized bases and
replacing them with monomeric bases.
9.6.3

Deamination

Figure 9.19 shows the consequences of deamination to a DNA base sequence.

Fig. 9.19: Amino (-NH2) group removal (deamination) from a base in one DNA strand results in a
base substitution during replication. Use the asterisks to help follow the deamination and changes
after replication.
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Deamination is the hydrolytic removal of amino (-NH2) groups from guanine (most
common), cytosine, or adenine, at a rate of one hundred per cell per day. Deamination does
not affect thymine (because it has no amino groups!). Uncorrected deamination results in a
base substitution on one chromosome (or in this example, a T-A pair substitution for the
original C-G) and no change on the other. Deamination of adenine or guanine results in
unnatural bases (hypoxanthine and xanthine, respectively). These are easily recognized and
corrected by DNA repair systems. Occasionally, some of the U-A base pairs remain unrepaired.

9.7

DNA Repair Mechanisms

Many enzymes and proteins are involved in DNA repair, including eleven out of fourteen DNA
polymerases in humans! Three DNA polymerases are for replication). Some of these function
in normal replication, mitosis and meiosis, but were co-opted for DNA repair activities. These
molecular co-optations are so vital to normal cell function that some repair activities and
molecular players are highly conserved in evolution. Among the DNA repair pathways that
have been identified, we will look at base excision repair, nucleotide excision repair,
transcription-coupled repair, nonhomologous end-joining and homologous recombination.
Of these, the last is perhaps the most complex.
9.7.3

Base Excision Repair

On detection of an error (e.g., oxidization, an open-ring, deamination, or bases containing
saturated C=C bonds), DNA glycosylases catalyze hydrolysis of the damaged base from its
deoxyribose. For more on these enzymes, see 9.4DNA Glycosylases. Figure 9.20 shows base
excision repair.

Fig. 9.20: In Base Excision Repair, (1) a glycosylase removes the sugar from the deaminated
nucleotide; (2) an endonuclease nicks the strand at that nucleotide; (3) a DNA polymerase adds
back a correct nucleotide and a DNA ligase seals the DNA strand to complete the repair.
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9.7.4

Nucleotide Excision Repair

The discovery of nucleotide excision repair earned Aziz Sancar a share of the 2015 Nobel
Prize in Chemistry. Figure 9.21 illustrates nucleotide excision repair for a pyrimidine dimer.

Fig. 9.21: In nucleotide excision repair, (1) a fragment containing the damaged DNA, e.g., a pyrimidine
(C-T) dimer is excised; (2) a polymerase fills in the missing nucleotides in the gap, and (3) a DNA ligase
seals the remaining nick, resulting repaired DNA strands.

In this example, an Excision Nuclease recognizes a pyrimidine dimer, where it hydrolyzes
phosphodiester linkages between nucleotides several bases away from either side of the dimer.
A DNA helicase then unwinds and separates the DNA fragment containing the dimerized
bases from the damaged DNA strand. Finally, DNA polymerase acts 5’ – 3’ to fill in the gap,
and DNA ligase seals the remaining nick to complete the repair.
9.7.5

Mismatch Repair

DNA mismatch repair occurs when the proofreading DNA polymerase misses an incorrect
base insertion into a new DNA strand. This repair mechanism relies on the fact that doublestranded DNA shows a specific pattern of methylation. The discovery of the mismatch repair
mechanism earned Paul Modrich a share of the 2015 Nobel Prize in Chemistry.
The methylation patterns themselves are related to epigenetic patterns of gene activity and
chromosome structure, which are expected to be inherited by daughter cells. When DNA
replicates, the methyl groups on the template DNA strands remain, but the newly synthesized
DNA is unmethylated. In fact, it takes some time for methylation enzymes to locate and to
methylate the appropriate nucleotides in the new DNA. In the intervening time, several
proteins and enzymes can detect inappropriate base pairing (the mismatches) and initiate
mismatch repair.
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The basic DNA mismatch repair process is illustrated in Figure 9.22.

Fig. 9.22: Repair of a base mismatch in DNA begins when two Mut proteins (MutS and Mut) detect the
mismatch (1); a third Mut protein (MutH) catalyzes cleavage at a methylated GATC site some distance
from the mismatch (2), removing the mismatch (3); DNA polymerase III replaces the missing bases
around the original mismatch (4); DNA ligase completes the repair (5).

Presumably, after mismatch repair is complete, the unmethylated new DNA is appropriately
remethylated.
9.7.6

Transcription-Coupled Repair (in Eukaryotes)

If an RNA polymerase reading a template DNA encounters a nicked template or one with an
unusual base substitution, it might stall transcription and seemingly “not know what to do
next.” A normal transcript would not be made, and the cell might not survive. That’s no big
deal in a tissue comprised of thousands if not millions of cells, right? But nevertheless,
Transcription Coupled Repair exists!
In this repair pathway, if RNA polymerase encounters a DNA lesion (i.e., damaged DNA)
while transcribing a template strand, it will indeed stall. This allows time for coupling proteins
to reach the stalled polymerase and to enable repair machinery (e.g., by base or nucleotide
excision) to make the repair. Once the repair is complete, the RNA polymerase “backs up”
along the template strand (with the help of other factors) and resumes transcription of the
corrected template.
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9.7.5

Nonhomologous End-Joining

DNA replication errors can cause double-stranded breaks, as can environmental factors
(ionizing radiation, oxidation). Repair by nonhomologous end-joining deletes damaged and
adjacent DNA and rejoins the “cut” ends. When a double-stranded break is first recognized,
nucleotides are hydrolyzed from the ends of both strands at the break-site, leaving “blunt
ends.” Ku among other proteins then bring DNA strands together and further hydrolyze single
DNA strands, creating overlapping staggered (complementary or sticky) ends. The
overlapping ends of these DNA strands form H-bonds. Finally, DNA ligase seals the Hbonded overlapping ends of DNA strands, leaving a repair with deleted bases. Repair by
nonhomologous end-joining is illustrated in Figure 9.23.

Fig. 9.23: During Non-homologous End-Joining, endonucleases find and trim back DNA at the break
(1); specific proteins bind to the trimmed ends of the DNAs (2); catalysis of single-strand trimming forms
complementary (sticky) ends that overlap the break site (3). After H-bonds form between the staggered
sticky ends (4), a DNA ligase seals the ends of the overlapping DNA strands (4) completing an effective
repair, albeit with a deletion.

In older people, there is evidence of more than two thousand “footprints” of this kind of
repair per cell. How is this possible? This quick-fix repair often works with no ill effects
because most of the eukaryotic genome does not encode genes or even regulatory DNA (the
damage of which would be more serious).
9.7.6

Homologous Recombination

Homologous recombination is a complex but normal, frequent part of meiosis in eukaryotes.
Recall that homologous recombination occurs in synapsis in the first cell division of meiosis
(meiosis I). During synapsis, alignment of homologous chromosomes may lead to DNA
breakage, an exchange of alleles, and ligation to reseal newly recombinant DNA molecules.
Novel recombinations of variant alleles in the chromosomes of sperm and eggs ensure genetic
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diversity in species. The key point is that DNA breakage is required to exchange alleles
between homologous chromosomes. Consult the genetics chapter in an introductory biology
textbook or the recombination chapter in a genetics text to be reminded of these events.
Cells use the same machinery to reseal DNA breaks during normal recombination and
to repair DNA damaged by single- or double-stranded breakage. A single DNA strand that is
nicked during replication can be repaired by recombination with the strands of homologous
DNA that are being replicated on the other strand. A double-stranded break can be repaired
using the same recombination machinery that operates on sister chromatids in meiosis. In both
cases, the process accurately repairs damaged DNA without any deletions. These mechanisms
are conserved in the cells of all species, further demonstrating an evolutionary imperative of
accurate repair to the survival of species, no less important than the imperative to maintain the
genetic diversity of species.
9.7.6.a Repair of a Single-Stranded Break
When a replisome reaches a break in one of the two strands of replicating DNA, the damage
must be repaired, and the replication fork (RF) must be reestablished. Figure 9.24 illustrates
the example of homologous recombination to repair a single strand break at a replication fork.

Fig. 9.24: Single-stranded break repair by homologous recombination: An RF reaches a break in the left
template strand (1), template DNA behind the break is trimmed back (2), while the 3’ end of the new
DNA strand invades the new, (complementary) DNA strand replicating on the homologous parental
template DNA and continues replicating (3). The missing DNA at the original break is re-synthesized (4).
homologous recombination accurately repairs the break (5).

Such a break may have occurred prior to replication itself. Repair begins when the RF reaches
the lesion. In the first step, a 5′-3’ exonuclease trims template DNA back along its newly
synthesized complement. Next, RecA protein monomers (each with multiple DNA-binding
sites) bind to the single-stranded DNA to form a nucleoprotein filament. With the help of
additional proteins, the 3’ end of the filament scans the other replicating strand for
homologous sequences. When such sequences are found, the RecA-DNA filament binds to the
homologous sequences, and the filament of new DNA “invades” the homologous (i.e.,
opposite) double-stranded DNA, separating its template from its newly replicated DNA. After
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this strand invasion, the replication of the leading strand continues from the 3’ end of the
invading strand. A new RF is established as the leading-strand template is broken and religated to the original break. New lagging-strand replication then resumes at the newly rebuilt
RF. The result is an accurate repair of the original damage, with no deletions or insertions of
DNA.

RecA is a bacterial protein, an example of another one of those evolutionarily
conserved proteins. Its homolog in the archaea is called RadA. In eukaryotes, the homolog is
called Rad51, and it initiates synapsis during meiosis. Thus, it seems that a role for RecA and
its conserved homologs in DNA repair predated its use in synapsis and crossing over in
eukaryotes! For more about the functions of RecA protein and its homologs, see 9.5The
Functions of RecA.
9.7.6.b Repair of a Double-Stranded Break
Homologous recombination can also repair a double-stranded DNA break with the aid of
several enzymes and other proteins. Alternate repair pathways are summarized in Figure 9.25
(below). Here is a list of proteins involved in these homologous-recombination pathways:
•

MRX, MRN: proteins that bind at double-stranded break and recruit other factors

•

Sae2: an endonuclease active when phosphorylated to hydrolyze internal phosphodiester
linkages

•

Sgs1: a helicase that unwinds DNA that is under repair at a damaged RF

•

Exo1, Dna2: single-strand exonucleases that hydrolyze terminal phosphodiester linkages

•

RPA, Rad51, DMC1: proteins that bind to overhanging DNA to form a nucleoprotein
filament and then initiate strand invasion at similar sequences

The activities of other enzymes involved in the repair are also identified in Figure 9.25
(below). But not shown in the illustration are products of the BRCA1 and BRCA2 genes which
binding to Rad51 (the human RecA homolog). Expressed mainly in breast tissue, their wildtype (normal) protein products participate in homologous recombination repair of doublestranded DNA breaks.
When mutated and dysfunctional, BRCA1 and BRCA2 genes increase the likelihood of
a woman getting breast cancer due to uncorrected DNA damage in breast cells. It doesn’t help
matters that the normal BRCA1 protein also plays a role in mismatch repair—and that the
mutated protein can’t!
To end this chapter, here is a bit of weird science! Consider the tardigrade, a tiny
critter that can survive the vacuum in space, along with assorted forms of radiation, resisting
DNA damage, and failing that, rapidly repairing DNA damage (9.6DNA Repair of the
Tardigrade Genome).
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Fig. 9.25: In repairing a double-stranded DNA break, MRX or MRN proteins detect the break, after which
several proteins (including exonuclease) enable trimming the strands at the break to make 'sticky ends'
((1). Other proteins, including Rad51, enable strand invasion while DNA polymerase replicates the
invading strand (2). Alternate mechanisms called second end capture (3a) or strand displacement (3b)
lead either to branch migration to resolve interlocking replicating DNA strands (4a), followed by
homologous recombination to complete the repair (5), or to DNA synthesis and ligation to complete the
repair without recombination (4b).
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Chapter 10

Transcription and RNA Processing
RNA transcription, RNA polymerases, initiation, elongation, termination, and processing
Reminder: For inactive links, google key words/terms for alternative resources.

10.1

Introduction

Transcription, the synthesis of RNA based on a DNA template, is the “central” step of the
Central Dogma proposed by Crick in 1958. The basic steps of transcription are the same as for
replication: initiation, elongation, and termination. The differences between transcription in
prokaryotes and eukaryotes are in the details. Here are some:
•

•
•
•

E. coli uses a single RNA polymerase enzyme to transcribe all kinds of RNAs, while
eukaryotic cells use different RNA polymerases to catalyze the syntheses of ribosomal
RNA (rRNA), transfer RNA (tRNA), and messenger RNA (mRNA).
In contrast to the eukaryotic genetic makeup, some bacterial genes are part of operons
whose mRNAs encode multiple polypeptides.
Most RNA transcripts in prokaryotes emerge from transcription ready to use.
Eukaryotic transcripts synthesized as longer precursors undergo processing by trimming,
splicing, or both!
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•
•

DNA in bacteria is virtually “naked” in the cytoplasm, while eukaryotic DNA is wrapped
up in chromatin proteins in a nucleus.
In bacterial cells, the association of ribosomes with mRNA and the translation of a
polypeptide can begin even before the transcript is finished. This is because these cells
have no nucleus. In eukaryotic cells, RNAs must exit the nucleus before they encounter
ribosomes in the cytoplasm.

In this chapter, you will meet bacterial polycistronic mRNAs (transcripts of operons
that encode more than one polypeptide). You’ll read about eukaryotic split genes, with introns
and exons). We will look at some details of transcription of the three major classes of RNA and
then at how eukaryotes process precursor transcripts into mature, functional RNAs. Along the
way, we will see one example of how protein structure has evolved to interact with DNA.

Learning Objectives
When you have mastered the information in this chapter, you should be able to do the
following:
1. Discriminate between the three steps of transcription in prokaryotes and eukaryotes, and
the factors involved in each.
2. State a hypothesis for why eukaryotes evolved complex RNA processing steps.
3. Speculate on why any cell in its “right mind” would have genes containing introns and
exons, with the result that their transcripts would have to be processed by splicing.
4. Articulate the differences between RNA and DNA structure.
5. Explain the need for sigma factors in bacteria.
6. Speculate on why eukaryotes do not have operons.
7. List structural features of proteins that bind and recognize specific DNA sequences and
speculate on why/how they came to differ.
8. Explain how proteins that do not bind specific DNA sequences can still bind to specific
regions of the genome.
9. Suggest a reason for why bacteria don’t polyadenylate most their mRNAs while eukaryotes
do so.
10. Formulate a hypothesis for why bacteria do not “cap” their mRNAs.

10.2

Overview of Transcription

Transcription, the synthesis of RNA, is the first step of the “central dogma” of DNA-to-protein
information transfer. As we will see, some RNAs are translated into polypeptides, while others
serve functional and even enzymatic roles in the cell. We begin with a look at the main kinds
of RNA in cells.
10.2.1 The Major Types of Cellular RNA
All cells make three main kinds of RNA: ribosomal RNA (rRNA), transfer RNA (tRNA) and
messenger RNA (mRNA). rRNA is a structural as well as enzymatic component of ribosomes,
the protein-synthesizing machine in the cell; it’s not surprising that rRNAs are by far the most
abundant RNAs in a cell. In contrast, mRNAs are the least abundant. Three rRNAs and about
fifty ribosomal proteins make up the two subunits of a bacterial ribosome, as illustrated in
Figure 10.1 below.

205

Fig. 10.1: Ribosomal RNAs (the 23S, 16S and 5S rRNAs) and as many as 50 proteins make up the
bacterial ribosome shown here. This structure probably does not exist in isolation, but only when the
subunits unite with an mRNA during translation. Eukaryotic ribosomal subunits are similar, but larger.

tRNAs decode base sequences of mRNAs into amino acids during protein synthesis
(translation), thereby converting nucleic-acid-sequence information into the amino-acid
sequences of polypeptides. The tRNAs that are attached to amino acids bind to ribosomes do
so based on codon-anticodon recognition (Figure 10.2).

Fig. 10.2: Complete ribosomes form when the subunits associate with mRNA. Transfer RNAs (tRNAs)
that decode the mRNA then 'enter' the ribosome. They are held in place by codon-anticodon
complementarity, as well as by tRNA-ribosomal forces.

186 Transcription Overview: Ribosomes and Ribosomal RNAs

187 Transcription Overview: Demonstrating the Major RNAs
In 2009, 10.1Venkatraman Ramakrishnan, 10.2Thomas A. Steitz, and 10.3Ada Yonath won a Nobel
Prize in Chemistry for their studies of the structure and molecular biology of the ribosome.
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CHALLENGE: Even though bacteria lack nuclei, the existence of mRNAs in
prokaryotes was simply assumed. Why?

The fact that genes reside inside the eukaryotic nucleus but that the synthesis of
polypeptides (encoded by those genes) happens in the cytoplasm led to the proposal that there
must be an mRNA. Sydney Brenner eventually confirmed the existence of mRNAs. Check out
his classic experiment in Brenner S. (1961; An unstable intermediate carrying information from
genes to ribosomes for protein synthesis. Nature 190:576-581).
Before we look at details of transcription, recall for future reference that multiple
ribosomes can load an mRNA and move along it as polyribosomes (or polysomes), translating
multiple copies of the same polypeptide (Figure 10.3).

Fig. 10.3: Polysomes form when ribosomes assemble on an mRNA, one after another, initiating
protein synthesis, each elongating and sequentially translating multiple polypeptides.

CHALLENGE: mRNAs are a small proportion of a cell’s RNAs, and they are
also unstable compared to rRNAs and tRNAs. Why should this be so?
10.2.2 Key Steps of Transcription
As in replication, in transcription an RNA polymerase uses the template DNA strand of a gene
to catalyze synthesis of a complementary, antiparallel RNA strand. Also like replication,
transcription is also error prone (though more so!). Here are some differences:
•

•
•

RNA polymerases hydrolyze ribose nucleotide triphosphate (NTP) precursors, as they link
the resulting nucleotide monophosphates (NMPs) to form RNA chains, while DNA
polymerases use deoxyribose nucleotide triphosphate (dNTP) precursors.
RNAs incorporate uridines (the uracil nucleotides) opposite a template adenine instead of
thymidines (the thymine nucleotide). Thymidines end up opposite adenines in new DNA.
In contrast to replication, RNA synthesis does not require a primer. With the help of
transcription initiation factors, RNA polymerase locates the transcription start site of a
gene and begins synthesis of a new RNA strand from scratch.
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CHALLENGE: Despite the many more mistakes made during transcription
than replication, why are transcription errors less consequential?
Several of the DNA sequences that characterize a gene are seen below in the summary
of the basic steps of transcription in Figure 10.4. The promoter is the binding site for RNA
polymerase. It usually lies upstream of (5’ to) the transcription start site (the bent arrow).
Binding of the RNA polymerase positions the enzyme near the transcription start site, where it
will start unwinding the double helix and begin synthesizing new RNA.

Fig. 10.4: The basic steps of transcription are (1) Initiation, the recognition of a promoter sequence
near the transcription start site (the bent arrow) by RNA polymerase; (2) Elongation, the successive
addition of nucleotides to a growing RNA strand; (3) Termination, the mechanism by which at the
end of the gene, the newly made RNA is released.

In each of the three panels, the transcription unit is the DNA region to be transcribed,
extending from the start site (the bent arrow to the right of the promoter) to a point just short of
the termination site. Termination sites are typically downstream of (5’ to) the transcription unit.
By convention, upstream and downstream positions designate 5’ and 3’ regions of a given
reference point on the DNA.

188-2 Transcription Overview: The Basics of RNA Synthesis
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Some bacterial transcription units encode more than one mRNA. Bacterial operons are
an example of this phenomenon. The resulting mRNAs can be translated into multiple
polypeptides at the same time. In Figure 10.5 (below) RNA polymerase is transcribing an
operon into a single mRNA molecule encoding three separate polypeptides.

Fig. 10.5: An operon is a contiguous group of two or more genes in a bacterial genome that are
transcribed as a single messenger RNA encoding all of the genes, all of which are then translated
into polypeptides.

CHALLENGE: Why do you think some genes are organized into operons in
bacterial cells, and why might eukaryotes lack (or have lost) this kind of
gene organization?

Transcription of all bacterial RNAs requires only one RNA polymerase. Different RNA
polymerases catalyze rRNA, mRNA, and tRNA transcription in eukaryotes. We already noted
that Roger Kornberg received the Nobel Prize in Medicine in 2006 for his discovery of the role
of RNA polymerase II and other proteins involved in eukaryotic mRNA transcription.

189 RNA Polymerases in Prokaryotes and Eukaryotes
While mRNAs, rRNAs, and tRNAs are most of what cells transcribe. A growing number
of other RNAs (e.g., siRNAs, miRNAs, and lncRNAs) are also transcribed. Some functions of
these transcripts (including control of gene expression or other transcript use) are discussed in
an upcoming chapter.
10.2.3 RNAs Are Extensively Processed After Transcription in Eukaryotes
Eukaryotic RNAs are processed (i.e., trimmed and chemically modified) from large precursor
RNAs into mature, functional RNAs. These precursor RNAs (pre-RNAs, or primary transcripts)
contain in their sequences the information necessary for their function in the cell.
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Figure 10.6 provides an overview of the transcription and processing of the three major
types of transcripts in eukaryotes.

Fig. 10.6: Eukaryotic mRNAs, rRNAs, and tRNAs are transcribed by different RNA polymerases and
are processed (hydrolyzed) by different mechanisms to yield functional RNAs. Pre mRNAs are spliced
to remove intron, ‘capped at their 5’ ends and polyadenylated at their 3’ ends (left). Pre-rRNAs are
methylated and cleaved based on methylation patterns (middle). Pre-tRNAs processed by trimming
their 5’ and 3’ ends and chemical modification of some bases (right).

To summarize the illustration:
•

Many eukaryotic genes are “split”, consisting of coding regions (called exons) and
intervening, or non-coding regions (called introns). Transcription of split genes generates
a primary mRNA (pre-mRNA) transcript. Pre-mRNA transcripts are spliced to remove the
introns from the exons; exons are then ligated into a continuous mRNA. In some cases,
the same pre-mRNA is spliced into alternate mRNAs that encode related but not identical
polypeptides!

•

Pre-rRNA is cleaved and/or trimmed (not spliced!) to make shorter mature rRNAs.

•

Pre-tRNAs are trimmed, and some bases within the transcript are modified. Then three
bases (not encoded by the tRNA gene) are enzymatically added to the 3’ end.

190 Posttranscriptional Processing; an Overview
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The details of transcription and processing differ substantially in prokaryotes and eukaryotes.
Let’s focus first on details of transcription itself and then RNA processing.

10.3

Details of Transcription

You can find a well-written summary of transcription in prokaryotes and eukaryotes on the
National Institutes of Health (NIH) website at 10.4Transcription in Prokaryotes and Eukaryotes.
At the link as well as here in this book, you will encounter proteins that bind DNA. Some
proteins bind DNA to regulate transcription, inducing or silencing the transcription of a gene;
we will discuss their role in the regulation of gene expression later. Other proteins interact
with DNA simply to allow transcription; these include one or more that, along with RNA
polymerase itself, must bind to the gene promoter to initiate transcription. We will look at
bacterial transcription first.
10.2.4 Details of Transcription in Prokaryotes
In E. coli, a single RNA polymerase transcribes all kinds of RNA, associating with one of
several sigma factor proteins (−factors) to initiate transcription. Different promoter sequences
and their corresponding −factors play roles in the transcription of different genes (Figure.
10.7).

Fig. 10.7: All transcription begins when RNA polymerase binds to a two-part 'promoter' in mRNA (here
shown as the '-35' and 'pribnow box' sequences). Bacterial RNA polymerase is associated with 'sigma
factors' that allow it to recognize and bind to the promoter. Different 'sigma factors' recognize different
promoter sequences.

In the absence of a −factor, E. coli RNA polymerase transcribes RNA, but it does so at
a high rate and from random sequences in the chromosome. With a −factor bound to the RNA
polymerase, the complex seemingly scans the DNA and recognizes and binds to the promoter
sequence of a gene. The overall transcription rate is slower, but rather than random bits of the
bacterial genome, only genes are transcribed! The Pribnow box, named for its discoverer, was
the first RNA polymerase-binding sequence in a promoter to be characterized.
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One way that bacteria regulate which genes are expressed is to selectively control the
cellular concentrations of different −factors available to the Pribnow box.   is the main
−factor of bacterial transcription initiation  , a structurally unrelated factor regulates a
variety of different genes, typically in response to stress (e.g., high temperature or antibiotic
attack). Still other “alternative” −factors participate in activating specific genes or gene
subsets (10.5Sigma Subunits and Bacterial Regulation). We shall see more modes of prokaryotic
gene regulation in the next chapter.
Typically, the −factor falls off the RNA polymerase very soon after transcription is
initiated, which then continues unwinding the double helix and elongating the transcript
(Figure 10.8).

Fig. 10.8: After a bacterial RNA polymerase binds to the promoter (at the left), translation begins.
No longer needed to initiate transcription, the 'sigma factor' dissociates from the polymerase (at
the right), which then continues transcribing the RNA.

Elongation is the successive addition of nucleotides complementary to their DNA
templates by forming phosphodiester linkages between nucleotides. The enzymatic
condensation reactions of elongation are much like DNA polymerase-catalyzed elongation
during replication.
CHALLENGE: How is chain (strand) elongation during replication different
from chain elongation during transcription? Try to describe the difference
in your own words.
There are two ways that bacterial RNA polymerase “knows” when it has reached the
end of a transcription unit. In one case, as the RNA polymerase nears the 3’ end of the nascent
transcript, it transcribes a 72-base, C-rich region. At this point, a termination factor called the
rho protein binds to the nascent RNA strand; rho is an ATP-dependent helicase that breaks the
H-bonds between the RNA and the template DNA strand, thus preventing further
transcription. Figure 10.9 (below) illustrates rho-dependent termination.
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Fig. 10.9: Rho-dependent termination is one mechanism by which an RNA polymerase knows when it
has finished transcribing. The Rho protein is an RNA-DNA helicase that recognizes a sequence near
the end of the gene and transcript that unwinds the nascent RNA from the gene, ending transcription.

In the other mechanism of termination, a sequence near the 3’ end of the transcript
folds into a hairpin loop secondary structure, which serves as a termination signal, also
causing dissociation of the RNA polymerase, template DNA, and the new RNA transcript. The
role of the hairpin loop in rho-independent termination is shown in Figure 10.10.

Fig. 10.10: Rho-independent termination is another mechanism for terminating bacterial
transcription. A sequence near the end of the nascent transcript has internal complementary
bases that fold into a hairpin-loop that acts as a termination signal.

191 Details of Prokaryotic Transcription
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10.2.5 Details of Transcription in Eukaryotes
Unlike prokaryotes, eukaryotes use three different RNA polymerases to synthesize the three
major RNAs (Figure 10.11).

Fig. 10.11: The work of Eukaryotic transcription is more complex than that of prokaryotes. The
latter transcribe all RNAs with a single RNA polymerase. Eukaryotes catalyze transcription of
their rRNAs, mRNAs and tRNAs with different RNA polymerases.

With the help of initiation proteins, each RNA polymerase forms an initiation complex
by combining with several transcription factors (TFs). Once the DNA at the start site of
transcription unwinds, RNA polymerases catalyze the successive formation of phosphodiester
linkages to elongate the transcript. Note that catalysis of the synthesis of most of the RNA in a
eukaryotic cell (i.e., rRNAs) is by RNA polymerase I!
These condensation reactions add ribose nucleotides to the free 3’ end of a growing
RNA molecule in reactions that are like those that elongate DNA strands. Unfortunately, the
details of the eukaryotic transcription termination are not as well understood as they are in
bacteria. Here we focus on initiation, followed by discussion of the processing of different
eukaryotic RNAs into ready-to-use molecules.
10.3.2.a Eukaryotic mRNA Transcription
Transcription of eukaryotic mRNAs by RNA polymerase II begins with sequential assembly of a
eukaryotic initiation complex at a gene promoter. The typical promoter for a protein-encoding
gene contains a -T-A-T-A- sequence motif, or TATA box, and other short upstream sequences
that recruit components of the initiation complex. The many steps of eukaryotic mRNA
transcription initiation are illustrated in Figure 10.12 (below).
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Fig. 10.12: Eukaryotic mRNA-transcription initiation starts with recognition of a promoter TATA box by
initiation factor TFIID (TBP) (1). The association of a series of initiation factors follows (2, 3). RNA
polymerase II binds last, and its phosphorylation starts mRNA transcription using the UTP, ATP, CTP,
and GTP nucleotide precursors (4).

TATA-binding protein (TBP) first binds to the TATA box, along with TFIID (transcription
factor IID). This intermediate in turn recruits TFIIA and TFIIB. Then TFIIE, TFIIF, and TFIIH
are added to form the core initiation complex. Finally, several other initiation factors and RNA
polymerase II bind to complete the mRNA transcription-initiation complex. Phosphorylation
adds several phosphates to the amino terminus of the RNA polymerase, after which some of
the transcription factors dissociate from the initiation complex. The remaining RNApolymerase transcription-factor complex can now start making the mRNA.
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The first task of the complete initiation complex is to unwind the template DNA strands
at the start site of transcription. Unlike prokaryotic RNA polymerase, eukaryotic RNA
Polymerase II does not have an inherent DNA helicase activity. For this, eukaryotic gene
transcription relies on the multi-subunit TFIIH protein, two of whose subunits have an ATPdependent helicase activity.
Once transcription is initiated, helicase activity is no longer required for continued
elongation of the RNA strand. Consistent with the closer relationship of archaea to eukaryotes
(rather than to prokaryotes), archaeal mRNA transcription initiation more closely resembles
transcription in eukaryotes, albeit requiring fewer initiation factors during formation of an
initiation complex.

192-2 Eukaryotic mRNA Transcription
A significant difference between prokaryotic and eukaryotic transcription is that RNA
polymerases and other proteins involved at a eukaryotic gene promoter do not see naked DNA.
Instead, they recognize specific DNA sequences behind a coat of chromatin proteins, and
some of whose bases have been chemically modified.
On the other hand, all proteins that interact with DNA have a common a need to
recognize the DNA sequences to which they must bind—within the double helix. In other
words, they must see the bases in the interior of the helix, not its uniformly electronegative
phosphodiester backbone surface. To this end, they must penetrate the DNA, usually through
the major groove of the double helix. We will see that DNA regulatory proteins face the same
problems in achieving specific shape-based interactions!

193-2 Recognition of Transcription Factors at Promoters
10.3.2.b Eukaryotic tRNA and 5S rRNA Transcription
It must have been something of a surprise to discover that the promoter sequence that binds
RNA polymerase III to begin transcribing 5S rRNAs and tRNAs is not upstream of the
transcribed sequence; instead, it is located within the transcribed sequence. To begin
transcription of these RNAs, RNA polymerase III associates with structural relatives of the
RNA polymerase II transcription factors (TFs) to form a core initiation complex at these
“internal promoters”. After additional, gene-specific TFs combine with this core complex, the
finished initiation complex repositions RNA polymerase III from the internal promoter
sequence to the upstream transcription start site to begin RNA synthesis. As a result, the final
5S rRNA and tRNA transcripts still contain retain the ‘promoter’ sequence! Note that, unlike
initiation of mRNA transcription, RNA polymerase III-dependent transcription initiation does
not require an independent DNA unwinding activity (i.e., a helicase). Figure 10.13 (below)
illustrates the transcription of a 5S rRNA (or a tRNA) by RNA polymerase III.
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Fig. 10.13: RNA polymerase III initiates 5S rRNA and tRNA transcription from an internal promoter
with the aid of transcription factors. After binding to the promoter, the polymerase repositions itself near
the transcription start site (1). Transcription begins, producing 5S rRNAs and tRNAs that include their
promoter sequences (2).

10.3.2.c Transcription of the Other Eukaryotic rRNAs
The production of the other rRNAs requires RNA polymerase I. A 45S precursor rRNA (prerRNA) is made and then processed into 28S, 18S, and 5.8S rRNAs (see section 10.5). RNA
polymerase I and “core” TFs form a core initiation complex at the upstream promoters of the
45S genes. The addition of several gene–specific TFs completes assembly of the initiation
complex, which then unwinds the promoter DNA, again without a separate helicase.
More information about the structure and function of eukaryotic transcription initiation
complexes can be had at 10.6Three Transcription Initiation Complexes. As already noted,
transcription termination is not as well understood in eukaryotes as in prokaryotes. Coupled
termination and polyadenylation steps common to most prokaryotic mRNAs are discussed in
more detail in the next section, and a useful summary can be found at the NIH-NCBI website,
10.7
Eukaryotic Transcription Termination.
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10.4

Details of mRNA Processing in Eukaryotic Nuclei

Eukaryotic mRNA primary transcripts undergo extensive processing, including splicing,
capping and polyadenylation. The steps described here are considered in order of (sometimes
overlapping!) occurrence. We begin with splicing—an mRNA phenomenon.
10.4.1 Spliceosomal Introns
The coding regions of bacterial genes are continuous. The discovery of eukaryotic split genes
with introns and exons came as quite a surprise. It seemed incongruous for evolution to have
stuck irrelevant DNA in the middle of coding DNA! For their discovery of split genes, Richard
J. Roberts and Phillip A. Sharp shared the Nobel Prize for Physiology or Medicine in 1993. In
fact, all but a few eukaryotic genes are split, and some have two or more introns separating
bits of coding DNA, the exons. Figure 10.14 summarizes splicing to remove introns in premRNAs and to splice exons (in the right order!) to make a mature, functional mRNA.

Fig. 10.14: Eukaryotic precursor mRNAs are encoded by split genes containing noncoding introns and
coding exons. After transcription of a pre-mRNA (1), splicing removes introns and ligates exons into a
contiguous polypeptide coding sequence (2).

snRNPs are particles composed of RNA and ribonuclear proteins. They bind to specific
sites in an mRNA and then direct a sequential series of cuts and ligations (the splicing)
necessary to process the mRNAs. The process was reminiscent of the way in which movies
were edited (see the photo of an early splicing “machine” at the top of this chapter), hence the
term splicing to describe mRNA processing. Figure 10.15 below highlights the role of small
ribonuclear proteins (snRNPs) in splicing.
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Fig. 10.15: Splicing a eukaryotic pre-mRNA involves association of the primary transcript (pre-mRNA)
with five snRNPs (small nuclear RiboNuclear Proteins) that catalyze cleavage (hydrolysis) of the preRNA at 5’ and 3’ splice sites (bottom of image), to be followed by ligation of the 3’ to 5’ exon ends.

When snRNPs (often pronounced “snurps”) bind to a pair of splice sites flanking a premRNA intron, they form a spliceosome, which completes the splicing, including the removal of
intermediate lariat structures of the intron. The last step is to ligate exons into a continuous
mRNA, with all its codons intact and in the right order—an impressive trick for some premRNAs with as many as fifty introns! Spliceosome action is summarized in Figure 10.16 and in
the “mRNA Splicing” animation at one of the following links.

Fig. 10.16: The binding of snRNPs to a pre-mRNA leads brings 5’ and 3’ splice sites close to each
other, catalyzing the hydrolysis at the sites and forming a lariat structure of the intron remnants.

194-2 The Discovery of Split Genes

195 mRNA Splicing
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10.4.2 Specific Nuclear-Body Proteins Facilitate snRNP Assembly and Function
Recall the organization of nuclei facilitated by nuclear bodies, discussed in an earlier chapter.
Nuclear speckles are associated regions of high mRNA transcription, processing, and splicing.
(Check out the animation at 10.8Nuclear Bodies and Transcription for a 3D localization of
markers of nuclear body activity.)

Cajal bodies (CBs) and Gems are nuclear bodies that are similar in size and have
related functions in assembling spliceosomal snRNPs. Some splicing defects correlate with
mutations in the coil protein associated with Cajal bodies; others correlate with mutations in
SMN proteins normally associated with Gems. One hypothesis was that CBs and Gems
interact in SnRNP and spliceosome assembly—but how?
Consider the results of an experiment in which fluorescence-tagged antibodies to

coilin and the SMN protein were localized in undifferentiated and differentiated
neuroblastoma cells (Figure 10.17).

Fig. 10.17: Light (A, B) micrographs of undifferentiated (A) and differentiated (B) neuroblastoma cells
show that Cajal bodies and Gems aggregate during differentiation. Fluorescent coilin and SMN
antibodies localize separately in undifferentiated cells (C), but together after in differentiation (D). Since
mutations in coilin and SMN proteins are associated with splicing defects, their co-localization after
differentiation suggests that Cajal bodies and Gems have become involved in snRNP function.

Panels A and C above are undifferentiated cells in culture; panels B and D are cells
that were stimulated to differentiate. In the fluorescence micrographs at the right, arrows point
to fluorescent nuclear bodies. In panel C, the green, fluorescent antibodies to coilin (arrows)
localize to CBs and the red fluorescent antibodies to SMN protein (arrowhead) binds to
Gems—as expected. But in panel D, the two antibodies co-localize, suggesting that the CBs
and Gems aggregate in the differentiated cells. This would explain the need for both coilin and
SMN proteins to produce functional snRNPs. The CBs and gems may aggregate in
differentiated cells because of an observed increase in expression of the SMN protein,
producing more Gems and driving the association with CBs.
This and similar experiments demonstrate that different nuclear bodies do have
specific functions, that they are not random structural artifacts sample preparation, and that
they have in fact, evolved to organize nuclear activities in time and space in ways that are
essential to the cell.
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10.4.3 Group I and Group II Self-Splicing Introns
While eukaryotic spliceosomal introns are spliced using snRNPs as described above, Group I or
Group II introns are removed by different mechanisms.

Group I introns interrupt mRNA and tRNA genes in bacteria and in the genomes of
mitochondria and chloroplasts. They are also occasionally found in bacteriophage genes, but
rarely in nuclear genes (and then only in lower eukaryotes). Group I introns are self-splicing!
Thus, they are themselves ribozymes. They do not require a spliceosome with its snRNPs or
other proteins for splicing activity. Instead, they fold into a secondary stem-loop structure that
positions catalytic nucleotides at appropriate splice sites to excise their own introns and to religate the exons.

Group II introns are found in chloroplast and mitochondrial rRNA, mRNA, tRNA and some
bacterial mRNAs. These can be quite long. They form complex stem-loop tertiary structures
and self-splice, at least in a test tube! However, Group II introns encode proteins required for
their own splicing in vivo. Like spliceosomal introns, they form a lariat structure at an Aresidue branch site. All of this suggests that the mechanism of spliceosomal intron splicing
evolved from that of Group II introns.
10.4.4 So Why Splicing?
Whether via spliceosomes or by self-splicing in organelles, the puzzle implied by any kind of
splicing is why? Why do higher organisms have split genes in the first place? While the
following discussion can apply to all splicing, it will reference mainly spliceosomal introns.
Here are some answers to the question.
•

•

•

Introns in the nuclear genes of some species are often longer (much longer!) than their
exons. Because introns are noncoding (i.e., non-informational) making them large targets
for mutation. In effect, most noncoding DNA—including introns—can buffer the ill effects
of random mutations.
You may recall that gene duplication on one chromosome and the loss of a copy from its
homologue arise from unequal recombination (nonhomologous crossing over). It can occur
when similar DNA sequences align during synapsis of meiosis. In unequal cross-over
involving whole genes, one chromosome will lose the gene while its homologue will
contain two copies of the gene. In an organism that inherits a chromosome with both gene
copies, the duplicate can accumulate mutations if the other retains original function. The
diverging gene then becomes part of a pool of selectable DNA, the grist of evolution.
Descendants of organisms that inherit the duplicated genes have diversified the gene pool,
again increasing the potential for evolution and species diversity.
Unequal recombination can also occur between similar sequences (e.g., in introns) in the
same or different genes, resulting in a sharing of exons between genes. After unequal
recombination between the introns that flank an exon, one gene will acquire another exon
while the other will lose it. Once again, if an organism retains a copy of the participating
genes with original function, the organism can make the required protein and survive.
Meanwhile, the gene with the extra exon may produce a similar protein, but one with a
new structural domain and function.
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•

Just like a complete duplicate gene, one with a new exon that adds a new function to an
old gene has been entered in the pool of selectable DNA. By creating proteins with
different overall functions that nonetheless share at least one domain and one common
function, the phenomenon of exon shuffling increases species diversity!

An example discussed earlier involves calcium-binding proteins that regulate many
cellular processes. Structurally related calcium (Ca++) binding domains are common to many
otherwise structurally and functionally unrelated proteins. Consider exon shuffling in the
unequal crossover (nonhomologous recombination) shown in Figure 10.18.

Fig. 10.18: Exon shuffling, the transfer or copying of an exon from one gene to another can occur by
unequal recombination (cross-over) between different (nonhomologous) genes due to some sequence
similarity within introns. The common sequences can align during synapsis in meiosis. If unequal
crossing over occurs within introns or non-coding DNA (1) it creates a new gene, in this case one with
three exons. Transcription and splicing of a pre-mRNA from this new gene produce a new protein.

In this example, regions of strong similarity exist in different (nonhomologous) introns
in the same gene. These regions align during synapsis of meiosis. Unequal crossing over
between the genes inserts exon C into one of the genes. The other gene loses the exon (not
shown in the illustration).
In sum, introns are buffers against deleterious mutations, and they are equally valuable
as potential targets for gene duplication and exon shuffling. This makes introns key players in
creating genetic diversity, the hallmark of evolution.

196-2 Origin of Introns

197 Intron Evolution: What was selected here?
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10.4.5 5-Prime Capping
Using GTP as a precursor, a methyl guanosine CAP added 5’-to-5’ to an mRNA functions, in
part, to help mRNAs leave the nucleus and associate with ribosomes. The CAP is added to an
exposed 5’ end, even as transcription and splicing are still in progress. A capping enzyme
places a methylated guanosine residue at the 5’ end of the mature mRNA. Figure 10.19 shows
the 5’ CAP structure (the check marks are 5’-3’ linked nucleotides).

Fig. 10.19: Capping of mRNA results from catalysis of a 5′-to-5’ condensation reaction linking the 5’
end of an mRNA to a methylated guanidine triphosphate (CH3-GTP).

10.4.6 3-Prime Polyadenylation
A poly(A) polymerase catalyzes the addition of adenine monophosphates (AMPs) to the 3’ end
of most eukaryotic mRNAs, even before any splicing is complete. Polyadenylation requires
ATP and can add several hundred AMPs to the 3’ terminus of an mRNA. The enzyme binds to
an -A-A-U-A-A- sequence near the 3’ end of an mRNA and starts adding the AMPs.
Polyadenylation after transcription termination is illustrated in Figure 10.20.

Fig. 10.20: mRNA polyadenylation is the addition of multiple adenine nucleotides to the 3’ end of an
mRNA, catalyzed by the enzyme poly(A) polymerase. Other than histone mRNAs, most eukaryotic
mRNAs are polyadenylated.
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The result of polyadenylation is a 3’ poly(A) tail whose functions include assisting in
the transit of mRNAs from the nucleus and regulating the half-life of mRNAs in the cytoplasm.
The poly(A) tail shortens each time a ribosome finishes translating the mRNA.

198 mRNA 5’ Capping and 3’ Polyadenylation
CHALLENGE: Bacterial mRNAs have been found with very short poly(A)
tails. Would you expect poly(A) tails on bacterial mRNAs to function the
same way they do in eukaryotic cells? Explain your expectation.

10.5

Ribosomal RNA Processing in Eukaryotic Nuclei

In most eukaryotes, a large rRNA gene transcribes a 45S precursor transcript containing (from
shortest to longest) 5.8S rRNA, 18S rRNA and 28S rRNA. The S comes from Theodor
Svedberg, the biochemist who developed the sedimentation velocity ultra-centrifugation
technique to separate molecules like RNA by size. The higher the S value, the larger the
molecule and therefore the faster it moves through the viscous sugar gradient during
centrifugation. RNA polymerase I transcribes 45S precursor rRNAs (pre-RNAs) from multiple
large transcription units in the genome. One such unit is shown in Figure 10.21.

Fig. 10.21: The 45S eukaryotic rRNA genes (1) encode the 18S, 5.8S and 28S ribosomal RNAs (2). PrerRNA transcripts contains the rRNAs (3). Hydrolytic cleavage of the pre-rRNA (3) will separate the rRNAs
and specific rRNA nucleases will hydrolyze spacer and flanking RNA, leaving behind mature rRNAs (4).
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The 45S pre-rRNA is processed by hydrolytic cleavage. The many copies (two hundred
to four hundred!) of the 45S gene in eukaryotic cells might be expected, since making proteins
(and therefore ribosomes) will be an all-consuming cellular activity. In humans, 45S genes
(45S rDNA) are distributed among five acrocentric chromosomes (those that have a centromere
very near one end of the chromosome).
Inside the nucleus, the 45S rDNA in chromosomes is packed into the nucleolus.
Because these genes are present in so many copies and are organized into a specific region of
chromatin, it is possible to visualize 45S transcription in progress in electron micrographs such
as the ones in Figure 10.22.

Fig. 10.22: As early as 1906, chromatic fibers were described in light micrographs of stained nucleoli
of salamander oocytes. At high power (left) these fibers looked like a bottle brush used for cleaning
bottles, or a lamp brush used to clean the chimneys of old-fashioned kerosene lamps. Today we know
chromatic fibers as lampbrush chromosomes, and we also know that the bristles are nascent strands
of rRNA arranged along transcribed 45S genes.

The term lampbrush comes from the shape of the 45S genes undergoing transcription;
the RNAs extending from the DNA template look like an old-fashioned brush used to clean the
chimney of a kerosene lamp. For a high-resolution transmission electron micrograph, see
10.9
High Res Lampbrush Chromosomes.
Multiple gene copies encode 5S rRNAs. However, unlike the 45S rRNA genes, 5S
rRNA genes may be spread among many chromosomes (seven in Neurospora crassa, the bread
mold). Or in the case of humans, 5S RNA gene copies are found distributed along chromosome
1. The 5S rRNA genes are transcribed by RNA polymerase III with minimal posttranscriptional
processing. As we noted, the promoters of the 5S genes are within the transcribed part of the
genes, rather than upstream of their 5S transcription units.

199-2 rRNA Transcription & Processing
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CHALLENGE: In the same species, rRNA genes can differ in copy number
as well as DNA sequence. This might be expected, especially when they
are repeated in tandem. Why?

10.6

tRNA Processing in Eukaryotic Nuclei

RNA polymerase III also transcribes tRNA genes from internal promoters, but unlike the 5S
rRNA genes, tRNA genes tend to cluster in the genome (Figure. 10.23).

Fig. 10.23: Genes encoding tRNAs for different amino acids are organized in characteristic geneclusters, with genes oriented (i.e., transcribed) in opposite directions.

Also unlike 5S rRNA genes, tRNA primary transcripts are processed by trimming, the
enzymatic addition of a 3’-terminal-C-C-A triplet, and the modification of bases internal to the
molecule. A yeast tRNA showing these modifications is illustrated in Figure 10.24.

Fig. 10.24: Structure of a processed, mature yeast tRNA, trimmed at 3' and 5' ends with an
enzymatically added three-nucleotide (C-C-A amino acid attachment site and modified bases.
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The yeast tRNA folds into several hairpin loops based on internal H-bond formation
between complementary bases in the molecule. An amino acid specific for the tRNA will be
enzymatically added to the A residue of the 3’ terminal -C-C-A.

200-2 tRNA Transcription and Processing
CHALLENGE: What do you think determines which amino acid will bind to
which tRNA?

10.7

Export of mRNA and Ribosomes from the Nucleus

The synthesis and processing of rRNAs are coincident with the assembly of the ribosomal
subunits (Figure 10.25).

Fig. 10.25: Cells coordinate the export of ribosomal subunits from nucleus to cytoplasm with
their assembly from mature rRNAs and ribosomal proteins imported from the cytoplasm.

227

The 45S pre-rRNAs initially bind to ribosomal proteins in the nucleolus (that big
nuclear body!) to initiate assembly, and then serve as a scaffold for the continued addition of
ribosomal proteins to both the small and the large ribosomal subunits. After the 5S rRNA is
added to the nascent large ribosomal subunit, processing (cleavage) of 45S rRNA is completed,
and the subunits are separated. The separated ribosomal subunits exit the nucleus to the
cytoplasm, where they will associate with mRNAs to translate new proteins. To better
understand what is going on, try summarizing what you see here in the correct order of steps.
You can also see this process animated at this link: 10.10Ribosome Assembly & Nuclear Export.
Messenger RNAs are independently exported from the nucleus. Their 5’ methyl
guanosine caps and poly(A) tails collaborate to facilitate transport into the cytoplasm. We now
understand that proteins in the nucleus participate in the export process: a nuclear transport
receptor binds along the mature (or maturing) mRNA; a poly(A)-binding protein binds along
the poly(A) tail of the message; and another protein binds at or near the methyl guanosine CAP
itself. These interactions enable transport of the mRNA through nuclear pores. After the mRNA
is in the cytoplasm, the nuclear transport receptor recycles back into the nucleus while a
translation initiation factor replaces the protein bound to the CAP. Figure 10.26 summarizes
the nuclear transport process for mRNAs.

Fig. 10.26: The 5' guanosine CAP and 3' Poly(A) tail on mRNAs function during mRNA export from
nucleus to cytoplasm. A nuclear transport factor along with specific 5’ guanosine CAP and 3’ poly(A)
binding proteins associate with the mRNA during export. After export, the CAP binding protein and
nuclear transport protein are recycled to the nucleus.

See a more detailed description of mRNA transport from the nucleus at 10.11mRNA
Export from the Nucleus. The mature mRNA, now in the cytoplasm, is ready for translation,
the process of protein synthesis mediated by ribosomes and a host of translation factors. The
genetic code directs polypeptide synthesis during translation. We will discuss the details of
translation shortly.
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mRNA capping
mRNA polyadenylation
mRNA splicing
operons
poly(A) polymerase
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RNA polymerase II
RNA polymerase III
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rRNA
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Chapter 11

The Genetic Code and Translation

The genetic code, tRNA (adapter) molecules, translation (protein synthesis)
Reminder: For inactive links, google key words/terms for alternative resources.

11.1

Introduction

While evidence was accumulating that DNA was “the stuff of genes,” many still believed that
proteins were genes—at least until the experiments of Hershey and Chase. It was in this
somewhat ambivalent context that investigators wondered about how genes (whether proteins
or nucleic acids) might encode metabolically functional proteins such as enzymes—which, of
course, are also proteins. In 1944, the physicist-philosopher Erwin Schrödinger published
What Is Life? The Physical Aspect of the Living Cell. Targeting the lay reader, Schrödinger
took a stab at explaining life, heredity, and development in terms of physical laws. Here in his
own words is what he had to say about the chemistry of heredity, which—when deciphered—
would dictate “patterns,” of development (abridging and highlighting courtesy of your
author!):

THE HEREDITARY CODE-SCRIPT
Now, this pattern is known to be determined by the structure of that one cell, the
fertilized egg. Moreover, we know that it is essentially determined by the structure of only
a small part of that cell, its large nucleus. This nucleus…usually appears as a network of
chromatine, distributed over the cell. But in the processes of cell division (mitosis and
meiosis) it is seen to consist of a set of particles, usually fibre-shaped o rod-like, called
the chromosomes, which number in man, 48 (2 × 24)…. I ought to have spoken of two
sets, in order to use the expression in the customary strict meaning of the biologist. For
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the two sets are almost entirely alike. As we shall see in a moment, one set comes from
the mother (egg cell), one from the father (fertilizing spermatozoon). It is these
chromosomes, or probably only an axial skeleton fibre of what we actually see under the
microscope as the chromosome, that contain in some kind of code-script the entire

pattern of the individual’s future development and of its functioning in the mature
state. Every complete set of chromosomes contains the full code; so there are, as a rule,
two copies of the latter in the fertilized egg cell, which forms the earliest stage of the
future individual. In calling the structure of the chromosome fibres a code-script we
mean that the all-penetrating mind, once conceived by Laplace, to which every causal
connection lay immediately open, could tell from their structure whether the egg would
develop, under suitable conditions, into a black cock or into a speckled hen, into a fly or
a maize plant, a rhododendron, a beetle, a mouse or a woman. To which we may add,
that the appearances of the egg cells are very often remarkably similar; and even when
they are not, as in the case of the comparatively gigantic eggs of birds and reptiles, the
difference has not been so much the relevant structures as in the nutritive material which
in these cases is added for obvious reasons. But the term code-script is, of course, too
narrow. The chromosome structures…are at the same time instrumental in bringing
about the development they foreshadow. They are law-code and executive power—or,
to use another simile, they are architect’s plan and builder’s craft—in one. (From
Schrödinger E: What is Life. Cambridge, Cambridge University Press; 1944.)
Once again, keep in mind that these speculations presage the identification of DNA as
the genetic chemical. The terms code, broken, and deciphered themselves came from the
recent World War II history. Winning the war relied on breaking enemy codes (see the Enigma
Machine at the top of this chapter), as well as on hiding strategic battle information from the
enemy (recall or look up the history of the Navajo Code Talkers).
In this chapter we will look at the experiments that broke the genetic code in
messenger RNA, and as a result in the genes…, in DNA). We’ll describe the elegant
experiments that deciphered at first, only one of the amino-acid codewords, then a few more of
these three-base codons, and finally, all sixty-four possible codons that could be ‘written’ using
four different nucleotides. Of these, it turns out that sixty-one codons code for amino acids and
three are stop codons. Experiments like those that broke the genetic code also led to our
understanding of the mechanism of protein synthesis. Earlier studies had indicated that genes
and proteins are colinear—that is, that the length of a gene was directly proportional to the
polypeptide it encoded. If so, it follows that the lengths of mRNAs are also colinear with (i.e.,
proportional to the lengths of) their translation products. Finally, colinearity also suggested
the obvious hypothesis that translation proceeded in three steps (initiation, elongation, and
termination), just like transcription itself.
We now know that initiation is a multi-step process involving the assembly of the

initiation complex of a “translation machine” at a start codon near the 5’ end of the mRNA.
This machine is made up of ribosomes, mRNA, several initiation factors, and requires a source
of chemical energy for assembly. Since mature mRNAs are longer than needed to specify a
polypeptide (even after splicing!), one function of initiation factors is to correctly position the
ribosome and associated proteins near a start codon. The start codon specifies the first amino
acid in a new polypeptide.
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Once the initiation complex forms, elongation begins. Cycles of condensation reactions
on the ribosome connect amino acids by peptide linkages, growing the chain from its amino
end to its carboxyl end. Translation finishes when the ribosome moving along the mRNA
encounters a stop codon. We will look at how we came to understand these discrete steps of
translation.

Learning Objectives
When you have mastered the information in this chapter, you should be able to do the
following:
1. Compare and contrast the mechanisms and energetics of initiation, elongation, and
termination in translation vs transcription.
2. Speculate on why the genetic code is universal (or nearly so).
3. Justify early thinking about a four-base genetic code.
4. Justify early thinking about an overlapping genetic code (for example, one in which the last
base of a codon could be the first base of the next codon in an mRNA.
5. Explain why all tRNA structures share some but not all features.
6. Compare and contrast the roles of the ribosomal A, E, and P sites in translation.
7. Trace the formation of an aminoacyl tRNA and the bacterial initiation complex.
8. Describe the steps of translation that require chemical energy from NTPs.
9. Formulate a hypothesis to explain why stop codons all begin with the base U.
10. Create a set of rules for inferring an amino-acid sequence from a DNA sequence.
11. Speculate about why large eukaryotic genomes encode so few proteins.

11.2

Overview of the Genetic Code

The genetic code contains the information for linking amino acids in polypeptides in the order
determined by the deoxynucleotide base sequence of three-base code words (codons) in the
DNA of genes and in the nucleotide sequences of messenger RNA (mRNA). With a few
exceptions (e.g., some prokaryotes, mitochondria, and chloroplasts), the genetic code is
universal—it’s the same in all organisms, from viruses and bacteria to humans. Here we’ll look
at the genetic code itself and at how the information in the RNA nucleotide sequences of
transcribed genes is translated into polypeptides.
11.2.1 The Universal, Degenerate Genetic Code
The three-base code words (codons) of the (nearly) universal genetic code are shown
in the “language” of RNA in the table in Figure. 11.1 (below). A look at this table reveals that
there is a single codon for each of two amino acids, methionine and tryptophan, but two or
more for each of the other eighteen amino acids (and in one case six!). For this reason, we say
that the genetic code is degenerate. The table highlights the AUG codon. At some point,
evolution dictated that methionine will be the first amino acid of polypeptides. It is in fact the
start codon for all polypeptides as well as for placing methionine in a polypeptide where it is
needed for its function. And even though all polypeptides start with an N-terminal methionine,
most lose it after translation. Finally, while the last amino acid in a polypeptide can be any
amino acid consistent with the function of the protein being made, the table also highlights
three stop codons in the standard genetic code that “tell” ribosomes the location of the last
amino acid of a polypeptide.
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Fig. 11.1: The Universal RNA Genetic Code Dictionary.

We will see in considerable detail that ribosomes are the living, biological equivalent
an Enigma machine, translating messages encrypted in DNA and RNA into polypeptides. And
the key to this remarkable mRNA translation machine is the tRNA decoding device. To
function as the key, each amino acid attaches to a specific tRNA whose short sequence
contains a three-base anticodon that is complementary to an mRNA codon. Enzymatic
reactions catalyze the dehydration synthesis reactions that link amino acids by peptide bonds in
the order specified by mRNA codons.

201 The Genetic Code Dictionary
11.2.2 Comments on the Nature and Evolution of Genetic Information
The nearly universal genetic code found in viruses and all organism, from bacteria to humans)
implies that the code was “fixed’” early in evolution. It is probable that portions of the code
were in place even before life began. Once in place however, the genetic code was highly
constrained against evolutionary change.
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The degeneracy of the genetic code enabled (and contributed to) this constraint by
permitting base changes in most codons without an effect on the amino acids that they
encoded. We can compare our gene and other DNA sequences to those of different organisms
precisely because the genetic code is universal and resistant to change. This is what allows us
to compare genomes and establish evolutionary relationships between larger groups of
organisms (genus, family, order), between species, and even between individuals of a species.
In addition to constraints imposed by a universal genetic code, the genomes of some
organisms show codon bias, a preference to use some codons over the use of others in their
genes. For example, codon bias is seen in organisms that favor codons rich in A and T or in
organisms that prefer codons richer in G and C. Interestingly, codon bias in genes often
accompanies a corresponding genome-wide nucleotide bias. Thus, an organism with an A-T
codon bias may also have an A-T biased genome. Likewise, a G-C rich genome can exhibit a
bias toward the use of G and C in their codons. If you check back, you can recognize genomic
nucleotide bias in Chargaff’s base ratios!
CHALLENGE: Here are two questions: What might lead to evolutionary
selection of codon bias? Could an organism have survived with less than
sixty-four triplet codons? We may never know the answer to the second
question, but we can see an engineered E. coli living on sixty-one codons
at

Survival on Less than 64 Codons.

11.1

Finally, we often think of genetic information in a genome as genes that specify protein
sequences, in other words, coding DNA. On the other hand, obvious examples of noncoding
but critically informational DNA include the genes for ribosomal and transfer RNAs. The
relative amounts of informational DNA (genes for polypeptides, rRNAs and tRNAs) and
noninformational DNA range across species, although they are higher in prokaryotes than
eukaryotes. In fact, ~88% of the E. coli genome encodes polypeptides, compared to the
humans, in which that figure is less than ~1.5%!
Some of less obvious informative DNA in higher organisms is transcribed (e.g.,
introns). But other informative DNA is never transcribed. They may not be called genes, the
latter include regulatory DNA sequences, sequences that support chromosome structure and
other DNA that contribute to development and phenotype.
As for truly noninformative (useless) DNA in a eukaryotic genome, that amount is
steadily shrinking as genome sequencing reveals novel DNA sequences, new potential genes,
and thus, new RNAs with new functions (topics covered elsewhere in this text).

11.3

Gene and Protein Colinearity and Triplet Codons

Serious efforts to understand how proteins are encoded began after Watson and Crick used the
experimental evidence of Maurice Wilkins and Rosalind Franklin (among others) to determine
the structure of DNA. Most hypotheses about the genetic code assumed colinearity, namely
that DNA (i.e., genes) and polypeptides were colinear.
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11.3.1 Colinearity of Genes and Proteins
For genes and proteins, colinearity just means that the length of a DNA sequence in a gene is
proportional to the length of the polypeptide encoded by the gene. The gene-mapping
experiments in E. coli (which we have already discussed) certainly supported this hypothesis.
Figure 11.2 illustrates the concept of the colinearity of genes and proteins.

Fig. 11.2: Colinearity of genes and proteins (polypeptides) in bacteria.

If the genetic code is colinear with the polypeptides it encodes, then a one-base codon
obviously would not work because such a code would only account for four amino acids. A twobase genetic code also doesn’t work because it could only account for sixteen (4 2) of the twenty
amino acids found in proteins. However, three-nucleotide codons could code for a maximum of
sixty-four (43) amino acids, more than enough to encode the twenty amino acids. And of
course, a four-base code also works; it satisfies the expectation that genes and proteins are
colinear, with the “advantage” that there would be 256 (44) possible codons to choose from.
11.3.2 How Is a Linear Genetic Code “Read” to Account for All genes in the genome of an
Organism?
George Gamow (a Soviet-American physicist working at the George Washington University)
was the first to propose triplet codons to encode the twenty amino acids. This was the simplest
hypothesis to account for the colinearity of genes and proteins, and for encoding twenty amino
acids. Once the concept of colinearity was accepted, a remaining concern was: Is there enough
DNA in an organism’s genome to fit all the codons needed to make all of its proteins?
Assuming that genomes did not have a lot of extra DNA lying around, scientists still wondered
how genetic information might be compressed into short DNA sequences consistent with
colinearity and assumptions about the number of genes required by an organism. One idea
assumed that there were twenty meaningful three-base codons (one for each amino acid) and
forty-four meaningless codons, and that the meaningful codons in a gene (i.e., an mRNA)
would be read and translated in an overlapping manner. A code where codons overlap by one
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base is shown in Figure 11.3 (below). You can figure out how compressed a gene could get
with codons that overlapped by two bases.

Fig. 11.3: A single base overlapping genetic code would fit more genetic information in less DNA!

As attractive as an overlapping codon hypothesis was in achieving genomic
economies, it sank of its own weight almost as soon as it was floated! If you look carefully at
the example above, you can see that each succeeding amino acid would have to start with a
specific base. A look back at the table of sixty-four triplet codons quickly shows that only one of
sixteen amino acids, those that begin with a C, can follow the first one in the illustration. Based
on the amino-acid sequences already accumulating in the literature, it was clear that virtually
any amino acid could follow another in a polypeptide. Therefore, overlapping genetic codes
are untenable. The genetic code must be nonoverlapping!
Sydney Brenner and Francis Crick performed elegant experiments directly
demonstrating the nonoverlapping genetic code. They showed that bacteria with a single base
deletion (and, likewise, a double base deletion) in the coding region of a gene failed to make
the expected protein. On the other hand, a bacterium containing a mutant version of a gene in
which three bases were deleted was able to make the protein. But the protein it made was less
active than the protein made by bacteria with genes that had no deletions.
CHALLENGE: Here are two questions: (1) The protein made by Brenner and
Crick was less active than the one in normal cells - why? (2) What would
happen if four consecutive nucleotides were deleted from a gene?
The next issue was whether there were only twenty meaningful codons and forty-four
meaningless ones. If only twenty codons encoded amino acids, how would the translation
machinery know the correct twenty to translate? What would prevent the translational
machinery from “reading the wrong” triplets (i.e., reading an mRNA out of phase)?
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For example, if the translation machine began reading an mRNA from the second or
third base of a codon, wouldn’t it likely encounter a meaningless three-base sequence in short
order? An alternate hypothesis speculated that the code was punctuated. That is, perhaps there
were the chemical equivalents of commas between the meaningful triplets. The commas would
of course, be additional nucleotides. In this punctuated code, the translation machinery would
recognize the “commas” and would not translate any meaningless three-base triplets, avoiding
out-of-phase translation attempts. Of course, a code with nucleotide commas would increase
the amount of DNA needed to specify a polypeptide by a third! Finally, Crick proposed the
Comma-less Genetic Code. He divided the sixty-four triplets into twenty meaningful codons
(encoding the amino acids) and forty-four meaningless ones that did not encode amino acids.
His code was such that when the twenty meaningful codons are placed in any order, any of the
triplets read in overlap would be among the forty-four meaningless codons. In fact, he could
arrange several different sets of twenty and forty-four triplet codons with this property! Crick
had cleverly shown how to read the triplets in correct sequence without nucleotide commas.

202 Speculations about a Triplet Code
Of course, we know now that while the genetic code is indeed comma-less, it is not
comma-less in the sense that Crick had envisioned. What’s more, thanks to experiments to be
described next, we know that ribosomes read the correct codons in the right order because they
know exactly where to start reading the mRNA!

11.4

Breaking the Genetic Code

Marshall W. Nirenberg and J. Heinrich Matthaei decoded the first triplet. They fractionated E.
coli as shown in Figure 11.4, and then identified which fractions were required for cell-free
protein synthesis, i.e., in vitro translation.

Fig. 11.4: Nirenberg and Matthaei fractionated bacterial cells and recombined different combinations of
fractions (e.g., 1+2, 1+3, 1+4, 2+3 etc.) proving the requirement for a “messenger RNA” fraction (#2) in
reconstituted cell components to synthesize proteins.
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Check out the original work in the classic paper by Nirenberg MW and Matthaei JH [(1961)
The dependence of cell-free protein synthesis in E. coli upon naturally occurring or synthetic
polyribo-nucleotides. Proc. Natl. Acad. Sci. USA 47:1588-1602]. Various combinations of the
isolated cell fractions were added back together, along with amino acids (one of which was
radioactive) and ATP (as an energy source). After the mixture underwent a short incubation,
Nirenberg and Matthaei looked for the presence of high molecular weight radioactive proteins
as evidence of in vitro translation.
They found that all four final fractions (1–4 in Figure 11.4) must be added together to
make radioactive proteins in the test tube. One of the essential cell fractions consisted of RNA
that had been gently extracted from ribosomes (fraction 2 in the illustration). Reasoning that
this RNA might be mRNA, they substituted a synthetic poly(U) preparation for this fraction in
their cell-free protein-synthesizing mix, expecting poly(U) to encode a simple repeating amino
acid. Nirenberg and Matthaei set up twenty reaction tubes, with a different amino acid in
each… and made only polyphenylalanine! (Figure 11.5).

Fig. 11.5: Nirenberg and Matthaei’s reconstitution of fractionated bacterial cells decodes the first codon.

Thus, the triplet codon UUU means phenylalanine. When other polynucleotides were
synthesized by H. G. Khorana, poly(A) and poly(C) were shown in quick succession to make
polylysine and polyproline using this experimental protocol. Thus, AAA and CCC must encode
lysine and proline respectively. With much ingenuity and despite a bit more difficulty,
additional codons were deciphered using poly di- and trinucleotides in cell-free systems.

203 Deciphering the First Codon
Nirenberg and Khorana shared the 1968 Nobel Prize in Physiology or Medicine for
with R. W. Holley their contributions to our understanding of protein synthesis (see Holley’s
contribution below).
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The process of deciphering the rest of the genetic code relied on Crick’s realization
that, chemically, amino acids have no attraction for either DNA or RNA (or triplets thereof).
Instead, he predicted the existence of an adaptor molecule that would contain nucleic acid
and amino acid information on the same molecule. Today we recognize this molecule as tRNA,
the genetic decoding device.
Nirenberg and Philip Leder designed the experiment that pretty much broke the rest of
the genetic code. They added individual amino acids to separate test tubes containing tRNAs,
in effect causing the synthesis of specific aminoacyl-tRNAs. They then mixed their amino acid–
bound tRNAs with isolated ribosomes and synthetic triplet codons. They had previously shown
that synthetic three-nucleotide fragments would bind to ribosomes, so they hypothesized that
triplet-bound ribosomes would in turn, bind appropriate amino acid–bound tRNAs. Figure 11.6
summarizes their experiment.

Fig. 11.6: Nirenberg and Leder’s experiment led to breaking the entire genetic code.

In this experiment, various combinations of tRNA, ribosomes, and aminoacyl-tRNAs
were placed over a filter. Nirenberg and Leder knew that aminoacyl tRNAs alone passed
through the filter and that ribosomes did not. They predicted that triplets would associate with
the ribosomes, that this complex would bind the tRNA with the amino acid encoded by the
bound triplet, and that the filters would retain this three-part complex, allowing identification
of the amino acid retained on the filter. They would then be able to match each amino acid to a
triplet codon(s). Ultimately, sixty-one of the codons were matched to specific amino acids:
Since 61 codons specify 20 amino acids, the genetic code was degenerate!

204 Deciphering All 64 Triplet Codons
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After the code was largely deciphered, Robert Holley sequenced and characterized a
yeast tRNA—which is what earned him his share of the Nobel Prize (above). This first
successful sequencing of a nucleic acid was possible because the RNA was short and
contained several modified bases that facilitated the sequencing chemistry. Holley found the
amino acid alanine at one end of his tRNA, and he found one of the anticodons for an alanine
codon roughly in the middle of the tRNA sequence. From regions of internal sequence
complementarity, Holley predicted that this (and other) tRNAs would fold and assume a stemloop (or cloverleaf) structure with a central anticodon loop. Figure 11.7 shows the stem-loop
structure of a phenylalanine tRNA and a subsequent computer-generated the molecular
structure with a now-familiar “L”-shape). Note the amino acid attachment site at the 3’ end at
the top of the molecule and the anticodon loop at the bottom.

Fig. 11.7: Cloverleaf (left) and computer-generated 3D (right) structures of a phenylalanyl tRNA.

205-2 tRNA Structure and Base Modifications
After a brief overview of translation, we’ll break this process down into its three steps
and see how aminoacyl-tRNAs function in the initiation and elongation steps of translation,
and we’ll look at the special role of an initiator tRNA.

11.5

Translation

Like any polymerization in a cell, translation occurs in three steps: initiation brings a
ribosome, mRNA, and an initiator tRNA together to form an initiation complex. Elongation is
the successive addition of amino acids to a growing polypeptide. Termination is signaled by
sequences (one of the stop codons) in the mRNA and by protein termination factors that
interrupt elongation and release a finished polypeptide.
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The events of translation occur at A, P, and E sites on the ribosome (Figure 11.8).

Fig. 11.8: A, P, and E sites, mostly on the large ribosomal subunit, are involved in mRNA translation.

11.5.1 Even Before Initiation—Making Aminoacyl-tRNAs
Translation is perhaps the most energy-intensive job a cell must do, starting with attaching
amino acids to their tRNAs. The amino-acylation reaction is the same for all amino acids. A
specific aminoacyl-tRNA synthase attaches a tRNA to (i.e., charges) an appropriate amino
acid. This process of charging tRNAs has its own three steps and requires ATP (Figure 11.9).

Fig. 11.9: The three steps of amino acid activation (tRNA acylation) require ATP hydrolysis.

In the first step, ATP and an appropriate amino acid bind to the aminoacyl-tRNA
synthase. The ATP is hydrolyzed, releasing a pyrophosphate (PPi) and leaving an enzymeAMP–amino acid complex, which transfers the amino acid is transferred to the enzyme,
releasing the AMP.
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Finally, the tRNA binds to the enzyme; the amino acid is transferred to the tRNA; and
the intact enzyme is regenerated and released. The charged tRNA is now ready for use in
translation. Several studies had already established that polypeptides are synthesized from
their amino (N-) terminal end to their carboxyl (C-) terminal end. When it became possible to
determine the amino-acid sequences of polypeptides, it turned out that around 40% of E. coli
proteins had an N-terminal methionine. This suggested that all proteins begin with a
methionine, but that the methionine was subsequently removed in a posttranslational
processing step. It also turned out that, even though there is only one methionine codon, two
different tRNAs for methionine could be isolated. One of the tRNAs was bound to a methionine
modified by formylation, called formyl-methionine-tRNAfmet (fmet-tRNAf for short). The
other was methionine-tRNAmet (met-tRNAmet for short), whose methionine was not
formylated. tRNAmet and tRNAf each have an anticodon to AUG, the only codon for
methionine. But they have different base sequences encoded by different tRNA genes.
tRNAmet is used to insert an encoded methionine anywhere in a polypeptide. tRNAf, the
initiator tRNA, is only used to start new polypeptides with formyl-methionine. In prokaryotes,
the amino group of the methionine on met-tRNAf is formylated by a formylating enzyme to
make the fmet-tRNAf. This enzyme does not recognize the methionine on met-tRNAmet.
Methionine and formylated methionine structures are compared in Figure 11.10.

Fig. 11.10: Discovery of met-tRNA and formyl-met-tRNAf, despite only one codon for methionine.

In E. coli, a formylase enzyme removes the formyl group from all N-terminal formyl
methionines at some point after translation has begun. As noted, methionines themselves (and
sometimes more N-terminal amino acids) are also removed from ~60% of E. coli polypeptides.
While eukaryotes inherited both a tRNAmet, and a tRNAf (using only met-tRNAf during
initiation), methionine on the latter is never formylated in the first place! What’s more,
methionine is absent from the N-terminus of nearly all mature eukaryotic polypeptides.
Apparently, early in evolution, the need for an initiator tRNA must have ensured a correct
starting point for translation on an mRNA and therefore the growth of a polypeptide from one
end to the other (i.e., from its N- to C-termini).
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At that time, formylation of the N-terminal methionine may have served to block
accidental addition of amino acids to the N-terminus of a polypeptide. Today, formylation is a
kind of molecular appendix in bacteria. In eukaryotes at least, evolution has selected other
features to replace actual formylation as a protector of the N-terminus of polypeptides.
11.5.2 Translation Initiation
Now that we have charged the tRNAs, we can look more closely at the three steps of
translation. Understanding translation initiation began with cell fractionation of E. coli, the
purification of molecular components required for cell-free (in vitro) protein synthesis, and
finally, reconstitution experiments. Cellular RNA was purified and the 30S ribosomal subunit
was separated from a ribosomal extract. These were then added to initiation-factor proteins
purified from the bacterial cells. Reconstitution experiments revealed that when added to each
other in the correct order, the separated fractions, along with the purified initiation factors,
formed a stable 30S ribosomal subunit–mRNA complex. We now know that a short ShineDalgarno sequence in in the 5’ untranslated region (5’ UTR) of the mRNA forms H-bonds
with its complementary sequence in the 16S rRNA in 30S ribosomal subunit. The ShineDalgarno sequence is just upstream of the initiator AUG codon. The first of 3 initiation steps is
a stable binding of the small (30S) ribosomal subunit to the mRNA, requiring two initiation
factors IF1 and IF3, which also bind to the 30S ribosomal subunit, shown in Figure 11.11.

Fig. 11.11: E. coli translation Initiation was experimentally divided into 3 steps. In step 1 shown here, the
small (30S) ribosomal subunit binds to mRNA. IF1 (initiation factor 1) enables complementary H-bonding
between a region of the 16S rRNA to the Shine-Dalgarno sequence near the 5’ end of the mRNA. IF3
(initiation factor 3) prevents premature attachment of the large (50S) ribosomal subunit.

206 Translation Initiation: mRNA Associates with 30S Ribosomal Subunit
CHALLENGE: When adding mRNAs to ribosomal subunits in the presence
of specific proteins, how might you tell whether mRNA had then bound to
a ribosomal subunit? And how could you tell if the purified initiation
factors had also bound to the subunit?
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Next, with the help of GTP and another initiation factor (IF2), the initiator fmet-tRNAf
recognizes and binds to the AUG start codon found in all mRNAs. Some call the resulting
structure (seen in Figure 11.12) the Initiation Complex, which includes the 30S ribosomal
subunit, IFs 1, 2, and 3, and the fmet-tRNAf.

Fig. 11.12: In the second bacterial translation initiation step, a GTP-bound IF2 enables fmet-tRNAfmet (the
first aminoacyl tRNA) to bind to the mRNA-bound 30S ribosomal subunit, making an initiation complex.

207 Initiation Complex Formation
In the last initiation step, the large ribosomal subunit binds to this complex; IFs 1, 2,
and 3 disassociate from the ribosome; and the initiator fmet-tRNAfmet is now in the P site.
Some prefer to call the structure formed at this point the initiation complex (Figure 11.13).

Fig. 11.13: In step three of translation initiation, GTP on IF2 is hydrolyzed, the three initiation
factors dissociate from the 30S subunit, and the 50S subunit binds to the initiation complex.

208 Adding the Large Ribosomal Subunit
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Initiation can happen multiple times on a single mRNA, forming the polyribosome, or
polysome (already described in chapter 1). Each of the complexes formed above will engage in
polypeptide elongation, described next.
11.5.3 Translation Elongation
Elongation is a sequence of protein factor–mediated condensation reactions and ribosome
movements along an mRNA. As you will see, polypeptide elongation proceeds in three discrete
stages and requires a considerable input of free energy.
11.5.3.a Translation Elongation 1
Elongation starts with the entry of the second aminoacyl tRNA (aa2-tRNAaa2) into the A site of
the ribosome drawn in by the codon-anticodon interaction and GTP hydrolysis. To get there, a
GTP-bound Elongation Factor Tu (EFTu-GTP) binds to an incoming aminoacyl-tRNA, in this
case aa2-tRNAaa2 (arrow 1). The resulting ternary complex enters the ribosome A site,
activating its GTPase function (arrow 2), hydrolyzing the GTP and releasing the reaction
products, EFTu-GDP and Pi, from the ribosome (arrow 3). To keep elongation moving along,
elongation factor Ts (EFTs) catalyzes a GTP-GDP exchange on EFTu, regenerating EFTu-GTP
(arrow 4). Figure 11.14 illustrates these activities of bacterial translation elongation.

Fig. 11.14: Entry of a second aminoacyl-tRNA into the ribosomal A site starts when the aminoacyl-tRNA
binds EFTu-GTP, a GTP-bound elongation factor (1). The aa2-tRNA2-EFTu-GTP complex enters the
ribosome A site (2). The now active GTPase function of EFTu-GTP hydrolyzes the GTP and the resulting
EFTu-GDP and Pi come off the ribosome (3). Elongation factor Ts (EFTs) swaps GDP for GTP on EFTu to
regenerating EFTu-GTP (4). These steps will be repeated in each elongation cycle of translation.

209 Elongation: Elongation Factors and GTP
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11.5.3.b Translation Elongation 2

Peptidyl transferase, a ribozyme component of the ribosome itself, links the incoming amino
acid to a growing chain in a condensation reaction. Figure 11.15 shows the results.

Fig. 11.15: In step 2 of translation elongation, a peptidyl transferase ribozyme activity of the 23S rRNA
(on the 50S ribosomal subunit) catalyzes hydrolysis of fmet from the fmet-tRNA, and formation of a
peptide bond (linkage) between the fmet and the second amino acid (aa2), still linked to its tRNAaa2.

In this reaction, the fmet is transferred from the initiator tRNAf to aa2-tRNAaa2 in the A site,
forming a peptide linkage with aa2, leaving the tRNAf in the P site.

210 Elongation: A Ribozyme Catalyzes Peptide Linkage Formation
11.5.3.c Translation Elongation 3
For translation to continue, the ribosome must move along the mRNA to expose the next codon
in its A site. This begins when GTP binds to elongation factor G (EFG) After formation of the
dipeptidyl-tRNA on the ribosome, GTP-EFG binds to the 50S ribosomal subunit where it acts
as a GTP-dependent translocase, hydrolyzing the GTP to power the movement (translocation)
of the ribosome along an mRNA to expose a new codon on the A site and shifting the
dipeptidyl-tRNA to the P site. The third tRNA (tRNAaa3) now binds in the A site; tRNAaa2, now
attached to a dipeptide, is in the P site. The tRNAfmet (tRNAf) that started in the A site, is now in
the E site of the ribosome. Note the free energy cost of elongation: at 3 NTPs per cycle,
translation is the most expensive polymer synthesis reaction in cells!
The tRNAf, no longer attached to an amino acid, will exit the E site as the next (third)
aa-tRNA enters the empty A site, based on a specific codon-anticodon interaction (assisted by
elongation factors and powered by GTP hydrolysis) to begin another cycle of elongation.
Figure 11.16 (below) illustrates the movement of the ribosome along the mRNA.
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Fig. 11.16: Elongation continues as the ribosome moves along the mRNA. Binding of elongation factor G
(GTP-EFG) to the 50S ribosomal subunit activates its translocase that then catalyzes GTP hydrolysis to
power ribosome movement along the mRNA. The first (fmet) tRNA in the E site is ready to exit the
ribosome, the dipeptidyl-tRNA is in the peptidyl (P) site, and the next codon is exposed in the A site. Entry
of the next aminoacyl-tRNA will begin the next round of elongation, repeating the events in Fig. 11.14.

211 Elongation: Translocase Moves Ribosome along mRNA

212 Adding the Third Amino Acid

213 Big Translation Energy Costs
As polypeptides elongate, they pass through a groove in the large ribosomal subunit.
As they emerge, the previously noted E. coli formylase catalyzes removal of the formyl group
from the now-exposed N-terminal initiation fmet of all growing polypeptides. While about 40%
of E. coli polypeptides begin with a methionine, specific proteases catalyze the hydrolytic
removal of the methionine, and sometimes more N-terminal amino acids) from the other 60%.
All of these N-terminal modifications are examples of posttranslational processing.

214 The Fates of fMet and Met: Cases of Posttranslational Processing
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11.5.4 Translation Termination
A ribosome’s translation of an mRNA ends when translocation exposes one of the three stop
codons in the A site of the ribosome. These stop codons, creatively called ochre, amber, and
opal (UAA, UAG, and UGA, respectively) are situated some distance from the 3’ end of an
mRNA. The region between a stop codon and the end of the mRNA is called the 3’
untranslated region of the messenger RNA (3′ UTR).
Since there is no aminoacyl-tRNA with an anticodon to any of the stop codons, the
ribosome actually stalls, and the translation slow-down is just long enough for a protein
termination factor to enter the A site. This interaction causes the release of the new
polypeptide and the disassembly of the ribosomal subunits from the mRNA. The process
requires energy from yet another GTP hydrolysis. After dissociation, ribosomal subunits can be
reassembled with an mRNA for another round of protein synthesis. Figure 11.17 illustrates
translation termination.

Fig. 11.17: Bacterial translation ends when the ribosome reaches a termination codon. Since there are
no aminoacyl-tRNAs with anticodons to bind to them in the A site, a termination factor enters the A site
instead, signaling the separation of mRNA, the new polypeptide, and the ribosomal subunits.

215-2 Translation Termination
We’ve seen some examples of posttranslational processing (formyl group removal in E.
coli, N-terminal methionine removal from most polypeptides, etc.). Most proteins, especially in
eukaryotes, undergo additional steps of posttranslational processing before becoming
biologically active. We will see examples in upcoming chapters.
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11.6

How Can the Genetic Code Be Degenerate and Accurate at the Same
Time?

The A-T and G-C complementarity in DNA is known as standard Watson-Crick base pairing.
Thinking about how a redundant, degenerate genetic code could work, Francis Crick realized
that most often, the first and second bases of codons for the same amino acid were fixed, while
the third base was variable (except of course, for methionine and tryptophan codons!). In his
Wobble Hypothesis, he proposed that the third base in the tRNA anticodon could recognize
more than one base in a corresponding mRNA codon because it was able to shift (i.e., wobble)
while the other two base pairings were fixed. According to Crick’s hypothesis, the wobble
would be due to a real freedom of movement, or flexibility of the third base in the anticodon,
allowing the formation of thermodynamically stable non-Watson-Crick base pairs.
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Chapter 12

Regulation of Transcription and Epigenetic Inheritance
Gene repression and induction (prokaryotes); multiple transcription factors (eukaryotes);
regulatory elements in DNA; memories of gene regulation (epigenetics)
Reminder: For inactive links, google key words/terms for alternative resources.

12.1

Introduction

Cells regulate their metabolism in several ways. We have already seen that allosterically
regulated enzymes monitor the cellular levels of metabolites. Recall that the glycolytic
intermediates rise and fall in cells based on cellular energy needs, binding to or dissociating
from allosteric sites. In response to interactions with allosteric effectors, allosteric enzymes
cause an increase or decrease in catalytic activity.
Cells can also control absolute levels of enzymes and other proteins by turning genes
on and off, typically by controlling transcription. Transcription regulation usually starts with
extracellular environmental signaling. The signals are chemicals in the air, in the water, or (in
the case of multicellular organisms) in the blood, lymph, or other extracellular fluids. Bacterial
and protist genes often respond to environmental toxins or fluctuating nutrient levels.
Familiar signal molecules in higher organisms include hormones, which are released at the
appropriate time in a sequential developmental program of gene expression or in response to
nutrient levels in body fluids.
Some signal molecules enter cells and bind to specific intracellular (and in a few cases,
intranuclear)receptors to convey their instructions. Others bind to cell surface receptors, which
transduce their “information” into intracellular molecular signals. When signals indicate the
need for gene regulation, responding cells ultimately produce transcription factors. These in
turn recognize and bind to specific regulatory DNA sequences associated with the genes that
they control.
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DNA sequences that bind transcription factors are relatively short. They can lie
proximal (close) to the transcription start site of a gene, and/or (in the case of eukaryotes)
distal to (far from) it. We will see that some of these regulatory DNA sequences are enhancers,
turning on or increasing gene transcription. Others are silencers, down-regulating or
suppressing transcription of a gene. Finally, eukaryotic DNA regulatory sequences are hidden
behind a thicket of chromatin proteins. As gene expression patterns change during
development, or in response to signaling molecules (like hormones), chromatin is reorganized,
cells differentiate, and new tissues and organs form. To this end, new gene expression patterns
and chromatin organization in cells must be remembered by their progeny.
In this chapter, we look at the path from cell recognition of a signal molecule to the
interaction of regulatory proteins with DNA in prokaryotic and with DNA and chromatin in
eukaryotic cells. We also consider how eukaryotic cells remember and pass on to their progeny
instructions that alter chromatin configuration and patterns of gene expression—topics in the
field of epigenetics.

Learning Objectives
When you have mastered the information in this chapter, you should be able to do the
following:
1. Compare and contrast transcription factors and so-called cis-acting elements.
2. Discuss the role of DNA bending in the regulation of gene expression.
3. Explain the benefits of organizing bacterial genes into operons and why some bacterial
genes are not part of operons.
4. Compare and contrast regulation of the lac and trp operons in E. coli.
5. Define and describe regulatory genes and structural genes in E. coli.
6. Discuss why a fourth gene was suspected in lac-operon regulation.
7. Distinguish between gene repression and derepression and between positive and negative
gene regulation, using real or hypothetical examples. For example, explain how it is
possible to have repression by positive regulation.
8. Draw and label all functional regions of prokaryotic and eukaryotic genes.
9. Define and articulate the differences (if any!) between gene expression, gene regulation,
and transcription regulation.
10. Describe the transcription-initiation complex of a regulated gene in eukaryotes.
11. Define a gene.
12. Compare and contrast different mechanisms of gene regulation in eukaryotic cells.
13. Distinguish between the roles of enhancers and other cis-acting elements in transcription
regulation.
14. Compare and contrast the genome and the epigenome.

12.2

Gene Regulation in Prokaryotes: The Lactose (lac) Operon

Many prokaryotic genes are organized into operons: linked genes transcribed into a single
mRNA that encodes two or more proteins. Operons usually encode proteins with related
functions. Regulating the activity of an operon (rather than multiple single genes encoding
single proteins) allows better coordination of the synthesis of several proteins at once. In E.
coli, the regulated lac operon encodes three enzymes involved in the metabolism of lactose (an
alternative nutrient to glucose).
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Regulation of an operon (or of a single gene for that matter) may occur by repression or by
induction. When a small metabolite in a cell binds to a regulatory repressor or inducer
protein, the protein undergoes an allosteric change that allows it to bind to or to unbind from a
regulatory DNA sequence.
We will see examples of such regulation in the lac and trp (tryptophan) operons.
Regulation of the lac-operon genes is an example of gene repression as well as gene
induction. We’ll see that trp-operon regulation is by gene repression. In both operons,
changes in levels of intracellular metabolites reflect the metabolic status of the cell, eliciting
appropriate changes in gene transcription. Let’s start with a look at lac-operon regulation.

216 Overview of Prokaryotic Gene Regulation
The mRNA transcribed from the lac operon is simultaneously translated into three
enzymes, as shown in Figure 12.1.

Fig. 12.1: E. coli lac operon transcription produces a single mRNA that encodes Z, Y and A polypeptides
involved in lactose metabolism. A regulatory (lac I) gene is to the left of the operon.

12.2.1 Working Out Regulation of the lac Operon in E. coli
In the animal digestive tract (including ours), genes of the E. coli lac operon regulate the use
of lactose as an alternative nutrient to glucose. Think “cheese” instead of “chocolate”! The
operon consists of lacZ, lacY, and lacA genes, which are all structural genes.
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Structural genes encode proteins that participate in cell structure and metabolic
function. As already noted, the lac operon is transcribed into an mRNA encoding the Z, Y, and
A proteins. Let’s zoom in on a single lac operon in Figure 12.2, to see how a gene on the left
(the lac I gene) controls the transcription of all the genes in the operon.

Fig. 12.2: The lacZ, lacY, and lacA genes of the lac operon are all controlled by the single promoter to the
left of the lacZ gene. A regulatory lac I gene at the left of the operon with its own promoter.

The lacZ gene encodes β-galactosidase, the enzyme that breaks lactose, a
disaccharide, into galactose and glucose. The lacY gene encodes lactose permease, a
membrane protein that facilitates lactose entry into the cells. The role of the lacA gene
(encoding a transacetylase) in lactose energy metabolism is not well understood. The lacI
gene to the left of the lac Z gene is a regulatory gene (distinct from structural genes).
Regulatory genes encode proteins that interact with the regulatory DNA sequences associated
with a gene to control transcription. As we describe next, the operator sequence separating the
lacI and lacZ genes is a transcription-regulatory DNA sequence.
The E. coli lac operon is usually silent (repressed) because these cells prefer glucose as
an energy and carbon source. In the presence of sufficient glucose, a repressor protein (the
lacI-gene product) is bound to the operator, blocking transcription of the lac operon. Even if
lactose is available, cells will not be able to use it as an alternative energy and carbon source
when glucose levels are adequate. However, when glucose levels drop, the lac operon is
active, and the three enzyme products are translated. We will see how lac-operon transcription
by both derepression and direct induction can lead to maximal transcription of the lac genes
only when necessary (i.e., in the presence of lactose and absence of glucose). Let’s look at
some of the classic experiments that led to our understanding of E. coli–gene regulation in
general, and of the lac operon in particular.
In the late 1950s and early 1960s, François Jacob and Jacques Monod were studying
the use of different sugars as carbon sources by E. coli. They knew that wild-type E. coli would
not make the β-galactosidase, the β-galactoside permease, or the β-galactoside transacetylase
proteins when grown on glucose. Of course, they also knew that the cells would switch to
lactose for growth and reproduction if they were deprived of glucose, producing the three
enzymes of lactose metabolism. Therefore, they hen searched for, found, and isolated different
E. coli mutants that could not grow on lactose, even when there was no glucose in the growth
medium.
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Here are some of the mutants they studied:
1. One mutant failed to make active β-galactosidase but did make permease.
2. One mutant failed to make active permease but made normal amounts of β-galactosidase.
3. Another mutant failed to make transacetylase but could still metabolize lactose in the
absence of glucose. Hence the uncertainty of its role in lactose metabolism.
4. Curiously, one mutant strain failed to make any of the three enzymes!
Since double mutants are very rare and triple mutants even rarer, François Jacob and
Jacques Monod inferred that the activation of all three genes in the presence of lactose were
controlled together in some way. In fact, it was this discovery that defined the operon as a set
of genes transcribed as a single mRNA, whose expression might therefore be effectively
coordinated by a simple chemical “on-off” switch . They later characterized the repressor
protein produced by the lacI gene as this switch. F. Jacob, J. Monod, and A. Lwoff shared the
Nobel Prize in Physiology or Medicine in 1965 for their work on bacterial gene regulation. We
now know that there are several layers of lac-operon regulation. Negative and positive
regulation of the operon depends on two regulatory proteins to control the rate of lactose
metabolism.
12.2.2 Negative Regulation of the lac Operon by Lactose
Repression of lac-operon activity involves a repressor protein that must be removed for gene
expression to occur. The repressor protein product of the I gene is always made and present in
E. coli cells; expression of the I gene is constitutive, meaning it is unregulated. In the absence
of lactose in the growth medium, the repressor protein binds tightly to the operator DNA.
While RNA polymerase is bound to the promoter and ready to transcribe the operon, the
presence of the repressor protein—which is bound to the operator sequence between the RNA
polymerase and the Z-gene transcription start site—physically blocks its forward movement.
Under these conditions, little or no transcript is made. Figure 12.3 shows the lac repressor
protein in its repressed state.

Fig. 12.3: Negative regulation of the lac operon: 'Negative regulation' of the lac operon: The lac operon
in this illustration cannot be transcribed because a 'lac repressor' protein is bound to the operator
sequence between the promoter and transcription start site of the operon, blocking RNA polymerase
movement.
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If cells are grown in the presence of lactose, the lactose entering the cells is converted
to allolactose. Allolactose in turn binds to the repressor sitting on the operator DNA to form a
two-part complex, as shown in Figure 12.4.

Fig. 12.4: Negative regulation of the lac operon: If present, lactose enters cells and is converted to
allolactose. Allolactose is a lac operon inducer. if it accumulates in the cell, it will bind the lac repressor
protein and reduce its affinity for the lac operon operator sequence.

The allosterically altered repressor dissociates from the operator, and RNA polymerase can
resume transcribing the lac-operon genes (Figure 12.5).

Fig. 12.5: Negative regulation of the lac operon: Allolactose 'induces' lac gene transcription by binding to
the lac repressor. The resulting allosteric change lowers the affinity of the repressor for the operator
sequence. The repressor then dissociates from the operator sequence, allowing RNA polymerase to move
forward and transcribe a low level of the lac genes.
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12.2.3 Positive Regulation of the lac Operon: Induction by Catabolite Activation
The second control mechanism regulating lac-operon expression is mediated by CAP (cAMPbound catabolite activator protein or cAMP receptor protein). When glucose is available,
cellular levels of cAMP (cyclic AMP) are kept low in the cells, and CAP is in an inactive
conformation. On the other hand, if glucose levels are low, levels of cAMP levels go up and
bind to the CAP; CAP is then active. If lactose levels are also low, the cAMP-bound CAP will
have no effect. But, if lactose is present and glucose levels are low, then allolactose will bind to
the lac repressor, causing it to change conformation and dissociate from the operator region.
Under these conditions, the cAMP-bound CAP can bind to the operator in lieu of the repressor
protein. When this happens, rather than blocking RNA polymerase, the activated cAMP-bound
CAP induces even more efficient lac-operon transcription. The result is synthesis of higher
levels of lac enzymes, which in turn, facilitate efficient cellular use of lactose as an alternative
energy source to glucose. Figure 12.6 illustrates this maximal lac-operon activation under high
lactose and low glucose conditions.

Fig. 12.6: Positive regulation of the lac operon: If lactose is present in the absence of glucose, the operon
is derepressed AND induced. Increased cAMP binds the catabolite activator protein (CAP), which binds to
the lac operator (instead of the lac repressor protein), inducing maximal lac-gene transcription. By positive
regulation

217 Regulation of the lac Operon
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cAMP-bound-CAP is a transcription inducer. It forces DNA in the promoter-operator region to
bend (Figure 12.7).

Fig. 12.7: Positive regulation of the lac operon: the cAMP-CAP-bound operator bends the double helix.
This loosens the H-bonds between the bases, making transcription-factor access to template strands
easier. Bending the double helix to facilitate transcription is also a regulatory feature in eukaryotes.

Binding of cAMP-CAP to the double helix loosens the H-bonds between the strands, making it
easier for RNA polymerase to find and to bind the promoter and for transcription to begin.
In recent years, additional layers of gene regulation in the lac-operon have been
uncovered. In one case, the ability of lac permease to transport lactose across the cell
membrane is regulated. In another, additional operator sequences have been discovered to
interact with a multimeric repressor to control lac-gene expression. We’ll consider inducer
exclusion first.
12.2.4 lac-Operon Regulation by Inducer Exclusion
When glucose levels are high (even in the presence of lactose), phosphate is consumed to
phosphorylate glycolytic intermediates. This keeps cytoplasmic phosphate levels low. Under
these conditions, an unphosphorylated elongation factor (EIIAGlc) binds to the lactose permease
in the cell membrane, preventing the enzyme from bringing lactose into the cell. The roles of
phosphorylated and unphosphorylated EIIAGlc in regulating the lac operon are shown below in
Figure 12.8.
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Fig. 12.8: lac-operon regulation by inducer exclusion: High glucose levels accelerate glycolysis,
depleting cellular phosphate, leading to protein dephosphorylation of proteins. One such proteins is
P-EIIAGlc, a translation elongation factor). Without the phosphate, to EIIAGlc inhibits lactose
permease (the lacA protein). Lactose can’t enter cells, the lac operon is needlessly transcribed.

High glucose levels block lactose entry into the cells, effectively preventing allolactose
formation and derepression of the lac operon. Inducer exclusion is thus a logical way for the
cells to handle an abundance of glucose, whether or not lactose is present. On the other hand,
if glucose levels are low in the growth medium, phosphate concentrations in the cells rise
sufficiently for a specific kinase to phosphorylate the EIIA Glc. Then, phosphorylated EIIAGlc
undergoes an allosteric change and dissociates from the lactose permease, making it active, so
that more lactose can enter the cell. In other words, the inducer is not “excluded” under these
conditions!
The kinase that phosphorylates EIIAGlc is part of a phosphoenolpyruvate- (PEP-)
dependent phosphotransferase system (PTS) cascade. When extracellular glucose levels are
low, the cell activates the PTS system to bring whatever glucose is around into the cell. The
last enzyme in the PTS phosphorylation cascade is the kinase that phosphorylates EIIAGlc. Now
activated, phosphorylated EIIAGlc dissociates from the lactose permease. The now-active
permease can bring available lactose from the medium into the cell.
CHALLENGE: One can imagine several different mutations of the lac I gene
that one can imagine affecting crucial functions of its repressor protein
product. Hypothesize at least three such mutations and describe their
effect on the lac repressor protein, and on lac operon gene expression.
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12.2.5 Structure of the lac-Repressor Protein and Additional Operator Sequences
The lac repressor encoded by the I gene is a tetramer of identical subunits (Figure 12.9).

Fig. 12.9: Computer-generated structure of the tetrameric lac repressor, which is bound to DNA via
helix-turn-helix motifs.

Each subunit contains a helix-turn-helix motif capable of binding to DNA. However,
the operator DNA sequence downstream of the promoter in the operon consists of a pair of
inverted repeats spaced apart in such a way that they can only interact with two of the
repressor subunits, leaving the function of the other two subunits unknown…that is, until
recently! Two more operator regions were recently characterized in the lac operon. Operator 2
(O2) is within the lac Z gene itself, and O3 is near the end but still within the lac I gene. Apart
from their unusual location within actual genes, these operators, which interact with the
remaining two repressor subunits, went undetected at first because mutations in the O2 or O3
regions individually do not contribute substantially to the effect of lactose in derepressing the
lac operon. Only mutating both regions at the same time results in a substantial reduction in
the binding of the repressor to the operon.
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12.3

Gene Regulation in Prokaryotes: the Tryptophan (trp) Operon

Let’s look at two of the ways that E. coli controls cellular levels of its metabolites such
as amino acids. Recall feedback inhibition, in which the synthesis of a cellular metabolite is
inhibited when an excess of the metabolite binds to and allosterically inhibits the activity of an
enzyme in the pathway to its own synthesis (Figure 5.4). Synthesis of the amino acid
tryptophan (trp) is allosterically regulated in this way. The 5 polypeptides encoded by the trp
operon comprise the three enzymes in the trp biosynthetic pathway as shown in Figure 12.10:
holoenzyme 1 is a dimer of proteins encoded by genes 4 and 5 of the operon; enzyme 2 is a
polypeptide encoded by gene 3; holoenzyme 3 is a dimer of proteins encoded by genes 1 and
2. When cell growth slows down, the cells initially accumulate excess trp, some of which will
bind to and allosterically inhibit the dimeric holoenzyme 1, the first enzyme in the pathway.
The result of the inhibition of intermediate B production is of course, a slowdown in trp
synthesis.
Bacterial cells use a second feedback mechanism to slow down trp synthesis. During rapid
growth, the trp operon is active and will continually synthesize the amino acid. The “on” state
of the trp operon is illustrated in Figure 12.10.

Fig. 12.10: Transcription of the five-gene tryptophan (trp) operon: the five resulting proteins are enzymes
in the pathway for trp synthesis. A trp-repressor gene to the left of the operator is always transcribed.

On the other hand, if tryptophan consumption slows down, tryptophan accumulates in the
cytoplasm. Excess tryptophan will then bind to the trp repressor, a protein encoded by the
repressor protein gene. The trp-bound repressor then binds to the trp operator, blocking RNA
polymerase from transcribing the operon. The repression of the trp operon by trp is shown in
Fig. 12.11 (below). In this scenario, tryptophan is a co-repressor. The function of a corepressor is to bind to a repressor protein and change its conformation so that it can bind to the
operator.
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Fig. 12.11: When there is enough tryptophan (trp) in cells, it acts as a corepressor, binding to and
changing the conformation of the trp-repressor, which then recognizes and binds the trp-operon operator
(O), blocking RNA polymerase from moving past the promoter (P), thus repressing operon transcription.

219 Repression of the Tryptophan (trp) Operon

12.4

The Problem with Unregulated (Housekeeping) Genes in All Cells

Before we turn our attention to the regulation of gene expression in eukaryotes, consider for a
moment the expression of constitutive (i.e., unregulated, or housekeeping) genes that are
always active. The requirement that some genes always be “on” raises questions about cellular
priorities of gene expression. Constitutive gene products include sets of many polypeptides that
form large macromolecular complexes in cells; they also include enzyme sets that participate
in vital biochemical pathways. How do cells maintain such polypeptides in stoichiometrically
reasonable amounts? Or can their levels rise or fall transiently without much effect? Recent
studies suggest that transcription of housekeeping genes is, in fact, not coordinated!
We also saw that the efficiency of glycolysis relies in part on allosteric regulatory
mechanisms that evolved to control the activities of glycolytic enzymes rather than their
transcription. While this takes care of some element of metabolic control, a problem remains.
Recall that protein synthesis is energy-intensive: each peptide linkage costs three NTPs (not to
mention the waste of an additional NTP per phosphodiester linkage made in the transcription
of an mRNA!). The overproduction of proteins would seem to be a waste of energy and thus an
evolutionary “mistake.” While we may not know just how expensive it is to express
housekeeping genes, whatever the energy expenses are, they are the cost of evolving complex
structures and biochemical pathways vital to their everyday function and survival. This is a
good example of a major precept of evolutionary theory: evolution is an accumulation of
improvements brought about by (one can almost say jerry-rigged by) natural selection; it is not
the result of perfect design in advance. Now back to our focus on regulated gene expression in
eukaryotes.
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12.5

Gene Regulation in Eukaryotes

Let’s recall an experiment described earlier and illustrated in Figure 12.12.

Fig. 12.12: Replacement of an egg’s nucleus with that from an adult cell enabled the cloning of
embryos and eventually, of complete organisms. This proved that adult cells contain all the genes
required to program and to complete the development of the organism.

Results of this experiment provided the evidence that even very different cells of an
organism contain the same genes. In fact, in any multicellular eukaryotic organism, every cell
contains the same genes in their DNA. Therefore, the different cell types in an organism differ
not in which genes they contain, but which sets of genes they express! Looked at another way,
cells differentiate when they turn on new genes and turn off old ones. Thus, gene regulation
produces different sets of gene products during differentiation, leading to cells that look and
function differently in the organism.

220 An Experiment: All of an Organism’s Cells Have the Same Genome
In eukaryotes many steps lie between the transcription of an mRNA and the
accumulation of a polypeptide end-product—many more steps than occur in prokaryotes.
Eleven of these eukaryotic steps are shown below in Figure 12.13, which lays out the pathway
from gene to protein.
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Fig. 12.13: A potential to regulate cellular metabolism by controlling mRNA and/or protein levels or activity.

Theoretically, eukaryotic cells can turn on, turn off, speed up, or slow down any step(s)
in this pathway, changing the steady-state concentration of a polypeptide in the cells. But the
expression of a gene is usually controlled at only one or a few steps. As in bacteria, control of
transcription initiation is a common mechanism for regulating gene expression (in principle if
not in detail).

221-2 Many Options for Regulating Eukaryotic Genes
12.5.1 Complexities of Eukaryotic Gene Regulation
Eukaryotic gene regulation is more complex than in prokaryotes. This is in part because their
genomes are larger and because they encode more genes. For example, the E. coli and human
genomes house about five and twenty-five thousand genes respectively. Furthermore, unlike
prokaryotes, eukaryotes produce more than twenty-five thousand proteins by alternative
splicing to recombine mRNA coding regions and—in a few cases—by initiating transcription
from alternative start sites in the same gene. And of course, the activity of many more genes
must be coordinated without the benefit of multigene operons! Eukaryotic gene regulation is
also more complicated because all nuclear DNA is wrapped in protein in chromatin and
chromosomes. Last but not least, all organisms control gene activity with transcription factors
that must penetrate chromatin to bind to specific DNA sequences (cis-regulatory elements). In
eukaryotes, these elements can be proximal to (near) the promoter of a gene or distal to (quite
far from) the gene they regulate.
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Figure 12.14 maps a eukaryotic gene to show its typical components (e.g., its promoter,
introns, and exons) and its associated cis-acting regulatory elements.

Fig. 12.14: Eukaryotic regulatory DNA sequences (CIS elements) are proximal (near a gene promoter)
or distal (far from the promoter). Here, a proximal element lies just left of the gene promoter, while distal
elements (in this case, 'enhancers') lie upstream (to the left) of the promoter, downstream (to the right)
of the last exon of the gene, and in the middle of an intron. Regulatory proteins (sometimes called
'TRANS' factors) bind to proximal and distal CIS elements to control transcription of regulated genes.

Enhancers are typical distal cis elements that recognize and bind transcription factors
to increase the rate of transcription of a gene. Oddly enough, these short DNA elements can be
in the 5′ or 3′ untranslated region of the gene or even within introns, often thousands of base
pairs away from promoters and transcription start-sites of the genes they control. Upstream
regulatory regions of eukaryotic genes (to the left of a gene promoter as shown in Figure
12.14) often have distal binding sites for more than a few transcription factors, some with
positive (enhancing) and others with negative (silencing) effects. Of course, which of these
DNA regions are active in controlling a gene depends on which transcription factor(s) are
present in the nucleus. Sets of positive regulators can work together to coordinate and to
maximize gene expression when needed and sets of negative regulators may bind negative
regulatory elements to silence a gene.

222-2 Transcription Factors Bind DNA Near and Far
We saw in eukaryotes that mRNA transcription initiation involves many transcription factors
(TFs) and RNA polymerase II acting at a gene promoter to form a transcription-preinitiation
complex. TFIID (the TATA-binding protein) is one of the first factors to bind DNA in the
promoter region, causing it to bend, much like the CAP-protein in bacteria. Once bound, TFIID
recruits other transcription factors to the promoter. As in bacteria, bending DNA loosens the Hbonds between bases, facilitating unwinding of the double helix near the gene. As the
eukaryotic DNA bends, regulatory proteins on distal enhancer sequences are brought close to
proteins bound to regulatory elements that are more proximal to the promoter, as shown in
Figure 12.15 (below).
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Fig. 12.15: Assembly of a eukaryotic transcription complex on a regulated gene: distal regulatory
protein/DNA interactions can cause DNA bending, recruiting transcription-initiation factors and
proximal regulatory factors to the transcription complex to control gene expression.

Nucleotide methylation sites may facilitate regulatory protein-enhancer binding. When
such regulatory proteins, here called activators of transcription, bind to their enhancers, they
acquire an affinity for protein cofactors, which allow recognition and binding to other proteins
in a transcription-initiation complex. This results in bending the DNA, which then makes it
easier for RNA polymerase II to initiate transcription from the appropriate strand of DNA.

223-2 Assembling a Eukaryotic Transcription-Initiation Complex
It is worth reminding ourselves that allosteric (shape) changes in proteins allow DNAprotein interactions (in fact, any interaction between macromolecules). The lac repressor we
saw earlier is a transcription factor with helix-turn-helix DNA-binding motifs. This motif and
two others (zinc finger and leucine zipper) that characterize DNA-binding proteins are
illustrated in Figure 12.16.

Fig. 12.16: Three DNA-binding motifs commonly found in trans-acting (i.e., regulatory) protein factors.
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The DNA-binding motifs shown (zipper, helices, zinc fingers) bind regulatory DNA sequences
that are “visible” to the transcription factor in the major groove of the double helix.

224-2 Transcription Factor Domains: Motifs Bind Specific DNA Sequences
We will look next at some common ways in which eukaryotic cells are signaled to turn
genes on or off in order to increase or decrease their rates of transcription. As we describe
different gene regulatory strategies, remember that eukaryotic cells regulate gene expression
in response to changes in extracellular as well as intracellular environments. These can be
unscheduled, unpredictable changes in blood or extracellular fluid composition (e.g., ions and
small metabolites), or they can be changes for the long term, dictated by genetic programs of
differentiation and development. Some changes in gene expression even obey circadian (daily)
rhythms, like the ticking of a clock.
In eukaryotes, changes in gene expression, expected or not, are usually mediated by
the timely release of chemical signals from specialized cells (e.g., hormones, cytokines, and
growth factors). We will focus on some better-understood models of the gene regulation that is
caused by these chemical signals.
12.5.2 Regulation of Gene Expression by Hormones That Enter Cells and Those That Don’t
Gene-regulatory (cis) elements in DNA and the transcription factors that bind to them have
coevolved—but not only that! Eukaryotic organisms have evolved complete pathways that
respond to environmental or programmed developmental cues and that lead to an appropriate
cellular response. In eukaryotes, chemicals released by some cells signal other cells to
respond, effectively coordinating the activity of the whole organism. Hormones released by
cells in endocrine glands are well-understood signal molecules. Hormones affect target cells
elsewhere in the body.

225 Chemicals That Control Gene Expression
12.5.2.a How Steroid Hormones Regulate Transcription
Steroid hormones cross the cell membranes to have their effects. Common steroid hormones
include testosterone, estrogens, progesterone, glucocorticoids, and mineral corticoids. Once
inside the target cell, such hormones bind to a cytoplasmic or nuclear steroid-hormone
receptor protein to form a steroid-hormone-receptor complex.
CHALLENGE: Hydrophobic steroid hormones must get past a hydrophilic cell
surface before, and one after on their way through a lipoidal membrane
interior on their way into a cell? How might they do this? Also, discuss
how steroid hormones get to receptors already in the nucleus.
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The receptor may be in the cytoplasm or in the nucleus, but in the end the hormonereceptor complex must bind to DNA-regulatory elements of a gene, either to enhance or to
silence transcription. Therefore, a steroid hormone must cross the plasma membrane and may
also need to cross the nuclear envelope. You can follow the binding of a steroid hormone to a
cytoplasmic receptor in Figure 12.17. Here the hormone (depicted as a red triangle in the
illustration) enters the cell. An allosteric change in the receptor releases a protein subunit
called Hsp90 (the black rectangle). The remaining hormone-bound receptor enters the
nucleus.

Fig. 12.17: Once in a target cell, some steroid hormones bind a receptor protein in the cytoplasm,
changing its shape. The resulting hormone-receptor complex translocates to the nucleus where it acts as
a transcription factor, binding to regulatory DNA sequences to activate, repress or modulate gene
transcription. Some steroid hormones find their receptors already in the nucleus!

The fascinating thing about Hsp90 is that it was first discovered in cells subjected to
heat stress. When the temperature gets high enough, cells shut down most of transcription and
instead transcribe Hsp90 and/or other special heat-shock genes. The resulting heat-shock
proteins seem to protect the cells against metabolic damage until temperatures return to
normal. Of course, most cells never experience such high temperatures, so the evolutionary
significance of this protective mechanism is unclear. But as we now know, heat-shock proteins
have critical cellular functions, in this case blocking the DNA-binding site of a hormone
receptor until a specific steroid hormone binds to it.
Back to hormone action! No longer associated with the Hsp90 protein, the receptor
bound to its hormone cofactor now binds to a cis-acting transcription-control element in the
DNA, turning the transcription of a gene on or off. The hormone receptors for some steroid
hormones are already in the nucleus of the cell, so the hormone must cross not only the plasma
membrane but also the nuclear envelope in order to access the receptor. As for steroidhormone functions, we’ve seen their roles in activating genes for gluconeogenesis. Steroid
hormones also control sexual development and reproductive cycling in females, sexual
development and sperm maturation in males, salt and mineral homeostasis in the blood,
metamorphosis in arthropods, and more, all by regulating gene expression.

226 Steroid Hormones Regulate Gene Transcription
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12.5.2.b How Protein Hormones Regulate Transcription
Compared to steroids, proteins are large and soluble and have highly charged surfaces. Even
protein-derived hormones like adrenalin, though small, are charged and hydrophilic. Large
and/or hydrophilic signal molecules cannot get across the phospholipid barrier of the plasma
membrane. To have any effect at all, they must bind to receptors on the surface of cells.
Typically, these receptors are membrane glycoproteins. The information carried by protein
hormones must be conveyed into the cell indirectly by a process called signal transduction.
One of two well-known pathways of signal transduction is shown in the left panel in Figure
12.18.

Fig. 12.18: Some signal molecules can't enter cells. They get their message into the cell by signal
transduction. Here, a large or polar signal molecule (e.g., a hormone) binds a membrane receptor (1). The
binding changes the shape of the receptor (2), which can then bind to a cell membrane protein (3), which
becomes an activated enzyme. This enzyme catalyzes the formation of cAMP (the structure seen at the
right). cAMP binds and activates the first in a series of protein kinases (4), starting a cascade of protein
phosphorylations, a phosphorylation cascade (5) that leads to a cellular response, e.g., the transcription
regulation shown here, or changes in cytoplasmic activities.

In this pathway, the binding of the hormone to a cell-surface receptor results in
formation of cAMP, a second messenger (Figure 12.18, right panel). cAMP forms when the
hormone-receptor in the membrane binds to and activates a membrane-bound adenylate
cyclase enzyme. Once formed, cAMP binds to and activates a protein kinase to initiate a
protein phosphorylation cascade in the cytoplasm. The phosphorylation cascade is a series of
consecutive protein phosphorylations, the last of which is often an activated transcription
factor which enters the nucleus and bind to a cis-regulatory DNA sequence to turn a gene on or
off or modulate its expression. As suggested in the illustration, that last phosphorylation can
also lead to one of many different cytoplasmic responses. Whether by regulating genes or their
enzyme products, signal transduction regulate biochemical pathways to control cellular
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metabolism. cAMP was the first second-messenger metabolite to be discovered. When
hormones bind to a membrane receptor that is itself a protein kinase, hormone-receptor
binding causes an allosteric change, activating the linked receptor kinase. This starts a
phosphorylation cascade without a second messenger. The cascade ends with the activation of
a transcription factor, as illustrated in Figure 12.19.

Fig. 12.19: Enzyme-linked receptors transduce hormonal signals directly, activating receptor kinases on
the cytoplasmic cell surface, initiating a phosphorylation cascade, which lead to any of several responses.

We’ll take a closer look at signal transduction in another chapter.

227 Signal Transduction Can Lead to Gene Regulation

12.6

Regulating Eukaryotic Gene Expression Means Contending with
Chromatin

Consider again the different levels of chromatin structure, as seen in Figure 12.20. (below).
Transcription factors bind specific DNA sequences by detecting them through the grooves
(mainly the major groove) in the double helix. The drawing reminds us, however, that unlike
the nearly naked DNA of bacteria, eukaryotic (nuclear) DNA is coated with proteins that, in
aggregate, are greater in mass than the DNA that they cover. The protein-DNA complex of the
genome is, of course, chromatin. Again, as a reminder, DNA coated with histone proteins
forms the 9 nm diameter beads-on-a-string structure in which the beads are the nucleosomes.
The association of specific nonhistone proteins with the nucleosome “necklace” causes it to
fold over on itself to form the 30 nm solenoid.
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Fig. 12.20: Chromatin organization: different levels of chromatin structure result from differential
association of DNA with histone and non-histone chromosomal proteins.

As we saw earlier, it is possible to selectively extract chromatin. Take a second look at
the results of typical extractions of chromatin from isolated nuclei (Figure 12.21).

Fig. 12.21: High-salt chromatin extraction from nuclei, or high-salt treatment of 10 nm filaments,
yields 30 nm solenoid structures, essentially coils of 10 nm filaments.
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Further accretion of nonhistone proteins leads to more folding and the formation of the

euchromatin and heterochromatin seen in nondividing cell nuclei. In dividing cells, the
chromatin further condenses to form the chromosomes that separate during either mitosis or
meiosis.
Recall that a biochemical analysis of the 10 nm filament extract revealed that the DNA wraps
around octamers of histone-protein - that is, the nucleosomes (the beads) in this beads-on-astring structure. Histone proteins are highly conserved in eukaryotic evolution; they are not
found in prokaryotes. They are also very basic (having many lysine and arginine residues) and
therefore very positively charged. This explains why they can arrange themselves uniformly
along DNA, binding to the negatively charged phosphodiester backbone of DNA in the double
helix.
Since the DNA in euchromatin is less tightly packed than it is in heterochromatin, perhaps
active genes are to be found in euchromatin and not in heterochromatin. Experiments in which
total nuclear chromatin extracts were isolated and treated with the enzyme deoxyribonuclease
(DNase) revealed that the DNA in active genes was degraded more rapidly than
nontranscribed DNA. More detail on these experiments can be found at the following two
links.

228 Question: Is Euchromatic DNA Transcribed?

229 Experiment and Answer: Euchromatin is Transcribed
The results of such experiments are consistent with the suggestion that active genes
are more accessible to DNase because they are in less-coiled or less-condensed chromatin.
DNA in more-condensed chromatin is surrounded by more proteins; thus, it is less accessible
to and protected from DNase attack. When packed up in chromosomes during mitosis or
meiosis, all genes are largely inactive.
Regulating gene transcription must occur in non-dividing cells or during the interphase of
cells, times when it is easier to silence or activate genes by chromatin remodeling (i.e.,
changing the shape of chromatin). Changing chromatin conformation involves enzymecatalyzed modification of chromatin proteins and DNA. For example, chromatin can be
modified by histone acetylation, and de-acetylation, methylation, and phosphorylation
reactions, catalyzed by histone acetyltransferases (HAT enzymes), de-acetylases, methyl
transferases and kinases, respectively.
Acetylation of lysines near the amino end of histones H2B and H4 tends to unwind
nucleosomes and open the underlying DNA for transcription. De-acetylation promotes
condensation of the chromatin in the affected regions of DNA. Likewise, the methylation of
lysines or arginines (basic amino acids that characterize histones!) in H3 and H4 typically
opens DNA for transcription, while demethylation has the opposite effect. These chemical
modifications affect recruitment of other proteins that alter chromatin conformation and
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ultimately activate or block transcription. This reversible acetylation and its effect on
chromatin are illustrated in Figure 12.22 (below).

Fig. 12.22: The chemical modification of histones e.g., acetylation catalyzed by HAT enzymes (Histone
Acetyl-Transferases) shown here, can change chromatin conformation, opening or closing it to transcription.

CHALLENGE: How do you imagine enzymes that acetylate, methylate,
de-acetylate and de-methylate recognize which histones to attack?

Epigenetic alterations can also account for changes in broader features of chromatin structure.
For example, topologically associated domains (TADs) are megabase regions of DNA that
associate with each other. The boundary DNA between TADs is methylated and a CTCF
protein bound to those regions is thought to insulate the TADs from one another, minimizing
interactions between TADs. CTCF is ubiquitous in the nucleus (on chromatin at least) and
thought generally to mediate chromatin interactions at a distance. Disruption of this insulation
is seen in cancer cells and can result from mutation (e.g., of CTCF) or epigenetic alteration. In
fact, hypermethylation of the boundary DNA between TADs is associated with many cancers.
For more details, check out 12.1Epigenetic Cancer Chromatin Signatures (P. Pinoli et al., 2020).

12.7

Regulating all Genes on a Chromosome at Once

Recall that male cells have only one X chromosome and that one of the X chromosomes in
human female adult somatic cells is inactivated, visible in the nucleus as a Barr body.
Inactivation of one of the X chromosomes in Drosophila females. But both males and females
require X chromosomes gene expression during embryogenesis. At that time, given the
difference in X chromosome gene dosage between males and females, how do male embryos
get by with only on X chromosome? Experiments looking at gene dosage via the expression of
X chromosome genes in male and female flies revealed similar levels of gene products. It turns
out that a protein called CLAMP (Chromatin-Linked Adaptor for Male-specific lethal Protein)
was shown to bind to GAGA nucleotide repeats lying between the genes for histones 3 and 4.
There are about 100 repeats of the five-gene histone locus on X chromosomes, and so, about
100 GAGA repeats. All those CLAMP proteins bound to those GAGA repeats can interact with a
nuclear body called HLB (Histone Locus Body). The HLB was previously implicated in higher
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levels of X chromosome gene expression. A recent study suggests that once bound to the
GAGA sequences, CLAMP recruits MSL (Male-Specific-Lethal) proteins to form an MSL
complex. This complex (the associated HLB/CLAMP/ MSL) has been shown to boost X
chromosome gene transcription in male fruit flies. The resulting MSL protein complexes that
form then globally increase X chromosome gene expression, compensating for the lower X
gene dosage in males. Read the original research at L. E. Reider et al. (2018) Genes &
Development 31:1-15). And finally, there is emerging evidence that the HLB action may also
be involved in inactivation of an entire female X chromosome later in embryogenesis in
females!

12.8

Mechanoreceptors: Capturing Nonchemical Signals

A discussion of hormone and other signal molecule-based signal transduction is incomplete
without acknowledging mechanoreceptors on cell surfaces that respond to mechanical stimuli,
such as touch, pain, temperature, pressure, stretching, and even changes in posture. The latter
are mediated by proprioceptors (proprio, “one’s own self”), or self-awareness receptors. In
joints, they respond to changes in posture to let us know where our arms and legs are at any
given moment! Piezoreceptors (piezo, meaning “squeeze” or “press”) respond to pressure or
stretch to open a Ca++ channel, as illustrated in Figure 12.23 below.

Fig. 12.23: Extracellular pressure on a CED domain (red arrows) and activation of spring-like arms
stretch the cell membrane (green arrows) to opens a piezo-linked ion channel.

Piezoreceptors in cells lining the urinary bladder signal when the bladder is full, with the
expected response. In blood vessel endothelial cells these alert the cells to changes in blood
pressure and mediate appropriate responses. In sensory cells in the skin, piezoreceptors
enable nerve-ending responses to touch or pain. The domain structure of one piezoreceptor
protein was shown to include springy domains that could respond to mechanical forces. For
more details check out 12.2About Piezoreceptors (Lin et al., 2019). David Julius and Ardem
Patapoutian shared the 2021 Nobel Prize in Physiology or Medicine for their mechanoreceptor
research. Patapoutian discovered the Piezo1 and Piezo2 cation channels that mediate
piezoreception, and the TRPM8 cation channel for cold perception. Julius identified the TRPV1
ion channel for heat (e.g., hot pepper!) perception and independently discovered TRPM8.
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12.9

Epigenetics

Aristotle thought that an embryo emerged from an amorphous mass, a “less fully concocted
seed with a nutritive soul and all bodily parts.” The much-later development of the microscope
led to more detailed (if inaccurate) descriptions of embryonic development. In 1677, no less a
luminary than Anton van Leeuwenhoek (who first saw and described pond-water protozoa and
other animalcules), looked at a human sperm with his microscope and thought he saw a
miniature human inside! The tiny human, or homunculus, became the epitome of
preformation theory.
William Harvey, also in the 17th century, described morphological changes in the developing
embryos of chickens (and other animals). Harvey coined the term epigenesis to counter the
notion that tiny adult structures in eggs or sperm simply grew bigger during embryonic
gestation. Other experiments had led embryologists to conclude that the physical and chemical
environment of an embryo strongly affected development. Thus temperature, pH, and in the
case of chicken eggs, the position of incubation can affect embryonic development.
In a series of elegant experiments Hans Speeman reported in 1924 that cells associated with
differentiation of one region of an embryo could be transplanted to a different part of the same
embryo, or to another embryo entirely, where it would induce new tissue development. He won
the 1935 Nobel Prize in Physiology and Medicine for his discovery of embryonic organizers
that induced morphogenesis. Other embryologists showed that cells killed by freezing or
boiling still induced morphogenesis after being placed on an embryo. This clearly implicated a
role for actual chemicals in embryogenesis. The fact that differences in physical or chemical
environment could affect embryonic development led many to conclude that environment
played the dominant role and that genes played only a minor one in an organism’s ultimate
phenotype. Unlike most of his fellow embryologists, Conrad Waddington believed in a more
equitable role of genes and environment in determining phenotype. Adapting the term
epigenesis, he coined the term epigenetics to describe the impact of environment on embryonic
development (1942, The Epigenotype. Endeavour. 1: 18–20).
At the time, the concept of epigenetics led to the nature vs. nurture controversy. On the nature
side, inheritance was mainly genetic, while the nurture side gave a dominant role to
environmental chemistry. We now know that environmental differences can and do cause
individuals with the same genes (genotype) to vary in appearance (phenotype). The modern
version of the nature vs. nurture argument has more to do with complex traits. For example,
how much do genetics vs environment influence intelligence, psychology, and behavior. There
is much to-do and little evidence to resolve these questions, and likely too many factors
affecting these traits to separate them experimentally. Today, epigenetic (epi meaning ‘over’ or
above) studies look at protein interactions in eukaryotes affecting gene expression, in other
words at interactions superimposed on genes. These interactions change the structure NOT of
genes or DNA, but of the proteins (and other molecules) that affect how and when genes are
expressed. As we’ve seen, control of transcription involves transcription factors that recognize
and bind to regulatory DNA sequences such as enhancers or silencers. These protein-DNA
interactions often require selective structural changes in chromatin conformation around
genes. These changes can be profound and stable, and they are not easily undone.
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12.9.1 Epigenetic Inheritance in Somatic Cells
Examples of somatic cell epigenetics include the inheritance of chromatin protein alterations
that accompany changes in gene expression that occur in development. Given the right
signal, say a hormone at the right time, a few cells respond with chromatin rearrangements
and new patterns of gene expression that can define a cell as differentiated. Hundreds, even
thousands of changes to chromatin and gene expression accompany progress from fertilized
egg to fully mature organism. Every one of these changes in a cell is passed on to future cell
generations of cells by mitosis, accounting for the correct formation different tissues and
organs in the organism. In this way, the many different epigenomes representing our
differentiated cells are heritable. Somatic cell epigenetics is therefore the study of when and
how undifferentiated cells (embryonic and later, adult stem cells) acquire their differentiated
characteristics and how they can then pass on this information to progeny cells. As we’ll see
shortly, epigenetic inheritance is not limited to somatic cells, but can span generations!
To help us understand this new aspect of inheritance and evolution, consider JeanBaptiste Lamarck’s belief that the ancestors of giraffes had short necks but evolved longer and
longer necks because longer necks enabled them to reach food higher up in the trees. That
new character would be inherited by the next giraffe generation. According to Lamarck,
evolution was purposeful, with the goal of improvement. Later, Charles Darwin published his
ideas about evolution by natural selection, where nature selects from preexisting traits in
individuals (the raw material of evolution). The individual that just randomly happens to have
a useful trait then has a survival (reproductive) edge in an altered environment. Evolution is
thus not purposeful. Later still, with the rediscovery of Mendel’s genetic experiments, it
became clear that it’s an organism’s genes that are inherited, are passed down the generations,
and are the basis of an organism’s traits. By the start of the twentieth century, Lamarck’s
notion of purposefully acquired characters was discarded.
With this brief summary, let’s look at epigenetic inheritance across generations of
sexually reproductive species.
12.9.2 Epigenetic Inheritance in the Germline
Epigenetic inheritance implies an epigenetic blueprint in addition to our DNA blueprint. This
means that in addition to the passing on of genes from male and female parents, epigenomic
characteristics (which genes are expressed and when) are also passed on from one generation
to the next. Waddington suspected as much early on, calling the phenomenon genetic
assimilation, and once again he created controversy! Does genetic assimilation make Lamarck
right after all? Prominent developmental biologists accused Waddington of promoting
Lamarck’s notions of purposeful evolution (the idea that what is best or necessary for the
survival of an organism leads it to evolve a new gene for the purpose). Waddington and others
denied the accusation, trying to explain how epigenetic information might be heritable,
without leading to purposeful evolution. So, is there, in fact, an epigenetic code? Let’s look at
data from the small Swedish town of Överkalix that led to renewed interest in epigenetic
phenomena. Consider the meticulous harvest, birth, illness, death and other demographic and
health records collected and analyzed by L. O. Bygren and colleagues at Sweden’s Karolinska
Institute. A sample of Bygren’s data is illustrated below in Figure 12.24.
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Fig. 12.24: Summary of health, birth, death, and demographic records for the town of Överkalix.

It looked to the good doctor as if environment were influencing germline inheritance,
as if the environment were indeed causing an acquired change in the grandparent that is
passed not to one, but through two generations—and in a sex-specific way!

230 Epigenetic Inheritance: First Inkling
CHALLENGE: Discuss the implications of the data in Fig. 12.24 for the
grandchildren of grandparents who grew up in hard times.
This phenomenon was subsequently demonstrated experimentally. For example, rat
pups born to rats exposed to a toxin while pregnant, suffered a variety of illnesses. This might
be expected if the toxic effects on the mother were visited on the developing pups (e.g.,
through the placenta). However, when the diseased male rat pups matured and mated with
females, the pups in the new litter grew up suffering the same maladies as the male parent.
This was the case even though the pregnant females were not exposed to the toxins. Because
the original female was already pregnant when she was exposed, the germline cells (eggs and
sperm) of her litter had not suffered mutations in utero. This could only mean that the
epigenetic patterns of gene expression caused by the toxin in pup germline cells (those
destined to become sperm and eggs) in utero were retained during growth to sexual maturity,
to be passed on to their progeny even while gestating in a normal, unexposed female.

231-2 Experimental Demonstration of Germ-Line Epigenetic Inheritance
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For some interesting experimental findings on how diet influences epigenetic change in
Drosophila, look at 12.3Diet and a Heritable Fly Epigenome. For an amusing (but accurate) take
on epigenetics, check out the YouTube at 12.4Epigenetics Explained!. So, given the reality of
epigenetic inheritance, let’s consider a most intriguing question: Is epigenetic inheritance
(like Mendelian genetic inheritance) the result of natural selection?
Several studies have correlated adverse conditions during pregnancy in animals (including
humans) with high incidences of health, behavioral and other anomalies in the adults. This
was the case in Holland for children and grandchildren of mothers pregnant during the famine
of the last winter of WWII, a season that became known as the Dutch Hunger Winter of 19441945. As adults, these descendants had higher incidences heart disease, obesity, and diabetes.
Such correlations were attributed to epigenetic changes in embryonic DNA in utero (read more
at 12.5Dutch Grandkids After the Hunger Winter.
Here is the question that should occur to us: Why should so many survivors of life in an
undernourished womb have suffered the same epigenetic changes at the same time? A study
of methylation patterns in specific DNA regions in survivors of Dutch Hunger Winter
pregnancies and a control group that missed the famine suggests an intriguing answer. The
study found unique DNA methylation patterns in the surviving adults. To explain the survival
of so many newborns that then suffered adult health anomalies, it was suggested that
epigenetic modifications occur at random in embryos…, and then that some of these (i.e., the
ones that marked the suffering adults) were selected during the pregnancy because they
actually conferred a survival advantage to embryos (see a more complete discussion at
12.6
Natural Selection in utero).
Did the many cases of epigenetic inheritance by large cohorts of individuals result from
survival advantages of epigenetic natural selection? In other words, could epigenetic
inheritance be subject to natural selection in the same way as genetic inheritance…, with more
complex results?
These days, the term epigenetics describes how heritable change in chromatin modification
(chromatin remodeling) affects gene expression. We now know that epigenetic configurations
of chromatin that are most stable include modifications such as acetylation, phosphorylation,
methylation of histones and methylation and phosphorylation of DNA. Such changes can
convert the 30nm fiber to the 10 nm ‘beads-on-a-string’ nucleosome necklace… and vice versa.
Chromatin remodeling can also lead to altered patterns of gene expression, whether during
normal development or when caused by environmental factors such as abundance or limits on
nutrition, toxins/poisons, or other life-style choices.
The active study of DNA methylation patterns even has its own name, methylomics! Check out
12.7
Epigenetics Nomenclature for more epigenetic nomenclature. Let’s close this chapter with
some socially, culturally, and personally relevant observations and questions.
If environmental causes of epigenetic change persist in a unique or isolated location or
demographic, could the natural selection of epigenetic traits result in geographic or
demographic differences in epigenetic characters just as it has done for genetic characters?
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Can we trace an epigenetic ancestry in the same way as our genetic one? That seems to be the
case from recent comparisons of methylation patterns of DNA between Mexican and Puerto
Ricans of Hispanic origin. DNA regions known to be sensitive to diesel emissions or intrauterine exposure to tobacco (and even social stressors) were differentially methylated in the
two groups. Read more about this at 12.8Heritable Effects of Environmental Exposure
Now think about the epigenetic consequences of smog that Los Angelinos endured and of lead
toxicity to folks drinking lead-laden water in Flint Michigan (especially in children) the
epigenetic effects of which remain to be seen. As you can see, epigenetics remains a hot topic,
with much more yet to be concerned about! If environmental causes of epigenetic change
persist in a unique or isolated location or demographic, could the natural selection of
epigenetic traits result in geographic or demographic differences in epigenetic characters, just
as it has done for genetic characters? Can we trace an epigenetic ancestry in the same way as
our genetic one? That seems to be the case in a recent comparison of DNA methylation
patterns between Mexicans and Puerto Ricans of Hispanic origin. The study revealed that
DNA regions known to be sensitive to diesel emissions or intra-uterine exposure to tobacco
(and even social stressors) were differentially methylated in the two groups. See details of this
study at 12.9Epigenetics of Culture and Ethnicity.
Finally, thinking about epigenetic selection of clearly harmful traits, can we start to see them
as analogous to the genetic selection of, say, β-globin gene mutations for sickle cell anemia
that confer a survival advantage in one context (the threat of malarial parasites in mosquitoes),
but that are harmful in another?
Here’s a bottom line you cannot avoid! Can you be sure that your smoking habit will not affect
the health of your children or grandchildren? What about eating habits? Drinking? It is not just
a little scary to know that I have a gullible germline epigenome that can be influenced by my
behavior, good and bad, and that my children (and maybe grandchildren) will inherit my
epigenetic legacy long before they get my house and money. And even that may not be the
limit; epigenetic memory in Caenorhabditis elegans can stretch to as many as 24 generations!
(12.10Epigenetic Memory in C. elegans) Also, read about epigenetic inheritance resulting from
Dad’s cocaine use 12.11Sins of the Fathers.

CHALLENGE: Chemical modification of DNA and chromatin proteins
explains active euchromatin vs mostly inactive heterochromatin. It now
seems that subtle physicochemical forces also lie behind interactions of
chromatin regions that pack 2 meters of DNA into a 6 m nucleus (see
The Physics of Chromatin Folding or 12.13Chromatin Dynamics for more).
While chromatin folding affects gene expression, interactions of chromatin
domains also correlates with recombinations to rearrange lymphocyte gene
12.12

segments that create antibodies of the immune response (12.14Rearranging
Immunoglobulin Genes). Since unwanted chromatin remodeling may cause
disease, it must be stable as well as responsive to cell status. In what
circumstances could chromatin folding result in epigenetic inheritance?
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Chapter 13:

Posttranscriptional Regulation of Gene Expression

Regulating gene expression with short and long noncoding RNAs, CRISPR-Cas, and protein
phosphorylation; controlling gene expression by regulating translation
Reminder: For inactive links, google key words/terms for alternative resources.

13.1

Introduction

The metabolic potential of cells is flexible, depending on various mechanisms that ultimately
determine the levels and activities of the proteins that dictate a cell’s metabolic state. We have
seen some of these regulatory mechanisms:
•

Extracellular chemical signals or developmental chemical prompts that regulate
transcription.

•

Allosteric regulation by cellular metabolites and chemical modification, (e.g., by
phosphorylation or dephosphorylation) can control the activity of enzymes or other proteins.

In this chapter, we look at different kinds of posttranscriptional regulation, events that
take place sometime between mRNA transcription and the maturation of the biological protein
activity of a protein. These control mechanisms are most diverse in eukaryotes. Like other
pathways for regulating gene expression, posttranscriptional regulation begins with
extracellular chemical signaling. Responses include changes in the rate of polypeptide
translation and changes in macromolecular turnover rate, such as changes in the half-life of
specific RNAs and proteins in cells.
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Regardless of mechanism, each up- or down-regulation of (i.e., increase or decrease in)
gene expression contributes to changes in the steady state of a particular RNA or protein
required for proper cell function. In considering posttranscriptional regulation, we will see how
cells use specific proteins and different noncoding RNA transcripts to target unwanted proteins
or RNAs for degradation.

Learning Objectives
When you have mastered the information in this chapter, you should be able to do the
following:
1. Explain what it is about C. elegans that makes it a model organism for studying the
development and regulation of gene expression.
2. Compare and contrast the origins and functions of miRNA and siRNA.
3. Search for examples of the miRNAs, siRNAs, lncRNAs, and circRNAs that regulate the
expression of specific genes, and explain their mechanisms.
4. Explain how a riboswitch functions to control bacterial gene expression.
5. Explain the evolutionary origins and roles of the bacterial CRISPR-Cas immune system
components.
6. Explain how eif2 activity is modulated to coordinate a red cell’s heme and globin levels.
7. Describe how eukaryotic cells degrade unwanted proteins and speculate on how bacteria
might do so.
8. Answer the question, “How did junk DNA arise?”
9. Explain ways in which so-called “junk DNA” has value.

13.2

Posttranscriptional Control of Gene Expression

Not too long ago, we thought that very little of the eukaryotic genome was ever transcribed.
We also thought that the only noncoding RNAs were tRNAs and rRNAs. Now we know that
other RNAs play roles in gene regulation and in the degradation of spent cellular DNA or
unwanted foreign DNA. These are discussed in detail next.
13.2.1 Riboswitches
The riboswitch is a bacterial transcription mechanism for regulating gene expression. While
this mechanism is not specifically posttranscriptional, it is included here because the action
occurs after transcription initiation and aborts the completion of an mRNA. When the mRNA
for an enzyme in the guanine synthesis pathway is transcribed, it folds into stem-and-loop
structures. Enzyme synthesis will continue for as long as the cell needs to make guanine. But if
guanine accumulates in the cell, excess guanine will bind stem-loop elements near the 5’ end
of the mRNA, causing the RNA polymerase and the partially completed mRNA to dissociate
from the DNA, prematurely ending transcription.
The ability to form folded stem-loop structures at the 5’ ends of bacterial mRNAs seems
to have allowed the evolution of translation-regulation strategies. Guanine interaction with the
stem-loop structure of an emerging 5′ mRNA can abort its own transcription; similarly, small
metabolite/mRNA and even protein/mRNA interactions can also regulate (in this case prevent)
translation. The basis of guanine riboswitch-regulation of the expression of a guaninesynthesis pathway enzyme is shown below in Figure 13.1.
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Fig. 13.1: Bacterial guanine riboswitch: The “switch” is the action of an mRNA encoding an enzyme in
the guanine-synthesis pathway. Excess guanine binds and distorts the stem-loop structure of the mRNA,
causing termination of further gene transcription.

As we will see shortly, 5’ mRNA folded structures also play a role in eukaryotic
translation regulation.

232 Riboswitches Interrupt Bacterial Transcription

233 Small Metabolites Also Regulate Bacterial mRNA Translation
13.2.2 CRISPR/Cas: A Prokaryotic Adaptive Immune System
In higher organisms, the immune system is adaptive. It remembers prior exposure to a pathogen
and can thus mount a response to a second exposure to the same pathogen. The discovery of an
“adaptive immune system” in many prokaryotes was therefore something of a surprise.
The CRISPR story begins in 1987 in Japan, with the discovery by Y. Ishino (et al.) of a
cluster of regularly interspaced short palindromic DNA sequences in E. coli. Clustered DNA
repeats were known, of course, but they were always consecutive and uninterrupted by other
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sequences (think rRNA genes). Ishino’s cluster was (at the time) of unknown origin and
function.

233a Discovery of the CRISPR Phenomenon
In 1993 similar clustered repeats were found in several strains of Mycobacterium
tuberculosis (the cause of tuberculosis), but the interspaced sequences interrupting the
palindromic repeats differed between the strains. By 2001 these clustered, interrupted repeats,
by then found in many prokaryotes (both bacterial and archaebacterial), were named CRISPR
(Clustered Regularly Interspaced Short Palindromic Repeats).
The discovery of an array of Cas-gene repeats was linked to some of the CRISPR
repeats in 2002. This was followed in 2005 by the revelation that some of the interspaced
sequences were derived from nonhost origins, specifically phage DNA and plasmids, and in
the same year, the protein encoded by the Cas gene was shown to have helicase and nuclease
activity. This led to a suggestion that CRISPR and Cas were part of a bacterial adaptive
immune system, a bacterial response to phage infection or other invasive DNA and (for the
lucky bacterial survivor), a protective mechanism against a second infection! In 2012 Jennifer
Doudna and Emmanuelle Charpentier realized that the CRISPR/Cas9 system in streptococcal
bacteria might be able to rapidly and accurately edit any DNA sequence, including genomic
DNA…, and then proceeded to prove it! Let’s look more closely at CRISPR and Cas DNAs to
see how they work as an adaptive immune system and how they can be used to edit DNA.

CRISPR RNAs are derived from phage transcripts that have interacted with CRISPRassociated (Cas) proteins. They make up the CRISPR/Cas system, which seems to have
evolved to fight off viral infections by targeting phage DNA for destruction. When viral DNA
gets into a cell during a phage infection, it can generate a CRISPR/Cas-gene array in the
bacterial genome, with spacer DNA sequences separating repeats of the CRISPR genes. These
remnants of a phage infection are the memory of this prokaryotic immune system. When a
phage attempts to re-infect a previously exposed cell, spacer RNAs and Cas genes are
transcribed. After Cas mRNA translation, the Cas protein and spacer RNAs will engage and
target the incoming phage DNA for destruction to prevent infection. CRISPR/Cas systems
(there are more than one!) remember prior phage attacks and transmit that memory to progeny
cells. The CRISPR/Cas9 system in Streptococcus pyogenes is one of the simplest of the
CRISPR/Cas immune defense systems (Figure 13.2).

Fig. 13.2: The array of CRISPR/Cas9 genes in S. pyogenes, including a tracr gene, multiple Cas9
genes, CRISPR DNA repeats separated by phage-derived spacer DNA, and a last Cas9 gene. The
phage-derived spacer DNAs are relics from the survival of an earlier phage infection.
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The CRISPR/Cas gene array consists of the following components:
•
•
•

Cas: Genes native to host cells
CRISPR: Twenty-four to forty-eight base-pair repeats native to host cells
Spacer DNA: DNA between CRISPR repeats—typically, phage DNA from prior phage

infection or plasmid transformation
Leader DNA: DNA containing a promoter for the transcription of CRISPR/spacer RNA
tracr gene: Gene encoding a transcription-activator (tracr) RNA (but not included in all
systems)
Let’s look at CRISPR/Cas in action.
•
•

13.2.2.a The CRISPR/Cas “Immune” Response
Consider the mechanism of action of this prokaryotic immune system. The action begins when
infectious phage DNA gets into the cell (Figure 13.3).

Fig. 13.3: Activation of the CRISPR/Cas9 array

Let’s summarize what has happened here:
• Incoming phage DNA was detected after phage infection (1).
• The tracr (2) and Cas9 (3) genes are transcribed, along with the CRISPR/phage-derived
spacer region (4). Cas9 mRNAs are then translated to make the Cas9 protein. Remember, the
spacer DNAs in the CRISPR region are the legacy of a prior phage infection.
• CRISPR/phage-derived spacer transcripts forms H-bonds with a complementary region of the
tracr RNA (5) and the hybridized RNAs associate with Cas9 proteins (6).
• Cas9 endonucleases hydrolyze spacer RNA from CRISPR RNA sequences (7). The spacer
RNAs remain associated with the complex, while the actual, imperfectly palindromic CRISPR
sequences (shown in blue in the illustration) fall off.
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In the next steps we’ll look at how phage-derived spacer DNA from a prior infection protect
progeny bacteria from a new phage infection. When transcribed, these spacer RNAs are now
called guide RNAs (gRNAs). They will guide mature Cas9/tracr-RNA/spacer RNA complexes to
the new incoming phage DNA. Figure 13.4 illustrates these events and subsequent events.

Fig. 13.4: Phage spacers in a CRISPR/Cas9 array (derived from an earlier phage infection) protect
against phage re-infection.

Once again, let’s summarize:
a)
b)
c)
d)

Spacer RNA (i.e., gRNA) in the complex targets incoming phage DNA.
Cas helicase unwinds the incoming phage DNA at complementary regions.
gRNA H-bonds to the incoming phage DNA.
Cas endonucleases create a double-stranded break (hydrolytic cleavage) at specific sites in
the incoming phage DNA. Because precise cleavage is guided by RNA molecules,
CRISPR/Cas endonucleases are classified as type V restriction enzymes.
e) The incoming phage DNA is destroyed, and a new phage infection is aborted.
Check out 13.1More About CRISPR to learn more about how bacteria acquire spacer DNAs (and
therefore how this primitive adaptive immune system “remembers”) in the first place.
13.2.2.b Using CRISPR/Cas to Edit/Engineer Genes
Early studies demonstrated the reproducible cleavage of incoming phage DNA at specific
nucleotides. Several labs quickly realized that it might be possible to adapt the system to cut
DNA at any specific nucleotide in a target DNA!
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It has turned out that the system works both in vivo and in vitro, allowing virtually
unlimited potential for editing genes and RNAs in a test tube—or in any cell. Here is the basic
process:
a) Engineer gDNA with a Cas-specific DNA sequence that targets a desired target in
genomic DNA.
b) Fuse the gDNA to tracr DNA to make a single guide DNA (sgDNA), so that it can be made
as a single guide transcript (sgRNA).
c) Engineer a CRISPR/Cas9 gene array that substitutes this sgDNA for its original spacer
DNAs.
d) Place the engineered array into a plasmid next to regulated promoters.
e) Transform cells by “electroporation”—which works for almost any cell type!
f) Activate the promoter to transcribe the CRISPR/Cas9 genes….
For demonstrating the power of CRISPR-Cas precision gene editing, Jennifer Doudna and
Emmanuelle Charpentier earned the 2020 Nobel Prize for Chemistry. The applications are
indeed powerful… and controversial!
13.2.2.c CRISPR—The Power and the Controversy
The application of gene editing with CRISPR/Cas systems has already facilitated studies of
gene function in vitro, in cells and in whole organisms. For a description of CRISPR/Cas
applications already on the market see 13.2CRISPR Apps from NEB. The efficiency of specific
gene editing using CRISPR/Cas systems holds great promise for understanding basic gene
structure and function, for determining the genetic basis of disease, and for accelerating the
search for gene therapies.
Here are a few examples of how CRISPR/Cas editing is being applied.
•

One can now engineer an sgRNA with mutations that target specific sites almost anywhere
in chromosomal DNA. The sgRNA is cloned into the CRISPR/Cas9 array on a plasmid.
After transformation of appropriate cells, the engineered CRISPR/Cas9 forms a complex
with target-DNA sequences. After both strands of the target DNA have been nicked, DNA
repair can insert the mutated guide sequences into the target DNA. The result is loss or
acquisition of DNA sequences at specific, exact sites, or precision gene editing. The ability
to do this in living cells has excited scientists in both the basic and clinical research
communities.

•

Before transforming cells, one can engineer the CRISPR/Cas9 gene array onto the plasmid
to eliminate both endonuclease activities from the Cas protein. Upon transcription of the
array in transformed cells, the CRISPR/Cas9-sgRNA still finds an sgRNA-targeted gene.
However, lacking Cas protein endonuclease activities, the complex that forms just sits
there blocking transcription. This technique is sometimes referred to as CRISPRi (CRISPR
interference), by analogy to RNA interference or RNAi (see section 13.2.3.a below). Applied
to organisms (and not just in vitro or to cells), it mimics the much more difficult knockoutmutation experiments that have been used in studies of the behavior of cells or organisms
that have been made unable to express a specific protein.
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Several newer, highly efficient CRISPR/Cas systems are exciting prospects for rapid,
targeted gene therapies to fight disease and their potential to alter entire populations using
gene drive technologies (see 13.3Gene Drive) to insert modified genes into germline cells of a
target organism. Gene drive could eliminate pesticide resistance in unwanted insects and
herbicide resistance in undesirable plants. It could even erase whole mosquito or invasive
species populations. For a recent proof-of-concept research, see Kryou et al. (2018) A CRISPRCas9 Gene Drive Targeting doublesex Causes Complete Population Suppression In Caged
Anopheles gambiae Mosquitoes. Nat. Biotech. 1062-1066. But the use of CRISPR-based gene
drive to control populations is also controversial (see J. Adler, (2016) A World Without
Mosquitoes. Smithsonian, 47, 36-42).
•

It is possible to edit out, i.e., delete an entire chromosome from cells. This bit of “global”
genetic engineering depends on our ability to identify multiple unique sequences on a
single chromosome and then to target these sites for CRISPR/Cas treatment. When the
system is activated, the chromosome is cut at those sites, fragmenting it beyond the
capacity of DNA-repair mechanisms to fix the situation. Imagine the possibilities for
therapeutically removing from a human genome, aneuploidies—for example, extra
chromosomes such as those found in trisomy 21 (the cause of Down syndrome) or those
correlated with some cancers. See 13.4CRISPR/Cas9 Deletes Whole Chromosome to learn
more.

•

For yet another twist on CRISPR power, check 13.5CRISPR-Based Gene ID in Fixed Cell
Chromatin to read about a technique to identify and to locate specific DNA sequences in
cells without disturbing chromatin structure.
CHALLENGE: Think of some examples of how CRISPR-based localization
of a gene in intact chromatin might be useful.

As with any powerful technique (or powerful person for that matter!), behind the power
as you might guess, lurks a dark side. The “dark side” of the CRISPR/Cas (and the related
newer gene-editing technologies) was quickly recognized by its practitioners, most notably
Jennifer Doudna herself. If for no other reason than its efficiency and simplicity, applications
of CRISPR for precision gene editing has raised ethical issues. Clearly the potential exists for
abuse or even for use with no beneficial purpose at all, and the availability of CRISPR kits only
intensifies the concerns. We can be hopeful that, as in all discussions of biological ethics,
scientists are very much engaged in the conversation. Listen to Doudna talk about CRISPR
and its potential to do good in the world and its potential to be abused by the foolish and
unscrupulous (13.6Dr. Doudna Talks About CRISPR).
We will no doubt continue to edit genes with CRISPR-based technologies, But if you
still have qualms, maybe RNA editing will be a useful alternative. Check out the link at 13.7Why
Edit RNA? for an overview of the possibilities! As a final point, “mice and men” (and women
and babies too) have antibodies to Cas9 proteins, suggesting prior exposure to microbial
CRISPR/Cas9 antigens. This observation may limit clinical applications of the technology! See
13.8
Uncertain Future of CRISPR/Cas9 Technology.
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13.2.3

The Small RNAs: miRNA, siRNA and piRNA in Eukaryotes

Micro RNAs (miRNAs) and small interfering RNAs (siRNAs) are found in Caenorhabditis
elegans, a small nematode (roundworm) that quickly became a model for studies of cell and
molecular biology and development. You can see this roundworm in the fluorescence
micrograph in Figure 13.5.

Fig. 13.5: Anatomy of the roundworm Caenorhabditis elegans.

What are the attractions of C. elegans? Its ~21,700 genes are comparable to the ~25,000 genes
in a human genome, its gene products produce an adult worm consisting of just 1,031 cells,
these few cells are organized into all of the major organs found in higher organisms, and
finally, it’s possible to trace the embryonic origins of each adult cell!
13.2.3.a Small Interfering RNA (siRNA)

siRNA was first found in plants and in C. elegans. But they are common in many higher
organisms. siRNAs were so named because they interfere with the function of other RNAs
foreign to the cell or organism. Their action was dubbed RNA interference (RNAi). For their
discovery of siRNAs, A. Z. Fire and C. C. Mello shared the 2006 Nobel Prize in Physiology or
Medicine. Figure 13.6 (below) illustrates the action of siRNA targeting foreign DNA.
When cells recognize foreign double stranded RNAs (e.g., some viral RNA genomes)
as alien, a nuclease called dicer hydrolyzes them. The resulting short, double-stranded
hydrolysis products (the siRNAs) combine with RNAi Induced Silencing Complex or RISC
proteins. The antisense siRNA strand in the resulting siRNA-RISC complex then binds to
complementary regions of foreign RNAs, targeting them for degradation. Cellular use of RISC
to control gene expression in this way may have derived from the use of RISC proteins by
miRNAs as part of a cellular defense mechanism, to be discussed next.
Custom-designed siRNAs have been used to disable the expression of specific genes to
study their function in vivo and in vitro. Both siRNAs and miRNAs are being investigated as
possible therapeutic tools to interfere with RNAs whose expression leads to cancer or other
diseases.
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Fig. 13.6: siRNAs (small interfering RNAs) form after a dicer nuclease recognizes and digests foreign
RNA into (siRNAs) short digest fragments (1) that bind to RISC protein to form a single-stranded
siRNA-RISC complex (2). The complex then finds and H-bonds to complementary sequences in
remaining foreign RNA (3), targeting them for destruction by the RISC nuclease (4).

234 siRNA Posttranscriptional Regulation

235 Did siRNA Co-opt RISC as a Strategy to Trash, Corrupt, or Wear Out RNA?
Check out the unexpected results of an experiment in which RNAi was used to block
embryonic expression of the orthodenticle (odt) gene that is normally required for the growth
of horns in a dung beetle. See the results at 13.9Genetically Modified Beetles Grow a Functional
3rd Eye. As expected, this knock-out mutation blocked horn growth. What was unexpected
however was the development of an eye in the middle of the beetle’s head (the “third eye” in
the micrograph). The third eye not only looks like an eye but also functions as one. This was
demonstrated by preventing normal eye development in odt-knockout mutants. The third eye
was responsive to light! Keep in mind that this was a beetle with a third eye, not Drosophila!
Sometimes, especially with new technologies, we can learn as much by studying an
unexpected critter as from a model research organism!
13.2.3.b Micro RNAs (miRNA)
miRNAs are widely distributed in eukaryotes, where they target unwanted endogenous cellular
RNAs for degradation. After transcription, pre-miRNAs fold into hairpin loop structures that
bind to protein complexes made up of DGCR8, RNAse III (among others), They are then
processed into mature miRNAs. Like SiRNAs, mature miRNAs combine with RISC proteins.
The RISC-protein/miRNA complex targets damaged or obsolete mRNAs. An estimated 250

291

miRNAs in humans may be sufficient to H-bond to diverse target RNAs; only targets with
strong complementarity to a RISC-protein/miRNA complex will be degraded. Figure 13.7
shows the pathway from the transcription of a pre-miRNA, its processing, and ultimately to
targeting unwanted mRNA for degradation.

Fig. 13.7: Formation and mechanism of action of miRNA (micro-RNA). miRNAs degrade unwanted
(e.g., damaged or old) RNA. RISC protein genes are expressed and combine with mature miRNAs
to form a RISC-Induced Silencing Complex that targets unwanted mRNAs for destruction.

236 miRNA Posttranscriptional Regulation
A recent study found that mutant embryonic stem cells (ESCs) unable to make the DGCR8 also
fail to differentiate normal neurons, suggesting a role for miRNA in embryonic development.
An experiment was designed to ask if the mutant DGCR8 protein disrupted development in
some novel way, or just by inhibiting pre-mi-RNA processing. An miRNA look-alike (mi-R-302)
was engineered that did not bind DGCR8 and thus, was not processed. When the mi-R-302
was introduced into the mutant ESCs, these cells went on to differentiate into neuronal cells,
even though the look-alike molecule was not processed. confirming the involvement of miRNA
in development.
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Challenge: miR-302 rescues mutant ESCs by bypassing the pre-miRNA
processing step… Why then process miRNA in the first place!!?

13.2.3.c Piwi-Interacting RNAs
By some estimates, PIWI-Interacting RNA (piRNA) is the largest separate class of non-coding
small RNA. It was first shown to be involved in destroying transposon transcripts to abort
transposition. The basics of piRNA synthesis and action in D. melanogaster are illustrated in
Fig. 13.8 below.

Fig. 13.8: PiRNA is transcribed from clustered Pi genes. PiRNAs associate with nuclear proteins, to
be exported, proteins and all, to the cytoplasm (starting upper right, (thick blue arrows). In the
cytoplasm, PiRNA engages with a Zuc protein. Thereafter, PiRNA follows one of two pathways
(black arrows labeled 1 or 2) to block transposition in D. melanogaster testis, illustrated here

The synthesis of piRNAs (follow the thick blue arrows) begins when the nascent primary
piRNAs transcribed from a piRNA gene cluster associate with proteins. Those proteins
remaining on the transcript after export to the cytoplasm are exchanged for a zucchini (Zuc)
nuclease. Primary piRNA is then hydrolyzed to generate the mature piRNA. piRNA blocks
transposition by two pathways (black arrows 1 and 2). In pathway 1, Zuc nuclease cleaves
primary piRNA to make mature piRNA, which is picked up by the Piwi protein. The latter
joins other proteins on the nascent transposon mRNA, activating Eggless (Egg), a histone
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methyltransferase. This enzyme catalyzes methylation of a histone to remodel chromatin to
heterochromatin, thereby silencing further transposon mRNA transcription. In pathway 2,
nascent transposon mRNA associates with proteins that target the mRNA for cytoplasmic
destruction. In the cytoplasm, the transposon mRNA is captured by the Argonaute Aub
(aubergine) protein by hybridization to complementary sequences in mature piRNA, a portion
of which has already been transferred from Zuc to the AUB protein. The transposon mRNA is
then digested, preventing actual transposition. Now, a remaining transposon mRNA fragment
is transferred to Ago3 (Argonaute-3), where it can hybridize to complementary sequences in
intact primary piRNA from Zuc and then digest it to mature piRNA. Aub and Ago-3 are part of
a ping-pong cycle. The ping-pong cycle is an alternate source of piRNA for the Aub protein,
while Zuc-mediated maturation of piRNA is the fork leading to the two pathways that block
transposition. Like siRNAs and miRNAs, piRNAs also use a RISC pathway to degrade
unwanted RNAs, notably in germline cells. Learn more about piRNA at 13.10PIWI-Interacting
RNA and 13.11PIWI Proteins and PIWI-Interacting RNA.
13.2.4 Long Noncoding RNAs
Long noncoding RNAs (lncRNAs) are a yet another class of noncoding eukaryotic RNAs. The
latter include transcripts of antisense, intronic, intergenic DNAs, as well as of pseudogenes
and retroposons (pseudogenes are recognizable but mutant genes whose transcripts are
nonfunctional; retroposons are one kind of transposon or mobile DNA element). While some
lncRNAs might turn out to be incidental transcripts that the cell simply destroys, others have a
role in regulating gene expression. A recently discovered lncRNA is XistAR, which—along
with its gene product, Xist—is required to form Barr bodies. Recall that Barr bodies form in
human females when one of the X chromosomes in somatic cells is inactivated. For a review of
lncRNAs, see Lee, J. T. (2012. Epigenetic Regulation by Long Noncoding RNAs; Science 338,
1435-1439).
CHALLENGE: CRISPR editing of embryos might eventually be used to
prevent the mutation causing the formation of the extra X chromosome of
trisomy 21 (preventing Down syndrome). Explain how this could be done,
in principle.
A recent article (at 13.12lncRNAs and smORFs) summarizes the discovery that some
long noncoding RNAs contain short open reading frames (smORFs) that are actually translated
into short peptides of at as many as thirty amino acids! Who knows? The human genome may
indeed contain more than twenty-one thousand to twenty-five thousand protein-coding genes
after all!
13.2.5 Circular RNAs (circRNA)
Though discovered more than twenty years ago, circular RNAs (circRNAs) are made in
different eukaryotic cell types. Look at 13.13Circular RNAs-circRNA) to learn more about this
peculiar result of alternative splicing. At first circRNAs were hard to isolate. When they were
isolated, they contained “scrambled” exonic sequences and were therefore thought to be
nonfunctional errors of mRNA splicing. In fact, circRNAs are fairly stable. Their levels can rise
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and fall in patterns suggesting that they are functional molecules. Levels of one circRNA,
called circRims1, rise specifically during neural development. In mice, other circRNAs
accumulate during synapse formation, likely influencing how these neurons will ultimately
develop and function.
Thus, circRNAs don’t appear to be “molecular mistakes.” In fact, errors occurring during their
synthesis may be correlated with disease! Speculations about circRNA functions include roles
in gene regulation, particularly regulation of the genes or mRNAs from which they themselves
are derived.

13.3

“Junk DNA” in Perspective

Not long ago we thought that less than 5% of a eukaryotic genome was transcribed (i.e., as
mRNA, rRNA, and tRNA), and that much of the nontranscribed genome served either a
structural function or no function at all! That “functionless” genetic material, labeled “junk
DNA,” included nondescript intergenic sequences, mutant pseudogenes, “dead” transposons,
long stretches of intronic DNA, and more. Thus, junk DNA was defined as DNA we could do
without. Junk DNAs were thought to be accidental riders in our genomes, hitchhikers picked
up on the evolutionary road. But while miRNA genes are a small proportion of a eukaryotic
genome, their discovery—and that of more abundant lnc RNAs—suggests a far greater amount
of functional DNA in the genome.
Might there be, in fact, no such thing as “junk DNA”?
The debate continues. Read all about it at 13.14Junk DNA—Not so useless After All and
13.15
Only 8.2% of Human DNA is Functional. Perhaps we should rethink what it means for
DNA to be “junk”, without “genetic purpose”, since more than 90% of our DNA has no known
genetic purpose, and its maintenance surely comes at an energy cost.
At the same time, all our DNA is grist for future selection, a source of the diversity
required for long-term survival. The same natural selection that picks up “hitchhiker” DNA
sequences, as we have seen, can at some point put them to work!

13.4

The RNA Methylome

You can think call this an RNA epitranscriptome if you like! Recall that methyl groups direct
the cleavage of ribosomal RNAs from eukaryotic 45S pre-RNA transcripts. tRNAs (among other
transcripts) are also posttranscriptionally modified. In the absence of a known function, these
modifications were thought to be nonfunctional. But are they?

CHALLENGE: Demethylating enzymes that
from mRNAs, tRNAs and lncRNAs suggest
on-off switches may control translation.
expression by the epitranscriptome benefit
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remove specific methyl groups
that methylation/demethylation
How might regulation of gene
an organism?

13.5

Eukaryotic Translation Regulation

Messenger RNAs (mRNAs) are made to be translated, and so they are! Nonetheless,
translation is regulated, largely by controlling translation initiation. Let’s be reminded about
the basics of eukaryotic initiation.
In many respects, the overall process is similar to prokaryotic translation initiation, described
elsewhere. The 40S ribosomal subunit itself can bind to and scan an mRNA, seeking the start
site of an ORF (open reading frame) encoding a polypeptide. When a GTP-bound eukaryotic
initiation factor 2 (GTP-eIF2) binds with met-tRNAf, it forms a ternary complex (TC). The TC
can associate with the scanning 40S subunit. When a TC-associated scanning subunit
encounters the start site of the ORF, scanning stalls. Additional eukaryotic initiation factors
(eIFs) help form the initiation complex, positioning the initiator tRNA anticodon over the start
site AUG in the mRNA. The initiation complex then recruits the large (60S) ribosomal subunit.
Since most of the regulation of translation involves controlling the activity of initiation factors
and the structure of the promoter region of genes, watch for these interactions in the following
descriptions. Let’s begin with a close look at Look at translation initiation in eukaryotes (Figure
13.9). Recall that the binding of the 60S ribosomal subunit to the initiation complex (lower left)
causes the release of all the eIFs and the hydrolysis of the GTP on eIF2; GDP remains bound to
eIF2 (upper right).

Fig. 13.9: Review of the steps in Eukaryotic translation initiation.

For protein syntheses to continue, new GTP must replace GDP on eIF2. Another initiation
factor, eIF2B, facilitates this GTP/GDP swap, recycling GTP-eIF2 for use in initiation (i.e., the
association of eIF2, the initiator tRNAf and formyl methionine to form the TC). The regulation
of translation is superimposed on these basic processes. But where? What steps in initiation are
controlled?
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We know that the 5’ methyl-guanosine caps and poly(A) tails on mRNAs are required
for efficient translation, because mRNAs engineered to lack one and/or the other are poorly
translated. But there is little evidence that cells control capping, polyadenylation, or the
structures themselves. Instead, translation is regulated largely by targeting interactions with
structural features and sequences in the 5’ region of mRNAs. Figure 13.10 below shows key
structural motifs in a gene that can contribute to translational control.

Fig. 13.10: Regions and specific sequences known to be involved in regulating translation.

Regulation of translation may be global, affecting the synthesis of many polypeptides;
or it may be specific, affecting a single polypeptide. The global regulation involves changes in
the activity of eIFs that would typically affect all cellular protein synthesis. Specific regulation
involves sequences or regions on one or a few mRNAs in turn can recognize and bind specific
regulatory proteins and/or other molecules. Such specific interactions would control translation
of only those mRNAs, without affecting overall protein biosynthesis. We will consider three
examples of the translational control of gene expression.
13.5.1 Specific Translation Control by mRNA-Binding Proteins
Translation initiation complexes typically scan the 5’ UTR of an mRNA. When the complex
finds the translation start site, it can bind the large subunit and begin translating the
polypeptide. Ferritin is a cytplasmic iron-binding protein, necessary because iron is of course,
insoluble and must be bound to proteins, both in cells and in the blood (the latter is a story for
another time and place!). Once in the cell, iron binds to the ferritin. As you may guess, cellular
iron metabolism depends on the amount of ferritin in the cell, which is regulated at the level of
translation. Here we consider the control of ferritin synthesis, shown in Figure 13.11, (below).
Ferritin is in fact a two-subunit protein. The 5’ UTRs of the mRNAs for both
polypeptide chains contain iron-responsive elements (IREs). These IREs are stem-loop
structures that recognize and specifically bind iron-regulatory proteins (IRP1, IRP2). The
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initiation complex scans the 5’ UTR of an mRNA. When it finds the normal translationstart site,
it can bind the large subunit and begin translating the polypeptide. In iron-deficient cells,
scanning by the initiation complex is thought to be physically blocked by steric hindrance.

Fig. 13.11: Iron-regulatory proteins disrupt promoter scanning to inhibit ferritin-polypeptide synthesis.

13.5.2 Coordinating Heme and Globin Synthesis

Reticulocytes (the precursors to erythrocytes, the red blood cells in mammals) synthesize
globin proteins. They also synthesize heme, an iron-bound porphyrin-ring molecule. Each
globin must bind to a single heme to make a hemoglobin protein subunit. Clearly, it would not
do for a reticulocyte to make too much globin protein and not enough heme, or vice versa. In
fact, hemin (a precursor to heme) regulates the translation initiation of both  and  globin
mRNAs. Recall that, in order to sustain globin mRNA translation, the GDP on GDP-eIF2
generated after each cycle of translation elongation must be exchanged for fresh GTP. This is
normally facilitated by initiation factor eIF2B. GDP-eIF2 can be phosphorylated or
unphosphorylated (active). Making sure that globin is not under- or overproduced relative to
heme biosynthesis involves controlling levels of active vs inactive eIF2B by hemin. Hemin
accumulates when there is not enough globin polypeptide to combine with heme in the cell.
Figure 13.12 below illustrates globin mRNA translation regulation by hemin. At low
hemin levels, expect reticulocytes to slow down globin translation. Low Hemin levels activates
an HRI kinase, causing phosphorylation of GDP-eIF2. eIF2B, instead of catalyzing the
GTP/GDP swap, binds to GDP-eIF2-P. Thus, neither GDP-eIF2 nor eIF2B are available for the
swap. When cellular hemin levels catch up to, or exceed globin levels, HRI kinase is itself
partially dephosphorylated and becomes inactive. The result is that GDP-eIF2 can’t be
phosphorylated, existing phosphorylated GDP-eIF2-P is dephosphorylated, and the GDP-eIF2
and eIF2B dissociate, making both available for the GTP/GDP exchange and a resumption of
globin synthesis.
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Fig. 13.12: Hemin (a heme precursor) and globin polypeptide syntheses are coordinated (panels 1-3).
At high [hemin], globin translation is maximized; at low [hemin], globin translation slows down.

CHALLENGE: The regulation of globin translation seems to be specific.
But wouldn’t changing translation-factor activity affect the translation of
all proteins? What do you think is going on here?

237 Translation Regulation of Globin Polypeptide Synthesis
13.5.3 Translational Regulation of Yeast GCN4
Like the coordination of heme and globin production, regulation of the yeast GCN4 protein is
based on controlling the ability of the cells to swap GTP for GDP on eIF2. But this regulation is
quite a bit more complex even though yeast is a more primitive eukaryote! GCN4 is a global
transcription factor, controlling the transcription of as many as thirty genes in pathways for
the synthesis of nineteen out of the twenty amino acids! The discovery that amino acid
starvation caused yeast cells to increase production of amino acids led to the discovery of the
General Amino Acid Control (GAAC) mechanism involving GCN4. GCN is short for General
Control Nondepressible, referring to its global, positive regulatory effects. It turns out that the
GCN4 protein is also involved in stress-gene expression, glycogen homeostasis, purine
biosynthesis… the list just goes on. In fact, the GCN4 protein is involved in the action of up to
10% of all yeast genes! Here we focus on the GAAC mechanism.
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Yeast cells with ample amino acids don’t need to make more. GCN4 levels are low in
these cells. But if the cells are starved of amino acids, GCN4 levels rise as much as tenfold in
two hours, causing increased general amino acid synthesis. Amino acid starvation initially
signals an increase in the activity of GCN2, another protein kinase that catalyzes GDP-eIF2
phosphorylation (Figure 13.13), which we just saw, cannot exchange GTP for GDP on eIF2.

Fig. 13.13: Amino acid starvation increases a GCN2 kinase activity that phosphorylates GDP-eIF2 (1).
eIF2B then binds GDP-eIF2-P (2), blocking GTP/GDP exchange (3). The resulting drop in ternary
complexes (4) favors GCN4 translation, leading to maximal amino acid synthesis (5).

There is a paradox here. You would expect a slowdown in GTP-eIF2 regeneration to
inhibit overall protein synthesis, and it does. However, the reduced levels of GTP-eIF2
somehow also stimulate translation of the GCN4 mRNA, leading to more transcription of the
amino acid synthesis genes. In other words, amino acid starvation leads yeast cells to use
available substrates to make their own amino acids, so that protein synthesis can continue… at
the same time as initiation complex formation is disabled! Let’s accept that paradox for now
and look at how amino acid starvation leads to increased translation of the GCN4 protein and
the upregulation of amino acid biosynthesis pathways. To begin with, we are going to need to
understand the structure of GCN4 mRNA (Figure 13.14). Note the four short upstream open
reading frames (uORFs) in the 5’ untranslated region (5’ UTR) of GCN4 mRNA.

Fig. 13.14: Short open reading frames (uORFs) in the GCN4 mRNA 5′ UTR act to regulate translation.
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Recall that eIF2 binds with GTP and the initiator met-tRNA to form a ternary complex
(TC). As we also noted earlier, TC-associated 40S ribosomal subunits scan mRNAs to find
translation start sites of ORFs, allowing initiation complexes to form. When a 60S ribosomal
subunit binds, polypeptide translation starts. But while uORFs in the GCN4 mRNA encode
only a few amino acids before encountering a stop codon, they can also be recognized during
scanning. When TCs and 40S subunits are plentiful, they engage uORFs in preference to the
GCN4-coding region ORF (Figure 13.15).

Fig. 13.15: At normal amino acid levels, abundant TC-40S (ternary) complexes scanning for ORFs
cluster at uORF start sites, slowing scanning to the GCN4 ORF and thus inhibit GCN4 translation.

Under these conditions, active eIF2B allows the GTP/GDP swap on GDP-eIF2, leading
to efficient GTP-eIF2 recycling and high TC levels. TCs were bound to the small (40S)
subunits during scanning and/or at the start sites of uORFs. At this point, they form initiation
complexes that bind 60S ribosomal subunits and begin uORF translation.
The effect of high TC levels, leads to high levels of initiation complexes that in turn
drive scanning for the GCN4 ORF, slowing down scanning the upstream ORFs (uORFs).
thereby inhibiting initiation complex formation at the actual GCN4 ORF. The result is
increased transcription of GCN4 mRNA and GCN4 protein synthesis.
CHALLENGE: State an hypothesis to explain how higher TC (ternary
complex) levels result in more efficient scanning and thus initiation at
the GCN4 promoter.
What happens in amino acid-starved cultures of yeast cells, when GTP-eIF2 cannot be
efficiently regenerated and GTP/initiator met-tRNA ternary complexes are in short supply? To
review, amino acid starvation signals an increase in GCN2 kinase activity, resulting in
phosphorylation and inactivation of eIF2B. Inactive phospho-eIF2 will not facilitate the
GTP/GDP swap at GDP-eIF2, inhibiting overall protein synthesis. The resulting reduction in
GTP-eIF2 also lowers the levels of TC and TC-associated 40S subunits. In Figure 13.16
(below), see how this phenomenon upregulates GCN4 translation, even as the translation of
other mRNAs has declined.
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Fig. 13.16: During amino acid starvation there are fewer TC-40S complexes scanning for ORFs and
they more readily bind to the GCN4 ORF, increasing GCN4 synthesis. At high levels, GCN4 regulates
the expression of many genes, including those encoding enzymes needed for amino acid synthesis.

Under these conditions, the formation of initiation complexes at uORFs is less likely,
thereby making the scanning for open reading frames by the remaining TC-40S complexes
more likely to reach the GCN4 ORF, resulting in an increase in GCN4 translation! The
increased production of the gene-regulatory GCN4 protein then turns on virtually all of the
genes for enzymes of amino acid biosynthesis. The cells thus make their own amino acids
when the medium has few to contribute! For a good review of translation-level regulation in
general and of GCN4, see 13.16GCN4 Translation Regulation.

13.6

Protein Turnover in Eukaryotic Cells: Regulating Protein Half-Life

We have already seen that organelles have a finite life span or half-life, defined as the time for
half of them to disappear in the absence of a regeneration (new synthesis) of the organelles.
Recall that lysosomes help to destroy worn-out mitochondria, including their molecular
components. Recall also the small RNAs (especially miRNA) that destroy old or damaged
cellular RNAs.
As we already know, the steady-state level of any cellular structure or molecule exists
when the rate of its manufacture or synthesis is balanced by the rate of its turnover. Of course,
steady-state levels of things can change. For example, the level of gene expression (the
amount of a final RNA or protein gene product in a cell) can change if rates of transcription,
processing, or turnover change. We should also expect the same for the steady-state levels of
cellular proteins. Here we consider the factors that govern the half-life of cellular proteins, a
property of all cellular molecules and structures. The half-lives of different proteins seem to be
inherent in their structure. Thus, some amino acid side chains are more exposed at the surface
of the protein and are thus more susceptible to change or damage over time than others.
Proteins with fewer “vulnerable” amino acids should have a longer half-life than those with
more of them. Proteins damaged by errors of translation, folding, or processing gone awry or
just worn out from use or “old age” will be targeted for destruction. The mechanism for
detecting and destroying unwanted, old, damaged, or misbegotten proteins involves a 76amino acid polypeptide called ubiquitin that binds to target proteins and delivers them to a
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large complex of polypeptides called the proteasome. The pathway to protein destruction is
shown below in Figure 13.17. Use the illustration to help you follow the numbered steps in the
outline that follows the illustration.

Fig. 13.17: Proteasomes are the main recycler of old and damaged protein in a cell. In this mechanism,
an activating enzyme binds ubiquitin (1), as the ubiquitin is activated, a conjugation protein replaces the
activation enzyme on ubiquitin (2). A protein targeted for destruction is covalently linked to ubiquitin (3 A
ubiquitin ligase recruits more ubiquitins to the complex (4). Next, ATP is hydrolyzed as the complex
binds to a proteasome Cap. The target protein dissociates from the complex and enters the proteasome
(6)to be hydrolyzed and the amino acids recycled (7).

1. The first step is to activate a ubiquitin. This starts when ATP hydrolysis fuels the binding
of ubiquitin to a ubiquitin-activating enzyme.
2. A ubiquitin-conjugating enzyme then replaces the ubiquitin-activation enzyme, forming a
complex with ubiquitin.
3. Proteins destined for destruction replace ubiquitin-conjugating enzymes on the ubiquitin.
4. Several more ubiquitins then bind to this complex.
5. The poly-ubiquinated protein delivers its protein to one of the 19S ‘CAP’ structures of a
proteasome,
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6. After binding to the proteasome-cap structure of a proteasome, the poly-ubiquinated target
proteins dissociate and ubiquitins are released and recycled as the target protein unfolds
(powered by ATP hydrolysis) and enters a 20S core proteasome.
7. The target protein is digested to short peptide fragments by proteolytic enzymes in the
interior of the proteasome core. The fragments are released from the CAP-complex at the
other end of the proteasome and digested down to free amino acids in the cytoplasm.
There is a mind-boggling variety of proteins in a cell—including as many as six hundred
different ubiquitin proteins, encoded by as many genes! Presumably, each ubiquitin handles a
subclass of proteins based on common features of their structure. The structurally complex 26S
proteasome is smaller than a eukaryotic small ribosomal subunit (40S). Nevertheless, it is one
of the largest cytoplasmic particles, even without the benefit of any RNA in its structure! To
see different animated versions of ubiquitin and proteasome in action, look at 13.17Proteasome
in Action-1 and 13.18Proteasome in Action-2.
For their discovery of the ubiquitin-proteasome system and its proteolytic actions, A.
Ciechanover, A. Hershko, and I. Rose shared the 2004 Nobel Prize in Chemistry.
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spacer RNA
steady state

Streptococcus pyogenes
tracr DNA
tracr gene
tracr RNA
translation elongation
ubiquitin
ubiquitination
uORF
XistAR
yeast GCN4
Zuc nuclease

CHAPTER 13 WEB LINKS

13.1

13.2

13.3

13.4

13.5

13.6

13.7

13.8

13.9

13.10

13.11

13.12

13.13

13.14

3.15

13.16

13.17

13.18

305

Chapter 14

Repetitive DNA: A Eukaryotic Genomic Phenomenon

Minisatellite DNA, microsatellite DNA, ribosomal RNA genes; transposons – selfish junk DNA or
architects of the genome?
Reminder: For inactive links, google key words/terms for alternative resources.

14.1

Introduction

Because of their small size, bacterial genomes have few repetitive DNA sequences. In
contrast, repetitive DNA sequences can make up as much as half of a eukaryotic genome.
Much of this repeated DNA consists of identical or nearly identical sequences of varying
length repeated many times (up to a million or more times!). Examples include satellite DNA
(minisatellite and microsatellite DNAs) and transposons, or transposable elements. Here we’ll
consider experiments that first revealed the existence and proportion of repeated DNA in
genomes. Next, we describe Barbara McClintock’s even earlier (and pretty amazing!)
discovery of transposable elements. After we describe the different classes of transposons and
different mechanisms of transposition, we tackle the question of why they and other repetitive
DNAs even exist. Elsewhere we introduced the notion of junk DNA as DNA sequences that
are not transcribed and serve no known purpose. Are repeated DNA sequences really junk
DNA? Are transposable elements just junk? We now understand and continue to learn that
transposons and other repetitive DNAs can have specific functions, from regulating gene
expression to reshaping genomes to increasing genetic diversity in evolution. Some are even
transcribed! Far from being “junk,” much of this redundant DNA exists in genomes because of
evolutionary selection.

Learning Objectives
When you have mastered the information in this chapter, you should be able to do the
following:
1. Compare and contrast renaturation kinetic data.
2. Explain CoT curves and DNA complexity.
3. List physical and chemical properties of main-band and satellite DNAs.
4. Outline an experiment to determine if a given sequence of DNA is repetitive or not.
5. Summarize how Barbara McClintock revealed the genetics of maize mosaicism.
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6. Outline the experiments suggesting that the Ds gene moves from one locus to another in
the maize genome.
7. Compare and contrast cut-and-paste and replicative transposition.
8. Compare the behaviors of autonomous and nonautonomous transposons.
9. List the differences between Mu phage infection and transposition.
10. Describe the common structural features of transposons.
11. Compare the mechanisms of LINE and SINE transposition.
12. Speculate on how a species with a high transposon load manages to avoid potentially
lethal consequences of transposition.
13. Speculate on which came first in evolution: DNA transposons, RNA transposons, or
retroviruses, and explain your reasoning.

14.2

The Complexity of Genomic DNA

By the 1960s, when Roy Britten and Eric Davidson were studying eukaryotic gene regulation,
they knew that there was more than enough DNA to account for the genes needed to encode
an organism. It was also likely that DNA was more structurally complex than originally
thought. They knew that cesium chloride (CsCl) density gradient centrifugation separated
molecules based on differences in density and that fragmented DNA would separate into main
and minor bands of different density in the centrifuge tube. The minor band was dubbed
satellite DNA, recalling the Sputnik satellite that had recently been launched by Russia (or
moons as satellites of planets!). DNA bands with different densities could not exist if the
proportions of A, G, T, and C in DNA (already known to be species-specific) were the same
throughout a genome. Instead, there must be regions of DNA that are richer in A-T than G-C
pairs, and vice versa. Analysis of the satellite bands that moved farther on the gradient (i.e.,
that were denser) than the main band were indeed richer in G-C content. Those that lay above
the main band were more A-T-rich.
Consider early estimates of how many genes it might take to make a human, mouse,
chicken, or petunia: about a hundred thousand! Such estimates may have been based on
notions of how many proteins a eukaryotic life requires. We know now that it takes fewer!
Nevertheless, the genome of a typical eukaryote contains one hundred to one thousand times
more DNA than necessary to account for even the inflated one hundred thousand gene
estimate. So, how do we explain all the seemingly extra DNA? Britten and Davidson performed
a series of elegant experiments to measure DNA renaturation kinetics that revealed some
physical characteristics of genes and what seemed to account for the excess DNA. Let’s look at
these experiments in some detail.
14.2.1 The Renaturation Kinetic Protocol
The first step in a renaturation kinetic experiment is to shear DNA isolates to an average size
of 10 Kbp (kilobase pairs) by pushing high molecular weight DNA through a hypodermic
needle at constant pressure. The resulting double-stranded fragments (dsDNA fragments) are
next heated to 100oC to denature (separate) the two strands. The solutions are then cooled to
60oC to allow the single-stranded DNA (ssDNA) fragments to slowly re-form complementary
double strands. At different times after incubation at 60 oC, the partially renatured DNA was
sampled, and ssDNA and dsDNA were separated and quantified.
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The experiment is summarized below in Figure 14.1.

Fig. 14.1: Renaturation kinetics: double-stranded DNA (dsDNA) is mechanically cut to ~10 Kbp
fragments, heated to denature the DNA, and then cooled to allow the ss DNAs find and renature with
their complements.

14.2.2 Renaturation Kinetic Data
Britten and Davidson then plotted the percentage of DNA that had renatured over time. Figure
14.2 is the plot of data from a renaturation kinetics experiment using rat DNA, showing the
rate of dsDNA formed at different times (out to many days!).

Fig. 14.2: Plot of rat dsDNA formed over time during renaturation of denatured DNA.

CHALLENGE: Why plot the time allowed for renaturation as the log of time
rather than simply as time?
In this example, the DNA fragments could be placed in three main groups with
different overall rates of renaturation. Britten and Davidson hypothesized that the dsDNA that
had formed most rapidly was composed of sequences that must be more highly repetitive than
the rest of the DNA. The rat genome also had a lesser amount moderately repeated (middlerepetitive) dsDNA fragments (which took longer to anneal than the highly repetitive fraction),
and even less of a very-slowly reannealing unique sequence DNA fraction (which took the
longest time to re-anneal).
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The latter sequences were so rare in fact, that it could take days for them to reform double strands, and they were classified as nonrepetitive, unique- (or nearly
unique-) sequence DNA, as illustrated below in Figure 14.3.

Fig. 14.3: The three “phases” of the curve in Fig. 14.2 have here been highlighted to identify the three
fractions of repeated and almost unique DNA sequences in the rat genome.

It became clear that the rat genome, and in fact most eukaryotic genomes, consists of
different classes of DNA that differ in their redundancy. From the graph, a surprisingly a large
fraction of the genome was repetitive, to a greater or lesser extent.

238 Discovery of Repetitive DNA
When renaturation kinetics were determined for E. coli DNA, only one “redundancy
class” of DNA was seen (Figure 14.4).

Fig. 14.4: Plot of E. coli dsDNA formed over time during renaturation of denatured DNA.
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Based on E. coli gene-mapping studies and the small size of the E. coli “chromosome,”
the reasonable assumption was that there is little room for “extra” DNA in a bacterial genome
and that the single class of DNA on this plot must be unique-sequence DNA.
14.2.3 Genomic Complexity
Britten and Davidson defined the relative amounts of repeated and unique (or single-copy)
DNA sequences in an organism’s genome as its genomic complexity. Thus, prokaryotic
genomes have a lower genomic complexity than eukaryotes. Using the same data as is in the
previous two graphs, Britten and Davidson demonstrated the difference between eukaryotic
and prokaryotic genome complexity by a simple expedient. Instead of plotting the fraction of
dsDNA formed vs time of renaturation, they plotted the percentage of reassociated DNA
against the concentration of the renatured DNA multiplied by the time the DNA took to
reanneal (the CoT value). When CoT values from rat and E. coli renaturation data are plotted
on the same graph, you get the CoT curves in the graph in Figure 14.5.

Fig. 14.5: DNA complexity is revealed by plotting rat and E. coli DNA renaturation kinetics as the
percentage of reassociated dsDNA over CoT (Concentration of reassociated dsDNA × time).

This deceptively simple extra calculation (from the same data!) allows direct
comparison of the complexities of different genomes. These CoT curves tell us that ~100% of
the bacterial genome consists of unique sequences (curve at the far right), compared to the rat
genome, which has two DNA redundancy classes and (at the right of the curve), only a small
fraction of unique- sequence DNA. Prokaryotic genomes are indeed largely composed of
unique (nonrepetitive) sequence DNA that must include single-copy genes (or operons) that
encode proteins, ribosomal RNAs, and transfer RNAs.

239 CoT Curves and DNA Complexity Explained!
14.2.4 Functional Differences between CoT Classes of DNA
The next questions, of course, were what kinds of sequences are repeated and what kinds of
sequences are “unique” in eukaryotic DNA? Eukaryotic satellite DNAs, transposons, and
ribosomal RNA genes were early suspects.
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To start answering these questions, satellite DNA was isolated from the CsCl gradients,
made radioactive, and then heated to separate the DNA strands. In a separate experiment,
renaturing rat DNA was sampled at different times of renaturation. The isolated CoT fractions
were once again denatured and mixed with heat-denatured radioactive satellite DNA probe.
The mixture was then cooled a second time to allow renaturation. The experimental protocol is
illustrated in Figure 14.6.

Fig. 14.6: Isolated CoT fractions of eukaryotic DNA were separately mixed with radioactive satellite
DNA isolated from a CsCl density gradient, then reheated to denature all of the DNA, and finally,
cooled to allow satellite DNA find complementary fragments in the CoT fractions.

The results of this experiment showed that radioactive satellite DNA only anneals to DNA from
the low-CoT fraction of DNA. Satellite DNA is thus highly repeated in the eukaryotic genome.
In similar experiments, isolated radioactive rRNAs formed radioactive RNA-DNA
hybrids when mixed and cooled with the denatured middle CoT of eukaryotic DNA. Thus,
rRNA genes were moderately repetitive. With the advent of recombinant DNA technologies,
the redundancy of other kinds of DNA was explored by probing renatured DNA fractions from
renaturation kinetics experiments using cloned genes encoding rRNAs, mRNAs, transposons,
and other sequences. Table 14.1 (below) summarizes the results of such experiments.
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Table 14.1

The table compares properties (lengths, copy number, functions, percentage of the genome,
location in the genome, etc.) of repetitive-sequence DNAs. The fact most of a eukaryotic
genome is made up of repeated DNA and that transposons can be as much as 80% of a
genome—came as a surprise! We’ll focus next on the different kinds of transposable elements.

240 Identifying Different Kinds of DNA Each CoT Fraction

241 Some Repetitive DNA Functions

14.3

The “Jumping Genes” of Maize

Barbara McClintock’s report that bits of DNA could jump around and integrate into new loci in
DNA was so dramatic and arcane that many thought the phenomenon was either a one-off or
not real! Only with the subsequent discovery of transposons in bacteria (and in other
eukaryotes) were McClintock’s jumping genes finally recognized for what they were.
To begin the tale, let’s look at the maize reproduction in Figure 14.7 (below).
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Fig. 14.7: Life cycle of maize: sperm from male plant pollen land on stigma atop corn silk to tunnel
through a pollen tube of their own making to the base of the silk. There, one sperm fertilizes the egg;
another fertilizes poplar bodies left over from oogenesis, which become triploid endosperm cells.

The different colors of corn seeds (kernels) result from anthocyanin pigments, which
are expressed differentially by cells of the aleurone tissue, derived from the triploid
endosperm. McClintock was studying the inheritance of color variation, which ranged from
colorless (white or yellow, due to an absence of anthocyanins) to brown, purple, spotted, or
streaked. The mosaic of kernel colors is vivid in the corncobs in the photo in Figure 14.8.

Fig. 14.8: Examples of mosaic corn cobs with different color kernels on the same cob
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Clearly, kernel color is inherited. The inheritance of colorless and purple seed color
does indeed follow Mendelian rules, but the genetics of mosaicism does not. Mosaic color
patterns after genetic crosses were not consistent, implying that the mutations responsible for
kernel colors were not due to mutations in germ cells. Rather, genes controlling anthocyanin
synthesis must have been undergoing mutations in the somatic cells that would become (or
already were) the ones in which the pigments were produced.

242 What Interested McClintock about Maize
14.3.1 Discovering the Genes of Mosaicism: The Unstable Ds Gene
As we describe McClintock’s experiments, keep in mind that her research and intuitions about
gene regulation and epigenetic inheritance came long before molecular technologies made it
possible to prove or to name these phenomena. McClintock was looking for a genetic
explanation for seed-color variation in the 1940s and early 1950s. DNA structure had only
recently been published, and gene cloning and DNA sequencing were decades into the future!
Her only available technologies were based on an understanding of Mendelian allelic
assortment in traditional breeding studies. Since seed color is expressed in cells derived from
endosperm, McClintock knew that the inheritance of the kernel-color phenotype must be
studied against a triploid genetic background. She was also aware of speculations that the
variegated-color phenotype might result when a specific unstable mutation, which usually
produced colorless kernels, “reverted” in some cells but not in others, thereby creating a
spotted or streaked phenotype. Just what made for an “unstable mutation” was, of course
unknown. McClintock identified three genes involved in seed-kernel coloration and ultimately
solved this puzzle.
CHALLENGE: Later in your study, you should be able to design one or more
experiments based on molecular technologies that might have quickly
revealed how transposons influence maize mosaicism.
Two of the genes studied by McClintock controlled the presence vs absence of kernel
color. These are the C and Bz genes:
1. C′ is the dominant inhibitor allele, so-called because if even one copy were present, the
kernels would be colorless (yellow), regardless of the rest of the genetic background.
2. Bz and bz are dominant and recessive alleles of the Bz gene, respectively. In the absence
of a dominant C′ allele, the presence of a Bz allele would lead to purple kernels. If the bz
allele were present without both C′ and Bz alleles, the kernels would be dark brown.
The third gene—the one required to get the variegated kernel color—was the Ds
(Dissociator) gene. McClintock knew that without a viable Ds gene, kernels were either
colored or colorless, depending on the possible genotypes dictated by the C and Bz alleles. In
other words, the Ds gene must suffer the “unstable mutations” that led to variegated kernel
color.
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The mutations occurred at random among aleurone layer cells, so the mutations must
have been occurring in a region of chromosomal instability (prone to damage or breakage) in
some cells but not in others. Let’s look at what McClintock did to figure out what was going on
in corn-kernel color genetics. Having already demonstrated crossing-over in maize (another
remarkable achievement!), McClintock mapped the C’, Bz, and Ds genes to chromosome 9.
She then selectively mated corn with genotypes shown in the protocol in Figure 14.9.

Fig. 14.9: An experimental cross between CCbzbz triploid (triple recessive) female with no Ds genes
and C′C′BzBzDsDs (triple dominant) male with Ds genes, showing predicted genotypes and kernel
color phenotypes, based on Mendelian assumptions.

Remember that triploid cell genotypes are being considered in this illustration! You
can refer to the phenotypic effects inherent in three-gene allelic backgrounds as we follow
McClintock’s cross. Her cross of a homozygous recessive with a homozygous dominant plant
should ring a bell! Let’s look more closely at this cross. Figure 14.10 shows the expected
triploid genotypes from the cross. Aleurone cells resulting from this cross should all be
colorless (yellow) because of the presence of the dominant C’ allele.

Fig. 14.10: Triploid genotypes expected for the cross in Fig. 14.9: The starting homozygous recessive
female and homozygous male genotypes (upper) are mated. The expected triploid genotypes for this
hybrid cross are shown (below).
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There were indeed many colorless kernels on the hybrid cob, as expected, but there
were also many mosaic kernels with dark spots or streaks against a colorless background.
McClintock’s interpretation of events is illustrated in Figure 14.11.

Fig. 14.11: McClintock’s interpretation of results of the triploid cross in Fig. 14.9

According to McClintock, if some aleurone-layer cells in some kernels were to suffer
chromosomal breakage at the Ds (Dissociator) locus (indicated by the double slash, //), the C’
allele would be inactivated. Without a functional C’ allele, the operative genotype in the
affected cells is CCbzbz. These cells will revert to making the brown pigment as directed by
the bz allele. When these cells divide, they form clusters of brown cells that are surrounded by
cells with an unbroken chromosome (and thus an active C’ allele), creating a mosaic—that is,
the appearance of pigment spots or streaks in some kernels, against the otherwise-colorless
background of the surrounding cells.

243 Variegated Maize Kernels Result from “Loss” of the Ds Gene
14.3.2 The Discovery of Mobile Genes: The Ac/Ds System
The experiments just described were reproducible using her original, single breeding stock of
maize. But when McClintock tried to repeat the experiments by crossing the homozygous
dominant males with homozygous recessive females from a different breeding stock, all the
kernels of the progeny cobs were colorless, as if the Ds gene had not caused any chromosomal
damage.
CHALLENGE: Outline the cross escribed above to show (i.e., explain)
the described genetic outcomes.
It seemed that the Ds genes contributed by the males were unable to function mutate
(i.e., “break”) chromosomes in females of this new breeding stock. McClintock hypothesized
that the female in the original cross must have contributed a factor that could somehow
activate the Ds gene to break, and that this factor, yet another gene, was absent or inactive
in the females of the new breeding stock. McClintock called the new factor the activator, or
Ac gene. Based on the dependence of Ds on the Ac locus, McClintock recognized that
mosaicism in maize kernels was controlled by these two “genes” as part of a two-element,
Ac/Ds system.
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She then demonstrated that Ac-dependent Ds “breakage” was in some cases also
associated with inactivation of a normal Bz gene, leading to a loss of purple kernels. At this
point McClintock concluded that, far from simply “breaking” the chromosome at a fragile Ds
locus, the Ds gene had moved to (or into) the Bz gene, disrupting its function. Again, this could
not happen in the absence of an active Ac gene.
McClintock had discovered the first transposon, earning her the 1983 Nobel Prize in
Physiology or Medicine, albeit an honor belated by decades! View the homage to, and a brief
history and summary of, McClintock’s work and impact at 14.1A short history of McClintock
Science. With the advent of recombinant DNA technologies, we now know the following:
1.
2.
3.
4.

The Ds transposon lacks a gene for a transposase enzyme required for transposition.
The Ac element has this gene and is capable of independent transposition.
Ac provides the transposase needed to mobilize itself and the Ds element.
The sequence similarity of Ds and Ac elements supports their common ancestry.

The basic structural features of the maize Ac/Ds system are listed here:
1.
2.
3.
4.

Ac is 4,563 bp long.
Ds is a truncated version of Ac.
There are eleven bp inverted repeats at either end of the Ac and Ds elements.
There are eight bp direct repeats of insertion site DNA created at the time of transposition
flanking each of the elements.

Look for these features as we describe prokaryotic and eukaryotic transposons.

244 Discovery of Mobile Elements and the Ac-Ds System

245 The Ac-Ds System Today

14.4

Since McClintock: Transposons in Bacteria, Plants, and Animals

Transposons exist everywhere we look in prokaryotes, and they account for much eukaryotic
repetitive DNA. Sometimes called “jumping genes,” they can be a large proportion of
eukaryotic genomes and include some “jumping genes” that no longer even jump (i.e.,
transpose). Transposons were also once considered useless; they were described as junk DNA
containing selfish genes, whose only purpose was self-replication to copy useless, junk DNA
sequences. But considering some new evidence, perhaps not!
As you will see, transposition shares many features with DNA replication,
recombination, repair, and even viral infection. As you study how transposons move, keep in
the back of your mind that transposition is often triggered by cellular stress. Let’s begin with a
look at some bacterial transposons first, and then we’ll look at eukaryotic transposons.

317

14.4.1 Bacterial Insertion Sequences (IS Elements)

IS elements are the first mobile bacterial elements described. Discovered in the late 1960s,
many were identified (IS1, IS2…, IS10, etc.). Some inserted into genes (e.g., in the lac operon),
but most did not, likely because there is little noncoding (“extra”) DNA in the compact
bacterial genome. Without this extra DNA acting as a buffer against damaging mutations, few
bacterial cells would live to tell a tale of transposition! Perhaps it should surprise us that IS
elements can be made to transpose in the lab but are generally silent in nature.
CHALLENGE: Transpositions of an IS or other element into or near genes
cause deleterious mutations. Why not in the lac operon?
Bacterial IS elements vary in length from about 750 to 1425 bp. One is shown in Fig. 14.12.

Fig. 14.12: Structure of a bacterial IS element

The entire IS element is flanked by direct repeats (i.e., repeated sequences facing the same
direction) derived from the mechanism of transposition insertion. Within the element lie
transposase and resolvase genes whose products are necessary for mobility. Flanking these
genes are a pair of repeat sequences facing in opposite directions. Because bacteria (and
plasmids) only tolerate low copy numbers of IS elements, there are typically less than ten
copies and as few as one!
14.4.2 Composite Bacterial Transposons: Tn Elements
If a pair of IS elements should lie close to each other, separated by a short stretch of genomic
or plasmid DNA, they can transpose together, carrying the DNA between them as part of a
composite transposon, or Tn element. If some of the DNA between IS elements in a Tn
element contains antibiotic-resistance genes, its transposition can carry and spread these
genes to other DNA in the cell. Tn elements (like IS elements) are present in low copy number.
Figure 14.13 illustrates a generic Tn element.

Fig. 14.13: Structure of a bacterial Tn element.
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Antibiotic resistance genes have the medical community worried; their spread has led
to antibiotic-resistant pathogens that cause diseases that are increasingly hard and even
impossible to treat. Earlier we saw the genetic “transformation” of streptococcal cells that pick
up virulence genes in DNA from dead cells. We routinely transform cells with plasmids as part
of recombinant DNA experiments, but bacteria can transfer plasmid DNA between themselves
quite naturally. During bacterial conjugation, an F (fertility) plasmid normally transfers DNA
between compatible bacterial mating types (review bacterial conjugation in chapter 8). An F
plasmid containing a Tn element that harbors an antibiotic-resistance gene can thus be passed
from donor to recipient during conjugation. The Tn element can then transpose into to the
recipient’s bacterial genome. In this way, transposition is a major pathway for the transfer and
spread of antibiotic resistance.
14.4.3 Complex Transposons That Can Act Like Bacteriophage
Bacterial complex transposons also contain other genes in addition to those required for
mobility. Some complex transposons resemble bacteriophage, and one type of transposon—the
Mu phage—is in fact one! Mu can function either as an infectious phage (which reproduces in
an infected cell) or as a transposon in the bacterial genome. Transposon genes in a Mu phage
are illustrated in Figure 14.14.

Fig. 14.14: Structure of Mu phage, a complex transposon.

After infecting a bacterium, Mu can enter the lytic phase of its life cycle, replicating its
DNA, producing new infectious phage “particles,” ultimately releasing these by lysing the host
bacterial cell. Alternatively, like other phage, Mu can undergo lysogeny, inserting its DNA
into the host-cell chromosome. Integrated copies of Mu can excise and reenter the lytic phase
to produce more phages, usually if some environmental stress threatens host bacterial survival.
But a third lifestyle choice, transposition, is available to Mu once the phage integrates into the
bacterial chromosome. The three lifestyle options for Mu phages are illustrated in the next few
pages. Figure 14.15 (below) illustrates the lytic and lysogenic lifestyle options for a bacterial
virus, and the next illustration (Figure 14.16) shows the additional lifestyle options of Mu
phage; the phage DNA can act as a transposable element while in the lysogenic pathway!
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Fig. 14.15: Life-cycle options for a bacteriophage: The lytic pathway ends with cell lysis and phage
release. In the lysogenic pathway, the phage DNA becomes part of the host-cell chromosome.

Fig. 14.16: The transposon (third) option for Mu phage: After lysogeny the phage DNA can replicate as
part of the host-cell chromosome and excise to produce new phage, or it can transpose itself to new
locations in the host cell chromosomal DNA circle.

246 Bacterial Mobile Elements
As we describe eukaryotic transposons, look for similarities to bacterial IS and Tn elements.
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14.5

Overview of Eukaryotic Transposable Elements

There are two classes of transposons in eukaryotes:
1. Class I (RNA) transposons move (i.e., jump) by transcription of RNA at one locus, followed
by reverse transcription and integration of the cDNA back into genomic DNA at a different
location. Called retrotransposons, they may be derived from (or be the source of)
retroviruses, since active retroviruses excise from and integrate into DNA much like
retrotransposons. Retroposons are a subclass of retrotransposons (see Table 14.2).
2. Class II (DNA) transposons move by either of two mechanisms. In the cut-and-paste
pathway, the transposon leaves one locus and integrates at another. In the replicative
pathway, the original transposon remains in place, but new copies are mobile. Table 14.2
summarizes the distribution and proportion of genomes represented by different classes
and types of transposable elements.
Table 14.2

The table confirms that bacteria contain relatively few transposons, in contrast to eukaryotes,
which vary widely in transposon load (transposons as a percentage of genomic DNA).
Transposon load can range from as low as 4% to more than 70% in different organisms.
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Table 14.3 summarizes transposable elements by class, subtype, size, genomic
distribution, mechanism of transposition, where they are found in nature, and other unique
characteristics.
Table 14.3

*

DNA transposons move from one place to another in one of two ways. In Cut & Paste
Transposition, the element excises and moves to another location in the genome. In
Replicative Transposition, DNA transposons are copied and the copy transposes to a new
location, leaving the original element in place. Retrotransposons are active if their transcripts
are reverse transcribed into cDNAs as well as translated into the enzymes required to integrate
their cDNA copies into genomic DNA.

**

Many transposons are inactive, having been silenced by mutation or other factors. Active
eukaryotic Class I or Class II transposons are either autonomous or non-autonomous.
Autonomous transposons have all of the structural features necessary for their transposition
(e.g., the maize Ac element). On the other hand, non-Autonomous transposons have all the
structural elements of autonomous transposons (e.g., inverted repeats and other DNA
necessary for transposition), except that they lack or can’t transcribe one or more of the genes
for enzymes needed for mobility (e.g., the maize Ds element). Nevertheless, they can be
mobilized with the assistance of an actively transposing autonomous element that can provide
the missing enzymes.
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Between the two tables above, we can conclude the following:
•

Transposon load is not correlated with the evolutionary complexity of organisms.

•

Shared transposons have different evolutionary histories in different organisms.

•

Where transposons remain active, they continue to shape genomic landscapes, especially
in organisms with a high transposons load.

We will revisit some of these conclusions later, after looking at the structure and
mechanism of mobility of different eukaryotic transposable elements.
CHALLENGE: Speculate on why some species (i.e., a flatworm, a fruit fly
and rice!) have so few transposable elements.

247 Introduction to Eukaryotic Transposons

14.6

Structure of Eukaryotic DNA (Class II) Transposons

Active eukaryotic DNA transposons share structural features with bacterial mobile elements,
including genes required for transposition, flanking inverted repeats, and flanking insertionsite direct repeats of host-cell DNA. As we’ll see, Class II transposons can “jump” by cut-andpaste or replicative mechanisms. Figure 14.17 illustrates the characteristic structure of a
eukaryotic DNA transposon, including its “all-purpose” transposase gene.

Fig. 14.17: Structure of a eukaryotic Class II DNA transposon.

14.6.1 Cut-and-Paste Transposition
This mechanism moves a copy from one location and transposes it to another location. As its
name suggests, replicative transposition leaves a copy of the original transposon in place,
while inserting a new copy elsewhere in the genome (Figure 14.18, below).
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Fig. 14.18: Cut-and-paste transposition of a DNA transposon.

Transposase excises the transposon, trims its 3’ OH ends to create a staggered cut, joins the
transposon ends, and mediates its insertion at a new DNA site. After ligating the 3′ OH
transposon ends to the 5′ OH at the insertion site, replication replaces missing bases to
generate the direct repeats of host-cell genomic DNA. Ligation completes the transposition.
14.6.2

Replicative Transposition

Figure 14.19 details the steps of replicative transposition. Like the cut-and-paste mechanism,
the transposon is nicked and trimmed at its source (i.e., original) insertion site.

Fig. 14.19: Replicative transposition of a DNA transposon.
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Unlike the cut-and-paste mechanism, transposons are not excised. Its transposase nicks the
transposon’s 3′ ends at the insertion site, holding the transposon ends together while it cuts
(hydrolyzes) DNA at a new insertion site. Replication from the 3′ OH ends of the insertion-site
DNA strands forms a cointegrate structure containing transposon copies. The cointegrate is
resolved by one of two recombinational mechanisms, leaving transposon copies at the original
site and the new insertion site.
Let’s compare and contrast features of cut-and-paste and replicative transposition. The
common features are that (first) a transposon-encoded transposase binds, brings transposon
ends together, and catalyzes single-stranded cleavage (hydrolysis), leaving “staggered ends,”
and (second) that the transposase holds the transposon ends together for the remaining steps.
The differences between the two mechanisms are that in cut-and-paste transposition, the
transposon is completely excised and then transposed to a new site in genomic DNA. In
contrast, after single-stranded cleavage in replicative transposition, the transposase-bound free
3′ ends of the transposon hydrolyze both strands of double-stranded DNA at a new insertion
site. After ligation of the 3’ ends of transposon strands to the 5′ ends of cut genomic DNA
insertion-site ends, the remaining 3’ ends of the insertion-site DNA will prime the replication
of the transposon to form the cointegrate, the which is then resolved by one of two
recombination pathways.
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14.7

Structures of Eukaryotic RNA (Class I) Transposons

Like DNA transposons, all RNA transposons leave insert-site footprints (i.e., direct repeats of
genomic DNA flanking the element). Unlike DNA transposons, active eukaryotic Class I
transposons move via an RNA intermediate. Also unlike DNA transposons, RNA transposons
lack terminal inverted repeats.
The mobility of the RNA intermediate of all retrotransposons requires a promoter,
which recognizes a reverse transcriptase enzyme as well as endonuclease and integrase
enzymes (to be described later). Autonomous Class I RNA transposons are characterized by
Long Terminal Repeats (LTRs) as well as Non-LTR retrotransposons (that lack LTRs). NonLTR retrotransposons include the autonomous Long Interspersed Nuclear Elements (LINEs)
and the non-autonomous Short Interspersed Nuclear Elements (SINEs). Both the autonomous
LTR and non-LTR LINEs contain and express genes needed for the enzymes required for
transposition. On the other hand, the nonautonomous SINEs (a subclass of non-LTR
retrotransposons) lack genes for the enzymes required for transposition and therefore cannot
transpose independently. Nonautonomous retrotransposons thus rely on “true” (autonomous)
retrotransposon activity for mobility. SINEs are sometimes called retroposons to distinguish
them from the autonomous retrotransposons.
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14.7.1 LTR retrotransposons: The Yeast Ty element
Here we look at structures, genes, and enzyme activities required for retrotransposition. The Ty
LTR retrotransposon in Figure 14.20 is an autonomous retrotransposon.

Fig. 14.20: Structure of yeast Ty, an RNA LTR retrotransposon

The Ty retroposon encodes several genes needed for transposition:
• Gag encodes group-specific antigen, a protein that forms a virus-like particle that will
contain reverse-transcribed transposon DNA.
• RT, encodes reverse transcriptase to reverse-transcribe retrotransposon RNAs.
• Prt encodes a protease to break down the virus-like particle as the retrotransposon enters
the nucleus.
• Int encodes integrase, needed to integrate the retrotransposon into a new insertion site. In
fact, many of the events in Ty transposition occur in the cytoplasmic “virus-like particle” in
yeast cells. To see more, see 14.2Virus-Like Particles in Ty Transposition. Note that the Pol
region in Figure 14.20 consists of overlapping open reading frames (ORFs) that encode the
Prt, RT, and Int genes. The ready-to-move transposon consists only of the bracketed region
of DNA, including the long terminal repeat sequences.
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14.7.2 Non-LTR Retrotransposons: LINEs
Like LTR retrotransposons, LINEs (long interspersed nuclear elements) encode the enzymes
needed for transposition. They also generate target-site direct repeats flanking the inserted
element (Figure 14.21). But they do not have long terminal repeats! Instead, their ORFs
(genes) are flanked by 5′ and 3′ untranslated regions (UTRs).

Fig. 14.21: Structure of a LINE, a non-LTR retrotransposon.
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The 5′ UTR contains a promoter from which cellular RNA polymerase II can transcribe the
downstream genes (see chapter 10 on transcription). The second of these (ORF2) encodes the
reverse transcriptase and an integrase activity that are essential for transposition of the LINE.
All autonomous Class I (RNA-intermediate) retrotransposons share the following features:

•
•
•
•

A promoter in the 5′ UTR from which they can be transcribed
A reverse transcriptase that generates a cDNA copy of the transposable element
An RNAse H (an endonuclease) that degrades the transcript after reverse transcription
An integrase (like a transposase) that catalyzes insertion of the retrotransposon copy at
insertion sites
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14.7.3 Non-LTR Retrotransposons: SINEs

Non-LTR SINE retrotransposons are non-autonomous, typically lacking genes. However their
nongenic DNA is flanked by 5’ and 3’ UTRs. RNA polymerase III can transcribe SINEs, but to
transpose, SINEs rely on the concurrent activity of an autonomous, non-LTR transposon (a
LINE) to provide the requisite enzymatic activities. The ~300bp human Alu element in Fig.
14.22 is a typical SINE (short interspersed nuclear element).

Fig. 14.22: Structure of the Alu SINE—a non-LTR retrotransposon, or retroposon.
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14.8

Mechanisms of Retrotransposition

There are two mechanisms of retrotransposition. They are extrachromosomally primed
retrotransposition (seen in e.g., LTR retrotransposons) and insertion-target-site-primed
retrotransposition (seen in non-LTR retrotransposons like LINEs and SINEs). We will
consider these two mechanisms next.
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14.8.1 Extrachromosomally Primed Retrotransposition (e.g., of a LINE)
As its name suggests, in extrachromosomally primed retrotransposition, a separate circular
reverse transcript of the retrotransposon attacks, nicks, and integrates into a genomic insertion
site (Figure 14.23). In this mechanism, reverse transcriptase creates a cDNA copy of a
transcribed retro-element. Integrase-endonuclease then binds the cDNA copy, holding the
ends together, in effect circularizing it. This isolable ribonucleoprotein resembles an intasome,
a structure similar to the nucleoprotein complex that catalyzes integration of retroviral cDNAs
during lysogeny. The 3D structure of a retroviral intasome interacting with DNA and
nucleosomes was recently determined (for more, see 14.3Retroviral Intasome 3D Structure). In
this form, the retrotransposon attacks DNA at an insertion site, creating staggered ends. After
insertion, the gaps in the DNA are filled in. Ligation seals the retrotransposon into its new
location, creating direct insertion-site repeats.

Fig. 14.23: Extrachromosomally primed transposition of a LINE.
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14.8.2 Target-Site Primed SINE Retrotransposition (e.g., of a SINE)
In target-site primed retrotransposition (retroposition) of a SINE, RNA polymerase III (the same
enzyme that catalyzes tRNA and 5S rRNA transcription) transcribes the SINE. If a LINE is
concurrently transcribed, its enzymes will be made. When its integrase-endonuclease catalyzes
hydrolysis of one strand of DNA at a new insertion site, the 3’ OH end of this strand can prime
reverse transcription of the one SINE cDNA strand by the LINE reverse transcriptase. After
hydrolysis of the second target-site DNA strand, its 3’ OH end primes replication of the second
strand of the SINE cDNA. Integrase then completes insertion of the copy-SINE into its new
genomic location.
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The key feature of target site-primed retrotransposition (retroposition) is the absence of
an integrase-bound, separate, circular, double-stranded reverse transcript (Figure 14.24).

Fig. 14.24: Target-primed transposition of a LINE.
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14.9

On the Evolution of Transposons, Genes, and Genomes

We noted that transposons in bacteria carry antibiotic resistance genes, a clear example of the
benefits of transposition in prokaryotes. Of course, prokaryotic genomes are small, as is the
typical bacterial transposon load. Yeast species also have low transposon load. But what can
we make of the high transposon load in eukaryotes? To many geneticists, the fact that genes
encoding proteins typically represent only 1–2% of a eukaryotic genome once suggested that
the rest of the genome was informationally nonessential. Even though transposons turned out
to be much of the noncoding DNA in some eukaryotic genomes, they seemed to serve no
purpose other than their own replication. These large amounts of transposon DNA were
dubbed “selfish DNA” and their genes, “selfish genes.”
So, are transposons just junk DNA—some kind of invasive or leftover genomic
baggage? Given their propensity to jump around and their potential to raise havoc in genomes,
how do organisms tolerate and survive them? Is the sole “mission” of transposons really just to
reproduce themselves? Or are transposons in fact neither selfish nor junk? By their sheer
proportions and activity in eukaryotic genomes, we will see that transposons have dispersed
into and reshaped genomic landscapes. Does their relocation and dispersal of transposons in a
genome (with the resulting disruption of genes and structural reorganization of genomes) have
any functional or evolutionary value?
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All of these questions are reasonable responses to the phenomena of jumping genes. A
rational hypothesis might be that, like all genetic change, the origin of transposition was a
random accident. But the spread and ubiquity of transposons in genomes of higher organisms
must in the long term have been selected by virtue of some benefit they provide to their host
cells and organisms.
Let’s briefly look at the evolutionary history of transposons to see if this assumption has
some merit.
14.9.1 A Common Ancestry of DNA and RNA Transposons
Transposases catalyze transposition of bacterial IS (and related) elements and eukaryotic Class
II (DNA) transposons. They are structurally similar and may share a common ancestry. Figure
14.25 compares the amino-acid sequences of the so-called integration domain of transposases
from different transposons.

Fig. 14.25: The alignment of consensus amino-acid sequences among bacterial IS transposases, Mu
phage, and Tc1 mariner transposases reveals conservation of D, D, and E amino acids (uppercase) at
key positions in the sequence. Other amino acids shared between some but not all of the sequences
are in lowercase. Slashes denote variable-length gaps in the alignments.

A universally conserved alignment of D…D…E amino acids—at key positions in
different transposase enzymes—defines a DDE domain, supporting the common ancestry of
bacterial and eukaryotic transposases. This, along with shared structural features of these
transposons (e.g., the flanking direct insertion-site repeats) further support a common ancestry
of the transposons encoding the enzymes.
Other sequence comparisons reveal that the transposons themselves comprise distinct
families of more closely related elements. This allows us to speculate on the origins of these
families in different species. For example, the TC1/mariner (DNA) transposon is found in
virtually all organisms that have been examined (except diatoms and green algae). Based on
sequence analysis, there is even an insertion element in bacteria that is related to the mariner
element. Clearly, mariner is an ancient transposon.
This amount and diversity of conservation bespeaks an early evolution of the enzymes
of transposition and of transposition itself within (and even between) species. Linear or
vertical descent (the “vertical” transmission of transposons from parents to progeny) is the
rule. However, horizontal transfer best explains the presence of similar, related transposons in
diverse species.
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In contrast to linear descent of sequences within a species, horizontal transfer defines
an interspecific sharing of DNA. That is, a transposon in one organism must have been the
“gift” of an organism of a different species!
Wherever their origins, moveable genes have been a part of life for a long time, speaking more
likely to their adaptive value for organisms than to the notion that they simply parasitic,
selfish, rogue DNAs only out for their own replication!
14.9.2 Retroviruses and LTR Retrotransposons Share a Common Ancestry
The integration domains of retrotransposon transposases and retrovirus integrases also share
significant sequence similarities, as shown in the amino-acid sequence alignment below
(Figure 14.26).

Fig. 14.26: A comparison of amino acid sequences of the COPIA retrotransposon and a retroviral (HIV)
integrase with typical transposase sequences: the alignments reveal conservation of the D, D, and E
amino acids in the DDE domain of the enzymes. Other amino acids are shared between some but not
all of the sequences (lowercase). Slashes denote variable gaps in the alignments.

Here the alignment of conserved D…D…E amino acids at key positions in DDE
domains supports the common ancestry of Class I (RNA transposon) retroviral integrases and
Class II (DNA transposon) transposases. In other words, Both DNA and RNA transposons may
share a common ancestry.
The common ancestry of retrotransposons and retroviruses raises yet other questions:
did transposons (specifically retrotransposons) arise as defective versions of integrated
retrovirus DNA (i.e., reverse transcripts of retroviral RNA)? Or did the retroviruses emerge
when retrotransposons evolved a way to leave their host cells? To approach this question, let’s
first compare mechanisms of retroviral infection and retrotransposition.
LTR retrotransposons and retroviruses both contain flanking long terminal repeats in
addition to the structural similarities of the enzymes they encode. But retrotransposition occurs
within the nucleus of a cell, while retroviruses must first infect a host cell before the retroviral
DNA can be replicated and new viruses produced.
A key structural difference between retrotransposons and most retroviruses is the ENV
gene-encoded protein envelope surrounding retroviral DNA. After infection, the incoming
retrovirus sheds its envelope proteins, and viral RNA is reverse-transcribed.
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After the reverse transcripts enter the nucleus, transcription of genes and translation of
enzymes necessary for the replication of the viral cDNA leads to the production of new
enveloped infectious viruses that will eventually lyse the infected cell. But here are two curious
phenomena:
First, retroviral DNA, like any genomic DNA, is mutable. If a mutation inactivates one
of the genes required for infection and retroviral release, it could become an LTR
retrotransposon. Such a genetically damaged retroviral integrate might still be transcribed, and
its mRNAs might still be translated. If detected by its own reverse transcriptase, the erstwhile
viral genomes would be copied. The cDNAs, instead of being packaged into infectious viral
particles, would become a source of so-called endogenous retroviruses (ERVs). In fact, ERVs
exist and make up a substantial portion of the mammalian genome (8% in humans)—and they
do, in fact, behave like LTR retrotransposons!
Second, yeast TY elements transcribe several genes during retrotransposition (see the
list in section 14.7.1 above) to produce not only a reverse transcriptase and an integrase but
also a protease and a structural protein called Gag (Group-specific antigen). All the translated
proteins enter the nucleus. Mimicking the retroviral ENV protein, the Gag protein makes up
most of a coat protein called VLP (virus-like particle). VLP encapsulates additional
retrotransposon RNAs in the cytoplasm, along with the other proteins. Double-stranded reverse
transcripts (cDNAs) of the viral RNA are then made within the VLPs. But instead of bursting
out of the cell, these encapsulated cDNAs (i.e., new retrotransposons) shed their VLP coat and
reenter the nucleus, where they can now integrate into genomic target DNA. Compare this to
the description of retroviral infection. During infection, retroviral envelope proteins attach to
cell membranes and release their RNA into the cytoplasm. There, the reverse transcriptase
copies viral RNA into double-stranded cDNAs that then enter the nucleus, where they can
integrate into host-cell DNA. When transcribed, the integrated retroviral DNA produces
transcripts that are translated in the cytoplasm into the proteins necessary to form an infectious
viral particle. The resulting viral RNAs are encapsulated by an ENV (envelope) protein
encoded in the viral genome.
Of course, unlike VLP-coated retrotransposon RNAs, the enveloped viral RNAs do
eventually lyse the host cell, releasing infectious particles. Nevertheless, while VLP-coated Ty
elements are not infectious, they sure do look like a retrovirus!
In much the same way as early biologists compared the morphological characteristics
of plants and animals to show their evolutionary relationships, comparisons of aligned
retroviral and retrotransposon reverse transcriptase gene DNA sequences reveal the
phylogenetic relationships of these genes, and therefore of the elements themselves.
A phylogenetic tree of retrotransposon and viral genes is shown in Figure 14.27
(below). The data in this analysis supports the evolution of retroviruses from retrotransposon
ancestors. From the “tree,” TY3 and a few other retrotransposons share common ancestry with
Ted, 17.6, and Gypsy ERVs (shown boxed in red in Figure 14.27) in the Gypsi-TY3 subgroup.
Further, this subgroup shares common ancestry with more-distantly-related retroviruses (e.g.,
MMTV and HTLV), as well as the even-more-distantly-related (older, longer-diverged!) CopiaTY1 transposon subgroup.
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Fig. 14.27: Retroviral and retrotransposon reverse transcriptases share a common evolutionary ancestor.
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This and similar analyses strongly suggest that retroviruses evolved from a retrotransposon
lineage. For a review of retroposon and retrovirus evolution, see Lerat P. & Capy P., 1999.
Retrotransposons and retroviruses: analysis of the envelope gene. Mol. Biol. Evol. 19: 11981207.
14.9.3 Transposons Acquisition by Horizontal Gene Transfer
As noted, transposons are inherited vertically, meaning that they are passed from cell to cell or
parents to progeny by reproduction. But they also may have spread between species, in which
an individual of species A inadvertently picks up a transposon from species B or even an
individual of the same species), becoming transformed and adding a new transposon to their
genome. Accidental mobility of transposons between species would have been rare, but when
it occurred, an exchange of genes by horizontal gene transfer would have accelerated with the
evolution of retroviruses. Once again, despite the potential to disrupt the health an organism,
retroviral activity might also have supported a degree of genomic diversity useful to organisms.

255 Transposon Evolution

14.10

Evolutionary Roles of Transposition in Genetic Diversity

Here we’ll see how transposition can affect genes and genetic diversity. We’ll also look at
parallels between transposition and the generation of immunological diversity, and we’ll
consider the provocative notion that our immune system owes at least some of its evolutionary
history to transposons, or at least to mechanisms of transposition!
14.10.1

Transposons and Exon Shuffling

A role for unequal recombination in moving exons in and out of eukaryotic split genes was
described earlier. This kind of exon shuffling could happen when short DNA sequences in two
different introns misalign during meiotic synapsis, allowing unequal crossing over. Expression
of a gene with a “new” exon produces a protein with a new domain and a new activity. If the
new domain is not harmful (e.g., found in only one of two alleles of a gene), the mutation need
not be lethal, and genetic diversity and the potential for evolution is increased!
Transposons embedded in introns are long regions of DNA similarity that can stabilize
synapsis, increasing opportunities for unequal alignment of chromosomal DNA and therefore,
chances for recombination and exon shuffling. For example, Alu (SINE) elements often
integrate within introns with no ill effect. The similarity of Alu elements in the introns of
unrelated genes seems to account for exon shuffling by unequal crossing over between the
different genes that share domains and, thus, specific functions.
Another way in which transposons facilitate germline-cell exon shuffling is more
direct. Imagine a pair of transposons in introns of a gene on either side of an exon. Should
such transposons behave like the two outer IS elements in a bacterial Tn element (discussed
earlier), they might be excised as a single, large transposon containing an exon.
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The paired transposons flanking the exon might then insert in an intron of a
completely different gene! The general pathway of exon shuffling involving paired proximal
DNA transposons is illustrated in Figure 14.28.

Fig. 14.28: Steps of paired DNA transposon-mediated exon shuffling.

In this generic example of exon shuffling, exon 2 of gene 1 has been inserted (along
with flanking transposons) into another gene (gene 2). Transposon-mediated exon shuffling
can explain the insertion of exon-encoded domains of epidermal growth factor (EGF) into
several otherwise-unrelated genes. The mitogen EGF was discovered because it stimulated
skin cells to start dividing. The gene for TPA (tissue plasminogen activator, a blood-clotdissolving protease) shares domains with the EGF gene. TPA is a treatment for heart attack
victims, and if it is administered rapidly after the attack, it can dissolve the clot and allow
coronary artery blood flow to heart muscle to resume. Other genes that contain EGF domains
include those for Neu and Notch proteins, both involved in cellular differentiation and
development.
CHALLENGE: Explain how insertion of a “foreign” exon (not to mention the
two transposable elements!) need not kill a cell, an organism, or its progeny.
Some exon shuffling mutations may have been mediated by LINE transposition and by
a special group of recently discovered transposons called helitrons. Helitrons replicate by a
rolling-circle mechanism. If you are curious about helitrons, do a Google search to learn more
about them and what role they may have had in refashioning and reconstructing genomes in
evolution.
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14.10.2

Transposon Genes and Immune-System Genes Have History

Several important eukaryotic genes may have been derived from transposons. Perhaps the
most intriguing example of this is to be found in the complex vertebrate immune system. Our
immune system includes immunoglobulins (antibodies). You inherited your immunoglobulin
genes for immunoglobulin proteins from your parents. These genes contain multiple variant V,
D, and J regions linked to a C region. V, D, J, and C are defined as variable, joining, diversity,
and constant DNA regions, respectively. These regions recombine to create many diverse V-DJ-C immunoglobulin antibody molecules (although the D region is not always included in the
recombined gene). The recombinations occur during the maturation of bone marrow stem cells
to become immune cells (B or T lymphocytes). In response to a challenge by foreign antigens,
(e.g., proteins on a bacterial surface or toxins released by invading cells), our immune system
will select B or T lymphocytes that contain rearranged immunoglobulin genes, which are able
to make immunoglobulins that can recognize, bind, and eliminate the invading antigens.
A discussion of the molecular biology of the immune system is beyond our scope here. Suffice
it to say that the recombinational immunoglobulin gene rearrangements include enzymatic
activities very similar to those of transposition. In fact, the so-called “RAG1 enzyme” active in
immunoglobulin gene rearrangement is closely related to genes in a family of transposons
(Transib) found in invertebrates and fungi. It looks like immune-gene rearrangement might
have origins in transposition!

14.11

Coping with the Dangers of Rampant Transposition

Most organisms do not have the degree of high transposon load that we humans have. Given a
general tendency of transposons to insert at random into new DNA loci, the question is, why
don’t they often insert and inactivate important genes? In other words, how come we exist at
all? Isn’t the danger of transposition into essential gene sequences magnified by the possibility
of multiple simultaneous transpositions of elements that have been generated by cut-and-paste
and (especially) replicative mechanisms?
An obvious explanation for how we have survived transposon activity is that most transposition
occurs in the greater-than-90% of the genome that does not code for proteins. But transposons
have been found in genes that are inactive as a result. In this case, the explanation is that
eukaryotic organisms have two copies of every gene, so if one is inactive, the other may sustain
us. Beyond this, several mechanisms exist to silence a transposon after transposition has
occurred, mitigating the dangers of rampant transposition. If a transposition is not lethal (e.g.,
its integration does not disrupt an activity essential to life), the cell and organisms can survive
the event. In time, mutations at the ends of transposons or in the genes needed for
transposition would eventually render them inactive.
Finally, there are more direct curbs on the activity of transposons. Recall the piRNAs we
encountered earlier that participate in silencing transposons by blocking their export from the
nucleus and silencing transposon genes themselves. There is also evidence that siRNAs target
transposon transcripts for destruction. In sum, transposition effects are limited by inherent
mutations and, more directly, by mechanisms that limit transposition and thus genetic
damage.
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Even though transposon mobility can be restrained, a last question remains. Recall the table
showing many species tolerate high transposon loads. If transposition was ipso facto
deleterious, then how do we explain that a single organism should have so many? Setting
aside the fact that a few transposons have evolved gene regulatory functions, a high
transposon count in eukaryotes is largely neutral. Therefore, many transposons in a species
may simply increase a pool of diversity that, over time, supports the selection of new genotypes
and phenotypic characteristics. Thus, mobile DNA elements may be neither selfish nor junk.
Check out 14.4Not Junk After All? and 14.5Eulogy for Junk DNA and the link below for more.
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Chapter 15

DNA Technologies

Manipulating DNA; cDNA libraries, genomic libraries, DNA sequencing, PCR, microarrays,
genomics, transcriptomics, proteomics
Reminder: For inactive links, google key words/terms for alternative resources.

How about that!?
DNA in Space

15.1Sequencing

15.1

Introduction

Let’s start chapter by looking at technologies that led to genetic engineering. The ability to
make recombinant DNA is such a seminal technology that just realizing it could be done and
then doing it in a test tube for the first time earned Paul Berg a share of the 1980 Nobel Prize
in Chemistry. First, we’ll look at cDNA synthesis (the synthesis of DNA copies of RNA),
something retroviruses routinely do as part of their reproductive pathway (Figure. 15.1).

Fig. 15.1: Infection by a retrovirus (left) requires reverse transcriptase encoded in its own genome to
make a copy (cDNA) of its genome leading to replication of viral cDNA and the reproduction of new
viruses in the infected cell (right).
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As shown, the retrovirus injects its RNA into a target cell. There it transcribes a reverse
transcriptase. This enzyme reverse-transcribes a copy DNA (cDNA) complementary to the viral
RNA. The same enzyme next makes a (ds)cDNA (double stranded cDNA), which then
replicates. These cDNAs are transcribed into new viral RNA genomes and mRNAs for viral
proteins. The latter encapsulate the RNA genomes into new viruses. Reverse transcriptases,
along with many viral, bacterial, and even eukaryotic enzymes and biomolecules, are now part
of our recombinant DNA and genetic engineering toolkit.
We will see how a cDNA library is made and screened for a cDNA clone, and how a
cloned cDNA can fish an entire gene out of a genomic library. Then we look at PCR (the
polymerase chain reaction ) and how it can produce (amplify) millions of copies of a single
gene (in fact DNA sequence) from as little DNA as is found in a single cell. In addition to its
well-publicized use in forensics and more recently in definitive tests for the SARS-Cov-2
viruses, PCR is also a vital laboratory tool for fetching, amplifying, and studying sequences of
interest. These venerable technologies illustrate important principles of cloning and sequence
analysis. Of course, the analysis of traditionally cloned and amplified DNA sequences has
been used to study the evolution and expression of individual genes.
A cautionary note: despite the realized and future promises of such powerful tools to
clone recombinant cDNAs and genomic DNA, we are sometimes misled! For example,
knowing that a genetic mutation is associated with an illness usually leads to a search for how
the mutation might cause the illness. But as researchers in any discipline keep warning us,
correlation is not causation! In fact, we know that many phenotypes, including genetic disease,
are not the result of a single mutant gene. Autism is just one example. Nevertheless, newer
fields of genomics and proteomics leverage a growing battery of tools to study many genes
and their regulatory networks at the same time. The molecular networking made possible by
genomics and proteomics (and other colorful, holistic terms we’ll discuss later) promise to get
us past naive and often incorrect notions of causation. We may soon be able to identify many
correlations that might add up—if not to causation—at least to a propensity for genetic illness.
We’ll look at some of these tools of leverage!
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Learning Objectives
When you have mastered the information in this chapter, you should be able to do the
following:
1. Design a molecular experiment using cDNA or a PCR product to clone a gene?
2. Determine when to make or to use a cDNA library or a genomic library.
3. Outline an experiment to purify rRNA from eukaryotic cells.
4. Outline an experiment to isolate and then clone human cDNA for further study.
5. Explain why (you might want to clone and to express a human growth hormone gene.
6. List components needed to make a cDNA library, using purified poly(A) RNA.
7. List the components needed to make a genomic library from isolated genomic DNA.
8. Compare PCR and genomic cloning as strategies for isolating a gene.
9. Outline a strategy for using fly DNA to obtain copies of a human DNA sequence.
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10. Ask a research question that requires screening a genomic library for a specific gene.
11. Ask a question that requires using a microarray to obtain a gene you want to study.

15.2

Make and Screen a cDNA Library

To make a cDNA library, first isolate cellular mRNA. This extract should represent all of the
transcripts in the cells at the time of isolation, or the cell’s transcriptome. This term is used in
analogy to genome. While the genome is all of the genetic information of an organism, a
transcriptome (usually eukaryotic) reflects all of the genes expressed in a given cell type at a
moment in time. Reverse-transcribed cDNAs from an mRNA extract are also referred to as a
transcriptome. A tube full of bacterial cells that were transformed with plasmids recombined
with cDNAs is a cDNA library. cDNA libraries made from mRNAs from different cell types are
in fact different transcriptomes; likewise, cDNA libraries from mRNAs taken from the same
cells but grown under different conditions. A cDNA library reflects the mRNAs transcribed in
cells at the moment of extraction. When cells in a cDNA library are spread out on a nutrient
agar petri dish, each cell grows into a colony; each cell in the colony is a clone of the starting
cell. cDNA libraries can be used to isolate and then to sequence the DNA encoding a
polypeptide that you are studying.
Recall that the mature mRNA in eukaryotic cells has been spliced. Thus, cDNAs made
from eukaryotic cells do not include introns. Introns, as well as sequences of enhancers and
other regulatory elements in and surrounding a gene, must be studied in genomic libraries (to
be discussed later). Here we look at how to make a cDNA library.
15.2.1 cDNA Construction
mRNA is only a few percent of eukaryotic cell RNA; most is rRNA. But that small
amount of mRNA can be isolated from other RNAs because of their 3′ poly(A) tails. Simply pass
a total RNA extract over an oligo(dT) column like the one illustrated in Figure 15.2.

Fig. 15.2: Poly(A) tail at the 3' end of most eukaryotic mRNAs make them easy to separate from other
cellular RNAs (e.g., rRNA, tRNA) by oligo(dT) column chromatography.
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The strings of thymidine (T) in the oligo(dT) column form H-bonds with the poly(A)
tails of mRNAs, tethering them to the column. All RNAs without a 3′ poly(A) tail will flow
through the column as waste. A second buffer is passed through the column to destabilize the
H-bonds to allow elution of an mRNA fraction. If “free” oligo(dT)is then added to the eluted
mRNA, it also forms H-bonds with the poly(A) tails of the mRNAs, where it can serve as a
primer for the synthesis of cDNA copies of the poly(A) mRNAs originally in the cells. Adding
four deoxynucleotide DNA precursors and reverse transcriptase (e.g., from chicken retrovirus–
infected cells) will start reverse transcription. Figure 15.3 shows the synthesis of a cDNA
strand complementary to an mRNA.

Fig. 15.3: Reverse transcriptase, supplied with deoxynucleotides, mRNAs, and an oligo(dT) primer, will
catalyze synthesis 5' - 3' cDNA synthesis from an mRNA template in vitro.

After being heated to separate the cDNAs from the mRNAs, the cDNA is replicated to
produce double-stranded cDNA, or (ds)cDNA (Figure 15.4).

Fig. 15.4: A new cDNA strand can form a loop at its 3′ end (upper) to act as a primer to synthesize
a (ds)cDNA. Reverse transcriptase is also a DNA polymerase catalyzes second-strand synthesis
(middle). The 'loop' can be removed (lower) by a single-stranded endonuclease (e.g. S1 nuclease).
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Replication of the second cDNA strand is also catalyzed by reverse transcriptase.
Second-strand synthesis is primed by the 3′ end of a stem-loop structure that can form with
most mRNAs. Reverse transcriptase is also a DNA polymerase, recognizing DNA as well as
RNA templates, with the same 5′-to-3′ DNA polymerizing activity as all DNA and RNA
polymerases. After second cDNA strand synthesis, an S1 nuclease (a specifically singlestranded endonuclease originally isolated from an East Asian fungus!) is added. This nuclease
will open the loop of the (ds)cDNA structure and trim the rest of the single-stranded DNA.
What remains is the (ds)cDNA.

258 Isolate mRNA and Make cDNA

259 Reverse Transcriptase

15.2.2 Cloning cDNAs into Plasmid Vectors
To understand cDNA cloning and other aspects of making recombinant DNA, let’s look again
at what’s in the recombinant DNA tool kit. In addition to reverse transcriptase and S1 nuclease,
other enzymes in the kit include restriction endonucleases (REs or restriction enzymes for
short) and DNA ligase. The natural function of REs in bacteria is to recognize and hydrolyze
specific restriction site sequences in phage DNA, destroying the phage DNA and avoiding
infection.
CHALLENGE: At 4–6 bp long, typical RE sites occur often and by chance in
DNA. How does a phage-infected bacterium keep its RE from attacking its
own genome?
Some restriction enzymes cut through the two strands of the double helix to leave blunt
ends. Others make a staggered cut on each strand at their restriction site, leaving behind
complementary (“sticky”) ends for H-bond formation (Figure 15.5).

Fig. 15.5: Bacterial restriction endonucleases (REs) recognize and hydrolyze “foreign” DNA
(e.g., phage DNA), blocking infection; most REs cut DNA at specific short DNA sequences, often
at different positions along the double helix, leaving staggered (or “sticky”) ends.
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CHALLENGE: Typical RE sites are palindromes. Consider one strand of this
EcoR1 RE site: 5′-GAATTC-3′. Fill in the opposite strand to see the
palindrome and look up how EcoR1 digestion leaves staggered ends.
If two dsDNAs from different sources (e.g., different species) are digested with an RE
that makes a staggered cut, the resulting fragments will have the same sticky ends. If you mix
these DNAs, their complementary ends will form H-bonds linking the fragments. If the linked
fragments are from different sources, we can add DNA ligase to covalently seal the fragments.
We say then that the fragments have been recombined. Such a protocol makes it relatively
easy to recombine any two different DNAs at will. Let’s look at how we recombine plasmid
DNAs and cDNA—the first steps in cloning cDNAs.
15.2.3 Preparing Recombinant Plasmid Vectors Containing cDNA Inserts

Vectors (such as plasmids or phage DNA) are carriers engineered to recombine with foreign
DNAs of interest. When a recombinant vector with its foreign DNA insert gets into a host cell,
it can replicate many copies of itself, enough for easy isolation and study. cDNAs are typically
inserted into plasmid vectors (usually “store-bought”). They can be cut with an RE at a suitable
location, leaving those sticky ends. However, it would not do to digest (ds)cDNA with
restriction endonucleases, since the goal is not to clone cDNA fragments but entire cDNA
molecules. Therefore, it will be necessary to attach linkers to either end of the (ds)cDNAs.
Plasmid DNAs and cDNA-linker constructs can then be digested with the same restriction
enzyme to produce compatible sticky ends. Figure 15.6 shows the steps in the preparation of a
vector and (ds)cDNA for recombination.

Fig. 15.6: Linearized plasmid with overlapping (“sticky”) ends is made by restriction digestion (left).
Synthetic linkers with compatible restrictions sites are linked to cDNAs with DNA ligase (right).
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To prepare for recombination, a plasmid vector is digested with a restriction enzyme to
open the DNA circle. The (ds)cDNAs to be inserted into the plasmid vector are mixed with
linkers and DNA ligase to attach a linker DNA at both ends of the (ds)cDNA. The linkers are
short, synthetic (ds)DNA oligomers, containing restriction sites recognized by the same
restriction enzyme that linearized the plasmid. Linkers attached to the (ds)cDNAs ends are
digested with the appropriate restriction enzyme to give them “sticky ends” complementary to
the staggered, plasmid ends.

260 Restriction Enzymes and Recombinant DNA
15.2.4 Recombining Plasmids and cDNA Inserts and Transforming Host Cells
The next step is to mix the digested plasmids with the digested linker-ended cDNAs in just the
right proportions so that most of the cDNAs form H-bonds with most of the sticky plasmid ends
(and not with each other!). Once the H-bonds have formed between the cDNAs and plasmids,
the addition of DNA ligase forms phosphodiester linkages between plasmid and cDNA insert
to complete the recombinant circle of DNA (Figure 15.7).

Fig. 15.7: Restriction-digested plasmid and linker-cDNAs with compatible “sticky ends” are mixed at
appropriate concentrations (upper); the double-stranded cDNAs H-bond to the compatible sticky ends of
plasmids. DNA ligase is added to covalently seal the recombinant plasmids with different cDNA
inserts(below).

In early cloning experiments, an important consideration was how to generate
plasmids with only one copy of a given cDNA insert (rather than how to make lots of re-ligated
plasmids with no inserts or how to make lots of plasmids with multiple inserts). Improved,
better-engineered vector and linker combinations made this issue less important.

344

CHALLENGE: Improvements include vectors with multiple restriction- enzyme
sites. Vectors with two different restriction enzymes could then be ligated
to cDNAs with different oligonucleotide linkers at each end. How might
this fix solve some of the recombination issues noted here?

261 Recombine a cDNA Insert with a Plasmid Vector
15.2.5 Transforming Host Cells with Recombinant Plasmids
The recombinant DNA molecules are now ready for the next step: the creation of a cDNA
library. The recombinant DNAs are added to E. coli (or other) host cells, which have been
made permeable so that they are easily transformed. Recall that transformation (as defined by
Griffith) is the bacterial uptake of foreign DNA, leading to a genetic change. The transforming
principle in cloning is the recombinant plasmid! The transformation step that results in a tube
full of transformed cells (which is, in fact, the cDNA library) is shown in Figure 15.8.

Fig. 15.8: To make a cDNA library, host cells are treated to make them permeable and then mixed
with recombinant plasmids at a concentration that will favor transformation of each cell by only one
plasmid (upper). The resulting tube of transformed cells (bottom) is the cDNA library.

262 Making the cDNA Library
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15.2.6 Plating a cDNA Library on Antibiotic-Agar to Select Recombinant Plasmids
After all these treatments, not all plasmid molecules in the mix are recombinant; some cells in
the mix haven’t even taken up a plasmid. So, when the recombinant cells are plated on agar,
how do you tell which of the colonies that grow came from cells that took up a recombinant
plasmid? Both the host strain of E. coli and plasmid vectors used these days were further
engineered to solve this problem. Specifically, the first really useful plasmid vectors were
designed to carry an antibiotic-resistance gene. In the following example, ampicillin-sensitive
cells are transformed with recombinant plasmids containing the ampicillin-resistance gene.
The cells are then plated on media containing ampicillin (a form of penicillin); the results are
shown in Figure 15.9.

Fig. 15.9: Only cells containing plasmids will grow into colonies (yellow) on agar containing ampicillin,
since the plasmids contain an ampicillin-resistance gene.

Transformed cells—that is, those that that took up a recombinant plasmid carrying the
ampicillin-resistance gene—can grow on the ampicillin-agar medium. Untransformed cells
(cells that failed to take up a plasmid) lack the ampicillin-resistance gene and cannot grow on
the ampicillin medium.
But there is still a question: How can you tell whether the cells that grew were really
transformed by a recombinant plasmid containing a cDNA insert? It is possible that some of
the transformants are nonrecombinant plasmids that still have the ampicillin-resistance gene!
To address this issue, plasmids were further engineered to contain a streptomycin-resistance
gene (as well as the ampicillin-resistance gene). But in this case, the restriction-enzyme sites
in the plasmid that were to be used for recombination were placed in the middle of the gene.
So inserting a cDNA into this plasmid would disrupt and inactivate the streptomycinresistance gene. This second bit of genetic engineering enabled harvesting only cells
transformed with recombinant plasmids (i.e., those containing a cDNA insert).
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We can tell transformants with recombinant plasmids apart from those with nonrecombinant plasmids by the technique of replica plating (Figure 15.10).

Fig. 15.10: In this example of replica plating, a filter picks up a few cells from colonies on an
original plate (left). The 'replica filter' is inverted and placed on a fresh agar plate containing an
antibiotic that selects for the growth of recombinant plasmids (right). Upon incubation, only cells
transformed with recombinant plasmids grow on the filter in the 'replica plate' (bottom).

After colonies grow on the ampicillin-agar plate, lay a filter over the plate. The filter will pick
up a few cells from each colony, in effect becoming a replica filter (i.e., a mirror image) of the
colonies on the plate. Next, place the replica filter on a new agar plate containing streptomycin.
Any colonies that grow on the filter must be streptomycin-resistant, containing only
nonrecombinant plasmids. Colonies containing recombinant plasmids, those that did not grow
in streptomycin, are easily identified on the original ampicillin-agar plate.
In practice, highly efficient recombination and transformation procedures typically
reveal very few streptomycin-resistant cells (i.e., colonies) after replica plating. When this
happens, the ampicillin-resistant cells constitute a good cDNA library, ready for screening.

263 Making a Replica Plate Filter
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15.2.7 Identifying Colonies Containing Plasmids with Inserts of Interest
The next step is to screen colonies in a cDNA library for those containing a specific cDNA.
Since cells typically make thousands of proteins at the same time, a cDNA library should
contain thousands of cDNAs made from thousands of mRNAs. Finding a single cDNA of
interest can require plating the cDNA library in a tube on more than a few agar plates.
Continuing with the example above, actual screening would be done using multiple
replica filters of ampicillin-resistant cells. The number of replica filters to be screened can be
calculated from assumptions and formulas for estimating the number of colonies to be
screened in order to represent an entire transcriptome (i.e., the number of different mRNAs in
the original cellular mRNA source (including in this example, globin mRNAs).
Once the requisite number of replica filters is made, they are subjected to in situ lysis
to disrupt cell walls and membranes. The result is that the cell contents are released, and the
DNA is denatured (unwound to become single-stranded). The DNA then adheres to the filter
in place (in situ), where the colonies were. The result of in situ lysis is a filter with faint traces
of the original colonies (Figure 15.11).

Fig. 15.11: Replica filters are lysed in situ (in place), leaving partially denatured DNA (including
recombinant plasmid DNA) from the colonies where the cells used to be. Filters can be probed for a
sequence of interest.

Next, a molecular probe is used to identify DNA containing the sequence of interest.
The probe is often a synthetic oligonucleotide, the sequence of which was inferred from
known amino acid sequences. These oligonucleotides are made radioactive and placed in a
bag with the filter(s). DNA from cells that contained recombinant plasmids with a cDNA of
interest will bind the complementary probe. The results of in situ lysis and hybridization of a
radioactive probe to a replica filter are shown in Figure 15.12 (below).
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Fig. 15.12: Replica filters of denatured DNA are exposed to a radioactive nucleic acid probe that can
hybridize to the target sequences on the filters. The asterisk on the lower filter is radioactive probe bound
to complementary DNA released by a recombinant colony.

264 Probing a Replica Plate Filter
The filters are rinsed to remove the unbound radioactive oligomer probe and then
placed on X-ray film. After a period of exposure, the film is developed. Black spots will form on
the film from radioactive exposure, creating an autoradiograph of the filter. The black spots in
the autoradiograph in Figure 15.13 correspond to colonies on a filter that contain a
recombinant plasmid with the target cDNA sequence.

Fig. 15.13: After rinsing the replica filter to remove excess radioactive probe, an autoradiograph
is made to detect a colony of interest. X-ray film is placed over the filter (upper image). After
exposure, the ‘X-ray’ is developed. The resulting autoradiograph shows a dark spot where the
probe hybridized to colony DNA.
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From a positive on the film, recombinant colonies are located on the original plate and
grown in liquid culture for plasmid DNA isolation. Next, cDNAs are sequenced and the amino
acid sequences they encode are inferred from the genetic-code dictionary. Once verified,
recombinant plasmids can be isolated, tagged (made radioactive or fluorescent), and used for
various purposes:
•
•
•

To probe for the genes from which they originated
To identify and to quantitate the mRNA and even to locate the transcripts in the cells
To quantitatively measure amounts of specific mRNAs

Isolated plasmid cDNAs can even be expressed in suitable cells to make the encoded protein.
These days, diabetics no longer receive pig insulin; rather, they get synthetic human insulin
made from expressed human cDNAs. Moreover, while the introduction of the polymerase
chain reaction (PCR; see section 15.5) has superseded some uses of cDNAs, they still play a
role in genome-level and transcriptome-level studies.

265 Pick a Clone from a Replica Filter and Play with It!

15.3

DNA sequencing

For some perspective, we should note that RNA sequencing came first, when Robert Holley
sequenced a yeast transfer RNA (tRNA) in 1965. The direct sequencing of tRNAs was possible
because they are small, short nucleic acids, and because many of the bases in tRNAs are
chemically modified after transcription, making them easy to identify.
Twelve years later, in 1977, two different methods for sequencing DNA were reported. One
method, developed by Allan Maxam and Walter Gilbert, involved fragmenting DNA,
sequencing the small fragments, and then aligning the overlapping sequences of the short
fragments to assemble longer sequences. This became known as Maxam-Gilbert DNA
sequencing. The other method was developed by Frederick Sanger and colleagues in England:
the DNA synthesis-based dideoxy-DNA sequencing technique. Sanger and Gilbert shared a
Nobel Prize in Chemistry in 1983 for their DNA-sequencing work. However, because of its
simplicity, Sanger’s dideoxy method quickly became the standard for sequencing all manner of
cloned DNAs, including the first complete sequencing of a genome—that of a bacterial virus
called bacteriophage φX174.
Early improvements in recombinant DNA technology were happening at the same time
as advances in sequencing. More efficient, rapid cloning and sequencing of DNA from
increasingly diverse sources led to genome projects. The first of these were on genomes of
important model organisms—for example, E. coli, C. elegans, S. cerevisiae (yeast), and of
course, us! By 1995 Craig Venter and colleagues at the Institute for Genomic Research
completed an entire bacterial genome sequence (of Haemophilus influenzae); by 2001 Venter’s
private group, along with Francis Collins and colleagues at the National Institutes of Health,
had published a first draft of the sequence of the human genome. Venter had proven the
efficacy of a whole-genome-sequencing approach called shotgun sequencing, which was much

350

faster than the gene-by-gene, fragment-by-fragment, “linear” sequencing strategy being used
by other investigators (more on shotgun sequencing later!). Since Sanger’s dideoxynucleotideDNA-sequencing method remains a common, economical methodology, let’s consider the
basics of the protocol.
15.3.1 Manual DNA Sequencing
Given a template DNA (e.g., a plasmid cDNA), Sanger used in vitro replication protocols to
demonstrate that he could do the following:
• Replicate DNA under conditions that randomly stopped nucleotide addition at every
possible position in growing strands
• Separate and then detect these DNA fragments of replicated DNA
Recall that DNA polymerases catalyze the formation of phosphodiester linkages by linking the
 phosphate of a nucleotide triphosphate to the free 3’ OH of a deoxynucleotide at the end of a
growing DNA strand. Recall also that the ribose sugar in the deoxynucleotide precursors of
replication lack a 2’ OH (hydroxyl) group. Sanger’s trick was to add dideoxynucleotide
triphosphates to his in vitro replication mix. The ribose on a dideoxynucleotide triphosphate
(ddNTP) lacks a 3’ OH, as well a 2’ OH (Figure 15.14).

Fig. 15.14: Chemical structure of a dideoxynucleotide.

Adding dideoxynucleotides to a growing DNA strand stops replication. Lacking an OH
at the 3’ end of the strand, DNA polymerase can’t catalyze a dehydration synthesis to form the
next phosphodiester linkage. Because they can stop replication in actively growing cells,
ddNTPs such as dideoxyadenosine (tradename, cordycepin,) are anticancer chemotherapeutic
drugs.

266 Treating Cancer with Dideoxynucleosides
A look at a manual DNA sequencing reveals what is going on in the sequencing
reactions. Four reaction tubes are set up, each containing the template DNA to be sequenced.
Each tube also contains a primer of known sequence and the required deoxynucleotide
precursors necessary for replication. Figure 15.15 (below) shows the setup for manual DNA
sequencing.
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Fig. 15.15: Each tube in Frederick Sanger’s manual DNA sequencing protocol contains the same
DNA to be sequenced, a DNA polymerase (usually Taq polymerase), an oligonucleotide primer, and
deoxynucleotide precursors, but each tube contains a different dideoxynucleotide.

A different ddNTP, (ddATP, ddCTP, ddGTP, or ddTTP) is added to each of the four
tubes. Then, DNA polymerase is added to each tube to start the DNA-synthesis reaction.
During DNA synthesis, different-length fragments of new DNA accumulate as ddNTPs are
incorporated at random, opposite complementary bases in the template DNA being sequenced.
A short time after adding the DNA polymerase, the mixture is heated to separate the DNA
strands, and fresh DNA polymerase is added to replace the enzyme destroyed by heating and
to repeat the synthesis reactions. These reactions are repeated as many as thirty times in order
to produce enough radioactive DNA fragments to be detected. Expectations for these
sequencing reactions in the four tubes are illustrated in Figure 15.16.

Fig. 15.16: In each of the 4 tubes in Fig. 15.15, different-length DNA fragments were synthesized
until replication was terminated by incorporating a dideoxy nucleotide, as illustrated here. The
fragments are separated by polyacrylamide gel electrophoresis to read a DNA sequence.
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CHALLENGE: dNTP and ddNTP concentrations are carefully controlled in
DNA sequencing reactions. What might result if ddNTP levels are too high?
When the Taq DNA polymerase from the thermophilic bacterium Thermus aquaticus
became available (more later!), it was no longer necessary to add fresh DNA polymerase after
each replication cycle, because the heating step required to denature new DNA made in each
cycle would not destroy the heat stable Taq DNA polymerase.
Thanks to Taq polymerase, the many heating and cooling cycles required for what
became known as dideoxy-chain-termination DNA sequencing were soon automated using
inexpensive programmable thermocyclers. Since a small amount of a radioactive
deoxynucleotide (usually 32P-labeled ATP) was present in each reaction tube, all newly made
DNA fragments are radioactive. After electrophoresis to separate the new randomly terminated
DNA fragments in each tube, autoradiography of the electrophoretic gel reveals the position of
each terminated fragment. The DNA sequence can then be read from the gel as illustrated in
the simulated autoradiograph (Figure 15.17).

Fig. 15.17: The electrophoretic gel of dideoxy-terminated DNA fragments in Fig. 15.16 is exposed to
X-ray film to create this autoradiograph. The bands are readable from the bottom up to reveal a DNA
sequence based on the different length dideoxy-terminated DNA fragments.

The DNA sequence can be read by reading the bases from the bottom of the film,
starting with the C at the bottom of the C lane. Try reading the sequence yourself!

267 Manual Dideoxy Sequencing
15.3.2 Automated First-Generation DNA Sequencing
The first semi-automated DNA sequencing method was invented in Leroy Hood’s California
lab in 1986. Though the method still used Sanger’s dideoxy sequencing, a radioactive
phosphate-labeled nucleotide was no longer necessary. Instead, each dideoxynucleotide
(ddNTP) in a sequencing reaction is tagged for detection with a different fluorescent dye.
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Sequence reaction products are electrophoresed on an automated DNA sequencer.
The migrating dideoxy-terminated DNA fragments pass through a beam of UV light, and a
detector “sees” the fluorescence of each DNA fragment. The color and order of the fragments is
sent to a computer, which generates a colored plot showing the length and order of the
fragments, and thus their sequences (Figure 15.18).

Fig. 15.18: An automated DNA sequence chromatograph; the sequence is read from left to right.

A most useful feature of this sequencing method is that a template DNA could be sequenced in
a single tube containing all the required enzymatic components, as well as all four of the
dideoxynucleotides! That’s because the fluorescence detector in the sequencing machine
separately sees all the short ddNTP-terminated fragments as they move through the
electrophoretic gel. Hood’s innovations were quickly commercialized, making major
sequencing projects possible (including many genome projects). Automated DNA sequencing
rapidly augmented large sequence databases in the United States and Europe. In the United
States, the National Center for Biological Information (NCBI) maintains a sequence database
and archives virtually all DNA sequences determined worldwide. New “tiny” DNA sequencers
have made the requirements for sequencing DNA so portable that in 2016, one was even used
in the International Space Station (see the photo at the top of this chapter!). New tools and
protocols (some described in this chapter) are used to find, compare, and globally analyze
DNA sequences almost as soon as they get into the databases.

268 Automated Sequencing Leads to Large Genome Projects
CHALLENGE: What chemical properties of Taq polymerase could explain
the stability of this enzyme at temperatures near 100oC?

15.3.3 Shotgun Sequencing
Large-scale sequencing targets entire prokaryotic and (typically much larger) eukaryotic
genomes. The latter require strategies that either sequence long DNA fragments or sequence
many short DNA fragments more quickly (or both). We already noted the shotgun sequencing
strategy used by Venter to sequence whole genomes (including our own—or, more accurately,
his own!).
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In shotgun sequencing, cloned DNA fragments of 1,000 bp or longer are broken down
at random into smaller, more easily sequenced fragments. The fragments are themselves
cloned and sequenced. Nonredundant sequences are then assembled by the aligning of
sequence-overlap regions.
When there are no gaps (which would be due to unrepresented DNA fragments that
fail to be sequenced), today’s computer software is quite adept at rapidly aligning the available
overlapping sequences and connecting them to display long, contiguous DNA sequences.
Shotgun sequencing is summarized in Figure 15.19.

Fig. 15.19: Overview of shotgun sequencing of DNA. Randomly fragmented genomic DNA is
recombined with vector (steps 1, 2). Host cells are transformed with recombinant DNAs and cultured
to make a genomic library (step 3). DNA is extracted from many colonies and sequenced (steps 4, 5).
Sequences are fed to a computer to find overlapping sequences and arrange sequenced fragments in
order (step 6).

Sequence gaps that remain after shotgun sequencing can be filled in by primer
walking. In this method, a sequencing primer (created based on a known sequence near the
gap) “walks” into the gap region on an intact DNA (i.e., that has not been fragmented).
Another “gap-filling” technique involves the polymerase chain reaction (PCR). Two
oligonucleotides are synthesized, based on sequence information on either side of a gap; then,
PCR is used to synthesize the missing fragment, which is sequenced to fill in the gap (PCR will
be described more fully in section 15.5).
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15.3.4 Next-Generation DNA Sequencing
The goals of next gen sequencing methods are to get an accurate reading of millions or even
billions of bases in a short time. Examples of these sequencing systems include
pyrosequencing, ligation-based sequencing, and ion-semiconductor sequencing; these involve
methods of massively parallel sequencing reactions. They differ in detail, but all require a
library (e.g., genomic, or transcriptomic) attached to a solid surface, not unlike a microarray.
The attached DNAs are amplified in situ into separate DNA clusters derived from single library
clones. The amplified, clustered DNAs then participate in the sequencing reaction. Sequences
are analyzed and generated by computer. However, accuracy is a problem. Longer reads take
more reactions and more time, and this leads to reduced accuracy. For a look at some of these
technologies, see 15.2Next Generation Sequencing Video. A more accurate new technology is
nanopore-based DNA sequencing, outlined in Figure 15.20. Nanopore sequencing was first
used on the space station in 2016.

Fig. 15.20: Nanopore DNA sequencing is one of several “next-gen” sequencing technologies. A helicasenanopore protein complex is embedded in a phospholipid bilayer membrane. An applied potential
difference (voltage) across the membrane drives double-stranded DNA through the helicase-nanopore. As
the DNA (now single-stranded) travels through the nanopore, disturbances of the voltage difference are
detected and converted to sequence data.

This device uses an artificial phospholipid membrane, in which is embedded a
synthetic, engineered helicase/motor-pore-protein complex. The nanopore is itself derived
from the Mycobacterium smegmatis porin A (MspA). A voltage is applied across the membrane
to create a membrane potential. Double-stranded DNA is propelled into the helicase, where it
is unwound. The resulting single-stranded molecules then pass through a tiny hole (the
nanopore) in the MspA. As the ssDNA (or RNA) passes through, its charge configurations
disturb the electrical field in the porin. These disturbances are different for each nucleotide,
generating a unique signal that is detected, recorded, and displayed in almost real time on a
small computer. Next-generation sequencing protocols and devices are already providing long
and increasingly more accurate data, which is required for research and for clinical
applications. Check out 15.1Sequencing DNA in Space (again) to see why one would want to
do this!
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While first-generation automated dideoxy-Sanger sequencing is still widely used to analyze
individual cDNAs, genes or PCR products, next-gen DNA sequencing is more rapid, and it can
also be used in the field, for research as well as for practical analyses. And, as if this weren’t
enough, now comes word of a marriage of a nano-sequencer and a cell phone analytical app to
make immediate sense of a nano-sequence (15.3iGenomics: A Nanotech Marriage). Check out
your Star Trek creds and ask can a real tricorder be on the way to a real Dr. McCoy even before
we have a real Enterprise? Will this new married couple be able to identify microbial agents of
disease on location?

15.4

Genomic Libraries

Any tube full of recombinant bacteriophage is basically a genomic library. Each phage DNA
molecule in the library should contain a fragment of foreign cellular DNA. A good genomic
library will contain a representation of all of the possible fragments of an organism’s genome.
Bacteriophage are often used as vectors to clone genomic DNA fragments because phage
genomes are bigger than plasmids and can be engineered to remove large amounts of DNA
that are not needed for infection and replication in host cells. The missing DNA can then be
replaced by large foreign DNA inserts—fragments as long as 18-20 Kbp. That’s nearly twenty
times longer than cDNA inserts in plasmids. Purified phage coat proteins can then be mixed
with the recombined phage DNA to reconstitute infectious phage particles (i.e., recombinant
phage). Infection of host bacteria by these “particles” leads to replication of the recombinant
phage DNA, new phage production, cell lysis, and the release of lots of new recombinant
phage.
Consider the following bit of math: A typical mammalian genome consists of more than
2,000,000,000 bp (3,200,000,000 in humans!). Inserts in plasmids are very short, rarely
exceeding 1,000 bp. If you divide two billion by one thousand, you get two million, the
minimum number of recombinant plasmid clones that must be screened to find a sequence of
interest. In truth, you would need much more than this number of clones to find the smaller
parts of a gene that add up to a whole gene! Of course, part of the solution to this “needle in a
haystack” dilemma is to clone larger DNA inserts in more accommodating vectors. And that is
the value of a bacteriophage vector and even more accommodating vectors, including whole
chromosomes! Consider the Yeast Artificial Chromosome (YAC), hosted by (replicated in)
yeast cells.
YACs can accept humongous foreign DNA inserts! To replicate in a yeast cell, a
chromosome need have only one centromere and two telomeres, and little else! Recall that
telomeres are needed in replication to keep the chromosome from shortening during
replication of the DNA. The centromere is needed to attach chromatids to spindle fibers so that
they can separate during anaphase in mitosis (and meiosis).
From this brief description, you may recognize a common strategy for engineering a
cloning vector: determine the minimum properties that your vector must have and remove
nonessential DNA sequences. Of course, for cloning, you must include some useful restriction
sites. Then you have enabled recombination with inserts as long as 2,000 Kbp. That’s a YAC…
The tough part, of course, is keeping a 2,000 Kbp-long DNA fragment intact long enough to
get it into the YAC!
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CHALLENGE: There is another “minimum” requirement for replicating
chromosomal DNA (in a YAC vector or a cell). What might that be, and why
do you think it’s not mentioned here?
Whatever the vector of choice, sequencing its insert can tell us many things. It can
show us how a gene is regulated by confirming known and/or revealing new regulatory DNA
sequences. It can show us neighboring genes, helping us to map them on chromosomes and
reveal evolutionary genetic relationships. Genomic DNA sequences from one species can
probe for similar sequences in other species, allowing comparative sequence analysis that can
tell us a great deal about gene evolution and the evolution of species. One early surprise from
gene sequencing studies was that we share many common genes and DNA sequences with
other (in fact most) species, like yeast, worms, flies, and (of course) vertebrates, including our
more closely related mammalian friends. You may already know that chimpanzee and human
genomes are 99% similar. And we have already seen comparative sequence analysis showing
how proteins with different functions in the same (and even across) species nevertheless share
structural domains.
Let’s look at how we would make a phage genomic library that targets a specific gene
of interest. As you’ll see, the approach is like cloning a foreign DNA into a plasmid or in fact,
into any other vector, but the numbers and details are shown here to exemplify cloning in
phage.
15.4.1 Preparing Specific-Length Genomic DNA for Cloning: The Southern Blot
To begin with, high molecular weight (i.e., long molecules of) the desired genomic
DNA are isolated, purified, and then digested with a restriction enzyme. Usually, the digest is
partial, aiming to generate overlapping DNA fragments of random length. The digested DNA
is mixed with ethidium bromide, a fluorescent dye that binds to DNA. After electrophoresis on
agarose gels and exposed to UV light, the DNA appears as a bright fluorescent smear. If we
wanted to clone the complete genome of an organism, we could recombine all DNA with
suitably digested vector DNA. But since we are only after one gene, we can reduce the number
of clones required to be screened to find a sequence of interest.
In the early days of cloning, we would do this by creating a Southern blot (named after
Edward Southern, the inventor of the technique). This technique lets us identify the size of
genomic DNA fragments most likely to contain a desired gene. A summary of the steps to
make a Southern blot follows:
1. Digest genomic DNA with one or more restriction endonucleases.
2. Run the digest products on an agarose gel to separate fragments by size (length). The DNA
appears as a smear when stained with a fluorescent dye.
3. Place a filter on the gel. The DNA transfers (blots) to the filter for about 24 hours (or more).
4. Remove the blotted filter and place it in a bag containing a solution that can denature the
DNA.
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5. Add a radioactive probe (e.g., cDNA) containing the gene or sequence of interest. The
probe hybridizes (binds) to complementary genomic sequences on the filter.
6. Prepare an autoradiograph of the filter and see a “band” representing the size of genomic
fragments of DNA that include the sequence of interest.
The Southern-blot protocol is illustrated in Figure 15.21 (below).

Fig. 15.21: Making a Southern blot: DNA fragments are electrophoresed on agarose gels (1). During
‘blotting’ (2), liquid and DNA fragments on the gel transfer and stick to a nylon membrane. After treating
the blot to denature (separate) DNA strands (between steps 2 and 3), radioactive probe (e.g., cDNA,
RNA) is allowed to hybridize to DNA on the filter (between steps 3 and 4). DNA fragments are detected
and their sizes revealed by autoradiography (4).

CHALLENGE: Why do the genomic DNAs on the gel (third panel, Fig. 15.21)
appear as a smear instead of as bands of discrete size/length?
Once you know the size (or size range) of restriction-digest fragments that contain the
DNA you want to study, you are ready to run another gel of digested genomic DNA, and then:
• cut out the piece of gel containing fragments of the size that “lit up” with your probe in the
autoradiograph.
• Remove (elute) the DNA from the gel piece into a suitable buffer.
• Prepare the DNA for insertion into (i.e., recombination with) a vector for genomic cloning.
15.4.2 Recombining Size-Restricted Genomic DNA with Phage DNA
After eluting the restriction-digested DNA fragments of the right size-range from the gels, we
mix the DNA with compatibly digested phage DNA at concentrations that favor the formation
of H-bonds between the ends of the phage DNA and the genomic fragments (rather than with
each other!). The addition of DNA ligase covalently links the recombined DNA molecules.
These steps are abbreviated in the illustration in Figure 15.22 (below).
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Fig. 15.22: Genomic DNA is digested with restriction enzymes (top left); the digest and phage
vectors with compatible “sticky” ends are mixed (top right & center), and then ligated to make
recombinant DNAs (bottom).

The recombinant phage to be made next will contain sequences that will become the genomic
library.
15.4.3 Creating Infectious Viral Particles with Recombinant phage DNA
The next step is to package the recombined phage DNA by adding purified viral coat proteins
to make infectious phage particles (Figure 15.23).

Fig. 15.23: In this ‘packaging’ step, recombinant phage DNA are mixed with phage coat proteins to
‘package’ the DNA into infectious recombinant phage particles (viruses).

269 Genomic Libraries: Make and Package Recombinant Phage DNA
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Packaged phages are added to a culture tube full of host bacteria (e.g., E. coli). After
infection, the recombinant DNA enters the cells, where it replicates and directs the production
of new phage eventually lyse the host cell (Figure 15.24).

Fig. 15.24: Recombinant phage infect host cells and replicate their recombinant DNA to make new
phage. The new phage accumulate, eventually lysing the host cells, forming plaques, allowing the
collection of large amounts of new recombinant phage containing genomic DNA, in other words, a
genomic library.

The recombined vector can also be introduced directly into the host cells by
transduction, which is to phage DNA what transformation is to plasmid DNA. Whether by
infection or transduction, the recombinant phage DNA ends up in host cells, which produce
new phage that eventually lyse the host cell. The released phages go on to infect more host
cells until all cells have lysed. What remains is a tube full of lysate, containing cell debris and
lots of recombinant phage particles.

270 Infect Host with Recombinant Phage to Make a Genomic Library
Just a note on some other vectors for genomic DNA cloning: For large genomes, the goal is to
choose a vector able to house larger fragments of “foreign” DNA, so that you end up screening
fewer clones. We’ve seen that phage vectors accommodate larger foreign DNA inserts than
plasmid vectors, and YACs even more. For a very large eukaryotic genome, it may be
necessary to screen more than a hundred thousand clones in a phage-based genomic library.
Apart from the size-selection of genomic fragments before you insert them into a vector, your
selection of the appropriate vector is just as important. The following table lists commonly used
vectors and the sizes of inserts they will accept.
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Cloning Vector type

Table 15.1
Insert size (thousands of bases)

15.4

up to 15

15.5

up to 25

15.6

up to 45

15.7

70 to 100

15.8

130 to 150

15.9

120 to 300

Plasmids
Phage lambda (λ)
Cosmids
Bacteriophage P1
P1 artificial chromosomes (PACs)
Bacterial artificial chromosomes (BACs)

15.10

Yeast artificial chromosomes (YACs)

250 to 2000

Open the links in the table or use the QR codes (at the end of the chapter) to learn more about
these cloning vectors. We will continue this example by screening a phage-lysate genomic
library for a recombinant phage with a genomic sequence of interest.
15.4.4 Screening a Genomic Library; Titering Recombinant Phage Clones
A bacterial lawn is made by plating so many bacteria on the agar plate that they simply grow
together rather than as separate colonies. If a small number of phages are evenly plated over
the bacterial lawn, each virus will infect one cell. Subsequent lysis of this cell releases many
phage, each infecting a neighboring cell. After a day or so of repeated lysis and infection,
plaques (clearings) appear in the lawn at the site of the first infection. Each plaque shown in
the illustration in Figure 15.25 is a clone of the original phage particle.

Fig. 15.25: After spreading and incubating the genomic library on a ‘lawn’ of host bacterial cells, clearings
form on the lawn; These are phage (viral) plaques, each of which is genomic clone.

To screen a phage genomic library, phage lysate is titered on bacterial lawns. Titration
of a phage lysate typically consists of serial 10-fold dilutions (10X, 100X, 1000X, etc.) with a
suitable medium. Each serial 10× dilution is then spread on a bacterial (e.g., E. coli) lawn,
and the plaques formed on each lawn are counted. Remember, a plaque is a clone of a single
virus. Let’s say that you spread 10 l of an undiluted lysate on a bacterial lawn. After a day or
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so, you see lots of tiny plaques, and after staring at the plate, you figure that there are
thousands of them on the lawn (i.e., too many to count!). But among the serial 10× dilutions of
the lysate on bacterial lawns you count 176 large, well-separated plaques on a ‘lawn’ that was
plated with 10 ml of the eighth serial dilution of the lysate. Therefore, there must have been
1,408 (8 × 176) phage particles in 10 l of the original undiluted lysate.
15.4.5 Screening and Probing a Genomic Library
To represent a complete genomic library, you will need many plates of a serial 10× dilution
containing, say, about five hundred to a thousand plaques per plate. If size-selected fragments
(e.g., identified by Southern blotting) were cloned to make a partial genomic library, then
fewer plaques must be screened to find a sequence of interest. Since plaques contain a lot of
phage DNA not yet packaged at the time of lysis, it is possible to transfer the unpackaged viral
DNA directly to filters by to replica plating (similar to replica plating of bacterial colonies). The
replica filters are treated to denature the DNA and then hybridized to a probe with a known
sequence. In the early days of cloning, the probes were often a sequenced cDNA previously
isolated from libraries of the same or different (usually related) species. After soaking the filters
in a radioactively labeled probe, you place an X-ray film over the filter to be exposed and
developed. Black spots will form where the film is lying over a plaque containing genomic
DNA complementary to the probe. In the example illustrated in Figure 15.26, a globin cDNA
might have been used to probe our partial genomic library. (Globin genes were, in fact, among
the first to be cloned!)

Fig. 15.26: Replica filters of plaques (upper left) are probed with (in this example) a globin DNA sequence).
Next, exposure to Xray film and development of the film (right) reveals spots on the autoradiographs where
the probe hybridized to recombinant phage plaques containing a globin gene sequence.

15.4.6 Isolating the Gene
Cloned genomic DNA fragments are much longer than any gene of interest, and always longer
than any cDNA from a cDNA library. They are also embedded in a genome that is thousands of
times as long as the gene itself, making the selection of an appropriate vector necessary. If the
genome can be screened from a reasonable number of cloned phage (about a hundred
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thousand plaques, for instance), the one plaque producing a positive signal on the
autoradiograph would be further studied. This plaque should contain the gene of interest. At
this point, we seem to have identified a clone containing a globin gene sequence. We can use
this clone to infect yet more host cells and to grow up much more of the globin-genecontaining DNA for further study.

271 Screen a Genomic Library; Pick and Grow a Phage Clone
Given that a gene of interest might be a short sequence embedded in a large genomic
insert that is often as long as 20 Kbp, we must further segregate the gene from the surrounding
genomic DNA. Once again, the traditional strategy involves Southern blotting. The cloned
DNA is purified and digested with restriction endonucleases, and the digest fragments are
separated by agarose gel electrophoresis. A Southern blot is made on a filter (e.g., a nylon
filter), which is soaked in a solution that denatures the DNA on the blot. The filter is then
probed with the same tagged probe used to find the positive clone (plaque). The smallest DNA
fragment containing the gene of interest will be typically subcloned and grown in a suitable
vector to provide enough target-sequence DNA for further study. That suitable vector is often a
plasmid easily grown in E. coli.

15.5

The Polymerase Chain Reaction

The polymerase chain reaction (PCR) can amplify a region of DNA from any source, like DNA
fragments obtained from a fossil or residue left at a crime scene, or even DNA from a single
cell. This amplification usually takes just a few hours, generating millions of copies of the
desired target-DNA sequence. The result is the purification of a specific region of DNA from
surrounding sequences in a single reaction! Kary B. Mullis was awarded a Nobel Prize in 1993
for his development of PCR, which is now the basis of innumerable research studies of gene
structure, function, and evolution as well as applications in criminal forensics, medical
diagnostics, and other commercial uses. PCR is described in detail next.

272 PCR: Design and Synthesize Opposing Oligonucleotide Primers

273 PCR: The Amplification Reaction
15.5.1

PCR—the Basic Process

Typical PCR relies on the investigator knowing just two bits of DNA sequence, which will be
used to design and synthesize short oligonucleotides (oligomers). The oligomers must be
complementary to sequences on opposite strands of double-stranded DNA containing the gene
of interest, with their 3’ ends facing ( opposing) each other on either side of the sequence to be
amplified. This way, the two oligomers can serve as primers for the replication of both strands
of a double-stranded target-DNA sequence. Check out link #272 for further explanation.
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The first step in PCR is to add oligomer primers to the target DNA from which a gene
(or other genomic sequence) is to be amplified. The mixture is then heated to denature the
target DNA. The mixture is cooled to allow the primers to H-bond to complementary targetDNA strands. Next, the four deoxynucleotide precursors to DNA (dATP, dCTP, dTTP and
dGTP) are added, along with a small amount of a DNA polymerase. New DNA strands will
now lengthen from the oligonucleotide primers on the template DNAs. To make lots of the
PCR product, this reaction cycle must be repeated many times. Therefore, after allowing
elongation, the mixture is heated to denature (separate) all the DNA strands. When the
mixture is again cooled, the oligomers again find complementary sequences with which to Hbond. Early versions of PCR originally relied on an E. coli DNA polymerase, which is
inactivated by heating, and so had to be re-added to the PCR mixture for each elongation
cycle. When the heat stable Thermus aquaticus DNA polymerase (Taq polymerase) became
available, it was adapted for PCR because it is active at high temperatures, eliminating the
need to add fresh DNA polymerase after each PCR reaction cycle. It also allowed automation
of PCR reactions with programmable thermocyclers, which raised and lowered the
temperatures during PCR reactions. PCR amplification with Taq polymerase is shown in Figure
15.27.

Fig. 15.27: In PCR, a template DNA to be amplified is mixed with a pair of primers whose
sequences target opposite ends of the template. Addition of DNA polymerase (usually Taq
Polymerase) initiates PCR. The actual sequence to be amplified (from primer to opposing primer)
has been synthesized by the end of the second PCR cycle. Multiple cycles of PCR follow during
which this ‘primer-to-primer’ DNA will be geometrically amplified.
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You can see from the illustration that the second cycle of PCR has generated the two
DNA strands that will be templates for doubling and redoubling the desired product after each
subsequent cycle. A typical PCR reaction might involve thirty PCR cycles, resulting in a nearly
exponential amplification of the desired sequence.
CHALLENGE: Starting with a pair of complementary target-DNA molecules
after the third PCR cycle, how many double-stranded PCR products should
you theoretically have at the end of all thirty PCR cycles?
PCR amplification products are in such abundance that they can be seen under fluorescent
illumination on an ethidium bromide-stained agarose gel (Figure 15.28).

Fig. 15.28: Agarose-gel electrophoresis of PCR-amplified DNA is stained with ethidium bromide to
make the DNA detectable under fluorescent light. PCR products of a globin gene clone from the insect
Chironomus thummi are in lanes 2-5. Their sizes (lengths in base pairs) can be determined by
comparison to the lengths of bands in a standard-DNA size ladder in lane 1.

Because they are so plentiful, PCR-amplified DNAs can be sequenced and used in
many subsequent studies. In this gel, the first lane (on the left) contains a DNA ladder, a
mixture of DNAs of known lengths that can be used to estimate the size of the bright bands
(i.e., PCR products) in the remaining lanes. In this example, four PCR products were amplified
from the same cloned genomic DNA preparation, using different combinations of
oligonucleotide primers.
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15.5.2 The Many Uses of PCR
PCR-amplified products can be labeled with radioactive or fluorescent tags to screen cDNA or
genomic libraries, to determine where a DNA sequence of interest migrates on a Southern blot,
or to determine where an RNA sequence of interest migrates on a Northern blot (a fanciful
name for RNAs that are separated by size on gels and blotted to filter). In a major PCR
advance, Quantitative PCR was developed to study differential gene expression and gene
regulation. The technique allows cDNA amplifications from RNAs under conditions that detect
not only the presence, but also the relative amounts of specific transcripts being made in cells.
Other variant PCR protocols and applications are manifold and often quite inventive! For a list,
see 15.11Variations on Basic PCR. A recent CRISPR/Cas9 variant amplifies DNA and may lead
to PCR at 37oC, eliminating the need for a thermocycler altogether! This could prove especially
useful for conducting PCR in the field. While not yet ready for prime time, check out 15.12Cas9
PCR-No Thermocycler! for more. Future technological advances aside, PCR already has broad
applications in research, forensic science, history, anthropology, ecological studies of species
diversity, and more, and it may even reveal your own genealogy. Let’s look at three of these.
15.5.2.a Forensics
PCR can be applied to identify a person or organism of interest by comparing its DNA to a
standard (control) DNA. Figure 15.29 is an example of a polyacrylamide-gel DNA fingerprint.

Fig. 15.29: A Electrophoretic DNA fingerprint
Using this technology, it is now possible to detect genetic relationships between near
and distant relatives (as well as to exclude such relationships), to determine paternity, to
demonstrate evolutionary relationships between organisms, and to solve recent and even
“cold-case” crimes using DNA left behind on surfaces at crime scenes. Recall that Alu
sequences are ~300 bp short-interspersed elements (SINES) that are highly repeated
throughout the human genome. DNA fingerprinting is possible in part because each of us has
a unique number and distribution of Alu SINEs in our genome. To read more about Alu
sequences and human diversity, look at 15.13Alu Sequences and Human Diversity. Also see
15.14
Sir Alec Jeffries to learn about the origins of DNA fingerprinting in real life—and on all
those TV CSI programs! For a video on DNA fingerprinting, check out
Fingerprinting video.

367

15.15

Alu DNA

15.5.2.b History and Society
DNA is a stable molecule (compared to RNA, which you may know is notably unstable!). This
property made it the ideal molecular repository of genetic information for all life…, and for
DNA fingerprinting. Not only is crime scene DNA stable, but it can also survive in bones and
teeth of long dead organisms, allowing the identification of Egyptian mummies, the Russian
Tsar and his family killed in 1918, and the unearthed English King Richard III.
Using DNA from the living, the missing African American ancestry is emerging,
revealing the consequences of slavery in the United States, including its legacy of lingering
racism (see 15.16Genetic Consequences of American Slave Trade, Micheletti et al., 2020, Amer.
J. Human Genet. 107, 265-277). Of more immediate impact on the living is the Innocence
Project, started in 1992 in the US to add forensic DNA evidence in re-evaluating convictions
(largely for capital crimes). The mission of the project is to use DNA fingerprinting evidence to
exonerate persons wrongfully convicted of serious crimes, either on death row or serving long
prison terms. As of this writing, the Innocence Project website reports 375 exonerations of
mostly males. Of these, 225 (60%) are African American and 29 are LatinX.
15.5.2.c Who Are Your Ancestors?
Tracing your ethnic, racial, and regional ancestry is related to DNA fingerprinting in that it
relies on PCR amplification of DNA and comparisons that distinguish markers in large
sequence databases. Prices for commercial services have dropped, and their popularity has
risen in recent years. You just provide spit or a salivary (buccal) swab. The service amplifies
and sequences DNA in your samples and then compares your DNA sequences to database
sequences for shared ethnic and regional markers. Based on these comparisons, you are
provided with a (more or less) accurate map of your DNA-based ancestry. Folks spending
about a hundred dollars (less when on sale!) often ask how accurate these analyses are and
what they really mean. For example, what does it mean if your DNA says you are 5% Native
American? In fact, different services can sometimes give you different results! Check out
15.17
DNA Ancestry Testing to get some answers and explanations.

274 The Power of PCR: Some Examples

15.6

Genomic Approaches: The DNA Microarray

Traditionally, if cellular protein levels changed in response to a chemical effector, molecular
studies focused on the regulation of its gene. These studies often revealed that the regulation
was at the level of transcription, turning a gene on or off through interactions of transcription
factors with DNA. However, protein levels are also controlled posttranscriptionally, by the
regulation of the rate of mRNA translation or degradation. Studies of transcriptional and
posttranscriptional regulation mechanisms are seminal to our understanding of how the correct
protein is made in the right amounts at the right time. We may have suspected, but now we
know that control of gene expression and cellular responses can be more complex than
increasing or decreasing the transcription of a single gene or translation of a single protein.
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Newer technologies make possible the study of the expression of virtually all genes in a cell at
the same time, a broadly defined field of investigation called genomics. As Plato might have
said, necessity was ‘the mother of invention’ of the microarray, a technology that can reveal
networks of regulated genes that must be understood to explain developmental and
physiological changes in an organism. To hear how Patrick O. Brown conceived of microarrays
as a tool to study whole genomes, and then how he made them, check out 15.18Using
Microarrays to Study Cancer; 15.19What’s On a Microarray; 15.20Making a DNA Microarray;
15.21
The Genome is the Script; and 15.22From the Microarray to Impossible Foods. Figure 15.30
is a simulated microarray simultaneously probing multiple transcripts.

Fig. 15.30: This simulation of a glass-slide microarray shows multiple-color fluorescent spots (enlarged
in the inset at the upper left), indicating a hunt for more than one DNA sequence at the same time.

Microarrays are typically made by “spotting” cloned DNA from a genomic or cDNA library,
PCR products, or oligonucleotides on a glass slide, or chip. In microarray language, the slide is
the probe. Spotting a chip is a robotic process. Since the DNA spots are microscopic, a cellspecific transcriptome (e.g., a cDNA library) can fit on a single chip. A small prokaryotic or
viral genome microarray might also fit on a single chip. Larger genomes need several slides. In
the simulated microarray above, the colored spots come from three different fluorescent tags on
specific DNA sequences. If the spots are three specific cDNAs synthesized from cellular RNA,
the microarray reveals that at least three different genes of interest were being actively
transcribed in those cells at the time of RNA extraction.
In another use of microarrays, spotted genomic clones could be used to probe cDNAs
made from total cellular mRNAs all of which attached to a single fluorescent tag. In this case,
the question is not if as few specific genes were being specific genes are expressed, but rather
which and how many genes are being expressed in the cell at the time of mRNA extraction. It
is an approach to characterizing a cell’s transcriptome. This is a more global question.
Identifying the proteins encoded by all those genes would be the next step. Microarrays can be
quantitative, so that the brightness (intensity) of the signal from each probe can be measured.
Quantitative microarrays can be designed to show how global gene expression changes in
cells during normal differentiation or in response to chemical signals.
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DNA microarrays are also valuable for genotyping, (i.e., characterizing the genes in an
organism). They are so sensitive that they can distinguish between genes or DNA regions that
differ by a single nucleotide. See 15.23Single Nucleotide Polymorphisms (SNPs) to learn more.
By analogy to genomics and transcriptomics, proteomics is the field of study of global
protein interactions. Primary tools of proteomics include mass spectroscopy (which can
distinguish slight differences in the mass of molecules), Western blotting (which can identify
specific proteins immunologically after electrophoresis), and protein microarrays. While
Western blotting has research and medical applications, the protein microarray is the most
recent power tool of proteomics.
Because mass spectroscopy can detect the specific proteins and protein variants in
samples, it was applied to an analysis of a Leonardo Da Vinci painting (Donna Nuda) to
determine if it was actually painted by the renaissance master, an artist or artists of his school,
or someone else entirely (take a look at 15.24Proteomics Determine Donna Nuda Provenance to
learn the verdict!).
Protein microarrays are in some ways similar to DNA microarrays, but they can look
globally at protein-protein interactions, as well as the different states of proteins under
different cellular conditions. Read even more about these exciting developments and their
impact on basic and clinical research at 15.25Protein Microarrays from NCBI. Now think about
this! Can we create a proteomic library analogous to a genomic library? This would seem a
daunting prospect, but efforts are underway. Check out 15.26Trying to Map a Human Proteome
for original research leading to the sampling of a tissue-specific human proteome, and see
15.27
Strategies for Approaching the Proteome for more general information.
Microarrays and related technologies are powerful tools that can shift our focus from
how single molecules influence events to how webs of biochemical interactions could more
completely explain molecular and physiological causes and effects. Table 15.2 (adapted from
Wikipedia) summarizes different applications of microarrays.
Table 15.2

The Power of Microarrays
Application or
Technology
Gene-expression
profiling
15.28

Comparative
genomic hybridization
15.29

GeneID

Synopsis
In a transcription (mRNA or gene expression) profiling experiment, the
expression levels of thousands of genes are simultaneously monitored to
study the effects of certain treatments, diseases, and developmental stages
of gene expression.
Genome content is assessed in different cells or in closely related
organisms, in which one organism’s genome is the probe for a target
genome from a different species.
Small microarrays check the IDs of organisms in food and feed for
genetically modified organisms (GMOs), mycoplasmas in cell culture, or
pathogens for disease detection. These detection protocols often combine
PCR and microarray technology.
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ChIP (chromatin
immunoprecipitation)
DamID

15.30

SNP detection

15.31

Alternative splicing
detection
15.32

Tiling array

15.33

DNA sequences bound to a particular protein can be isolated by
immunoprecipitating the protein. The fragments can be hybridized to a
microarray (such as a tiling array) allowing the determination of protein
binding-site occupancy throughout the genome.
Analogously to ChIP, genomic regions bound by a protein of interest can
be isolated and used to probe a microarray to determine binding site
occupancy. Unlike ChIP, DamID does not require antibodies but makes
use of adenine methylation near the protein’s binding sites to selectively
amplify those regions, introduced by expressing minute amounts of the
protein of interest fused to bacterial DNA-adenine methyltransferase.
Microarrays allow the detection of single-nucleotide polymorphism among
alleles within or between populations. Some microarray applications make
use of SNP detection, including genotyping, forensic analysis, measuring
predisposition to disease, identifying drug-candidates, evaluating germline
mutations in individuals or somatic mutations in cancers, assessing loss of
heterozygosity, or analyzing genetic linkage.
An exon-junction array uses probes specific to expected or potential splice
sites of predicted exons for a gene. Its density (coverage) is intermediate to
gene expression arrays (one to three probes per gene) and genomic tiling
arrays (hundreds or thousands of probes per gene). It assays the expression
of alternative splice forms of a gene. Exon arrays employ probes designed
to detect each individual exon for known or predicted genes, and they can
be used for detecting different splicing isoforms.
Genome tiling arrays consist of overlapping probes designed to densely
represent a genomic region of interest, sometimes as large as an entire
human chromosome. The purpose is to empirically detect expression of
transcripts or alternatively spliced forms which may not have been
previously known or predicted.

Find QR codes for the numbered links in this table at the end of this chapter.

275-2 The Power of Microarrays

15.7

Ome-Sweet -Ome

Early technologies like the ones described in this chapter were applied to understanding the
structure, function, and regulation of specific genes. Some more recent technologies (e.g.,
microarrays) are well adapted to a more holistic approach to studying cell function. Terms we
have already seen (e.g., genome, epigenome, transcriptome) were coined in an effort to define
different objects of study whose underlying network of molecular interactions can more
accurately explain cell function. These objects of study often overlap and can be confusing.
Here is a short compendium of -omes, with an attempt at clarification:
• Genome: total DNA content of a cell, identical in every cell of an organism
• Proteome: a cell’s protein profile and steady state at any given moment
• Exome: A cell’s total coding DNA (excluding noncoding DNA)
• Epigenome: A cell’s total DNA-modification/chromatin topography
• Methylome: The pattern of methylation of DNA in the genome
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•
•
•
•
•

Paleoproteome: Profile of proteins found in ancient remains by mass spectroscopy
Transcriptome: A cell’s RNA-transcript profile and steady state at any given moment
Epitranscriptome: A map of chemical modifications of RNAs that inform their function
Metabolome: All of the small metabolites in a defined sample (cell, organelle, tissue, etc.)
Mechanobiome: the molecular network cells use to generate, sense and respond to intra-

•

and extracellular forces
Regulome: a cell’s regulatory components, including metabolites, proteins, mRNAs, genes,
cis DNA elements.

One might be excused for assuming that such cellular profiles would be the same for
all cells in a tissue, only changing as gene expression is regulated during development or
when signaled by extracellular events or chemical signals. But even genomic and exomic
profiles can change! Recall somatic mutations in dividing cells, and genome loss in some cells
(e.g., erythrocytes that emerge from our reticulocytes). Studies of large numbers of individual
cells suggest profile variation even in cells of the same tissue or cell culture. How and why this
is so is a rapidly growing new area of study, made possible by new tools for studying DNA,
RNA and proteins molecules in single cells (see 15.34Mapping Protein Networks, 15.35The Dark
Proteome, 15.36What on Earth is Paleoproteomics? 15.37A Human Transcriptome Study,
15.38
Nature vs Nurture: Diet, Behavior, & the Epigenome, 15.39Epitranscriptomics-Functional
Modification of RNAs, 15.40Sex-Specific Human Transcriptomes (15.41Sex-Specific Human
Transcriptomes-full article. Can you name the next…-ome? Maybe the chondrome (see
15.42
Mining Mitochondrial Transcriptomes).
CHALLENGE: Consider the axolotl (a salamander) genome, 10 times bigger
than our own (15.43The HUGE Axolotl Genome, or

15.44Axolotl

Genome-full

(15.45The

article), or the lungfish genome, 14 times the size of ours
World
Record Lungfish Genome!). What do they do with all that DNA? Can our
current technologies figure it out? And what’s a lungfish anyway!!?

15.8

From Genetic Engineering to Genetic Modification

Genomic, transcriptomic, and proteomic technologies have vastly increased our knowledge of
how cells work at a molecular level and how genes and their regulation have evolved. We
continue to add to our knowledge of the disease process and, in at least a few cases, how we
can treat disease. The use of technologies to genetically engineer (i.e., modify) organisms is
more controversial, despite the best of human intentions. The creators of some genetically
modified organisms (GMOs) aim to rid the world of environmental waste and increase food
productivity to better feed the world. The introduction of “beneficial” genes into microbes
enabled the engineering of oil- and plastic-eating bacteria and food species, to create GMOs
such as:
•
•
•

drought-resistant crops to increase the range of land where major food crops can be grown.
pest-resistant crops which reduce reliance on environmentally toxic chemical pesticides.
herbicide-resistant crops which will survive the chemicals used to destroy harmful plants.
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The quest for “improved” plant and animal varieties dates back to a time long before
recorded history when farmers were crossbreeding cows, sheep, and dogs, as well as crop
varieties from corn to wheat, in the hope that mating better with lesser varieties, all in the hope
of producing faster-growing, larger, hardier, (you name it) varieties. It is the manipulation of
DNA (the essence of the genetic material itself) to do the same that is at the root of the
controversy. Controversy is reflected in opinions that GMO foods are potentially dangerous
and that their cultivation should be banned. But the general consensus is that attempting to
ban GMOs is too late! In fact, you are probably already partaking of some GMO foods without
even knowing it. Perhaps the good news is that after many years of GMO crops already in our
food stream, the emerging scientific consensus is that GMO foods are no more harmful than
unmodified foods. The current debate is whether to label foods that are (or contain) GMO
ingredients as genetically modified. In an odd but perhaps amusing take on the discomfort
some folks feel about GMOs, a startup company has genetically modified petunias. When
grown in water, their flowers are white, but when “watered” with beer, they will produce pink
or purple flowers, depending on how much beer they get. (Check it out at 15.46Can Beautiful
Flowers Change Face?) According to the company, it seeks “to bring what it sees as the beauty
of bioengineering to the general public” (and perhaps some profit as well?).
Finally, new CRISPR and related tools can precisely edit any DNA sequences. While
not yet ready for prime time, we already noted a CRISPR-based protocol even promises to
amplify genes from DNA without prior denaturation at 37oC, and therefore without a
thermocycler. Unlike the “quack medicines” of old, these tools have the real potential to cure
disease, to destroy disease-carrying vectors, to cure cancer, to improve crops and possibly even
alter the course of evolution. We may also need to mobilize such technologies to cope with the
coming effects of climate change! The speed with which one can accomplish such good (or
evil) is truly awesome.
Some iText & VOP Key Words and Terms
alternative splicing
automated DNA sequencing
autoradiography
BACs and YACs
bacterial artificial chromosome
vectors
blunt ends
cDNA
cDNA hairpin loop

genome
genome projects
genomic library
insert DNA
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regulatory networks
restriction endonucleases
reticulocyte
reverse transcriptase
RNA probes
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Northern blot
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chemiluminescence
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dideoxy-chain termination
dideoxy-sequencing method
DNA ligase

PCR
PCR primers
PCR steps
Phage-lambda vectors
plasmids
poly(A) tail
polymerase chain reaction

RNAse
shotgun sequencing
single-nucleotide
polymorphisms
SNPs
Southern blot
sticky ends
systematics
Taq polymerase
thermophilic bacteria
thermophilic DNA
polymerases

DNA sequencing
elution
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primer
primer walking
probe hybridization
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Thermus aquaticus
transcriptome
transformation

fluorescence

proteome

vectors

forensics
genetic (DNA) fingerprint

recombinant vector
recombination

Western blot
yeast artificial chromosomes
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Chapter 16

Membrane Structure

Structure and function: a fluid mosaic, membrane proteins, glycoproteins, glycolipids
Reminder: For inactive links, google key words/terms for alternative resources.

16.1

Introduction

All cellular membranes share the same phospholipid-bilayer construction. All restrict the flow
of substances from one side to the other (i.e., they are semipermeable). All are a fluid mosaic
of proteins attached to or embedded in the phospholipid bilayer. Specific proteins and
phospholipids structurally and functionally differentiate one kind of cellular membrane from
another, both structurally and functionally. Integral proteins are held in the membrane by a
hydrophobic domain, which anchors them to the hydrophobic interior of the membrane. Some
integral membrane proteins span the phospholipid bilayer, with hydrophilic domains on either
side of the membrane. In the case of the plasma membrane, the hydrophilic domains of
transmembrane proteins interact with the watery extracellular fluid on one side and the
aqueous cytoplasm on the other. Once embedded in the fatty acid innards of a cellular
membrane, integral membrane proteins cannot escape! In contrast, peripheral membrane
proteins are more loosely held in place by hydrophilic interactions with charged features of the
membrane surface (e.g., phospholipid heads and hydrophilic surface-domains of integral
proteins). Integral membrane proteins are often glycoproteins, the sugars of which face the
outside of the cell. These cells thus present a sugar coating, or glycocalyx, to the outside world.
As cells form tissues and organs, they become bound to extracellular proteins (which they
themselves or other cells secrete) to form an extracellular matrix. We will spend much of this
chapter looking at characteristic structures and biological activities of plasma membrane
proteins and their functions.
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Learning Objectives
When you have mastered the information in this chapter, you should be able to do the
following:
1. Distinguish between membrane components that can move (diffuse) laterally in the
membrane and those that flip from outer to inner surfaces of the phospholipid bilayer.
2. Compare the fluid mosaic model of membrane structure to other membrane models and
argue pro and con for each.
3. Describe how cells might make their plasma membranes and suggest an experiment that
would demonstrate your hypothesis.
4. Distinguish between transmembrane and peripheral membrane proteins, with examples.
5. Determine whether a newly discovered protein might be a membrane protein.
6. Predict the effect of molecular and physical influences on membrane fluidity.
7. Suggest how organisms living in warm tropical waters have adapted to the higher
temperatures. Likewise, fish living under the arctic ice.
8. Explain how salmon can spend part of their lives in the ocean and another part swimming
upstream in freshwater, without their cells shriveling or exploding.
9. List the diverse functions of membrane proteins.
10. Speculate on why only eukaryotic cells have evolved sugar-coated cell surfaces.
11. Compare and contrast the glycocalyx and extracellular matrix of cells.

16.2

Plasma Membrane Structure

In eukaryotic cells, the plasma membrane surrounds a cytoplasm that is filled with ribosomes,
organelles, cytoskeletal (actin, intermediate) filaments and microtubules. Organelles are
structures that are themselves encased in membranes. Some organelles (nuclei, mitochondria,
chloroplasts) are even surrounded by double membranes. All cellular membranes are
composed of two layers of phospholipids embedded with proteins. All are selectively
permeable (semipermeable), allowing only certain substances to cross the membrane. The
unique functions of cellular membranes are due to different phospholipid and protein
compositions. Decades of research have revealed these functions. (See earlier discussions of
mitochondrial and chloroplast functions, for instance.) Here we’ll describe general features of
membranes, using the plasma membrane as our example.
16.2.1 The Phospholipid Bilayer
In 1925, E. Gorter and F. Grendel reported red blood cell counts and the surface areas of
samples of human, rabbit, dog, sheep, guinea pig, and goat red blood cells and used this data
to predict a bilayer membrane structure as early as 1925. They knew that red blood cells
(erythrocytes) have no nucleus or other organelles, and thus only a plasma membrane. They
also knew that the membranes were mainly composed of phospholipids. They then disrupted a
known number of red blood cells and measured the number of phospholipids in their
membrane extracts. They next calculated that there were enough phospholipid lipid molecules
per cell to wrap around each cell twice. Since they knew that phospholipids had charged and
hydrophobic regions, Gorter and Grendel predicted a phospholipid bilayer, within which
nonpolar fatty acid domains interact with each other. A space-filling model of a phospholipid
in Figure 16.1 (below) highlights its hydrophilic (polar) head and hydrophobic (nonpolar) tail.
Molecules with hydrophilic and hydrophobic domains are called amphipathic.
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Fig. 16.1: Structural and Space-Filling models showing components of a phospholipid.

Curiously, Gorter and Grendel made two calculation errors in determining the amount
of phospholipids per cells. Nevertheless, their errors compensated for each other, so—while
not strictly speaking correct—their conclusion was prophetic! Figure 16.2 shows some common
membrane phospholipids.

Fig. 16.2: Examples of common membrane phospholipids.
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When mixed with water, the amphipathic phospholipid molecules spontaneously
aggregate to “hide” their hydrophobic regions from the water, forming structures called
liposomes, which sediment when centrifuged (see Section 16.2.5 and link 277-2 below).

276-2 Membrane Lipids & Phospholipid Bilayer

277-2 Experiments with & Uses of Liposomes
Liposome membrane structure is consistent with the predicted bilayer, in which the
phospholipid hydrophobic tails interact with each other, and the polar heads face away from
each other. This conceptual understanding led to a model of membrane architecture based on
phospholipid interactions, in which the fatty acid tails make up a hydrophobic membrane
interior, with the hydrophilic (polar) phosphates on the surfaces, facing the opposite, aqueous
sides of the membrane. The iconic image of a phospholipid bilayer is illustrated in Figure 16.3

Fig. 16.3: Phospholipid bilayer membrane.

16.2.2 Models of Membrane Structure
In 1935, H. Davson and J. Danielli suggested that proteins might be bound to the polar heads
of the phospholipids in the plasma membrane, creating a protein-lipid-protein sandwich.
Decades later, J. D. Robertson observed membranes in the transmission electron microscope at
high power, revealing that all cellular membranes had a trilamellar structure. The classic
trilamellar a cellular membrane can be seen in the electron micrographs in Figure 16.4.

Fig. 16.4: Low- and high-magnification transmission electron micrographs of the trilamellar membrane.
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The trilamellar structure is consistent with the protein-lipid-protein model proposed by
Hugh Davson and James Danielli (since known as the Davson-Danielli model) of the
phospholipid bilayer. Since all cellular membranes had this trilamellar structure when seen by
electron microscopy, J. David Robertson further proposed his Unit Membrane model: all
membranes consist of a clear phospholipid bilayer, coated with electron-dense proteins.
The static view implied by the Davson-Danielli or Robertson models of membrane
structure was replaced in 1972 by Singer and Nicolson’s Fluid Mosaic model (see S. J. Singer
and G. L. Nicolson, The fluid mosaic model of membranes. Science 175:720-731). They
suggested that, in addition to peripheral proteins (which bind to the membrane surfaces),
many integral membrane proteins span the membranes. Integral-membrane proteins were
imagined as a mosaic of protein “tiles” embedded in a phospholipid medium. But unlike a
mosaic of glazed tiles set in a firm, cement-like structure, the protein “tiles” were predicted to
float in a phospholipid sea.
In the model, these proteins are anchored in membranes by one or more hydrophobic
domains, while hydrophilic domains face either or both aqueous environments (external and
cytosolic). Thus, like phospholipids themselves, membrane proteins are amphipathic. We know
that cells expose different structural and functional surface features to their aqueous
environments. Since the exposed domains of membrane proteins would be different on
opposite sides of a membrane, we say that cellular membranes are asymmetric. Figure 16.5 is
a model of the plasma membrane of a cell and includes its integral proteins, peripheral
proteins, and glycoproteins.

Fig. 16.5: This model of the eukaryotic plasma membrane demonstrates membrane asymmetry, with a
sugarless cytoplasmic surface and a glycoprotein-rich extracellular surface.

In this model, some integral proteins have a hydrophobic domain that does not span
the membrane but that anchors it to one side of the membrane. Peripheral (or so-called
“surface”) proteins are also shown. These are less firmly bound to the membrane via charge
interactions with the polar phosphate groups of phospholipids or via the polar domains of the
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integral membrane proteins. Because of their own aqueous, hydrophilic domains, membrane
proteins present a natural barrier to the free passage of charged molecules across the
membrane.
Membrane proteins are also responsible for the selective permeability of membranes,
facilitating the movement of specific molecules into and out of cells (endocytosis and
exocytosis, respectively). Membrane proteins also account for specific and selective
interactions with their extracellular environment. These interactions include the adhesion of
cells to each other, the cell’s attachment to surfaces, communication between cells (both direct
and via hormones and neurons), and more.
The “sugar coating” of the extracellular surfaces of plasma membranes comes from

oligosaccharides that are covalently linked to membrane proteins (to form glycoproteins) or to
phospholipids (to make glycolipids). Carbohydrate components of glycosylated membrane
proteins inform their function. Thus, glycoproteins enable specific interactions of cells with
each other to form tissues. They also allow interaction with the extracellular surfaces to which
they must adhere. In addition, they figure prominently as part of receptors for many hormones
and other chemical-communication biomolecules. The intracellular domains of plasma
membrane proteins (as well as those regions crossing the lipoidal region of the membrane
itself) are not glycosylated. The cytoplasmic domains of some membrane proteins become
attached to components of the cytoskeleton, giving cells their shape and allowing them to
change shape when necessary. Other intercellular membrane protein domains have essential
enzymatic features, as we will see. Given the crucial role of proteins and glycoproteins in
membrane function, it should come as no surprise that proteins constitute an average of 4050% of the mass of a membrane. In some cases, proteins are as much as 70% of membrane
mass (think cristal membranes in mitochondria!).

278-2 Properties of Proteins Embedded in a Phospholipid Bilayer

279 Different Membrane Compositions
16.2.3 Evidence for Membrane Structure

Membrane asymmetry, in which the features facing one side of the membrane differ from
those facing the opposite side, was directly demonstrated by the scanning electron microscope
technique of freeze-fracture. The technique involves freezing isolated membranes in water,
then chipping the ice. When the ice cracks, the encased membranes split along a line of least
resistance, which turns out to be between the hydrophobic fatty acid opposing tails in the
interior of the membrane. Scanning electron microscopy of a freeze-fractured membrane
reveals features of the interior and exterior membrane surfaces that confirm membrane
asymmetry. Among the prominent features shown by these micrographs are the pits and
opposing mounds in the interior of the membrane. Figure 16.6 (below) illustrates the results of
freeze-fracture electron microscopy of a plasma membrane.
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Fig. 16.6: In this drawing of a scanning-electron micrograph of a freeze-fractured plasma membrane,
pits and mounds are seen on opposing phospholipid layers of the membrane.

Other features shown here are also consistent with phospholipid membrane structure.

280-2 Freeze-Fracture Electron Microscopy of Cell Membranes
Cytochemical studies also confirmed plasma membrane asymmetry, showing that only
the external surfaces of plasma membranes are sugar coated. Check the following link for
more detailed descriptions of the experiments.

281-2 EM Cytochemical Demonstration of Membrane Asymmetry
Finally, membrane asymmetry was also demonstrated biochemically. In one
experiment, investigators treated whole cells with proteolytic enzymes, then extracted the
membranes and isolated the membrane proteins. In a second experiment, investigators
isolated plasma membranes from untreated cells first, and then treated the membranes with
the enzymes. In a third experiment, investigators isolated plasma membranes from untreated
cells, and then extracted the membrane proteins. Size separation of the three protein extracts
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by electrophoresis demonstrated that different components of integral membrane proteins were
present in the two digest experiments, confirming the asymmetry of the plasma membrane. For
more details, check the following link.

282-2 Electrophoretic Demonstration of Membrane Asymmetry
The idea that membranes are fluid was also tested experimentally. Here is a description of the
experiment:
1. Antibodies were made to mouse and human cell membrane proteins by isolating their
membranes and injecting the isolates into a different animal (rabbits, most likely). Each
rabbit’s cells saw the membranes and their associated proteins as foreign and responded
by making specific anti-membrane antibody molecules.
2. The rabbit antibodies against each membrane source were then isolated and separately
tagged with colored fluorescent labels, so that each type would glow a different color when
subjected to ultraviolet light.
3. Next, mouse and human cells were mixed under conditions that caused them to fuse,
making human-mouse hybrid cells.
4. The tagged antibodies were added to the fused human-mouse cells and examined in a
fluorescence microscope.
At first, the mouse and human antibodies were seen to bind to the mouse and human
portions of the fused cell, as shown in Figure 16.7.

Fig. 16.7: Fluorescent antibodies against human and mouse membrane proteins localize their
cell surface antigens (i.e., proteins) on opposite poles of recently fused cells.
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After a short time, the different fluorescent antibodies were seen to mix under a fluorescence
microscope under UV light. The fluorescent tags seemed to be moving from their original
location in the fused membranes (Figure. 16.8).

Fig. 16.8: Immunofluorescent human (green) and mouse (red) membrane proteins diffuse and mix
over time in fused cells.

Clearly, proteins embedded in the membrane are not static; rather, they are able to
move laterally in the membrane, in effect floating and diffusing in a “sea of phospholipids.”

283 Two Demonstrations of Membrane Fluidity: The Fluid Mosaic
16.2.4 Chemical Factors Affecting Membrane Fluidity
As you might expect, the fluidity of a membrane depends on its chemical composition and the
physical conditions surrounding the cell (e.g., outside temperature). Just as heating a solution
causes dissolved molecules and particulates to move faster, so also at higher external
temperatures, membrane phospholipids and proteins are more fluid. Also, the fatty acids of
phospholipids that have more unsaturated (C=C) carbon bonds have more kinks, or bends.
These tend to push apart the phospholipid tails. With more space between the fatty acid tails,
membrane components can move more freely. Thus, membranes with higher levels of
polyunsaturated fatty acids are more fluid. On the other hand, cholesterol molecules tend to fill
the space between fatty acids in the hydrophobic interior of the membrane. This reduces the
lateral mobility of the phospholipid and protein components in the membrane. By reducing
fluidity, cholesterol reduces membrane permeability to some ions. Factors that affect
membrane fluidity are summarized in Figure 16.9 (below).
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Fig. 16.9: Several factors affect the rate of diffusion (membrane fluidity) of components in a fluid mosaic
phospholipid membrane. Cholesterol is one of these factors.

Evolution has adapted cell membranes to different and changing environments in
order to maintain the fluidity necessary for proper cell function. Poikilothermic (i.e., coldblooded) organisms, from prokaryotes to fish and reptiles, do not regulate their body
temperatures. When exposed to lower temperatures, poikilotherms respond by increasing the
unsaturated fatty acid content of their cell membranes. At higher temperatures, they increase
their cell membrane’s saturated fatty acid content. Thus, the cell membranes of fish living
under the arctic ice maintain fluidity by having high levels of both monounsaturated and
polyunsaturated fatty acids. What about fish species that range across warmer and colder
environments (or that live in climates with changing seasons)? These fish regulate their cell
membrane composition to adjust to the demands of their changing environment. The warmblooded (homeothermic) mammals and birds maintain a constant body temperature. Thus,
their membrane composition is also relatively constant. But there is a paradox! Their cell
membranes are very fluid, with a higher ratio of polyunsaturated fat to monounsaturated fats
than, say, in reptiles. But the paradox is resolved when we understand that this greater fluidity
supports the higher metabolic rate of the warm-blooded species compared to poikilotherms.
Just compare the lifestyles of almost any mammal to a lazy floating alligator or a snake
basking in the shade of a rock!

284-2 Factors Influencing Membrane Fluidity
CHALLENGE: Consider the paradox just mentioned. Why might a higher
metabolic rate result in more fluid cellular membranes in homeotherms?
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16.2.5 Making and Experimenting with Artificial Membranes
Membrane-like structures can form spontaneously. When phospholipids interact in an
aqueous environment, they aggregate to exclude their hydrophobic fatty tails from water,
forming micelles. Micelles are spherical phospholipid monolayer vesicles that self-assemble, a
natural aggregation of the hydrophobic fatty acid domains of these amphipathic molecules.
Figure 16.10 illustrates a micelle.

Fig. 16.10: Micelles are phospholipid monolayers with hydrophobic interiors that self-assemble in water.

Micelles can further form spherical phospholipid bilayer liposomes (Figure 16.11).

Fig. 16.11: A liposome is a synthetic lipid bilayer that can be formed from micelles.

Liposomes have a trilamellar membrane and behave somewhat like cells; for example, forming
a pellet at the bottom of a tube when centrifuged. Liposomes can be custom designed from the
different kinds of phospholipids and amphipathic proteins that have become integral to their
membranes. When investigators prepare liposomes in the presence of specific proteins or other
molecules that can’t diffuse across the liposomes’ membranes, these molecules become
trapped in the vesicles. The trapped molecules cannot get out of this synthetic “organelle.”
Such were the studies that allowed the identification of the mitochondrial respiratory-chain
complexes. The ability of investigators to manipulate liposome content and membrane
composition also makes liposomes candidates for drug delivery to specific cells and tissues.
(Google “liposome” for more information.)
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16.2.6 Separate Regions of a Plasma Membrane with Unique Fluidity and Permeability
Properties
As we’ll see shortly, fluidity does not result in an equal diffusion of all membrane components
around the cell-membrane surface. Instead, extracellular connections between cells, along
with intracellular connections of the membrane to differentiated regions of the cytoskeleton,
effectively compartmentalize the membrane into subregions. To understand this, imagine an
epithelial cell sheet like the one below based on electron micrographs in Figure 16.12.

Fig. 16.12: Properties of plasma membranes may differ in ways determined by cell-to-cell associations
during tissue development. The lavender (short arrows), green (arrow heads), and purple (long arrows)
indicate the differentiation of a sheet of epithelial cells into specific regions.

This sheet of cells exposes a domain (surface) with unique functions to the inside of the
organ it lines. It exposes the opposite sheet surface, one with a quite different function, to fluid
surrounding the organ. The lateral cell surfaces comprise yet another membrane compartment,
one that functions to connect and communicate between the cells in the sheet. Membrane
proteins, illustrated here with different symbolic shapes and colors, may remain fluid within a
compartment. Of course, tissue-level macro-differentiation of cell membranes enabling cell–
cell and cell–environmental interactions make intuitive sense. The possibility that cellular
membranes are even more compartmentalized was perhaps less anticipated. In fact,
membranes are further divided into micro-compartments. Within these compartments,
components are fluid but seldom move between compartments. Studies indicate that
cytoskeletal elements maintain these micro discontinuities. For example, integral membrane
proteins are immobilized in membranes if they are attached to cytoskeletal fibers (e.g., actin)
in the cytoplasm. Furthermore, aggregates of these proteins can line up due to similar
interactions, forming a kind of fence, inhibiting other membrane components from crossing. By
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analogy, this mechanism of micro-compartmentalization is called the Fences and Pickets
model: proteins attached to the cytoskeleton serve as the pickets (i.e., the usually white, pointy
boards attached to a literal picket fence). The movement across the fences (i.e., from one
membrane compartment to another) is infrequent. Extra kinetic energy is presumably needed
for a molecule to “jump” a fence between compartments. Hence, this kind of motion (hop
diffusion) differs from the Brownian motion implied by the original fluid mosaic model.

285-2 Regional Differentiation of a Plasma Membrane Domains

16.3

Membrane Proteins

Of course, membrane proteins themselves have domains. These provide catalytic and other
activities inside and outside of cells and organelles, and keep them attached to the membrane.
Like phospholipids, membrane proteins are amphipathic, with hydrophobic domains that
noncovalently interact strongly within the fatty-acid interior of membranes. Some integralmembrane proteins span the entire membrane, with hydrophilic domains facing the cytosol or
cell exterior. Peripheral proteins bind to a membrane surface through noncovalent interactions.
The different interactions of membrane proteins with e.g., a plasma membrane are shown
below in Figure 16.13.

Fig. 16.13: Integral-membrane proteins may penetrate or span the membrane; also shown are peripheral
proteins and lipoproteins.

286-2 Domains of Membrane Proteins
CHALLENGE: Count and identify specific or generic functional domains
in the proteins in Fig 16.13.
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Hydrophobic amino acids of membrane proteins are organized into functional regions.
These consist of one or more nonpolar alpha-helical domains that interact with the fatty-acid
interior of the membranes. Hydrophilic domains tend to have a more tertiary structure. These
domains face the aqueous cytosol and cell exterior. Two transmembrane proteins are cartooned
in Figure 16.14.

Fig. 16.14: Integral transmembrane proteins cross the membrane one or more times.

The protein on the left in Figure 16.14 crosses the membrane once, while the one on
the right crosses the membrane three times. Regardless of the number of times a polypeptide
crosses the membrane its C-terminus always ends up on the extracellular surface of the cell.
CHALLENGE: Can the N-terminal amino acid of a plasma membrane
polypeptide ever face the outside of a cell?

Alpha-helical domains that anchor proteins in membranes are mostly nonpolar and
hydrophobic themselves. For example, consider the amino acids in the alpha-helical domain of
the red blood cell–membrane protein glycophorin A, a protein that prevents red blood cells
from aggregating or clumping in the circulation. One glycophorin A polypeptide with its
hydrophobic transmembrane alpha helix is cartooned in Figure 16.15 (below).
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Fig. 16.15: Hydrophobic amino acids in glycophorin form a helix spanning a red blood cell plasma
membrane.

Glycophorin A monomers pair to form dimers in the plasma membrane (not shown
above). Proteins that span membranes multiple times may include amino acids with charged
polar side chains, provided that these side chains interact between helices, so that they are
shielded from the fatty acid environment in the membrane. Because of these hydrophilic
interactions, such proteins can create pores for the transport of polar molecules and ions.
(We’ll see some of these proteins later).
Integral membrane proteins that do not span the membrane also have a hydrophobic
helical domain to anchor them in the membrane, while their hydrophilic domains typically
interact with intracellular or extracellular molecules that can hold cells in place, give cells and
tissues their structure, and the like.
The very presence of hydrophobic alpha-helical domains in transmembrane proteins
makes them difficult if not impossible to isolate from membranes in a biologically active form.
But the peripheral polypeptide cytochrome c readily dissociates from cristal membranes,
making it easy to purify. The inability to purify other biologically active cristal membrane
electron carriers is what slowed our understanding of the structure and function of the
mitochondrial electron transport system.
CHALLENGE: How was this problem solved? Find the answer in an earlier
chapter!
It is possible to determine the primary structure of a polypeptide encoded by a gene
before the protein itself has been isolated. Just by knowing the DNA sequence of a gene, we
can infer the amino acid sequence of the protein encoded by the gene. Then we can identify
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all of the hydrophobic amino acids in the inferred sequence and generate a hydrophobicity (or
hydropathy) plot, such as the one below, in Figure 16.16.

Fig. 16.16: Hydropathy plots correlate amino acid hydrophobicity with its position in a polypeptide.
Long regions of hydrophobic amino acids suggest a possible membrane-protein domain.

The protein in this hypothetical example has two regions, or domains of hydrophobic
amino acids. They are identified as stretches of uninterrupted hydropathy (hydrophobicity)
above the 0 level along the X-axis. The protein shown here is probably a transmembrane
protein. To see how a hydropathy plot can predict whether a protein is a membrane protein,
check out the following link.

287-2 Hydropathy Predicts Hydrophobic-Membrane Protein Domains

16.4

A Diversity of Membrane Protein Functions

Membrane protein functions include doing the following:
• serving as receptors for hormones or neurotransmitters.
• working as immune-system antibodies (immunoglobulins) to recognize foreign substances
(antigens).
• acting as cell-recognition molecules that bind cells together.
• forming cell membrane structures that directly pass chemical information between cells.
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•
•
•
•
•

anchoring cells to extracellular surfaces like connective tissue.
anchoring the plasma membrane to proteins of the cytoskeleton (e.g., actin).
facilitating molecular transport (entry or exit of substances into or out of cells).
working as enzymes to catalyze crucial reactions in cells.
electron transport (in mitochondria and chloroplasts).

Figure 16.17 summarizes some membrane protein functions.

Fig. 16.17: Examples of the many functions of membrane proteins.

Transmembrane proteins perform most of the functions illustrated in this illustration.
However, peripheral membrane proteins also play vital roles in membrane function.
Cytochrome c is an example. It is a redox component loosely bound to the rest of the electron
transport system in the mitochondrial cristal membrane. Other peripheral membrane proteins
may serve to regulate transport or signaling activities of transmembrane-protein complexes or
may mediate connections between the membrane and cytoskeletal elements. As shown here,
peripheral proteins do not penetrate membranes. They bind reversibly to the internal or
external surfaces of the biological membrane with which they are associated.
Shortly, we’ll take a closer look at what holds membrane proteins in place and how
they perform their unique functions. Check out major membrane-protein functions, actions,
and cellular locations in Table 16.1, below.
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Table 16.1

Some Functions of Membrane Proteins

Basic Function
Electron transport

Facilitated transport,
facilitated diffusion

Active transport

Signal transduction

Cell-cell interactions
Anchors to cytoskeleton
Enzymatic

Specific Actions
Oxidizes reduced energy
substrates (e.g., NADH,
FADH2, NADPH)
Regulate diffusion of
substances across
membranes along a
concentration gradient
Use energy to move ions
from low to high
concentration across
membranes
Conveys information from
molecular signals to
cytoplasm (e.g., for
hormones that can’t enter
cells), leading to a cellular
response
Cell-cell recognition and
binding to form tissues
Link membrane proteins to
cytoskeleton
Usually multifunctional
proteins with enzymatic
activities

Examples
Mitochondrial respiration, photosynthesis

Ca++ and other ion channels, glucose
transporters

Mitochondrial protein pumps, the Na+/K+ ion
pump in neurons

Protein hormone and growth factor signaling,
antibody/antigen interactions, cytokine
mediation of inflammatory responses.

Formation of desmosomes, gap junctions,
and tight junctions
Cell shape, cell movement, and cell response
to molecular signals
F1 ATP synthase; uses proton gradient to
make ATP; adenylyl cyclase, which makes
cAMP during signal transduction; note that
some receptor proteins are linked to
enzymatic domains in the cytoplasm.

288-2 Diversity of Membrane Protein Structure & Function

289-2 Pore Proteins May Cross the Membrane Many Times

290-2 Red Blood Cell (Erythrocyte) Membrane Protein Functions

16.5

Glycoproteins and Glycolipids

Membrane proteins are often covalently linked to oligosaccharides, which are branched
glycoside-linked sugars (averaging around fifteen sugar residues). As glycans, they are the
sugars linked to glycoproteins and glycolipids.
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Glycoproteins are rare in the cytosol but common on secreted and membrane proteins.
Oligosaccharides are typically linked to proteins via the hydroxyl group on serine or threonine
amino acids (O-glycosylation) and are occasionally to modified amino acids (e.g.,
hydroxylysine, hydroxyproline) or to the amide nitrogen on asparagine (N-glycosylation). As a
major feature of the glycocalyx, oligosaccharide domains of glycoproteins and glycolipids are
the “face” of a plasma membrane that communicates with the extracellular world. Figure 16.18
illustrates the glycocalyx.

Fig. 16.18: The glycocalyx is the sugar-rich region on the extracellular surface of cells, formed by
covalently bound sugars on glycoproteins and glycolipids. It is the basis of many cell functions and is
associated with other macromolecules to form an extracellular matrix.

Oligosaccharides begin their synthesis in the rough endoplasmic reticulum (RER), with
the creation of a core glycoside. These partial glycans are enzymatically linked to compatible
amino acids of a membrane protein. As these proteins travel through the Golgi vesicles of the
endomembrane system, terminal glycosylation attaches more sugars to the core glycoside to
complete glycoprotein synthesis. When vesicles budding from the trans-Golgi vesicles fuse
with the plasma membrane, the sugars on the glycoproteins end up on the exterior cell surface.
This is illustrated in the following link.

291 The Path to Sugar-Coated Cells
Like glycoproteins, glycolipids are only found on the extracellular surface. Glycolipids
are synthesized in much the same way as glycoproteins. Specific enzymes catalyze initial
glycosylation of phospholipids and polypeptides, followed by terminal glycosylation reactions.
Glycoproteins, glycolipids, and proteoglycans on cell surfaces play critical roles in cell-cell
recognition and the formation of tissues. They recognize and bind to carbohydrate receptors
(lectins) on adjacent cells, leading to cell-cell attachment as well as intracellular responses in
the interacting cells.
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Glycoproteins and glycolipids also mediate the interaction of cells with extracellular
molecular signals and with chemicals of the ECM, or extracellular matrix (Figure 16.19). The
ECM includes components of connective tissue, basement membranes, and, in fact, any
surface to which cells attach.

Fig. 16.19: The extracellular matrix (ECM) forms by a noncovalent association of e.g., fibronectin, collagen,
proteoglycans, and other macro-molecules with membrane proteins and elements of the glycocalyx.

292-2 The Extracellular Matrix

16.6

Glycoproteins and Human Health

We’ll close this chapter with a few examples of glycoproteins that play crucial roles in human
physiology. Let’s look first at the major human A, B, AB, O, and Rh blood groups that result
from the presence or absence of glycoprotein antigens embedded in red blood cell membranes
and the presence or absence in the blood of antibodies against the antigens. Typically, an
exposure to antigens (e.g., foreign substances like bacteria, viruses, and toxins) generates
immunoglobulins, the antibody molecules of our immune system. The immunoglobulins are
glycoproteins. Since blood-group antibodies already in the blood of a healthy person are not a
response to foreign antigen invasion, they are something of a paradox!
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You probably know that blood groups must be compatible for a successful blood
transfusion. A mismatch between donor and recipient can be devastating. An interaction of the
red blood cell (erythrocyte) antigens of one blood group with antibodies in another blood group
will cause the red cells to clump, restricting blood flow, and ultimately killing the transfusion
recipient. Figure 16.20 summarizes why transfusions with mismatched A, B, AB, and O blood
groups must be avoided.

Fig. 16.20: Blood groups with membrane proteins and elements of the glycocalyx.

From the table above, you can see why type O blood is called the universal donor and is thus in
high demand by clinics and hospitals.
Now, thanks to enzymes produced by members of our gut microbiomes, the current absolute
requirement, that blood groups must be matched for safe transfusions, may someday be a thing
of the past! These enzymes include glycosidases that catalyze glycoside bond hydrolysis. Thus,
glucosidases can digest the sugars on A and B antigens on the surfaces of A, B, and AB blood
cells. Removal of these antigenic sugars effectively converts these red blood cells to type O
cells! Check the Red Cross website (16.1About A, B, AB, & O Blood Types-Red Cross) or
Wikipedia (16.2Blood type - Wikipedia) for more details about blood groups. See 16.3Conversion
of A, B & AB to O for a summary of recent research on enzymatically converting all blood types
to type O.
Another red blood cell antigen is the Rh (rhesus) factor. Rhesus factors are antigens
originally found to define blood types in rhesus monkeys, but humans have equivalent
antigens, so human Rh blood groups have nothing to do with the monkeys! People either have
their own Rh factor and are Rh+, or they don’t have the factor and are Rh−.
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When an Rh− recipient is transfused with blood from an Rh+ donor, the recipient’s
immune system makes anti-Rh antibodies in the usual way. This too can cause blood-cell
clumping with bad consequences. A well-known example is when an Rh− pregnant woman is
carrying an Rh+ fetus; if mother and baby’s blood should mix, the mother will make antibodies
to the Rh factor that could cause fetal hemolytic disease, damaging and destroying fetal red
blood cells.
A word to the wise: While you should be “typed” in the event you need a transfusion,
it’s always a good idea to know your own ABO and Rh blood groups!
CHALLENGE: The basis of selection of the different blood groups is
something of a mystery. What benefit did they confer on us at the time of
selection, and do we still benefit today? Check out a discussion of bloodgroup evolution at 16.4Evolution of Blood Groups, and briefly summarize any
one part of the discussion that grabs your interest.
The last example here involves cell surface antigens of the MHC (Major
Histocompatibility Complex) glycoproteins that distinguish self from nonself in body tissues
and organs. Transplantation of liver, kidneys, heart, and other major organs, from donors into
patients with failing organs has become if not routine, then at least increasingly common.
Before a transplant, MHC tissue typing determines donor and recipient compatibility to
reduce the chances of the rejection of the transplanted organ. Since available donors are few
and good matches even fewer, patients wait on prioritized lists for a matched organ. Even
when MHC typing is a match, the transplant recipient’s immune system must be suppressed
with hormones to further reduce chances of rejection. Unlike the limited number of blood
groups, there are many MHC proteins that must be analyzed to determine a match. Thus, it is
not practical (or routinely necessary) to “know” your MHC type! In the next chapter, we look
at membrane functions intrinsic to cellular existence itself.

16.7

A Brief Summary of Membrane Surface Functions

As the ultimate barrier and interface between the cell and its environment, the plasma
membrane has a number of easily defined functions. In anticipation of the next chapter, here
are some of them:
•
•
•
•
•
•

Cell-cell recognition during development to form tissues and then organs.
Cell-cell recognition leading to cell junctions during tissue repair following wound
healing.
Communication by selective ion channels and energy-dependent ion pumps.
Facilitated diffusion of molecules (e.g., glucose) that can’t diffuse into or out of cells.
Recognition of signaling molecules in the environment or even on other cells leading
to the transduction of chemical information from outside to inside the cell.
Participation in the immune recognition of humoral (blood- or lymph-borne) or
cellular components of the immune system.
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CHALLENGE: The localization in 2020 of a fluorescent-tagged RNA
known to regulate genes to the extracellular surface of human cells was
quite a surprise! This RNA was dubbed Membrane-AssociatedeXtracellular, or maxRNA. Check out 16.5maxRNAs at cell surfaces, or
16.6
Human Nuclear RNA found at extracellular surface-full paper (Huang
et al.) for some details. Discuss ways that maxRNAs could bind to a
plasma membrane, how they might get to the extracellular surface, and
how they would stay there?
Also, hypothesize some functions of
maxRNAs and how they might work?
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Chapter 17

Membrane Function

Passive diffusion, facilitated diffusion, and active transport; the traffic of proteins in cells;
cell–cell interactions, excitability, and signal transduction
Reminder: For inactive links, google key words/terms for alternative resources.

17.1

Introduction

Small molecules like O2 or CO2 can cross cellular membranes unassisted, since neither the
hydrophilic surfaces nor the hydrophobic interior of the phospholipid bilayer are barriers to
their transit. On the other hand, most molecules (even water) need the help of membranetransport proteins to get into, or out of cells and organelles.
Transport proteins can act as gates, which may be open or closed. When open, these
gates permit the diffusion of molecules into or out of cells along a concentration gradient, so
that their concentrations equalize across the membrane. Like the passive diffusion of small
gases, facilitated diffusion by membrane proteins does not require an input of energy.
Unlike passive or facilitated diffusion, active transport uses chemical energy to
transport substances across a membrane against a concentration gradient. Membrane
transport proteins that do this are in fact, pumps. We already saw one in the cristal membrane
of the mitochondrion. This pump uses the energy of electron transport to actively push protons
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across the cristal membrane to create a concentration gradient; the free energy in this gradient
is coupled to ATP synthesis by oxidative phosphorylation. Other membrane pumps use
chemical energy (typically from ATP hydrolysis) to move ions or molecules across membranes
and to create or to maintain chemical gradients. For example, pumps that create sodium- and
potassium-ion gradients are responsible for the excitability of cells. Recall that this is a
fundamental property of life: the ability of cells and organisms to respond to stimuli. As you
read this chapter, look for how allosteric changes regulate membrane function. We’ll consider
the following:
•
•
•
•
•

How membrane gates and pumps work
How membrane protein interactions allow cells to self-assemble into tissues and organs
How cells direct protein traffic (e.g., to the cytoplasm, into membranes, into organelles, or
out of the cell
How membrane proteins participate in direct communication between adjacent cells
How membrane proteins are receptors for long-distance communications, responding to
neurotransmitters, hormones, and other external chemical signals

Learning Objectives
When you have mastered the information in this chapter, you should be able to do the
following:
1. Explain how and why one cell type’s plasma membrane differs from that of another cell
type.
2. Explain how and why the plasma membrane differs from other membranes in the same
cell.
3. Predict and then determine if solutes will cross a plasma membrane by passive or
facilitated diffusion.
4. Explain how salmon can spend part of their lives in the ocean and part swimming
upstream in freshwater to spawn, without their cells shriveling or bursting.
5. Explain how active transport stores chemical energy. (Recall electron transport and
oxidative phosphorylation.)
6. Explain the role of active transport in maintaining/restoring a cell’s resting potential.
7. Compare and contrast different kinds of gated channels.
8. Describe the order of ion movements that generate an action potential.
9. Define and compare exocytosis, pinocytosis, phagocytosis, and receptor-mediated
endocytosis.
10. Distinguish between signal molecules that enter cells to deliver their chemical message
and those that deliver their message only as far as the plasma membrane.
11. Trace an intracellular response to a steroid hormone, from its beginning to its likely cellular
effect.
12. Trace a liver-cell response to adrenalin, from the plasma membrane to glycogenolysis
(glycogen breakdown) in the cytoplasm of the cell.
13. Compare the signal-transduction activities of different G-protein receptors leading to the
first active kinase enzyme in a phosphorylation cascade.
14. Explain how a liver cell can respond the same way to two different hormones (e.g.,
adrenalin and glucagon) and why this should be possible.
15. Describe/explain how a phosphorylation cascade amplifies the cellular response to a small
amount of an effector (signal) molecule.
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16. Discuss the differences and interactions between the glycocalyx, basement membrane, and
extracellular matrix (ECM).
17. Explain ECM functions and identify components involved in those functions.
18. Describe how the molecular structure of fibronectin supports its different functions.
19. Describe some structural relationships and interactions between cell surfaces and the
cytoskeleton.
20. Compare and contrast the structures and functions of the different cell junctions.
21. Distinguish between the structures and functions of cadherins, clathrin, COPs, adaptin,
selectins, SNAREs, and CAMs.
22. State a hypothesis to explain why some cancer cells divide without forming a tumor.

17.2

Membrane Transport

The first control on the passage of molecules across membranes is the semipermeable
character of the membrane itself. Molecules move in and out of cells in one of three ways:
passive diffusion, facilitated diffusion, and active transport.
Only a few small, relatively uncharged molecules can cross a membrane unassisted
(i.e., by passive diffusion). Hydrophilic molecules that must enter or leave cells require help
(i.e., from facilitated diffusion). Passive and facilitated diffusion release the free energy
inherent in concentration gradients as molecules diffuse across a membrane.
In contrast, active transport (i.e., membrane pumps) consumes energy to create
concentration gradients of specific solutes. The specificity of facilitated diffusion and active
transport lies in the integral membrane proteins that recognize and bind specific solutes for
transport. As you may predict, allosteric regulation of these proteins controls the movement of
their target molecules into or out of cells.
Despite water’s polarity, many believed that the small water molecules crossed
membranes without help. Indeed, they do to a limited extent. However, others suspected that
given its highly charged polar covalent bonds relative to its small size, a water molecule would
require an assist to get across membranes efficiently. Let’s begin with a closer look at passive
diffusion and diffusion by facilitated diffusion, followed by osmosis (a special case of facilitated
diffusion of water), and finally active transport.
17.2.1 Passive Diffusion of Solutes
Diffusion across membranes does not require energy. In fact, diffusion to relieve a solute
concentration gradient can release energy—recall the movement of protons through the F1
ATP synthase proton gate that synthesizes ATP during mitochondrial oxidative
phosphorylation. Passive diffusion in solution is the movement of molecules over time by
random motion (also called Brownian motion) from regions of higher to regions of lower
concentration. Significant passive diffusion across cellular membranes is limited to a few
molecules, mostly gases like O2, CO2, and N2, that can freely cross the hydrophobic
phospholipid barrier. The rapid diffusion of gases is essential for O 2 and CO2 exchange
between the alveolar capillaries and the cells of the lungs during physiological respiration. O2
and CO2 exchange also occurs in mitochondria during cellular respiration.
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The rate of diffusion of a molecule is dependent only on its own concentration. It is
unaffected by the concentration of other molecules. Over time, the random motion of solutes
within and across compartments results in a dynamic equilibrium for each different solute. At
equilibrium, solute molecules continue to diffuse across the membrane, but for each molecule
moving across in one direction, another molecule of the same solute crosses in the other
direction.
17.2.2 Facilitated Diffusion of Solutes and Ions
Like the passive diffusion of those gasses, facilitated diffusion (e.g., of ATP through an F1 ATP
synthase) is the spontaneous (downhill) passage of molecules or ions across membranes, but
with the help of specific transmembrane proteins. The kinetics of passive and facilitated
diffusion reveals the differences between the two processes. To understand the latter, recall
that the rate of enzyme catalysis is saturable. That is, as the concentration of substrate is
increased, the rate of the catalyzed reaction approaches a maximum (Vmax). This occurs when
all enzyme molecules in solution are bound to substrate molecules. The same saturation
phenomenon applies to facilitated diffusion—the rate of diffusion of a solute across a
membrane is directly proportional to the concentration of the solute but is limited by the
number of transport proteins in the membrane. Figure 17.1 plots the kinetics of passive and
facilitated diffusion.

Fig. 17.1: The graphed rates of passive and facilitated diffusion show that facilitated diffusion is a
saturable process.

Perhaps you see another similarity between facilitated diffusion and enzyme catalysis
in this graph! Relative rates of facilitated diffusion are typically rapid, compared to those of
passive diffusion. This is because the allosteric changes that accompany facilitated diffusion
are rapid, just as they are during enzyme catalysis. This should suggest yet another similarity
between enzymatic catalysis and facilitated transport: both can be regulated! Figure 17.2
(below) illustrates three kinds of facilitated transport of solutes.
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Fig. 17.2: Three kinds of facilitated diffusion: left, transport of s single molecule; middle, co-transport of two
molecules; right, exchange of molecules by opposing transport.

The GLUT (GLUcose Transporter) protein (Figure 17.2, left) allows glucose uniport, the
specific transport of a single substance in or out of cells. In symport (Figure 17.2, middle)
glucose transporters couple the simultaneous movement of glucose and sodium ions (e.g., in
kidney cells). The SGLT (Sodium-GLucose Transporter) serves a similar function in small
intestine cells, enabling absorption of dietary glucose and sodium. Antiport (Figure 17.2, right)
allows the specific exchange of molecules across a membrane. In the example shown, ATP
leaves the mitochondrial matrix, crossing the cristal membrane at the same time as ADP enters
the matrix. Whether by uniport, symport, or antiport, each solute will independently cross a
membrane down its concentration gradient, moving from regions where it is at a higher
concentration to regions of lower concentration. Recall that the direction of diffusion depends
on relative concentrations of the solutes, and that diffusion along (i.e., down) a gradient
releases free energy.
CHALLENGE: Each of the examples in Fig. 17.2 is accompanied by
allosteric changes in a transporter. Model the allosteric changes needed to
complete an act of symport or antiport and state your hypothesis!
Proteins mediating facilitated diffusion are of two kinds: carrier proteins and channel
proteins. Carrier proteins allow diffusion of large solutes across the membrane. While small,
ions also need help to cross the hydrophobic membrane barrier because they have a high
charge-to-mass ratio. This is the job of channel proteins, which essentially serve as ion pores.
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Like all transporter proteins, both carrier and channel proteins undergo allosteric
change during transport. They are also typically subject to allosteric regulation, rather than
being in a constant “open” state. Examples of facilitated diffusion are considered in more
detail next.
17.2.2.a Carrier Proteins
When a carrier protein binds a solute that must cross the membrane, it undergoes the first of a
series of allosteric changes, as shown in Figure 17.3.

Fig. 17.3: Transporter proteins (e.g., a glucose transporter) enable facilitated diffusion do the following:
(1) bind the solute, (2) undergo allosteric change to initiate transfer, (3) change shape again to release
the solute on the other side of the membrane, and (4) finally return to the starting shape after releasing
the solute (4).

During transport itself, the carrier protein undergoes another change in shape. When
the solute reaches the other side of the membrane, it no longer has a high affinity for the
carrier protein. After release of the solute, a final allosteric change restores the original
conformation of the transport protein.
A given carrier protein is specific for a single solute, or at most a single family of
closely related solutes. Thus, GLUT1, a glucose uniport transporter, allows glucose (but not
fructose or ribose!) to cross membranes. Other specific carrier proteins facilitate the transport
of amino acids or charged solutes across cell membranes. Once again, molecules that indicate
cell status (i.e., a need to import or export solute) are allosteric effectors that regulate carrier
proteins. Insulin is a perfect example of the regulation of solute transport, specifically glucose
transport into cells. One consequence of insulin being released during a meal (or in
anticipation of a meal!) is the stimulation of glucose transporters to take up glucose. An
inability of those transporters to respond to insulin accounts, in part for type-2 (adult-onset)
diabetes.
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Water gets across membranes by osmosis; we’ll look more closely at how osmosis
affects cells in a moment. But first, recall that small amounts of water can cross the
phospholipid bilayer unassisted. Water can also cross a membrane incidentally when ions flow
through their channel proteins. But most osmosis involves facilitated diffusion mediated by
aquaporins. Some aquaporins only transport water. Others have evolved to co-facilitate the
transport of glucose (see above), glycerol, urea, ammonia, carbon dioxide, and even ions
(protons) along with water.
Like other carrier proteins, aquaporins are allosterically regulated to allow cells to meet
specific water balance requirements. Understanding how cells managed their water balance
was so fundamental that the discovery of aquaporins earned Peter Agre a Nobel Prize in
Chemistry in 2003.
Since Agre’s discovery (in 1992), several genetic diseases have been linked to
aquaporin gene mutations. Kidney cells are critically involved in vertebrate water balance and
have many aquaporins in their membranes. In a rare form of diabetes, abnormal aquaporins
cause the kidneys to excrete unusually large volumes of water. In another example, aquaporin
gene mutations lead to the development of cataracts in both eyes. Since their initial discovery,
aquaporins have also been described in bacteria and plants. To learn more, see 17.1Aquaporins.
17.2.2.b Ion Channels
Allosteric regulation of ion channel proteins controls ion homeostasis in blood and
extracellular fluids within narrow limits. Often, multiple integral proteins contribute to the
formation of an ion channel. When stimulated, channel proteins rearrange to open a pore,
allowing specific ion transport. Some ion channels, like the glucose-sodium ion symport
system noted earlier, mobilize the energy of diffusion of one solute (the ion in this case) to
rapidly transport another solute through the same channel (acting like an ion channel and a
carrier protein). Finally, ion channels are responsible for the excitability of cells, where Na+,
K+, and Ca++ channels collaborate in ion movements into and out of cells leading to neuronal
or muscle cell responses (more shortly!).

293-2 Passive & Facilitated Diffusion (Transport)

17.3

Osmosis

Osmosis is the diffusion of water across membranes from low to high solute concentrations, an
essential cellular activity. It allows cells to use water to maintain cellular integrity or to adapt
to changes in the solute composition in the extracellular environment. Osmosis relies on the
transport of water by aquaporins. The passive diffusion of water molecules can be
demonstrated with artificial (e.g., dialysis) membranes. If solute concentrations are higher on
one side of the membrane, free water will cross the membrane “trying” to equalize the solute
concentrations on both sides of the membrane. In effect, water movement is away from the side
of a membrane where the free water concentration is higher (i.e., where the concentration of
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solute is lower) and goes to the side where the concentration of free water is lower (basically,
the side where the concentration of solute is higher).
CHALLENGE: What do you think is meant by the term free water here?
17.3.1 Osmosis in Plant and Animal Cells
We could present this section in the context of free-water concentrations, but we will do so in
the more familiar terms of solute concentrations. Osmosis affects plant and animal cells
according to the same principles, but with different effects. The effects of different
experimental solute concentrations on animal cells are illustrated in Figure 17.4.

Fig. 17.4: Differences in solute concentrations inside and outside animal cells affect the movement of
water into or out of the cells (i.e., osmosis). Cellular solute concentrations are higher than (left), similar
to (middle) or lower than (right) than the surrounding solution.

If the solute concentration inside and outside the cell is the same, there is no net water
movement into or out of the cells. The extracellular medium and cytosol are said to be isotonic
to each other. When water diffuses into the cells from a low-solute medium, the medium is said
to by hypotonic to (less concentrated than) the cytosol. In this case, movement of water into a
cell lowers the cytosol-solute concentration. Animal cells swell and burst in a hypotonic
solution. Animal cells in hypertonic solutions (with higher solute concentrations than the
cytosol) shrivel up as water leaves the cell. From this brief description, you should conclude
that water crosses from the hypotonic to the hypertonic side of a membrane. As with animal
cells, exposure of plant cells to hypotonic or hypertonic solutions causes the same directional
water movements, but with some key differences due to their cell walls. Figure 17.5 (below)
shows the effects of different solutions on plant cells.
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Fig. 17.5: Differences in solute concentrations in and out of plant cells affect water movement into or out
of the cells, (i.e., osmosis), with different effects than in animals because (a) plants have a rigid cell wall,
and (b) plant cell membranes are attached to the cell wall. During transient changes in extracellular solute
concentrations, a tonoplast accumulates or releases water to achieve correct cytoplasmic solute.

In hypotonic solutions, water enters plant cells, moving into the cytosol and then into
water vacuoles called tonoplasts. This results in higher osmotic pressure (water pressure) in
the tonoplasts. The expanding tonoplast creates turgor pressure, compressing the cytosol
against the cell wall. Rather than swelling excessively and bursting like animal cells, plant
cells and therefore the plant tissues, stiffen and become turgid. Since water cannot enter plant
cells indefinitely, water stops entering the cells when the osmotic pressure outside the cells and
the turgor pressure inside the cells are at equilibrium. You’ve would have seen this
phenomenon if you ever overwatered houseplants. Turgor pressure stiffens the leaves and
stems that then become brittle and are easily snapped and broken. In hypertonic medium,
plant cells (like animal cells) lose water. The resulting shrinkage of the plasma membrane
away from the cell walls is called plasmolysis, in which bits of plasma membrane remain
tightly attached to the plant cell wall at several points, limiting shrinkage (especially if the
water loss is transient). You may have seen under-watered plants with floppy or droopy stems
and leaves. These have become flaccid due to loss the loss of turgor pressure needed to keep
leaves and stems upright. Formally, osmotic or turgor pressure is defined as the force per unit
area (i.e., pressure) required to prevent the passage of water across a semipermeable
membrane from a hypotonic to a hypertonic solution.
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17.3.2 Osmosis in Plant Life
While individual plant cells respond to changes in solute concentrations, these changes are
rapidly communicated to adjacent cells through plasmodesmata. These structures connect the
plasma membranes of adjacent cells through their cell walls, allowing rapid, direct sharing of
physical and chemical information. A plasmodesma is illustrated in Figure 17.6.

Fig. 17.6: Plasmodesmata are cell wall “tunnels” connecting plant cells and allowing direct movement of
water between cells to transmit changes in osmotic pressure in one part of a plant (e.g., roots).

In this way, the effects on osmotic pressure in a few cells—effects created by changes
in water availability—are transmitted to adjacent cells, affecting turgor pressure in those cells
and, ultimately, in plant tissues. Finally, plant life depends on water! Recall that plant cells
require a continual supply of water for use in photosynthesis, to provide hydrogen to reduce
CO2 to glucose. Photosynthesis, as well as the loss of excess water from plant tissues
(especially leaves) by transpiration, lowers cellular osmotic pressure. As water moves up from
the roots to replace water used and lost by leaf cells, the osmotic pressure drops in the fine
root-hair cells (with their high surface area). This draws water into the root cells by osmosis.
Thus, osmotic pressure is the main force driving water into plants and, defying gravity, moving
it up from the roots to the rest of the plant.
17.3.3 Osmosis in Animal Life
Changes in osmotic environment can stress or kill an organism. For example, freshwater
organisms (protozoa or fish) placed in sea water will die. Likewise, salt-water fish placed in
freshwater. But cells and organisms can osmoregulate (i.e., control the osmotic pressure in
their cells), at least to a point. For example, as a paramecium takes on water, a contractile
vacuole expels excess water to prevent the cell from bursting (Figure 17.7, below).
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Fig. 17.7: The light micrograph of a paramecium highlights a contractile vacuole, an organelle that
pumps out excess water from the cell, protecting it from osmotic shock.

Water constantly enters these freshwater protists because the solute concentration in the
cytosol is always higher than the fresh water they live in. To cope with a constant uptake of
water, their contractile vacuoles collect excess water and then contract to expel the water. At a
high energy cost, paramecia constantly pump water out of the cell to maintain water balance
(i.e., correct osmotic pressure).
Another protist strategy to cope with changes in environmental solute concentrations
(e.g., salinity) is to pump salts (or suitable salt-solute substitutes into or out of the cell, as
needed. (For some details, see 17.2Protist Osmoregulation Genes from Bacteria?.)
Larger organisms, like freshwater fish, cope with their hypotonic environment by
urinating a lot! At the other end of the spectrum, salt-water fish cope with the high solute
concentration of solutes (salts) in their environment by excreting excess salt. Salmon spend
time in seawater growing to maturity and later swim upstream in fresh water to spawn. You
can imagine how salmon and similar organisms have to osmoregulate to adapt to their
changing, very different environments. In this case, osmoregulation begins when hormonal
changes respond to changes in living circumstance and dictate a compensatory response.
17.3.4 Summing Up Osmosis
Osmosis is the movement of water across membranes to the side where solutes are at a higher
concentration. At the same time, solutes diffuse across membranes, moving into or out of cells
toward the side where they are at lower concentration, either passively or with the help of
transporter proteins. We’ve evolved different facilitated diffusion proteins specific for the crossmembrane transport of different solutes. And finally, most water crosses membranes by
facilitated diffusion through aquaporin proteins that serve as pores in cellular membranes.

294-2 Osmosis
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17.4

Active Transport

Excitability (adaptation) is another of the defining properties of life. This property of all cells is
based on chemical and electrical reactivity. Neurotransmitters released at a synapse cross the
synaptic cleft from a “sending” neuron to a responding cell (another neuron or a muscle cell).
The neurotransmitter binds to receptors on the responding cell resulting in a membrane
depolarization, a rapid change in electrical potential difference across the cell membrane.
While responses to neurotransmitters occur in fractions of a second, all kinds of cells are
responsive, albeit not always as fast as neurons or muscle cells.
Changes in the membrane polarity of any cell depend on unequal concentrations of
ions inside and outside cells. These ionic differences across membranes enable all cells, but
especially neurons and muscle cells, to respond to chemical and other (e.g., electrical) signals.
Thus, cells have a resting potential due to a higher [K+] in the cytosol and higher [Cl−] and
[Na+] outside the cell. The measured resting potential (difference in charge or potential
difference) of most cells is typically between −50 mv to −70 mv, negative because negative
(i.e., Cl−) ions are at higher concentration inside the cell than outside. Such ion concentration
gradients permit physiological response to chemical or other signals. They change when cells
are excited when they (quite normally) leak ions. Whether incidental or intentional, the correct
ion balance must be restored to maintain excitability. Relative concentrations of K+, Cl−, and
Na+ ions accounting for a cell’s resting potential are shown in Figure 17.8.

Fig. 17.8: The resting potential of a cell results from an ion-concentration imbalance across the plasma
membrane. Sodium and chloride ion concentrations are normally higher outside cells while potassium ion
levels are higher inside the cell. Thus, the cytoplasm is slightly negative compared to the extracellular fluid.

Maintaining a cell’s resting potential requires energy, and this is accomplished by the
ATP-dependent Na+/K+ pump, an active-transport protein complex. Follow the allosteric
changes as the Na+/K+ pump (Figure 17.9 below) works to restore ion gradients.
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Fig. 17.9: After a change in the resting potential (e.g., depolarization) of a cell, Na+/K+ ion balance across
the cell membrane is restored by an ATP-powered sodium/potassium pump. Three Na+ ions are pumped
out of the cell for every two K+ ions that enter the cell.

In operation, the ATPase domain of the Na+/K+ pump protein hydrolyzes ATP, leaving
a phosphate attached to the pump and inducing the first of several allosteric changes in the
pump proteins (step 1 in the illustration). In its new conformation, the pump binds three Na +
ions, causing a second conformational change that in turn releases the Na + ions into the
extracellular fluid (step 2). The release of Na+ ions outside the cell causes a third allosteric
change (step 3), after which two K+ ions from the extracellular fluid can bind to the pump
protein. K+ binding causes the hydrolysis of the phosphate from the pump protein, returning it
to its original conformation (step 4) and releasing the two K+ ions into the cytosol. The Na+/K+
pump is ready for action again!

295 Potassium Leakage Helps Maintain Cellular Resting Potentials

296 Active Transport by the Sodium/Potassium Pump
For his discovery of the ATPase-powered sodium/potassium pump and for his studies
of how it works to maintain intracellular ion balance, Jens C. Skou earned a share of the Nobel
Prize in Chemistry in 1997. Read more at 17.31997 Chemistry Nobel prize-Skou.
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17.5

Ligand- and Voltage-Gated Channels in Neurotransmission

Ligand- and voltage-gated channels play a major role in neurotransmission and muscle
contraction by regulating a flow of ions into and out of responding cells. With the advent of the
patch-clamp device, it became possible to correlate ion flow with measurements of membrane
potential and to define the sequence of electrical and chemical events leading to muscle
contraction (Figure 17.10).

Fig. 17.10: A patch-clamp device can measure ion flow through voltage-gated channels in a
membrane during a depolarization event. After a voltage is applied across the plasma membrane,
specific ion sensors measure ion follow into or out of the cell.

17.5.1 Measuring Ion Flow and Membrane Potential with a Patch-Clamp Device
When neurotransmitters bind to their receptors, ion channels in responding neuron or muscle
cells open. The resulting influx of Na+ ions disrupts the resting potential of the target cell. The
effect is transient if the membrane potential remains negative. But if enough Na+ ions enter
the cell, the membrane becomes depolarized. If the cell experiences hyperpolarization, a
localized reversal of normal membrane polarity (say from −70 mV to +65 mV or more) will
generate an action potential. This action potential will travel like a current along the neural or
muscle cell membrane, eventually triggering a physiological response (e.g., the excitation of
the next nerve cell in a neuronal pathway or the contraction of the muscle cell).
In this example of patch-clamp measurements, closing the power supply switch sends
an electrical charge to the cell, opening a voltage-gated ion channel. A potassium sensor in
the device then detects a flow of K+ ions through the channel out of the cell; at the same time,
a voltmeter registers the resulting change in membrane potential. In addition to voltage-gated
ion channels, the patch-clamp device can measure ion flow through ligand-gated ion
channels and mechanically gated ion channels. The former channels are receptor-ion gates
that open when they bind an effector molecule.

413

Mechanically gated ion channels detect physical pressure or stress that cause a local
membrane deformation, and then open the channel (recall piezoreceptors discussed earlier).

297 Patch-Clamp Device Records Membrane Potential and Ion Flow

298 Patch-Clamp Measures Resting Potential and Depolarization

299 Gated Ion Channels

300 Two Types of Gated Ion Channels

Finally, cells maintain a high intracellular concentration of K + ions, causing K+ ions to
slowly leak from the cell, a phenomenon detectable by a patch-clamp. Cl− ions, as well as
other, organic, anions inside a cell, limit the leakage, helping to create the relatively
electronegative interior of a cell that is its resting potential. The patch-clamp technique has
been used to correlate the flow of ions and changes in membrane potential when a neuron
fires, causing an action potential in a responding cell (e.g., Figure 17.11).

Fig. 17.11: With the patch-clamp device, follow changes in ion flow through gated channels and resulting
changes in potential (voltage) across e.g., a muscle cell membrane during an action potential.
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In the illustration, follow the opening and closing of ion channels and the resulting
flow of ions along their concentration gradients. A shift from resting potential and possibly an
action potential will result from facilitated diffusion of specific ions into or out of the cell
through gated ion channels that must open and close in sequence. The behavior of two
different voltage-gated ion channels is illustrated in the graph. Electrical stimulation opens
Na+ channels, allowing Na+ ions to rush into the cell. This reduces the membrane potential
from the resting state to zero. If the Na+ influx continues, it can make the cytoplasm more
positive than the extracellular fluid, which may lead to an action potential. If the reversal in
polarity is high enough, a voltage-gated K+ opens, and potassium ions rush out of the cell,
restoring the resting potential of the cell.
A cell can continue to respond to stimuli with action potentials for as long as there is sufficient
Na+ outside the cell and K+ inside the cell. While active transport of Na+ and K+ is not
required to reestablish the resting potential, it will eventually be necessary to restore the
balance of the two cations in the cell. If a nerve or muscle cell fires several times (or even if it
just leaks ions), the [K+] inside the cell and the [Na+] outside the cell can drop to a point where
the cell can’t generate an action potential when stimulated. The role of ATP-dependent Na+/K+
pump is, ultimately, to restore the Na+/K+ balance across the responding cell membrane. As we
have seen, each cycle of pumping exchanges three Na+ ions from the intracellular space for
two K+ ions from the extracellular space. Operation of this ion pump has two effects:
•
•

It restores Na+ concentrations in the extracellular space relative to the cytoplasm.
It restores K+ concentrations in the cytoplasm relative to the extracellular space.

301 Gated Ion Channels Open & Close in Order during an Action Potential
Together with the higher negative-ion concentrations in the cytosol, the unequal
exchange of Na+ for K+ ions maintains the resting potential of the cell over the long term and
ensures that nerve and muscle cells remain excitable. Next, we will take a closer look at the
role of both ligand-gated and voltage-gated ion channels in neurotransmission.
17.5.2 Ion Channels in Neurotransmission
Action potentials result in an orderly, sequential opening and closing of voltage- and ligandgated channels along the neuronal axon. In the following link, you can see the sequential
cycles of voltage-gated channels that propagate a localized action potential (membrane
depolarization) along an axon toward a synapse.

302 Propagating an Action Potential along an Axon
When a propagated depolarization reaches a synapse, gated ion channels either open
or close in the neuron and the responding cell. The cooperation of voltage- and ligand-gated
channels at a neuromuscular junction is illustrated in Figure 17.12 (below).
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Fig. 17.12: Neurotransmission starts with an action potential in the cell body of a neuron. The action
potential is propagated along the axon to the nerve terminal synapse. The depolarization pulse initiates
Ca++ flow into the neuron through voltage-gated channels. This causes a release of neurotransmitters
into the synaptic cleft. The neurotransmitter binds to a ligand-gated channel on the responding cell,
causing Na+ ions to flow into the responding cell and leading to an action potential.

As you can see from the illustration, when a neuron fires, a region of hyperpolarization
(an electrical impulse) travels down the axon to the nerve ending. There, the traveling charge
difference across the cell membrane (electrical potential) stimulates a Ca++-specific voltagegated channel to open. Ca++ ions, at higher concentration in the synaptic cleft than in the
cytoplasm, flow into the neuron. The Ca++ ions cause synaptic vesicles to fuse with the presynaptic membrane at the nerve ending, causing the release of neurotransmitters into the
synaptic cleft.
Acetylcholine, the neurotransmitter in this example, crosses the synaptic cleft and
binds to receptors on the responding (e.g., muscle) cell plasma membrane. This receptor is a
ligand-gated channel (also called a chemically gated channel). Binding of the acetylcholine
ligand opens the gated channel. A rapid diffusion of Na+ ions into the muscle cell creates an
action potential leading to the response, in this case, muscle contraction. We have already
seen the role of K+ channels in restoring the membrane resting potential after an action
potential, and we have also seen the role of the sodium/potassium pump in restoring the
cellular Na+/K+ balance.

303-2 The Role of Gated Ion Channels at a Neuromuscular Junction
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CHALLENGE: Many of the neurotoxic snake and spider venoms interfere
with ion channels to paralyze and immobilize prey organisms. Which of
the channels mentioned here would you expect to be affected by these
neurotoxins (or for that matter, neurotoxic gases), and why?

17.6

Endocytosis and Exocytosis

Endocytosis internalizes extracellular molecules (e.g., proteins), insoluble particles, or even
microorganisms. The main pathways of endocytosis are phagocytosis, pinocytosis, and receptormediated endocytosis. Pinocytosis of molecules is nonspecific. Phagocytosis is also nonspecific,
internalizing large structures (e.g., bacteria and food particles). In contrast, receptor-mediated
endocytosis is specific for substances recognized by a cell-surface receptor. Some endocytotic
processes are even used to recycle membrane components. Exocytosis is the secretion of large
molecules like digestive enzymes and peptide or polypeptide hormones, each of which must
exit the cell to the extracellular fluid or circulation. Exocytotic pathways also deliver
membrane proteins to the cell surface, either new or to replace older, worn-out proteins.
17.6.1 Endocytosis
The three main kinds of endocytosis are summarized in Figure 17.13.

Fig. 17.13: Illustration of three main kinds of endocytosis, routes/mechanisms of import of extracellular
materials into cells.
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From left to right in Figure 17.13:
1. Phagocytosis (above left): phagocytes extend pseudopodia by evagination of the cell
membrane. The pseudopodia of amoeba (and amoeboid cells generally) engulf particles of
food, which end up in digestive vesicles ( phagosomes) inside the cytosol. Phagocytes are a
class of white blood cells that are part of our immune system. They engulf foreign particles
that must be eliminated from the body. A lysosome fuses with the phagosome, after which
inactive hydrolytic enzymes stored in the lysosomes are activated. The result is the
digestion of the engulfed particles. Phagocytosis begins upon contact between the outer
cell surface and those particles.
2. Pinocytosis (above center): pinocytosis is a nonspecific, more-or-less constant pinching off
of small vesicles that engulf extracellular fluid containing solutes; they are too small to
include significant particulates.
3. Receptor-mediated endocytosis (above right): this kind of endocytosis relies on the affinity
of receptors for specific extracellular substances. Upon binding their ligands, the
membrane receptors aggregate in differentiated regions of plasma membrane called
coated pits. The coated pits then invaginate and pinch off, forming a coated vesicle,
bringing their extracellular contents into the cell. After the coated vesicles deliver their
contents to their cellular destinations, their membranes are recycled to the plasma
membrane. Receptor-mediated endocytosis is the best understood mechanism for bringing
larger substances into cells. The drawings in Figure 7.14 are taken from electron
micrographs that illustrate the invagination of coated pits to form clathrin-coated vesicles.

Fig. 17.14: Stages of receptor-mediated endocytosis. Receptors at coated pits bind substances to
be imported into a cell, triggering the invagination of the pit to form a cytoplasmic vesicle with imported
contents (shown from left to tight). Invagination is mediated by several proteins, including clathrin.

Receptor and coat proteins are seen as larger structures on the inner surfaces of the
pits and on outer surfaces of clathrin-coated vesicles. Clathrin, the principal protein on
surfaces of invaginated, coated pits, is linked to specific integral membrane proteins by AP1
(adaptor protein 1, one of several adaptins). AP1 recruits specific cargo proteins to bring into
the cell as coated pits invaginate. Some details of receptor-mediated endocytosis are illustrated
below in Figure 17.15.
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Fig. 17.15: Follow ligand import into a cell by receptor-mediated endocytosis, from receptor binding at,
and invagination of a coated pit, to fusion with an early endosome, formation of a sorting vesicle (late
endosome), finally becoming a lysosome that digests and release imported material to the cytoplasm.

In the illustration, substances to be internalized bind to membrane receptors that then cluster
to form a coated pit. Assisted by dynamin (a GTPase), the coated pits invaginate. The final
pinch-off of a coated vesicle requires GTP hydrolysis (not shown). Once internalized, coated
vesicles lose their clathrin and associated adaptor-protein coat. Uncoated vesicles fuse with
early endosomes to form sorting vesicles (i.e., late endosomes). Sorting vesicles separate
imported content from their receptors. The latter are recycled to the membrane. The vesicles
that remain are lysosomes, with digestive enzymes that digest (hydrolyze) vesicle contents that
are released and recycled in the cytoplasm. Watch live video of fluorescently labeled proteins,
the bright spots, entering cells at 17.4Receptor-Mediated Endocytosis (watch the two left panels).
The uptake of cholesterol bound to low-density lipoprotein (LDL) is a well-known example of
receptor-mediated endocytosis (Figure 17.16).

Fig. 17.16: A low-density lipoprotein coated with cholesterol
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A single LDL phospholipid-protein complex carries as many as fifteen thousand molecules of
cholesterol. LDL, sometimes called “bad cholesterol,” is not good for you at high levels,
whereas high-density lipoprotein (HDL) is “good cholesterol.” As one gets older, it is important
to monitor one’s HDL/LDL ratio; the higher it is, the better!
17.6.2 Exocytosis and the Formation of Protein-Storage Organelles
Maintaining cell size or volume seems to be a built-in task of the receptor-mediated
endocytosis machinery, which balances endocytosis with membrane recycling. Exocytosis is
also necessary to restore plasma membrane internalized by pinocytosis and phagocytosis, and
for eliminating cellular waste products. Exocytosis is also the end point of the process of
packaging proteins for secretion, for intracellular storage (e.g., in lysosomes, peroxisomes) and
for insertion into the membrane itself. Endocytotic and secretion vesicles form in “opposite
directions,” but both share common structural features with the cell membrane, from which
one vesicle type is derived and with which the other fuses (respectively). The formation of
lysosomes and secretion vesicles starts in the rough endoplasmic reticulum (RER), followed
by passage and maturation through Golgi vesicles, as shown in Figure 17.17.

Fig. 17.17: Follow protein sorting (traffic) from translation on RER to-and-through Golgi vesicles (lower
right and center-right) to either secretion vesicles (upper right) or storage vesicles (e.g., lysosomes,
upper left), and the roles of each pathway in exocytosis and endocytosis.

As we have seen, many secretory and membrane proteins are glycoproteins, and their
glycosylation begins in the RER. Check the following link to review the process.

291 The Path to Sugar-Coated Cells
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A cell often produces many packaged proteins at the same time that must be sorted to
the correct place—extracellular fluids, lysosomes, peroxisomes, other “microbodies,” and of
course, membranes. How do they do it? Table 1 lists some representative packaged proteins
that must be segregated from the cytoplasm.
Table 17.1
Hormones
insulin

growth hormone

follicle-stimulating
hormone (FSH)
oxytocin

Immune-System Proteins
immunoglobulin G (IgG), a
class of circulating
antibodies
IgM and other cell
membrane antibodies

Neurotransmitters
acetylcholine

Other
epidermal growth factor
(EGF)

dopamine,
adrenaline,
noradrenaline, and
other monoamines

neural growth factor
(NGF)

major histocompatibility
complex (MHC) proteins

serotonin

fibrinogen (and other
blood-clotting factors)

some amino acids
(glutamate,
aspartate, glycine)

fibronectin (and other
extracellular matrix
proteins

prolactin

plant cell wall
components

adrenocorticotropic
hormone (ACTH)

trypsin, pepsin (gut
digestive enzymes)
chloroplast and
mitochondrial proteins
nuclear proteins

17.7

Directing the Traffic of Proteins in Cells

All polypeptide proteins have been translated by ribosomes from a sequence of bases in an
mRNA, and each has a specific functional location, whether in the cytoplasm, on cellular
membranes, inside organelles, or in extracellular fluids. In this section we consider the
movement and sorting of proteins from RER through vesicles of the endomembrane system, as
well as the transport of proteins into and out of organelles.
17.7.1 Proteins Packaged in RER Are Made as Larger Precursor Proteins
All protein synthesis begins with the formation of an initiation complex and subsequent
elongation cycles of peptide-bond formation and carboxyl-terminal amino acid addition. But
proteins to be packaged for secretion or into lysosomes, peroxisomes, or other microbodies will
complete translation elongation directly into the cisternae (enclosed spaces) of the RER. What
traffic signal led some proteins to the RER and others elsewhere in the cytoplasm? A model
system for studying secretory protein synthesis is mouse myeloma cells, cancerous
lymphocytes of the immune system. Normal lymphocytes make immunoglobulin G (IgG) with
light- and heavy-chain polypeptide subunits. IgGs are circulating antibodies. The myeloma
cells make only IgG light chains, which are easily isolated from a cell culture medium.
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In an early experiment, mouse myeloma cells were cultured under different conditions,
and the secreted IgG light chain that was produced was analyzed. The results revealed that the
secreted mouse light-chain IgG proteins that had been made in an in vitro translation system
were in fact larger than proteins naturally secreted by the cells. The experimental protocol is
illustrated in Figure 17.18.

Fig. 17.18: Experimental strategy for determining the role of RER in the synthesis of secretory proteins.

In one part of this experiment, myeloma cells were grown in the presence of radioactive amino
acids. The resulting radioactive IgG light-chain polypeptides secreted by the cells were
isolated (follow the arrows across the top of Figure 17.18). In another part of the experiment,
mRNA was isolated from a different batch of the myeloma cells and added to an in vitro
translation system containing radioactive amino acids (follow the arrows down the left and
across the bottom of the figure). The radioactive polypeptides made in vivo and in vitro were
electrophoresed (follow the arrows to the gel) and the gels then autoradiographed. From the
results at the lower right, you can see that the secreted polypeptides made in vivo had
migrated faster on the gel than those translated in vitro. So, the cell-free translation product
was indeed larger than the mature secreted polypeptide. To explain these results, Günter
Blobel and colleagues extended the “Signal Hypothesis,” proposing that the signal was a short
N-terminal signal peptide that directs a growing secretory polypeptide to the RER. They
further proposed that the signal peptide is a temporary “traffic” signal, removed by an RERassociated enzyme as the polypeptide crossed the RER membrane into the cisternal space.

304 Formulating the Signal Hypothesis: Early Experiments
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17.7.2 Testing the Signal Hypothesis for Packaging Secreted Proteins in RER
In the test of the Signal Hypothesis (which earned Blobel the 1999 Nobel Prize in Physiology or
Medicine), isolates of RER membranes were included with mouse myeloma cell mRNA in cellfree protein-synthesis systems. This time, when secreted and cell-free synthesized IgG light
chain polypeptides were electrophoresed and the gel was autoradiographed, both polypeptides
were the same size as the mature, secreted polypeptides. Therefore, as predicted, RER contains
processing activity—that is, a signal peptidase that removes the signal peptide! The steps of
the signal hypothesis that emerged from the experiments of Blobel and his colleagues are
illustrated in Figure 17.19.

Fig. 17.19: Molecular details (steps) of the Signal Hypothesis leading to protein secretion

Recall that in translation, during polypeptide elongation, the growing polypeptide moves
through and emerges from a channel or groove in the large ribosomal subunit. As the Nterminal signal sequence (i.e., the signal peptide) of a secretory polypeptide emerges from this
groove, it interacts with the RER membrane. Beginning at the lower left in Figure 17.19, the
steps of protein packaging for the secretion process are these:
1.
2.
3.
4.

An SRP (signal recognition particle) binds to the hydrophobic signal peptide.
Elongation stops until the SRP-ribosome complex finds the RER membrane.
The ribosome-SRP complex binds to an SRP receptor on the RER membrane.
The SRP detaches from the growing polypeptide chain and is recycled.
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5. Translation elongation resumes through a translocation channel, and a signal peptidase
in the RER membrane catalyzes cotranslational hydrolysis of the signal peptide, which
remains embedded in the RER membrane.
6. Elongation continues, and the growing polypeptide begins to fold in the RER.

305 Testing the Signal Hypothesis

306-2 Details of the Signal Hypothesis
Step 2 requires that the SRP find and bind to the signal peptide before the nascent polypeptide
gets too long and starts folding into a 3D (tertiary) conformation that would hide the signal
peptide. The ribosome itself may keep the signal peptide available by destabilizing
electrostatic interactions that would otherwise lead to premature folding and an undoubtedly
incorrect conformation. For more on ribosome involvement in protein folding, see 17.5ProteinFolding starts Near The Ribosome Making It.
Bacterial secretions include proteins involved in nutrient scavenging as well in cellwall synthesis, using a secretory mechanism like that of eukaryotes, with obvious differences
in detail. Partially elongated signal peptides guide mRNA-bound ribosomes to the cytoplasmic
side of the plasma membrane, where the ribosomes bind and then pass elongating proteins
through the plasma membrane into the space between the cell membrane and wall. As the
protein exits the cell, a bacterial signal peptidase ( SPase) cleaves the signal peptide.
Apparently, the basic mechanism for the secretion of proteins evolved early and is conserved in
prokaryotes. Early on, we knew that some antibiotics stop bacterial growth by disrupting the
cell wall or by killing the cells outright. Others (e.g., arylomycins) disrupt plasma membrane
SPase function, preventing proteins needed in the space between the cell wall and membrane
from ever making it out of the cell. Once widely used against S. aureus, arylomycins are no
longer effective because many Staphylococcus strains have become resistant to these
antibiotics. Check out 17.6Bacterial SPase and Antibiotic Resistance to read about the
mechanism of arylomycin resistance. As you may already know, S. aureus is now resistant to
most antibiotics, and illness from untreatable infections has its own name, MRSA (MethicillinResistant S. Aureus—dig on your own to see more about methicillin resistance). While named
for methicillin resistance, the MRSA acronym has also come to describe untreatable S. aureus
infections in general.
We turn now to well-studied mechanisms for packaging proteins into eukaryotic
organelles and into the membranes themselves.

17.8

Synthesis of Integral Membrane Proteins

Integral membrane proteins may span a membrane one or more times or may simply be
anchored (embedded) in the membrane at one end (Figure 17.20, below).
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Fig. 17.20: Integral membrane proteins that span the entire membrane have one or more very
hydrophobic stop transfer signals, in addition to their signal sequence. Such membrane proteins
cross the membranes one or more times during their synthesis.

N-terminal signal sequences guide ribosomes translating integral membrane proteins to the
RER. But before such a protein can pass completely into the RER cisternae, a stop-transfer
sequence (a hydrophobic domain within the polypeptide chain) traps the protein in the fatty
acid interior of the membrane. Multiple stop-transfer sequences account for transmembrane
proteins that span a membrane more than once.

308-2 Integral Proteins Have Stop-Transfer Sequences

17.9

Moving and Sorting Proteins to Their Final Destinations

Like proteins packaged in RER, those made in the cytoplasm go to different destinations before
they become functional. What’s more, cells can truly multitask (unlike most of us!), handling
the synthesis and distribution (or secretion) of many proteins at the same time! Let’s begin
with a look at the sorting mechanisms for proteins sequestered by the endomembrane system.
17.9.1 Traffic on the Endomembrane Highway
We have already seen that, once packaged in the RER cisternae, proteins begin
posttranslational modification (e.g., by “core glycosylation”). Transport vesicles that bud off
from the RER carry packaged and membrane proteins to the cis vesicles of the Golgi
apparatus. There, vesicle fusion is mediated by the recognition of complementary integral
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membrane proteins embedded in the two membranes. Later, such packaged proteins are sorted
to different organelles or to the plasma membrane. Protein sorting starts as proteins move from
the cis to the trans face of the Golgi vesicles, where specific sorting proteins associate with
different packaged proteins in the trans Golgi vesicles. The packaged proteins then sort to
vesicles that bud off from trans Golgi stacks. These vesicles move to their final destinations,
recognizing and then fusing with appropriate membranes. James E. Rothman, Randy W.
Schekman, and Thomas C. Südhof won the 2013 Nobel Prize in Physiology or Medicine for
their studies of the regulation of vesicle traffic (check out 17.72013 Physiology or Medicine
Nobel Prize for more information). Let’s follow some proteins in and on RER membranes
through the cell (also animated at 17.8Events of Protein Trafficking) from the RER to their
cellular destinations, as summarized in Figure 17.21.

Fig. 17.21: Alternate pathways for sorting of cellular (e.g., secreted, vesicular, other) proteins.
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Here are the steps to follow the traffic of protein sorting shown in the illustration:
•

Transition vesicles, carrying their mix of packaged proteins, bud off from the RER with the
help of COPI and COPII coat proteins, dissociating from ribosomes. Transition vesicles,
however, remain associated with the COP proteins.

•

These vesicles fuse with cis Golgi vesicles, a process also mediated by COP proteins. COPI
proteins detach during or after fusion, recycling back to the RER.

•

Packaged proteins and membrane proteins are further processed as they pass through the
Golgi vesicle stack (e.g., undergoing terminal glycosylation).

•

A key step in sorting packaged proteins occurs as vesicles bud off from the trans Golgi face
with the help of clathrin, other COP proteins, and specific cargo-receptor proteins. The
cargo-receptor proteins recruit specific packaged proteins (now called cargo proteins) and
enrich them in their nascent vesicles. V-SNARE (for vesicle-SNARE) proteins also
associate with the vesicles, guiding them to their ultimate destination.

When V-SNARE proteins on their vesicles next bind to complementary Target-Snare (TSNARE) proteins on receiving membranes, the two membranes fuse, at which point the
different types of vesicle part ways. Some vesicles follow a pathway to organelles, fusing with
lysosomes or similar vesicles along the way to stock up on appropriate enzymes and other
required protein content. Coat proteins come off the fusing vesicle and are recycled, while
vesicle contents are transferred into the next generation vesicle. Those containing secretory
proteins typically fuse to form larger secretory vesicles (or secretion vesicles). These will next
fuse with the plasma membrane, releasing their contents to the extracellular fluid. Once again,
coat proteins and clathrin dissociate from the secretory vesicle during this fusion. At some
point, secretory vesicles will release their contents, but until they are signaled to do so, they
will remain resident in the cell cytoplasm, not unlike the other vesicles formed in these sorting
pathways.
Other players have been left out of this discussion, notably those that hydrolyze
nucleotide triphosphates to provide the energy for protein trafficking. In addition, you may
recognize clathrin as a molecular player that also functions in receptor-mediated endocytosis.
Maybe that’s not a surprise! After all, endocytosis is at least partly molecular traffic in the
opposite direction of vesicle formation and secretion.
CHALLENGE: Cargo receptors that sort packaged proteins raise questions!
Where do they come from, and why do they become active when they do?

17.9.2 Nuclear Protein Traffic
We saw earlier that large molecules (mRNAs, tRNAs) and even whole particles (i.e., ribosomal
subunits) can cross the nuclear envelope through nuclear pores. But what about those large
proteins that are destined to enter the nucleus?
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It turns out that these proteins have nuclear localization signals rich in positively charged
amino acids (lysine, proline), which enable binding to the negatively charged domain of a
nuclear transport receptor protein in the cytosol (Figure 17.22).

Fig. 17.22: Nuclear proteins made in the cytoplasm contain a positively charged nuclear localization
signal. This signal binds to the electronegative region of a nuclear transport receptor(1) which enables
the nuclear protein to bind nuclear pore fibrils (2), guiding the protein into the nucleus (3), a step that
requires energy supplied by ATP hydrolysis.

As the complex of the two proteins approaches a nuclear pore, it interacts with nuclear pore
fibrils, causing the pore to open. The two bound proteins then cross the double membrane of
the nuclear envelope, where they accumulate against a concentration gradient. This active
transport comes from ATP hydrolysis as the nuclear proteins enter the nucleus.
17.9.3 Mitochondrial Protein Traffic
Recall that mitochondria contain their own genome and translational machinery. Thus, they
transcribe RNAs and translate proteins of their own. But genes in the nucleus also encode
many of the proteins found in mitochondria. Figure 17.23 (below) illustrates how the
mitochondria import these proteins.
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Fig. 17.23: Nuclear-encoded proteins destined for mitochondria are synthesized with a mitochondrial Nterminal signal sequence that is removed by a mitochondrial signal peptidase. Polysomes don’t attach to
mitochondria. A different mechanism engages the signal sequence with membrane proteins for transport.

Unlike the cotranslational packaging of proteins by the RER, mitochondrial protein
transfer is posttranslational. This means that mitochondrial proteins formed in the cytoplasm
have already folded into a tertiary structure. However, the folded protein exposes an Nterminal signal peptide on its surface that recognizes and binds to a receptor protein at the
outer mitochondrial membrane (1). The receptor protein spans both the mitochondrial outer
membrane (OM) and the cristal membrane (CM). The receptor protein delivers the protein to
be imported to membrane-contact proteins, which also span both mitochondrial membranes
(2). The membrane-contact proteins act as channels or pores, through which a mitochondrial
protein made in the cytoplasm will cross into the mitochondrial matrix. But there is a problem:
the folded protein cannot cross the membrane by itself, precisely because it is folded!
The entry of completed proteins into a mitochondrion requires chaperone proteins—in
this case, the HSP70 (heat-shock 70). HSP70 controls unfolding of the mitochondrial protein as
it traverses the membranes into the matrix (3). Upon removal of the signal peptide by a
mitochondrial signal peptidase (4) another HSP70 molecule resident in the matrix facilitates
refolding of the protein into a biologically active shape (5). Recall that HSPs were initially
discovered as 70 Kd proteins that accumulated in heat-stressed organisms!

309 Protein Traffic to Nuclei and Mitochondria

429

CHALLENGE: How do signal peptides mitochondrial cytoplasmic proteins
differ from those of proteins to be secreted from the cell?

17.10 How Cells Are Held Together and How They Communicate
Proteins and glycoproteins on cell surfaces play a major role in how cells interact with their
surroundings and with other cells. We’ll look first at some of the proteins in the glycocalyx of
adjacent cells that interact to form different kinds of cell-cell junctions. Then we’ll see how
some of these proteins interact with extracellular proteins and carbohydrates to form the
extracellular matrix (ECM). Still other membrane proteins are part of receptor systems that
bind hormones and other signaling molecules at the cell surface, conveying information into
the cell by signal transduction.
17.10.1 Cell Junctions
Cell junctions serve different functions in cells and tissues. In healthy cells they serve to bind
cells tightly, to give tissues structural integrity, and to allow cells in contact with one another
to pass chemical information directly between them. Electron micrographs and illustrations of
different cell junctions are shown in Figure 17.24.

Fig. 17.24: Tight, gap, and adherens junctions of animal cells involve different membrane proteins.
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Tight Junctions (zonulae occludentes) are typical in sheets of epithelial cells that line
the lumens of organs (e.g., intestines and lungs). Zonulae (singular: zonula) refers to the fact
that these structures form a band encircling an entire cell, attaching it to all surrounding cells.
Occludentes (singular: occludens) refers to the “watertight” seal, or occluding barrier of tight
junctions that stops extracellular fluids from passing between cells to cross to the other side of
a sheet of cells. Tight-junction membrane proteins (TJMPs) create this waterproof barrier.
Gap junctions enable chemical communication between cells. Connexon structures
made of connexin proteins act as pores that open to allow direct movement of ions and small
molecules between cells. Communication by ion or molecular movement is quite rapid,
ensuring that all cells in a sheet or other tissue in one metabolic state can respond to each
other and switch to another state simultaneously. In plants we have seen the plasmodesmata,
which perform functions similar to those of gap junctions of animal cells.

Desmosomes (adherens junctions) essentially glue (adhere) cells together, giving
tissues their strength. Belt desmosomes (zonula adherens) surround entire cells, strongly
binding them to adjacent cells. Spot desmosomes (macula adherens) act like rivets, attaching
cells at spots. In both cases, cadherin proteins cross cell membranes from intracellular plaque
proteins, spanning the intercellular space to link adjacent cell membranes together. Plaques
are connected to intermediate filaments (keratin) in the cytoskeleton, strengthening
intercellular attachments and, thus, the tissue cell layer.

310-2 Cell-Junction Structure and Function
CHALLENGE: Do plant cells have (or need) tight junctions and
desmosomes (or similar structures)? Explain your reasoning.
Many glycocalyx proteins that interact to form junctions between cells are
glycoproteins. Generally, proteins that interact to bind cells together are called ICAMs
(Intercellular Cell Adhesion Molecules), or just CAMs.
•

Selectins are one kind of ICAM. During blood clotting, selectins on one platelet recognize
and bind to specific receptors on other platelets, contributing to the clot.

•

NCAMs are another kind of ICAM, ones with sugary immunoglobulin domains that
interact specifically to enable neural connections.

•

We’ve already seen the calcium-dependent cadherins involved in forming adherens
junctions (desmosomes). These are essentially the “glue” that binds cells together to form
strong cohesive tissues and sheets of cells. Cell-cell binding begins with recognition and
connection via the glycocalyx and extracellular matrix.

Figure 17.25 (below) illustrates several examples of membrane proteins that enable cell-cell
recognition and adhesion.
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Fig. 17.25: Glycocalyx protein interactions play roles in cell-cell recognition, attachment, and junctions.
Asterisks indicate plasma membrane bilayers between attached cells.

CHALLENGE: What kind of experiment might you do to show that NCAM
interactions in neuron-neuron attachments are not Ca++-dependent?

311-2 Glycocalyx Sugars Covalently Link to Plasma Membrane Proteins

312 Cell-Adhesion Molecule Functions in the Glycocalyx
17.10.2 Microvesicles and Exosomes
Of the several ways cells take up material from their environment, pinocytosis, or bulk
transport, seems to be a random process in which tiny bits of plasma membrane engulf small
amounts of extracellular fluids along with ions, particles, and incidental solutes. Pinocytotic
vesicles range from 0.5 to 5 mm in diameter. On the other hand, exosomes and microvesicles
are spherical bits of plasma membrane and endosomes (respectively) that are shed by cells into
the extracellular space. Known by several names, these extracellular vesicles ( EVs) were first
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reported in the 1980s as small vesicles released by reticulocytes. At around 1,000 nm (1 mm),
microvesicles are similar in size to pinocytotic vesicles. Exosomes are about a tenth the size of
microvesicles, ranging in size from 40–100 nm in diameter (see Figure 17.26).

Fig. 17.26: Left: Transmission electron micrograph of melanoma cell exosomes. Some of the larger
vesicles show an irregular, cup-like shape (arrows). Right: Transmission electron micrograph of a
reticulocyte endosome containing exosomes about to fuse with the plasma membrane.

There is much evidence that microvesicles and exosomes are not artifacts. For example:
• Microvesicles, such as those from melanoma cells (Figure 17.26, left panel), may be
released normally, suggesting that they are not cellular waste products.
• Reticulocyte endosomal vesicles were caught in the act of fusing with the cell membrane,
releasing exosomes with their contents (Figure 17.26, right panel).
• Microvesicles released by dendritic cells can stimulate T cells, both of which are cells of the
immune system.
We can conclude that microvesicles are physiologically significant structures. We know
that cells talk to each other by releasing chemicals that can act over short or long distances.
Familiar examples include information transfer by hormones from endocrine glands, chemicals
released into the intercellular space, and the neurotransmitters of the nervous system.
Microvesicle activity may be part of intercellular communication pathways, and they are
clearly involved in normal reticulocyte maturation to erythrocytes. Perhaps exosomes are yet
another unique mechanism of intercellular communication. For a review, see 17.9Exosomes &
Intercellular Communication.
17.10.3 Cancer and Cell Junctions
During embryogenesis, cells migrate from a point of origin by attaching to and moving along
an extracellular matrix (ECM), which acts as a path to each cell’s destination. This ECM (or
basal lamina) is made up of secretions from other cells…, or from the migrating cells
themselves! One major secretion is fibronectin, one of whose functions is to bind to integrins,
integral membrane proteins that attach cells to the ECM.
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During development, integrins respond to fibronectin by signaling cell and tissue
differentiation, complete with the formation of appropriate cell junctions. An orderly sequence
of gene expression and membrane protein syntheses enables developing cells to recognize
each other as different or the same (summarized in the drawing below (Figure 17.27).

Fig. 17.27: Migration and attachment of cells during development requires the synthesis of membrane
proteins that recognize and bind proteins on the membranes and glycocalyx of other cells, forming cell
junctions that enable tissue formation.

An early difference between eukaryotic normal and cancer cells is how they grow in
culture. Normal cells settle to the bottom of a culture dish when placed in growth medium.
Then they grow and divide, increasing in number until they reach confluence, when a single
layer of cells completely covers the bottom of the dish. The cells in this monolayer seem to
“know” to stop dividing, as if they had completed formation of a tissue (e.g., a layer of
epithelial cells). This phenomenon, originally called contact inhibition, implies that cells let
each other know when they have finished forming a tissue and can stop cycling and dividing.
In contrast, cancer cells do not stop dividing at confluence. Instead, they continue to grow and
divide, piling up in multiple layers.
Among other deficiencies, cancer cells do not form gap junctions and typically have
fewer cadherins and integrins in their membranes. Thus, cancer cells cannot inform each other
of when they reach confluence. Neither can they form firm adherens junctions. In vivo, a
paucity of integrins would inhibit cancer cells from binding and responding to fibronectin. As a
result, they also have difficulty attaching firmly to an extracellular matrix, which may explain
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why many cancers metastasize, or spread from their original site of formation. These
differences in growth in culture between normal and cancer cells are shown in Figure 17.28.

Fig. 17.28: Density-dependent inhibition (contact inhibition) occurs when cells multiplying and
spreading on a surface cease dividing when there is no more room on the surface. Cancer cells
have lost the property of contact inhibition and keep growing over one another in layers. Loss of
contact inhibition is correlated with an absence of gap junctions in cancer cells.

313 Formation of a Glycocalyx: Normal Development and Cancer

314-2 Role of the Extracellular Matrix in Cell Migration & Development

17.11 Signal Transduction
When hydrophobic chemical effector molecules, such as steroid hormones, reach a target cell,
they can cross the hydrophobic membrane and bind to an intracellular receptor to initiate a
response. When large effector molecules (e.g., protein hormones) or highly polar hormones
(e.g., adrenalin) reach a target cell, they can’t cross the cell membrane. Instead, they bind to
transmembrane protein receptors on cell surfaces. A conformational change initiated on the
extracellular domain of the membrane receptor protein induces further allosteric change on its
cytoplasmic domain. A sequential series of molecular events then converts information
delivered by the external effector into intracellular information, a process called signal
transduction. A general outline of signal-transduction is illustrated below in Figure 17.29.
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Fig. 17.29: Signal transduction by effectors (e.g., hormones) can lead to many different effects in the
cytoplasm as well as in nuclei.

Many effects of signal transduction are mediated by a sequence, or cascade of protein
phosphorylations catalyzed by protein kinases inside the cell, all of which share some common
features as described in the elegant YouTube video at 17.10Cell Messaging by Signal
Transduction. Here we will consider G-Protein-linked and enzyme-linked receptors.

315-2 Introduction to Signal Transduction
17.11.1 G-Protein-Mediated Signal Transduction by PKA (Protein Kinase A)
Figure 17.30 illustrates seven steps of G-protein-mediated signal transduction.

Fig. 17.30: G-proteins cycle between bound GTP and bound GDP. They are intermediates in signal
transduction between an active, effector-bound membrane receptor and an adenylate cyclase.
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GTP-binding proteins (G-Proteins) transduce extracellular signals by inducing
synthesis of second-messenger molecules in the cells. When hormones or other effector
(signal) molecules bind to a membrane receptor, an allosteric change on the extracellular
domain of the receptor is transmitted to the cytoplasmic domain of the receptor, increasing its
affinity for trimeric G-proteins embedded in the cytoplasmic surface of responsive cell
membranes. G-protein trimers consist of   and  subunits. The receptor changes shape upon
binding its effector signal molecule (steps 1 and 2). In this altered conformation, the receptor
recognizes and binds to the G-protein trimer (step 3). Upon the binding of the trimer to the
receptor, GTP displaces GDP on the  subunit of the G-protein (step 4). After a conformational
change in the  subunit, it dissociates from the  and  subunits (step 5). In this illustration,
the GTP- subunit can now bind to a transmembrane adenylate cyclase enzyme (step 6).
Finally, the initial extracellular chemical signal is transduced to an intracellular response,
involving a second-messenger molecule (step 7). In this case, the second messenger is cAMP.

316-2 G-Protein Signal Transduction
The well-known fight-or-flight response to adrenalin in the liver cells of higher
animals is a good example of a cAMP-mediated cellular response. Once formed, cAMP binds
to and activates protein kinase A (PKA), setting off a phosphorylation cascade that leads to a
physiological response. Details of a G-protein-mediated fight-or-flight signal amplification
cascade are shown in Figure 17.31.

Fig. 17.31: In the fight-or-flight response to adrenalin (adrenalin rush), cAMP activates protein
kinase A, and a phosphorylation cascade leads to the release of glucose into the circulation.
cAMP is a second messenger of signal transduction for many different cellular responses.
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After activation of adenylate cyclase (steps 1 and 2 above), cAMP is synthesized. A
cAMP binds to each of two of the four subunits of an inactive PKA (step 3). An allosteric
change dissociates the tetramer into two cAMP-bound inert subunits and two active PKA
subunits (step 4). Each active PKA enzyme catalyzes the phosphorylation and activation of the
enzyme phosphorylase kinase (step 5). In step 6, phosphorylase kinase catalyzes glycogen
phosphorylase phosphorylation.
In the cascade, activation of just a few enzyme molecules at the top of the sequence
results in the activation of multiple subsequent enzymes, resulting in a much-amplified
cellular response, referred to as an amplification cascade. The result can be an immediate
dramatic response. At the end of the fight-or-flight phosphorylation cascade, a now-active
glycogen phosphorylase catalyzes the hydrolysis glycogen to glucose-1-phosphate (step 7).
This results in a rapid retrieval of free glucose from liver cells into the circulation.
See again how this works by reviewing the conversion of glucose-1-phosphate (G-1-P)
to G-6-P in glycolysis and its fate in gluconeogenesis. Of course, the increase in circulating
glucose provides the energy for the fight-or-flight decision.

317 G-Protein Activation of Protein Kinase A: a Fight-or-Flight Response
In addition to activating enzymes that break down glycogen, cAMP-activated PKA
mediates cellular responses to different effectors, resulting in a phosphorylation cascade
leading to several results:
•
•
•
•
•
•

Activation of the enzymes catalyzing glycogen synthesis
Activation of the lipases that hydrolyze fatty acids from triglycerides
Microtubule assembly
Microtubule disassembly
Mitogenic effects (activation of the enzymes of replication)
Activation of transcription factors, which increases or decreases gene expression

Of course, when a cellular response is no longer needed by the organism, it must stop
producing the signal molecules (hormones or other effectors). As their levels drop, effector
molecules dissociate from their receptors and the response stops. This is all possible because
the binding of signals to their receptors is freely reversible!
CHALLENGE: We take advantage of the power of amplification cascades in
medicine. How does this happen on TV and/or in real life?
17.11.2 Signal Transduction using PKC (Protein Kinase C)
A different G-protein-mediated signaling pathway activates a protein kinase C (PKC). The
activation of PKC is illustrated in Figure 17.32 (below).
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Fig. 17.32 G-proteins mediate signal transduction through different membrane receptors and enzymes.
Interactions shown here generate second messengers, which activate protein kinase C, leading to a
phosphorylation cascade with different responses in target cells.

The role of G-proteins is similar for PKA- and ‘PKC-signal transduction’, but PKC
activation does not involve cAMP and requires two intervening cellular responses to an
effector. The net result is to generate different second messengers. These in turn activate
different phosphorylation cascades. Like PKA, PKC-mediated signal transduction also
amplifies the cell’s first molecular response to the effector. Here are the steps:
1. An effector-signal molecule binds to its receptor.
2. The effector-bound receptor now binds the G-protein trimer, the GTP for GDP swap on the
alpha subunit of the trimer, dissociating the beta-m and gamma-subunits from the trimer.
The receptor-bound GTP-alpha- subunit activates an inactive membrane-bound
phospholipase C enzyme.
3. Active phospholipase C catalyzes formation of cytosolic ‘inositol triphosphate’ (‘IP3‘) and
of membrane-bound ‘diacyl glycerol’ (‘DAG’), two of those other intracellular second
messenger molecules.
4. IP3 interacts with receptors on smooth endoplasmic reticulum, causing the release of
sequestered Ca++ ions into the cytoplasm.
5. DAG finds and binds PKC in the membrane.
6. The Ca++ ions also fin and bind PKC, completing activation of the ‘protein kinase C’
(‘PKC’) enzyme.
7. Activated PKC initiates a phosphorylation-amplification cascade leading to cell-specific
responses.

318-2 G-Protein Activation of Protein Kinase C and Phospholipase C
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PKC-mediated effects include the following:
•
•
•

Neurotransmitter release
Hormone (e.g., growth hormone, luteinizing hormone, and testosterone) secretion, leading
to cell growth, division, and differentiation
Glycogen hydrolysis, fat synthesis

Additional independent phospholipase C effects include these:
•
•
•

Liver glycogen breakdown
Pancreatic amylase secretion
Platelet aggregation

PKA and PKC are both serine-threonine kinases, which place phosphates on serine or
threonine in target polypeptides. Let’s consider tyrosine kinases next.
CHALLENGE: Research and explore the details of some of these effects.

17.11.3 Receptor Tyrosine Kinase-Mediated Signal Transduction
The intracellular activity of tyrosine kinase receptors is in the cytoplasmic domain (and is
part) of the receptor itself. When bound to its effector molecule, these receptor kinases catalyze
the phosphorylation of specific tyrosine amino acids in target proteins. While studying the
actions of nerve growth factor (NGF) and epidermal growth factor (EGF) in stimulating
growth and differentiation of nerves and skin, Stanley Cohen and Rita Levi-Montalcini
discovered the EGF receptor, the first enzyme-linked tyrosine kinase, and they won the 1986
Nobel Prize in Physiology or Medicine for their discovery! Watch the animation of receptorkinase signal transduction at the following link (a description is provided in the next few
paragraphs).

319 Receptor-Kinase Signal Transduction
Monomer membrane receptor kinases dimerize when they bind effector ligands,
activating kinase domains that catalyze multiple cross-phosphorylation of the monomers. The
phosphorylated dimer kinases recruit and phosphorylate yet other cytoplasmic proteins to
continue the response pathway. A typical response to EGF and NGF signaling is mitogenic.
Not surprisingly, the mutations correlated with cancer cells often lie in mitogenic signaling
pathways that lead to cell proliferation (growth and division). Cancer-causing genes, or
oncogenes, were first discovered in viruses. But as humans, we own our own oncogenes! For
being the first to show that eukaryotic cells were the origin of a chicken retrovirus (the Rous
sarcoma virus), J. Michael Bishop and Harold Varmus earned the 1989 Nobel Prize in
Physiology or Medicine. Oncogenes turn out to be mutations of animal genes for proteins
involved in mitogenic signal transduction pathways.
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Under normal circumstances, mitogenic chemical signals binding to a receptor
tyrosine kinase induces target cells to begin dividing (see the YouTube video link above). One
of the end-products of a receptor kinase-mediated phosphorylation cascade is MAP kinase
(mitogen-activated protein kinase). MAP kinase enters the nucleus where it catalyzes the
phosphorylation of transcription factors and other nuclear proteins, that lead to cell
proliferation and differentiation, as shown in Figure 17.33.

Fig. 17.33: The effects of MAP kinase include the phosphorylation and activation of DNA-binding
transcription factors and other nuclear proteins, which leads to cell proliferation.

CHALLENGE: What might the “other nuclear proteins” in the illustration be?
The Ras protein-mediated activation of a phosphorylation cascade leading to the MAP
kinase is an example of such a signal transduction pathway. It plays a central role in many
receptor-kinase signaling events. The Ras gene was one of those originally discovered as an
oncogene, the mutation of which leads to uncontrolled cell division (i.e., cancer). Ras gene
protein activity may in fact be responsible for up to 30% of all cancers!

320-2 The RAS Oncogene: Its Normal Mitogenic Effects and Cancer
CHALLENGE: What kind of MAP-kinase mutation might cause cancer?
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17.12 Signal Transduction in Evolution
We saw that signal transduction typically requires just a few signal molecules interacting with
a few cell-surface receptors start a dramatic amplification cascade of enzyme-catalyzed
reactions (typically phosphorylations) to get a strong cellular response that will ultimately
activate or inactivate target proteins. Amplification cascades can take a single effector-receptor
interaction and magnify its effect in the cell by orders of magnitude, making the signaling
systems rapid and highly efficient. The range of cellular and systemic (organismic) responses
to the same chemical signal is broad and complex. Different cell types can have receptors for
the same effector but may respond differently. For example, adrenalin targets cells of liver and
blood vessels, among others, with different effects in each. As it happens, adrenalin is also a
neurotransmitter.
As organisms evolved, they must have responded to environmental imperatives by
adapting and co-opting already existing signaling systems in the service of new pathways. Just
as the same signal transduction event can lead to different pathways of response in different
cells, evolution has allowed different signal transduction pathways to engage in what has come
to be called crosstalk. This occurs when two different signal transduction pathways intersect in
the same cell. For example, cAMP produced at the front end of the PKA signaling pathway can
activate (or under the right circumstances, inhibit) enzymes in the MAP kinase pathway.
These effects result in changes in the levels of active or inactive transcription factors and can
therefore modulate the expression of a gene using two (or more) signals. We are only
beginning to understand something that looks less like a linear pathway and more like a web
of signal transduction.
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Chapter 18

The Cytoskeleton & Cell Motility

Microfilaments, intermediate filaments, and microtubules—roles in cell structure, secretion, cell
migration, and organelle and muscle movements
Reminder: For inactive links, google key words/terms for alternative resources.

18.1

Introduction

To early microscopists the cell looked like a sack of liquid containing a nucleus. Recall Nikolai
Koltsov, the Russian biologist who nearly 35 years before Watson and Crick had already
predicted that the genetic material would be a” large genetic molecule” composed of “two
mirror-image strands” that would replicate semi-conservatively? Well, in 1903 Nikolai also
predicted the existence of a network of tubes in cells to account for cell shape (18.1The
Remarkable Nikolai Koltsov). He called this network a cytoskeleton! His prediction predates
the mid-twentieth century electron microscope observations of the cytoskeleton composed of
rods, tubes, and filaments which are responsible for maintaining cell shape and for cell
motility. We will see that intracellular structures and organelles are enmeshed in these
microfilaments, intermediate filaments and microtubules. To start this chapter, we revisit
these structures and more closely examine how they work to support cell shape, motility, and
overall organization. Remember that cell motility includes the movement of cells and
organisms, as well as the movements of organelles (e.g., vesicles) and other structures inside
the cell. Of course, these movements are not random, and they require chemical energy. After
a close look at movements in and of cells, we’ll look at the interaction of actin and myosin in
skeletal muscle contraction. We’ll look at a famous paradox arising from early studies that
showed that ATP was required for muscle contraction but also for relaxation. Then we’ll look at
experiments that resolve the paradox. Animals control skeletal muscle contraction, but some
muscles contract rhythmically or with little or no control on the part of the animal—think
cardiac muscles of the heart or smooth muscles like those in the digestive and circulatory
systems. We focus here on the regulation of skeletal muscle contraction by calcium ions and
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regulatory proteins and at responses of voluntary (i.e., skeletal) muscle to neural commands.
Finally, we’ll look at skeletal muscle elasticity and its contribution to skeletal muscle function.

Learning Objectives
When you have mastered the information in this chapter, you should be able to do the
following:
1. Compare and contrast roles of cytoskeletal structures indifferent kinds of cell motility.
2. Distinguish between the roles of microfilaments, microtubules, and intermediate filaments
in the maintenance and alteration of cell shape and structure.
3. Consider how and why microtubule length in cilia is stable but dynamic in spindle-fibers.
4. Propose an experiment to ask what part of a motor protein (e.g., dynein) has ATPase
activity.
5. Describe the key experiments that led to the actin-myosin contraction paradox.
6. Outline the steps of the microcontraction cycle involving myosin and actin.
7. Compare and contrast muscle and flagellar structure and function.
8. Explain why smooth muscles do not show striations in the light microscope.
9. Outline the structure of a skeletal muscle, from a whole muscle down to a sarcomere.
10. Hereditary muscle weakness involves specific genes and proteins. Propose alternate
hypotheses to explain how gene action or a particular protein could cause muscle
weakness and suggest how you could test one of your hypotheses.

18.2

Overview of Cytoskeletal Filaments and Tubules

In early microscopy, eukaryotic cells looked like membrane-bound sacs of cytoplasm
containing nuclei and assorted organelles. By the late nineteenth century, microscopists were
describing the dynamic fibers that accompanied dramatic changes in the structure of dividing
cells. No doubt you recognize this as mitosis, in which duplicated chromosomes (chromatids)
materialize just as the nuclear membrane dissolves, and spindle fibers form. Over time the
fibers seem to pull the chromatids apart to opposite poles of the cell. Spindle fibers turn out to
be bundles of microtubules, each of which is a polymer of tubulin proteins. Let’s look again at
a fluorescence micrograph of a mitosing metaphase cell (Figure 18.1). Most of the cell, other
than what is fluorescing, is not visible in the micrograph.

Fig. 18.1: Drawing (left) and fluorescence micrograph (right) of a cell in metaphase of mitosis: aligned
chromosomes (chromatids) at the center of the cell (blue in the micrograph) are just about to be pulled
apart by microtubules of the spindle apparatus (green) extending from the poles to the center of the cell.
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To get the micrograph in Fig. 18.1, antibodies were made against purified microtubule,
kinetochore, and chromosomal proteins (or DNA), and then linked to different fluorophores
(organic molecular fluorescent tags). When the tagged antibodies were added to dividing cells
in metaphase, they bound to their respective fibers. In a fluorescence microscope, the
fluorophores emit different colors of visible light. Microtubules are green, metaphase
chromosomes are blue, and kinetochores are red in the micrograph. Both mitosis and meiosis
are very visible examples of movements within cells.
As for muscle movement in whole organisms, early-to-mid-twentieth-century studies asked
what the striations (stripes) seen in skeletal muscle by light microscopy might have to do with
muscle contraction. The striations turned out to be composed of an isolable protein complex
that investigators called actomyosin (acto for “active”; myosin for “muscle”). Electron
microscopy later revealed that actomyosin (or actinomyosin) is composed of thin filaments
(actin) and thick filaments (myosin) that slide past one another during muscle contraction.
Electron microscopy also hinted at a more complex cytoplasmic structure of cells in
general. The cytoskeleton consists of fine rods and tubes, in more or less organized states, that
permeate the cell and in which organelles are embedded. As noted, the most abundant of these
are microfilaments, microtubules, and intermediate filaments. Though myosin is less
abundant, it is nonetheless present in nonmuscle cells. Microtubules account for chromosomal
movements of mitosis and meiosis; and together with microfilaments (i.e., actin) they enable
organelle movement inside cells. (You may have seen cytoplasmic streaming of Elodea
chloroplasts in a biology lab exercise.) Microtubules also underlie the movements of the cilia
and flagella, which power the movement of whole cells like paramecia, amoebas, phagocytes,
and the like. Actin and myosin enable muscle contraction and thus, higher animal movement.
Finally, the cytoskeleton is a dynamic structure. Its fibers not only account for the
movements of cell division but also give cells their shape and mechanical strength. All the
fibers can disassemble, reassemble, and rearrange, allowing cells to change shape. These
changes range from the pseudopodia extended by amoeboid cells to the spindle fibers that
stretch cells in mitosis and meiosis, to the constriction of a dividing cell that eventually pinches
off daughter cells, and more! In this chapter we look in some detail at the roles of these tubules
and filaments in cell structure and in different forms of cell motility.

18.3

Molecular Structure and Organization of Cytoskeletal Components

Of the three main cytoskeletal fibers, intermediate filaments serve a mainly structural role in
cells. Microtubules and microfilaments have dual functions, dynamically maintaining cell
shape and enabling cell motility. For example, when attached to the plasma membrane, actin
microfilaments maintain cell shape. And when they interact with motor proteins (e.g., myosin),
they can pull or push against a muscle-cell membrane, changing the shape of the cell.
Likewise, motor proteins such as dynein and kinesin can move cargo back and forth along
microtubule tracks from one point to another in the cell.
We will look at how motor proteins interact with microtubules and microfilaments shortly. For
now, let’s take another look at the drawings and micrographs of the three main cytoskeletal
filaments of eukaryotic cells, which we also saw earlier in the text (Figure 18.2, below).
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Fig. 18.2: The assembly, structure, and polarity of microtubules, microfilaments (actins), and intermediate
filaments, alongside immunofluorescence micrographs made using fluorescent antibodies against isolated
microtubule (top), microfilament (middle), and intermediate-filament (bottom) proteins.

321-2 Introduction to the Cytoskeleton
We also saw earlier the location and general functions of microtubules, microfilaments,
and intermediate filaments. Let’s look at those fluorescence micrographic localizations of fibers
in cells, shown again in Figure 18.3 (below). They are consistent with known functions of the
major cytoskeletal component filaments in cell structure and motility. Despite the small size of
prokaryotic cells, they too were recently found to have previously unsuspected cytoplasmic
structures that could function as a cytoskeleton. For more about such cytoplasmic structures,
see 18.2A Prokaryotic Cytoskeleton. So perhaps not just eukaryotic cells, but all cells are more
than an unorganized bag of fluid sap!
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Fig. 18.3: Illustration and immunofluorescence and confocal microscope localization of microtubules,
microfilaments (actins), and intermediate filaments in cells.

322-2 Microtubules, Microfilaments, and Intermediate Filaments in Cells
Next, we’ll consider the specific roles of microtubules, microfilaments, intermediate
filaments, and related proteins in the structure of the eukaryotic cytoskeleton and how
cytoskeletal interactions enable cell motility.

18.4

Microtubules: Dynamic Structures Composed of Tubulin Monomers

Microtubules assemble from dimers of −tubulin and −tubulin monomers. After their
formation, −tubulin dimers add to a growing, or plus end (+end), fueled by GTP hydrolysis
(see Figure 18.2). Disassembly at the −end of microtubules powers the changes in cell shape
or in the separation and movement of chromatids to opposite poles of cells during mitosis or
meiosis.
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Isolated single microtubules were shown to grow by addition to one end and to
disassemble at the opposite end, thus distinguishing the +ends and −ends. Find a summary of
evidence for microtubule polarity in the following link.

323-2 Demonstration of the Polarity & Dynamics of Microtubules
Microtubules in most cells (other than when they are dividing) can seem disordered. In
nondividing (interphase) animal cells, they tend to radiate from centrioles without forming
discrete structures. But as cell division approaches, microtubules reorganize to form spindle
fibers. The reorganization is nucleated from centrioles in animal cells and from a more
amorphous MicroTubule Organizing Center (MTOC) in plant cells. A typical centriole (or
basal body) has a “nine-triplet” microtubule array, as seen in electron-micrograph cross
sections (Figure 18.4).

Fig. 18.4. Transmission-electron micrograph of the characteristic “nine triplet microtubule” array
of centrioles and basal bodies.

18.4.1 The Two Kinds of Microtubules in Spindle Fibers
The spindle fibers of mitosis and meiosis are made up of kinetochore microtubules and polar
microtubules. The former use chemical energy to pull duplicated chromatids apart; the latter
use chemical energy to separate daughter cells during cytokinesis.
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18.4.1.a Kinetochore Microtubules
Duplicated chromosomes condense in prophase of mitosis and meiosis, forming visible paired
chromatids attached at their centromeres. Specific proteins associate with centromeres to
make a kinetochore during condensation. As the spindle apparatus forms, some spindle fibers
attach to the kinetochore; these are the kinetochore microtubules. By metaphase, bundles of
kinetochore microtubules stretch from the kinetochores at the cell center to the centrioles at
opposite poles of a dividing animal cell, as drawn in Figure 18.5.

Fig. 18.5: As a cell starts its mitotic anaphase, spindle-fiber microtubules exert forces that separate
and pull chromatids apart and push the poles of the cell apart.

The +ends of kinetochore microtubules are in fact at the kinetochores, where these fibers
assemble! During anaphase, kinetochore microtubules disassemble and shorten at their −ends
(at the centrioles in animals or at the MTOCs in plant cells). The forces generated by these
activities pull against the centromeres of the chromatids, separating them and then, drawing
what are now daughter chromosomes to the opposite poles of the dividing cell.
The role of kinetochore microtubule disassembly at the centrioles (i.e., at their −ends) was
shown in a clever experiment in which a tiny laser beam was aimed into a cell at the spindle
fibers attached to the kinetochore of a pair of chromatids. (See Figure 18.6 below as well as an
animation of these events at the link that follows.)
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Fig. 18.6: Disrupting a kinetochore spindle fiber demonstrates the presence of a strong force
from microtubule disassembly, which quickly pulls a pair of chromatids toward the centrioles.

324 Spindle-Fiber Microtubules Generate Force on Chromatids
18.4.1.b Polar Microtubules
Spindle-fiber polar microtubules extend from centrioles/MTOCs at opposite poles, toward the
center of dividing cells. But instead of binding to kinetochores, they overlap at the center of the
dividing cells. While the kinetochore microtubules are tugging apart the paired chromatids at
the center of the cell, the polar microtubules are sliding past one another in opposite directions,
pushing apart the poles of the cell. In this case, dynein motor proteins attached to
microtubules (illustrated in Figs. 18.5 and 18.6) hydrolyze ATP to power microtubule sliding.
The dynein motors on the microtubules at one pole of the cell in effect “walk” along
overlapping microtubules extending from the opposite pole.
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18.4.2 Microtubules in Cilia and Flagella
The microtubules of cilia or flagella emerge from a basal body, shown in the electron
micrograph at the left in Figure 18.7.

Fig. 18.7: Transmission-electron micrographs of a basal body (left) and of cross sections of a pair of
9 + 2 microtubule arrays (right), each of which would emerge from a basal body (white line #1). The
position of the 9-triplet microtubule array of microtubules seen in Fig. 18.4 is indicated by white line #2.

Basal bodies, organized as nine-triplet microtubule rings, are structurally similar to centrioles.
It turns out that eukaryotic flagella and cilia can be stripped from their cells in a very highspeed blender (not the kind you may have in your kitchen!). Treatment with detergents
dissolves their membranes, leaving behind axonemes with a 9 + 2 array of microtubules.
While the formation of cilia and flagella begins at the basal bodies, both structures soon show a
typical 9 + 2 arrangement (i.e., nine outer doublets plus two central singlet microtubules) seen
in the cross section at the right in the micrograph). Axonemes from cilia and flagella are
virtually identical.
CHALLENGE: Detergents, including those found in shampoo and laundry
“detergents”, contain emulsifying chemicals like sodium lauryl sulfate.
Why would a detergent be effective in isolating axonemes?
Microtubules and axonemes are shown in greater detail in Figure 18.8 (below). In the inset at
the upper left, it is possible to see the tubulin subunits that make up a microtubule polymer in
cross section. Each tubule is made up of a ring of thirteen tubulin subunits. In the highmagnification, high resolution cross section micrograph of an axoneme at the right in Figure
18.8, the microtubules in the doublets share tubulins but are also composed of thirteen
tubulins. When fully formed, the 25 nm diameter microtubules appear to be hollow cylinders.
When isolated, they typically come along with the dynein motor proteins and other
Microtubule-Associated Proteins (MAPs), indicated in the micrograph on the right (Figure
18.8). These proteins hold microtubules together in an axoneme and play a role in motility.
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Fig. 18.8: Transmission-electron micrographs of axonemes show that a microtubule is made up of a ring
of thirteen tubulins (left) and that those microtubules in cilia or flagella are arranged in typical 9 + 2 arrays
(middle). The enlarged cross section illustrates specific microtubule-associated proteins (MAPs) that
maintain the 9 + 2 structure, and it shows the dynein motors that power motility.

When fully formed, the 25 nm diameter microtubules appear to be hollow cylinders. When
isolated, they typically come along with the dynein motor proteins and other MAPs labeled in
the micrograph at the right. These proteins hold microtubules together in an axoneme and play
a role in motility.
18.4.3 Microtubule Motor Proteins Move Cargo from Place to Place in Cells
Motor proteins, such as dynein and kinesin, are ATPases; they use the free energy of ATP
hydrolysis to power intracellular motility. Let’s take a closer look at how these two major motor
proteins carry cargo from place to place inside of cells. Organelles are a typical cargo.
Examples include vesicles formed at the trans-Golgi face, which contain secretory proteins,
pigments, or neurotransmitters. Secretory vesicles move along microtubule tracks to the
plasma membrane for exocytosis. Vesicles containing neurotransmitters move from the cell
body of neurons, along microtubule tracks in the axons, and reach the nerve ending where
they become synaptic vesicles. In a chameleon, pigment vesicles in skin cells disperse or
aggregate along microtubule tracks to change skin color to match the background.
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Vesicle transport in neurons is well understood. Neurotransmitter vesicles arise from
the endomembrane system in neuron cell bodies. ATP-dependent kinesin motor proteins
power anterograde movement of the vesicles (from the cell body to the nerve endings). In
contrast, ATP-dependent dynein motors (part of a dynactin complex) power retrograde
movement of empty vesicles back to the cell body. Motor protein structure and action are
shown in Figure 18.9.

Fig. 18.9: Roles of dynein and kinesin in retrograde (backward) and anterograde (forward) movement
of cargo vesicles along microtubules.

325-2 Microtubule Motor Proteins
A fanciful (and not too inaccurate!) animation of a motor protein in action on an axonal
microtubule is at this link: 18.3Kinesin 'Walks' An Organelle Along a Microtubule. Next let’s
look at some elegant studies of isolated axonemes and see what they tell us about microtubulebased cell motility.
18.4.4 Demonstrating Sliding Microtubules
Experiments on axonemes that have been isolated from demembranated cilia or flagella
confirm the sliding-microtubule mechanism of ciliary and flagellar motility. For example,
adding ATP to detached cilia or flagella makes them beat in much the same way as they do
when attached to their cells. The phenomenon is easily seen in a light microscope. But isolated
axonemes (with their original 9 + 2 microtubule arrangement) also “beat” (after a fashion!) in
the presence of ATP! The experiment is illustrated in Figure 18.10 (below).
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Fig. 18.10: Removing membranes from isolated cilia or flagella leaves behind the axoneme. In the
presence of ATP, the Isolated cilia, the flagella, and the axonemes will “beat” as they hydrolyze the ATP.

326-2 9+2 The Microtubule Array in Axonemes that Beat
Selective addition of different detergents removes radial spokes, nexin, and other
proteins from the axoneme, causing the microtubules to separate. Dissociated microtubule
doublets and central “singlets” can then be observed in the electron microscope. When such
separated microtubules are dialyzed to remove the detergents, doublet microtubules reassociate to form sheets, as shown in Figure 18.11.

Fig. 18.11: Detergents can dissociate axonemes into individual and doublet microtubules. Dialysis
of separated microtubules to remove the detergent will cause the microtubules to re-associate (i.e.,
to reconstitute) into a sheet, with connections resembling those seen in intact axonemes.
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ATP added to reconstituted microtubule doublets causes the microtubules to separate
as the ATP is hydrolyzed. When such preparations are fixed for electron microscopy
immediately after adding the ATP, the microtubules are caught in the act of sliding. See this
animated in the following link (#327-2).

327-2 Proof of Sliding Microtubules in Flagella and Cilia

328 Bacterial Flagella are Powered by a Proton Gradient

329 The Effects of Different Drugs on Microtubules…and Cancer
18.4.5 The Motor Protein Dynein Enables Axonemes to Bend
Take another look at the cross section of axonemes in Figure 18.9. In the 9 + 2 axoneme of
cilia and flagella, dynein arms attached to the A tubules of the outer doublets walk along the B
tubules of the adjacent doublet. If the doublets on one side of an axoneme take a walk while
those on the other side hold still, the microtubules will slide past one another, and the
axoneme (and therefore a cilium or flagellum) will bend. This microtubule sliding is
constrained by flexible nexin and radial spoke attachments. Figure 18.12 compares the
movements of cilia and flagella.

Fig. 18.12: Comparison of the ciliary beat with the propeller-like flagellar wave motion.
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The differences in flagellar motion (wave-like propeller) and ciliary motion (back-and-forth
beat in a single plane) result in part from which microtubules are sliding at a given moment
and the nature of their restraint by axoneme proteins.

18.5

Microfilaments—Structure and Role in Muscle Contraction

At 7 nm in diameter, microfilaments (actin filaments) are the thinnest cytoskeletal component.
Globular actin (G-actin) monomers polymerize to form linear F-actin polymers. Two polymers
then combine to form a twin-helical actin microfilament. As with microtubules, microfilaments
have a +end, to which new actin monomers are added to assemble F-actin, and a −end, at
which they disassemble when they are in a dynamic state, such as when a cell is changing
shape. When one end of a microfilament is anchored to a cellular structure, (e.g., to plaques in
the cell membrane, motor proteins like myosin can use ATP to generate a force that deforms
the plasma membrane and, thus, the shape of the cell. One of the best-studied examples of
myosin/actin interaction is in skeletal muscle, where the sliding of highly organized thick
myosin rods and thin actin microfilaments results in muscle contraction.
18.5.1 The Thin (Micro) and Thick Filaments of Skeletal Muscle
Bundles of parallel muscle cells make up a skeletal muscle. Thin sections of skeletal muscle
cells, called myocytes, appear striated in the light microscope (Figure 18.13).

Fig. 18.13: Light micrograph of skeletal muscle, stained to show characteristic striations.

During development, myoblast cells (muscle cell precursors) fuse to form a myoctes
(myofibers). The dark structures surrounding the striations are the multiple nuclei that end up
in the mature myocyte. Multinucleate cells resulting from such fusions are called syncytia
(singular: syncytium). Each syncytial myocyte also contains many mitochondria to provide ATP
to fuel contraction. Skeletal muscle is made up of aligned, bundled myocytes (the myofibers),
which are in turn, further organized into fascicles, which are finally bundled to form a muscle.
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Figure 18.14 shows the anatomical organization and fine structure of a muscle.

Fig. 18.14: Skeletal muscle organization and the anatomy of a muscle cell sarcomere.

Light passing through the more or less ordered regions of the sarcomere will bend to
different degrees because each region has a different refractive index. Polarizing light
microscopy detects these differences, enhancing the contrast between the regions of the
sarcomere and defining them as either isotropic (i.e., with a low refractive index) or
anisotropic (with a high refractive index). High-resolution electron microscopy from the 1940s
revealed the fine structure of skeletal muscle (right panel). Paired, dark, vertical Z-lines define
a sarcomere in the electron micrograph. In the illustration of the myofiber (lower left) the Zlines (shown in gray) are aligned in register in bundled myofibers as well as in the fascicles
(upper left); these are what appear as the striations characteristic of skeletal muscle seen in
Figure 18.13. Based on light and electron microscopy, we can define regions within a
sarcomere:
• The A band (anisotropic band) of overlapping, aligned actin and myosin filaments, which
runs down the middle of the sarcomere, is more ordered than the I-band, so it has a higher
refractive index.
• The I-band (isotropic band) has a low refractive index compared to the A band. It is
largely made up of thin (actin) microfilaments.
• The paired Z-lines demarcate the sarcomere (Z for zwischen, German for between).
• The H zone is a region where myosin does not overlap actin filaments.
• An M-line lies at the center of the H zone.
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18.5.2 The Sliding Filament Model of Skeletal Muscle Contraction
Electron microscopy of relaxed and contracted muscle is consistent with the sliding of thick
and thin filaments during contraction (Figure 18.15).

Fig. 18.15: The transmission-electron micrograph and its corresponding illustration show a sarcomere
shortening, consistent with the sliding of filaments during skeletal muscle contraction.

Additional key structures of the sarcomere can be seen in the interpretive illustration at
the right. Note that in the sarcomeres of a contracted muscle cell, the H zone has virtually
disappeared. The width of the A band (essentially, the length of the myosin filaments spanning
the sarcomere) has not changed after contraction, but the length of the I-bands from the Zlines has decreased, bringing the Z-lines of the sarcomere closer. The best explanation here
was the Sliding Filament Hypothesis (or model) of skeletal muscle contraction.

330-2 The Sliding Filament Model of Skeletal-Muscle Contraction
18.5.3 The Contraction Paradox: Contraction and Relaxation Require ATP
The role of ATP in fueling the movement of sliding filaments during skeletal muscle
contraction was based in part on experiments with glycerinated fibers. These are muscle fibers
that were soaked in glycerin, which permeabilizes the plasma membrane, allowing the soluble
components to diffuse out of the muscle cells, but. leaves intact most of the sarcomere-based
contractile structure, as seen in electron micrographs.
Investigators found that if ATP and calcium were added back to glycerinated fibers, the ATP
was hydrolyzed, and the fibers could still contract—and even lift a weight! Contraction of a
glycerinated muscle fiber in the presence of ATP is illustrated below in Figure 18.16.
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Fig. 18.16: The skeletal muscle contraction Paradox: When given ATP, glycerinated muscle fibers contract
and pull a weight. When all the ATP is hydrolyzed, the fiber can’t stretch unless more ATP is added.

Assays showed that when all the added ATP had been hydrolyzed, the muscle
remained contracted. It would not relax, even with the weight it had lifted still attached.
Attempts to manually force the muscle back into its relaxed position didn’t work. But the fiber
could be stretched when fresh ATP was added to the preparation. Moreover, if the
experimenter let go immediately after stretching the fiber, it would again contract and lift the
weight. A cycle of forced stretching and contraction could be repeated until all of the added
ATP was hydrolyzed. At that point, the fiber would again no longer contract—or if contracted,
it could no longer be stretched.
The contraction paradox, then, was this: ATP hydrolysis is required for muscle
contraction as well as for relaxation (stretching). The paradox was resolved when the functions
of the molecular actors in contraction were finally understood. Here we review some of the
classic experiments that led to this understanding.

331 The Contraction Paradox

18.6

Actin-Myosin Interactions In Vitro: Dissections and Reconstitutions

Several experiments hinted at the interaction of actin and myosin in contraction. For example,
actomyosin was first observed as the main component of viscous skeletal muscle homogenates.
Under appropriate conditions, adding ATP to such actomyosin preparations caused a decrease
in viscosity. However, after the added ATP was hydrolyzed, the mixture became viscous again.
Extraction of the nonviscous preparation (before it recongealed and the ATP was consumed)
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led to the biochemical separation of the two main substances we now recognize as the actin
and myosin (thin and thick) filaments of contraction. What’s more, adding these components
back together reconstituted the viscous actomyosin (now renamed actinomyosin). Adding ATP
once again to the reconstituted solution eliminated its viscosity. The ATP-dependent viscosity
changes of actinomyosin solutions were consistent with an ATP-dependent separation of thick
and thin filaments. Do actin and myosin also separate in glycerinated muscles exposed to ATP,
allowing them to stretch and relax? This question was answered with the advent of electron
microscopy. The purification of skeletal muscle myosin from actin (still attached to Z-lines) is
cartooned in Figure 18.17, showing what the separated components looked like in the electron
microscope.

Fig. 18.17: Overview of an isolation of actin (thin) filaments (still on Z-lines) from myosin (thick) filaments.

Next, after mixing actin Z-line and myosin fractions, electron microscopy of the resulting
viscous material revealed thin filaments interdigitating with thick filaments (Figure 18.18).

Fig. 18.18: Reconstitution of actin filaments (on Z-lines) with myosin filaments.
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As expected, when ATP was added to these extracts, the solution viscosity dropped, and
electron microscopy revealed that the myosin and actin filaments had again separated. The
two components could again be isolated and separated by centrifugation.
In yet further experiments, actinomyosin preparations could be spread on over an
aqueous surface, producing a film on the surface of the water. When ATP was added to the
water, the film visibly “contracted,” pulling away from the edges of the vessel, reducing its
surface area! Electron microscopy of the film revealed shortened, sarcomere-like structures,
with closely spaced Z-lines and short I-bands—further confirming the sliding-filament model
of muscle contraction.

332 In Vitro & Electron Microscope Evidence for a Sliding-Filament Model
When actin and myosin were further purified from isolated actinomyosin, the thick
myosin rods could be dissociated into large myosin monomers. In fact, at ~599 Kd, myosin
monomers are among the largest known proteins. Thus, thick filaments are massive polymers
of huge myosin monomers! The molecular structure of myosin (thick) filaments is shown in
Figure 18.19.

Fig. 18.19: Structure of a skeletal-muscle myosin filament and the myosin monomer. Shown is myosin
II, the thick filament that spans both sides of the H zone in a sarcomere (upper). The head-and-tail
structure of a myosin monomer is shown in the high-magnification electron micrograph and is
illustrated in the cartoon (lower). The myosin monomer is itself a polymer of four polypeptides.
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An early observation of isolated mammalian actin filaments was that they had no
ATPase activity. We’ve seen isolated myosin preparations do have ATPase activity, but they
would catalyze ATP hydrolysis only very slowly compared to intact muscle fibers. Faster ATP
hydrolysis occurred only if myosin filaments were mixed with microfilaments (either on or
detached from Z-lines). In the electron microscope, isolated myosin protein monomers each
appeared to have a double-head and a single-tail region. Biochemical analysis showed that the
monomers themselves were composed of the two heavy-chain polypeptides and two pairs of
light-chain polypeptides, as shown in the Figure 18.19 illustration. In Figure 18.20, a highmagnification, high-resolution electron-micrograph simulation and corresponding drawings
illustrate a myosin monomer and its component structures.

Fig. 18.20: Purified myosin monomers are digested with enzymes that hydrolyze peptide bonds between
specific amino acids. This produces an S1 (head) fragment and a tail fragment with different properties.

Proteolytic enzymes that only hydrolyze peptide linkages—and only between specific
amino acids—“cut” the myosin monomers into S1 (head) and tail fragments. Shown in Figure
18.20 are electron micrographs of enzymatic digest fractions separated by ultracentrifugation.
The tail fragments are parts of the two-myosin heavy-chain polypeptides. The S1 fragments
consist of a pair of light chains and the rest of the heavy chains. On further analysis, the S1
myosin head fraction had a slow ATPase activity, while the tails had none. The slow activity
was not an artifact of isolation; mixing the S1 fraction with isolated actin filaments resulted in
a higher rate of ATP hydrolysis. Thus, the myosin heads must be ATPases that bind and
interact with actin microfilaments.

333-2 Thick Filament & Myosin Monomer Structure
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CHALLENGE: What do you think is going on here? Why the faster catalytic
rate when actin and myosin (or their parts) are mixed?
In fact, S1 myosin heads bind directly to actin, decorating the actin with “arrowheads” visible
in the electron microscope (see 18.4S1 Arrowheads On Muscle Actin). Even intact myosin
monomers could decorate muscle actin. These results are consistent with the requirement that
myosin must bind to actin to achieve a maximum rate of ATPase activity during contraction.
The arrowheads on decorated actin still attached to Z-lines are illustrated in Figure 18.21.

Fig. 18.21: Actin decoration by myosin-monomer S1 fragments in a kind of reconstitution experiment
shows an opposing polarity of actin filaments on opposite sides of the Z-line.

Note that the “arrowheads” always face in opposite directions on either side of the Z-line.
These opposing arrowheads suggest that the actin filaments attached to the two Z-lines of a
sarcomere are drawn toward each other along the opposite sides of bipolar myosin rods. This is
consistent with sliding filaments that draw Z-lines closer together during skeletal muscle
contraction, shortening the sarcomeres. For another look at “arrowheads” and other aspects of
muscle structure, check out the slide show at 18.5Muscle Structure & Physiology-J. Rosenbluth.

334-2 Myosin Monomers & S1 Heads Decorate Actin
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CHALLENGE: Explain how the phenomenon of “arrowhead decoration” of
sarcomeres can be interpreted to indicate actin “polarity.”

18.7

Allosteric Change and the Microcontraction Cycle

Whereas dynein and kinesin are motor proteins that “walk” along microtubules, myosins are
motor proteins that walk along microfilaments. All these motor proteins are ATPases that use
the free energy of ATP hydrolysis to effect conformational changes that result in the walking
(i.e., motility). In skeletal muscle, allosteric changes in myosin heads enable the myosin rods to
do the walking along the sarcomere thin (F-actin) filaments. When placed in sequence, the
different myosin head conformations illustrated in Figure 18.22 are the likely changes that
would occur during a microcontraction cycle.

Fig. 18.22: The steps in the microcontraction cycle explain the muscle contraction paradox.

To help you follow the sequence find and follow the small dot on a single monomer in
the actin filament. Here are the steps:
a. Calcium is required for contraction; in the presence of Ca ++ ions, myosin-binding sites on
actin are open. (Ca++-regulation of muscle contraction is discussed in detail shortly.)
b. Myosin heads with attached ADP and Pi bind to open sites on actin filaments.
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c.

Actin-myosin binding causes the hinge region of the myosin head to bend, micro-sliding
(pulling) the attached microfilament; this is the power stroke (the dot on the actin has
moved to the left. The myosin head remains bound to an actin monomer in the F-actin.

d. ATP displaces ADP and Pi on myosin heads in this bent conformation. The resulting
allosteric change in the head breaks the crossbridge between it and the actin.
e. Once dissociated from actin, myosin heads catalyze ATP hydrolysis, resulting in yet
another conformational change. The head, still bound to ADP and Pi, has bent at its hinge,
taking on a high-energy conformation that stores the energy of ATP hydrolysis.

Microcontraction cycles of actin sliding along myosin continue if ATP and Ca++ are
available. During repetitive microcontraction cycles, myosin heads on the thick filaments pull
actin filaments attached to Z-lines, as stored free energy is released during power strokes,
bringing the Z-lines closer together. The result is the shortening of the sarcomere, the muscle
cells, and ultimately of the entire muscle. When the muscle no longer needs to contract, the
Ca++ required for contraction is withdrawn; microcontraction cycles cease; the myosin heads
remain in the high-energy conformation of step e, and the muscle can relax (stretch). Neural
stimulation can cause another release of Ca++ that will again signal contraction.
The microcontraction cycle also stops when ATP is gone, the permanent state of affairs
brought about by rigor mortis after death! At this time, myosin heads remain attached to the
actin filaments in the state of muscle contraction that existed at the time of death. This is rigor
at the molecular level (shown in the illustration above). At the level of whole muscle, rigor
mortis results in the inability to stretch or otherwise move body parts when ATP has once-andfor-all departed. You will have encountered this phenomenon if you watch any police or
detective story that includes a coroner!

18.8

The Microcontraction Cycle Resolves the Contraction Paradox

The microcontraction cycle resolves the contraction paradox:
•

ATP is necessary for muscle contraction: In step e in the illustration above, as ATP on
myosin heads is hydrolyzed, the heads change from a low energy to a high-energy
conformation. The myosin heads can now bind to actin monomers (step b in the
microcontraction cycle). This results in the power stroke (step c). Free energy that is
released by an allosteric change in myosin will pull the actin along the myosin, in effect
causing a micro-shortening of the sarcomere—in other words, a contraction!

•

ATP is necessary for muscle relaxation: At the end of step c, myosin remains bound to
actin until ATP can again bind to the myosin head. Binding of ATP in step d displaces ADP
and inorganic phosphate (Pi)…and breaks actin-myosin crossbridges. A removal of Ca++
from sarcomeres at the end of a contraction event blocks myosin-binding sites on actin,
while the rapid breakage of actin-myosin crossbridges by ATP-myosin binding allows
muscle relaxation and the sliding apart of the actin and myosin filaments (i.e., stretching).
This leaves the myosin heads in the “cocked” (high-energy) conformation, ready for the
next round of contraction.
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No more paradox! The displacement of ADP and Pi by ATP binding to myosin heads breaks
actin-myosin crossbridges, allowing for relaxation (stretching) of the sarcomeres, and hence
muscles. The hydrolysis of the ATP bound to myosin cocks the myosin head in a high free
energy conformation whose energy is released during the microcontraction power stroke.
Electron-microscopic examination of myosin-monomer heads at different ionic
strengths provides visual evidence that myosin heads are flexible and can take on alternate
stable conformations, as would be expected during the microcontraction cycle (Figure 18.23).

Fig. 18.23: The ability of flexible myosin heads to bend and to change conformation is consistent with their
proposed activity during the microcontraction cycle.

The arrows point to myosin heads in different conformations. This visualization was made
possible by treating the preparations with antimyosin antibodies (immunoglobulins). See a
cool video of conformational change in myosin monomers at 18.6Myosin Heads in Action.

335-2 Actin-Myosin Contraction Cycle Resolves the Contraction Paradox

336-2 ATP Binding & Hydrolysis Changes Myosin-Head Conformation

18.9

Ca++ Ions Regulate Skeletal Muscle Contraction

Typically, the neurotransmitter acetylcholine released by a motor neuron binds to receptors on
muscle cells to initiate contraction. Early experiments had already revealed that Ca++ was
required, along with ATP, to get glycerinated skeletal muscle to contract. It was later shown
that Ca++ ions were stored in the sarcoplasmic reticulum (the smooth endoplasmic reticulum)
of intact muscle cells. As we have seen, an action potential generated in the cell body of a
neuron propagates along an axon to the nerve terminal, or synapse.
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The action potential at a neuromuscular junction that initiates contraction is summarized in
the illustration in Figure 18.24 (below).

Fig. 18.24: Innervation leads to Ca++ release from sarcoplasmic reticulum to regulate contraction.

A neural impulse reaches the nerve ending (1), signaling a flow of Ca++ ions into the
nerve ending that cause synaptic vesicles to fuse with the cell membrane and release
acetylcholine (2). The neurotransmitter crosses the synaptic cleft and binds to receptors (3),
initiating an action potential in the muscle cell 4) that travels along the sarcolemma (the
muscle plasma membrane) to points where it is continuous with transverse tubules (Ttubules). The action potential moves along the T-tubules and then along the membranes of the
sarcoplasmic reticulum (4). This propagation of an action potential opens Ca ++ channels in the
sarcoplasmic reticulum and T-tubules(5), releasing Ca++ to bathe the myofibril sarcomeres
where they bind to one of three troponin molecules; this will allow skeletal muscle contraction
(i.e., to allow filaments to slide). The three troponins and a tropomyosin molecule are bound
to actin filaments.
Experiments using antitroponin and antitropomyosin antibodies localized the three
proteins in electron micrographs at regularly spaced intervals along actin filaments, as
modeled in Figure 18.25 below.
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Fig. 18.25: Thin skeletal muscle filaments consist of actin associated with troponins and tropomyosin,
which play a role in regulating actin-myosin interactions during contraction.

In resting muscle, tropomyosin (a fibrous protein) lies regularly spaced along the actin
filament, where it covers up the myosin-binding sites of seven G-actin monomer subunits in
the microfilament. The negatively stained electron micrograph in 18.7Actin Bound to
Tropomyosin is consistent with the model illustrated in Figure 18.25. The cross section drawn
in Figure 18.26 illustrates how troponin T (tropomyosin-binding troponin) and troponin I
(inhibitory troponin) hold the tropomyosin in place, and how the binding of Ca ++ ions to
troponin C regulates contraction.

Fig. 18.26: Ca++ ions bind troponin C to Initiate the uncovering of myosin-binding sites on G-actin
monomers of F-actin, resulting in allosteric changes in the troponins, and ultimately tropomyosin.
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A chain reaction of conformational changes begins when Ca ++ ions bind to troponin C. The
result is that the three-subunit troponin complexes that are bound to tropomyosin will shift
position along the filament to expose the myosin-binding sites on the G-actin subunits. Only
after this shift can ATP-bound myosin in turn bind to actin and initiate the microcontraction
cycle discussed earlier. The regulation of contraction by Ca++ is animated in the following link.

337 Regulation of Skeletal Muscle Contraction by Calcium
18.9.1 Muscle Contraction Generates Force
Contraction by ATP-powered sliding of thin along thick filaments generates force on the Zlines. In three dimensions, the Z-lines are actually Z-discs, to which the actin filaments are
attached. The protein −actinin in the Z-discs anchors the ends of the actin filaments to the
discs. That way when the filaments slide, force transduction draws the Z-discs closer,
shortening the sarcomeres. Another Z-disc protein, desmin, is an intermediate filament
organized around the periphery of the Z-discs. Desmin connects multiple Z-discs in a
myofibril. With the Z-discs being kept in register, the muscle cell—and ultimately whole
muscle contraction—is coordinated. Finally, actin filaments at the ends of the muscle cell must
be connected to the plasma membrane so that force transduction will cause the muscle cell to
shorten during myofibril contraction.
Several proteins, including syntrophins and dystrophin (an intermediate filament protein)
anchor the free ends of microfilaments coming from Z-discs to the cell membrane. Still other
proteins anchor the cell membrane in this region to the ECM (extracellular matrix) tendons,
which are in turn attached to bones! The force generated by myosin hydrolysis of ATP and the
sliding of filaments in individual sarcomeres is thus transmitted to the ends of muscles to effect
movement. If the name dystrophin sounds familiar, it should! The gene and its protein were
named for a mutation that causes muscular dystrophy, resulting in a progressive muscle
weakening.

338 Contraction Generates Force Against Z-Discs and Cell Membranes
18.9.2 The Elastic Sarcomere: Do Myosin Rods Just Float in the Sarcomere?
In fact, myosin rods do not “float” in sarcomeres but are instead anchored to proteins in the Zdiscs and M-lines. In 1954, R. Natori realized that when contracted muscle relaxes, it
lengthens beyond its resting state, then shortens again to its resting length. Natori proposed
that this elasticity must be due to a fiber in the sarcomere. Twenty-five years later, the elastic
structure was identified as titin, a protein that holds several molecular records! The gene for
titin contains the largest number of exons (363) of known proteins. After actin and myosin, titin
is also the most abundant protein in muscle cells. At almost 4 × 106 Da, the aptly named titin is
also the largest known polypeptide, much larger than even myosin! As it extends from the Zdiscs to the M-line of sarcomeres, titin coils around thick filaments along the way. The Titin is
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anchored at Z-discs by −actinin and telethonin proteins. At the M-line, titin binds to myosinbinding protein C (MYBPC3) and to calmodulin, among others (myomesin, obscurin,
skelamin…). Some if not all of these proteins must participate in keeping the myosin (thick)
filaments positioned and in register in the sarcomere. This is like how desmin binds Z-discs to
each other to keep sarcomeres in register. The location of titin and several other sarcomere
proteins is illustrated in Figure 18.27.

Fig. 18.27: Structure of titin and its location in the sarcomere.

Coiled titin molecules (red in the illustration) extend from the Z to M lines. The
colorized electron micrograph of one extended titin molecule in the middle of the illustration
should convince you of the length (35,213 amino acids!) of this huge polypeptide. Titin’s
elastic features are largely in a region labeled P in the electron micrograph—between the Zdiscs and the ends of the myosin rods. The many domains of this P region are shown expanded
at the bottom of Figure 18.27. With all the binding (and other) functions, you might expect that
titin has many domains. It does! They include Ig (immunoglobulin) domains, fibronectin
domains (not shown here), and PEVK and N2A domains, some of which help bind titin to
−actinin in Z-discs. Which ones and how many of the Ig and/or PEVK domains are present in
a particular muscle depends on which alternative splicing pathway is used to form a titin
mRNA. Over a micron long, titin functions as a molecular spring, as Natori predicted. Its
coiled domains compress during contraction, passively storing some of the energy.
When a skeletal muscle relaxes, Ca++ is withdrawn from the sarcomere. ATP can still
displace ADP from myosin heads, breaking actin-myosin crossbridges. When actin and myosin
heads dissociate in the absence of Ca++, the troponins and tropomyosin reverse their allosteric
changes, once more covering myosin-head binding sites on F-actin. The muscle then stretches,
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typically under the influence of gravity or an opposing set of muscles. But during contraction,
244 individually folded titin domains had been compressed, so during relaxation, these
domains decompress. The stored energy of compression thus also helps to power muscle
relaxation. At the same time, titin connections limit the stretch so that a potentially
overstretched muscle can “bounce” back to its normal relaxed length. In a particularly elegant
experiment, Wolfgang A. Linke (et al.) provided a visual demonstration of myofiber elasticity
consistent with the coiled-spring model of titin structure. They made antibodies to peptide
domains on either side of the PEVK domain of titin (N2A and I20-I22) and attached them to
nanogold particles. The gold particles were electron-dense and would appear as black
granules in transmission electron microscopy. In the experiment, individual myofibers were
stretched to different lengths, fixed for electron microscopy, and treated with the nanogoldlinked antibodies. The antibodies localize to and define the boundaries of the titin PEVK
domains in myofibers, stretched to different lengths (Figure 18.28, showing electron
micrographs with simulated localization of nanogold particles, which reflect the actual results).

Fig. 18.28: Skeletal-muscle elasticity shown by the changes in location of anti-N2A- and anti-120/122linked nanogold particles in sarcomeres. Note the increased separation of the PEVK domains targeted
by the antibodies as a muscle fiber is increasingly stretched. Titin elasticity facilitates muscle relaxation.

In the experiment, increased stretch lengthened the I-bands on either side of the Zlines of sarcomeres (blue bars under each pair of micrographs). Likewise, titin PEVK domains
have also lengthened, as seen in the increased distance between the nanogold-linked N2A and
the 120/122 antibody localization flanking the PEVK domains. This demonstration of titin (and
thus, sarcomere) elasticity is consistent with a storage of some of the free energy of contraction
when the titin is compressed, and a passive release of that energy during relaxation. Titin
tethers thick filaments to Z-discs and M-lines and thus also limits sarcomere stretch during
relaxation. Titin elasticity is animated at 18.8Elasticity of Titin Domain.
CHALLENGE: It seems that the many myofiber nuclei don’t behave the same
way. 18.9Myofiber Nuclei Express Different Genes; How can this be so?

473

18.10 Actin Microfilaments in Nonmuscle Cells
Microfilaments are found throughout the Eukarya category. Electron microscopy revealed that
thin (~10 nm) filaments permeate the cytoskeleton of eukaryotic cells (see Figure 18.3). They
typically lie in the cortex of cells, just under the plasma membrane, where they support cell
shape. These same microfilaments can also reorganize dynamically, allowing cells to change
shape. A dramatic example of this occurs during cytokinesis in dividing cells, when the
dividing (meiotic or mitotic) cell forms a cleavage furrow in the middle of the cell (discussed
further in another chapter). The cortical microfilaments slide past each other with the help of
nonmuscle myosin, progressively pinching the cell until it divides into two new cells. To test
whether these 10 nm “microfilaments” were in fact actin, scientists placed myosin monomers
or S1 myosin head fragments atop actins isolated from many different cell types. When seen in
the electron microscope, such preparations always revealed that the 10 nm actin
microfilaments were decorated with arrowheads, just like S1 fragments decorated muscle cell
actin or Z-line-bound actin. See S1 arrowheads on cortical actin and on microvillar actin at
18.10
S1 Fragment Decorates Cortical Actin and 18.11S1 Fragment Decorates Ciliary Actin Bundle
(respectively) Clearly the cytoplasmic microfilaments are a form of F-actin. The role of cortical
filaments in cell division is animated at 18.12Cortical Actin Filament Action in Cytokinesis. We
now know that actin microfilaments are involved in all manner of cell motility, in addition to
their role in cell division, enabling cell movement and cytoplasmic streaming within cells.
They give intestinal microvilli strength; they even enable them to move independently of the
passive pressures of peristalsis. Other examples of microfilaments in cell motility include the
ability of amoeba and other phagocytic cells to extend pseudopodia to engulf food or foreign
particles (e.g., bacteria). A well-studied example of microfilament-powered cell movement is
the spread of fibroblast cells along surfaces, shown in Figure 18.29.

Fig. 18.29: In the anti-actin immunofluorescence micrograph of fibroblasts, actin localizes with stress
fibers, which help maintain cell shape (left). Actin also localizes in lamellipodia and retraction fibers in
migrating fibroblasts (right), orienting in the direction of movement.
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Migrating fibroblasts move forward by extending lamellipodia (and thin filipodia
beyond them), by assembling actin bundles along the axis of movement. In the
immunofluorescence micrograph (left, Figure 18.29), the actin stress fibers that maintain cell
shape fluoresce green; the dual roles of actin in fibroblast shape and movement are also
illustrated at the right.
The extension of filipodia at the moving front of a fibroblast is mainly based on actin
assembly and disassembly (not unlike motility based on microtubules). A retraction fiber forms
at the hind end of the cell as the fibroblast moves forward. The retraction fiber remains
attached to the surface (substratum) on which it is migrating until actin-myosin interactions (in
fact, sliding) cause retraction of most of this “fiber” back into the body of the cell.
Studies of nonmuscle cell motility suggest the structure and interacting molecular
components of stress fibers modeled in Figure 18.30.

Fig. 18.30: The molecular structure of stress fibers: Myosin as well as other actin-binding proteins
interact with actin in nonmuscle cell motility.

The illustration suggests roles for actin-binding proteins in the sliding of overlapping
myosin and actin filaments during movement. This model may also explain the cytoplasmic
streaming that distributes cellular components and nutrients throughout a cell. In fact, both
movements involve actin-myosin interactions. Filamin in this drawing is shown holding actin
filaments together at an angle, while −actinin also helps to bundle the actin filaments. Titin
(not shown) also seems to be associated with stress fibers.
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Unlike the highly organized skeletal muscle sarcomeres, the proteins and filaments in
stress fibers are not part of Z- or M-line superstructures. Were these less-organized nonmuscle
stress-fiber actin bundles the evolutionary ancestors of muscle cell sarcomeres? Or vice-versa?

18.11 Both Actins and Myosins are Encoded by Large Gene Families
Actin may be the most abundant protein in cells! At least six different actin isoforms encoded
by a large actin gene family have nearly identical amino acid sequences, all of which are
involved in cytoskeletal function. While the −actin isoform predominates, genes for some
isoforms are expressed in a cell-specific manner. In mice, the loss of a −actin gene has little
effect on the organism, while loss of the −actin gene in mice is lethal at embryonic stages.
So what is the function of −actin? Does it even have one? Or is −actin a vestigial protein that,
like our appendix, once served a now long-lost function? And what about all those other
isoforms? To date, the amino acid sequence differences among actins don’t predict
dramatically different protein function. Despite yet undefined functional differences between
them, virtually all actin isoforms are decorated by myosin monomers (or S1 heads), so any
function should involve interaction with myosin. These observations make one wonder if most
actin isoforms are adaptations, however subtle, such that the absence of one isoform would
pose a significant threat to the survival of an organism. So, could isoform differences underlie
some as-yet-unidentified physiological advantage to different cells? Or are they simply a bank
of mutations lying in wait for natural selection to reveal a new function?
Studies in humans show that a nonlethal −actin mutation correlates with delayed
development and later neurological problems (e.g., epilepsy) and kidney and heart
abnormalities. Still, people with such mutations can lead nearly normal, healthy lives,
suggesting that a maintaining a bank of isoforms offer some protection against such nonlethal
mutations.

CHALLENGE: Mouse embryos unable to make -actin die. But consider a
CRISPR/Cas study in which the -actin gene was edited to express only actin. Unable to make -actin, the mice transcribe a hybrid /-actin gene
and translate this hybrid mRNA into -actin. These mice lived normal lives,
increasing their -actin synthesis to compensate for the missing -actin.
The study concludes that “essential in vivo function of β-actin is provided
by the gene sequence independent of the encoded protein isoform.” For
more detail, check out 18.13Essential β-actin function in alternate isoforms.

Finally, genes encoding variant myosin isoforms comprise a large eukaryotic gene
family. All isoforms have ATPase activity and some (if not all) are clearly involved in cell
motility. Unique functions are not yet known for the isoforms, but different myosin monomers
can decorate actin, and myosins from one species can decorate actin filaments of other species,
even across wide phylogenetic distances. Clearly, one can still make a career studying why
there are so many isoforms of actin and myosin!
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18.12 Intermediate Filaments
The 10 nm intermediate filaments are proteins with extended secondary structure that don’t
readily fold into tertiary structures, and they have no known enzymatic activity. The
extracellular keratins that make up fur, hair, fingernails, and toenails are proteins related to
intermediate filaments. Keratins are bundles of rigid, insoluble extracellular proteins that align
and bind to form stable, unchanging secondary structures. Intermediate filaments also
permeate other cells, where they participate in regulating and maintaining cell shape. Recall
their intercellular location in desmosomes, where they firmly bind cells together to confer
tensile strength to tissues. Also recall the role of intermediate filaments in anchoring actin to
either Z-discs or plasma membrane plaques in muscle cells. There they transmit the forces of
contraction to the coordinated shortening of the sarcomeres and ultimately to the actual
shortening of a muscle. Finally, intracellular intermediate filaments are not confined to the
cytoplasm; lamins are intermediate filaments that make up structural elements of the nuclear
lamina, a kind of nucleoskeleton. The structural features of intermediate filaments are
illustrated in the cartoon in Figure 18.31.

Fig. 18.31: The coiled secondary structure of the proteins permits the elasticity of intermediate-filament
bundles that contributes to the viscosity of cytoplasm.

As we saw earlier, intermediate filament subunits have a common structure, consisting
of a pair of monomers. The monomers are nonpolar; unlike microtubules and actin filaments,
they do not have “plus” and “minus” ends. Globular domains at the C- and N-terminal ends of
monomer filaments are separated by coiled-rod regions. The basic unit of intermediate
filament structure is a dimer of monomers. Dimers further aggregate to form tetramers and
larger filament bundles. Like microtubules and actin filaments, intermediate filament bundles
can disassemble and reassemble as needed when cells change shape.
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Unlike microtubules and actin, intermediate filaments can stretch—a property
conferred by the coiled-rod regions of the filaments. This should be reminiscent of titin
molecules. In the bundled intermediate filaments that permeate the cytoplasm of cells, the
ability to stretch contributes to the viscosity of cytoplasm and is called viscoelasticity. This
elastic property is thought to allow actins and microtubules some freedom of movement of and
within cells. Like the actins, there are many isoforms of intermediate filaments, but in this case
with some known different functions.
CHALLENGE: How many intermediate filaments can you identify by name
and function?
Some iText & VOP Key Words and Terms
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 tubulin
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actin-binding proteins
actin-myosin interactions
actin-myosin paradox
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Microtubule-organizing center
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myofiber
myofibril
myosin
myosin ATPase
myosin “heads”
neuromuscular junction
nuclear lamina
plus and minus ends
pseudopodia
sarcomere
sarcoplasmic reticulum
sarcolemma
Secretion vesicle transport
skeletal muscle contraction
skeletal muscle relaxation
sliding-filament model
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thick and thin filaments
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tubulins
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Chapter 19

Cell Division and the Cell Cycle

Separation of replication from cell division in eukaryotes; cell-cycle checkpoints,
cyclins, and MPF; apoptosis, cancer, radiation, chemotherapy, and immunotherapy
Reminder: For inactive links, google key words/terms for alternative resources.

Real-Time Drosophila
Embryogenesis

19.1

Introduction

Bacteria divide by binary fission, duplicating their nearly “naked” circular chromosomes as the
cell enlarges and divides into two daughter cells. Under favorable conditions, bacteria (e.g., E.
coli) can divide every twenty to forty minutes. Many eukaryotic cells stop dividing when they
reach maturity (their terminally differentiated state), while those that do divide may have
varying life spans between divisions, ranging from fifteen to twenty-four hours. Cell division
begins with mitosis, the condensation of chromosomes from chromatin. Cytokinesis is the
process near the end of mitosis that physically divides one cell into two new cells after the
duplicated chromosomes are safely on opposite sides of the cell. Although mitosis lasts only
about an hour in the life of the typical eukaryotic cell, it has been parsed into four or five
phases (depending on whose text you are reading!); it is the last of these phases that overlaps
cytokinesis. Usually, mitosis and cytokinesis together take about 1.5 hours. By far the longest
period between successive cell divisions or the cell cycle is interphase, so-called because
nineteenth-century microscopists who described mitosis saw nothing happening in cells when
they were not actually dividing. But by the 1970s, experiments had shown that interphase itself
was divisible into discrete phases of cellular activity called G1, S, and G2 (occurring in that
order). It turns out that kinases regulate progress through the cell cycle, catalyzing timely
protein phosphorylations. The first of these kinases to be discovered was mitosis-promoting
factor (MPF). Kinase-regulated events are checkpoints a cell must pass through to enter the
next phase of the cell cycle. As you might guess, the failure of a checkpoint can have serious
consequences. One consequence is carcinogenesis, a runaway proliferation of cancer cells. We
begin this chapter with a brief description of binary fission in E. coli, followed by a closer look
at the eukaryotic cell cycle. We close with a look at alternate fates of eukaryotic cells and at
details of cellular end-of-life events, including apoptosis, or programed cell death.
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Learning Objectives
When you have mastered the information in this chapter, you should be able to do the
following:
1. Distinguish between mitotic and cell-cycle phases and what occurs in each of the phases.
2. Interpret the experiments leading to our understanding of the separation of chromosomal
events from the duplication of the DNA contained in those chromosomes.
3. Describe and compare the roles of different cyclins and cdks in regulating the cell cycle.
4. Define cell-cycle checkpoints and how/why they monitor progress through the cell cycle,
including their roles in detecting DNA damage and pathways to apoptosis.
5. State a hypothesis for how cell-cycling errors could make normal cells become cancer cells.
6. Compare cell-cycle disruption in somatic and germline cells that affect cancers.
7. List some examples of apoptosis in humans and other organisms.
8. Compare and contrast examples of apoptosis and necrosis.
9. Formulate a hypothesis to account for the degradation of cyclin after mitosis.
10. Explain the biochemical/molecular basis of several chemotherapies and their side effects.

19.2

Cell Division in a Prokaryote

The life of actively growing bacteria is not separated into discrete times for duplicating genes
(i.e., DNA synthesis) followed by binary fission (dividing and partitioning the duplicated DNA
into new cells). Instead, the single circular chromosmome of a typical bacterium starts
replicating even before fission is complete, so that the new daughter cells already contained
partially duplicated chromosomes. Cell growth, replication, and fission as it might be seen in
E. coli are illustrated in Figure 19.1.

Fig. 19.1: Bacteria divide by binary fission. When growing in culture, they divide continually,
partially replicating their circular DNA molecules during one division in preparation for the next.

339 Binary Fission
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In marked contrast to to bacteria, the life cycle of a typical eukaryotic cell is divided
into separate events. Next we will see how the timing of separated events of the cell cycle was
discovered.

19.3

Cell Division in Eukaryotes

Depending on cell type, typical eukaryotic cells have a cell cycle of sixteen to twenty-four
hours, which is divided into phases. One of these phases, mitosis, was discovered in the late
1800s with light microscopy (you may have seen mitosing onion root-tip cells in a biology class
laboratory). In any given cluster of cells, some were seen to lose their nuclei and to form
chromosomes (from chroma, colored; soma, bodies). In mitosis, paired chromosomes
(chromatids) are attached at their centromeres. The chromatids were seen to separate and to
be pulled apart by spindle fibers. Once separated and on their way to opposite poles of
dividing cells, they are once again called chromosomes.
Thus, homologous chromosomes were equally partioned to the daughter cells at the end of cell
division. Because the same chromosomal behavior was observed in mitosis in diverse
organisms, chromosomes were soon recognized as the stuff of inheritance, the carrier of genes!
The events of mitosis, lasting about an hour, were seen as occurring in four phases over that
short time (Figure 19.2).

Fig. 19.2: Mitosis and cytokinesis in eukaryotic cells are separated in time, and mitosis is further divisible
into five phases.

To the early microscopists, this short period of intense mitotic activity was in stark
contrast to a much longer “quiet” time in the life of the cell. For lack of a more descriptive
term, they called this period interphase. Also, depending on whom you ask, cytokinesis (the
cell movements that divide a cell in two) might not be considered a part of mitosis. In that
sense, we can think of three stages in the life of a cell: interphase, mitosis, and cytokinesis. Of
course, it turned out that interphase is not cellular “quiet time” at all!
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19.3.1 Defining the Phases of the Eukaryotic Cell Cycle
Correlation of the inheritance of specific traits with the inheritance of chromosomes was shown
early in the twentieth century, most elegantly in genetic studies of the fruit fly, Drosophila
melanogaster. At that time, chromosomes were assumed to contain the genetic material, and it
was assumed that both were duplicated during mitosis. The first clue that this was not so came
only after the discovery that DNA was in fact the chemical stuff of genes. The experiment
outlined in Figure 19.3 was the first step in working out details of the cell cycle, distinguishing
the time of chromosome formation from the time of DNA duplication.

Fig. 19.3: This experiment asked how many cells in a random culture are in mitosis and how many
were actively replicating their DNA. The results showed that mitosing cells were not synthesizing DNA.

Here are the details of the experiment:
1. Cultured cells were incubated with 3H-thymine, the radioactive base that cells will
incorporate into deoxythymidine triphosphate (dTTP, one of the four nucleotide precursors
to DNA synthesis).
2. After a short period of culture, unincorporated 3H-thymine was washed away, and the cells
were fixed and spread on a glass slide.
3. Slides were dipped into a light-sensitive emulsion containing chemicals like the lightsensitive chemical coat on the emulsion-side of film. (Do you remember photographic
film?)
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4. After sufficient time to allow the radioactivity on the slide to “expose” the emulsion, the
slides were developed (in much the same way as developing photographic film).
5. The resulting autoradiographs in the microscope revealed images in the form of dark spots
created by exposure to hot (i.e., radioactive) DNA.
If DNA replicates in chromosomes undergoing mitosis, then when the developed film is placed
back over the slide, any dark spots should lie over the cells in mitosis, and not over cells that
are not actively dividing. But observation of the autoradiographs showed that none of the cells
in mitosis were radioactively labeled. On the other hand, some of the cells in interphase were!
Therefore, DNA synthesis must take place sometime in interphase, before mitosis and
cytokinesis, as illustrated in Figure 19.4.

Fig. 19.4: The autoradiographic data from the experiment outlined in Fig. 19.3 demonstrates that DNA
synthesis begins and ends some time before the beginning of mitosis.

340-2 Experiments Revealing Replication in Cell-Cycle Interphase
As we will see, the synthesis of nuclear DNA in eukaryotic cells (replication) occurs many
hours before the start of mitosis, and in fact it lasts a good chunk of the time of interphase.
Next a series of pulse-chase experiments were done to determine when in the cell
cycle DNA synthesis takes place. Cultured cells given a short pulse (exposure) to 3H-thymine
and then allowed to grow in a nonradioactive medium for different times (the chase). At the
end of each chase time, cells were spread on a glass slide and again prepared for
autoradiography. Analysis of the autoradiographs identified distinct periods of activity in
interphase: G1 (Gap 1), S (a time of DNA synthesis), and G2 (Gap 2). Described here are the
details of these very creative experiments, performed before it became possible to synchronize
cells in culture so that they would all be growing and dividing at the same time:
1. Cells were exposed to 3H-thymine for just five minutes (the pulse) and then centrifuged.
The radioactive supernatant was then discarded.
2. The cells were rinsed and spun again to remove as much labeled precursor as possible.
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3. The cells were resuspended in fresh medium containing unlabeled (i.e., nonradioactive)
thymine and were further incubated for different times (the chase periods).
4. At each chase time, cells were washed free of radioactive precursor, then spread on glass
slides.
After dipping the slides in light-sensitive emulsion and exposing and developing the
film, the autoradiographs were examined, with the results shown in Figure 19.5.

Fig. 19.5: These autoradiographs from a pulse-chase labeling experiment led to the identification of the
phases of the eukaryotic cell cycle.

Here is a description of the results:
•

•
•

After a three-hour (or shorter) chase period, the slides looked just as they would
immediately after the pulse: that is, while 7% of the cells were in mitosis, none of those
were radioactively labeled. In contrast, many interphase cells showed labeled nuclei.
After four hours of chase, a few of the 7% of the cells that were in mitosis were labeled,
along with others in interphase.
After a five-hour chase, most cells in mitosis (still about 7% of cells on the slide) were
labeled; many fewer cells in interphase were labeled.
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•

After a twenty-hour chase, none of the 7% of cells that were in mitosis were labeled.
Instead, all the labeled cells were in interphase.
CHALLENGE: Here is a question to ponder: in these illustrations, the
way the radioactive labeling is depicted is not exactly correct. Can you
see the “error” and explain what you might really see?

The graph in Figure 19.6 plots a count of radiolabeled mitotic cells against chase times.

Fig. 19.6: A graph plotting the number of radioactive cells in mitosis over the time of chase in the pulsechase experiment described in Figure 19.5 and in the text.

The plot defines the duration of events (phases) of the cell cycle as follows:
1. The first phase (interval #1 on the graph) must be the time between the end of DNA
synthesis and the start of mitosis, defined as Gap 2 (G2).
2. Cell doubling times are easily measured. Assume that the cells in this experiment doubled
every twenty hours. This would be consistent with the time interval of twenty hours
between successive peaks in the number of radiolabeled mitotic cells after the pulse
(interval #2).
3. Interval #3 is easy enough to define. It is the time when DNA is synthesized, from start to
finish; this is the synthesis, or S phase.
4. One period of the cell cycle remains to be defined, but it is not on the graph! That would be
the time between the end cell division (i.e., mitosis and cytokinesis) and the beginning of
DNA synthesis (replication). That interval can be calculated from the graph as the time of
the cell cycle (about twenty hours) minus the sum of the other defined periods of the cycle.
This phase is defined as the Gap 1 (G1) phase of the cycle.
CHALLENGE: So, what then is interval #4 on the graph? Think about it and
try to explain this roughly nine-to-ten-hour period.
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Events in each phase of a typical eukaryotic cell cycle are summarized in Figure 19.7.

Fig. 19.7: In a typical eukaryotic cell cycle, phases G1, S, and G2 follow cytokinesis and G2 immediately
precedes prophase of mitosis. The length of time for each phase differs for different cell types.

During interphase (G1, S, G2) cells grows in size, preparing for the next cell division. As you
might guess, G1 includes synthesis of enzymes and other proteins needed next for replication.
CHALLENGE: Review and name some of these proteins!
DNA replicates in the S phase, along with the synthesis of new histone and other
proteins that will be needed to assemble new chromatin. G2 is the shortest time of interphase
and is largely devoted to preparing the cell for the next round of mitosis and cytokinesis.
Among the proteins whose synthesis increases in this time are the tubulins and proteins
responsible for condensing chromatin into paired chromatids that represent the duplicated
chromosomes. Cohesin is a more-recently discovered protein made in the run-up to mitosis. It
holds centromeres of chromatids together until they are ready to separate.

341-2 Events in the Phases of the Cell Cycle
Recall that generation times of dividing cells range from sixteen to twenty-four hours.
Atypical cells, like newly fertilized eggs, might divide every hour or so! In these cells, events
that normally take many hours must be completed in just fractions of an hour.
CHALLENGE: How might a shortened cell cycle look? How would events
that normally take a long time occur in a much shorter time?
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19.3.3 When Cells Stop Dividing…
Terminally differentiated cells are those that spend the rest of their lives performing a specific
function. These cells no longer cycle. Instead, shortly after entering G1, they are diverted into a
phase called G0, as shown in Figure 19.8.

Fig. 19.8: Terminally differentiated cells no longer divide but instead enter the G 0 state. While they can
sometimes resume cycling, such cells more typically experience cell death and replacement by stem cells.

Referred to as terminally differentiated, these cells normally never divide again. With
a few exceptions (e.g., many neurons), most terminally differentiated cells have a finite
lifespan, and must be replaced by stem cells. A well-known example is the erythrocyte, or red
blood cell. With a half-life of about sixty days, these cells are regularly replaced by precursor
reticulocytes produced in bone marrow.

19.4

Regulation of the Cell Cycle

Progress through the cell cycle is regulated. The cycle can be controlled or put on “pause” at
any one of several phase transitions. Such checkpoints monitor whether the cell is on track to
complete a successful cell-division event. Superimposed on these controls are signals that
promote cell differentiation. Embryonic cells differentiate as the embryo develops. Even after
terminal differentiation of cells that form all adult tissues and organs, adult stem cells will
divide and differentiate to replace worn out cells. Once differentiated, cells are typically
signaled in G1 to enter G0 and to stop cycling. In some circumstances cells in G0 are recruited
to resume cycling. However, if this resumption should occur by mistake, the cells may be
transformed to cancer cells. Here we consider how the normal transition between phases of the
cell cycle is controlled.
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19.4.1 Discovery and Characterization of Maturation Promoting Factor (MPF)
To monitor their progress through the cell cycle, cells produce internal chemical signals that
tell them when it’s time to begin replication or mitosis, or even when to enter into G0 when
they reach their terminally differentiated state. The experiment that first demonstrated a
chemical regulator of the cell cycle involved fusing very large frog’s eggs! The experiment is
described in Figure 19.9.

Fig. 19.9: Experiment leading to the discovery of meiosis-promoting factor (MPF), the first known chemical
regulator of cell division.

The hypothesis tested here was that frog oocyte cytoplasm from germinal vesicle-stage
oocytes (i.e., oocytes in mid meiosis) contain a chemical that causes the cell to lose its nuclear
membrane, to condense its chromatin into chromosomes, and to enter meiosis. The test was to
withdraw cytoplasm from one of these large, mid meiotic oocytes with a fine hypodermic
needle and to inject it into a pre meiotic oocyte. The result of the experiment was that the mid
meiotic oocyte cytoplasm induced premature meiosis in the immature oocyte.
Subsequently, a Maturation Promoting Factor (MPF) was isolated from the mid
meiotic cells—a factor that when injected into pre meiotic cells, would cause them to enter
meiosis. MPF turns out to be a protein kinase made up of two polypeptide subunits (Figure
19.10, below). MPF was subsequently shown to stimulate somatic cells in G2 to enter premature
mitosis. So (conveniently) MPF can also be Mitosis Promoting Factor! Hereafter we will
discuss the effects of an MPF as being equivalent in mitosis and meiosis. When active, MPF
targets many cellular proteins.
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Fig. 19.10: MPF was shown to be a two-subunit protein kinase that transfers phosphates from ATP to
several different proteins.

342 Discovery of MPF Kinase and Its Role in Meiosis and Mitosis
Assays of MPF activity as well as the actual levels of the two subunits over time during
the cell cycle are graphed in Figure 19.11.

Fig. 19.11: Graph comparing plots of cellular cdk and cyclin levels over time with one of MPF activity.
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One subunit of MPF is cyclin. The other subunit, cyclin-dependent kinase (cdk), contains the
kinase-enzyme active site. Both subunits must be bound to make an active kinase. Cyclin was
so named because its levels rise gradually after cytokinesis, peak at the next mitosis, and then
fall. Levels of the cdk subunit do not change significantly during the life of the cell. Because
the kinase activity of MPF requires cyclin, it tracks the rise in cyclin near the end of the G2,
and its fall after mitosis. Cyclin begins to accumulate in G1, rising gradually and binding to
more and more cdk subunits. MPF reaches a threshold concentration in G2 that triggers entry
into mitosis. For their discovery of these central molecules, L. H. Hartwell, R. T. Hunt, and P.
M. Nurse won the 2001 Nobel Prize in Physiology or Medicine.

CHALLENGE: What kinds of proteins might be activated by cdk-catalyzed
phosphorylation to promote progress through the cell cycle?

19.4.2

Other Cyclins, CDKs, and Cell-Cycle Checkpoints

Other chemical signals accumulate at different points in the cell cycle. For example, when
cells in S are fused with cells in G1, the G1 cells begin synthesizing DNA (visualized as 3Hthymine incorporation). Figure 19.12 describes an experiment showing control of progress to
different phases of the cell cycle.

Fig. 19.12: Cell-fusion experiments revealed additional chemical regulators of the cell-cycle activity.

An S phase factor could be isolated from the S phase cells. This factor also turns out to
be a two-subunit protein kinase, albeit a different one from MPF. Just as MPF signals cells in
G2 to begin mitosis, the S-phase kinase signals cells in G1 to enter the S phase of the cell cycle
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and to start replicating DNA. MPF and the S-phase kinase govern activities at two of several
cell-cycle checkpoints. In each case, the activity of the kinases is governed by prior progress
through the cell cycle. In other words, if the cell is not ready to begin mitosis, active MPF
production is delayed until it is. Likewise, the S-phase kinase will not be activated until the
cell is ready to begin DNA synthesis.

343 Cell-Cycle Control at Check Points and the G0 “Phase”
Control of progress through the cell cycle is more intricate than we currently know, but
the best-described checkpoints separate G1, G2, and M (Figure 19.13).

Fig. 19.13: Simplified diagram of cell-cycle checkpoints at which progress through the cycle is assessed.
If progress through a phase is incomplete, cell-cycle regulators (kinases) delay onset of the next phase.

We generally envision checkpoints as monitoring and blocking progress until essential
events of a current phase of the cell-cycle phase are completed. These kinases are part of
molecular sensing mechanisms that act by phosphorylating cytoplasmic and/or nuclear
proteins required by upcoming phases of the cycle. Let’s look at some events that are
monitored at these checkpoints in more detail.
19.4.2.a The G1 Checkpoint
The G1 checkpoint controls the transition from the G1 to the S phase of the cell cycle. If
actively dividing cells (e.g., stem cells) in G1 fail to complete their preparation for replication,
the S-phase kinase won’t be produced, and the cells won’t proceed to the S phase until the
preparatory biochemistry catches up with the rest of the cycle. To enter S, a cell must be ready
to make proteins of replication, like DNA polymerases, helicases, and primases, among others.
Only when these molecules have accumulated to (or become active at) appropriate levels is it
“safe” to enter S and begin replicating DNA.

492

Now, what about those cells that are fully differentiated? Terminally differentiated cells
stop producing the active G1-checkpoint kinase and stop dividing. Thus, they are arrested in G0
(see section 19.4.2.d).
19.4.2.b The G2 Checkpoint
Passage through the G2 checkpoint is only possible if DNA made in the prior S phase is not
damaged. Or if it was, then that damage has been (or can be) repaired. (Review the
proofreading functions of DNA polymerase and the various DNA-repair pathways.) Cells that
do successfully complete replication and pass the G2 checkpoint must prepare to make the
proteins necessary for the upcoming mitotic phase. These include nuclear proteins necessary
to condense chromatin into chromosomes, tubulins for making microtubules, and more. Only
when levels of these and other required proteins reach a threshold can the cell begin mitosis.
Consider the following two tasks required of the G2 checkpoint (in fact, any checkpoint):
•
•

Sensing whether prior phase activities have been successfully completed
Delaying transition to the next phase if those activities are unfinished

But what if sensing is imperfect and a checkpoint is leaky? A recent study suggests that either
the G2 checkpoint is leaky, or at least, that incomplete activities in the S phase are tolerated,
and that some DNA repair is not resolved until mitosis is underway in M! See more about this
at 19-1 DNA repair at mitosis.
19.4.2.c The M Checkpoint
The M checkpoint is monitored by the original MPF-catalyzed phosphorylation of proteins,
which do the following:
a)
b)
c)
d)

Bind to chromatin, causing it to condense and to form chromatids
Lead to the breakdown of the nuclear envelope
Enable spindle-fiber formation and their attachment to chromatids
Lead to the onset of mitosis

We have seen that the tension in the spindle apparatus at metaphase tugs at the kinetochores
holding the duplicated chromatids together. As this tension reaches a threshold, MPF peaks
and an activated separase enzyme catalyzes the separation of the chromatids at their
centromeres. Starting in anaphase, continuing tension in the spindle apparatus draws the new
chromosomes (mostly by their centromeres) to opposite poles of the cell. Near the end of
mitosis and cytokinesis, proteins phosphorylated by MPF initiate the breakdown of cyclin in
the cell. Passing the M checkpoint means that the cell will complete mitosis and cytokinesis,
and that each daughter cell will enter a new G1 phase.
During cell division, yeast cells seem to have the three checkpoints discussed here.
More-complex eukaryotes use more cyclins and cdks to control the cell cycle at more
checkpoints. Different cyclins show cyclic patterns of synthesis, while their cdks remain at
constant levels throughout the cell cycle (as in MPF).
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Although the different cdk and cyclin gene families are evolutionarily conserved,
each cyclin/cdk pair has been co-opted in evolution to monitor different cell-cycle events and
to catalyze phosphorylation of phase-specific proteins. To learn more, see Elledge S. J.
(1996) Cell Cycle Checkpoints: Preventing an Identity Crisis. Science 274:1664-1672.

344-2 Cyclin/cdk Checkpoints for Cell-Cycle Phases
19.4.2.d The G0 State

G0 is not really a phase of the cell cycle, since the cells in G0 have reached a terminally
differentiated state and have stopped dividing. For example, the terminally differentiated cells
that make up mature tissues and organs no longer divide. But these cells do have a finite halflife. Recall that our red blood cells lack a nucleus. In circulation, they have a half-life of about
60 days and old erythrocytes are removed from circulation at 100-120 days. It is stem cells in
bone marrow that replace aging re cells. Most of our cells retain their nuclei, but when
terminally differentiated cells in G 0 age, they too are replaced by adult stem cells, which can
still divide and differentiate. Life-time length in G0 can vary. Some cells live so long in G0 that
they are nearly never replaced (muscle cells, neurons). Others live short lives in G0 (e.g., stem
cells and some embryonic cells).
CHALLENGE: Here’s something to ponder - recall that somatic cells are
diploid, and that germ cells (sperm, egg) are haploid. When in the life of a
somatic cell is it truly diploid? How would you characterize cells in G 2?

Lymphocytes are differentiated immune-system cells that can reenter G1. Exposure of
lymphocytes to foreign chemicals or pathogens activates mitogens, causing the cells to exit G0
to start dividing, and to produce the legions of cells that make antibodies that neutralize toxins
and fight off pathogens. The retinoblastoma (Rb) protein is mitogen, a transcription factor that
turns on genes leading to cell proliferation.
But what if cells resume cycling when they shouldn’t? What if they are inappropriately
signaled to exit G0? Such cells are in trouble! Having escaped normal controls on cell division,
they can become a focal point of cancer-cell growth. You can guess from its name that the
retinoblastoma gene was discovered as a mutation that causes retinal cancer. For more about
the normal function of the Rb protein and its interaction with a G1 cdk, check out the following
link.

345-2 Rb Gene Encodes the regulatory subunit of a Transcription Factor
CHALLENGE: What kind of Rb gene mutation might cause cancer?
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19.5

When Cells Die

As noted, few cell types live forever; most are destined to turn over (another euphemism for
dying), mediated by programmed cell death, or apoptosis. Apoptosis occurs in normal
development when cells are only temporarily required for a maturation process (e.g.,
embryonic development and metamorphosis). When older cells are no longer necessary or
when cells are genetically damaged, they too are detected and signaled to undergo apoptosis.
Frog metamorphosis is a well-known example of apoptosis. Signaled by thyroid hormone,
tadpoles digest their tail cells, reabsorbing and recycling the digestion products. These in turn
serve as nutrients to grow adult frog structures. Normal and apoptotic cells are compared in
micrographs and drawings in Figure 19.14.

Fig. 19.14: Electron micrographs and corresponding drawings compare normal (A,A′) with apoptotic
cells (B,B′ and C,C′). In (B,B′), a black arrowhead indicates pyknosos (nuclear condensation), gray
arrowheads indicate membrane blebs, and a white arrowhead indicates apoptotic bodies. Later in
apoptosis, nuclei break down (karyorrhexis, lower right in C; upper left in C'), leaving ghost cells (gc in
C), and apoptotic bodies (arrowheads, C'). A phagocyte is engulfing an apoptotic body containing a
mitochondrion in C′.

Apoptosis is first associated with nuclear fragmentations and cell shrinkage ([B, B′] and
[C, C′] in Figure 19.14). Apoptotic bodies in the cell leave the cell in or as “blebs”
(evaginations) where they may be engulfed by phagocytes. Look at 19-2Cancer Cell Apoptosis to
see a time-lapse movie of live prostate cancer cells that were chemically induced to undergo
apoptosis. Look for the formation of numerous apoptotic bodies; you might also see some
nonapoptotic cells undergoing cytokinesis!
We now understand the basic metabolic pathway leading to apoptosis. During
development, apoptotic cell death starts with an external signal programmed to appear at a
specific time in development. Similar signals appear in response to cell obsolescence or
genetic damage. The biochemical pathway to apoptosis is illustrated below in Figure 19.15.
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Fig. 19.15: Mitochondrial proteins play a role in the biochemistry of apoptosis (programmed cell death).

The signal molecule acts on target cells to induce transcription of Bcl2 genes. Bcl2
proteins Bak and Bax are outer-mitochondrial-membrane channel components that allow the
release of cytochrome C into the cytoplasm. This sets off molecular events leading to apoptosis.
Mitochondrial exit of cytochrome C is possible because it is a peripheral membrane
protein, only loosely bound to the cristal membrane. It exists in equilibrium between
membrane-bound and unbound states. As some cytochrome C molecules exit the
intermembrane space, others detach from the cristal membrane and follow.
In the cytosol, cytochrome C binds to adaptor proteins, which then aggregate. The
cytochrome C-adaptor complex has a high affinity for a biologically inactive procaspase.
Binding of procaspase to the cytochrome C-adaptor complex causes an allosteric change in the
procaspase, releasing an active caspase.
Caspases are proteolytic enzymes that start the autodigestion of the cell. For their work
in identifying apoptosis genes, Sydney Brenner, H. Robert Horvitz, and John E. Sulston shared
the 2002 Nobel Prize in Physiology or Medicine.
In contrast to apoptosis, cells that die unexpectedly from external injury undergo
necrosis, an accidental rather than a programmed death. Key differences between the two cell
deaths are summarized below in the illustration in Figure 19.16.
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Fig. 19.16: Comparison of the cellular events of apoptosis and necrosis.

From the illustration,
•
•

The nuclei of necrotic cells do not shrink or fragment while plasma membranes extend
processes to form blebs and eventually burst, releasing the cell contents.
The nuclei of apoptotic cells shrink and fragment while the plasma membrane blebs also
form, enclosing organelles and eventually fusing. The organelles can remain functional for
a time.

19.6

Disruption of the Cell-Cycle Checkpoints Can Cause Cancer

As we’ve noted, cycling cells continue to divide until they attain G0 in the terminally
differentiated state. Most terminally differentiated cells are cleared by apoptosis when they
reach the end of their effective lives, to be replaced by stem cells. We also noted that accidental
signaling can bring cells out of G0, leading to renewed cell proliferation. Even though such
cells are abnormal, their defects may not be detected by apoptotic defense mechanisms. As a
result, they undergo uncontrolled cell divisions, becoming cancer cells. Likewise, if a
checkpoint fails or if a cell suffers physical damage to chromosomes during cell division, or if it
suffers a debilitating somatic mutation in a prior S phase, it may self-destruct in response to a
consequent biochemical anomaly. This is another example of apoptosis. But if a physically
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damaged or mutated cell should escape apoptotic clearance, it too may begin replication and
proliferation, producing cancer cells. Apoptotic clearance and uncontrolled cancer-cell
proliferation are compared in Figure 19.17 (below).

19.17: Results of noncancer-cell divisions, in which abnormal cells are targeted for apoptosis (left),
and cancer-cell division, in which damaged or altered cells escape apoptotic controls (right).

346-2 Regulating Cell Death—Apoptosis vs Necrosis

19.7

p53 Protein Mediates Normal Cell-Cycle Control

Cancerous growth can result if a normal dividing cell suffers a somatic mutation that disrupts
normal cell-cycle control. The overexpression of cdk, for example, or higher cyclin levels in
daughter cells that never drop; such cells would never stop cycling.
CHALLENGE: What is a somatic mutation? What does it mean to say that
certain cancers run in families or that specific genes are associated with a
particular cancer?
Other possibilities include a cell in G0 that is stimulated to begin cycling again by an
inappropriate encounter with a hormone or other signal. If undetected, these anomalies can
transform normal cells to cancer cells. This is apparently the case for a mutation in the human
p53 gene that causes Li-Fraumeni syndrome. The symptoms include a high incidence of earlyage bone, blood, and breast cancers (see 19-3Li-Fraumeni Syndrome for more). How the p53
protein in regulating cancer cell formation was shown using knock-out mice.
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We noted earlier the use of knock-out mutations in studies of specific gene function. A
protocol for making knock-out mutations in mice is shown below in Figure 19.18.

Fig, 19.18: How to make knock-out mutant mice: Specific deoxynucleotides in a cloned gene of interest
are altered by site-directed mutagenesis. The altered gene is inserted into embryonic stem cells, where
it recombines with and replaces the homologous gene already in the chromosome. Recombinant clones
are selected and reinjected into embryos, which are then incubated in the uteri of “foster mother” mice.
Knockout mice in the newborn litter can be selected and studied for the effects of removing a gene.

For demonstrating how knock-out organisms can be genetically engineered, M. R.
Capecchi, M. J. Evans, and O. Smithies shared the 2007 Nobel Prize in Physiology or
Medicine. (Read all about it at 19-4The Knockout Nobel Prize.)
The role of p53 protein in regulating cancer-cell formation in mice was shown in a
knock-out experiment, when the normal mouse p53 genes were replaced with a pair of mutant
p53 genes that were unable to make functional p53 protein. The resulting knock-out mice
developed tumors and cancers at a much higher rate than normal mice. In general, many
knock-out organisms have been created to study the effects of loss-of-function mutations in
vivo (i.e., in whole animals). Using similar strategies, knock-in protocols can insert normal
genes into an organism lacking the genes, allowing study of the effects of gain-of-function
mutations.
19.7.1

p53 is a DNA-Binding Protein

If a G0 cell is stimulated to start cycling again by an inappropriate encounter with a hormone
or other signal, it may be transformed into a cancer cell. The job of the p53 protein is to detect
such anomalies and to enable dividing cells to repair the damage before they proceed through
the next cell-cycle checkpoint. Failing that, the p53 protein signals apoptosis of the cell.
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p53 is a DNA-binding, gene-regulatory protein. Figure 19.19 (below) shows the structure of
the p53 protein and how it binds to the DNA double helix.

Fig. 19.19: Structure of the p53 gene-regulatory protein bound to DNA. p53 was originally called a tumor
suppressor protein because when mutated, tumors arose.

Mutations in the gene for the p53 protein in humans (where it is called TP53) are
associated with many human cancers. Cultured cells of mutagenized p53 genes also exhibit
key characteristics of cancer cells, including uncontrolled replication and cell proliferation and
the suppression of apoptosis.
19.7.2

How p53 Works to Salvage Cells

p53 protein is normally bound to an active Mdm2 protein. The p53 must separate from Mdm2
for p53 to enable cell progress through checkpoints. Physical or chemical stress on dividing
cells, such as DNA damage during cell growth, can activate an ATM kinase that will
phosphorylate p53 and Mdm2, causing their dissociation p53. The same kinase also
phosphorylates Chk2. ATM-kinase-initiated events are detailed in Figure 19.20.

19.20: Normal functions of the p53 gene-regulatory protein
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Each of the proteins and enzymes phosphorylated by the ATM kinase has a role in cell-cycle
checkpoint function and cell-cycle arrest while errors are corrected:
1. Now separated from Mdm2, active pospho-p53 upregulates several genes, including the
p21 gene.
2. The p21 protein binds to cdks; cyclins can’t bind p21-cdks.
3. Active phospho-Chk2 catalyzes cyclin phosphorylation; phospho-cyclins can’t bind to p21cdks.
4. The inability of cyclins to bind cdks specifically blocks the cell cycle between the G1 and S
phases and the G2-to-M phases.
Figure 19.21 illustrates the kinase-mediated events at cell-cycle checkpoints.

19.21: Role of the p53 in decision-making at cell-cycle checkpoints.

The cell cycle will remain arrested while the cell attempts to finish the
biochemical activities necessary to correct stress-induced or other physical or
aberrations, before moving on to the next phase of the cycle. If DNA repairs
corrections are successful, the cell can progress to the next phase. But what happens
are unsuccessful?
19.7.3

essential
chemical
or other
if repairs

How p53 Works When Cells Can’t Be Saved

If DNA repair or other corrections fail, the damaged cell is routed to apoptosis. In this case,
proteasomes target the Chk2-cyclin complex for degradation. Any p53 remaining bound to
unphosphorylated Mdm2 is also targeted destruction. The result is that the cell, unable to
correct effects of stress or chemical damage or to repair DNA damage, is now a target for
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apoptosis. Levels and activity of multiple proteins control the amount of active p53 protein
available to respond to cell-cycling anomalies. Active phospho-p53 rapidly arrests the cell
cycle and turns on genes needed for DNA repair and for apoptosis (just in case repair efforts
fail!). Figure 19.22 summarizes these and related p53 interactions and their consequences.

19.22: A: Inactive p53 & active Mdm2 bind, head for proteasome, & [p53] decreases; B: Active Mdm2 &
p14ARF bind, both are sequestered in the nucleolus, increasing available [p53]; C. Inactive Mdm2 can’t
bind p53, increasing available p53. D. If ATM kinase is active, available p53 is phosphorylated & active p53
turns of genes for DNA repair, apoptosis & protein factors that arrest cell cycling at G1 or G2; E.
Phosphorylated Chk2 activity causes cyclin inactivation, sending it to the proteasome, blocking cell cycling.

To sum up, p53 suppresses malignant tumor growth by either of two methods:
• by allowing DNA or other cellular repair, after which p53 and other proteins are
inactivated and/or destroyed, and the cell cycle can resume.
• by upregulating apoptosis genes in case repairs aren’t successful leading to apoptosis,
thereby killing off damaged cells and blocking tumorigenesis.
This is why a mutant p53 that reduces or eliminates p21-protein production, blocking essential
DNA-repair, causes damaged cells to enter S, transforming them into cancer cells.
In a new twist, whales or elephants rarely suffer cancer, even though they have
thousands of times more cells than we do. In elephants the reason may be that they also have
around 20 copies (40 alleles) of their p53 genes. Mutation of one allele may have little effect if
the remaining p53 genes still suppress tumors (19-5No Cancer for Big Animals). A duplication
of many tumor suppressor genes that may protect large mammals from cancer may have
originated in small animals, perhaps facilitating their evolution in large ones (19-6Elephantine
Evolution).
CHALLENGE: How might p53 function in the rapid seasonal growth of deer
antlers? (See 19-7Ruminant Headgear & Fast Antler Regeneration).
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19.8

The Centrality of p53 Action in Cell-Cycle Regulation

Because of its multiple roles in regulating and promoting DNA repair, and in controlling cellcycle checkpoints, p53 has been called “the Guardian of the Genome”! Here is further
evidence of this central role.
19.8.1 “Oncogenic Viruses”
Cancer-causing viruses include Human Papilloma Virus (HPV), Epstein-Barr Virus (EBV),
human immunodeficiency virus (HIV), Hepatitis B and C viruses (HBV, HCV), Human Herpes
Virus-8 (HHV-8), and Simian Virus 40 (SV40). The oncogenic SV40 virus was discovered
because it was a contaminant of polio vaccines which were used in the 1960s.

CHALLENGE: What are the cancers linked to these viruses?

While an association of SV40 and cancer in humans is yet unproven, there is a
demonstrated link between SV40, p53, and cancer in other mammals. After an infection of
cells by SV40, viral DNA enters the nucleus, where it can integrate into the host cell genome.
Such SV40 infections are usually latent, meaning that they cause no harm. But when activated,
they can lead to cellular transformation and the growth of malignant sarcomas in muscles, as
well as tumors in other organs. If activated in an infected cell, the host-cell RNA polymerase II
transcribes the SV40 genes to produce enzymes that replicate viral DNA and the viral
structural proteins that encapsulate the DNA in a membrane envelope to make new viral
particles. Since the relatively small SV40 genome does not encode all of the enzymes and
factors needed for viral DNA replication, the infected cells also provide these factors,
producing them only during the S phase. At that time, the SV40 large T antigen (already made
soon after infection) enters the host-cell nucleus, where it regulates transcription of the genes
essential to viral replication and viral particle formation.
All these strategies and activities may be OK for the SV40 virus, but the kicker is that
the large T antigen also binds to p53, interfering with transcription of proteins whose genes are
regulated by p53. Unable to exercise its normal checkpoint functions, the host cell starts
dividing uncontrollably, forming cancerous tumors. Deregulation of the cell cycle by large T
antigen ensures progress to the S phase and unregulated co-replication of viral and host-cell
DNA.
19.8.2 p53 and Signal Transduction
Stress can activate signal transduction pathways. For example, mutations affecting the MAP-K
(MAP kinase) signaling pathway can lead to tumorigenesis. This can be explained by the
observation that when activated, the MAPK pathway leads to amplified production of a kinase
that phosphorylates p53.
Active phospho-p53 in turn augments activation of the MAPK signal transduction pathway,
and you may recall that MAPK signal transduction typically ends with a mitogenic response.
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Another example of p53 interaction is with FAK (focal adhesion kinase) proteins. FAK
activity is increased by integrin-mediated signal transduction. Recall that membrane integrins
bind fibronectin, contributing to formation of the extracellular matrix. Elevated FAK activity
participates in the regulation of cell-cell and cell-ECM adhesion at focal adhesion points.
Another role for FAK is to bind directly to inactive p53 and to increase p53-Mdm2
binding. As we have just seen, persistent p53-Mdm2 is targeted for ubiquitination—and
ultimate destruction! In fact, abnormally high levels of FAK are associated with many different
tumor cell lines—for example, ovarian, colon, breast, thyroid, skin (melanoma), and muscle
(sarcoma) cell lines. These result when p53 is unable to properly activate cell-cycle
checkpoints.
While these complex interactions under active study, they certainly confirm the central
role of p53 as both guardian of the genome and as guardian of cell division.

19.9

Cancer-Cell Growth and Behavior; Cancer Treatment Strategies

Different cancer cell-types have different growth and other behavioral properties. You may
have heard of slow-growing and fast-growing cancers. Colon cancers are typically slow
growing. Periodic colonoscopies that detect and remove colorectal tumors in middle-aged or
older people can prevent the disease (although the risks of disease and the procedure itself
must be balanced). Pancreatic cancers are fast growing and usually go undetected until they
reach an advanced stage.
The twin goals of medical research are to detect the different cancers early enough for
successful intervention and, of course, to find effective treatments.
19.9.1 Cancer-Cell Origins, Growth, and Behavior
A single mutated cell in a tissue can become the growth point of a tumor, essentially a mass of
cells cloned from the original mutated one. Benign tumors or growths (e.g., breast and uterine
fibroids in women or common moles in any of us) usually stop growing and are not life
threatening. They are often surgically removed for the comfort of the patient (or because cells
in some otherwise-benign tumors may have a potential to become cancerous).

Malignant tumors (also called malignant neoplasms) are cancerous and can grow
beyond the boundaries of the tumor itself. When tumor cells are shed, they may enter the
bloodstream and travel to other parts of the body, a phenomenon called metastasis.
Cancer cells that metastasize can become the focal points of new tumor formation in
many different tissues. Because cancer cells continue to cycle and to replicate their DNA, they
can undergo yet more somatic mutations. These further changes can facilitate metastasis and
cancer-cell growth in different locations in the body.
CHALLENGE: Where might you find mutations that could be most directly
involved in metastasis?
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19.9.2 Cancer Treatment Strategies
Many kinds of cancers originate in different tissues of the body (and most are capable of
metastasis). All cancers share the property of uncontrolled cell division, albeit for different
molecular (and not always well-understood) reasons. In addition to surgical removal of tumors,
the two major cancer treatment strategies, developed in the twentieth century, all aim at
disrupting replication in some way.
•

Radiation therapy relies on the fact that most cells in our bodies do not divide and are thus
less prone to mutational damage. They aim mutagenic radiation at tumors in the hope that
the replicating DNA will be mutated at so many sites (i.e., genes) that the tumor cells can
no longer survive or replicate properly.

•

Chemotherapy is used to attack tumors that do not respond well to radiation or that are not
easily reached by radiation technologies and to fight cancers that do not even form focused
tumors (such as lymphomas and leukemias, involving lymph and blood cells). These
chemotherapies also aim to derange replication or mitotic activities. For example, recall
cordycepin (dideoxyadenosine triphosphate, or ddATP). When present during replication,
ddATP is incorporated into a growing DNA chain, after which no additional nucleotides
can be added to the DNA strand. That makes ddATP a potent chemotherapeutic disruptor
of replication. Taxol is another chemo drug. In this case, it prevents the depolymerization
of spindle-fiber microtubules, thus blocking mitotic anaphase and telophase in the latter
part of the M and C phases of the cycle. Colchicine (a plant alkaloid) attacks cancer (and
other dividing) cells by blocking microtubule polymerization in the first place, thus
preventing spindle-fiber formation in mitotic prophase.

These therapies are not effective against all cancers, and of course, they don’t target
specific kinds of cancer cells. Their success simply relies on the fact that cancer cells
proliferate rapidly and constantly in contrast to other, normal cell. Despite the differences in
proliferation rates between cancer and normal cells, many if not all the side effects of radiation
and chemotherapies result from the damage done to normal dividing cells (e.g., hair-follicle
cells, accounting for hair loss among many cancer patients; or the damage and resulting
depletion of blood cells that fail to be replaced by stem cells in bone marrow). For the last
twenty years or so, much research has been focused on mobilizing the body’s own immune
system to create more specific, targeted cancer treatments that might avoid such side effects.
In fact, over a hundred years ago, Dr. William B. Coley read a paper about a cancer
patient who had become infected with streptococcal bacteria but had survived infection…and
emerged cancer-free. He searched for and found more anecdotal reports of patients who had
suffered coinfection and survived cancer-free, some of whom remained in remission for as
many as seven years! In an experiment that we would have frowned upon today, Coley, then at
the Memorial Sloan Kettering Cancer Center, intentionally injected a terminal cancer patient
with the bacteria! Remarkably, this patient (and later, many others similarly treated) emerged
tumor-free upon recovery from the coinfection. For more details, check out 19-8The Earliest
Cancer Immunotherapy Trials). Coley eventually started to inject heat-killed bacteria into his
cancer patients, to reduce the danger of actual infection. These injections of what came to be
known as Dr. Coley’s Toxins also proved effective for some of his patients.
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Dr. Coley’s son, Bradley, became a doctor and succeeded his father as head of the
bone-tumor service at the Sloan Kettering. Bradley Coley successfully treated many cancer
patients with his father’s toxins through the 1950s. William Coley is still thought of today as
the father of cancer immunotherapy.
The effects of Coley’s “toxins” were at first thought to be a direct antitumor action. But
without a known mechanism for the effect and due to remaining concerns over treating
patients with infectious microbes, bacterial coinfection therapy was superseded by more
predictable (somewhat) radiation and chemotherapy treatments.
Dr. Lloyd Old (also at Sloan Kettering) attempted coinfection therapy once again in the
mid-1970s. In this case, he injected a vaccine made from attenuated Mycobacterium bovis (the
cause of tuberculosis) directly into the bladders of patients with bladder cancer. Called the
BCG (Bacillus Calmette-Guérin) vaccine, this immunotherapy was highly effective, approved
by the FDA in 1990, and is still used today!
CHALLENGE: Does the BCG treatment act as a vaccine to achieve its
therapeutic effects? Explain your answer.
As an understanding of immunology grew, the idea of a direct effect of the bacteria on
tumors faded. Already by 1948, Coley’s phenomenon had become widely attributed to an
immune response activated by the infection. In 1957 Frank Macfarlane Burnet realized that
cancer cells arise from mutations in normal cells, causing their unregulated proliferation. He
further suggested that cancer cells multiply by evading our immune system’s surveillance
mechanism. This immunosurveillance is the job of circulating T lymphocytes (T cells) to
distinguish self from non-self (i.e., “foreign” molecules and cells different from our own). For
their recognition of acquired immunological tolerance (the failure of immunosurveillance) F.
M. Burnet and P. B. Medawar earned the 1960 Nobel Prize in Physiology or Medicine.
Perhaps an explanation of Coley’s phenomenon and the success of BCG therapy were
at hand. Were infectious agents boosting immune systems in some cancer patients to restore
immunosurveillance and to allow T cells to recognize cancer cells as foreign…and kill them.
In the 1990s, scientists revisited the immune response to cancer, and by the turn of the
twenty-first century, studies of cancer immunotherapy picked up steam (and more substantial
research funding!). As a case-in-point, consider James Allison’s studies that identified the Tlymphocyte surface receptor that detects foreign cells and allows their destruction. He
discovered that another T-cell membrane protein, CTLA-4 (cytotoxic T lymphocyte antigen 4)
would bind to potential target cells and block their destruction. Allison reasoned that CTLA-4 is
an immune checkpoint inhibitor that evolved to slow the destructive capacity of the cellular
immune response, leading to as false immune response against that the body’s own cells. His
next insight was that antibodies against CTLA-4 could relieve the checkpoint, allowing T cells
to resume immunosurveillance… and if so, that it could be a strategy for attacking cancer cells!
Allison eventually demonstrated that anti-CTLA-4 antibodies could kill melanoma tumors in
mice and then that they were also effective against several cancers in humans. These findings
would save hundreds of thousands of lives. He and Tasuku Honjo were recognized with the
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2018 Nobel Prize in Physiology or Medicine for their discovery of cancer therapy by inhibition
of negative immune regulation.
New animal and human immunotherapy trials are promising. A few (including
Allison’s) were approved in the US by the FDA (Food and Drug Administration). As somatic
mutants, cancer cells make proteins that are just “foreign” enough to elicit an immune
response, however slight. This understanding leads to multiple and overlapping approaches to
cancer immunotherapy aimed at improving immunosurveillance to get a strong immune
response to cancer-cell antigens. Some strategies, like anti-CTLA-4 immunotherapy, seek to
boost that innate immune response. Others seek to isolate or to synthesize unique cancer-cell
antigens in vitro, which upon injection into a patient will generate an immune response strong
enough to kill the cancer cells. Different immunotherapies are summarized in the following
table.
Table 19.1
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As you can see from the table, the immuno-targeting of cancer cells has already proven
to be highly effective. In some cases, the therapy is an example of personalized medicine, in
which treatments are uniquely tailored to you as a patient. Yet these immunotherapies have
some known issues:
• They are time and labor intensive… and costly to produce.
• While they may “cure” you, they may not work on someone else.
• Like radiation and chemotherapy, some immunotherapies come with their own unpleasant
and sometimes-severe side effects.
The promise of the checkpoint blockade demonstrated by Allison continues to be an active
area of research.
CHALLENGE: Remember exosomes, those bits of plasma membrane vesicle
released by almost all cells with possible roles in cell-cell communication.
Exosomes from natural killer (NK) immune cells were recently harvested
and shown to be effective in killing cancer cells. Read the articles at

19-9NK-

19-10NK-Cell

Cell exosomes Kill Cancer Cells or at
exosomes Kill Cancer
Cells-full paper Then summarize in your own words and discuss what these
exosomes are and how they can kill cancer cells

NOTE: The term checkpoint inhibitor in the context of immunotherapies differs from
the checkpoints monitoring progress through the eukaryotic cell cycle. A more detailed
discussion of cancer immunotherapies is at Cancer.gov (19-11Cancer Immunotherapy).
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Chapter 20

Origins of Life

A short history; Origins under reductive vs non-reductive conditions; Prebiotic chemical and
metabolic evolution; Origins of communication (catalysis, autocatalysis, co-catalysis,
biochemical pathways; Transition from the RNA World
Reminder: For inactive links, google key words/terms for alternative resources.

20.1 Introduction
It is nearly universally accepted that there was a time, however brief or long, when the Earth
was lifeless. Given that the cell is the basic unit of life, and that to be alive is to possess all the
properties of life, any cell biology textbook would be remiss without addressing at some
length, the questions of when and how the first cells appeared on our planet. Abiogenesis is
the origin of life from non-living matter. Of course, any observation of abiogenesis in nature is
no longer possible! But a combination of experiment and educated guesswork makes it
possible to construct reasonable (if sometimes conflicting) scenarios to explain the origins of
life, and hence our very existence.
In this chapter, we will see that different scenarios require consistent assumptions
about climatic, geologic, thermodynamic, and chemical conditions that favored abiogenesis.
The “right” conditions would lead to a prebiotic accumulation of organic molecules, chemical
reactions and proto-structures that could support the formation of a cell. One might reasonably
speculate such a prebiotic laboratory would have led to spontaneous experiments in chemical
evolution, which chemical combinations best survived and interacted in a hostile pre-biotic
environment, well before the origin of the first cell… or cells. Hence the chapter title “Origins
of Life”!
While many consider the creation of the first cell to be a singular, one-off event, it has
been argued that multiple independent origins were not only possible under these conditions,
but also probable! According to Jeremy England, of MIT, the laws of thermodynamics dictate
that "...when a group of atoms is driven by an external source of energy (like the sun or
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chemical fuel) and surrounded by (heat) like the ocean or atmosphere), matter inexorably
acquires the key physical attribute(s) associated with life”. Check out A New Physics Theory of
Life at 20.1Thermodynamic Laws Predict the Origins of life! for more information. Here is a
reminder of those key attributes, or properties of life:
Evolution:
Cell-based:
Complexity:
Homoeostasis:
Requires Energy:
Irritability:
Reproduction:
Development:

long-term adaptation/speciation
the cell is the fundamental unit of life
dynamic order; allows physical/biochemical change
living things maintain balance between change and order
needed to do work, i.e., all cellular functions
immediate sensitivity and response to stimuli
sort of self-explanatory, yes?!
programmed change; most obvious in multicellular organisms
but found in some form in all organisms.

Remember that to be alive is to possess not just some, but all these properties! If
entities with the required properties of life (i.e., cells) did originate independently, they would
have reproduced to form separate populations of cells, each of which would embark on an
independent evolutionary pathway. In this scenario, less successful populations would go
extinct as successful ones become dominant. Successful organisms would have spread,
spawning populations, evolving, and generating new species. This could go on until all other
independent lineages of life were extinct.
The take-home message here is that if conditions on a prebiotic earth favored the
formation of a single progenitor ‘first cell’, then why not the formation of two or dozens or even
hundreds of ‘first cells? We may never know because there are no survivors of such lineages.
If they ever existed, they are now extinct! We will see the evidence that there is only one
successful population of cells from which common ancestor came all known living things. As to
the question of when life began, we will look at geological and geochemical evidence
suggesting the presence of life on Earth as early as 4.1 billion years ago. As for how life began,
this remains the subject of ongoing speculation.
After a brief history of thought about life origins, all the scenarios to be described
below try to understand the physical, chemical, and energetic conditions that might have been
the ideal laboratory for prebiotic “chemistry experiments”. We will examine two of these
scenarios in some detail. What all Origins of Life scenarios must account for include the
following:
• prebiotic synthesis of organic molecules, monomers & polymers
• origins of catalysis
• sources of free energy to sustain prebiotic chemistry
• beginnings of metabolism sufficient for life
• origins of molecular communication (information storage and retrieval)
• enclosure of life’s chemistry behind a semipermeable boundary
• the legacy in all organisms of common life and genetic chemistries
Now let’s consider some tricky definitions. If one believes (as is still common), that the
origin of earthly life was so unlikely that it could only have happened once, then the first cell,
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the progenote, is indeed the progenitor of us all, the common ancestor of all living things. The
evolutionary tree in Figure 20.1 (below) puts the progenote at the root of the tree.

Fig. 20.1: Descent (evolution and speciation) from a single progenitor cell formed by sheer luck on
a prebiotic Earth.

The progenote, that first and only cell, would have reproduced and diverged into multiple,
separate, giving rise to multiple lineages. In other words, the descendants of the progenote
would have evolved from the get-go. Like any populations of cells and organisms, whether
from of a one or many “progenotes”, descendant populations would have competed for
resources (and ultimately survival) on an early Earth. Thus, one of these lineages (the dashed
line in the illustration) would have survived as others fell to extinction, a process that
continues today as the fossil record attests. Now let’s imagine multiple independent ‘first cells’.
How would that change our view of life’s descent? Figure 20.2 illustrates a hypothetical
scenario.

Fig. 20.2: Descent (evolution and speciation) from multiple “first’ cells” assumes no progenote and the
extinction of all but one lineage, whose descendants include our ‘last universal common ancestor’ (LUCA).

If we assume multiple life origins (“first cells”), there was no progenote. But without evidence
(we have none!), we must surmise that the evolution of all but one of these “first cells” led to
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extinction of their lineage, leaving only one path to the evolution of life on Earth, the one on
the right. Descendants of the ‘first cell’ in that path survived to evolve their own lineages,
among which many themselves went extinct. The surviving lineage that produced all living
things traces back to the Last Universal Common Ancestor (LUCA).
In other words, whether life had one or many origins in a permissive prebiotic
environment, we can anchor our assumptions on the evolution of life from a single origin. We
will see clear evidence to support that all organisms alive today are descended from a single
cell. In a scenario where only one cell population survives the competition with other
populations, its evolved cells would have been the source of our Last Universal Common
Ancestor, or LUCA. The LUCA must be that highly evolved cell whose genome, biochemistry,
and basic metabolic infrastructure is shared among all things alive today (Figure 20.3).

Fig. 20.3: Evolutionary (i.e., phylogenetic) tree of all living organisms showing descent of the 3 domains
of life (Bacteria, Archea and Eukaryota) from a LUCA. The node separating archaea from eukaryota is
the LECA, (Last Eukaryotic Common Ancestor), but could just as well be called the LACA!

This and similar evolutionary trees for known living things on Earth are based on studies of
nucleotide sequences of many genes in existing organisms. Whatever the prebiotic pathway
(or pathways) to the first living cells on Earth, computers can be used to trace differences in
gene nucleotide sequences back to changes that would have begun in that single common
ancestor that we have defined as our LUCA.
What is the basis for our conclusion that the progeny of multiple ‘first cells’ are no
longer with us? Even if there were multiple life origins, each of the “first cells” might survive
long enough to produce its own lineage of evolved cell populations. But the cellular
biochemistries and structures of these independently lineages would likely have been quite
different as they evolved their own solutions to the tasks of survival. Perhaps it will be easiest
to imagine that they evolved very different genetic codes, even if they used RNA and DNA as
their genetic material, and even if the best solution to storing and retrieving genetic
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information was the three-base codon for their amino acids. If life originated multiple times
and any of their descendants survived to this day, we would expect them to have a different
genetic code, if not a totally different way to store genetic information. With only evidence of a
shared genetic code among today’s living things, we can conclude that but one of many early
cell lineages went extinct, or that they never happened. Either way, among the descendants of
our progenote is a lineage, a population that includes the first cell with a DNA genome with
the same genetic code used by virtually all organisms alive today. This, our LUCA, and its
descendants display the high level of conservation of gene and protein sequences that we find
today. We’ll look at more supporting evidence that this is so as we move through this chapter.
We’ll learn that this evidence is perhaps the strongest support for realized expectations. Let’s
begin by looking at the following basic requirements of any life-origins scenario:
•
•
•
•
•

reduction of inorganic molecules to form organic molecules
a source of free energy to fuel the formation of organic molecules
a mechanism for anabolic metabolism, the synthesis of macromolecular polymers from
organic monomers.
a pathway to the catalytic acceleration of biochemical reactions
separation of early biochemical experiments by a semipermeable boundary.

Then, we’ll consider some proposed scenarios for the creation of organic molecules:
•
•
•

import of organic molecules (or even life itself) from extraterrestrial sources.
organic molecule synthesis on an Earth with a reducing atmosphere.
organic molecule synthesis on an Earth with a non-reducing atmosphere.

We’ll explore alternate free energy sources and pathways to the essential chemistry of life
dictated by these alternatives. Then we look at specific scenarios of prebiotic chemical
evolution. Finally, we consider how primitive (read “simpler”) biochemistries could evolve into
the metabolisms shared by all existing life forms today…, including a common genetic code!

347 What any Life Origins Scenario Must Explain

Learning Objectives
When you have mastered the information in this chapter, you should be able to do the
following:
1. Explain how organic molecules would capture chemical energy on a prebiotic earth.
2. List the essential chemistries required for life and why they might have been selected
during chemical evolution.
3. Discuss the different fates of prebiotically synthesized organic monomers and polymers,
and how these fates would influence the origins of the first cells on Earth.
4. Compare and contrast two scenarios for extraterrestrial origins of organic molecules.
5. Summarize the arguments for and against Oparin’s primordial soup hypothesis.
6. Summarize the evidence for and against life origins in a non-reducing Earth atmosphere.
7. Explain the difference between a progenote and the LUCA.
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8. Discuss the evidence suggesting an origin of cellular life in the late Hadean eon.
9. Describe how life might have begun in deep ocean vents – compare the possibilities of life
beginning in black smokers vs white smokers.
10. Argue for and against an autotroph-first scenario for cellular origins.
11. Explain why some investigators place significance on the early origins of free energy
storage in inorganic proton gradients.
12. Speculate on what selective forces drove the evolution of electron transport.
13. Define autocatalysis, co-catalysis, and co-catalytic sets; provide examples.
14. Describe the significance and necessity of coevolution before life. In what ways is
coevolution a feature of living things? Explain.

20.2

Thinking about Life’s Origins: A Short Summary of a Long History

By all accounts, the Earth must have been a very unpleasant place soon after its formation!
For that reason, the period from 4.8 to 4.0 billion years ago is called the Hadean Eon, after
Hades (‘hell’ to the ancient Greeks, but a great free energy source!). Until recently, geological,
geochemical, and fossil evidence suggested that life arose between 3.8 and 4.1 billion years
ago. More recently, the 2017 discovery of evidence for life in 3.95 billion year-old sedimentary
rocks in Labrador points to a 4 billion year old earlier origin of life (see 20.2Oldest Evidence for
Life on Earth-from Canada).
In fact, questions about life’s origins are probably “as old as the hills…” or at least as old as the
ancient Greeks! We only have records of human notions of life’s origins dating from biblical
accounts and, just a bit later, from Aristotle’s musings. Aristotle did not suggest that life began
in ‘hell’. Instead, he and other ancient Greeks speculated about life’s origins by spontaneous
generation, in the sense of abiogenesis, or life originating from non-life. Aristotle further
speculated that the origins of life were gradual. Later, the dominant theological accounts of
creation in Europe in the Middle Ages muted all notions of natural origins and evolution.
While a few mediaeval voices ran counter to strict biblical readings of the creation stories, it
was not until the Renaissance (in the fourteenth-seventeenth centuries) that an appreciation of
ancient Greek humanism was reawakened and with it, scientific curiosity, and the ability to
engage in rational questioning and research.
You may recall that Louis Pasteur in the mid-nineteenth century put to rest any lingering
notions of life forming from dead (e.g., rotten, or fecal) matter. He showed that life would not
form in sterilized nutrient solutions unless the broth was exposed to the air. Fewer know that
much earlier, Anton Van Leeuwenhoek (the seventeenth century sheriff of Delft, amateur lens
grinder and microscopist who first described pond water bacteria and protozoan animalcules)
had already tested the notion of spontaneous generation. By observing open and sealed
containers of meat over time, he became convinced that ‘large’ animals like fleas and frogs do
not arise de novo from putrid meat or slime. He also declared that insects come from other
insects, and not from the flowers that they visited. In 1859, no lesser a light than 20.3Charles
Darwin himself favored the idea that life might have begun in a "…warm little pond, with all
sorts of ammonia and phosphoric salts, light, heat, electricity, &c., present, that a proteine
compound was chemically formed ready to undergo still more complex changes." He even
realized that these chemical constituents would not have survived in the atmosphere and
waters of his day but must have been doing so in a prebiotic world.
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In On the Origin of Species, Darwin referred to life having been ‘created’. However,
Darwin makes it clear that he was not referring to a biblical basis of creation. Rather, he meant
that life originated “by some wholly unknown process" at a time before which there was no life.
Finally, Pasteur’s 1861 contribution was the irrefutable, definitive proof that ‘invisible’
microbial life likewise did not arise by spontaneous generation. Thus, the creatures already on
Earth could only arise by biogenesis (life-from-life), the opposite of abiogenesis, a term that
now applies to only the first origins of life! Among Darwin’s contemporaries and friends were
Charles Lyell and Roderick Murchison, both geologists who understood much about the slow
geological changes that shaped the Earth. Darwin was therefore familiar with the concept of
extended periods of geological time, amounts of time he believed were necessary for the
natural selection of traits leading to species divergence.
OK, spontaneous generation is disproven. But…, appropriate conditions on earth must have
made life’s origins spontaneous! So let’s fast-forward to the 1920s when J. H. B. S. Haldane
and A. Oparin offered a hypothesis about the life’s origins based on notions of the chemistry
and physical conditions they believed might have existed on a prebiotic earth. Their proposal
assumed that the Earth’s atmosphere was hot, hellish, and reducing (i.e., filled with inorganic
molecules able to give up electrons and hydrogens). There are more than a few hypotheses for
which kinds of chemicals were already present on Earth, or that formed along with the planet
about 4.8 billion years ago, but all posit a source of free energy for their formation. We’ll start
our exploration with Oparin and Haldane’s reducing atmosphere. Then we look at possibility
that life began under non-reducing conditions, with passing reference to a few other ideas!

348 Early Ideas to Explain the Origins of Life

20.3

Formation of Organic Molecules in an Earthly Reducing Atmosphere

A prerequisite to prebiotic chemical experimentation is a source of organic molecules. Just as
life requires energy (to do anything and everything), converting inorganic molecules into
organic molecules requires an input of free energy. As we have seen, most living things today
get free energy by oxidizing nutrients or directly from the sun by photosynthesis. Recall that all
the chemical energy sustaining life today ultimately comes from the sun. But before there were
cells, how did organic molecules form from inorganic precursors? Oparin and Haldane
hypothesized a reducing atmosphere on the prebiotic earth, rich in inorganic molecules with
reducing power (like H2, NH3, CH4, and H2S) as well as CO2 to serve as a carbon source. They
predicted that the physical conditions on a prebiotic earth would include lots of water (oceans);
high heat (no free O2); lots of ionizing (e.g., X-, -) radiation from space, (no protective ozone
layer); frequent ionizing (electrical) storms generated in an unstable atmosphere; and lots of
volcanic and thermal vent activity.
20.3.1 Origins of Organic Molecules and a Primordial Soup
Oparin suggested that abundant sources of free energy fueled the reductive synthesis of the
first organic molecules to create what he called a “primeval soup”. No doubt, he called this
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primeval concoction a “soup” because it would have been rich in chemical (nutrient) free
energy. Harold Urey, who had already won the 1934 Nobel Prize in Chemistry for discovering
deuterium, and Stanley Miller tested the prediction that, under Haldane’s and Oparin’s
prebiotic earth conditions, inorganic molecules can produce the organic molecules in what
became known as the primordial soup. In their classic experiment, a mix of inorganic
molecules provided with an energy source was reduced to very familiar organic molecules,
supporting the Oparin/Haldane proposal. Their experiment is shown below in Figure 20.4.

Fig. 20.4: The Miller & Urey experiment: organic molecules seen in living things today form spontaneously
in the lab under reducing conditions like those expected in a prebiotic earth atmosphere.

Miller’s earliest published data indicated the presence of several organic molecules in their
ocean flask, including a few familiar metabolic organic acids (lactate, acetate, several amino
acids…) as well as several highly reactive aldehydes and nitriles. The latter can interact in
spontaneous chemical reactions to form organic compounds. Later analyses further revealed
purines, carbohydrates, and fatty acids in the flask. Some 50 years after Miller’s experiments
(and a few years after his death), some un-analyzed samples collected from those early
experiments were discovered. When their contents were re-analyzed with newer, more
sensitive detection techniques, they were shown to contain organic molecules not originally
reported, including 23 amino acids (to read more, see 20.4Surprise Goodies in the Soup!).
Clearly, the thermodynamic and chemical conditions proposed by Oparin and Haldane
would support reductive synthesis of organic molecules. But, these evolving chemistries would
have to be captured inside semipermeable aggregates (or boundaries) destined to be a cell.
Proposals for such structures are discussed below. Such events in a nutrient-rich primordial
soup would likely have led to the genesis of heterotrophic cells that could use environmental
nutrients for energy and growth. This implies an early evolution of fermentative pathways like
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glycolysis. But here’s the rub: these first cells would have quickly consumed the nutrients in
the soup, quickly ending the Earth’s new vitality!
To stop life from becoming a dead-end experiment, one must propose the early
evolution of autotrophs, cells that could capture free energy from inorganic molecules
(chemoautotrophs) or even sunlight (photoautotrophs). As energy-rich organic nutrients in
the ‘soup’ declined, autotrophs would be selected, for example photoautotrophs that could fix
(i.e., reduce) CO2, with H- ions split from water. In this way, photosynthesis would replenish
carbohydrates and other nutrients in the oceans and splitting water would add O2 to the
atmosphere. Oxygen would have been toxic to most cells at the time, but some of those cells
already had the ability to survive oxygen. These survived, evolving into cells that could respire,
i.e., use oxygen to burn environmental nutrients. In fact, respiratory metabolism must have
followed hard on the heels of the spread of photosynthesis. After photosynthesis emerged,
sometime between 3.5 and 2.5 billion years ago (the Archaean Eon), photosynthetic and
aerobic cells and organisms achieved a natural balance to become the dominant species in our
oxygen-rich world.
20.3.2 The Tidal Pool Scenario for an Origin of Polymers and Replicating Chemistries
In this scenario, prebiotic organic monomers concentrate in tidal pools and polymerize in the
heat of a primordial day by dehydration synthesis. This uphill reaction requires free energy.
Very high temperatures (heat of baking) can link monomers by dehydration synthesis in the
lab and may have formed random polymers in tidal pool sediments, as shown in Figure 20.5,
which further assumes dispersal of these polymers with the ebb and flow of the tides.

Fig. 20.5: Scenario for the synthesis of prebiotic polymers in tidal pools.
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The catalytic properties of metals (e.g., nickel, platinum, silver, magnesium, and manganese)
are exploited in the laboratories to speed up chemical reactions. Such metals were likely
present in primordial ocean sediments in the early Earth’s crust, including, just as they are
there today. And their catalytic properties in soil and clay aggregates have also been
demonstrated. In fact, metals like magnesium and manganese are now an integral part of
many enzymes, consistent with an origin of biological catalysts as prebiotic benthic minerals.
Finally, some metals like magnesium (Mg++) readily associate with nucleotides. Before life,
the microsurfaces of ocean sediments, if undisturbed, may have catalyzed the same or at least
similar reactions repeatedly, leading to related sets of polymers. Consider the possibilities for
RNA monomers and polymers, based on the assumption that life began in an “RNA world”
(Figure 20.6). The concentration of putative organic monomers at the bottom of mineral-rich
tidal pools may have accelerated polymerization reactions.

Fig. 20.6: Scenario for the synthesis of redundant prebiotic nucleic acid polymers in tidal pools.

The result predicted by this scenario is the formation not only of RNA-like polymers
(perhaps only short ones at first), but of H-bonded double-stranded molecules that might
effectively replicate at each cycle of concentration, polymerization, and dispersal. High heat
could have supported polymerization, while catalysis enhanced the fidelity of template-based
replication. Of course, repeated high heat or other physical or chemical attack might degrade
newly formed polymers, unless some double strands were resistant to destruction. These would
accumulate at the expense of the weaker, more susceptible ones. In this way, the fittest
replicated molecules would be stable in the environment. The environmental accumulation of
structurally related, replicable, and stable polymers reflects a prebiotic chemical homeostasis
(one of those properties of life!). For this scenario to work, prebiotic nucleosides must have
been available and stable. We’ll revisit this issue shortly

349 Life Origins in a Reducing Atmosphere?
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Overall, the tidal pool scenario for life origins in a reducing environment hung
together nicely for many decades. But there are now challenging questions about the premise
of a prebiotic reducing environment. Newer evidence suggests an Earth atmosphere that was
not at all reducing, casting doubt on the idea that heterotrophs were the first cells on the
planet. Recent proposals posit alternative sources of prebiotic free energy and organic
molecules that look quite different from those assumed by Oparin, Haldane, Urey and Miller.

20.4 Origins of Organic Molecules in a NON-Reducing Atmosphere
A prebiotic non-reducing atmosphere is based on several assumptions: (1) The early Earth
would have had insufficient gravity to hold H 2 and other light gasses; (2) as a result,
“outgassing” would have resulted in a loss of H2 and other reducing agents from the
atmosphere; (3) The geological evidence suggests that the Earth’s oceans and crust formed
early in the Hadean Eon, just a few hundred million years after formation of the planet; (4)
studies of 4.4-billion-year-old (early Hadean Eon) Australian zircon crystals suggest that their
oxidation state is the same as modern day rocks, meaning that the early Hadean atmosphere
was largely N2 and CO2, a distinctly non-reducing one! Solid geological evidence of cellular
life dates to 3.5-3.95 billion years ago (i.e., the Archaean Eon). Softer evidence of microbial life
exists in the form of graphite and other possible footprints of life as old as 4.1 billion years ago,
near the end of the Hadean Eon. If this is true, the discovery of an oxidizing Hadean
atmosphere at least 3 billion years earlier (4.4 billion years ago) argues for the origins of life in
a non-reducing atmosphere. Therefore, regardless of whether life began 3.5 or even 4.1 billion
years ago, the evidence suggests that life’s beginnings had to contend with a non-reducing
environment. A colorized image of the Australian zircon is shown in Figure 20.7.

Fig. 20.7: The oxidation state of this Australian zircon crystal supports an oxidizing atmosphere on Earth
as far back as 4.4 billion years ago. Photo Courtesy of J. W. Valley et al.

Before we look more closely at other evidence of life origins under non-reducing
conditions, let’s consider the Panspermia, the possibility that life came to Earth from
extraterrestrial sources and a related hypothesis that prebiotic organic molecules came from
extraterrestrial sources. Then we’ll return to the question of how cells might have formed in
localized, favorable terrestrial environments.
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20.4.1 Panspermia – an Extraterrestrial Origin of Earthly Life
Panspermia posits that life itself arrived on our planet by hitchhiking on comets or meteorites.
Since these are unlikely to have sustained life in space, they must have been a kind of
interstellar ‘mailbox’ into which dormant life forms were deposited. The cells in the mailboxes
must have been cryptobiotic. Examples of cryptobiosis exist today (e.g., bacterial spores, brine
shrimp!). Once they were delivered to Earth’s life-friendly environment, such organisms would
emerge from dormancy, eventually populating the planet. But there is no evidence of dormant
or cryptobiotic life on comets or meteorites, and no hard evidence to support Panspermia.
On the other hand, there is evidence at least consistent with an extraterrestrial source of
organic molecules, and even more to support more terrestrial origins of life. In any case,
notions of Panspermia (and even extraterrestrial sources of organic molecules) just beg the
question of the conditions that would have led to the origins of life elsewhere!
Not a favored scenario, panspermia is still intriguing in the sense that it is in line with a
likelihood that organic molecules formed soon after the Big Bang. Moreover, if ready-made
organic molecules and water were available, we can expect (and many do!) that there is life on
other planets. This possibility has stimulated discussion and serious funding of programs
looking for signs of extraterrestrial life. It supported the earlier Search for Extraterrestrial
Intelligence (SETI) program based on the assumption that life not only exists elsewhere, but
that it evolved high level communication skills (and why not?)! More recently NASA funded
Rover’s search for signs of water on Mars and Cassini’s recent discovery of water on Enceladus,
one of Saturn’s moons. For a fascinating story about meteorites from Mars that contain water
and that are worth more than gold, check out 20.5Martian Obsession. For one about Titan (a
moon of Saturn’s), see 20.6Life on Titan?.
And then there is this! Maybe, just maybe we have exported earthly life to comets
when they bumped into us and skittered away instead of crashing and burning. And maybe,
just maybe they scraped up a few upper atmospheric microbes along their way to other outerspace encounters (upper-atmosphere microbial colonies). Will we discover earthlike forms of
life on exoplanets as a result? Read about the possibilities and realities at. 20.7Maybe, just
maybe... Or did all this sharing of our gift of life just explain the presence of organic molecules
found on some space objects that have visited us from time to time!
CHALLENGE: We spend a lot of money on our space programs, designing
experiments to probe for water and life on Mars, other planets, and/or their
moons. If life is discovered there some day, would it argue for multiple
origins of life on earth? Do you think we should be spending the money!!?
20.4.2 Extraterrestrial Origins of Organic molecules
Even if life did not come to us ready-made, could organic molecules already in space have
arrived safely on Earth? They are abundant, for example in interstellar clouds, and could have
become part of Earth as the planet and our solar system formed around 4.8 billion years ago.
This suggests that there was no need to create them de novo. Meteorites, comets, and asteroids
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are known to contain organic molecules and could have brought them here during fiery
impacts on our planet. Such bombardments would have been common 3.8 or more billion years
ago. In this scenario the question of how (not on Earth!) free energy and inorganic molecular
precursors reacted to form organic molecules…, is moot! A related hypothesis suggests that
those fiery hits themselves provided the free energy necessary to synthesize organic molecules
from inorganic ones… a synthesis-on-arrival scenario. With this hypothesis on the one hand,
we are back to an organic oceanic primordial soup. On the other, some have suggested that
organic molecules produced in this way (not to mention any primordial life forms) would likely
have been destroyed by the same ongoing impacts by extraterrestrial bodies; witness the
relatively recent dinosaur extinction by an asteroid impact off the coast of Mexico some 65.5
million years ago. If organic molecules could not have come from space, then where from?

350 Life Origins in a Non-Reducing Atmosphere?

20.5 Organic Molecular Origins of Life Closer to Home
Deep in the oceans, far from violent meteoric encounters and rampant free energy of an ozoneless sky, deep-sea hydrothermal vents would be spewing reducing molecules (e.g., H2S, H2,
NH4, CH4), much as they do today. Some vents are also high in metals such as lead, iron,
nickel, zinc, and copper. Combined with their clay or crustal substrata, some of these minerals
could have provided catalytic surfaces to enhance organic molecule synthesis. Could such
localized conditions have been the focus of prebiotic chemical experimentation leading to the
origins of life? Let’s look at two kinds of deep-sea hydrothermal vents: volcanic and alkaline.
20.5.1 Origins in a High-Heat Hydrothermal Vent (Black Smoker)
The free energy available from a volcanic hydrothermal vent would come from the high heat
temperatures ranging to 3500C) and the minerals and chemicals expelled from the Earth’s
mantle. Figure 20.8 (below) shows a volcanic hydrothermal vent.

Fig. 20.8: An oceanic volcanic hydrothermal vent, or black smoker.
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Conditions assumed for prebiotic volcanic hydrothermal vents could have supported
the catalytic synthesis of organic molecules from inorganic precursors (see 20.8Volcanic Vents
and Organic Molecule Formation) or 20.9Volcanic Vents & Organic Molecule Formation-full
paper). Available catalysts would have been inorganic, for example metals like nickel and iron.
Chemical reactions tested include some that are reminiscent of biochemical reactions in
chemoautotrophic cells alive today.
Günter Wächtershäuser proposed the 20.10Iron-Sulfur World Theory of life’s origins in
these vents, also called “black smokers”. These vents now spew large amounts of CH4 and
NH4 and experiments favor the idea that iron-sulfur aggregates in and around black smokers
could provide catalytic surfaces for the prebiotic formation of organic molecules like methanol
and formic acid from dissolved CO2 and the CH4 and NH4 coming from the vents. A variety of
extremophiles (e.g., thermophilic archaea) now living in and around black smokers would
seem to be testimony supporting a black smoker hypothesis for life origins.
Wächtershäuser also realized that prebiotic selection acted not so much on isolated
chemical reactions, but on aggregates of metabolic reactions. We might think of such metabolic
aggregates as biochemical pathways or multiple integrated biochemical pathways.
Wächtershäuser also proposed the selection of cyclic chemical reactions that released free
energy that could then be used by other reactions. Clearly, some version of a prebiotic scenario
of metabolic evolution, or selection of metabolic chemistries, something more complex than a
simple chemical evolution, would have been essential to the origins of life.
CHALLENGE: Does co-selection of multiple metabolic pathways (i.e.,
“aggregates of metabolic reactions”) seem feasible? Can you think of a
metabolic aggregate that might illustrate co-selection? Explain.

While the idea of selecting metabolic pathways has great merit, there are problems
with a life-origins scenario in volcanic hydrothermal vents. For one thing, their very high
temperatures would likely have destroyed as many organic molecules as were created. Also,
the extremophilic archaea now found around these volcanic vents cannot be the direct
descendants of any cells that might have originated there. Woese’s phylogeny clearly shows
that archaea share a lineage with eukaryotes (not eubacteria). Thus, extremophilic cellular life
originating in the vents must have given rise to a more moderate LUCA first, before then going
extinct. Then, extremophiles we find in the black smokers would once again have had to
evolve independently to re-colonize the vents! Such twists and turns militate against an
extremophiles-first origins scenario. Given these concerns, recent proposals focus on life
origins in less extreme alkaline hydrothermal vents.
20.5.2 Origins in an Alkaline Deep-Sea Vent (White Smoker)
Of the several scenarios discussed here, an origin of autotrophic life in alkaline vents is one of
the more satisfying alternatives to a soupy origin of heterotrophic cells. For starters, at
temperatures closer to 1000C-1500C, alkaline vents (white smokers) are not nearly as hot as
are black smokers. An alkaline hydrothermal vent is shown below in Figure 20.9.
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Fig. 20.9: An alkaline deep-sea hydrothermal ocean vent, or White smoker

Other chemical and physical conditions of alkaline vents are also consistent with an origins-oflife scenario dependent on metabolic evolution. For one thing, the interface of alkaline vents
with acidic ocean waters has the theoretic potential to generate many different organic
molecules [Shock E, Canovas P. (2010) The potential for abiotic organic synthesis and
biosynthesis at seafloor hydrothermal systems. Geofluids 10 (1-2):161-92)].
In laboratory simulations of alkaline vent conditions, the presence of dissolved CO 2
favors serpentinization, a reaction of water and heat with serpentinite, an iron-containing
mineral found on land and in the oceanic crust. Figure 20.10 is a sample of serpentinite.

Fig. 20.10: Serpentinite from Deer Lake in upper Michigan is a mineral also found in the oceanic crust
that under conditions found in an alkaline vent, can form methane from CO 2.

Experimental serpentinization produces hydrocarbons, and a warm aqueous oxidation
of iron produces H2 that could account for abundant H2 in today’s white smoker emissions.
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Also, during serpentinization, a mineral called olivine [(Mg+2, Fe+2)2SiO4] reacts with dissolved
CO2 to form methane (CH4). So, the first precondition of life’s earthly origins, the energetically
favorable creation of organic molecules, is possible in alkaline vents.
Proponents of cellular origins in a late-Hadean non-reducing ocean also realized that organic
molecules formed in an alkaline (or any) vent would disperse and be rapidly neutralized in the
wider acidic ocean waters. Somehow, origins on a non-reducing planet had to include a way to
contain newly formed organic molecules from the start, and a way to power further
biochemical evolution.
What then, were the conditions inside an alkaline vent that could have sequestered organic
molecules and led to metabolic evolution and ultimately, life? Let’s consider an intriguing
proposal that gets at an answer!
The porous rock structure of today’s alkaline deep-sea vents provides micro-spaces or
micro-compartments that might, in a prebiotic past, have captured some of the alkaline liquids
they emitted. In fact, conditions in today’s white smokers also support the formation of
hydrocarbon biofilms, primitive organic membranes that could have been lined those porous
rocky micro-compartments. Alkaline vent emissions would then be trapped within primitive
biofilm membrane vesicles enclosed by rocky “cell walls”.
An interesting consequence of this scenario would be the existence of a natural proton
gradient between the alkaline contents of the micro-compartments and the surrounding acidic
ocean waters. Did all this happen?
Perhaps! Without a nutrient-rich environment, heterotrophs-first is not an option. That
leaves only the alternate option: an autotrophs-first scenario for the origins of life. Nick Lane
and his coworkers proposed that the natural proton gradients suggested above were the
selective force behind the evolution of early metabolic chemistries in alkaline vents
(20.11Prebiotic Proton Gradient Fuels Origin of Life). Organized around biofilm compartments,
prebiotic structures and chemistries would have harnessed the free energy of these proton
gradients. In Lane’s view, the first protocells, and therefore the first cells, may have been
chemoautotrophs. If so, ask yourself if early autotrophy could have evolved without an
electron transport system!
Last but not least, how might chemoautotrophic chemistries on a non-reducing planet
have supported polymer formation, as well as polymer replication? Today we see storage and
replication of information in nucleic acids as separate from enzymatic catalysis of biochemical
reactions. But are they all that separate? If replication is the faithful reproduction of the
information needed by a cell, then enzymatic catalysis ensures the redundant production of all
molecules essential to make the cell! Put another way, if catalyzed polymer synthesis is the
replication of the workhorse molecules that accomplish cellular tasks, then what we call
‘replication’ is nothing more than the replication of nucleic acid information needed to
faithfully reproduce these workhorse molecules. Was there an early, coordinated, concurrent
selection of mechanisms for the catalyzed metabolism as well as catalyzed polymer synthesis
and replication? We’ll return to these questions shortly, when we consider the origins of life in
an RNA world.
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An origin of life scenario in a non-reducing (and oxygen-free) atmosphere raises
additional questions. Would proton gradients provide enough free energy to fuel and organize
life’s origins? If so, how did cells arising from prebiotic chemiosmotic metabolism harness the
energy of a proton gradient? Before life, were protocells already able to transduce gradient free
energy into chemical free energy? Was ATP selected to hold chemical free energy from the
start? Or was it selected only concurrent with metabolic selection? Alternatively, was the relief
of the gradient coupled at first to the synthesis of other high-energy intermediate compounds,
with for example, thioester linkages? Later, how did cells formed in alkaline vents escape the
vents to colonize the rest of the planet?
By whatever series of primordial events the energy of a natural proton gradient would
be initially captured, the chemoautotrophic LUCA must already have been using membranebound proton pumps coupled to electron transport, and a membrane ATP synthase to make a
proton gradient and then harness its free energy to make ATP, since all of its descendants do
so.
Finally, when did photoautotrophy (specifically oxygenic photoautotrophy) evolve?
Was it a late evolutionary event? Is it possible that photosynthetic cells evolved quite early
among some of the chemoautotrophic denizens of the white smokers, biding their time before
exploding on the scene to create our oxygenic environment?

351 Life Origins in a Thermal Vent

20.6

Heterotrophs-First vs. Autotrophs-First: Evolutionary Considerations

In the alkaline vent scenario, chemiosmotic metabolism predated life. Therefore, the first
chemoautotrophic cells did not need the fermentative reactions required by cells in a
heterotrophs-first origin scenario. Even though all cells alive today incorporate a form of
glycolytic metabolism, glycolysis may in fact, not be the oldest known biochemical pathway, as
we have thought for so long. In support of a late evolution of glycolytic enzymes, those of the
archaea show little structural resemblance to those of bacteria. If fermentative heterotrophy
was a late evolutionary development, then LUCA and its early descendants would lack a welldeveloped glycolytic pathway. Instead, the LUCA must have been one of many ‘experimental’
autotrophic cells, most likely a chemoautotroph deriving free energy from inorganic chemicals
in the environment. To account for heterotrophy in the three domains of life, it must have
evolved separately in the two antecedent branches descending from the last universal common
ancestor of bacterial, archaeal, and eukaryotic organisms. The evolution of similar traits
(fermentative biochemical pathways in this case) in unrelated organisms is called convergent
evolution.
The phylogenetic tree in Figure 20.11 below features an autotrophic LUCA in an
autotrophs-first scenario. The tree traces a separate (convergent) evolution of heterotrophy in
two branches of the descendants of the LUCA by tracing the spread of fermentative pathways
in all living things on the familiar three domain phylogeny.
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Fig. 20.11: This evolutionary (phylogenetic) tree of living organisms assumes autotrophic first cells and
an autotrophic LUCA, with heterotrophy and heterotrophic metabolism evolving independently in
ancestors of Bacteria on the one hand (left) and Archaea and Eukaryota on the other (right)

20.7

Life’s Origins, A Summing Up

Speculation about life’s origins begins by trying to identify a source of free energy with which
to make organic molecules. The first cells might have been heterotrophs formed in a reducing
Earth environment, from which autotrophs later evolved. On the other hand, the earliest cells
may have been autotrophs formed under non-reducing conditions in the absence of a
primordial soup. Then, only after these autotrophs had produced enough nutrient free energy
to sustain themselves, did heterotrophs belatedly emerge. Evidence suggesting that the Earth’s
atmosphere was a non-reducing one more than 4 billion years ago (soon after the formation of
the planet) and suggesting life on Earth 3.95 billion years ago favor metabolic origins of
autotrophic life in a thermal vent, likely an alkaline one. Questions nevertheless remain about
life-origins under non-reducing conditions. Even the composition of the prebiotic atmosphere
is still in contention. For now, let us put these concerns aside and turn to events that get us
from the LUCA and its early descendants to the still more elaborated chemistries common to
all cells today. The descriptions that follow are educated guesses about early pathways on the
road to the familiar cellularity we see now on Earth. They mainly speculate on the selection of
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catalytic mechanisms, replicative metabolism, the web of intersecting biochemical pathways,
and even more intricate chemical communications that organize cell function and complexity.

352 Phylogenetic Support for Autotrophs-First Origins of Life

20.8

Origins of Life Chemistries in an RNA World

Following the origins of organic monomers in a reducing environment in the tidal pool
scenario, the energy for polymer formation came from cycling temperatures on an overheated
Earth. In that scenario, we considered how chains of nucleotides could be synthesized and
even replicated to form populations of nucleic acids with similar sequences. But if the prebiotic
environment was non-reducing, where would the energy have come from to make any
polymers, let alone ones that could replicate themselves? If you guessed that the energy was
provided by a proton gradient between biofilm-enclosed acidic proto-cells and an alkaline
ocean…, you would have been right! In this case, polymers would have been synthesized in
enclosed spaces, and not in tidal pools only to be dispersed and diluted in the wider oceans.
But then, how would replicative, informational, and catalytic chemistries have arisen from
these organic monomers and polymers? Polypeptides would have formed, but they have no
inherent chemical or structural basis for self-replication. Unlike polypeptides, we saw in
describing the tidal pool scenario that polynucleotides (nucleic acids) do! In fact, as we have
already seen, evidence is accumulating to support the hypothesis that life (and its first
genome) originated in a RNA world:
•
•
•

•

Glycoside bond synthesis between prebiotic bases and sugars may have been possible.
Today’s RNAs include ribozymes that catalyze their own replication self-splicing introns).
Some RNAs are part of ribonucleoproteins that have at least co-catalytic activities, like
ribosomes, the small ribonucleoproteins (snRNPs) in spliceosomes, and the secretory
signal recognition particle.
Retroviruses (e.g., HIV) store their genetic information in RNA genomes that may have
been integral to the emergence of cellular life.

Ribozymes, ribonucleoprotein structures, and retroviruses may be legacies of a
prebiotic RNA world. In fact, in an ‘in vitro evolution study’, self-replicating ribozyme
polymerases in a test tube become more efficient at replicating a variety of increasingly longer
and more complex RNAs over time. For more about these autocatalysts that support an RNA
world, check out 20.12Real & Artificial Ribozymes Catalyze RNA synthesis.
There are hypothetical RNA world scenarios for the origins of replicating, catalytic
polymers, and even a real organic chemical, an autocatalyst that can catalyze its own
synthesis. So, which may have come first? A self-replicating RNA or other self-replicating
organic molecule? Arguably, chemical evolution of an autocatalytic RNA is a stretch, but at
least one organic molecule, Amino Adenosine Triacid Ester (AATE), is a present-day selfreplicating autocatalyst. Could a molecule like AATE have been a prebiotic prelude to the RNA
world? Figure 20.12 (below) shows the structure and replication of AATE.
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Fig. 20.12: Aminoadenosine triacid ester (AATE) catalyzes its own replication by the mechanism
suggested here.

The replicative reaction proceeds in the following steps:
1. An aminoadenosine triacid ester molecule binds a second aminoadenosine.
2. A second triacid ester molecule binds to “di-aminoadenosine triacid ester”. The two
aminoadenosines, now in opposite orientations, can attract and bind a second triacid ester.
3. After bond-rearrangements, the “di-aminoadenosine, di-triacid ester” molecule separates
into two molecules of AATE.
This reaction is catalytic because the stereochemistry of the reacting molecules creates
an affinity of the AATE molecule first for another free aminoadenosine molecule. The structure
formed allows (i.e., catalyzes) linkage of a second free triacid ester, leading to the separation of
two AATE molecules. Subtle, sequential changes in the molecular conformation of the
molecules result in the changes in affinities of the molecules for each other. In the replicative
reaction, the AATE, free ester and free aminoadenosine concentrations would drive the
reaction. Could AATE-like molecules have been progenitors of autocatalyzed polymer
replication? And before that, could something like reduced NAD (NADH) have supplied free
energy to fuel AATE synthesis in the first place? After all, it too contains a nucleotide! Could
replication of a prebiotic AATE-like molecule then have led to an RNA world? Could primitive
RNAs have been stabilized by binding to short prebiotic peptides, becoming forerunners of
ribozymes? The possibility of a prebiotic AATE-like precursor to an RNA world is intriguing
because the ‘triacid’ includes the purine adenosine! On the other hand, the possibility of
prebiotic replicating RNA-peptide complexes implies the origins of life in an RNA-Protein
world (rather than exclusively RNA-world)! Whether life began in an RNA world or an RNAprotein world, catalyzed replication is of course another property of life.

353 AATE: An Autocatalytic, Self-Replicating Organic Molecule
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20.9

Experimental Evidence for an RNA World

There is some circumstantial evidence for at least one organic autocatalyst as a candidate
precursor to an RNA world. There is also evidence that the prebiotic chemistries could have
supported the linkage of bases to sugars to make nucleosides (see 20.13Prebiotic Ribonucleotide
Synthesis). Also, cyclic nucleotides (e.g., cAMP) were shown to be stable in hot water
(20.14Stable Prebiotic cAMP). Could cyclic nucleotides have served as substrates for prebiotic
RNA synthesis? In fact, investigators probing an RNA world hypothesis reported the
requirements for RNA replication in a test tube. Adding salt, magnesium ions, a bit of RNA
primer and A, U, G and C (precursor bases to RNA) to a buffered basic solution resulted in
RNA synthesis… without an RNA polymerase! The reaction was slow and prone to error. But
RNA was synthesized against the primer in a simple solution, the kind that might have been
found on Earth at life’s beginnings. The study further found that adding the base inosine to the
reactions increased the rate as well as the accuracy of RNA replication under what were
otherwise the same conditions. Of course, this is not what happens today! First, the bases are
part of nucleosides and nucleotides that are the actual precursors of replication. And, while
inosine is in fact found in some tRNAs, it does not result from the use of inosine nucleotide
precursors, but from the chemical modification (deamination) of adenine bases already in the
transcript as seen in Figure 20.13 (below).

Fig. 20.13: The deamination of adenine in a ribonucleotide chain to inosine in a tRNA by the adenine
deaminase enzyme.

OK, calling inosine the “missing ingredient” in life’s origins might be hyperbole. Still,
if cell-free RNA synthesis using nucleobases is more efficient with inosine than without it,
could inosine have participated in an early RNA world at life’s origins, to be replaced later by
our DNA world? Read more about possible roles for inosine or other unusual bases in a
prebiotic RNA world at 20.15Inosine-a Missing Ingredient in the Origin-of Life?.
CHALLENGE: Inosine has an unusual property in tRNAs. Remind yourself
of (or look up) that property and consider how it might have enhanced an
early role for the base in life’s origins.
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20.10

Molecules Talk: Molecular Communication and Complexity

In our complex human society, we define communication by its specificity. Without a careful
choice of words, our speech would at best, be a source of magnificent misunderstanding…, or
just plain babel! What does this mean for prebiotic chemistries? In any prebiotic chemical
evolution, selection would have favored the protective accumulation of longer-lived molecular
aggregates. Over time, the same selective imperatives would create webs of such aggregates,
increasing the range and specificity of molecular interactions in a very challenging
environment. If this were to have occurred in an enclosed proto-cellular space, it would have
resulted in a primitive molecular communication and the potential for a growing complexity
(another property of life!). In fact, properties of life must have arisen before life itself, as they
underlie the achievement of more and more complex intermolecular communication. Simply
put, a prebiotic (or for that matter a cellular) genetic change that alters the rate of one catalytic
reaction (if not destructive) will drive the selection of changes in components of other,
interconnected metabolic chemistries. Finally, if we agree that molecular communication
required the evolution of catalytic specificity, then we must agree that the elaboration of
complexity and order in fact, a property of life, required the selection of mechanisms of
regulation and coordination.
20.10.1

Intermolecular Communication: Establishment of Essential Interconnected
Chemistries

Earlier, we suggested that inorganic catalyst precursors to biological enzymes could be
minerals embedded in clay or other substrata, providing surfaces that would naturally
aggregate organic molecules and catalyze repetitive reactions. The initial objects of prebiotic
selection must have included stable monomers and polymers outside, or as seems more likely,
inside proto-cells. Later, chemical selection would have favored polymers that enhanced
growth and reproduction of successful aggregates. These polymers were likely those that
catalyzed their own synthesis, perhaps collaborating with inorganic catalytic minerals. The
result would be the elaboration of a web of interconnected chemical reactions between
molecules with high affinity for each other, thereby increasing the specificity of those
reactions. In the context of life origins and evolution, co-catalysis describes the activities of
these interconnected metabolic reactions.
As noted, high-affinity interactions are inherently protective. During prebiotic
chemical and/or metabolic evolution, protected stable molecular assemblies would be targets
of selection. Continuing co-evolution of catalysts, substrates, and co-catalytic reaction sets
would lead to more and more sophisticated molecular communication. Once established,
efficient biochemical reaction sets would be constrained against significant evolutionary
change. Any change (mutation) that threatened this efficiency would mean the end of a
prebiotic chemical (or for that matter, cell) lineage! This explains why we find common
pathways for energy-generation (e.g., autotrophic and fermentative), reproduction (i.e.,
replication), and information storage and retrieval (DNA, RNA, protein synthesis) in all of
LUCA’s descendants. In other words, an organizing principle must have been selected to
enable communication between molecules and their reactions. Such complex and effective
communication requires coordination. In fact, effective communication is defined by
coordination, the capacity to make chemical decisions. Selection of molecular aggregates that
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sequestered metabolic reactions behind a semipermeable membrane ensures that only certain
molecules communicate with each other within a protocell (or cell). This sequestration is likely
to have occurred repeatedly during chemical evolution, beginning with the synthesis of larger,
polymeric molecules and possibly, an aggregation of primitive lipoidal molecules. We can
think of increasingly effective catalysis in an enclosed, sheltered environment as a
conversation mediated by good speakers! Thus, coordination is a property that started with
prebiotic chemistry and likely co-evolved with life itself.
20.10.2

Origins of Coordination

Let’s look some possible structures churning around in the prebiotic chemistry set that might
have self-assembled and sequestered compatible chemistries of life. Along with the alkaline
vent biofilm compartment, proteinoid microspheres, coacervates, and liposomes have been
considered as possible progenitors of biological membranes. Each can be made in the
laboratory, shown to be semipermeable and in some cases can even replicate! Production of
coacervates, proteinoid microspheres, and liposomes is summarized in Figure 20.14.

Fig. 20.14: Proteinoid microspheres, coacervates and liposomes can all be made in a laboratory and
are candidates for boundary structures that could protect early prebiotic organic molecules and reactions.
See more micrographs of these synthetic compartments at 20.16Candidates for Early Compartments .

Oparin had proposed that the action of sunlight in the absence of oxygen could cause
ionized, oppositely charged organic molecules (e.g., amino acids, in a primordial soup to form
“colloids,” or “droplets” which were immiscible with water. These coacervates were actually
produced in 1932, visualized by microscopy and shown to be a semi-permeable compartment.
They even behaved as if they were able to grow and reproduce (also as Oparin originally

532

suggested they might). Sidney Fox produced proteinoid microspheres from short peptides In
the 1950s; they formed spontaneously from aqueous amino acid solutions heated to dryness,
not unlike what happens in the tidal pool scenario of polymer formation from organic
monomers. These can be seen by light and electron microscopy.

Liposomes are also easily made in a laboratory, but it isn’t clear that they could have
formed spontaneously on a pre-biotic earth. Nevertheless, cell membranes must have had
acquired their phospholipid bilayer structure by the time of LUCA since we all have them!
Prior to LUCA (perhaps in or soon after formation of our progenote), chemical rearrangements
must have occurred to enable incorporation of a phospholipid bilayer into whatever
semipermeable boundary life started with.
We have already considered the biofilm proposed for cellular origins in an alkaline
vent, and that the formation of such biofilms in alkaline vents would have separated acidic
ocean protons from the interior of such protocells, creating a proton gradient. Such a gradient
could have driven the early evolution of chemiososis as a means of capturing chemical energy,
complete with the eventual selection of ATP synthases and the enzymes of proton transport,
again because all cells descendent from LUCA posess these biochemistries.
Of course, proteinoid microspheres, coacervates, biofilm-based membranes, and
liposomes are not alive, and are therefore not cells. But one or another of them must have been
where the enhanced coordination of molecular communication required for life began their
elaboration.

354-2 Protected Molecular Communication-Semipermeable Membranes
CHALLENGE: Briefly outline an experiment to demonstrate that proteinoid
microspheres, coacervates or biofilm compartments are surrounded by a
semipermeable boundary.
An important take-home message here is that whatever the original structure of the
first cells was, they arose soon after the organic chemical prerequisites of life began to acquire
familiar metabolic functions. We need to see chemical and structural progress to cellularity as
concurrent metabolic evolutionary events. At some point, selection of sequestered
biochemistries led to protocells, then to the first cell or cells, each with all the properties of life.
Finally, selection of highly specific pathways of communication between cellular molecules
allowed cells themselves to talk to one another, engage in group activities, and eventually join
to form multicellular organisms.
Multicellularity is of course a characteristic of many if not most eukaryotes. But watch
an excellent TED Talk on bacterial intercellular communication by Dr. Bonnie Bassler at
20.17
Intercellular Communication in Bacteria.

533

20.10.3

An RNA World: Origins of Information Storage and Retrieval

Let us accept for now that molecular communication began concurrently with the packaging of
interconnected co-catalytic sets into semipermeable structures. Then the most ‘fit’ of these
structures were selected for their efficient coordination of meaningful, timely chemical
messages. Ultimately, coordination requires information processing, storage and retrieval,
something we recognize in Francis Crick’s Central Dogma of information flow from DNA to
RNA to protein. Cells and organisms do coordination quite well, but what do its beginnings
look like? The answer may lie in the pre-biotic RNA world. Figure 20.15 below is a statement
of The Central Dogma, modified to account for the role of reverse transcription in the behavior
of retroviruses and retrotransposons, both sources of lateral gene transfer (the exchange of
genes between cells and organisms.

Fig. 20.15: Genetic information flows from DNA to RNA to protein (the Central Dogma) but can also flow
from RNA to DNA by reverse transcription.

We do not really know how cells came to rely on DNA to store, pass on and mobilize
genetic information, but we have presented reasons to believe that the first replicating nucleic
acid was RNA, creating an RNA world. Here is the evidence that leads us to this conclusion.
• Based on the stem-and-loop and other structures that form when RNA molecules undergo
internal H-bonding, we know that RNAs can take on varied and intricate shapes.
• Diverse conformations are consistent with the evolution of specificity in the interaction of
RNAs with themselves and/or with other molecules in the prebiotic environment.
• RNAs, either alone as autocatalysts (for example, self-splicing mRNAs) or in catalytic
ribonucleoprotein complexes (e.g., ribosomes, snRNPs) that exist in cells today.
• Some of these RNAs (specifically rRNAs), have a long phylogenetic heritage, shared by
cells in all three domains of life.

534

The propensity of single stranded RNA molecules to fold based on internal H-bonding
can lead to those diverse 3D shapes (tertiary structure). These structures could have interacted
with other molecules in a prebiotic environment. Because they could be replicated according to
different prebiotic scenarios, the same RNAs could also pass on simple genetic information
contained in their base sequences. The combination of informational and catalytic properties
in a single molecule is illustrated in Figure 20.16 below.

Fig. 20.16: RNA sequences contain genetic information. In retroviruses, they are molecules of inheritance.
But single stranded RNAs made in cells can fold into 3-dimensions, creating specific shapes that can act as
catalysts (e.g., ribozymes) combining information storage with catalytic activities.

The capacity of RNAs to be catalysts and warehouses of genetic information at the
same time speaks to an efficient candidate for the first dual or multi-purpose polymer, a
property that is not known and cannot be demonstrated for DNA. To read more about the
proposed ‘RNA worlds’ in which life may have begun, see Cech T. R. (2012) [The RNA Worlds
in Context. In Cold Spring Harbor Perspectives in Biology (Cold Spring Harbor, NY: Cold
Spring Harbor press) 4(7):a006742e].

355 Self-Replication: Information, Communication & Coordination
20.10.4

From Self-Replicating RNAs to Ribozymes to Enzymes; From RNA to DNA

What might RNA catalysis beyond self-replication have looked like in simpler times? One can
envision a pair of different RNA molecules, each uniquely folded, with affinities for two
different aminos acids (Fig. 20.17, below). After they bind to 'their' amino acids, the RNAs are
attracted to each other, presumably by refolding to permit complementary H-bonding between
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the RNAs (not shown). The resulting ribozyme catalyzes formation of a peptide linkage
between the amino acids (i.e., a dehydration synthesis), after which the dipeptide and the two
RNAs would separate.

Fig. 20.17: Hypothetical origin of RNA catalysis, suggesting how some early (prebiotic) RNAs may have
evolved to catalyze peptide bond formation between amino acids.

As we know, the formation of a peptide bond requires an input of free energy (recall
that this one of the most energy intensive reactions in cells). For now, assume a chemical
energy source and let us focus on the specificities required for RNA catalytic activity.
We know now that tRNAs are the intermediaries between nucleic acids and
polypeptide synthesis. So, it’s fair to ask how the kind of activity illustrated above could have
led to the tRNA-amino acid interactions we see today. There is no obvious spontaneous
binding chemistry between today’s amino acids and RNAs, but there may be a less obvious
legacy of the proposed bindings. This has to do with the fact that the genetic code is universal,
which means that any structural relationship between RNA and amino acids must have been
selected early (at the start!) of cellular life on Earth. Here is the argument.
1. The code is indeed universal (or nearly so)
2. There is a correlation between the chemical properties of amino acids and their codons, for
example:
• Triplet codons for charged (polar) amino acids contain more G (guanine) bases
• Triplet codons for uncharged amino acids more often contain a middle U (uracil) than
any other base.

536

These correlations would mean that an early binding of amino acids to specifically folded
RNAs was replaced in evolution by enzyme-catalyzed covalent attachment of an amino acid to
a ‘correct’ tRNA, such as we see today.
What forces might have selected separation of the combined template and
informational functions from most of the catalytic activities of RNAs? Perhaps it was the
selection of the greater diversity of structure (i.e., shape) that folded polypeptides can achieve,
compared to folded RNAs. After all, polypeptides are strings of 20 different amino acids
compared to the four bases that make up nucleic acids. This potential for molecular diversity
would in turn accelerate the pace of chemical (and ultimately cellular) evolution. A scenario
for the transition from earlier self-replicating RNA events to the translation of proteins from
mRNAs is suggested in Figure 20.18.

Fig. 20.18: Suggested steps in evolution from an RNA world to our DNA world. The first of the steps would be
to divorce the self-replication activity of RNAs from their information storage function, as illustrated here.

Adaptor RNAs in the illustration will become tRNAs. The novel, relatively unfolded
RNA is a presumptive mRNA (even though mRNAs can sometimes engage in intrastrand Hbonding). Thus, even before the intrusion of DNA into our RNA world, we can imagine
selection of the defining features of the genetic code and mechanism of translation (protein
synthesis) that characterizes all life on Earth. Next, we’ll consider “best-speculations” for how
RNA-based information storage and catalytic chemistries might have made the evolutionary
transition to DNA-based information storage and largely protein-based enzyme catalysis.
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CHALLENGE: An early association of specific amino acids with folded
RNAs, along with correlations between bases in codons and specific
amino acids suggests how the present-day tRNA/amino acid relationships
may have evolved. Does this argument mitigate for or against the origins
of multiple “first cells” on earth?
20.10.4.a

Ribozymes Branch Out: Replication, Transcription and Translation

The term co-catalysis describes biochemical reactions in which a catalyst accelerates a
chemical reaction whose product feeds back in some way on its own synthesis. We saw this in
action when we discussed allosteric enzyme regulation and the control of biochemical
pathways. Catalytic feedback loops must have been significant events in the evolution of the
intermolecular communication and the metabolic coordination required for life. Here we look at
some scenarios for the transition from an RNA world to something more recognizable as
today’s nucleic acid information storage and protein-based catalytic metabolism.
If early RNAs catalyzed their own replication, they were functioning as primitive
ribozymes. If some of these ribozymes bound and polymerized amino acids, they may have
catalyzed the synthesis of short peptides. What if some of the polypeptides occasionally bound
to their shapely catalytic RNAs and enhanced the catalytic properties of the aggregate? What
if one of these aggregates enhanced the rate of synthesis of its own RNA, or evolved to catalyze
other reactions useful to life? Such a structure might presage the ribosome, which is a
ribonucleoprotein with catalytic properties. If later in evolution, a peptide changed just enough
to accomplish the catalysis on its own, it might dissociate from its RNA, flying solo as a protein
enzyme catalyst, as suggested in Figure 20.19.

Fig. 20.19: If RNAs could bind peptides whose synthesis they catalyze, evolution could have selected
ribozymes from some RNA-peptide complexes that did not separate. Later, the peptides themselves
could have evolved to take over catalytic functions from ribozymes.

Selection favoring the synthesis of short oligopeptides and polypeptides is consistent
with a catalytic diversification that led to the dominance of protein catalysts, i.e., enzymes. The
primitive enzyme shown here must have been selected because at first, it assisted the
autocatalytic replication of the RNA itself! Over time, the enzyme would evolve along with the
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RNA. This co-evolution then eventually replaced autocatalytic RNA replication with the
enzyme-catalyzed RNA synthesis we recognize as transcription today. In this scenario, selfsplicing pre-mRNAs and ribozymes are surviving remnants of an RNA world!

356 Information Storage and Retrieval in an RNA World
Let’s turn now to some speculations about how an RNA world could make the transition to the
DNA-RNA-protein world we have today.
20.10.4.b

Transfer of Information Storage from RNA to DNA

The transfer of function from RNA to DNA is by no means a settled issue among students of
life origins and early evolution. A best guess is that the elaboration of protein enzymes begun
in the RNA world would lead to reverse transcriptase-like enzymes that copied RNA
information into DNA molecules. The basic transfer scenario is illustrated below in Fig 20.20.

Fig. 20.20: A final evolutionary scenario gets us from the RNA world to a DNA world that governs most
life on earth today.

DNA information may have been selected because DNA is chemically more stable than RNA.
All cells alive today store information in DNA (only some viruses have an RNA genome).
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Therefore, transition to the use of DNA as an information molecule would have preceded the
origin of life. At least, it must have occurred in the cells from which the LUCA arose. Details of
this key change involve evolutionary steps yet to be worked out to everyone’s satisfaction!

357 The Transition from an RNA World to a DNA World

20.11 The Evolution of Biochemical Pathways
The tale of the evolution of enzymes from ribozymes and of informational DNA from RNA, and
the other metabolic chemistries behind prebiotic semipermeable boundaries is ongoing in cells
today. Undoubtedly, early cellular metabolism involved only reactions crucial to life…,
catalyzed by a limited number of enzymes. But, if evolution inexorably trends towards greater
complexity of molecular communication and coordination—in other words, towards
increasingly refined regulation of metabolism—how did the repertoire of enzymes get larger
and how did biochemical pathways become more elaborate? We answered the first question
elsewhere, when we discussed gene duplication (e.g., by unequal crossing over). Duplicated
genes encoding the same enzyme could provide the raw material for new enzymes and new
enzymatic functions.
Whether in cells or in prebiotic structures, we can hypothesize how a new chemical
reaction could evolve. For example, assume that a cell usually gets molecule D required for an
essential function, from an external, environmental source. What would happen if levels of D
in the environment become limiting? Clearly, cells would die without enough D. That is,
unless some cells in the population already have a duplicated, redundant gene that has
mutated and now encodes an enzyme with the ability to make D in the cell. Such a cell might
have coexisted with cells without the mutation, but a D-limited environment would select the
mutant cell for survival and reproduction. Imagine the scenario illustrated in Fig 20.21.

Fig. 20.21: One selective pressure that contributes to the complexity of biochemical pathways would
be the depletion of a particular chemical resource, say molecule D, in the environment). The few cells
in the population that happen to have an enzyme that can convert C to D will survive and proliferate.
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Challenge: Using the illustration in Fig. 20.21 as a guide, draw the steps
leading to the evolution of a biochemical pathway converting A to B and
B to C. Explain what you assume in each step of your drawing.

358 Origins and Evolution of Biochemical Pathways

In a similar scenario, a mutation in a duplicated gene could result in a novel enzyme
activity that can convert some molecule (e.g., C or D) in the cell into a new molecular product.
If the new enzyme and molecular product do not kill or debilitate the cell, the cell might
survive to be selected by some future exigency.
Challenge: How did cells originating in thermal vents or warm tidal pools
escape and survive in the oceans, especially as the planet cooled down?
Based on a phylogenetic identification of a likely ‘ancient’ bacterial
adenylate kinase (adk) enzyme, Dorothee Kern may have the answer.
Click 20.18Enzyme Evolution on a Cooling Planet to read a summary of her
research. Then suggest a hypothetical structure to explain the actual
structure of the “transitional” adk that she synthesized!

20.12

A Grand Summary and Some Conclusions

Our consideration of how life began on Earth was intentionally placed at the end of this
textbook, waiting for us to get a handle on how cells work. Clearly any understanding of life
origins scenarios is very much a matter of informed if divergent speculations. Alternative
notions for the origins of life entertained here all address events that presaged life under ‘bestguess’ hypothetical conditions. After trying to get a grip on prebiotic events, we asked how we
got from what could have happened under a given set of prebiotic conditions to the cellular life
we recognize today.
All proposals recognize that the first cells had all the properties of life (including
evolution itself). Starting with that common understanding, all arguable scenarios try to
navigate pathways from primitive, less controlled chemistries to more regulated and
coordinated metabolisms, in other words from chemical simplicity to biochemical complexity.
The chemical and metabolic evolution that began before life may have overlapped in time with
cellular evolution, at least until the arrival of the LUCA.
While chemical evolution was mainly a series of selections by the physicality of a
prebiotic world, the arrival of our LUCA, of life, contends with both that physical world, and
with life itself. LUCA, the universal common ancestor, had already escaped the RNA world,
replicating DNA, transcribing RNA, and translating mRNAs into polypeptides, all behind a
semipermeable phospholipid bilayer.
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Whether a heterotroph or (increasingly more likely) an autotroph, LUCA used the
energy of ATP to power all of its cellular work, as do its descendants. Thus, evolution after the
LUCA, is focused on continued selection of the complexities of metabolism that enables the
spread and diversification of life from wherever it started. The selection of chemistries and
characters encoded among by already, accumulated random neutral genetic changes is
ongoing, and continues to increase the diversity of species and their spread to every
conceivable ecological niche on the planet. The take-home message of this chapter should thus
be that:
• Prebiotic chemicals interacted with each in a free energy rich environment.
• Protected chemistries that resisted environmental degradation were subject to a prebiotic
selection (chemical evolution).
• Chemical evolution led to a diversified chemistry set with which to experiment with
combinations that could produce an entity with all the properties of life…, the first cell.
• Life has been evolving ever since!
• An understanding of the molecular basis of evolution can help us understand how life may
have begun, spread, diversified, and been sustained on Earth (or elsewhere!).
Here are two final Challenge Questions to ponder:

Challenge: The platypus is one of a few monotreme mammals that preceded

all other mammals alive today. They are found only in Australia and
Tasmania. The fact that they have 10 sex chromosomes, a duck-like bill,
and lay eggs are not their only peculiarities. Define the term “missing link”,
check out the link at 20.19The Peculiar Platypus and explain why you would
or would not consider the platypus a missing link?

Challenge: Stephen Hawking, the famous astrophysicist, worried that as
artificial intelligence (AI) matures (in computers or more ‘hands–on’
devices), it/they will evolve. Here’s a link to part of a 2016 interview:
20.20
Hawking on the Evolution of AI). What do you think Hawking meant by
this? Or, what do you think it might mean if, as I have intimated by this
discussion, evolution is the prime directive of living things? Hawking also
argued against trying to contact extraterrestrial intelligence; check it out at
20.21
Hawking Cautions Don't talk to Extraterrestrials.
Some iText & VOP Key Words and Terms
AATE
abiogenesis
adaptor RNA
alkaline hydrothermal vent
aminoadenosine triacid ester
Archean eon
autocatalysis
autotrophs-first
biofilm
biogenesis
black smoker
chemoautotrophs
coacervate

Hadean eon
heat of baking
heterotrophs-first
ionizing radiation
Last universal common
ancestor
liposome
LUCA
metabolic evolution
molecular communication
non-reducing atmosphere
ozone layer
Panspermia
photoautotrophs
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proteinoid microsphere
protocell
reducing atmosphere
retroviruses
ribonucleoproteins
ribozymes
progenote
RNA world
serpentinite
serpentinization
spontaneous generation
tidal pool scenario
white smoker

co-catalysis
deep sea hydrothermal vent

platypus
primordial soup

zircon
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Epilogue

Reminder: If links have become inactive, google key words/terms for alternative sources.
We began this textbook with a testimony to the marvels of what science can accomplish. In
Chapter 1 we defined the scientific enterprise as both intuitive and disciplined and learned
that the goal of learning science and its methods is to prepare us to ask creative questions and
to answer them. In Chapter 1 we learned that prebiotic chemical evolution set the stage for
life’s origins and that evolution is a key property of life itself, leading inexorably to the
incredible diversity of life on which Darwin predicated his theory of natural selection. In
Chapter 1 we also noted the natural role of extinction in favoring diversity… and how recent
human activity accelerated the near extinction of the American bison and the final extinction
of the passenger pigeon. The role of evolution in creating diversity is emphasized throughout
the book. This is a moment to consider the threat of human activity to life on Earth that has
only increased since the last known passenger pigeon died in 1914. Here are some more
recent threats.
•

Smog Problems in big cities (notably Los Angeles) date back to the 1940s. After much
resistance to evidence that auto emissions were the cause, public acceptance came in the
1950s. Congress responded in 1963 by passing the first E1Clean Air Act and set some
emission standards 2 years later. In 1975 the U.S. mandated catalytic converters on all new
cars. California still has some of the worst air in the country. But ozone in Los
Angeles has been at 40% of its mid-1970s level, despite twice the number of cars.
Here is smog in L.A. in 2006:

By Diliff-Own work; CC-BY-SA 3.0,

E2

L.A. Smog in 2006

And now, read about days of smog and ozone in June, 2020 at
Pollution Battle in L.A.?
•

E3

Winning the Air

Plagues, epidemics and pandemics have been with us since ancient times. More recent
ones include an 1889 influenza (flu) pandemic, thought to have started in Russia, that
killed an estimated million people worldwide by 1890. World War I began 24 years later,
ending in 1918 with 20 million (mostly men) dead. Then the flu pandemic of 1918 wasted
no time killing an estimated 50,000,000+ men and women worldwide, proving once again,
that nature always gets the upper hand. The 2009 swine flu (H1N1pdm09) pandemic killed
an estimated 100,000-500,000+ people worldwide, coming after other recent gentle
reminders that nature can still plague us (e.g., SARS in 2002-03, the ‘bird flu in 2003-07).
As if to drive home this message, in 2020 we have COVID-19, a respiratory disease caused
by SARS-CoV-2 , a novel corona RNA virus (shown below).
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COVID-19 Viral Particle: Public Domain;
E4
SARS-CoV-2 (CDC/Alissa Eckert, MS;
Dan Higgins, MAMS) .
The red projections on the surface are
composed of ‘spike proteins’ that that enable
the virus infect cells

COVID-19 surfaced in China in late 2019, spreading rapidly. By March 11, 2020 with
>250,000 infections world-wide and >10,000 dead, the WHO (World Health Organization)
labeled COVID-19 a pandemic. With the SARS-CoV-2 genome quickly sequenced and
PCR-based and serological tests for the virus rapidly developed, several countries (e.g.,
China, Israel, Italy, South Korea…) seemed to have controlled the spread of COVID-19
with the help of quarantines and shutdowns of schools, businesses and large entertainment
and other events. Pfizer, Moderna and Johnson & Johnson became household names when
these companies rapidly developed the first vaccines against SARS-CoV-2. The Pfizer
vaccine first became available in the U.S. in December of 2020. The Johnson & Johnson’s
is a traditional vaccine, using a purified virus spike protein to stimulate the immune
response. The Pfizer and Moderna vaccines are cDNA-based vaccines. The cDNAs encode
the viral spike protein that, when injected, are taken up by cells that transcribe it, translate
its spike protein mRNA and secrete it to elicit an immune response. You may be surprised
to learn that Katalin Kariko’s pursuit of the idea for mRNA vaccines long-predate the
SARS-Cov-2 vaccine. Learn more at E5https://www.youtube.com/watch?v=b3hWEC553sU.
Our individual response to the pandemic has been to rally around our relatives, neighbors
and even strangers to help them through tough times. We bring them food and medical
supplies and keep up their spirits if they are in quarantine or physically isolated by their
illness. But, despite the promise of testing and highly effective mRNA vaccines, the
pandemic is still with us, assisted by the rapid spread a Greek alphabet-full of variants,
against which the first generation of vaccines is less effective. The lethal Delta variant
accounted for 99% of COVID-19 infections between August and December, 2021. Less
deadly but highly infectious Omicron BA subvariants were next. As of this writing,
Omicron BA.5 accounted for 43% of infections worldwide and 54% of infections in the U.S.
BA variants seem to account for more re-infections and infections of already vaccinated
people and may also result in cases of “long COVID” a compendium of more or less varied
post-infection symptoms. Check out the link at E6https://www.cdc.gov/coronavirus/2019ncov/long-term-effects/index.html for more details. Also as of this writing (July, 2022), the
world-wide COVID-19 infection (case) count is >560,000,000 with >6,000,000 deaths.
These figures include a massive spike in infections in early 2022, more than 3X the daily
infection rate than any time since the pandemic began. Contributing to these figures are
low vaccination rates (especially in developing nations), the spread of new variants, and
premature re-openings and “business-as-usual’ decisions virtually everywhere. Preventing
the spread of COVID is now a race between vaccine development and distribution, and the
emergence of new variants.
How soon will the pandemic end? While economies in developed countries recover from a
subsiding pandemic, surging infections in parts of the developing world in Africa and
South America reflect inequities of vaccine availability. These inequities even threaten
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even developed nations with infectious variants. Nevertheless, vaccines targeting more
infectious COVID variants are being developed and in the developed world, the COVID-19
pandemic may already be on the way to becoming endemic and perhaps, like the flu,
preventable with annual vaccinations. In addition, new antiviral medications in the
pipeline (e.g., Paxlovid) even promise effective treatments for COVID-19. Unfortunately,
these hopes come only after the damage already done by collaboration between the virus
and us.
Still, after more than two years, we suffer a plague of ignorance and ill-advised behavior
within the pandemic! There are about 35% of eligible Americans that are unvaccinated,
many of whom distrust the science that produced the vaccines and believe the
misinformation that spread virally on social media…, all of which led to the rise of the
variants and surges of infection. The question is, do we now know how to cope with the
next pandemic? This will depend on how we have learned from COVID-19, how we use
available science, how our leaders respond, and how we all respond!
•

Polar ozone holes were first discovered over the Antarctic in 1984; a smaller one now
hovers over the Arctic.
The largest Ozone hole, over the Antarctic,
slowly began to close after CFCs were banned
in 1987. The blue and purple colors define this
10.6 million square mile zone of ozone
depletion. Public Domain; E7Ozone Over the
Antarctic

We worried as we watched the Antarctic ozone hole grow. Then we discovered that
chlorofluorocarbons (CFCs) were the cause. CFCs are a propellant that used to be in spray
cans filled with things like hair spray and paint. They are also a refrigerant that was part of
every household refrigerator. Since the international 1987 Montreal Protocol banned
CFCs, more countries agreed to the ban. While the expanse of the Antarctic ozone hole has
slowly receded, it still reopens every year. The Arctic ozone hole opens periodically and
varies in size. The one that opened in the winter of 2019-2020 was three times the size of
Greenland, one of the largest (see the report in the figure above). Concern over upper
atmospheric ozone depletion continues, and now, new information links it to climate
change (for more information, see E8Ozone Holes and Climate Change).
•

Plastics are produced from petrochemicals (i.e., oil), often by oil companies themselves.
Most everyday disposable plastics are not biodegradable.

E9

Public Domain: From Ocean
Microplastics… not good
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Water bottles and milk jugs are typically recyclable. However, most other consumable
plastics (straws, cups, plates, packing materials, particles in cosmetics and toothpaste,
grocery bags, clamshells, tubs and other food wrappings…) are not, even when marked as
recyclable with the ‘chasing arrows’.

They just cost too much to sort, clean up and recycle. Some ends up in landfills; most is
shipped to the far east third world countries (e.g., Indonesia), intended for recycling. But
it’s too expensive to recycle even there. So, some is incinerated and much ends up dumped
into the Pacific Ocean. This plastic debris now floats in The Great Pacific Garbage Patch
(actually two patches), circulated by vortex current that distributes the plastic trash from
the United States to Japan. Either as whole pieces or as degraded microplastics, the trash
accumulates in the bodies of marine animals feeding around the patches. Toxic
polychlorinated biphenyls (PCBs) that leach from plastics made before 2001 (when PCBs
were effectively banned worldwide) also spread through the marine food chain. The
floating patches can also block light from penetrating the ocean water, killing off
photoautotrophic marine phytoplankton and algae, the photoautotrophic primary
producers reduce atmospheric CO2 and feed marine life. Microplastics and plastic debris
has been found at 29,000 feet, atop Mt. Everest, and has settled more than 6000 feet to the
bottom of the Pacific Ocean Marianna Trench. There, a new crustacean species was
discovered in 2020, already having ingested a polyethylene-derived bit of plastic garbage.
The new species was named Eurythenes plasticus!

CC-BY-SA; By Johanna Weston, Alan
Jameson - Newcastle University, WWF
E10
Germany, Attribution,
The crustacean
Eurythenes plasticus.
E11

For more, check out the video at
Plastics,
microplastics and Eurythenes plasticus video.

•

Climate change and global warming: Are these an endpoint of human evolution? Recall
our last chapter where we revisited in detail physical and chemical conditions that could
support life chemistries and the origins of life itself, noting that evolution began the
pathway to the generation of new species and the spectacular diversity on display to
everyone in magazines like National Geographic, Smithsonian and the like.
By the 1960s, a few scientists saw a role of human activity in global warming. Now, 97% of
scientists form the consensus that we caused a dramatic acceleration in climate change,
raising global temperatures by 10 C. We are seeing stronger storms, more severe coastal
flooding and inland droughts that most scientists view as the result. And, despite
agreement on the human impact on climate change, international agreement has done
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little to slow increases in the greenhouse gas (90% CO2 and CH4) emissions that aggravate
global warming. Tropical deforestation and the consumption of vehicle, residential and
industrial fossil fuels continue with little restraint (check out the link at E12EPA Overview of
Greenhouse Gases for some more details.
So, have we reached a temperature “tipping point” past which climate change is
irreversible, ecological losses will drive extinctions and dramatically change the course of
evolution, and above which, faith in solutions from science becomes a rush to cope? Is the
recent spate of forest fires in California caused by climate change? Does an estimate of
loss of a billion animals (not counting small critters like insects and worms…) in the
southern Australia bush fires mean that we have reached or even surpassed that tipping
point?

Firefighters move in to protect properties
from an out-of-control bushfire in SW
Sydney, Australia.
CC-BY-SA (From Helitak430, Dec. 2019,
E13
2019 Australian Bush Fire)
…and Google for images of the 2022
deadly flooding in and around Sydney and
elsewhere in Australia.

And should we be concerned about the extensive and deadly flooding in Sydney
(E14https://www.youtube.com/watch?v=xqldJfqMyWM) and elsewhere in Australia?
With a measure of pessimism, young people are asking these questions and making
demands of their elders. Click E15Speaking Truth At the UN to see Greta Thunberg’s
address to the United Nations 2019 Climate Action Summit. With a measure of optimism, I
hope that the children will find the answers. As of this writing (2022) and a more recent
climate action summit, there is more acceptance that climate change is upon us, and more
international promises, but the criticism is that it’s getting close enough to “too-late”, and
that the promises and good intentions may not go far enough to reverse climate change
and its effects.
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Appendix I: List of Figures & Sources
Click or copy and paste the links below into your browser for access; some may no longer be
active.

Chapter 1
Chapter Top-Art: Public Domain: left, R. Hooke, (1865) Micrographia’; middle 19th century travelogue;
right, Debbie Stinson photograph from https://notesfromstillsong.blogspot.com/2012/02/eremiticallife.html ; and https://www.pinterest.com/pin/138485757266449322/
Fig. 1.1: Evolution of three domains showing a closer relationship between archaebacteria and
Eukaryotes. Illustration by G. Bergtrom
Fig. 1.2: Tobacco mosaic virus symptoms on a tobacco leaf.
USDA Forest Service, http://www.forestryimages.org/browse/detail.cfm?imgnum=1402027 and
https://en.wikipedia.org/wiki/Tobacco_mosaic_virus#/media/File:Tobacco_mosaic_virus_symptoms_tobac
co.jpg
Fig. 1.3: Transmission electron micrographs of giant viruses, the AIDS (HIV) virus and the bacterium E.
coli. K. casanovai is at least the same size and M. horridgei is twice the size of the bacterium. All the giant
viruses, even the mimivirus, dwarf HIV, a typical eukaryotic virus. CC-BY, from Barthelmy, R.M., Faure,
E. and Goto, https://www.hilarispublisher.com/open-access/serendipitous-discovery-in-a-marineinvertebrate-phylum-chaetognatha-of-the-longest-giant-viruses-reported-to-date.pdf
Fig. 1.4: Transmission and scanning electron micrographs of the gram-negative E. coli bacterium (left
and middle), with its basic structure illustrated at the right.
• Left: from Peter Highton - Estate of Peter Highton a molecular biologist working at University of
Edinburgh 1968-1990& Middle, CC-0 (Public Domain), https://en.wikipedia.org/wiki/Escherichia_coli
• Middle: CC 0, From photo by Eric Erbe, digital colorization by Christopher Pooley at USDA, EMU,
ARS, https://commons.wikimedia.org/w/index.php?curid=958857
• Right: From Jeff Dahl - Own work, GFDL, https://commons.wikimedia.org/w/index.php?curid=3647374
Fig. 1.5: Localization of FtsZ proteins in Z rings in cross-sections in the middle of dividing E. coli cells
The immunofluorescence micrograph (left) is drawn at the right.
• CC SA. Fluorescence micrograph adapted from https://commons.wikimedia.org/wiki/File:Zrings.png
• Public domain, Illustrated cross section of a dividing bacterium showing location of FtsZ cortical ring
protein https://commons.wikimedia.org/wiki/File:FtsZ_Filaments.svg
• Illustration by G. Bergtrom
Fig. 1.6: Electron micrographs of Carboxysomes in a cyanobacterium (left), carboxysomes after isolation.
From https://en.wikipedia.org/wiki/Carboxysome#/media/File:Carboxysomes_EM; Tsai Y, Sawaya MR,
Cannon GC, et al (June 2007). Structural analysis of CsoS1A and the protein shell of the Halothiobacillus
neapolitanus carboxysome. PLoS Biol. 5 (6): e144
Fig. 1.7: Scanning electron micrograph of Halobacterium salinarium, a salt-loving bacterium. CC-BY;
Adapted from: https://openi.nlm.nih.gov/imgs/512/185/3495301/PMC3495301_gbi0010-0424-f2.png
Fig. 1.8: Scanning electron micrograph of ‘heat-loving’ Thermus aquaticus bacteria. CC-0 (public
domain) Adapted From: https://upload.wikimedia.org/wikipedia/commons/4/48/Thermus aquaticus.JPG
Fig. 1.9: Illustration of the structural components of a typical animal cell. Source: Public Domain; From
Mariana Ruiz, Image: Animal cell structure.svg
https://commons.wikimedia.org/w/index.php?curid=4266142
Fig. 1.10: Illustration of the structural components of a typical plant cell. Source: Public Domain; From
Mariana Ruiz, Image: Animal cell structure.svg,
https://commons.wikimedia.org/w/index.php?curid=4266142
Fig. 1.11: Fig. 1.11: LEFT: Transmission electron micrograph of an insect cell nucleus showing the
nuclear envelope (ne) and nucleolus (n); RIGHT: Drawing of a nucleus with chromatin (purple) and
nuclear pores. Left; From Bergtrom et al., (1977) J. Ultrastr. Res. 60:395-406: Research by G. Bergtrom;
Right; CC BY 3.0; Blausen.com staff (2014). "Medical gallery of Blausen Medical 2014". WikiJ. Medicine
1(12); Own work, https://commons.wikimedia.org/w/index.php?curid=28223971
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Fig. 1.12: Simulated fluorescence micrograph showing the immunolocalization of antibodies against
fibrillarin, coilin and ASF/SF2 protein to nuclear bodies (nucleolus, Cajal Bodies and nuclear speckles,
respectively). Illustration by G. Bergtrom, adapted from a fluorescence micrograph in
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138913/12
Fig. 1.13: Drawing (LEFT) and fluorescence micrograph (RIGHT) of a cell in metaphase of mitosis:
aligned chromosomes (chromatids) at the center of the cell (blue in the micrograph) are just about to be
pulled apart by microtubules of the spindle apparatus (green) extending from the poles to the center of
the cell. LEFT, Adapted from Kelvinsong; https://en.wikipedia.org/wiki/Metaphase; CCBY 3.0, unported
license; RIGHT, Public Domain, from Afunguy-Transferred to Commons by Lije also using
CommonsHelper; https://commons.wikimedia.org/w/index.php?curid=5148470
Fig. 1.14: To form a polysome, ribosomes (blue) assemble at the left on an mRNA molecule. As they
move along the mRNA from left to right, they translate the message into a polypeptide (green), shown
growing and emerging from ribosomes in the polysome. Illustration by G. Bergtrom.
Fig. 1.15: Transmission electron micrographs of cells from desiccated and fully hydrated Selaginella
lepidophylla plants. Free ribosomes or ribosomal subunits in the desiccated cells (LEFT) appear to have
organized to form polysomes in the hydrated plant cells (RIGHT). From Bergtrom et al. (1982) J. Ultrastr.
Res 78:269-282. Research by G. Bergtrom
Fig. 1.16: An illustration of the differences between prokaryotic and eukaryotic ribosomes; Eukaryotic
ribosomes and their subunits are larger and contain more proteins and larger ribosomal RNAs (rRNAs)
than those of e.g., bacteria. The components were separated by sucrose density gradient centrifugation
in which particles and macromolecules (like RNA) move through a sugar gradient at rates dependent on
their mass (in effect, their size). Illustration by G. Bergtrom
Fig. 1.17: Transmission electron micrograph of a Golgi apparatus, or Golgi body. Adapted from
OpenStax; CC BY 4.0; https://cnx.org/contents/FPtK1zmh@8.25:fEI3C8Ot@10/Preface;
wikimedia.org/w/Golgi/index.php?curid=30131198
Fig. 1.18: Illustration of ‘packaged’ protein traffic through a cell, from the RER to organelles (e.g.,
lysosomes) or to the plasma membrane for exocytosis (i.e., secretion). RER and Golgi vesicles are major
sites for the modification (i.e., maturation) of packaged proteins. Illustration by G. Bergtrom
Fig. 1.19: Transmission electron micrograph of mitochondria (LEFT) and drawing of a mitochondrion
(RIGHT).
• Electron micrograph from: Bergtrom et al. (1977) J. Ultrastr. Res. 60:395-405. Research by G. Bergtrom
• Public Domain; By Mariana Ruiz Villarreal LadyofHats,
https://commons.wikimedia.org/w/index.php?curid=6195050
Fig. 1.20: Transmission electron micrograph of chloroplast that could have begun photosynthesizing
(LEFT), and one that has photosynthesized long enough to accumulated starch granules (RIGHT). S,
starch granule; T, thylakoids.
• Left: GNU Free Documentation License; By and3k & caper437-Own work by uploaders,
https://commons.wikimedia.org/w/index.php?curid=7153916
• Right: CC-BY; Transmission electron micrograph of chloroplast [T=thylakoids, S = starch] ; Adapted
from PLOS one: http://redoxbiologycenter.unl.edu/ee00b8d7-d7fc-43f8-bab9-5570b2dbd731.pdf
Fig. 1.21: Transmission electron micrograph of a leucoplast, a chloroplast that has become filled with
starch granules (S). From Bergtrom et al. J. Ultrastr. Res. 78:269-282. Research by G. Bergtrom
Fig. 1.22: Illustration of assembly, structure and polarity of microtubules, microfilaments and
intermediate filaments alongside fluorescence micrographs made using fluorescent antibodies against
isolated microtubule, microfilament and intermediate filament proteins (TOP, MIDDLE and BOTTOM,
respectively).
• CC-BY 2.0; Adapted from: http://bmcbiochem.biomedcentral.com/articles/10.1186/1471-2091-9-23
Open Access
• CC-BY-SA-2.5 and GNU.org; Adapted from
https://en.wikipedia.org/wiki/media/MEF_microfilaments.jpg, By Y Tambe (Y tambe's file) via
Wikimedia Commons
• CC-BY; Adapted from: www.plosone.org/article/info:doi/10.1371/journal.pone.0012115
• Illustrations by G. Bergtrom
Fig. 1.23: Transmission electron micrograph showing a flagellum (#1) emerging from a basal body (2).
Number 3 is another basal body, this time in cross section. Public Domain, By Dartmouth Electron
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Microscope Facility, Dartmouth College – http://remf.dartmouth.edu/imagesindex.html ,
https://commons.wikimedia.org/w/index.php?curid=2787228
Fig. 1.24: The characteristic “9+2” arrangement of microtubules seen in cross-sections of eukaryotic cilia
and flagella is maintained the axoneme, a structure remaining after removing the plasma membrane from
isolated cilia or flagella. Illustration by G. Bergtrom
Fig. 1.25: A cell fractionation involving disruption of cells and the isolation of sub-cellular components,
including organelles, ribosomes and a soluble fraction, the cytosol. Separation is achieved by successive
centrifugations at different speeds (centrifugal forces) that sediment subcellular structures on the basis of
mass; the lowest mass structures require the highest G-forces (fastest spin), requiring an ultracentrifuge.
Illustration by G. Bergtrom
Fig. 1.26: Organelles isolated by cell fractionation from eukaryotic cells.
• CC-BY-NC-ND-SA; Adapted from Hancock, 2009:
https://openi.nlm.nih.gov/detailedresult.php?img=PMC2762040_pone.0007560.g001&query=isolated
+nuclei&it=xg&req=4&npos=23
• CC-BY-NC-ND-SA Adapted from Siekevitz and Palade , 1956:
https://openi.nlm.nih.gov/detailedresult.php?img=PMC2854378_JCB_201002147R_GS_Fig1&query=is
olated+rough+endoplasmic+reticulum&it=xg&req=4&npos=5
• CC-BY-NC-ND-SA Adapted from Beznoussenko et al., 2015;
https://openi.nlm.nih.gov/detailedresult.php?img=PMC4394477_ijms-16-05299g005b&query=isolated+golgi+vesicles&it=xg&req=4&npos=1
• CC-BY-NC-ND-SA; Adapted from Soubannier et al., 2012
https://openi.nlm.nih.gov/imgs/512/66/3530470/PMC3530470_pone.0052830.g001.png?keywords=abse
nces
• CC-BY-SA: Adapted from S. Saleh, https://commons.wikimedia.org/wiki/File:Chloroplast.jpeg
• CC-BY-SA 4.0; Adapted from Boone et al. Isolation of Plasma Membrane from HeLa Cell,
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2107758/
• CC-BY 2.0: From https://media.springernature.com/lw785/springerstatic/image/art%3A10.1186%2F1471-2172-1041/MediaObjects/12865_2009_Article_261_Fig3_HTML.jpg

Chapter 2
Chapter Top-Art: Images and videos are released under the Pixabay License and may be used freely for
almost any purpose - even commercially. Attribution” mariolayaquerevalu MARIO OLAYA • Age 52 •
TRUJILLO/PERU • Member since Oct. 5, 2017
Fig. 2.1: The shell (Bohr) and orbital models of atoms respectively emphasize the energy of electrons and
space occupied by the electrons moving around the atomic nucleus. Illustration by G. Bergtrom
Fig. 2.2: The Periodic Table of the Elements, emphasizing those found in living things (blue, purple,
green or brown). Illustration by G. Bergtrom
Fig. 2.3: Excited electrons gain their energy by absorbing light. Absorbance of one photon causes an
electron to ‘jump’ to the next shell further from the atomic nucleus. Excited electrons have potential
energy that is released as the electron returns to ground state, releasing heat or light (fluorescence).
Illustration by G. Bergtrom
Fig. 2.4: Non-polar covalent bonds vs polar covalent bonds. Illustration by G. Bergtrom
Fig. 2.5: Electrons on the H atoms of water molecules are drawn close to the large, positively charged
nucleus of the O atom. Thus, the H atoms ‘lose’ electrons and acquire a partial positive charge, while the
oxygen atoms ‘gain’ those electrons and have a partial negative charge. The resulting polar covalent
water molecules attract other water molecules. Illustration by G. Bergtrom
Fig. 2.6: Computer-generated space-filling (LEFT) and ‘ribbon’ models (RIGHT) of insulin structure.
Source: CC-BY 2.5 http://commons.wikimedia.org/wiki/File:InsulinMonomer.jpg
Fig. 2.7: Ionic bonds in table salt (NaCl) crystals; Opposite charges on Na + and Cl- hold the ions together
in a regular crystalline array. Illustration by G. Bergtrom
Fig. 2.8: Table salt (NaCl) dissolving in water. Water’s solvent properties result from its polar covalent
structure, allowing interactions with Na+ and Cl- in the crystal. Illustration by G. Bergtrom
Fig. 2.9: Charged groups on the macromolecule (e.g., protein) attract the partial charges on water
molecules, hydrating the molecule. Illustration by G. Bergtrom
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Fig. 2.10: Structural and geometric isomers of hydrocarbons create molecules with the same chemical
formula but different shapes. Illustration by G. Bergtrom
Fig. 2.11: The two different generic molecules (enantiomers) are mirror images of one another. They
form from alternate arrangements of the same molecular groups around a chiral carbon. Illustration by
G. Bergtrom
Fig. 2.12: Two straight chain forms of glucose (d-glucose and l-glucose) are enantiomers (optical
isomers), differing in the arrangement of the H atom and the OH group around C5. Illustration by G.
Bergtrom
Fig. 2.13: A generic monomer is linked to a growing polymer by water removal (dehydration synthesis);
Water addition across the linkage between monomers (hydrolysis) breaks the polymer back down to
monomers. Illustration by G. Bergtrom
Fig. 2.14: Dehydration synthesis forms peptide linkage (circled); hydrolysis is the reverse reaction.
Illustration by G. Bergtrom
Fig. 2.15: When straight chain glucose forms a cyclic molecule in solution in water, C1 becomes
optically active (chiral), creating a racemic mixture of (d)glucose and (d)glucose enantiomers.
Illustration by G. Bergtrom
Fig. 2.16: Polysaccharide sugar polymers form by dehydration synthesis: (d)glucose monomers
polymerize to form energy-storage molecules (e.g., starch, glycogen), while -d-glucose monomers
polymerize to form structural polysaccharides (starch, cellulose. Illustration by G. Bergtrom
Fig. 2.17: Two enantiomers (optical isomers) of Thalidomide (R and S) form in water. Public Domain; By
Vaccinationist - (R)-(+)-Thalidomide & (S)-(−)-Thalidomide on PubChem,
https://commons.wikimedia.org/w/index.php?curid=50750574

Chapter 3
Chapter Top-Art: Attribution: Released into the public domain by Attribution: Released into the Public
Domain by Ysangkok: https://en.wikipedia.org/wiki/File:US_Beef_cuts.svg
Fig. 3.1: The four orders (levels) of protein structure. Primary, secondary and tertiary structures describe
polypeptides
Fig. 3.2: Chemical characteristics of the 20 amino acids found in the proteins of cells. Illustrated by G.
Bergtrom
Fig. 3.3: Partial polypeptide; the amino and carboxyl ends of a polypeptide define the polarity of the
molecule, with positively charged amino and negatively charged carboxyl ends at physiological pH.
Illustration by G. Bergtrom
Fig. 3.4: In the secondary structure of a polypeptide, more organized -helical and -pleated sheet
structures are separated by less organized, random coil stretches of amino acids.
• Public Domain; From: Fvasconcellos - Own work. Created by uploader upon request by Opabinia
regalis, https://commons.wikimedia.org/w/index.php?curid=1587088
• CC-0 (public domain); Adapted from: Jo, H et al. BMC Structural Biology (cc-by Open Access,
http://bmcstructbiol.biomedcentral.com/articles/10.1186/s12900-014-0024-y
Fig. 3.5: Tertiary structure is created by non-covalent hydrophobic amino acid interactions as well as Hbonding in the interior of a polypeptide, leaving charged (hydrophilic) amino acid side chains to interact
with water on the exterior of a typical “globular” protein. Stable covalent disulfide bonds between
cysteine amino acids help stabilize tertiary structures. Illustration by G. Bergtrom
Fig. 3.6: Disulfide bridges form in oxidation reactions between SH (sulfhydryl) groups on cysteine amino
acids (‘residues’) in a polypeptide. Illustration by G. Bergtrom
Fig. 3.7: Light micrograph of a sickled erythrocyte (red blood cell). CC BY 3.0; By OpenStax College Anatomy & Physiology, Connexons Web site; http://cnx.org/content/col11496/1.6/
Fig. 3.8: Mutations in a normal gene for a prion protein (PrPc) may produce some abnormally folded
prion proteins (PrPSc). The misfolded PrPSc molecules interact with other (even normal) prions to mis-fold,
precipitating PrPSc proteins into aggregated amyloid plaques. Adapted from: CC-BY-SA: M. R. Muntada
(217) Prions: Special Proteins;
https://allyouneedisbiology.wordpress.com/2017/11/12/prions-special-proteins/
Fig. 3.9: Steps in the formation of -amyloid plaques. Amyloid precursor proteins (APP) are embedded in
cell membranes (upper left). Enzymes digest APP, releasing -amyloid protein fragments (middle panel).
Unregulated accumulation of -amyloid protein results in the formation of extracellular amyloid plaques.
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• Public Domain; By ADEAR: "Alzheimer's Disease Education and Referral Center, a service of the
National Institute on Aging." - http://www.nia.nih.gov/Alzheimers/Resources/HighRes.htm,
https://commons.wikimedia.org/w/index.php?curid=4475153
• Public Domain ; By National institute on aging http://www.nia.nih.gov/Alzheimers/Publications/UnravelingTheMystery/Part1/Hallmarks.htm
https://commons.wikimedia.org/w/index.php?curid=3481613
• Public Domain,; By National institute on aging http://www.nia.nih.gov/Alzheimers/Publications/UnravelingTheMystery/Part1/Hallmarks.htm ,
https://commons.wikimedia.org/w/index.php?curid=3481649
Fig. 3.10: Non-fluorescent immunostaining of tau proteins of an Alzheimer’s brain reveals tau tangles.
CC-BY-SA 3.0; From Wikimedia Commons User Patho; Neurofibrillary tangles in the Hippocampus of an
old person with Alzheimer-related pathology, immunohistochemistry for tau protein.JPG
Fig. 3.11: The formation of tau tangles occurs in diseased neurons that cannot maintain normal
microtubule structure; in the absence of stabilizing tau molecules microtubules degenerate and tau
proteins clump. Public Domain; Adapted from:
https://commons.wikimedia.org/wiki/File:TANGLES_HIGH.jpg
Fig. 3.12: The vertebrate hemoglobin molecule, consisting of 4 globin subunits (two and two
polypeptides). Each globin is associated with a heme group bound to iron. GNU Free Documentation
License; Adapted from: https://en.wikipedia.org/wiki/Hemoglobin
Fig. 3.13: The Pleckstrin Homology (PH) domains shown here are an example of common domains
(maroon colored sequences) in two different proteins. Because they have a PH domain, both proteins can
interact with cell signaling factors with roles in intercellular communication. CC BY-SA 3.0; By Fdardel
- Own work, https://commons.wikimedia.org/w/index.php?curid=17659815
Fig. 3.14: Screenshot of NCBI portal to 3D protein structure database based on X-Ray crystallographs. At
https://www.ncbi.nlm.nih.gov/structure?db=Structure
Fig. 3.15: Screenshot of NCBI protein structure database search leading to available macromolecular
structures for human insulin.
Fig.3.16: Screenshot of the dynamic 3D X-Ray structure of a human insulin in the NCBI protein structure
database.

Chapter 4
Chapter Top-Art: Public Domain; https://pixabay.com/photos/space-universe-night-sky-sky-fog-11099/
(Wikiimages)
Fig. 4.1: The sum of all things contained in the universe (e.g., as mass and other, more familiar kinds of
energy). In this simple “Venn” diagram, the universe is a closed system; nothing (mass, energy) can get
into or exit the universe, consistent with the First Law of Thermodynamics. Illustration by G. Bergtrom
Fig. 4.2: Since even mass is a form of energy, the universe shown here consists of only two components,
entropy and free energy (defined as available to do work), still consistent with the First law of
Thermodynamics. Illustration by G. Bergtrom
Fig. 4.3: The reciprocal relationship between entropy and free energy graphed over time. If all activities
in the universe proceed by increasing entropy, and if the universe consists only of free energy and
entropy, then as entropy increases, free energy must be decreasing in the universe. Illustration by G.
Bergtrom
Fig. 4.4: Basic design of a bomb calorimeter, with an inner chamber for conducting reactions, and an
outer chamber containing water with a thermometer to measure temperature change (heat absorption or
release, or H) during the reaction. Illustration by G. Bergtrom

Chapter 5
Chapter Top-Art: Illustration by G, Bergtrom
Fig. 5.1: Illustration of the early Lock-&-Key mechanism for enzyme-substrate interaction, in which the
substrate key fits an enzyme lock. Illustration by G. Bergtrom
Fig. 5.2: The Induced Fit mechanism of enzyme-substrate interaction. Initial interaction of substrate with
enzyme based on mutual affinity causes an allosteric change in the enzyme. This results in the induced
‘better’ fit of substrate to enzyme, to be followed by catalysis. Illustration by G. Bergtrom
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Fig. 5.3: Graph of change in free energy over time as chemicals A and B react. The high Activation
Energy peak in the graph is the free energy barrier that A and B must overcome before much C and D can
be made. This barrier is due mainly to thermal motion of the A and B molecules, with only rare
encounters in relatively dilute solutions. Enzymes are even more efficient that inorganic catalysts in
lowering the activation energy barrier to a reaction. Illustration by G. Bergtrom
Fig. 5.4: A generic biochemical pathway in which the final product of three enzymatic reactions
accumulates. To prevent wasteful accumulation of the final product, the pathway is regulated, in this
case, when some of the accumulating reaction product (E) binds to enzyme 1, blocking the reaction from
A to form B. Illustration by G. Bergtrom
Fig 5.5: Allosteric effectors are small metabolites whose amounts in a cell reflect the cell’s metabolic
status. They bind to enzymes at a regulatory site, causing an allosteric (conformational) change in the
enzyme that affects the shape of the Active Site, either inhibiting catalysis (as suggested here) or
stimulating it. Illustration by G. Bergtrom
Fig. 5.6: Saturation kinetics of an enzyme-catalyzed reaction. At high substrate concentrations, all the
active sites of all enzymes are occupied. Under these conditions, the reaction occurs at its fastest rate.
Illustration by G. Bergtrom
Fig. 5.7: Experimental protocol for determining the kinetics of an enzyme-catalyzed reaction.
Illustration by G. Bergtrom
Fig. 5.8: This graph plots the rate of product (P) formation at 4 different substrate concentrations, while
holding the enzyme concentration constant. Illustration by G. Bergtrom
Fig. 5.9: This graph shows the slopes of the initial reaction rates (red) taken from the curves in the
previous graph (Fig. 5.8). Illustration by G. Bergtrom
Fig. 5.10: This graph plots the initial reaction rates (slopes, or v0) for the reactions plotted in Fig. 5.9. The
formula shown for this curve is that of a rectangular hyperbola. Illustration by G. Bergtrom

Chapter 6
Chapter Top-Art: From Evans Love - Own work, CC BY-SA 4.0,
https://en.wikipedia.org/wiki/File:Human_Metabolism_-_Pathways.jpg
Fig. 6.1: The flow of free energy through life, from visible light to chemical energy (e.g., photosynthesis of
glucose) to the high-energy intermediates like ATP (fermentation or respiration) and finally to cellular
work. Illustration by G. Bergtrom
Fig. 6.2: The energetics of ATP synthesis and hydrolysis. Illustration by G. Bergtrom
Fig. 6.3: Stoichiometry of glucose metabolism and ATP productions by glycolysis, the Krebs Cycle,
electron transport and oxidative phosphorylation. Illustration by G. Bergtrom
Fig. 6.4: Glycolysis: Glucose (6-C) becomes 2 pyruvates (3-C); 2 ATPs are consumed in Stage 1 but 4 are
made in Stage 2; The oxidation of glyceraldehyde-3-P marks the start of Stage 2. Illustration by G.
Bergtrom
Fig. 6.5: Alternate Fates of Pyruvate: Fermentation (the anaerobic reduction to e.g., alcohol, lactate) or
Respiration (aerobic oxidation of pyruvate using oxygen as a final electron acceptor, resulting in H2O and
CO2 production). Illustration by G. Bergtrom
Fig. 6.6: In Reaction 1, phosphorylation of glucose to make glucose-6-P (G-6-P) consumes a molecule of
ATP. If cellular energy needs are being met, G-6-P will be polymerized to make storage polysaccharides.
The G-6-P can be retrieved by polysaccharide breakdown (hydrolysis) when the cells require nutrient
energy; at that time, the G-6-P will resume glycolysis. Illustration by G. Bergtrom
Fig. 6.7: Free energy flow (exchange) for Reaction 1 of glycolysis. Illustration by G. Bergtrom
Fig. 6.8: Enzymatics of the Hexokinase reaction. This enzyme catalyzes a biologically irreversible
reaction and is allosterically regulated. Illustration by G. Bergtrom
Fig. 6.9: Reaction 2 of glycolysis. G-6-P isomerase catalyzes the isomerization of G-6-P to F-6-P (i.e., the
isomerization of glucose to fructose). The reaction is endergonic and reversible. Illustration by G.
Bergtrom
Fig. 6.10: Reaction 3 of glycolysis. A kinase catalyzes phosphorylation of F-6-P to F1,6-di-P in a
biologically irreversible reaction, consuming a molecule of ATP. Illustration by G. Bergtrom
Fig. 6.11: Reactions 4 and 5 of glycolysis. In reaction 4, F1,6-di-P is split into dihydroxyacetone
phosphate (DHAP) and glyceraldehyde-3-P (G-3-P) by an aldolase enzyme. In reaction 5, DHAP is
isomerized to G-3-P. Both reactions are endergonic, consuming free energy. These reactions mark the
end of Stage 1 of glycolysis. Illustration by G. Bergtrom
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Fig. 6.12: Reaction 6, a redox reaction catalyzed by G-3-P dehydrogenase, is freely reversible. G-3-P is
oxidized to 1,3 diphosphoglyceric acid (1,3 diPG), transferring electrons as a hydride (H-) ion to NAD+ to
make NADH. Illustration by G. Bergtrom
Fig. 6.13: Reaction 7, a reversible, exergonic, coupled reaction generates ATP using free energy released
by the hydrolysis of one of the phosphates from 1,3diPG. The mechanism of ATP synthesis here is called
substrate-level phosphorylation. Illustration by G. Bergtrom
Fig. 6.14: Reaction 8 is a reversible, endergonic reaction catalyzed by a mutase. Mutases catalyze transfer
of a chemical group from one part of a molecule to another; here, 3-PG is converted to 2PG. Illustration
by G. Bergtrom
Fig. 6.15: Reaction 9 is a reversible endergonic reaction. An enolase catalyzes the conversion of 2-PG to
phosphoenol pyruvate (PEP). Illustration by G. Bergtrom
Fig. 6.16: Reaction 10 is catalyzed by a kinase that transfers the phosphate on PEP to ADP to make ATP
and pyruvate. Pyruvate kinase catalyzes a coupled, highly exergonic and biologically irreversible
reaction. Illustration by G. Bergtrom
Fig. 6.17: Free energy and ATP yields of complete glycolysis (a fermentation) and incomplete glycolysis
(i.e., respiration). Percentages represent the (efficiency of ATP production. They are based on the ratios
of the free energy captured as ATP to the free energy released by the different pathways for metabolizing
glucose. Froom the data, incomplete glycolysis is a more efficient way to extract nutrient free energy.
Illustration by G. Bergtrom
Fig. 6.18: Comparison of incomplete glycolysis to gluconeogenesis. The two pathways are essentially the
reverse of one another, except for the bypass enzymes in gluconeogenesis (shown in green), required to
get around biologically irreversible enzymes of glycolysis. Illustration by G. Bergtrom
Fig. 6.19: The Cori cycle reveals the relationship between glycolysis and gluconeogenesis. Lactic acid
produced by complete glycolysis in active skeletal muscle goes to the liver where it could be converted to
pyruvate, and then to glucose. CC-BY-SA 3.0; From
https://commons.wikimedia.org/wiki/File:Cori_Cycle.SVG and GNU Free Documentation License
User:Petaholmes, user:PDH, user:Eyal Bairey
Fig. 6.20: Control of gluconeogenesis by hormones of the hypothalamic-pituitary axis. A need for glucose
for energy stimulates hypothalamic hormones that, in turn, stimulates the release of adrenocorticotropic
hormone (ACTH) from the pituitary gland. ACTH then stimulates release of glucocorticoids rom the
adrenal glands. Glucocorticoid hormones stimulate many tissues to control gluconeogenic glucose
production as well as the use alternate nutrient fuels by many cells in the body. Illustration by G.
Bergtrom
Fig. 6.21: Entry of pyruvate into a mitochondrion, followed by its oxidation to acetyl-S-Coenzyme A
(acetyl-S-CoA). Illustration by G. Bergtrom
Fig. 6.22: Pyruvate dehydrogenase catalyzes pyruvate oxidation to Ac-S-CoA, releasing a molecule of
CO2 and reducing NAD+ to NADH. Illustration by G. Bergtrom
Fig. 6.23: Highlights of the Krebs Cycle. The first reaction is condensation of Acv-S-CoA and
oxaloacetate (OAA) to form citric acid (citrate). Four of the reactions in the cycle are redox reactions that
create reduced electron carriers (NADH, FADH2), while one reaction is coupled to GTP synthesis by
substrate level phosphorylation. Illustration by G. Bergtrom

Chapter 7
Chapter Top-Art: Illustration by G, Bergtrom
Fig. 7.1: Overview of electron transport and oxidative phosphorylation. NADH and FADH2 oxidation
feed electrons into electron transport, releasing free energy that powers proton (H+ ions) pumps to force
H+ ions out of the mitochondrion. The resulting H+ gradient fuels ATP synthesis as the protons flow into
the mitochondrial matrix through a regulated ATP synthase in the cristal membrane (at the right in the
drawing). Illustration by G. Bergtrom
Fig. 7.2: The flow of protons through the cristal membrane ATP synthase relieves the proton gradient,
releasing free energy that fuels ATP synthesis in the mitochondrial matrix. Illustration by G. Bergtrom
Fig. 7.3: A bacterial electron transport system can pump protons and other cations (Na+, Ca++) from the
cytoplasm into the periplasmic space, at the left on the inner (cell) membrane. Relief of the proton
gradient can power an ATP synthase or motility by fueling a spinning flagellum (at the right). In both
cases. proton flow into the cell powers complex protein motors. Illustration by G. Bergtrom
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Fig. 7.4: Summary of carbon flow through life. Organic carbon is oxidized to release free energy and
make ATP. Sunlight provides free energy for photosynthesis to turn inorganic carbon (CO2) into organic
carbon (e.g., glucose). Illustration by G. Bergtrom
Fig. 7.5: The light dependent and light independent (‘dark’) reactions of photosynthesis. The lightdependent reactions ‘split’ water, releasing oxygen and protons. The light-independent reaction ‘fix’ CO2
in organic molecules. Illustration by G. Bergtrom
Fig. 7.6: Experimental design to test the hypothesis that photosynthesis is supported by absorption of
light by chlorophyll pigments. Illustration by G. Bergtrom
Fig. 7.7: Graph showing the action spectrum of photosynthesis, showing that photosynthesis is supported
across a wide range of visible light wavelengths. Illustration by G. Bergtrom
Fig. 7.8: Graph plotting the absorbance spectrum of purified chlorophylls, showing two main peaks of
absorbance. Illustration by G. Bergtrom
Fig. 7.9: Low (LEFT) and high (RIGHT) power transmission micrographs of typical chloroplasts,
thylakoid membranes and grana (thylakoid stacks). From and3k and caper437 - Own work by uploaders,
CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=7153976
Fig. 7.10: Graph superimposing the action spectrum of photosynthesis over the absorbance spectra of
different plant pigments. The multiple absorbance peaks of different chloroplast pigments are consistent
with the action spectrum. Illustration by G. Bergtrom
Fig. 7.11: In the “Z-Scheme” of photosynthesis, PSI and PSII pigments absorb light energy that excites
electrons captured by electron acceptors. Electrons excited from PSI reduce NADPH, the starting point of the
light-independent reactions. Electrons excited out of PSII come from splitting water (releasing oxygen). These
electrons will flow down a photosynthetic electron transport chain to replace electrons lost from PSI. Along the
way, free energy from those excited electrons fuels ATP synthesis. Illustration by G. Bergtrom
Fig. 7.12: Cyclic Photophosphorylation cycles electrons excited from PSI along part of the photosynthetic
electron transport chain, bypassing PSII and returning the electrons to PSI. ATP made during Cyclic
photophosphorylation is used for cellular work when there is no need or capacity to make more sugar.
Illustration by G. Bergtrom
Fig. 7.13: Overview of the Calvin Cycle for carbon fixation in C3 (most) plants. Three RuBP molecules fix
3 CO2 molecules, catalyzed by ribulose bisphosphate carboxylase –oxygenase (RUBISCO). The three 6C
molecules produced split into six 3C carbohydrates, becoming six glyceraldehyde-3-P (GA3P in the
illustration). Five of these go on to regenerate 3 RuBP molecules; the 6th G3P waits for the Calvin Cycle
to repeat, producing another G3P. Two G3Ps from 2 turns of the cycle are substrates for glucose
synthesis. Illustration by G. Bergtrom
Fig. 7.14: Calvin Cycle Arithmetic: Making one glucose and regenerating 5 RubP molecules. Illustration
by G. Bergtrom
Fig. 7.15: Photorespiration is a C3 plant strategy to survive a dry spell or a heat wave. Water-starved C3
plants resort to fixing oxygen using RuBP. This reaction is catalyzed by RUBISCO, the same enzyme that
fixes CO2 to RuBP, but using its oxygenase activity. Illustration by G. Bergtrom
Fig. 7.16: Crassulacean Acid Metabolism in CAM plants. To survive in arid climates and minimize water
loss, CAM plants o[pen their stomata and fix CO2 in oxaloacetate (OAA) that is converted to malic acid to
be stored until daylight. Stomata close at daybreak to conserving water, while malic acid releases CO2 to
be re-fixed to make glucose. Illustration by G. Bergtrom
Fig. 7.17: C4 Photosynthesis pathway reactions in tropical plants. C4 plants separate their ‘dark’ reactions
into 2 cell types. Mesophyll cells can keep stomata open part of the day, allowing CO2 into the cells where
it is fixed to PEP to make OAA and then malate. Unlike CAM plants, the malate is not stored, but
transferred to bundle sheath cells where it can release CO2 to be re-fixed by the Calvin Cycle.
Illustration by G. Bergtrom

Chapter 8
Chapter Top-Art: Photos from left to right:
• Fair use, https://en.wikipedia.org/w/index.php?curid=22197113
• http://www.nobelprize.org/nobel_prizes/medicine/laureates/1958/
• Public Domain, https://commons.wikimedia.org/w/index.php?curid=3677045
• CC-BY https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.0030341
• Public Domain, https://commons.wikimedia.org/w/index.php?curid=15615954
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• Public Domain, https://commons.wikimedia.org/w/index.php?curid=15616085
• Fair use, https://en.wikipedia.org/w/index.php?curid=24959067
Fig. 8.1: The experiments of F. Griffith demonstrating the existence of a chemical that could transfer a
genetic trait (i.e., virulence) between bacteria. Illustration by G. Bergtrom
Fig. 8.2: The experiments of O. Avery et al. demonstrating for the first time that the chemical stuff of
genes, of inheritance is DNA. Illustration by G. Bergtrom
Fig. 8.3: Life cycle of a bacteriophage: The phage coat remains attached to a cell after infection, but the
chemicals inside the phage enter the infected cell. Illustration by G. Bergtrom
Fig. 8.4: The experiments of Alfred Hershey and Martha Chase demonstrating that the chemical stuff of
viral genes is DNA. Illustration by G. Bergtrom
Fig. 8.5: Photo 51, the X-Ray crystallograph of DNA taken by Rosalind Franklin revealed 3 crucial
molecular dimensions that ultimately led to the double helical DNA model. Fair Use (Ref. Wikipedia); By
Source (WP:NFCC#4), https://en.wikipedia.org/w/index.php?curid=38068629;
https://en.wikipedia.org/wiki/Photo_51
Fig. 8.6: The 3 molecular dimensions from Franklin’s Photo 51 was best explained by proposing a DNA
double helix (Left). Model building by Watson and Crick revealed the antiparallel structure of the double
helix (Right).
• Public domain; From: https://commons.wikimedia.org/wiki/File:DNA_double_helix_vertikal.PNG
• CC BY-SA 3.0; By Madprime (talk · contribs) - Own work The source code of this SVG is valid. This
vector image was created with Inkscape., https://commons.wikimedia.org/w/index.php?curid=1848174
Fig. 8.7: Three possible modes of DNA replication could be imagined. Illustration by G. Bergtrom
Fig. 8.8: Meselson and Stahl predict experimental outcomes based on 3 possible modes of DNA
replication. Illustrated by G. Bergtrom
Fig. 8.9: Light micrograph of a human female chromosome stained for banding patters, showing the
centromere constriction and defining telomeres (chromosome ends). Public Domain; Adapted from
National Human Genome Research Institute; Cropped from Human male karyotype.jpg,
https://commons.wikimedia.org/w/index.php?curid=40960106
Fig. 8.10: Spread of human mitotic cell chromosomes. CC BY-SA 3.0; By Steffen Dietzel - Own work,
https://commons.wikimedia.org/w/index.php?curid=1369763
Fig. 8.11: Computer-colorized human karyotype. Public Domain; Adapted From
https://commons.wikimedia.org/w/index.php?curid=7853183C Courtesy: National Human Genome
Research Institute - Found on: National Human Genome Research (USA); copied from wikipedia:en.
Fig. 8.12: Transmission micrograph of euchromatin and heterochromatin in the nucleus. From Bergtrom
et al., (1977) J. Ultrastr. Res. 60:395-406; Research by G. Bergtrom
Fig. 8.13: Low salt fractionation of interphase nuclei yields 10nm nucleosome beads on a string.
• Upper; From Bergtrom et al., (1977) J. Ultrastr. Res. 60:395-406: Research by G. Bergtrom;
• Lower left; CC-BY-SA 3.0; Adapted from:
https://commons.wikimedia.org/wiki/File:Chromatin_nucleofilaments_%28detail%29.png
Fig. 8.14: High salt chromatin extraction from nuclei or high salt treatment of 10 nm filaments yields 30
nm solenoid structures, essentially coils of 10 nm filaments.
• Electron micrograph of nucleus, From Bergtrom et al., (1977) J. Ultrastr. Res. 60:395-406: Research by
G. Bergtrom
• CC-BY-SA 3.0; Adapted from:
https://commons.wikimedia.org/wiki/File:Chromatin_nucleofilaments_%28detail%29.png
• CC BY-SA 4.0; Alt: Adapted from: Richard Wheeler
https://en.wikipedia.org/w/index.php?curid=53563761
Fig. 8.15: Five different levels (orders) of chromatin structure. CC-BY-SA 3.0; Adapted From
https://en.wikipedia.org/wiki/Chromatin.
Fig. 8.16: Short times of DNase I digestion of 10 nm filaments leaves behind shortened beads on a string.
A long time of DNase I digestion releases single nucleosomes associated with some DNA. Illustration by
G. Bergtrom
Fig. 8.17: Electrophoresis of nucleosomal proteins from digested 10 nm filaments reveals five different
histones with the stoichiometry shown. Gel illustration by G. Bergtrom; nucleosome illustration adapted
from CC-BY-SA drawing on https://commons.wikimedia.org/wiki/File:Chromatosom.png
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Fig. 8.18: Acid extraction of chromatin to remove histones and leave more basic non-histone proteins
behind. See original micrograph at
https://www.flickr.com/photos/185778834@N06/49368658231/ Illustration by G. Bergtrom.
Fig. 8.19: Bacterial conjugation (sex in bacteria): The F plasmid (Fertility plasmid) can transfer bacterial
chromosomal DNA from the F+ mating strain of E. coli to an opposite, F- mating strain, leading to a
measure of genetic diversity. Illustration by G. Bergtrom
Fig. 8.20: Possible results of conjugation in E. coli. The F plasmid transferred from an F+ donor cell may
or may not integrate into the F- (recipient) cell. If integration occurs, the recipient cell becomes Hfr, with
a high frequency of conjugation. Illustration by G. Bergtrom
Fig. 8.21: During conjugation with Hfr donor strain cells, portions of donor chromosomal DNA follow the
excised plasmid across the conjugation bridge into the F- recipient cell. Illustration by G. Bergtrom
Fig. 8.22: Map of the E. coli chromosome based on conjugation of F- recipient cells with different strains
of Hfr donor cells indicated as Hfr 1, 2 ,… The different Hfr donors are cells in which the Hfr plasmid
integrated at different place on a recipient cell chromosome. When these different Hfr strains transfer
DNA to new F- cells, they bring along different regions of the donor cell chromosome (and thus different
genes) into their conjugated F- cells Illustration by G. Bergtrom
Fig. 8.23: The lysogenic life cycle of phage. Illustration by G. Bergtrom

Chapter 9
Chapter Top-Art: From CC BY-SA 2.0; By Ion Chibzii from Chisinau, Moldova. "Hands of mother”
https://commons.wikimedia.org/w/index.php?curid=12799400
Fig. 9.1: Illustration of J. Cairns’ autoradiographs of DNA extracted from E. coli cells allowed to grow on
3
H- thymidine for more than one generation of cells so that all cellular DNA would become radioactive.
Silver tracks represented in the figure are exposures of bacterial chromosomal DNA. Illustration by G.
Bergtrom
Fig. 9.2: An ordering of Cairns’ autoradiograph images to suggest the progress of replication of the E. coli
circular chromosome. Illustration by G. Bergtrom
Fig. 9.3: Image of an E. coli circular chromosome with two replication forks (RFs) unwinding and
replicating DNA in both directions from an origin of replication (OR); the E. coli OR is a defined
sequence. Illustration by G. Bergtrom
Fig. 9.4: Eukaryotic replication enlarges replicons that eventually merge
Fig. 9.5: DNA polymerase activity grows a DNA strand from the 5’ to 3’ direction. CC BY-SA 3.0;
Adapted from: I. Madprime, https://commons.Wikimedia.org/w/index.php?curid=2527732
Fig. 9.6: Detection of replication errors and correction by DNA polymerase proofreading. CC BY-SA
3.0; Adapted from: I. Madprime, https://commons.Wikimedia.org/w/index.php?curid=2527732
Fig. 9.7: Initiation proteins recognize and begin unwinding the double helix by bending E. coli DNA at
the OR. Helicase then continues to unwind the DNA. SSBs (single stranded binding proteins) stabilize
unwound DNA as DNA polymerase and other enzymes begin replication in both directions away from the
OR. Illustration by G. Bergtrom
Fig. 9.8: 5’-to-3’ replication creates the problem at the replication fork shown here. Illustration by G.
Bergtrom
Fig. 9.9: Hypothesis proposing that at least one DNA strand at a replication fork (the lagging strand) is
synthesized in pieces, each starting with an RNA primer that must be later correctly stitched together.
Illustration by G. Bergtrom
Fig. 9.10: Growth curves for wild type and a mutant T4 bacteriophage phage that synthesized a slowacting DNA ligase enzyme. This suggested that slower growth might be due to inefficient ligation of
lagging strand DNA fragments made during replication. the Illustration by G. Bergtrom
Fig. 9.11: Steps in the synthesis of DNA against the lagging template strand. Illustration by G. Bergtrom
Fig. 9.12: A pair of replication forks (RFs), each assembling proteins and enzymes required for
replication, including DNA primases. Illustration by G. Bergtrom
Fig. 9.13: The problem with linear chromosomes is that the lagging strand at the end (telomere) of a
double helix can’t be primed and thus cannot be replicated, causing chromosome shortening at each cell
division. Illustration by G. Bergtrom
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Fig. 9.14: The ribonucleoprotein enzyme telomerase resolves the dangers of chromosome shortening by
using its RNA sequence to generate repeats on the telomeric end of lagging strand DNAs. Illustration by
G. Bergtrom
Fig. 9.15: The Processive Replication hypothesis unites all components needed to replicate both strands of
DNA in a replisome, so both strands are replicated in the same direction. Illustration by G. Bergtrom
Fig. 9.16: Unwinding a circular DNA molecule (or any double helix that is rigidly associated with
chromosomal proteins wherever it is not replicating) causes the DNA to twist and coil on itself, a
phenomenon called supercoiling. Cairns’ saw such supercoils in E. coli chromosomes. Illustration by G.
Bergtrom
Fig. 9.17: Spontaneous depurination results in hydrolytic removal of a guanine or adenine from a
nucleotide, resulting in a nucleotide deletion at that site in the DNA during replication. Illustration by G.
Bergtrom
Fig. 9.18: Exposure of DNA to UV light can cause adjacent thymines to dimerize, resulting in deletion of
two nucleotides at that site in the DNA during replication. Illustration by G. Bergtrom
Fig. 9.19: -NH2 removal (deamination) of a base in one DNA strand results in a base substitution during
replication. Illustration by G. Bergtrom
Fig. 9.20: Base Excision Repair mechanisms can detect and fix e.g., a deamination prior to replication.
Illustration by G. Bergtrom
Fig. 9.21: Nucleotide Excision Repair mechanisms can detect and fix e.g., a pyrimidine dimer prior to
replication. Illustration by G. Bergtrom
Fig. 9.22: DNA Mismatch Repair can detect and fix post-replication errors (i.e., mismatched base pairing.
• CC-BY 4.0; Adapted from Kenji Fukui,
https://commons.wikimedia.org/wiki/File:DNA_mismatch_repair_Ecoli.png
• Illustration by G. Bergtrom
Fig. 9.23: Non-Homologous End-Joining detects and repairs double-stranded breaks in DNA, but can
leave nucleotide deletions. Illustration by G. Bergtrom
Fig. 9.24: Single-Stranded Break Repair by Homologous Recombination can fix a break in one DNA
strand when the break is detected at a replication fork. The fix leaves an accurate repair with no deletion
or base substitution. Illustration by G. Bergtrom
Fig. 9.25: Double-Stranded Break Repair by Homologous Recombination can detect and fix a break in
double stranded breaks in DNA. Illustration by G. Bergtrom

Chapter 10
Chapter Top-Art: Photo by G. Bergtrom
Fig. 10.1: Ribosomal RNAs and proteins in a bacterial ribosome. Illustration by G. Bergtrom
Fig. 10.2: Transfer RNA (tRNA) associated with a ribosome, held in place by codon/anticodon
complementarity as well as tRNA-ribosomal forces. Illustration by G. Bergtrom
Fig. 10.3: Polysomes form along an mRNA. Multiple ribosomes can assemble at the 5’ end of an mRNA
and then sequentially translate multiple polypeptides Illustration by G. Bergtrom
Fig. 10.4: Transcription - The basic Steps: Initiation is the recognition of a promoter sequence near the
transcription start site by RNA polymerase. Elongation is the successive addition of nucleotides to a
growing RNA strand. Termination occurs at the end of the gene, releasing the newly made RNA.
Illustration by G. Bergtrom
Fig. 10.5: An Operon is a contiguous group of 2 or more genes that are transcribed as a single messenger
RNA that will be translated into two or more polypeptides. Illustration by G. Bergtrom
Fig. 10.6: Eukaryotic mRNAs, rRNAs and tRNAs are transcribed by different RNA polymerases and are
processed by different mechanisms to yield usable, mature RNAs. Illustration by G. Bergtrom
Fig. 10.7: Bacterial transcription requires initiation factors (i.e., −factors) to help the RNA polymerase
find and bind to a gene promoter to begin transcription. Illustration by G. Bergtrom
Fig. 10.8: After transcription has been initiated,  factors soon fall away as elongation continues.
Illustration by G. Bergtrom
Fig. 10.9: rho-dependent termination of bacterial transcription involves recognition of sequences at the
end of the gene and transcript. Illustration by G. Bergtrom
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Fig. 10.10: rho-independent termination of bacterial transcription involves complementary bases near the
end of the transcript that form a stem/loop, or hairpin loop structure that serves as a termination signal.
Illustration by G. Bergtrom
Fig. 10.11: Comparison of transcription in prokaryotes and eukaryotes; the roles of three RNA
polymerases in Eukaryotes. Illustration by G. Bergtrom
Fig. 10.12: Eukaryotic mRNA transcription initiation begins with recognition of a gene promoter
(including the TATA box) by initiation factor TFIID. The sequential association of a series of initiation
factors and finally, RNA polymerase II with the mRNA. RNA polymerase phosphorylation starts
transcription. Illustration by G. Bergtrom
Fig. 10.13: 5S rRNA transcription in eukaryotes is initiated from an internal promoter by RNA polymerase
III. After binding to the promoter, the polymerase re-positions itself near the transcription start-site.
Illustration by G. Bergtrom
Fig. 10.14: Transcription and processing of eukaryotic mRNA. Many mRNAs in eukaryotes are encoded
by split genes containing coding regions (exons) and non-coding regions (introns). These genes are
transcribed as precursor (pre-) mRNAs that must be processed by splicing before they can be used in
translation Illustration by G. Bergtrom
Fig. 10.15: Splicing of a eukaryotic pre-mRNA involves association of the primary transcript (pre-mRNA)
with snRNPs, small ribonuclear proteins that catalyze cleavage of the pre-RNA at 5’ and 3’ splice sites
followed by ligation of the 3’ to 5’ exon ends. Illustration by G. Bergtrom
Fig. 10.16: Formation of a spliceosome by the binding of snRNPs to an mRNA leads to hydrolysis of
splice sites and the formation of a lariat structure from the intron remnants. Illustration by G. Bergtrom
Fig. 10.17: Immunofluorescence staining with antibodies to coilin and SMN protein show that Cajal
bodies and Gems aggregate when undifferentiated cells (panels A and C) are stimulated to differentiate
(panels B and D). Since mutations in coilin and SMN proteins are associated with splicing defects, colocalization of Cajal bodies and Gems suggests their co-involvement of snRNP function. Creative
Commons Deed, NC, Attribution 2.5 Adapted from: https://www.ncbi.nlm.nih.gov/pubmed/19735367
Fig. 10.18: Exon shuffling, transfer/copying of an exon from one gene to another, can occur by unequal
recombination (cross--over) between different genes based on regions of sequence similarity within
introns. Illustration by G. Bergtrom
Fig. 10.19: mRNA capping results from a 5’–to–5’ condensation reaction linking the 5’ end of an mRNA to
a methylated guanidine triphosphate (CH3-GTP) . Illustration by G. Bergtrom
Fig. 10.20: mRNA polyadenylation; this is the addition of multiple adenine nucleotides to the 3’ end of an
mRNA, catalyzed by the enzyme poly(A) polymerase. Other than histone mRNAs, most eukaryotic
mRNAs are polyadenylated. Illustration by G. Bergtrom
Fig. 10.21: Posttranscriptional processing of the 45S rRNA encoding three of the four eukaryotic rRNAs
by hydrolytic cleavage. Illustration by G. Bergtrom
Fig. 10.22: Early (1906) low power (left) and high power (right) light micrographs of stained amphibian
(salamander) oocyte nucleolar DNA in amphibian oocytes showing the “chromatic fibers” that (resemble)
a bottle brush , now called lampbrush chromosomes because they were also reminiscent of brushes used
to clean the chimneys of old-fashioned oil lamp chimneys. We now know that the bristles are nascent
strands of rRNA . For a more recent, high resolution transmission electron micrograph, see
http://www.cellimagelibrary.org/images/11043. Public Domain; O. Hertwig, Image:O.Hertwig1906Fig26.jpg. & https://commons.wikimedia.org/wiki/File:O.Hertwig1906Fig5.jpg
Fig. 10.23: Characteristic clustering of eukaryotic tRNA genes. Illustration by G. Bergtrom
Fig. 10.24: Structure of a Yeast tRNA. CC-BY-SA 3.0; Own work; Yikrazuul;
https://commons.wikimedia.org/w/index.php?curid=10126790
Fig. 10.25: The assembly of ribosomal subunits and their export to the cytoplasm is coordinated with the
synthesis and association with the rRNAs and their ribosomal proteins. Illustration by G. Bergtrom
Fig. 10.26: Role of the 5’ guanosine CAP and poly-A binding proteins and a nuclear transport factor in
the export of an mRNA to the cytoplasm. Illustration by G. Bergtrom

Chapter 11
Chapter Top-Art: Both images are in the Public Domain; other source information not found
Fig. 11.1: The Universal RNA Genetic Code Dictionary. CC-BY-SA; From:
https://en.wikipedia.org/wiki/Genetic_code
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Fig. 11.2: Colinearity of genes and proteins (polypeptides) in bacteria. Illustration by G. Bergtrom
Fig. 11.3: A single-base overlapping genetic code would get more genetic information in less DNA!
Illustration by G. Bergtrom
Fig. 11.4: Nirenberg et al.’s fractionation of bacterial cell RNAs. Illustration by G. Bergtrom
Fig. 11.5: Nirenberg et al.’s reconstitution of fractionated bacterial cell RNAs. Illustration by G. Bergtrom
Fig. 11.6: Nirenberg and Leder’s experiment that led to breaking the entire genetic code. Illustration by
G. Bergtrom
Fig. 11.7: Cloverleaf (LEFT) and computer-generated 3D (RIGHT) structures of a phenylalanyl-tRNA.
Sources:
• CC BY-SA 3.0; By Yikrazuul - Own work,
https://commons.wikimedia.org/w/index.php?curid=10126790
• CC-BY 3.0; Adapted from Qinhua Zhou at English Wikipedia, via Wikimedia Commons; TRNA-Phe
yeast 1ehz - Transfer RNA - Wikipedia
Fig. 11.8: A, P and E sites, mainly on the large ribosomal subunit, involved in mRNA translation.
Illustration by G. Bergtrom
Fig. 11.9: Three steps of amino acid activation (tRNA acylation) require ATP hydrolysis. Illustration by
G. Bergtrom
Fig. 11.10: Discovery of met-tRNA and formyl-met-tRNA, despite only one codon for methionine.
Illustration by G. Bergtrom
Fig. 11.11: Bacterial Translation Initiation: association stabilized of the small ribosomal subunit with an
mRNA requires two initiation factors (IF1 and IF3). The association is by complementary H-bonding
between a region of the 16S rRNA and the Shine-Delgarno sequence near the 5’ end of the mRNA.
Illustration by G. Bergtrom
Fig. 11.12: Bacterial Translation Initiation: GTP-bound IF2 enables binding of the first aminoacyl tRNA
(the initiator fmet-tRNAfmet) to the 30S ribosomal subunit/mRNA complex to create a bacterial initiation
complex. Illustration by G. Bergtrom
Fig. 11.13: Bacterial Translation Initiation: addition of the large ribosomal subunit to the initiation
complex, hydrolysis of GTP and dissociation of initiation factors completes assembly of the ribosome on
an mRNA. Illustration by G. Bergtrom
Fig. 11.14: Bacterial Translation Elongation: EF2-GTP and EF3 facilitate entry of the second aminoacyl
tRNA into the A site of the ribosome to begin elongation; GTP is hydrolyzed. Illustration by G. Bergtrom
Fig. 11.15: Bacterial Translation Elongation: The peptidyl transferase ribozyme (part of the ribosome)
catalyzes peptide bond formation between the fmet on its tRNAf and the second amino acid (aa2). The
fmet is transferred from its tRNAf as it condenses with an aa2 still linked to its tRNAaa2 Illustration by G.
Bergtrom
Fig. 11.16: Bacterial Translation Elongation: Translocase (on the ribosome) catalyzes movement of the
ribosome along the mRNA, exposing the next codon in the A site with its attached peptidyl tRNA now in
the peptidyl (P) site. Illustration by G. Bergtrom
Fig. 11.17: Bacterial Translation Termination: translocation stalls when the ribosome reaches a
termination codon for which there is no corresponding aminoacyl tRNA.. Then, GTP is hydrolyzed as a
protein release factor enters A site, causing release of the new polypeptide and dissociation of the
ribosome from the mRNA. Illustration by G. Bergtrom

Chapter 12
Chapter Top-Art: Illustration by G, Bergtrom
Fig. 12.1: Transcription of the E. coli lac operon produces a single mRNA encoding three polypeptides
(nicknamed ‘z’, ‘y’ and ‘a’) which is translated into 3 enzymes involved in lactose metabolism.
Illustration by G. Bergtrom
Fig. 12.2: The lacZ, lacY and lacA genes of the lac operon are all controlled by the single promoter to the
left of the lacZ gene. A regulatory gene (lacI) with its own promoter lies further to the left of the lac
operon. Illustration by G. Bergtrom
Fig. 12.3: Negative regulation of the lac operon: The I gene transcribes a repressor protein. When bound
to the operator sequence (between the promoter and beginning of the Z gene), RNA polymerase is
blocked and the operon cannot be transcribed. Transcription will require derepression (i.e., removal of
the repressor protein). Illustration by G. Bergtrom
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Fig. 12.4: Negative regulation of the lac operon: When present, lactose enters cells and is converted to
allolactose. Accumulating allolactose binds to the lac repressor protein. Illustration by G. Bergtrom
Fig. 12.5: Negative regulation of the lac operon: Allolactose binding causes allosteric change in the lac
repressor that then dissociates from the operator sequence, allowing RNA polymerase to transcribe the
operon. Illustration by G. Bergtrom
Fig. 12.6: Positive regulation of the lac operon: If lactose is present but glucose is unavailable, the operon
is derepressed AND induced. Increased cAMP binds the Catabolite Activator Protein (CAP), which binds
to the lac operator, inducing) lac gene transcription The lac operon is maximally transcribed under
these conditions. Illustration by G. Bergtrom
Fig. 12.7: Positive regulation of the lac operon: cAMP-CAP-bound operator bends the double helix. This
loosens the H- bonds between the bases, making transcription factor access to template strands easier.
Illustration by G. Bergtrom
Fig. 12.8: lac operon regulation by inducer exclusion: High glucose levels accelerate glycolysis, depleting
cellular phosphate. Low phosphate leads to the dephosphorylation of EIIAGlc, among other proteins.
Dephosphorylated EIIAGlc is an inhibitor of lactose permease (i.e., the lacA protein). Without active
permease, lactose can’t get into cells, allolactose cannot be made, and the lac gene cannot be transcribed.
Illustration by G. Bergtrom
Fig. 12.9: Computer generated structure of the tetrameric lac repressor bound to DNA via helix-turn-helix
motifs. CC-BY-SA; From: http://en.wikipedia.org/wiki/Lac_repressor
Fig. 12.10: Transcription of the 5-gene tryptophan (trp) operon: The 5 resulting enzymes are in the
pathway for tryptophan synthesis. A tryptophan (trp) repressor gene to the left of the operator is always
transcribed. Illustration by G. Bergtrom
Fig. 12.11: When there is sufficient tryptophan in the cells, excess tryptophan binds to and changes the
conformation of the trp repressor protein, which then recognizes and binds the trp operon operator,
blocking RNA polymerase and repressing operon transcription. Illustration by G. Bergtrom
Fig. 12.12: Replacement of an egg nucleus with that from an adult cell enabled cloning of embryos and
eventually complete organisms, proving that adult cells contain all of the genes required to program
development of, and to make the organism. Illustration by G. Bergtrom
Fig. 12.13: Potentials for gene regulation in eukaryotes: Control of transcript and/or protein abundance,
as well as protein activity can regulate cellular metabolism. CC-BY-SA 3.0; Adapted From
https://en.wikipedia.org/wiki/Chromatin; Illustration by G. Bergtrom
Fig. 12.14: Cis-acting sequence elements associated with a gene function as gene regulators when bound
to regulatory proteins (trans-acting factors). Regulatory sequences may be near the gene promoter
(proximal) or far from it (distal). Enhancers are examples of distal regulatory sequences. Illustration by
G. Bergtrom
Fig. 12.15: Assembly of a eukaryotic transcription complex on a regulated gene. Distal regulatory
protein/DNA interactions can cause DNA bending, recruiting transcription initiation factors and proximal
regulatory factors to the transcription complex. CC BY 3.0; Adapted from Kelvinsong - Own work,
https://commons.wikimedia.org/w/index.php?curid=23272278 and
https://en.wikipedia.org/wiki/Transcription_factor#/media/File:Transcription_Factors.svg
Fig. 12.16: Three DNA binding motifs commonly found in trans-acting (i.e. regulatory) protein factors.
• CC BY-SA 4.0; By Latacca - Own work, https://commons.wikimedia.org/w/index.php?curid=37140265
• CC BY-SA 3.0; By Zephyris at the English language Wikipedia,
https://commons.wikimedia.org/w/index.php?curid=2426895
• Public Domain; From: Boghog at en.wikipedia - Own work Public Domain,
https://commons.wikimedia.org/w/index.php?curid=15966067
Fig. 12.17: Steroid hormones regulate genes. Once in a target cell, the hormone binds a receptor either
in the nucleus, or as in this example, in the cytoplasm. An active cytoplasmic hormone-receptor complex
forms and translocates to the nucleus. Inside the nucleus, the steroid hormone receptor complex
becomes transcription factor, binding to regulatory DNA sequences to turn genes on or off or simply
modulate their transcription. Illustrated by G. Bergtrom
Fig. 12.18: Large or polar signal molecules bind to membrane receptors, resulting in signal transduction,
Here, a second messenger molecule (cAMP) forms in the cytoplasm to deliver the hormonal message. A
phosphorylation cascade leads to responses including gene regulation and/or control of existing protein
activity. Illustration by G. Bergtrom
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Fig. 12.19: Enzyme-linked receptors transduce hormonal signals directly, activating receptor kinases on
the cytoplasmic surface of the cell, initiating phosphorylation cascades leading to any of several
responses. Illustration by G. Bergtrom
Fig. 12.20: Chromatin Organization: different levels of chromatin structure result from differential
association of DNA with chromosomal proteins. CC-BY-SA 3.0; Adapted From
https://en.wikipedia.org/wiki/Chromatin
Fig. 12.21: Low or high salt nuclear chromatin extraction yields 10 nm filaments or 30 nm solenoids
respectively.,
• From Bergtrom et al., (1977) J. Ultrastr. Res. 60:395-406: Research by G. Bergtrom; Research by G.
Bergtrom
• Lower left; Public Domain; from Wikimedia Commons, Electron micrograph of decondensed
chromatin from chicken erythrocytes;
https://commons.wikimedia.org/wiki/File:Chromatin_nucleofilaments.png
• Lower right;; Adapted from OpenStax Biology 2nd Edition, licensed under a Creative Commons
Attribution 4.0 International License,
Fig. 12.22: Chemical modification of histones can open or close chromatin to transcription. CC BY-SA
1.0; By Annabelle L. Rodd, Katherine Ververis, and Tom C. Karagiannis.
http://www.hindawi.com/journals/lymph/2012/290685/,
https://en.wikipedia.org/w/index.php?curid=42441420
Fig. 12.23: Extracellular pressure (arrowheads) on a CED domain or activating spring-like arms by
stretching the cell membrane (e.g., from inside the cell (arrow) opens a piezo-linked ion channel.
Illustration by G. Bergtrom
Fig. 12.24: Summary of health, birth, death and demographic records by L/. O. Bygren for the town of
Överkalix

Chapter 13
Chapter Top-Art: Illustration by G, Bergtrom, and recycling bin photos courtesy of Pixabay.com; Public
Domain, https://pixabay.com/vectors/recycle-bin-container-recycling-24543/ and
https://pixabay.com/vectors/recycling-container-bin-boxes-41078/
Fig. 13.1: Bacterial guanine riboswitch: The ‘switch’ is an mRNA encoding an enzyme in the guanine
synthesis pathway. Excess guanine binds and distorts the stem-loop structure of the mRNA, causing
termination of further gene transcription. Illustration by G. Bergtrom
Fig. 13.2: The array of CRISPR/Cas9 genes, spacers and other components in the genome of
Streptococcus pyogenes. Illustration by G. Bergtrom
Fig. 13.3: Phage infection triggers formation of CRISPR/Cas9 array. Illustration by G. Bergtrom
Fig. 13.4: Phage spacers in a CRISPR/Cas9 array (derived from an earlier phage infection) protects
against phage re-infection. Illustration by G. Bergtrom
Fig. 13.5: Anatomic illustration of the roundworm Caenorhabditis elegans. CC-BY 2.5 J.D. McGhhee
(2007) The C. elegans intestine, Worm Book -The Online Review of C. elegans Biology;
http://www.wormbook.org/chapters/www_intestine/intestine.html
Fig. 13.6: Mechanism of action of siRNA (small interfering RNA) defense against foreign DNA.
Illustration by G. Bergtrom
Fig. 13.7: Mechanism of action of miRNA (micro RNA) in degrading unwanted (e.g., old or damaged )
RNA. Illustration by G. Bergtrom
Fig. 13.8: Synthesis of piRNA (thick blue arrows) and two pathways for blocking transposition in D.
melanogaster testis (black arrows 1 and 2). Illustration by G. Bergtrom
Fig. 13.9: Review of the steps in translation initiation. Illustration by G. Bergtrom
Fig. 13.10: Regions and specific sequences known to be involved in regulating translation. Illustration
by G. Bergtrom
Fig. 13.11: Specific inhibition of ferritin polypeptide synthesis by iron regulatory proteins. Illustration by
G. Bergtrom
Fig. 13.12: Regulation of globin mRNA Translation initiation by hemin, a heme precursor. Illustration by
G. Bergtrom
Fig. 13.13: Role of GCN2 kinase in regulating translation by phosphorylating initiation factor eIF2B,
preventing formation of an initiation complex. Illustration by G. Bergtrom
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Fig. 13.14: Multiple short open reading frames (uORFs) found in the 5’ untranslated region (5’UTR) of
GCN4 mRNA play a role in regulating its translation. Illustration by G. Bergtrom
Fig. 13.15: GCN4 translation is reduced when cellular amino acid levels are normal. Illustration by G.
Bergtrom
Fig. 13.16: GCN4 translation is highest when cellular amino acid levels are reduced (amino acid
starvation). GCN4 then regulates the expression of many genes, including those encoding enzymes
needed for amino acid synthesis. Illustration by G. Bergtrom
Fig. 13.17: Mechanism of ubiquitin and proteasome action in the removal/destruction of old and
damaged proteins in cells, and the recycling of their amino acids. Illustration by G. Bergtrom

Chapter 14
Chapter Top-Art: Public Domain
Fig. 14.1: Renaturation kinetics protocol: Double-stranded (ds)DNA is mechanically sheared to ~10Kb
fragments, heated to denature the DNA, then cooled to let single strands find their complements and
renature. Illustration by G. Bergtrom
Fig. 14.2: Plot of rat dsDNA formed over time during renaturation of denatured DNA. Illustration by G.
Bergtrom
Fig. 14.3: The 3 ‘phases’ of the curve in Fig. 14.2 highlighted to identify the 3 fractions of repeated and
almost unique DNA sequences in the rat genome. Illustration by G. Bergtrom
Fig. 14.4: Plot of E. coli dsDNA formed over time during renaturation of denatured DNA. Illustration by
G. Bergtrom
Fig. 14.5: DNA complexity revealed by plotting rat and E. coli DNA renaturation kinetics as the percent
of re-associated dsDNA over CoT (Concentration of re-associated dsDNA X Time). Illustration by G.
Bergtrom
Fig. 14.6: Experimental demonstration of satellite DNA in low CoT renaturation kinetic fractions.
Illustration by G. Bergtrom
Fig. 14.7: Life-style of maize.
• Left, CC-BY-SA 3.0: From https://commons.wikimedia.org/wiki/File:Corntassel_7095.jpg ; By Spedona
(en:Image:Corntassel 7095.jpg) via Wikimedia Commons
• Middle, CC-BY-SA 3.0; From: https://commons.wikimedia.org/wiki/File:Cornsilk_7091.jpg ; By The
original uploader was Pollinator at English Wikipedia [GFDL (http://www.gnu.org/copyleft/fdl.html]
via Wikimedia Commons
• Right, CC-BY 3.0; From: Kiesselbach, T. A.
https://commons.wikimedia.org/wiki/File:Double_Fertilization.jpg ,By The original uploader at English
Wikipedia (Transferred from en.wikipedia to Commons, via Wikimedia Commons
Fig. 14.8: Mosaic corn cobs. GNU Free Documentation License, V. 1.2
https://en.wikipedia.org/wiki/Maize
Fig. 14.9: Experimental cross of females with CCbzbz triploid genotype with males having a
C’C’BzBzDsDs genotype with progeny genotypes and phenotypes based on Mendelian assumptions.
Illustration by G. Bergtrom
Fig. 14.10: Triploid genotypes expected the cross in Fig. 14.9. Illustration by G. Bergtrom
Fig. 14.11: McClintock’s interpretation of the results of the triploid cross shown in Fig. 14.9. Illustration
by G. Bergtrom
Fig. 14.12: Structure of a bacterial IS element. Illustration by G. Bergtrom
Fig. 14.13: Structure of a bacterial Tn element. Illustration by G. Bergtrom
Fig. 14.14: Structure of a complex transposon (Mu phage). Illustration by G. Bergtrom
Fig. 14.15: Life cycle options for bacteriophage. Illustration by G. Bergtrom
Fig. 14.16: The transposon option for Mu Phage. Illustration by G. Bergtrom
Fig. 14.17: Structure of a eukaryotic Class II DNA transposon. Illustration by G. Bergtrom
Fig. 14.18: Cut-&-paste transposition of a DNA transposon. Illustration by G. Bergtrom
Fig. 14.19: Replicative transposition of a DNA transposon. Illustration by G. Bergtrom
Fig. 14.20: Structure of yeast Ty, an RNA LTR retrotransposon. Illustration by G. Bergtrom
Fig. 14.21: Structure of a LINE, a non-LTR retrotransposon. Illustration by G. Bergtrom
Fig. 14.22: Structure of the Alu SINE, a non-LTR retrotransposon or retroposon. Illustration by G.
Bergtrom
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Fig. 14.23: Extrachromosomally-primed transposition of a LINE. Illustration by G. Bergtrom
Fig. 14.24: Target-primed transposition of a LINE. Illustration by G. Bergtrom
Fig. 14.25: Alignment of consensus amino acid sequences of bacterial IS transposases with Mu phage
and Tc1 mariner transposases reveals conservation of D, D and E amino acids (upper case) at key
positions in the sequence. Other amino acids are shared between some but not all of the sequences
(lower case). Slashes are variable gaps in the alignments. Adapted from
https://www.researchgate.net/publication/11063189_Presence_of_a_Characteristic_D-DE_Motif_in_IS1_Transposase
Fig. 14.26: Comparison amino acid sequences of the COPIA retrotransposon and a retroviral (HIV)
integrase with typical transposase sequences. The alignments reveal conservation of the D, D and E
amino acids in the DDE domain of the enzymes. Other amino acids are shared between some but not all
of the sequences (lower case). Slashes are variable gaps in the alignments. Adapted from
https://www.researchgate.net/publication/11063189_Presence_of_a_Characteristic_D-DE_Motif_in_IS1_Transposase
Fig. 14.27: Retroviral and retrotransposon reverse transcriptases share a common evolutionary ancestor.
Tree drawn by G. Bergtrom, based on data from Nakamura et al. 1997 and Eickbush 1994
Fig. 14.28: Steps of paired DNA transposon-mediated exon shuffling. Illustration by G. Bergtrom

Chapter 15
Chapter Top-Art: Public Domain NASA .gov image;
https://www.nasa.gov/sites/default/files/thumbnails/image/hand.jpg
Fig. 15.1: Retroviral infection requires reverse transcriptase to make a copy (cDNA) the viral genome,
which will then replicate and reproduce new viruses. Illustration by G. Bergtrom
Fig. 15.2: Most eukaryotic mRNAs have poly(A) tails; Poly(A) RNA is isolable by oligo d(T)
chromatography. Illustration by G. Bergtrom
Fig. 15.3: Reverse transcriptase supplied with deoxynucleotides, mRNAs and an oligo d(T) primer will
catalyze synthesis of DNA copies (cDNAs) of the mRNAs. Illustration by G. Bergtrom
Fig. 15.4: The first cDNA strand often forms a loop at its 3’ end that can serve as a primer to synthesize a
(ds)cDNA. Reverse transcriptase is also a DNA polymerase and can catalyze 2nd strand synthesis.
Illustration by G. Bergtrom
Fig. 15.5: Bacterial restriction endonucleases (REs) recognize and hydrolyze ‘foreign’ DNA (e.g., phage
DNA), blocking infection; most REs cut DNA at specific short DNA sequences; often leaving staggered
ends. Illustration by G. Bergtrom
Fig. 15.6: Preparing cDNAs for insertion into plasmid vectors prior to cloning cDNAs sequences.
Illustration by G. Bergtrom
Fig. 15.7: Making recombinant plasmids containing cDNA inserts. Illustration by G. Bergtrom
Fig. 15.8: Making the cDNA library. Illustration by G. Bergtrom
Fig. 15.9: Only cells containing plasmids will grow on agar containing ampicillin since the plasmids
contain an ampicillin resistance gene. Illustration by G. Bergtrom
Fig. 15.10: Replica plating creates a filter replica of colonies from one agar plate to be grown on another
plate, e.g., containing ‘selective’ media containing for example an antibiotic that screens for recombinant
plasmids. Illustration by G. Bergtrom
Fig. 15.11: Replica filters are lysed in situ (in place), leaving partially denatured DNA (including
recombinant plasmid DNA) from the colonies where the cells used to be. Filters can be probed for a
sequence of interest. Illustration by G. Bergtrom
Fig. 15.12: A denatured, sequence-specific probe can be used to probe lysed replica filters for a sequence
of interest, here detected as a radioactive colony (see Fig. 15.12 and text for details). Illustration by G.
Bergtrom
Fig. 15.13:. X-ray exposure of a replica filter incubated earlier with radioactive probe. The developed
autoradiograph shows a dark spot where probe hybridized to colony DNA. Illustration by G. Bergtrom
Fig. 15.14: Chemical structure of a di-deoxynucleotide. Illustration by G. Bergtrom
Fig. 15.15: The four tubes in a manual DNA sequencing protocol contain the same ingredients, except
that each contains a different di-deoxynucleotide. Illustration by G. Bergtrom
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Fig. 15.16: Cartoon of results of the four different manual sequencing reactions. The dideoxy-terminated
DNA fragments are electrophoresed to read the sequence of a DNA (see Fig 15.16). Illustration by G.
Bergtrom
Fig. 15.17: Drawing of a manual dideoxy sequencing autoradiograph with a readable sequence.
Illustration by G. Bergtrom
Fig. 15.18:. Automated DNA sequence chromatograph readout. CC BY 3.0; Adapted from Intechopen
book (Book chapters are distributed under the Creative Commons Attribution 3.0)
https://www.intechopen.com/books/nucleic-acids-from-basic-aspects-to-laboratory-tools/nucleic-acidisolation-and-downstream-applications
Fig. 15.19: Overview of shotgun sequencing of DNA. CC-0 (Public domain, By İnfoCan, from Wikimedia
Commons); https://commons.wikimedia.org/wiki/File:DNA_Sequencing_gDNA_libraries_tr.jpg
Fig. 15.20: Basics of Nanopore DNA Sequencing, one of several ‘next gen’ sequencing technologies.
Illustration by G. Bergtrom
Fig. 15.21: Overview of Southern blotting, a technique that transfers electrophoresed DNA to a filter for
hybridization with a probe. Illustration by G. Bergtrom
Fig. 15.22: Genomic DNA restriction enzyme digest is mixed with phage vector with compatible ‘sticky’
ends and ligated to make recombinant DNAs. Illustration by G. Bergtrom
Fig. 15.23: Mixing recombinant phage DNA with phage coat proteins creates infectious recombinant
phage particles. Illustration by G. Bergtrom
Fig. 15.24: Recombinant phage infection, the replication of phage DNA and production of new phage
leads to host cell lysis, allowing the collection of new recombinant phage. Illustration by G. Bergtrom
Fig. 15.25: Phage plaques formed on a bacterial lawn; each plaque is a genomic clone. Illustration by G.
Bergtrom
Fig. 15.26: Replica filters of plaques probed with a sequence of interest (in this case a globin DNA
sequence) locates autoradiographic spots where probe hybridized to recombinant phage. Illustration by
G. Bergtrom
Fig. 15.27: Progress of a PCR reaction: at the end of the second PCR cycle, the strands of DNA that will
be geometrically amplified in succeeding PCR cycles have been synthesized. Illustration by G. Bergtrom
Fig. 15.28: Agarose gel electrophoresis of PCR amplified DNAs, stained with ethidium bromide to be
detectable under fluorescent light: PCR products of the amplification of a globin gene clone from the
insect Chironomus thummi. The sizes (lengths in base pairs) of the 4 PCR products in lanes 2-5 are close
to those of the bands in the standard DNA size ladder in lane 1. Adapted from Kao et al. (1994), J. Mol.
Evol. 38: 241-249. Research by G. Bergtrom
Fig. 15.29: Electrophoretic DNA fingerprint. Public domain; By James Tourtellotte, photo editor of CBP
Today[1],
http://www.cbp.gov/xp/cgov/newsroom/multimedia/photo_gallery/afc/laboratories/13_5flab_5fhiresa.xml
(file Cbp13_5flab_5fhires.jpg, part of America's Frontline Photography / CBP Laboratories Photography),
https://commons.wikimedia.org/w/index.php?curid=2875876
Fig. 15.30: Simulated glass slide microarray showing multiple color fluorescent spots, indicating a hunt
for more than one DNA sequence at the same time. Illustration by G. Bergtrom

Chapter 16
Chapter Top-Art: Public Domain; https://pixabay.com/photos/lion-mosaic-art-museum-berlin-510159/
Fig. 16.1: Structural and Space-filling models showing components of a phospholipid. CC-BY; Adapted
from OpenStax Biology 2nd Edition, licensed under a Creative Commons Attribution 4.0 International
License,
Fig. 16.2: Examples of common membrane phospholipids. Public Domain CC-0 1.0: Adapted from
https://commons.wikimedia.org/w/index.php?curid=63827468
Fig. 16.3: Phospholipid bilayer membrane. Public Domain; Adapted from Mariana Ruiz Villarreal,
LadyofHats - Own work, https://commons.wikimedia.org/w/index.php?curid=3032610
Fig. 16.4: Low and high magnification Transmission electron micrographs of trilamellar membrane
structure. Public domain; Adapted from: http://en.wikipedia.org/wiki/History_of_cell_membrane_theory
By Sandraamurray
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Fig. 16.5: Model of the eukaryotic plasma membrane demonstrating asymmetry, with a sugarless
cytoplasmic surface and a glycoprotein rich extracellular surface. Public domain, from:
https://commons.wikimedia.org/wiki/File:Cell_membrane_detailed_diagram_en.svg or
https://upload.wikimedia.org/wikipedia/commons/thumb/d/da/Cell_membrane_detailed_diagram_en.svg/
877px-Cell_membrane_detailed_diagram_en.svg.png By LadyofHats.
Fig. 16.6: Illustration of a scanning electron micrograph of freeze-fractured plasma membrane with pits
and mounds showing on opposing phospholipid layers of the membrane. Illustration by G. Bergtrom
Fig. 16.7: Fluorescent antibodies against human and mouse membrane proteins localize their cell
surface antigens (i.e., proteins) on opposite poles of recently fused cells. Illustration by G. Bergtrom
Fig. 16.8: Immunofluorescent human (green) and mouse (red) membrane proteins diffuse and mix over
time in fused cells. Illustration by G. Bergtrom
Fig. 16.9: Factors affecting membrane fluidity (i.e. rate of diffusion of membrane components).
Illustration by G. Bergtrom
Fig. 16.10: Illustration of a micelle. Public domain; Adapted from:
https://upload.wikimedia.org/wikipedia/commons/c/c6/Phospholipids_aqueous_solution_structures.svg
Fig. 16.11: A liposome is a synthetic lipid bilayer that can be formed from micelles. Public domain;
Adapted from:
https://upload.wikimedia.org/wikipedia/commons/c/c6/Phospholipids_aqueous_solution_structures.svg
Fig. 16.12: Properties of plasma membranes may differ in ways determined by cell-to-cell associations
during tissue development. The lavender (short arrows), green (arrow heads), and purple (long arrows)
regions indicate basal differentiation of a sheet of epithelial cells. Illustration by G. Bergtrom
Fig. 16.13: Integral membrane proteins may penetrate or span the membrane; Also shown are peripheral
proteins and lipoproteins. Illustration by G. Bergtrom
Fig. 16.14: Integral transmembrane proteins cross the membrane one or more times. Illustration by G.
Bergtrom
Fig. 16.15: Hydrophobic amino acids of glycophorin form a helix that spans the red blood cell plasma
membrane. Illustration by G. Bergtrom
Fig. 16.16: Hydropathy plot s correlate the degree of amino acid hydrophobicity with its position in a
polypeptide. Long regions of hydrophobic amino acids suggest a possible membrane protein domain
Illustration by G. Bergtrom
Fig. 16.17: Examples of the many functions of membrane proteins. Illustration by G. Bergtrom
Fig. 16.18: The glycocalyx is the sugar- rich region on the extracellular surface of cells, the result of
covalently bound sugars on glycoproteins and glycolipids. It is the basis of many cell functions and is
associated with other macromolecules to form an extracellular matrix. CC-BY; Adapted from:
http://cnx.org/The Glycocalyx with Illustration by G. Bergtrom
Fig. 16.19: The extracellular matrix (ECM) forms when proteins (e.g., fibronectin, collagen) and other
macromolecules (e.g., proteoglycans) associate non-covalently with membrane proteins and elements of
the glycocalyx. CC-BY; From: http://cnx.org/Extracellular Matrix
Fig. 16.20: Blood groups with membrane proteins and elements of the glycocalyx. Public domain;
Adapted from InvictaHOG - Own work, Public Domain,
https://commons.wikimedia.org/w/index.php?curid=1088507

Chapter 17
Chapter Top-Art: Illustration by G. Bergtrom and Public Domain: https://pixabay.com/illustrations/trafficlights-traffic-light-phases-2147790/
Fig. 17.1: Graph plotting rates of passive and facilitated transport show that facilitated diffusion is a
saturable process. Illustration by G. Bergtrom
Fig. 17.2: Three kinds of facilitated diffusion. Illustration by G. Bergtrom
Fig. 17.3: Facilitated transport proteins (e.g., glucose transporter) undergo sequential allosteric changes
as they recognize a solute (e.g., glucose) and then transfer and release it on the other side of the
membrane. Illustration by G. Bergtrom
Fig. 17.4: Effects of differences in solute concentrations inside and outside animal cells on the
movement of water into or out of the cells, i.e., Osmosis. Illustration by G. Bergtrom
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Fig. 17.5: Osmotic effects of differences in solute concentrations inside and outside plant cells on the
movement of water into or out of the cells, i.e., Osmosis. Correct cytoplasmic solute concentrations are
achieved by accumulating excess water in the tonoplast. Illustration by G. Bergtrom
Fig. 17.6: Plasmodesmata are cell wall ‘tunnels’ connecting plat cells that allow direct movement of
water between cells to transmit and balance changes in osmotic pressure in one part of a plant (e.g.,
roots) throughout the plant. Illustration by G. Bergtrom
Fig. 17.7: Light micrograph of Paramecium highlighting a contractile vacuole, an organelle that pumps
out excess water from the cell, protecting it from osmotic shock. CC-BY-SA 3.0; From:
http://commons.wikimedia.org/wiki/File:Paramecium_caudatum_Ehrenberg,_1833.jpg
Fig. 17.8: The resting potential of a cell results from an ionic concentration imbalance across the plasma
membrane. Sodium and chloride ions concentrations are higher inside cells while potassium ions are at
higher levels outside the cell. Thus, the cytoplasm is slightly negative compared to the extracellular
fluid. Illustration by G. Bergtrom
Fig. 17.9: After a change in the resting potential (e.g., depolarization) of a cell, the ion balance across
the cell membrane is restored by an ATP-powered sodium/potassium pump. Illustration by G. Bergtrom
Fig. 17.10: A patch-clamp device can measure ion flow through voltage-gated channels in a membrane
during a depolarization event. Illustration by G. Bergtrom
Fig. 17.11: Voltage changes across e.g., a muscle cell membrane during an action potential correlated
with the flow of specific ions, determined with the patch-clamp device. Illustration by G. Bergtrom
Fig. 17.12: Neurotransmission starts with an action potential in the cell body of a neuron. The resulting
action potential is propagated down the axon to the nerve terminal synapse. The depolarization pulse
initiates Ca++ flow into the neuron through voltage-gated channels that eventually cause
neurotransmitter release into the synaptic cleft between the neuron and the responding cell. The
neurotransmitter binds to a ligand gated channel on the responding cell, causing Na+ ions to flow into
the responding cell, leading to an action potential. Illustration by G. Bergtrom
Fig. 17.13: Illustration of three main kinds of endocytosis, routes/mechanisms of import of extracellular
materials into cells. Illustration by G. Bergtrom
Fig. 17.14: Illustration of the stages of receptor-mediated endocytosis.. Drawn by G. Bergtrom based on
http://www.zoology.ubc.ca/~berger/b200sample/unit_8_protein_processing/images_unit8/14_18.jpg
Fig. 17.15: Molecular details of receptor-mediated endocytosis. Illustration by G. Bergtrom
Fig. 17.16: A low-density lipoprotein coated with cholesterol. Adapted from
http://cdn.intechopen.com/pdfs-wm/39539.pdf by G. Bergtrom
Fig. 17.17: Rough endoplasmic reticulum (RER), Golgi and other vesicles participate in the trafficking of
proteins destined for secretion or vesicular packaging/storage in the cell. Illustration by G. Bergtrom
Fig. 17.18: Determining the role of RER in the synthesis of secretory and other packaged protein
synthesis. Illustration by G. Bergtrom
Fig. 17.19: Molecular details (steps) of the Signal Hypothesis. Illustration by G. Bergtrom
Fig. 17.20: Integral membrane-spanning proteins have one or more very hydrophobic stop transfer
signals in addition to their signal sequence. Such membrane proteins cross the membranes one or more
times during their synthesis. Illustration by G. Bergtrom
Fig. 17.21: Sorting and directing the traffic of secreted, vesicular and other proteins in cells. Illustration
by G. Bergtrom
Fig. 17.22: Nuclear proteins made in the cytoplasm contain a positively charged nuclear localization
signal. This signal binds to the electronegative region of a nuclear transport receptor that then binds
nuclear pore fibrils, guiding the protein into the nucleus. Illustration by G. Bergtrom
Fig. 17.23: Nuclear proteins destined for mitochondria are synthesized with an N-terminal mitochondrial
signal sequence that is removed by a mitochondrial signal peptidase. Since polysomes do not attach to
mitochondria, a different mechanism engages the N-terminal signal with membrane proteins required for
transfer. Illustration by G. Bergtrom
Fig. 17.24: Tight, Gap and Adherens junctions between animal cells involve different membrane proteins.
Public domain (all drawings); Top left, https://commons.wikimedia.org/wiki/File:Cellular_tight_junctionen.svg; Middle, https://commons.wikimedia.org/wiki/File:Gap_cell_junction-en.svg; Top right,
https://en.wikipedia.org/wiki/Adherens_junction;
• CC BY-SA 2.5 Lower left micrograph adapted from Eric Yale Hayden,
https://commons.wikimedia.org/w/index.php?curid=6223080;
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• Public domain; Middle
https://en.wikipedia.org/wiki/Gap_junction#/media/File:Annular_Gap_Junction_Vesicle.jpg,
• CC-BY-SA; http://www.cellimagelibrary.org/images/7620 (M. Farquhar & G. E. Palade (1963) J. Cell
Biol. 17:375-412.)
Fig. 17.25: Glycocalyx protein interactions; roles in cell-cell recognition and attachment. Illustration by
G. Bergtrom
Fig. 17.26: LEFT, Transmission electron micrograph of a Melanoma cell exosomes (bar, 100nm). Some
of the larger vesicles show an irregular, cup-like shape (arrows). RIGHT: Transmission electron
micrograph of a reticulocyte endosome containing exosomes about to fuse with the plasma membrane
(bar, 200 nm.
• CC-BY-NC-SA 3.0 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575529/
• CC-BY-NC-SA 3.0 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575527/
Fig. 17.27: Migration and attachment of cells during development requires the synthesis of membrane
proteins that will recognize and bind proteins on the membranes and glycocalyx of other cells, forming
cell junctions and enabling tissue formation. At the same time, the specificity of these membrane proteins
prevents incorrect cell-cell associations. Integrin is an early cell membrane protein ‘receptor’ that
interacts with many proteins to form a glycocalyx and then respond to cell-surface proteins of other cells.
Illustration by G. Bergtrom
Fig. 17.28: Density-dependent inhibition (aka. Contact Inhibition) occurs when cells multiplying and
spreading on a surface cease dividing when there is no more room on the surface. Cancer cells have lost
the property of contact inhibition and keep growing over one another in layers. Loss of contact inhibition
is correlated with an absence of gap junctions in cancer cells. Illustration by G. Bergtrom
Fig. 17.29: Signal transduction by effectors (e.g., hormones) can lead to many different effects in the
cytoplasm as well as in nuclei. Illustration by G. Bergtrom
Fig. 17.30: G-proteins cycle between bound GTP and bound GDP. They are intermediates in signal
transduction between an active, effector-bound membrane receptor and adenylate cyclase (follow
detailed steps in the text). Illustration by G. Bergtrom
Fig. 17.31: The fight-or-flight response to adrenalin (adrenalin rush): cAMP activates protein kinase A; a
phosphorylation cascade leads to the release of glucose into the circulation. cAMP is a second messenger
of signal transduction for many different cellular responses. Illustration by G. Bergtrom
Fig. 17.32 G-proteins also mediate signal transduction through different membrane receptors and
different enzymes, as well as protein kinase C. These interactions generate different 2nd messenger
molecules that lead to a phosphorylation cascade and many different responses in different target cells
(follow detailed steps in the text). Illustration by G. Bergtrom
Fig. 17.33: The effects of MAP kinase include phosphorylation and activation of DNA-binding
transcription factors and other nuclear proteins that lead to cell proliferation. Illustration by G. Bergtrom

Chapter 18
Chapter Top-Art: Public Domain; https://pixabay.com/vectors/lifting-box-wood-heavy-crate24401/
Fig. 18.1: LEFT, drawing of metaphase spindle fibers RIGHT, fluorescence micrograph of a mitotic
spindle showing chromosomes (blue) and spindle fiber (green).
• LEFT, adapted from Kelvinsong; https://en.wikipedia.org/wiki/Metaphase; CCBY 3.0 Unported
License;
• RIGHT , Public Domain, from Afunguy-Transferred to Commons by Lije also using CommonsHelper;
https://commons.wikimedia.org/w/index.php?curid=5148470
Fig. 18.2: Illustration of assembly, structure and polarity of microtubules, microfilaments and
intermediate filaments alongside fluorescence micrographs made using fluorescent antibodies against
isolated microtubule, microfilament and intermediate filament proteins (TOP, MIDDLE and BOTTOM,
respectively).
• CC-BY 2.0; Adapted from: http://bmcbiochem.biomedcentral.com/articles/10.1186/1471-2091-9-23
Open Access
• CC-BY-SA-2.5 and GNU.org; Adapted from
https://en.wikipedia.org/wiki/Cytoskeleton#/media/File:MEF_microfilaments.jpg Y Tambe (Y Tambe's
file) via Wikimedia Commons
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• CC-BY; Adapted from: www.plosone.org/article/info:doi/10.1371/journal.pone.0012115
• Illustrations by G. Bergtrom
Fig. 18.3: Illustration and immunofluorescence microscopic localization of microtubules, microfilaments
and intermediate filaments in cells.
• Public domain; From: https://en.wikipedia.org/wiki/Fluorescence_microscope
• CC-BY-SA 3.0 From: http://en.wikipedia.org/wiki/Vimentin#mediaviewer/File:VIMENTIN.JPG By
Simon Caulton
Fig. 18.4. Transmission electron micrograph of the characteristic 9 triplet microtubule array of centrioles
and basal bodies. From: Chernov et el. (2008) BMC Biochemistry 2008; 9:23: Public Domain;
http://commons.wikimedia.org/wiki/File:Spindle_centriole; _embryonic_brain_mouse_-_TEM.jpg
Fig. 18.5: Starting mitotic anaphase, spindle fiber microtubules exert forces that separate and pull
chromatids apart and also push the poles of the cell apart. Illustration by G. Bergtrom
Fig. 18.6: Disrupting a kinetochore spindle fiber demonstrates a strong force from microtubule
disassembly that quickly pulls a pair of chromatids towards centrioles. Illustration by G. Bergtrom
Fig. 18.7: Transmission-electron micrographs of a basal body (left) and of cross sections of a pair of 9 + 2
microtubule arrays (right), each of which would emerge from a basal body (white line #1). The position of
the 9-triplet microtubule array of microtubules seen in Fig. 18.4 is indicated by white line #2.
• Public domain; From: http://en.wikipedia.org/wiki/File:Chlamydomonas_TEM_09.jpg as per:
http://remf.dartmouth.edu/imagesindex.html
• Public domain; From: http://en.wikipedia.org/wiki/File:Chlamydomonas_TEM_17.jpg as per:
http://remf.dartmouth.edu/imagesindex.html
Fig. 18.8: Transmission electron micrographs of axonemes show that microtubules are made up of a ring
of 13 tubulins (LEFT). Microtubules in cilia or flagella are arranged in typical 9+2 arrays (MIDDLE).
The enlarged cross-section illustrates specific microtubule-associated proteins (MAPs) that maintain
the 9+2 structure, including dynein motors that powers motility.
• CC-BY 4.0; Adapted from: http://bmcbiochem.biomedcentral.com/articles/10.1186/1471-2091-9-23
Public domain; From: http://en.wikipedia.org/wiki/File:Chlamydomonas_TEM_17.jpg as per:
http://remf.dartmouth.edu/imagesindex.html
• Illustration of axoneme components by G. Bergtrom
Fig. 18.9: Roles of dynein and kinesin in retrograde (backwards) and anterograde (forward) movement of
cargo vesicles along microtubules.
CC-BY; Adapted from J. E. Duncan & L. S. B. Goldstein (2006) The Genetics of Axonal Transport and
Axonal Transport Disorders, PLOS Cognitive Neuroscience Channel at
https://doi.org/10.1371/journal.pgen.0020124
Fig. 18.10: Removing the membrane from isolated cilia or flagella leaves behind the axoneme; when
provided ATP, both the isolated structures and demembranated axoneme will beat as the ATP
hydrolyzed. Illustration by G. Bergtrom
Fig. 18.11: Detergents can dissociate axonemes into individual and doublet microtubules. Dialysis of
separated microtubules to remove the detergent cause the microtubules to re-associate (reconstitute) into
a sheet with connections resembling those seen in intact axonemes.. Illustration by G. Bergtrom
Fig. 18.12: Comparison of ciliary beat with propeller like generation of flagellar wave motion.
CC-BY 3.0; Adapted From: http://en.wikipedia.org/wiki/File:Flagellum-beating.svg
Fig. 18.13: Light micrograph of skeletal muscle stained to showing characteristic striations. CC-BY:
From OpenStax: Anatomy and Physiology; https://openstax.org/books/anatomy-and-physiology/pages/101-overview-of-muscle-tissues
Fig. 18.14: Skeletal muscle organization and the anatomy of a muscle cell sarcomere.
• LEFT, CC-BY 4.0; From: https://commons.wikimedia.org/wiki/File:1007_Muscle_Fibes_(large).jpg By
OpenStax via Wikimedia Commons; [Inset: From : File:Skeletal muscle 横纹肌1.JPG - Wikimedia
Commons]
• RIGHT, CC-0 (Public Domain) From User:Sameerb (en:WP; Author User:Sameerb in English WP) , via
Wikimedia Commons http://upload.wikimedia.org/wikipedia/commons/a/a4/Sarcomere.gif
Fig. 18.15: Transmission electron micrograph and a corresponding illustration showing sarcomere
shortening, consistent with the sliding of filaments during skeletal muscle contraction.
• CC-BY-SA 4.0 (LEFT); From: https://www.mrgscience.com/topic-112-movement.html
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• GNU FDL (RIGHT); Adapted from
https://upload.wikimedia.org/wikipedia/commons/6/6e/Sarcomere.svg By Richfield, David (2014).
"Medical gallery of David Richfield". WikiJournal of Medicine 1 (2). DOI:10.15347/wjm/2014.009. ISSN
2002-4436 (GFDL licensure: http://www.gnu.org/copyleft/fdl.html),from Wikimedia Commons
Fig. 18.16: The skeletal muscle Contraction Paradox: Given ATP, glycerinated muscle fibers contract and
pull a weight. When all the ATP is hydrolyzed the fiber can’t stretch unless more ATP is added.
Illustration by G. Bergtrom
Fig. 18.17: Overview of the isolation of actin thin filaments (still on Z-Lines) from myosin thick filaments.
Illustration by G. Bergtrom
Fig. 18.18: Reconstitution of actin thin filaments (on Z-Lines) with myosin filaments. Illustration by G.
Bergtrom
Fig. 18.19: Structure of a skeletal muscle myosin filament and the myosin monomer. Shown is myosin
II, the thick filament that spans both sides of the H zone in a sarcomere (upper). The head-&-tail
structure of a myosin monomer is shown in the high magnification electron micrograph and is illustrated
in the cartoon (lower). The myosin monomer is itself a polymer of four polypeptides.
• CC-BY 4.0; Adapted from
http://plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.0020356 By D. Hostetter et al.
(2004) PLoS Biology
• CC-BY 4.0; Adapted from: Adapted from
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0093272 By H. Sugi et al. (2014) PLOS
One; PLoS ONE 9(6): e93272; doi:10.1371/journal.pone.0093272
• Illustrations by G. Bergtrom
Fig. 18.20: Digestion of purified myosin monomers with enzymes that hydrolyze peptide bonds between
specific amino acids produces an S1 head and a tail fraction with different properties.
• CC-BY 4.0; Adapted from http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0093272 , By
H. Sugi et al. (2014) PLOS One; PLoS ONE 9(6): e93272; doi:10.1371/journal.pone.0093272
• Illustrations by G. Bergtrom
Fig. 18.21: Illustration of myosin decoration by myosin monomer S1 fragments, showing opposing
polarity of actin filaments on opposite sides of the Z-line. Illustration by G. Bergtrom
Fig. 18.22: Steps in the Microcontraction Cycle explain the muscle contraction paradox. Illustration by G.
Bergtrom
Fig. 18.23: The ability of flexible myosin heads to bend and change conformation is consistent with their
proposed activity during the microcontraction cycle. CC-BY 4.0; Adapted from
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0093272 By H. Sugi et al. (2014) PLoS
ONE 9(6): e93272; doi:10.1371/journal.pone.0093272
Fig. 18.24: Innervation leads to Ca++ release from sarcoplasmic reticulum to regulate contraction.
• CC-BY 4.0; From S. Guarnieri et al. (2013) https://doi.org/10.1371/journal.pone.0053267 and
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0053267#pone-0053267-g006
• CC-BY 4.0; https://opentextbc.ca/anatomyandphysiology/chapter/10-2-skeletal-muscle/
• Overlay text and illustration by G. Bergtrom
Fig. 18.25: Skeletal muscle thin filaments consist of actin associated with troponins and tropomyosin.
These actin-associated proteins participate in the response to Ca++ ions to regulate interactions with
myosin.
Public domain; Adapted from:
https://upload.wikimedia.org/wikipedia/commons/thumb/a/a3/Myofilament.svg/994pxMyofilament.svg.png
Fig. 18.26: Ca++ ions initiate uncovering myosin binding sites on actin by binding to troponin-C,
resulting in allosteric changes in the troponins and ultimately tropomyosin. Illustration by G. Bergtrom
Fig. 18.27: Structure of titin and its location in the sarcomere.
• CC-BY 4.0: Colorized micrograph of titin adapted from Zsolt Mártonfalvi and Miklós Kellermayer
(2014): http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085847
• Illustration by G. Bergtrom
Fig. 18.28: Elasticity of skeletal muscle shown by the location of anti-N2A-linked and anti-120/122linked nanogold particles in sarcomeres. Note the increased separation of the PEVK domains targeted by
the antibodies as a muscle fiber is increasingly stretched. This titiin elasticity facilitates skeletal muscle
relaxation; Adapted from https://commons.wikimedia.org/w/index.php?curid=764619, By User:Sameerb
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(en:WP; Author User:Sameerb in English WP), Copyrighted free use; via Wikimedia Commons.
Adaptations included adding simulated nanogold particles and elongating parts of the sarcomere to
create an image replicating results of work from the laboratory of Wolfgang Linke.
Fig. 18.29: In the anti-actin immunofluorescence micrograph of fibroblasts, actin localizes with stress
fibers which help maintain cell shape (LEFT). Actin also localizes in lamellipodia and retraction fibers in
migrating fibroblasts (RIGHT), orienting in the direction of movement.
• Adapted from CC BY-SA 3.0 https://commons.wikimedia.org/w/index.php?curid=378394 By Y Tambe Y Tambe's file
• Illustration by G. Bergtrom
Fig. 18.30: The molecular structure of stress fibers; myosin as well as other actin-binding proteins
interact with actin in nonmuscle cell motility. Illustration by G. Bergtrom
Fig. 18.31: Coiled secondary structure of the proteins permits elasticity of intermediate filament bundles
that contribute to the viscosity of cytoplasm. Illustration by G. Bergtrom

Chapter 19
Chapter Top-Art: Public Domain: https://pixabay.com/photos/microscope-sea-urchin-egg-splitting1276131/
Fig. 19.1: Bacteria divide by binary fission. When growing in culture, they divide continually, partially
replicating their circular DNA molecules during one division in preparation for the next. Illustration by
G. Bergtrom
Fig. 19.2: Mitosis and cytokinesis in eukaryotic cells are separated in time, and mitosis is further
divisible into 5 phases. Illustration by G. Bergtrom
Fig. 19.3: First experiment demonstrating that replication and cell division in eukaryotes are separate
events.. Illustration by G. Bergtrom
Fig. 19.4: The autoradiographic data from the experiment outlined in Fig. 19.3 demonstrates that DNA
synthesis begins and ends some time before the beginning of mitosis. Illustration by G. Bergtrom
Fig. 19.5: These autoradiographs from a pulse-chase labeling experiment led to the identifying the
phases of the eukaryotic cell cycle (see text for explanation). Illustration by G. Bergtrom
Fig. 19.6: Graph plotting the number of radioactive cells in mitosis over time of chase in the pulse-chase
experiment described in Fig. 19.5 (see text for further explanation). Illustration by G. Bergtrom
Fig. 19.7: A typical eukaryotic cell cycle: phases G1, S and G2 follow cytokinesis, and G2 immediately
precedes prophase of mitosis. The length of time for each phase differs for different cell types.
Illustration by G. Bergtrom
Fig. 19.8: Terminally differentiated cells no longer divide, entering the Go state. While they can
sometimes resume cycling, such cells more typically experience cell death and replacement by stem cells.
Illustration by G. Bergtrom
Fig. 19.9: Experiment leading to the discovery of meiosis-promoting factor (MPF), the first known
chemical regulator of cell division. Illustration by G. Bergtrom
Fig. 19.10: MPF was shown to be a two-subunit protein kinase that transfers phosphates from ATP to
several different proteins. Illustration by G. Bergtrom
Fig. 19.11: Graph comparing plots of cellular cdk and cyclin levels over time with one of MPF activity.
Illustration by G. Bergtrom
Fig. 19.12: Cell fusion experiments revealed additional chemical regulators of the cell cycle activity.
Illustration by G. Bergtrom
Fig. 19.13: Simplified diagram of cell cycle checkpoints at which progress through the cycle is assessed.
If progress through a phase is incomplete, cell cycle regulators (kinases) delay onset of the next phase.
Illustration by G. Bergtrom
Fig. 19.14: Apoptotic Cells: In the 3 electron micrographs and corresponding illustrations, normal cells
(A & A’) are followed by apoptotic cells [B & B’] and [C & C’]. In [B & B’], a black arrowhead indicates
nuclear condensation (pyknosos), membrane blebbing (grey arrowheads) and apoptotic bodies (white
arrowhead). In [C & C’] the nucleus has broken down (karyorrhexis) and the cell itself cell has
fragmented into apoptotic bodies (white arrowheads). In C’, a phagocyte is engulfing one of them.
• Electron micrographs, CC-BY; Adapted from: V. Wilhelmi et al. (2013) Zinc Oxide Nanoparticles
Induce Necrosis and Apoptosis in Macrophages in a p47phox- and Nrf2-Independent Manner.
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0065704
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• Illustrations: Public Domain; File adapted from a German Wikipedia entry:
https://commons.wikimedia.org/wiki/File:Apoptosis.png or http://de.wikipedia.org/wiki/Bild:Apoptosegerman.png
Fig. 19.15: Biochemical steps of apoptosis, or programmed cell death. Illustration by G. Bergtrom
Fig. 19.16: Comparison of the cellular events of apoptosis and necrosis. Public Domain; Adapted from
National Institute on Alcohol Abuse and Alcoholism (NIAAA) via Wikimedia Commons;
https://commons.wikimedia.org/wiki/File:Structural_changes_of_cells_undergoing_necrosis_or_apoptosis.
png
Fig. 19.17: Results of non-cancer cell divisions in which abnormal cells are targeted for apoptosis, and
cancer cell division, in which damaged or altered cells escape apoptotic controls. Illustration by G.
Bergtrom
Fig. 19.18: Making knockout mutant mice. Specific nucleotides in a cloned gene of interest are altered
by site-directed mutagenesis. The altered gene is inserted into embryonic stem cells where it recombines
with and replaces the homologous gene already in the chromosome. Recombinant clones are selected reinjected into embryos that are then incubated in the uteri of ‘foster mother’ mice. Knockout mice in the
newborn litter can be selected and studied for the effects of removing a gene. Illustration by G. Bergtrom
Fig. 19.19: Structure of the P53 gene-regulatory protein bound to DNA. P53 was originally called a tumor
suppressor protein because when mutated, tumors arose. CC-BY-SA 3.0; From Thomas Splettstoesser, via
Wikimedia Commons
https://upload.wikimedia.org/wikipedia/commons/b/bb/P53.png
Fig. 19.20: Normal function of the P53 gene-regulatory protein. Illustration by G. Bergtrom
Fig. 19.21: Role of the P53 in decision-making at cell cycle checkpoints. Illustration by G. Bergtrom
Fig. 19.22: Summary of different roles of p53 protein in protein degradation and apoptosis, cell cycle
progress and DNA repair. Illustration by G. Bergtrom

Chapter 20
Chapter Top-Art: Public Domain photos; https://pixabay.com/illustrations/sperium-cum-sperm-darkwinner-326157/ and https://pixabay.com/photos/halloween-pumpkin-scary-giant-309296/
Fig. 20.1: Descent (evolution and speciation) from a single progenitor cell formed by sheer luck on a
prebiotic Earth.. Illustration by G. Bergtrom
Fig. 20.2: Descent (evolution and speciation) from multiple progenotes, or “first’ cells”. Illustration by G.
Bergtrom
Fig. 20.3: Evolutionary (i.e., phylogenetic) tree of all living organisms, showing descent from the Last
Universal Common Ancestor (LUCA) of the 3 domains of life (Bacteria, Archaea and Eukaryota).
Public Domain; Adapted from: https://en.wikipedia.org/wiki/Phylogenetic_tree
Fig. 20.4: Classic Miller & Urey experiment showing that organic molecules found in living things today
could be synthesized in a laboratory under reducing conditions similar to those expected for a prebiotic
earth atmosphere. Illustration by G. Bergtrom
Fig. 20.5: Scenario for the synthesis of prebiotic polymers in tidal pools. Illustration by G. Bergtrom
Fig. 20.6: Scenario for the synthesis of redundant prebiotic nucleic acid polymers in tidal pools.
Illustration by G. Bergtrom
Fig. 20.7: Analysis of this Australian zircon supports an oxidizing atmosphere on a prebiotic earth.
Valley, J. W. et al. (2014) Hadean age for a post-magma-ocean zircon confirmed by atom-probe
tomography, Nature Geoscience vol. 7, p 219-223; http://dx.doi.org/10.1038/ngeo2075; Used by
permission of J. W. Valley, University of Wisconsin - Madison;
http://geoscience.wisc.edu/geoscience/people/faculty/ john-valley/john-valley-incle-on-zircons/
Fig. 20.8: An oceanic volcanic hydrothermal vent, or black smoker. Public domain:
https://commons.wikimedia.org/w/index.php?curid=262511
Fig. 20.9: An oceanic volcanic hydrothermal vent, or White smoker. Public domain:
http://oceanexplorer.noaa.gov/explorations/04fire/logs/hirez/champagne_vent_hirez.jpg
Fig. 20.10: Serpentinite from Deer Lake in upper Michigan. It is a mineral also found in the oceanic
crust that under conditions found in an alkaline vent, can form methane from CO2. From: Gabriel HM,
Own work, CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=48672474
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Fig. 20.11: Evolutionary (i.e., phylogenetic) tree of all living organisms reveals 3 domains of life: Bacteria
(Prokarya), Archaebacteria (archaea) and Eukaryotes (Eukaryota). Public Domain; Adapted from:
https://en.wikipedia.org/wiki/Phylogenetic_tree
Fig. 20.12: Aminoadenosine triacid ester (AATE) catalyzes its own replication by the mechanism
suggested here. Illustration by G. Bergtrom
Fig. 20.13: The deamination of adenine in a ribonucleotide chain to inosine in a tRNA by the adenine
deaminase enzyme. Public domain; adapted from
https://commons.wikimedia.org/wiki/File:Adenosinmonophosphate
Fig. 20.14: Proteinoid microspheres, coacervates and liposomes can all be made in a laboratory and are
candidates for boundary structures that could have protected early prebiotic organic molecules and
reactions.
•
Liposome image adapted from: https://upload.wikimedia.org/wikipedia/commons/c/c6/MicellesLiposomes;
•
Proteinoid microsphere image adapted from CC-0 (public domain;
http://ejournal8.com/journals_n/1450718865.pdf; I. Ignatov and O. Mosin , 2015. S. Miller’s
Experiments in Modelling of Non-Equilibrium Conditions with Gas Electric Discharge Simulating
Primary Atmosphere. European Journal of Molecular Biotechnology 10, 197-209
•
Coacervate image adapted from
https://commons.wikimedia.org/Coacervates/index.php?curid=92728896; By Spruijtlab - Own work,
CC BY-SA 4.0,
•
Illustration by G. Bergtrom
Fig. 20.15: Genetic information flows from DNA to RNA to protein (the Central Dogma) but can also flow
from RNA to DNA by reverse transcription. Illustration by G. Bergtrom
Fig. 20.16: RNA Sequences contain genetic information, and in retroviruses, they are molecules of
inheritance. As single stranded molecules, RNAs can fold into 3-dimensional shapes, creating specific
shapes that can act as catalysts (e.g., ribozymes). Thus RNAs can combine information storage with
catalytic activities. Illustration by G. Bergtrom
Fig. 20.17: Hypothetical origin of RNA catalysis, suggesting how some early (prebiotic) RNAs may have
evolved to catalyze peptide bond formation between amino acids. Illustrated by G. Bergtrom
Fig. 20.18: Suggested steps in evolution from an RNA world to our DNA world. The first of these steps
would be to divorce the self-replication activity of RNAs from their information storage function, as
illustrated here. Illustration by G. Bergtrom
Fig. 20.19: If RNAs could bind peptides whose synthesis they catalyze, evolution could have selected
ribozymes from some RNA-peptide complexes that did not separate. Later, the peptides themselves
could have evolved to take over catalytic functions from ribozymes. Illustration by G. Bergtrom
Fig. 20.20: A final evolutionary scenario gets us from the RNA world to a DNA world that governs most
life on earth today. Illustration by G. Bergtrom
Fig. 20.21: One selective pressure that contributes to the complexity of biochemical pathways would be
the depletion of a particular chemical resource, say molecule D, in the environment). The few cells in the
population that happen to have an enzyme that can convert C to D will survive and proliferate.
Illustration by G. Bergtrom
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Appendix II: Context-Embedded YouTube Videos

The following links are inactive in the print version of this book (CMB5p). Please use QR
codes in this book or download the digital Annotated CMB5e at
https://dc.uwm.edu/biosci_facbooks_bergtrom/
to access to the links.

Chapter 1: Cell Tour, Life’s Properties and Evolution, Studying
Cells
100-2 The RER-Rough Endoplasmic Reticulum
101 Ribosomes and Polysomes
102 Golgi Vesicles and the Endomembrane System
103-2 Smooth Endoplasmic Reticulum
104-2 The Nucleus
105-2 Endosymbiosis-Mitochondria & Chloroplasts
106-2 Filaments & Tubules of the Cytoskeleton
107-2 Dissecting the Cell-a Cell Fractionation Scheme
108-2 Isolated Nuclei
109-2 Isolated RER
110-2 Isolated Golgi Vesicles
111-2 Lysosomes & Peroxisomes
112-2 Isolated Mitochondria
113-2 Isolated Chloroplasts
114-2 Isolated Membranes Form Vesicles
115 Properties of Life
116 The Universal Genetic Code
117 Origins of Life
118 Life Origins vs Evolution
119 The Random Basis of Evolution
120-2 Genomic Fossils-Molecular Evolution
121-2 Electron Microscopy

Chapter 2: Basic Chemistry, Organic Chemistry and Biochemistry
122-2 Atoms and Elementshttps://youtu.be/_-mLaDeYV6E
123 Electron Energy and Fluorescence
124 Covalent Bonds
125-2 Water-Hydrogen & Ionic Bonds
126 Organic Molecules Monomers and Polymers
127-2 Carbohydrates-Sugars & Polysaccharides
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128-2 Lipids-Triglycerides-Phospholipids
129-2 Proteins-Amino Acids & Polypeptides
130-2 DNA & RNA-Nucleotides & Nucleic Acids
131-2 Shape & the Specificity of Molecular interactions

Chapter 3: Details of Protein Structure
132-2 Amino Acid Sequence & Protein Primary Structure
133-2 Protein Secondary Structure
134-2 Protein Tertiary structure
135-2 Disulfide Bridges Stabilize 3o Structure
136-2 Protein Quaternary Structure & Prosthetic Groups
137-2 Protein Domain Structure &Function

Chapter 4: Bioenergetics
138 Different Kinds of Energy; Chemical Equilibrium
139 First Law of Thermodynamics
140-2 Second Law of Thermodynamics
141 Deriving Closed System Thermodynamics
142 Determining DH and DG in Closed Systems
143 Determining DS in Closed System
144 The Energetics of Open Systems

Chapter 5: Enzyme Catalysis and Kinetics
145 Enzymes vs Other Catalysts
146-2 Induced Fit mechanism of Enzyme Action
147 Enzyme Activation Energy
148-2 Allosteric Regulation of Enzyme Activity
149 Measuring Enzyme Kinetics
150 Graphing Enzyme Kinetic Data

Chapter 6: Glycolysis, The Krebs Cycle and the Atkins Diet
151 Overview of Glycolysis
152-2 Glycolysis Stage 1, Reaction 1
153 Glycolysis Stage 1; Reactions 2-5
154 Glycolysis Stage 2; Reaction 6
155-2 Glycolysis Stage 2; Reactions 7-10
156 Fermentation: Regulation of Pyruvate Reduction is NOT Allosteric!
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157-2 Balance Sheet of Glycolysis
158-2 Gluconeogenesis & the Atkins Diet
159-2 Highlights of the Krebs Cycle
160 Discovery of the Krebs Cycle

Chapter 7: Electron Transport, Oxidative Phosphorylation and
Photosynthesis
161 Mitochondrial Electron Transport Oxidizes Reduced Electron Carriers
162-2 Finding the Free Energy of Electron Transport
163-2 Separating Electron Transport from Oxidative Phosphorylation
164-2 Proton Pumps Store Free Energy of the ETC in Proton Gradients
165-2 Proton Gates Capture Proton Gradient Free Energy as ATP
166 Balance Sheet of Respiration

Chapter 8: DNA Structure, Chromosomes and Chromatin
167-2 Transformation In & Out of Mice-Griffith, McCarty et al.
168 Hershey and Chase: Viral Genes are in Viral DNA
169-2 Unraveling the Structure of DNA
170 Replication is Semiconservative
171-2 DNA, Chromosomes, Karyotypes & Gene Maps
172-2 Nucleosomes-DNA and Protein
173-2 Chromatin Structure-Dissecting Chromatin
174-2 Histones and Non-Histone Proteins

Chapter 9: DNA Replication and Repair
175 Seeing E. coli Chromosomes
176 Semiconservative Bidirectional Replication From Two RFs
177 Multiple Replicons in Eukaryotes
178 DNA Polymerases and Their Activities
179 Replication Initiation in E coli
180-2 Okazaki Experiments-Solving a Problem at an RF
181 Okazaki Fragments are Made Beginning with RNA Primers
182 Replication Elongation in E coli
183 Telomerase Replicates Telomeres to Prevent Chromosome Shortening
184 Processive Replication
185-2 Topoisomerases Relieve Supercoiling During Replication
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Chapter 10: Transcription and RNA Processing
186 Transcription Overview: Ribosomes and Ribosomal RNAs
187 Transcription Overview: Demonstrating the Major RNAs
188-2 Transcription Overview- Basics of RNA Synthesis
189 RNA Polymerases in Prokaryotes and Eukaryotes
190 Post Transcriptional Processing Overview
191 Details of Prokaryotic Transcription
192-2 Eukaryotic mRNA Transcription
193 Recognition of Transcription factors at Promoters
194-2 The Discovery of Split Genes
195 mRNA Splicing
196-2 Origin of Introns
197 Intron Evolution: What was selected here?
198 mRNA 5' Capping and 3' Polyadenylation
199-2 rRNA Transcription & Processing
200-2 tRNA Transcription and Processing

Chapter 11: The Genetic Code and Translation
201 The Genetic Code Dictionary
202 Speculations About a Triplet Code
203 Deciphering the First Codon
204 Deciphering all 64 Triplet Codons
205-2 tRNA Structure and Base Modifications
206 Translation Initiation: mRNA Associates with 30S Ribosomal Subunit
207 Initiation Complex Formation
208 Adding the Large Ribosomal Subunit
209 Elongation: Elongation Factors and GTP
210 Elongation: A Ribozyme Catalyzes Peptide Linkage Formation
211 Elongation: Translocase Moves Ribosome Along mRNA
212 Adding the Third Amino Acid
213 Big Translation Energy Costs
214 The Fates of fMet and Met; Cases of Posttranslational Processing
215-2 Translation Termination

Chapter 12: Regulation of Transcription and Epigenetic
Inheritance
216 Overview of Prokaryotic Gene Regulation
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217 Regulation of the lac Operon
219 Repression of the Tryptophan (TRP) Operon
220 An Experiment: All of an Organism's Cells Have the Same Genome
221-2 Many Options for Regulating Eukaryotic Genes
222-2 Transcription Factors Bind DNA Near & Far
223-2 Assembling a Eukaryotic Transcription Initiation Complex
224-2 Transcription Factor Domains-Motifs Bind Specific DNA Sequences
225 Chemicals That Control Gene Expression
226 Steroid Hormones Regulate Gene Transcription
227 Signal Transduction Can Lead to Gene Regulation
228 Question: Is Euchromatic DNA Transcribed?
229 Experiment and Answer: Euchromatin is Transcribed
230 Epigenetic Inheritance: First Inkling
231-2 Experimental Demonstration of Germ-Line Epigenetic Inheritance

Chapter 13: Posttranscriptional Regulation of Gene Expression
232 Riboswitches Interrupt Bacterial Transcription
233 Small Metabolites Also Regulate Bacterial mRNA translation
234 siRNA Posttranscriptional Regulation
235 Did siRNA Coopt RISC from a Strategy to Trash Corrupt or worn out RNA?
236 miRNA Posttranscriptional Regulation
237 Translation Regulation of Globin Polypeptide Synthesis

Chapter 14: Repetitive DNA; A Eukaryotic Phenomenon
238 Discovery of Repetitive DNA
239 CoT Curves and DNA Complexity Explained!
240 Identifying Different Kinds of DNA Each CoT Fraction
241 Some Repetitive DNA Functions
242 What Interested McClintock About Maize
243 Variegated Maize Kernels result from “Loss” of the Ds Gene
244 Discovery of Mobile Elements and the Ac-Ds System
245 The Ac-Ds System Today
246 Bacterial Mobile Elements
247 Introduction to Eukaryotic Transposons
248 Eukaryotic Class II (DNA) Transposition
249 Introduction to Features of Retrotransposition
250 LTR Retrotransposons
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251 LINEs (Long Interspersed Nuclear Elements): LTR Retrotransposons
252 SINEs (Short Interspersed Nuclear Elements): Non-LTR Retrotransposons
253 Extrachromosomally Primed Retrotransposition
254 Target Primed Retrotransposition
255 Transposon Evolution
256 Transposons-Junk or Not

Chapter 15: DNA Technologies
257 Overview of DNA Technologies
258 Isolate mRNA and Make cDNA
259 Reverse Transcriptase
260 Restriction Enzymes and Recombinant DNA
261 Recombine a cDNA Insert with a Plasmid Vector
262 Making the cDNA Library
263 Making a Replica Plate
264 Probing a Replica Plate Filter
265 Probe Replica Filters, Get a Clone and Play With It!
266 Treating Cancer with Dideoxynucleosides
267 Manual Dideoxy Sequencing
268 Automated Sequencing Leads to Large Genome Projects
269 Genomic Libraries: Make and Package Recombinant Phage DNA
270 Infect Host with Recombinant Phage to Make a Genomic Library
271 Screen a Genomic Library, Pick and Grow a Phage Clone
272 PCR: Design and Synthesize Opposing Oligonucleotide Primers
273 PCR: The Amplification Reaction
274 The Power of PCR: Some Examples
275-2 The Power of Microarrays

Chapter 16: Membrane Structure
276-2 Membrane Lipids & Phospholipid Bilayer
277-2 Experiments with & Uses of Liposomes
278-2 Properties of Proteins Embedded in a Phospholipid Bilayer
279 Different Membrane Compositions
280-2 Freeze Fracture Electron Microscopy of Cell Membranes
281-2 EM Cytochemical Demonstration of Membrane Asymmetry
282-2 Electrophoretic Demonstration of Membrane Asymmetry
283 Two Demonstrations of Membrane Fluidity: The Fluid Mosaic
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284-2 Factors Influencing Membrane Fluidity
285-2 Membrane Domains-Regional Differentiation of a Plasma Membrane
286-2 Domains of Membrane Proteins
287-2 Hydropathy Predicts Hydrophobic Domains and Membrane Proteins
288-2 Diversity of Membrane Protein Structure & Function
289-2 Pore Proteins May Cross the Membrane Many Times
290-2 Red Blood Cell (Erythrocyte) Membrane Protein Functions
291 The Path to Sugar Coated Cells
292-2 The Extracellular Matrix

Chapter 17: Membrane Function
293-2 Passive & Facilitated Diffusion
294-2 Osmosis
295 Potassium Leakage Helps to Maintain Cellular Resting Potentials
296 Active Transport by the Sodium/Potassium Pump
297 A Patch-Clamp Device Can Record Membrane Potential and Ion Flow
298 Patch-Clamp Measurement of Membrane Resting Potential and
Depolarization
299 Gated Ion Channels
300-2 Types of Ion Gated Channels
301 Gated Ion Channels Open and Close in Sequence During an Action
Potential
302 Propagating an Action Potential Along an Axon
303-2 Gated Ion Channels Open & Close During an Action Potential
304 Formulating the Signal Hypothesis: Early Experiments
305 Testing the Signal Hypothesis
306-2 Details of the Signal Hypothesis
308-2 Integral Proteins Have Stop-Transfer Sequences
309 Protein Traffic to Nuclei and Mitochondria
310-2 Cell Junction Structure and Function
311-2 Glycocalyx-Sugars Covalently link to Plasma Membrane Proteins
312 Cell Adhesion Molecule Functions in the Glycocalyx
313 Formation of a Glycocalyx, Normal Development and Cancer
314 The Role of the Extracellular Matrix in Cell Migration and Development
315-2 Introduction to Signal Transduction
316-2 G-Protein Signal Transduction
317 G-Protein Activation of Protein Kinase A and the Fight-or-Flight Response
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318-2 G-Protein Activation of Protein Kinase C and Phospholipase C
319 Receptor Kinase Signal Transduction
320-2 The RAS Oncogene-its Normal Mitogenic Effects and Cancer

Chapter 18: The Cytoskeleton and Cell Motility
321-2 Introduction to the Cytoskeleton
322-2 Microtubules, Microfilaments and Intermediate Filaments in Cells
323-2 Demonstration of the Polarity & Dynamics of Microtubules
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